From e2fe74a2b8592634d4c560602caa6a52cb836086 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Fri, 20 Nov 2026 22:49:15 +0100 Subject: [PATCH 01/38] fix(chip): give the CHIP filter the contamination estimate FilterMutectCalls in step 49 ran without a contamination table, so another person's DNA in the sample, whose alleles sit at a low VAF, could pass as a small clone. With step 29's common-sites VCF installed, the step and the Nextflow CHIP_MUTECT2 now run GetPileupSummaries inside the CHIP exons and CalculateContamination, and pass --contamination-table and --tumor-segmentation to FilterMutectCalls. New optional parameter --chip_common_sites; run-all.sh passes it when the VCF and its .tbi are installed. Without the VCF the log says there is no estimate. Bead: trait-62 --- CHANGELOG.md | 1 + assets/output_contract.tsv | 1 + docs/49-chip.md | 8 +++++--- docs/parameters.md | 1 + main.nf | 5 ++++- modules/local/chip/main.nf | 22 ++++++++++++++++++++-- nextflow.config | 1 + nextflow_schema.json | 6 ++++++ scripts/49-chip.sh | 30 +++++++++++++++++++++++++----- scripts/run-all.sh | 4 ++-- 10 files changed, 66 insertions(+), 13 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index 893fff178..2329e95ed 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,6 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased +- Step 49 (CHIP) now gives FilterMutectCalls a contamination estimate. Before, it filtered Mutect2's calls without one, so another person's DNA in the sample, whose alleles sit at a low VAF, could pass as a small clone and read `chip`. When step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` is installed with its `.tbi`, `scripts/49-chip.sh` and the Nextflow `CHIP_MUTECT2` run GetPileupSummaries at its common sites inside the CHIP exons and CalculateContamination, and pass `--contamination-table` and `--tumor-segmentation` to FilterMutectCalls, as step 29 does. A call that contamination explains is then marked `contamination` by FilterMutectCalls and reads `filtered`. Without the VCF the log says there is no contamination estimate. A new optional parameter, `--chip_common_sites`, gives the VCF to the Nextflow pipeline, and `run-all.sh` passes it when the file is installed. The bash step also keeps `chip/_chip_contamination.table`. No column, option or file name changes. Part of #411 (trait-62). - The live site's family page and its pedigree drawing are now built by `og live family`, in Rust. `bin/owngenome_live_family.py` asks `og` for a family's state, its `family.json`, the list of files it serves and `pedigree.svg`, and no longer reads the family's tables itself; `bin/pedigree_svg.py` and `bin/family_report.py` are gone. The page shows the same thing: `family.json` and the drawing were compared with the old code on the demo family and the test families, field by field and number by number, and matched. The live site therefore needs `og` (`scripts/setup.sh --og` installs it); without it a family's `family.json` answers 500, its `pedigree.svg` answers 503, and the run list marks each family unreadable. A family file that cannot be read still gives no page and an unreadable family. - The local genome viewer runs on `og` and no longer needs `python3` on the host. `scripts/owngenome-view.sh` starts `og view serve` (through `bin/og`, or `OG`), which serves the same page, config and byte ranges on 127.0.0.1 as `assets/viewer/serve.py` did. Two requests it answered before are now refused. A locus whose end comes before its start (`chr1:13000-12000`) stops the script with exit 2 and the reason, instead of opening a view igv.js cannot show. A request with a `Forwarded`, `X-Forwarded-*` or `X-Real-IP` header gets 403: the viewer has no password, so a reverse proxy in front of it would hand the sample to anyone who reaches the proxy; an ssh port forward still works. The default SV track is now Manta's diploid SVs (step 4), else step 22's consensus, which keeps only the calls two callers agree on. `docs/viewer.md` says that every account on the machine can reach 127.0.0.1. No option of the script, file or output name changes; `og view serve` takes the flags `serve.py` took, plus `--assets`, the page's folder. The live site's viewer also opens Manta's diploid SVs first; the rest of it is unchanged until its server moves to `og`. Part of #411 (plat-11, plat-12). - Step 22's SV consensus no longer counts a record a caller did not call as a second caller. Before, every PASS record went to SURVIVOR, so a PASS Delly record genotyped `0/0`, a Delly call whose sample filter (`FT`) says `LowQual`, or a CNVpytor segment no quality rule had read sat beside a Manta-only call and made it read "2 callers". A new verb, `og sv survivor-prep --caller NAME IN OUT`, now writes each caller's input for both the script and the Nextflow `SURVIVOR_PREP`, in place of the bcftools and awk they each carried. A record votes when its FILTER and its sample `FT` are `PASS` or `.` and its genotype is not reference only (`0/0`, `0|0`, haploid `0`, `0/.`); a no-call (`./.`) and a sites-only record still vote. A CNVpytor call votes when its e-value is below 0.01 and its share of MAPQ 0 reads below 0.5, the rule step 05 already applies when it adds CNVpytor's calls; the VCF step 22 makes from CNVpytor's table now carries the table's e-value, `q0` and `pN` as `pytorP1`, `pytorQ0` and `pytorPN`, so the rule reads both inputs. A header without `GT` or without these tags no longer matters. Step 18's closing hint and `docs/18-cnvpytor.md` gave e-value below 0.05 and size over 1 kb; they now give the same rule. What changes in the output: `sv_merged/inputs/.vcf` holds only the records that vote, and the consensus can hold fewer records. No file, column or option is renamed or removed. Part of #411 (sv-05, sv-06, sv-09, sv-10, sv-11, sv-40). diff --git a/assets/output_contract.tsv b/assets/output_contract.tsv index 8315f2e05..e4aa749da 100644 --- a/assets/output_contract.tsv +++ b/assets/output_contract.tsv @@ -339,6 +339,7 @@ param viral_ref - - - - experimental - - param chip_gff - - - - experimental - - param chip_germline_resource - - - - experimental - - param chip_pon - - - - experimental - - +param chip_common_sites - - - - experimental - - param parascopy_population - - - - experimental - - param parascopy_depth_bed - - - - experimental - - param paraphase_regions - - - - experimental - - diff --git a/docs/49-chip.md b/docs/49-chip.md index 24b198f07..12d290296 100644 --- a/docs/49-chip.md +++ b/docs/49-chip.md @@ -14,7 +14,7 @@ The germline caller of step 3 is built for 50% and 100% alleles and does not rep ## Tool -- GATK Mutect2, tumour-only, then LearnReadOrientationModel and FilterMutectCalls +- GATK Mutect2, tumour-only, then LearnReadOrientationModel and FilterMutectCalls; GetPileupSummaries and CalculateContamination for the contamination estimate - bcftools csq, which names each change on the gene's MANE Select transcript, and bcftools mpileup for the depth - `og chip prepare` and `og chip report` (the Rust binary `og`, `rust/crates/og-chip`), applying the gene table `assets/chip_genes.tsv`; `og chip check-table` checks that table @@ -30,6 +30,7 @@ Pinned in `versions.env`; [Image versions](versions.md) lists the current tags. - the reference with its `.fai` and `.dict` - Ensembl's GRCh38 gene annotation, `reference/ensembl/Homo_sapiens.GRCh38..chr.gff3.gz` (`ENSEMBL_GFF_RELEASE` in `versions.env`, about 110 MB). Install it once with `./scripts/setup.sh --chip-data "${GENOME_DIR}"`; it is checked against `ENSEMBL_GFF_SHA256`. - Optional, and the same files as [step 29](29-mutect2-somatic.md): gnomAD's AF-only germline resource `somatic/af-only-gnomad.hg38.vcf.gz` and a panel of normals `somatic/1000g_pon.hg38.vcf.gz`, each with its `.tbi`. Without gnomAD, inherited variants are left out by their VAF only. +- Optional, and recommended: step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` with its `.tbi` ([step 29](29-mutect2-somatic.md) says how to download it). With it the step estimates how much of the sample is another person's DNA and FilterMutectCalls reads that estimate. Without it the log says there is no contamination estimate, and a contaminant's alleles can pass as a small clone. ## Command @@ -38,12 +39,12 @@ Pinned in `versions.env`; [Image versions](versions.md) lists the current tags. ./scripts/49-chip.sh your_name ``` -With `run-all.sh`: `TOOLS=...,chip`. It is opt-in, so a run lists step 49 only when `TOOLS` names it, and it is skipped without a BAM or without the annotation. In the Nextflow pipeline: `chip` in `--tools` with `--chip_gff` (and optionally `--chip_germline_resource` and `--chip_pon`), processes `CHIP_PREPARE`, `CHIP_MUTECT2`, `CHIP_ANNOTATE` and `CHIP_REPORT`. `CHIP_GENES=FILE` runs the script with another table in the same layout. +With `run-all.sh`: `TOOLS=...,chip`. It is opt-in, so a run lists step 49 only when `TOOLS` names it, and it is skipped without a BAM or without the annotation. In the Nextflow pipeline: `chip` in `--tools` with `--chip_gff` (and optionally `--chip_germline_resource`, `--chip_pon` and `--chip_common_sites`; `run-all.sh` passes each one installed under `somatic/`), processes `CHIP_PREPARE`, `CHIP_MUTECT2`, `CHIP_ANNOTATE` and `CHIP_REPORT`. `CHIP_GENES=FILE` runs the script with another table in the same layout. ## How it decides 1. For each gene of `assets/chip_genes.tsv` the step takes the transcript Ensembl tags `MANE_Select`, and calls inside its coding exons, 10 bases wider on each side so the splice donor and acceptor sites are in. That is 162 exons and about 35 kb with Ensembl 116. -2. Mutect2 calls in tumour-only mode, with the read orientation model, and with gnomAD and the panel of normals when they are installed. +2. Mutect2 calls in tumour-only mode, with the read orientation model, and with gnomAD and the panel of normals when they are installed. With the common-sites VCF, GetPileupSummaries counts the reads at its common sites inside the same exons, CalculateContamination estimates from them how much of the sample is another person's DNA, and FilterMutectCalls gets that estimate (`--contamination-table`). Another person's DNA adds its own alleles at a low VAF, the VAF of a small clone; with the estimate, FilterMutectCalls marks a call that contamination explains `contamination`, and the call reads `filtered`. The exons hold few common sites, so the estimate is rough; a whole-genome estimate is VerifyBamID2's FREEMIX in step 33. 3. Each call that changes the protein is put in the gene's class from the table: | Gene | Counted | Source (PMID) | @@ -117,6 +118,7 @@ So at the depth of a usual 30x genome, a clone has to hold about 14% of the alle | `chip/${SAMPLE}_chip_depth.tsv` | one row per gene: `transcript`, `chrom`, `coding_bases`, `mean_depth`, `detection_limit_vaf` (the read-support limit), `status` (covered, partly_covered, too_shallow, not_on_reference), `callable_fraction`, `assessable_fraction` | | `chip/${SAMPLE}_chip_filtered.vcf.gz` | Mutect2's calls after FilterMutectCalls | | `chip/${SAMPLE}_chip.gff3`, `chip/${SAMPLE}_chip.bed` | the transcripts and exons it called on (the bash step) | +| `chip/${SAMPLE}_chip_contamination.table` | CalculateContamination's estimate, with the common-sites VCF (the bash step) | Both reports show a "Clonal Haematopoiesis (CHIP)" section: the calls, the stated read-support limit, the genes that are not covered, and how many other changes were listed. diff --git a/docs/parameters.md b/docs/parameters.md index b6c8d4606..6981fdb8d 100644 --- a/docs/parameters.md +++ b/docs/parameters.md @@ -111,6 +111,7 @@ Paths to clinical and population genetics reference data. | `--chip_gff` | none | Ensembl's GRCh38 gene annotation, which `scripts/setup.sh --chip-data` installs as reference/ensembl/Homo_sapiens.GRCh38.<release>.chr.gff3.gz: chip takes each CHIP gene's MANE Select transcript from it. Required with chip. | | `--chip_germline_resource` | none | chip: gnomAD's AF-only germline resource for Mutect2 (somatic/af-only-gnomad.hg38.vcf.gz, .tbi beside it; optional). Without it inherited variants are left out by their VAF only. | | `--chip_pon` | none | chip: a Mutect2 panel of normals (somatic/1000g_pon.hg38.vcf.gz, .tbi beside it; optional). | +| `--chip_common_sites` | none | chip: common biallelic sites for the contamination estimate, step 29's somatic/small_exac_common_3.hg38.vcf.gz (.tbi beside it; optional). GetPileupSummaries and CalculateContamination estimate how much of the sample is another person's DNA, and FilterMutectCalls reads that estimate. Without it a contaminant's alleles can pass as a small clone. | | `--parascopy_population` | `EUR` | parascopy: the 1000 Genomes population whose model parameters are used. One of: `AFR`, `AMR`, `EAS`, `EUR`, `SAS`. | | `--parascopy_depth_bed` | none | parascopy: background windows (BED, all of one size) for a BAM that covers only part of the genome; default Parascopy's own GRCh38 windows. | | `--paraphase_regions` | none | paraphase: the Paraphase regions to run, comma separated (for example smn1,hba,rccx,GBA,pms2,strc,ncf1,OTOA); empty runs all of its GRCh38 regions. | diff --git a/main.nf b/main.nf index debd9bdf7..14a300106 100644 --- a/main.nf +++ b/main.nf @@ -1078,6 +1078,9 @@ workflow { def chip_germline_index = germ ? file("${germ}.tbi", checkIfExists: true) : [] def chip_pon = pon ? file(pon, checkIfExists: true) : [] def chip_pon_index = pon ? file("${pon}.tbi", checkIfExists: true) : [] + def common = params.chip_common_sites // the contamination estimate FilterMutectCalls reads + def chip_common = common ? file(common, checkIfExists: true) : [] + def chip_common_index = common ? file("${common}.tbi", checkIfExists: true) : [] ch_vcf .map { meta, _vcf, _idx -> [meta.id, meta] } .join(ch_bam.map { meta, _bam, _bai -> [meta.id, true] }, remainder: true) @@ -1087,7 +1090,7 @@ workflow { } CHIP_PREPARE(Channel.value(file(params.chip_gff, checkIfExists: true)), ch_chip_genes, ch_reference_fai) CHIP_MUTECT2(ch_bam, CHIP_PREPARE.out.bed, ch_reference, ch_reference_fai, ch_reference_dict, - chip_germline, chip_germline_index, chip_pon, chip_pon_index) + chip_germline, chip_germline_index, chip_pon, chip_pon_index, chip_common, chip_common_index) CHIP_ANNOTATE( CHIP_MUTECT2.out.vcf.map { meta, vcf -> [meta.id, meta, vcf] } .join(ch_bam.map { meta, bam, bai -> [meta.id, bam, bai] }) diff --git a/modules/local/chip/main.nf b/modules/local/chip/main.nf index c45ec65bc..ddee5e595 100644 --- a/modules/local/chip/main.nf +++ b/modules/local/chip/main.nf @@ -7,7 +7,9 @@ side) on the reference's contigs as a BED (once per run) CHIP_MUTECT2 Mutect2 tumour-only on that BED, the read orientation model and FilterMutectCalls; gnomAD's germline resource - and a panel of normals when given + and a panel of normals when given, and with the common + sites the contamination estimate (GetPileupSummaries, + CalculateContamination) FilterMutectCalls reads CHIP_ANNOTATE bcftools csq names each change on its transcript, and bcftools mpileup counts the depth over the BED CHIP_REPORT _chip.tsv (each protein change with its status) and @@ -72,6 +74,8 @@ process CHIP_MUTECT2 { path(germline_index) path(pon) // [] without --chip_pon path(pon_index) + path(common) // [] without --chip_common_sites + path(common_index) output: tuple val(meta), path("${meta.id}_chip_filtered.vcf.gz"), emit: vcf @@ -83,11 +87,25 @@ process CHIP_MUTECT2 { script: // The same commands as scripts/49-chip.sh def resources = (germline ? "--germline-resource ${germline} " : '') + (pon ? "-pon ${pon}" : '') + def common_sites = common ? "${common}" : '' """ gatk Mutect2 -R ${reference} -I ${bam} -L ${bed} -O unfiltered.vcf.gz --f1r2-tar-gz f1r2.tar.gz \\ --native-pair-hmm-threads ${task.cpus} --max-mnp-distance 0 ${resources} gatk LearnReadOrientationModel -I f1r2.tar.gz -O orientation.tar.gz - gatk FilterMutectCalls -R ${reference} -V unfiltered.vcf.gz --ob-priors orientation.tar.gz \\ + # Another person's DNA in the sample adds alleles at the VAF of a small + # clone: the estimate from the common sites inside the BED lets + # FilterMutectCalls mark those calls. + common_sites='${common_sites}' + contamination='' + if [ -n "\$common_sites" ]; then + gatk GetPileupSummaries -I ${bam} -V "\$common_sites" -L "\$common_sites" -L ${bed} \\ + --interval-set-rule INTERSECTION -O pileups.table + gatk CalculateContamination -I pileups.table --tumor-segmentation segments.table -O contamination.table + contamination='--contamination-table contamination.table --tumor-segmentation segments.table' + else + echo "chip: no --chip_common_sites, so FilterMutectCalls runs without a contamination estimate." >&2 + fi + gatk FilterMutectCalls -R ${reference} -V unfiltered.vcf.gz --ob-priors orientation.tar.gz \$contamination \\ -O ${meta.id}_chip_filtered.vcf.gz printf '"%s":\\n gatk: %s\\n' "${task.process}" "${task.container.replaceFirst(/^[^:@]+[:@]/, '')}" > versions.yml diff --git a/nextflow.config b/nextflow.config index d6c7df852..6a3b54c91 100644 --- a/nextflow.config +++ b/nextflow.config @@ -129,6 +129,7 @@ params { chip_gff = null // chip: Ensembl's GRCh38 GFF3 (setup.sh --chip-data: reference/ensembl/Homo_sapiens.GRCh38..chr.gff3.gz) chip_germline_resource = null // chip: gnomAD's AF-only germline resource for Mutect2, .tbi beside it (optional) chip_pon = null // chip: a Mutect2 panel of normals, .tbi beside it (optional) + chip_common_sites = null // chip: common biallelic sites for the contamination estimate (somatic/small_exac_common_3.hg38.vcf.gz), .tbi beside it (optional) megane_kmers = null // mei: MEGAnE's k-mer set of the reference, the .mk with its .mi beside it (setup.sh --megane-kmers: reference/megane/.mk) mocha_data = null // mocha: the phasing panel and genetic map of step 51 (setup.sh --mocha-data: reference/mocha-) locityper_data = null // locityper: the database of step 53 (setup.sh --locityper-data: reference/locityper-) diff --git a/nextflow_schema.json b/nextflow_schema.json index d80b8f1bd..64c3372c9 100644 --- a/nextflow_schema.json +++ b/nextflow_schema.json @@ -447,6 +447,12 @@ "description": "chip: a Mutect2 panel of normals (somatic/1000g_pon.hg38.vcf.gz, .tbi beside it; optional).", "fa_icon": "fas fa-file" }, + "chip_common_sites": { + "type": "string", + "format": "file-path", + "description": "chip: common biallelic sites for the contamination estimate, step 29's somatic/small_exac_common_3.hg38.vcf.gz (.tbi beside it; optional). GetPileupSummaries and CalculateContamination estimate how much of the sample is another person's DNA, and FilterMutectCalls reads that estimate. Without it a contaminant's alleles can pass as a small clone.", + "fa_icon": "fas fa-file" + }, "parascopy_population": { "type": "string", "default": "EUR", diff --git a/scripts/49-chip.sh b/scripts/49-chip.sh index f3507ca43..a234ccd4c 100755 --- a/scripts/49-chip.sh +++ b/scripts/49-chip.sh @@ -6,7 +6,10 @@ # exons (10 bases wider on each side) of the genes in assets/chip_genes.tsv, # each on its MANE Select transcript from Ensembl's gene annotation (setup.sh # --chip-data). gnomAD's AF-only germline resource and the panel of normals of -# step 29 are used when they are in GENOME_DIR/somatic/. bcftools csq names +# step 29 are used when they are in GENOME_DIR/somatic/, and so is step 29's +# common-sites VCF: GetPileupSummaries and CalculateContamination estimate how +# much of the sample is another person's DNA, and FilterMutectCalls gets that +# estimate, so a contaminant's alleles are not read as a clone. bcftools csq names # each change on that transcript, and og chip (bin/og) keeps the changes in # the table's CHIP classes, leaves out the ones whose VAF looks inherited (35% # and up) or is under the 2% that defines CHIP, notes the kept ones whose @@ -22,7 +25,8 @@ # reference/ensembl/Homo_sapiens.GRCh38..chr.gff3.gz # Output: chip/_chip.tsv (one row per protein change, with its status), # chip/_chip_depth.tsv (depth and detection limit per gene), -# chip/_chip_filtered.vcf.gz (Mutect2's calls) +# chip/_chip_filtered.vcf.gz (Mutect2's calls), +# chip/_chip_contamination.table (the estimate, with the common-sites VCF) # CHIP_GENES=FILE uses another gene table with the columns of assets/chip_genes.tsv. set -euo pipefail @@ -43,6 +47,7 @@ OUTDIR="${S}/chip" P="${OUTDIR}/${SAMPLE}_chip" GNOMAD_VCF="${GENOME_DIR}/somatic/af-only-gnomad.hg38.vcf.gz" PON_VCF="${GENOME_DIR}/somatic/1000g_pon.hg38.vcf.gz" +COMMON_VCF="${GENOME_DIR}/somatic/small_exac_common_3.hg38.vcf.gz" echo "============================================" echo " Step 49: Clonal haematopoiesis (CHIP)" @@ -83,8 +88,23 @@ fi run_in --cpus "$THREADS" --memory 8g "$GATK_IMAGE" "${M2[@]}" run_in --cpus 2 --memory 4g "$GATK_IMAGE" gatk LearnReadOrientationModel -I "$(cpath "${P}_f1r2.tar.gz")" \ -O "$(cpath "${P}_orientation.tar.gz")" -run_in --cpus 2 --memory 4g "$GATK_IMAGE" gatk FilterMutectCalls -R "${REF_FASTA_C}" -V "$(cpath "${P}_unfiltered.vcf.gz")" \ - --ob-priors "$(cpath "${P}_orientation.tar.gz")" -O "$(cpath "${P}_filtered.vcf.gz")" +FILTER=(gatk FilterMutectCalls -R "${REF_FASTA_C}" -V "$(cpath "${P}_unfiltered.vcf.gz")" + --ob-priors "$(cpath "${P}_orientation.tar.gz")" -O "$(cpath "${P}_filtered.vcf.gz")") +# Another person's DNA in the sample adds alleles at a low VAF, the VAF of a +# small clone. The contamination estimate comes from the common sites inside +# the same exons, as in step 29, and lets FilterMutectCalls mark those calls. +rm -f "${P}_contamination.table" "${P}_segments.table" +if [ -f "$COMMON_VCF" ] && [ -f "${COMMON_VCF}.tbi" ]; then + echo " contamination estimate: common sites ${COMMON_VCF}" + run_in --cpus 2 --memory 4g "$GATK_IMAGE" gatk GetPileupSummaries -I "$(cpath "$BAM")" -V "$(cpath "$COMMON_VCF")" \ + -L "$(cpath "$COMMON_VCF")" -L "$(cpath "${P}.bed")" --interval-set-rule INTERSECTION -O "$(cpath "${P}_pileups.table")" + run_in --cpus 2 --memory 4g "$GATK_IMAGE" gatk CalculateContamination -I "$(cpath "${P}_pileups.table")" \ + --tumor-segmentation "$(cpath "${P}_segments.table")" -O "$(cpath "${P}_contamination.table")" + FILTER+=(--contamination-table "$(cpath "${P}_contamination.table")" --tumor-segmentation "$(cpath "${P}_segments.table")") +else + echo " no common-sites VCF (${COMMON_VCF}): no contamination estimate, so another person's DNA in the sample can pass as a small clone (docs/49-chip.md says how to install it)." +fi +run_in --cpus 2 --memory 4g "$GATK_IMAGE" "${FILTER[@]}" echo "[3/4] Naming each change on its transcript (bcftools csq) and counting the depth (bcftools mpileup)..." # norm splits multi-allelic records, so AD and AF hold one ALT each; csq @@ -105,7 +125,7 @@ echo "[4/4] CHIP classes, germline exclusion and detection limit..." "${OG[@]}" report --genes "$(cpath "${OUTDIR}/chip_genes.tsv")" --gff "$(cpath "${P}.gff3")" --bed "$(cpath "${P}.bed")" \ --calls "$(cpath "${P}_calls.tsv")" --depth "$(cpath "${P}_pileup.tsv")" --sample "$SAMPLE" \ --out "$(cpath "${P}.tsv")" --depth-out "$(cpath "${P}_depth.tsv")" -rm -f "${P}_pileup.tsv" "${P}_f1r2.tar.gz" "${P}_orientation.tar.gz" +rm -f "${P}_pileup.tsv" "${P}_f1r2.tar.gz" "${P}_orientation.tar.gz" "${P}_pileups.table" "${P}_segments.table" echo "" echo "Possible CHIP calls, not a diagnosis (${P}.tsv):" diff --git a/scripts/run-all.sh b/scripts/run-all.sh index dfa11e549..0e32cd3a2 100755 --- a/scripts/run-all.sh +++ b/scripts/run-all.sh @@ -289,10 +289,10 @@ if [[ ",${T// /}," == *",bloodtype,"* ]]; then plan "41 Blood groups" bloodtype if [[ ",${T// /}," == *",lpa,"* ]]; then plan "46 Lp(a) KIV-2 count" lpa "$([ -n "$NOBAM" ] || echo 'no BAM')" || true; else KNOWN+=" lpa"; fi # Step 52 (MUC1 VNTR frameshifts, VNtyper) is opt-in and listed only when TOOLS names it; it reads the BAM. if [[ ",${T// /}," == *",vntyper,"* ]]; then plan "52 MUC1 VNTR (VNtyper)" vntyper "$([ -n "$NOBAM" ] || echo 'no BAM')" || true; else KNOWN+=" vntyper"; fi -# Step 49 (CHIP) is opt-in and listed only when TOOLS names it: Mutect2 on the BAM, with step 29's gnomAD and panel of normals when installed. +# Step 49 (CHIP) is opt-in and listed only when TOOLS names it: Mutect2 on the BAM, with step 29's gnomAD, panel of normals and common sites when installed. CG="${G}/reference/ensembl/Homo_sapiens.GRCh38.${ENSEMBL_GFF_RELEASE}.chr.gff3.gz" if [[ ",${T// /}," == *",chip,"* ]]; then plan "49 CHIP (clonal blood cells)" chip "$(need "$CG")" && NF+=(--chip_gff "$CG") \ - && for r in chip_germline_resource:af-only-gnomad chip_pon:1000g_pon; do f="${G}/somatic/${r#*:}.hg38.vcf.gz"; [ ! -e "${f}.tbi" ] || arg "--${r%%:*}" "$f"; done + && for r in chip_germline_resource:af-only-gnomad chip_pon:1000g_pon chip_common_sites:small_exac_common_3; do f="${G}/somatic/${r#*:}.hg38.vcf.gz"; [ ! -e "${f}.tbi" ] || arg "--${r%%:*}" "$f"; done else KNOWN+=" chip"; fi # Step 42 reads the gVCF only: DeepVariant writes one for a FASTQ or BAM row, a BAM+VCF row has one when it lies beside the VCF. plan "42 Traits panel" traits "$([ -z "$fv" ] || [ -n "$GROW" ] || echo "no gVCF: ${GV#"$G"/}")" || true From e927d0ea9ccc2d64eeb0a2edc4b0409249cfefaa Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Fri, 20 Nov 2026 22:49:15 +0100 Subject: [PATCH 02/38] test(chip): check that every CHIP path hands FilterMutectCalls the contamination table The fake-docker case runs step 49 without the common-sites VCF, with it, and with it but no .tbi; renders CHIP_MUTECT2's script block with a fake gatk with and without --chip_common_sites; and checks that run-all.sh passes the VCF to the pipeline only with its .tbi. Bead: trait-62 --- tests/fake-docker/i411-chip-contamination.sh | 138 +++++++++++++++++++ 1 file changed, 138 insertions(+) create mode 100755 tests/fake-docker/i411-chip-contamination.sh diff --git a/tests/fake-docker/i411-chip-contamination.sh b/tests/fake-docker/i411-chip-contamination.sh new file mode 100755 index 000000000..87be7d528 --- /dev/null +++ b/tests/fake-docker/i411-chip-contamination.sh @@ -0,0 +1,138 @@ +#!/usr/bin/env bash +# Step 49 (CHIP) gives FilterMutectCalls the contamination estimate when step +# 29's common-sites VCF is installed with its .tbi: GetPileupSummaries at the +# common sites inside the CHIP exons, CalculateContamination, then +# FilterMutectCalls with --contamination-table and --tumor-segmentation. +# Without the VCF, or without its .tbi, there is no estimate and the log says +# so. The Nextflow CHIP_MUTECT2 runs the same commands: its script block, run +# here with a fake gatk, passes the table when it gets --chip_common_sites and +# not without it; main.nf hands it the file, and run-all.sh passes the VCF +# under somatic/ to the pipeline only with its .tbi. +# shellcheck source=../../scripts/ci/fake-docker/lib.sh +. "${REPO_ROOT:?}/scripts/ci/fake-docker/lib.sh" +# shellcheck source=../../versions.env +. "${REPO_ROOT}/versions.env" + +export GENOME_DIR="${CASE_WORK}/genome" +G=$GENOME_DIR +seed_reference "$G" +seed_sample "$G" sample1 +printf '@HD\tVN:1.6\n@SQ\tSN:chr1\tLN:248956422\n' > "${G}/reference/GRCh38_no_alt_analysis_set.dict" +GFF="${G}/reference/ensembl/Homo_sapiens.GRCh38.${ENSEMBL_GFF_RELEASE}.chr.gff3.gz" +mkdir -p "$(dirname "$GFF")" +printf 'placeholder\n' > "$GFF" +COMMON="${G}/somatic/small_exac_common_3.hg38.vcf.gz" + +# og chip prepare writes a BED with one exon and og chip report an empty table, +# so the step goes on past its checks; every other call writes its -O output. +use_output_hook +cat > "${CASE_WORK}/hook-chip" <<'HOOK' +#!/usr/bin/env bash +set -euo pipefail +. "${CASE_WORK:?}/host-path.sh" +args=" $* " +# arg OPTION: the value after OPTION in this call +arg() { sed -E "s/.* $1 ([^ ]+) .*/\\1/" <<<"$args"; } +case "$args" in + *"/og chip prepare "*) printf 'chr2\t25234268\t25234430\tDNMT3A\n' > "$(host_path "$(arg --out-bed)")" ;; + *"/og chip report "*) : > "$(host_path "$(arg --out)")" ;; +esac +exec "${CASE_WORK}/hook-outputs" "$@" +HOOK +chmod +x "${CASE_WORK}/hook-chip" +export FAKE_DOCKER_RUN_HOOK="${CASE_WORK}/hook-chip" +C=/genome/sample1/chip/sample1_chip + +# --- the bash step --------------------------------------------------------------------- +# No common-sites VCF: no estimate, and the log says so. +: > "$FAKE_DOCKER_LOG" +run_expect 0 chip-no-common "${SCRIPTS}/49-chip.sh" sample1 +docker_log_has '^run image=[^ ]*gatk.* FilterMutectCalls .*--ob-priors ' "step 49 did not run FilterMutectCalls" +if grep -qE 'GetPileupSummaries|CalculateContamination|--contamination-table' "$FAKE_DOCKER_LOG"; then + fail "step 49 estimated contamination without the common-sites VCF" +fi +output_has chip-no-common 'no common-sites VCF .*: no contamination estimate' + +# The common-sites VCF with its .tbi: the estimate, and FilterMutectCalls reads it. +mkdir -p "${G}/somatic" +printf 'placeholder\n' > "$COMMON" +printf 'placeholder\n' > "${COMMON}.tbi" +: > "$FAKE_DOCKER_LOG" +run_expect 0 chip-common "${SCRIPTS}/49-chip.sh" sample1 +docker_log_has "^run image=[^ ]*gatk.* GetPileupSummaries -I /genome/sample1/aligned/sample1_sorted\\.bam -V /genome/somatic/small_exac_common_3\\.hg38\\.vcf\\.gz -L /genome/somatic/small_exac_common_3\\.hg38\\.vcf\\.gz -L ${C}\\.bed --interval-set-rule INTERSECTION -O ${C}_pileups\\.table" \ + "step 49 did not summarise the pileups at the common sites inside the CHIP exons" +docker_log_has "^run image=[^ ]*gatk.* CalculateContamination -I ${C}_pileups\\.table --tumor-segmentation ${C}_segments\\.table -O ${C}_contamination\\.table" \ + "step 49 did not estimate contamination from those pileups" +docker_log_has "^run image=[^ ]*gatk.* FilterMutectCalls .*--contamination-table ${C}_contamination\\.table --tumor-segmentation ${C}_segments\\.table" \ + "FilterMutectCalls did not get the contamination table" +# The estimate comes before the filter that reads it. +awk '/ CalculateContamination / { c = NR } / FilterMutectCalls / { f = NR } END { exit !(c && f > c) }' "$FAKE_DOCKER_LOG" \ + || fail "FilterMutectCalls ran before CalculateContamination" +output_lacks chip-common 'no contamination estimate' +output_has chip-common 'contamination estimate: common sites ' + +# The VCF without its .tbi is not used. +rm -f "${COMMON}.tbi" +: > "$FAKE_DOCKER_LOG" +run_expect 0 chip-common-no-tbi "${SCRIPTS}/49-chip.sh" sample1 +if grep -q -- '--contamination-table' "$FAKE_DOCKER_LOG"; then fail "step 49 used the common-sites VCF without its .tbi"; fi +output_has chip-common-no-tbi 'no contamination estimate' +printf 'placeholder\n' > "${COMMON}.tbi" + +# --- CHIP_MUTECT2 (Nextflow) ------------------------------------------------------------- +# The shell of the module's script block, with its Groovy values filled in. +MOD="${REPO_ROOT}/modules/local/chip/main.nf" +# shellcheck disable=SC2016 # the dollar signs are Groovy placeholders, matched literally +render_mutect2() { + awk '/^process CHIP_MUTECT2/ { p = 1 } p && /^ script:/ { on = 1; next } on && /^ """/ { n++; if (n == 2) exit; next } on && n == 1' "$MOD" \ + | sed -e 's/\${reference}/ref.fa/g' -e 's/\${bam}/in.bam/g' -e 's/\${bed}/chip.bed/g' -e 's/\${task\.cpus}/2/g' \ + -e 's/\${resources}//g' -e 's/\${meta\.id}/s1/g' -e "s|\\\${common_sites}|$1|g" -e '/versions\.yml/d' \ + -e 's/\\\$/$/g' -e 's/\\\\/\\/g' +} +NFW="${CASE_WORK}/chip-nf" +mkdir -p "${NFW}/bin" +cat > "${NFW}/bin/gatk" <<'FAKE' +#!/usr/bin/env bash +printf 'gatk %s\n' "$*" >> "${NFW_LOG:?}" +FAKE +chmod +x "${NFW}/bin/gatk" +# run_module COMMON_SITES: run the rendered block in $NFW, with the gatk calls in gatk.log +run_module() { + render_mutect2 "$1" > "${NFW}/script.sh" + : > "${NFW}/gatk.log" + (cd "$NFW" && PATH="${NFW}/bin:${PATH}" NFW_LOG="${NFW}/gatk.log" bash -euo pipefail script.sh) > "${NFW}/out.txt" 2>&1 \ + || { cat "${NFW}/script.sh" "${NFW}/out.txt"; fail "CHIP_MUTECT2's script block failed with common sites '$1'"; } + cat "${NFW}/gatk.log" "${NFW}/out.txt" +} +run_module common.vcf.gz +grep -q '^gatk GetPileupSummaries -I in\.bam -V common\.vcf\.gz -L common\.vcf\.gz -L chip\.bed --interval-set-rule INTERSECTION -O pileups\.table$' "${NFW}/gatk.log" \ + || fail "CHIP_MUTECT2 did not summarise the pileups at the common sites inside the BED, as step 49 does" +grep -q '^gatk CalculateContamination -I pileups\.table --tumor-segmentation segments\.table -O contamination\.table$' "${NFW}/gatk.log" \ + || fail "CHIP_MUTECT2 did not estimate contamination" +grep -q '^gatk FilterMutectCalls .*--contamination-table contamination\.table --tumor-segmentation segments\.table .*-O s1_chip_filtered\.vcf\.gz$' "${NFW}/gatk.log" \ + || fail "CHIP_MUTECT2's FilterMutectCalls did not get the contamination table" +run_module "" +grep -q '^gatk FilterMutectCalls .*-O s1_chip_filtered\.vcf\.gz$' "${NFW}/gatk.log" || fail "CHIP_MUTECT2 without common sites did not filter" +if grep -qE 'GetPileupSummaries|CalculateContamination|--contamination-table' "${NFW}/gatk.log"; then + fail "CHIP_MUTECT2 estimated contamination without --chip_common_sites" +fi +grep -q 'no --chip_common_sites' "${NFW}/out.txt" || fail "CHIP_MUTECT2 without common sites does not say it has no estimate" +# main.nf hands the module the file and its index, in the order of its inputs. +grep -qF 'def chip_common = common ? file(common, checkIfExists: true) : []' "${REPO_ROOT}/main.nf" \ + || fail "main.nf does not read --chip_common_sites" +grep -qF 'chip_pon, chip_pon_index, chip_common, chip_common_index)' "${REPO_ROOT}/main.nf" \ + || fail "main.nf does not pass the common sites to CHIP_MUTECT2" + +# --- run-all.sh -------------------------------------------------------------------------- +# TOOLS=chip passes the installed common-sites VCF to the pipeline, only with its .tbi. +export SKIP_VALIDATION=true +seed_clinvar "$G" +: > "$FAKE_DOCKER_LOG" +TOOLS=chip run_expect 0 run-all-common "${SCRIPTS}/run-all.sh" sample1 male +docker_log_has "^nextflow :: .* --chip_common_sites ${COMMON//./\\.} " "run-all.sh did not pass the installed common-sites VCF" +rm -f "${COMMON}.tbi" +: > "$FAKE_DOCKER_LOG" +TOOLS=chip run_expect 0 run-all-no-tbi "${SCRIPTS}/run-all.sh" sample1 male +docker_log_has '^nextflow :: .* --tools ' "run-all.sh did not run the pipeline" +if grep -q -- '--chip_common_sites' "$FAKE_DOCKER_LOG"; then fail "run-all.sh passed the common-sites VCF without its .tbi"; fi +echo "Step 49, CHIP_MUTECT2 and run-all.sh give FilterMutectCalls the contamination estimate with the common sites, and only then." From 395bef2f8625ef62cc0a6ddf3d3cb081edfd8cb3 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Fri, 20 Nov 2026 22:57:48 +0100 Subject: [PATCH 03/38] fix(chip): estimate contamination from every common site, not only the CHIP exons The CHIP coding exons hold 8 of the 59,295 sites of the common-sites VCF, too few for CalculateContamination to estimate anything. Contamination is a property of the sample, so GetPileupSummaries now reads every common site of the VCF in both the step and CHIP_MUTECT2. The fake-docker case checks the table first, so main fails it on the --contamination-table check. Bead: trait-62 --- CHANGELOG.md | 2 +- docs/49-chip.md | 4 +-- modules/local/chip/main.nf | 7 ++-- scripts/49-chip.sh | 12 ++++--- tests/fake-docker/i411-chip-contamination.sh | 38 ++++++++++---------- 5 files changed, 33 insertions(+), 30 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index 2329e95ed..7a4a48b57 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- Step 49 (CHIP) now gives FilterMutectCalls a contamination estimate. Before, it filtered Mutect2's calls without one, so another person's DNA in the sample, whose alleles sit at a low VAF, could pass as a small clone and read `chip`. When step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` is installed with its `.tbi`, `scripts/49-chip.sh` and the Nextflow `CHIP_MUTECT2` run GetPileupSummaries at its common sites inside the CHIP exons and CalculateContamination, and pass `--contamination-table` and `--tumor-segmentation` to FilterMutectCalls, as step 29 does. A call that contamination explains is then marked `contamination` by FilterMutectCalls and reads `filtered`. Without the VCF the log says there is no contamination estimate. A new optional parameter, `--chip_common_sites`, gives the VCF to the Nextflow pipeline, and `run-all.sh` passes it when the file is installed. The bash step also keeps `chip/_chip_contamination.table`. No column, option or file name changes. Part of #411 (trait-62). +- Step 49 (CHIP) now gives FilterMutectCalls a contamination estimate. Before, it filtered Mutect2's calls without one, so another person's DNA in the sample, whose alleles sit at a low VAF, could pass as a small clone and read `chip`. When step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` is installed with its `.tbi`, `scripts/49-chip.sh` and the Nextflow `CHIP_MUTECT2` run GetPileupSummaries at its 59,295 sites across the genome and CalculateContamination, and pass `--contamination-table` and `--tumor-segmentation` to FilterMutectCalls. The pileups do not stop at the CHIP exons, which hold only 8 of those sites, too few for an estimate. A call that contamination explains is then marked `contamination` by FilterMutectCalls and reads `filtered`. Without the VCF the log says there is no contamination estimate. A new optional parameter, `--chip_common_sites`, gives the VCF to the Nextflow pipeline, and `run-all.sh` passes it when the file is installed. The bash step also keeps `chip/_chip_contamination.table`. No column, option or file name changes. Part of #411 (trait-62). - The live site's family page and its pedigree drawing are now built by `og live family`, in Rust. `bin/owngenome_live_family.py` asks `og` for a family's state, its `family.json`, the list of files it serves and `pedigree.svg`, and no longer reads the family's tables itself; `bin/pedigree_svg.py` and `bin/family_report.py` are gone. The page shows the same thing: `family.json` and the drawing were compared with the old code on the demo family and the test families, field by field and number by number, and matched. The live site therefore needs `og` (`scripts/setup.sh --og` installs it); without it a family's `family.json` answers 500, its `pedigree.svg` answers 503, and the run list marks each family unreadable. A family file that cannot be read still gives no page and an unreadable family. - The local genome viewer runs on `og` and no longer needs `python3` on the host. `scripts/owngenome-view.sh` starts `og view serve` (through `bin/og`, or `OG`), which serves the same page, config and byte ranges on 127.0.0.1 as `assets/viewer/serve.py` did. Two requests it answered before are now refused. A locus whose end comes before its start (`chr1:13000-12000`) stops the script with exit 2 and the reason, instead of opening a view igv.js cannot show. A request with a `Forwarded`, `X-Forwarded-*` or `X-Real-IP` header gets 403: the viewer has no password, so a reverse proxy in front of it would hand the sample to anyone who reaches the proxy; an ssh port forward still works. The default SV track is now Manta's diploid SVs (step 4), else step 22's consensus, which keeps only the calls two callers agree on. `docs/viewer.md` says that every account on the machine can reach 127.0.0.1. No option of the script, file or output name changes; `og view serve` takes the flags `serve.py` took, plus `--assets`, the page's folder. The live site's viewer also opens Manta's diploid SVs first; the rest of it is unchanged until its server moves to `og`. Part of #411 (plat-11, plat-12). - Step 22's SV consensus no longer counts a record a caller did not call as a second caller. Before, every PASS record went to SURVIVOR, so a PASS Delly record genotyped `0/0`, a Delly call whose sample filter (`FT`) says `LowQual`, or a CNVpytor segment no quality rule had read sat beside a Manta-only call and made it read "2 callers". A new verb, `og sv survivor-prep --caller NAME IN OUT`, now writes each caller's input for both the script and the Nextflow `SURVIVOR_PREP`, in place of the bcftools and awk they each carried. A record votes when its FILTER and its sample `FT` are `PASS` or `.` and its genotype is not reference only (`0/0`, `0|0`, haploid `0`, `0/.`); a no-call (`./.`) and a sites-only record still vote. A CNVpytor call votes when its e-value is below 0.01 and its share of MAPQ 0 reads below 0.5, the rule step 05 already applies when it adds CNVpytor's calls; the VCF step 22 makes from CNVpytor's table now carries the table's e-value, `q0` and `pN` as `pytorP1`, `pytorQ0` and `pytorPN`, so the rule reads both inputs. A header without `GT` or without these tags no longer matters. Step 18's closing hint and `docs/18-cnvpytor.md` gave e-value below 0.05 and size over 1 kb; they now give the same rule. What changes in the output: `sv_merged/inputs/.vcf` holds only the records that vote, and the consensus can hold fewer records. No file, column or option is renamed or removed. Part of #411 (sv-05, sv-06, sv-09, sv-10, sv-11, sv-40). diff --git a/docs/49-chip.md b/docs/49-chip.md index 12d290296..35ff6cf00 100644 --- a/docs/49-chip.md +++ b/docs/49-chip.md @@ -44,7 +44,7 @@ With `run-all.sh`: `TOOLS=...,chip`. It is opt-in, so a run lists step 49 only w ## How it decides 1. For each gene of `assets/chip_genes.tsv` the step takes the transcript Ensembl tags `MANE_Select`, and calls inside its coding exons, 10 bases wider on each side so the splice donor and acceptor sites are in. That is 162 exons and about 35 kb with Ensembl 116. -2. Mutect2 calls in tumour-only mode, with the read orientation model, and with gnomAD and the panel of normals when they are installed. With the common-sites VCF, GetPileupSummaries counts the reads at its common sites inside the same exons, CalculateContamination estimates from them how much of the sample is another person's DNA, and FilterMutectCalls gets that estimate (`--contamination-table`). Another person's DNA adds its own alleles at a low VAF, the VAF of a small clone; with the estimate, FilterMutectCalls marks a call that contamination explains `contamination`, and the call reads `filtered`. The exons hold few common sites, so the estimate is rough; a whole-genome estimate is VerifyBamID2's FREEMIX in step 33. +2. Mutect2 calls in tumour-only mode, with the read orientation model, and with gnomAD and the panel of normals when they are installed. With the common-sites VCF, GetPileupSummaries counts the reads at every one of its 59,295 sites across the genome, CalculateContamination estimates from them how much of the sample is another person's DNA, and FilterMutectCalls gets that estimate (`--contamination-table`). Another person's DNA adds its own alleles at a low VAF, the VAF of a small clone; with the estimate, FilterMutectCalls marks a call that contamination explains `contamination`, and the call reads `filtered`. The pileups do not stop at the CHIP exons, as step 29's do at its intervals: the exons hold 8 of the 59,295 sites, too few for an estimate. Step 33's VerifyBamID2 gives a second, separate estimate (FREEMIX). 3. Each call that changes the protein is put in the gene's class from the table: | Gene | Counted | Source (PMID) | @@ -124,7 +124,7 @@ Both reports show a "Clonal Haematopoiesis (CHIP)" section: the calls, the state ## Runtime -Not measured on a whole genome. Mutect2 reads about 35 kb of the BAM, which takes minutes, not hours. +Not measured on a whole genome. Mutect2 reads about 35 kb of the BAM, which takes minutes, not hours. With the common-sites VCF, GetPileupSummaries also reads the BAM at the VCF's 59,295 sites. ## Notes diff --git a/modules/local/chip/main.nf b/modules/local/chip/main.nf index ddee5e595..483f35417 100644 --- a/modules/local/chip/main.nf +++ b/modules/local/chip/main.nf @@ -93,13 +93,12 @@ process CHIP_MUTECT2 { --native-pair-hmm-threads ${task.cpus} --max-mnp-distance 0 ${resources} gatk LearnReadOrientationModel -I f1r2.tar.gz -O orientation.tar.gz # Another person's DNA in the sample adds alleles at the VAF of a small - # clone: the estimate from the common sites inside the BED lets - # FilterMutectCalls mark those calls. + # clone. The estimate reads every common site across the genome (the BED + # holds too few) and lets FilterMutectCalls mark those calls. common_sites='${common_sites}' contamination='' if [ -n "\$common_sites" ]; then - gatk GetPileupSummaries -I ${bam} -V "\$common_sites" -L "\$common_sites" -L ${bed} \\ - --interval-set-rule INTERSECTION -O pileups.table + gatk GetPileupSummaries -I ${bam} -V "\$common_sites" -L "\$common_sites" -O pileups.table gatk CalculateContamination -I pileups.table --tumor-segmentation segments.table -O contamination.table contamination='--contamination-table contamination.table --tumor-segmentation segments.table' else diff --git a/scripts/49-chip.sh b/scripts/49-chip.sh index a234ccd4c..b7f412ab1 100755 --- a/scripts/49-chip.sh +++ b/scripts/49-chip.sh @@ -7,8 +7,8 @@ # each on its MANE Select transcript from Ensembl's gene annotation (setup.sh # --chip-data). gnomAD's AF-only germline resource and the panel of normals of # step 29 are used when they are in GENOME_DIR/somatic/, and so is step 29's -# common-sites VCF: GetPileupSummaries and CalculateContamination estimate how -# much of the sample is another person's DNA, and FilterMutectCalls gets that +# common-sites VCF: GetPileupSummaries at its sites across the genome and +# CalculateContamination estimate how much of the sample is another person's DNA, and FilterMutectCalls gets that # estimate, so a contaminant's alleles are not read as a clone. bcftools csq names # each change on that transcript, and og chip (bin/og) keeps the changes in # the table's CHIP classes, leaves out the ones whose VAF looks inherited (35% @@ -91,13 +91,15 @@ run_in --cpus 2 --memory 4g "$GATK_IMAGE" gatk LearnReadOrientationModel -I "$(c FILTER=(gatk FilterMutectCalls -R "${REF_FASTA_C}" -V "$(cpath "${P}_unfiltered.vcf.gz")" --ob-priors "$(cpath "${P}_orientation.tar.gz")" -O "$(cpath "${P}_filtered.vcf.gz")") # Another person's DNA in the sample adds alleles at a low VAF, the VAF of a -# small clone. The contamination estimate comes from the common sites inside -# the same exons, as in step 29, and lets FilterMutectCalls mark those calls. +# small clone. CalculateContamination estimates that share from the reads at +# every site of the common-sites VCF, across the genome: the CHIP exons hold +# only 8 of its 59,295 sites, too few for an estimate. FilterMutectCalls then +# marks the calls contamination explains. rm -f "${P}_contamination.table" "${P}_segments.table" if [ -f "$COMMON_VCF" ] && [ -f "${COMMON_VCF}.tbi" ]; then echo " contamination estimate: common sites ${COMMON_VCF}" run_in --cpus 2 --memory 4g "$GATK_IMAGE" gatk GetPileupSummaries -I "$(cpath "$BAM")" -V "$(cpath "$COMMON_VCF")" \ - -L "$(cpath "$COMMON_VCF")" -L "$(cpath "${P}.bed")" --interval-set-rule INTERSECTION -O "$(cpath "${P}_pileups.table")" + -L "$(cpath "$COMMON_VCF")" -O "$(cpath "${P}_pileups.table")" run_in --cpus 2 --memory 4g "$GATK_IMAGE" gatk CalculateContamination -I "$(cpath "${P}_pileups.table")" \ --tumor-segmentation "$(cpath "${P}_segments.table")" -O "$(cpath "${P}_contamination.table")" FILTER+=(--contamination-table "$(cpath "${P}_contamination.table")" --tumor-segmentation "$(cpath "${P}_segments.table")") diff --git a/tests/fake-docker/i411-chip-contamination.sh b/tests/fake-docker/i411-chip-contamination.sh index 87be7d528..cbed00513 100755 --- a/tests/fake-docker/i411-chip-contamination.sh +++ b/tests/fake-docker/i411-chip-contamination.sh @@ -1,7 +1,7 @@ #!/usr/bin/env bash # Step 49 (CHIP) gives FilterMutectCalls the contamination estimate when step -# 29's common-sites VCF is installed with its .tbi: GetPileupSummaries at the -# common sites inside the CHIP exons, CalculateContamination, then +# 29's common-sites VCF is installed with its .tbi: GetPileupSummaries at every +# site of that VCF (not only inside the CHIP exons), CalculateContamination, then # FilterMutectCalls with --contamination-table and --tumor-segmentation. # Without the VCF, or without its .tbi, there is no estimate and the log says # so. The Nextflow CHIP_MUTECT2 runs the same commands: its script block, run @@ -44,27 +44,18 @@ export FAKE_DOCKER_RUN_HOOK="${CASE_WORK}/hook-chip" C=/genome/sample1/chip/sample1_chip # --- the bash step --------------------------------------------------------------------- -# No common-sites VCF: no estimate, and the log says so. -: > "$FAKE_DOCKER_LOG" -run_expect 0 chip-no-common "${SCRIPTS}/49-chip.sh" sample1 -docker_log_has '^run image=[^ ]*gatk.* FilterMutectCalls .*--ob-priors ' "step 49 did not run FilterMutectCalls" -if grep -qE 'GetPileupSummaries|CalculateContamination|--contamination-table' "$FAKE_DOCKER_LOG"; then - fail "step 49 estimated contamination without the common-sites VCF" -fi -output_has chip-no-common 'no common-sites VCF .*: no contamination estimate' - # The common-sites VCF with its .tbi: the estimate, and FilterMutectCalls reads it. mkdir -p "${G}/somatic" printf 'placeholder\n' > "$COMMON" printf 'placeholder\n' > "${COMMON}.tbi" : > "$FAKE_DOCKER_LOG" run_expect 0 chip-common "${SCRIPTS}/49-chip.sh" sample1 -docker_log_has "^run image=[^ ]*gatk.* GetPileupSummaries -I /genome/sample1/aligned/sample1_sorted\\.bam -V /genome/somatic/small_exac_common_3\\.hg38\\.vcf\\.gz -L /genome/somatic/small_exac_common_3\\.hg38\\.vcf\\.gz -L ${C}\\.bed --interval-set-rule INTERSECTION -O ${C}_pileups\\.table" \ - "step 49 did not summarise the pileups at the common sites inside the CHIP exons" -docker_log_has "^run image=[^ ]*gatk.* CalculateContamination -I ${C}_pileups\\.table --tumor-segmentation ${C}_segments\\.table -O ${C}_contamination\\.table" \ - "step 49 did not estimate contamination from those pileups" docker_log_has "^run image=[^ ]*gatk.* FilterMutectCalls .*--contamination-table ${C}_contamination\\.table --tumor-segmentation ${C}_segments\\.table" \ "FilterMutectCalls did not get the contamination table" +docker_log_has "^run image=[^ ]*gatk.* GetPileupSummaries -I /genome/sample1/aligned/sample1_sorted\\.bam -V /genome/somatic/small_exac_common_3\\.hg38\\.vcf\\.gz -L /genome/somatic/small_exac_common_3\\.hg38\\.vcf\\.gz -O ${C}_pileups\\.table" \ + "step 49 did not summarise the pileups at every common site" +docker_log_has "^run image=[^ ]*gatk.* CalculateContamination -I ${C}_pileups\\.table --tumor-segmentation ${C}_segments\\.table -O ${C}_contamination\\.table" \ + "step 49 did not estimate contamination from those pileups" # The estimate comes before the filter that reads it. awk '/ CalculateContamination / { c = NR } / FilterMutectCalls / { f = NR } END { exit !(c && f > c) }' "$FAKE_DOCKER_LOG" \ || fail "FilterMutectCalls ran before CalculateContamination" @@ -76,7 +67,18 @@ rm -f "${COMMON}.tbi" : > "$FAKE_DOCKER_LOG" run_expect 0 chip-common-no-tbi "${SCRIPTS}/49-chip.sh" sample1 if grep -q -- '--contamination-table' "$FAKE_DOCKER_LOG"; then fail "step 49 used the common-sites VCF without its .tbi"; fi -output_has chip-common-no-tbi 'no contamination estimate' +output_has chip-common-no-tbi 'no common-sites VCF .*: no contamination estimate' + +# No common-sites VCF: no estimate, and the log says so. +rm -f "$COMMON" +: > "$FAKE_DOCKER_LOG" +run_expect 0 chip-no-common "${SCRIPTS}/49-chip.sh" sample1 +docker_log_has '^run image=[^ ]*gatk.* FilterMutectCalls .*--ob-priors ' "step 49 did not run FilterMutectCalls" +if grep -qE 'GetPileupSummaries|CalculateContamination|--contamination-table' "$FAKE_DOCKER_LOG"; then + fail "step 49 estimated contamination without the common-sites VCF" +fi +output_has chip-no-common 'no common-sites VCF .*: no contamination estimate' +printf 'placeholder\n' > "$COMMON" printf 'placeholder\n' > "${COMMON}.tbi" # --- CHIP_MUTECT2 (Nextflow) ------------------------------------------------------------- @@ -105,8 +107,8 @@ run_module() { cat "${NFW}/gatk.log" "${NFW}/out.txt" } run_module common.vcf.gz -grep -q '^gatk GetPileupSummaries -I in\.bam -V common\.vcf\.gz -L common\.vcf\.gz -L chip\.bed --interval-set-rule INTERSECTION -O pileups\.table$' "${NFW}/gatk.log" \ - || fail "CHIP_MUTECT2 did not summarise the pileups at the common sites inside the BED, as step 49 does" +grep -q '^gatk GetPileupSummaries -I in\.bam -V common\.vcf\.gz -L common\.vcf\.gz -O pileups\.table$' "${NFW}/gatk.log" \ + || fail "CHIP_MUTECT2 did not summarise the pileups at every common site, as step 49 does" grep -q '^gatk CalculateContamination -I pileups\.table --tumor-segmentation segments\.table -O contamination\.table$' "${NFW}/gatk.log" \ || fail "CHIP_MUTECT2 did not estimate contamination" grep -q '^gatk FilterMutectCalls .*--contamination-table contamination\.table --tumor-segmentation segments\.table .*-O s1_chip_filtered\.vcf\.gz$' "${NFW}/gatk.log" \ From 3ae8eccbd809c6fd2e6239e7aae70bad8fe20f11 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Fri, 20 Nov 2026 22:59:02 +0100 Subject: [PATCH 04/38] fix(carrier): keep the low-confidence mark and the zygosity on every carrier row The carrier list parsed each hit with the default call floor (GQ 30, DP 10) and dropped the floor the hits file states, and it wrote no call quality at all, so a weak call read like a sure one. Each row now has zygosity, gq, dp and low_confidence, judged against the file's own ##PGP_CALL_FLOOR, as the ClinVar section judges the same hit. A homozygous or hemizygous P/LP row has no unchanged copy, so it moves from carriers to a new list, hom_or_hemizygous. Two different heterozygous hits in one recessive gene get pair and phase from the haplotype rule of the secondary-findings card (two hits, possible two hits, or one copy in cis). A pair resting on a low-confidence call, and a deletion plus a low-confidence call (two_hits), is at most possible. The schema describes the carrier section; the summary-collect goldens change only in the carrier section. og-render's hemizygous tests read the row from its new list. Bead: clin-15 Bead: clin-19 --- rust/crates/og-render/tests/clinical.rs | 13 +- rust/crates/og-summary/src/collect/carrier.rs | 231 +++++++++++- .../crates/og-summary/src/collect/two_hits.rs | 24 +- .../tests/i411_carrier_confidence.rs | 335 ++++++++++++++++++ .../all-history/all-history.json | 56 ++- .../golden/summary-collect/all-nf/all-nf.json | 60 +++- .../golden/summary-collect/all/all.json | 56 ++- .../summary-collect/cb-full/cb-full.json | 64 +++- .../golden/summary-collect/cb-nf/cb-nf.json | 60 +++- .../summary-collect/cb-nfbad/cb-nfbad.json | 56 ++- .../summary-collect/cb-notbi/cb-notbi.json | 56 ++- .../cb-quoted-dosage/cb-quoted-dosage.json | 64 +++- .../cb-quoted-interval.json | 64 +++- .../cb-quoted-smn/cb-quoted-smn.json | 64 +++- .../cb-unicode-contig/cb-unicode-contig.json | 64 +++- tests/schema/summary.schema.json | 177 +++++++++ 16 files changed, 1309 insertions(+), 135 deletions(-) create mode 100644 rust/crates/og-summary/tests/i411_carrier_confidence.rs diff --git a/rust/crates/og-render/tests/clinical.rs b/rust/crates/og-render/tests/clinical.rs index 6bbd24cee..a235a8eea 100644 --- a/rust/crates/og-render/tests/clinical.rs +++ b/rust/crates/og-render/tests/clinical.rs @@ -812,7 +812,7 @@ fn a_homozygous_call_inside_a_deletion_is_hemizygous() { Some(&del("0/1", None)), ); let c = carrier_of(&d); - let item: Vec<&Value> = list(at(&c, &["carriers"])) + let item: Vec<&Value> = list(at(&c, &["hom_or_hemizygous"])) .iter() .filter(|x| s(at(x, &["gene"])) == "MUTYH") .collect(); @@ -836,7 +836,7 @@ fn a_homozygous_call_inside_a_deletion_is_hemizygous() { Some(&del("0/1", None)), ); let c = carrier_of(&d); - list(at(&c, &["carriers"])) + list(at(&c, &["hom_or_hemizygous"])) .iter() .find(|x| s(at(x, &["gene"])) == "MUTYH") .map(|x| s(at(x, &["genotype"])).to_owned()) @@ -923,8 +923,13 @@ fn both_reports_print_the_two_hit_line_and_the_hemizygous_genotype() { let (txt, html) = reports(&collect(&d)); assert!(txt.contains("Biallelic: MUTYH")); assert!(html.contains("Biallelic: MUTYH")); - assert!(html.contains("hemizygous (called homozygous inside DEL")); - assert!(txt.contains("hemizygous (called homozygous inside DEL")); + // The hit has no unchanged copy, so the summary lists it apart from the + // carriers (hom_or_hemizygous); the two-hit line still names it. + assert!( + html.replace(">", ">") + .contains("chr1:45336000 G>A hemizygous") + ); + assert!(txt.contains("chr1:45336000 G>A hemizygous")); assert!(txt.contains("biallelic with DEL chr1:45335000-45337000")); assert!(html.contains("biallelic with DEL chr1:45335000-45337000")); } diff --git a/rust/crates/og-summary/src/collect/carrier.rs b/rust/crates/og-summary/src/collect/carrier.rs index e02396a91..bafa8a8cd 100644 --- a/rust/crates/og-summary/src/collect/carrier.rs +++ b/rust/crates/og-summary/src/collect/carrier.rs @@ -6,18 +6,177 @@ //! called homozygous inside a deletion is shown as hemizygous. A hit that //! is part of step 06's combined allele, or the combined allele itself, //! carries the note the ClinVar table prints for it. +//! +//! Each row keeps its zygosity and step 06's call quality: GQ, DP and the +//! low-confidence mark against the hits file's own call floor. A carrier +//! has one changed copy, so a row called homozygous or hemizygous is listed +//! apart (`hom_or_hemizygous`), never as a carrier. Two different +//! heterozygous hits in one recessive gene are counted as copies, the way +//! the secondary-findings card counts them: read-backed phase on different +//! copies is two hits, phase unknown is possible two hits, both on one copy +//! is one hit. use super::assets::carrier_genes; -use super::clinvar::{Floor, Hit, HitRecords, allele_copies, carrier_genotype, obj}; +use super::clinvar::{ + Floor, Hit, HitRecords, VarKey, allele_copies, carrier_genotype, obj, opt_int, zygosity_word, +}; use super::text::{self, gt_field}; -use super::two_hits::{DeletionInputs, Spans, Variant, gene_deletions, two_hits}; +use super::two_hits::{DeletionInputs, Spans, Variant, gene_deletions, phase_haps, two_hits_with}; use indexmap::IndexMap; use pycompat::json::Value; +use std::collections::{BTreeSet, HashSet}; /// The section's data: the list, or why it could not be made. #[derive(Debug, Clone, PartialEq)] pub struct Carrier(pub Value); +/// One heterozygous carrier hit of a recessive gene, as the pair rule +/// counts it. +#[derive(Clone)] +struct Het { + key: VarKey, + gt: String, + ps: Option, + /// The parts of a combined allele (step 06's `PGP_JOINED_FROM`). + joined: Vec, + low: bool, +} + +impl Het { + /// The copies read-backed phase puts the alt allele on, with its phase + /// set: only a `|` GT with every copy called and a non-empty PS. + fn phased(&self) -> Option<(&str, BTreeSet)> { + let ps = self.ps.as_deref().filter(|p| !p.is_empty())?; + let h = phase_haps(Some(&self.gt)).filter(|h| !h.is_empty())?; + Some((ps, h)) + } + + /// The copy a half call (`1/.`, `./1`) puts its alt allele on. + fn half(&self) -> Option { + let a: Vec<&str> = self.gt.split(['/', '|']).collect(); + match a.as_slice() { + [x, "."] if !matches!(*x, "0" | ".") => Some(0), + [".", y] if !matches!(*y, "0" | ".") => Some(1), + _ => None, + } + } +} + +/// `CHROM:POS:REF:ALT` joined by `|`, as step 06 writes `PGP_JOINED_FROM`. +fn joined_keys(r: &[String]) -> Vec { + let info = r.get(7).map(String::as_str).unwrap_or(""); + let v = text::info_map(info) + .get("PGP_JOINED_FROM") + .copied() + .unwrap_or(""); + v.split('|') + .filter_map(|p| { + let mut it = p.rsplitn(4, ':'); + let (alt, rf, pos, chrom) = (it.next()?, it.next()?, it.next()?, it.next()?); + let pos = crate::int(pos).ok()?; + Some((chrom.to_owned(), pos, rf.to_owned(), alt.to_owned())) + }) + .collect() +} + +/// How two or more different heterozygous hits of one gene pair up: the +/// pair word (`two hits`, `possible two hits`, none when they sit on one +/// copy) and why. `None` when fewer than two distinct alleles are left +/// once a combined allele and its parts count once. +fn het_pair(hets: &[Het]) -> Option<(Option, String)> { + // A combined allele and its parts count once, under the combined + // allele, when its call is phased or at most one part is here; an + // unphased one with two or more parts here counts through its parts, + // which may sit on different copies. + let present: HashSet<&VarKey> = hets.iter().map(|h| &h.key).collect(); + let mut gone: HashSet<&VarKey> = HashSet::new(); + for h in hets.iter().filter(|h| !h.joined.is_empty()) { + let parts: Vec<&VarKey> = h.joined.iter().filter(|k| present.contains(k)).collect(); + if h.phased().is_some() || parts.len() <= 1 { + gone.extend(parts); + } else { + gone.insert(&h.key); + } + } + let kept: Vec<&Het> = hets.iter().filter(|h| !gone.contains(&h.key)).collect(); + if kept.len() < 2 { + return None; + } + let mut n = 0; + let mut sets: IndexMap<&str, (BTreeSet, usize)> = IndexMap::new(); + let mut halves: IndexMap<(&str, i128), (BTreeSet, usize)> = IndexMap::new(); + for h in &kept { + if let Some((ps, hs)) = h.phased() { + let s = sets.entry(ps).or_default(); + s.0.extend(hs); + s.1 += 1; + } else if let Some(i) = h.half() { + let s = halves.entry((h.key.0.as_str(), h.key.1)).or_default(); + s.0.insert(i); + s.1 += 1; + } else { + n += 1; + } + } + let mut proof: Option = None; + let mut cis: Option<&str> = None; + for (ps, (h, count)) in &sets { + n += h.len(); + if h.len() >= 2 { + proof.get_or_insert_with(|| { + format!( + "in trans: read-backed phase puts them on different copies (phase set {ps})" + ) + }); + } else if *count >= 2 { + cis.get_or_insert(ps); + } + } + for ((chrom, pos), (h, count)) in &halves { + if h.len() >= 2 { + n += 2 + count - h.len(); + proof.get_or_insert_with(|| { + format!("in trans: the two alt alleles of one call at {chrom}:{pos}") + }); + } else { + n += count; + } + } + let (word, why) = match (proof, cis) { + (Some(p), _) => ("two hits", p), + (None, _) if n >= 2 => ( + "possible two hits", + "phase unknown: no read-backed phase links the variants, so they may sit on the same \ + copy (cis)" + .to_owned(), + ), + (None, Some(ps)) => { + return Some(( + None, + format!( + "two heterozygous variants in cis: read-backed phase puts them on the same \ + copy (phase set {ps}), so one copy is hit" + ), + )); + } + (None, None) => { + return Some(( + None, + "the variants sit on one copy, so one copy is hit".to_owned(), + )); + } + }; + if kept.iter().any(|h| h.low) { + return Some(( + Some("possible two hits (low-confidence call)".to_owned()), + format!( + "a call below the call floor (low confidence) is one of them, so confirm it first; {why}" + ), + )); + } + Some((Some(word.to_owned()), why)) +} + impl Carrier { /// `carrier_list_or_note`. An `Err` is the collector's note (a hit /// whose POS is no integer). @@ -31,16 +190,22 @@ impl Carrier { Ok(g) => g, Err(e) => return Ok(unavailable(e)), }; - let recs = match hits { - Ok((_, r)) => r, + // The hits file's own call floor (`##PGP_CALL_FLOOR`), as the + // ClinVar section judges the same rows. + let (floor, recs): (Floor, _) = match hits { + Ok((f, r)) => (*f, r), Err(e) => return Ok(unavailable(e.clone())), }; let mut items: Vec> = Vec::new(); // Which list each item is on: carriers (false) or set aside (true). let mut aside: Vec = Vec::new(); let mut variants: Vec<(Variant, usize)> = Vec::new(); + let mut low: HashSet<(String, VarKey)> = HashSet::new(); + // The heterozygous carrier hits of each recessive gene, with the + // items they are. + let mut hets: IndexMap> = IndexMap::new(); for r in recs.iter().filter(|r| r.len() >= 8) { - let row = Hit::parse(r, Floor::default())?; + let row = Hit::parse(r, floor)?; let gt = text::gt_of(r).to_owned(); let (copies, ploidy) = allele_copies(>); let key = row.key(); @@ -50,8 +215,15 @@ impl Carrier { item.insert("gene".into(), Value::Str(g.to_owned())); item.insert("variant".into(), Value::Str(row.variant())); item.insert("genotype".into(), Value::Str(carrier_genotype(>, &row))); + item.insert( + "zygosity".into(), + Value::Str(zygosity_word(copies, ploidy).into()), + ); item.insert("significance".into(), Value::Str(row.significance.clone())); item.insert("stars".into(), Value::Int(row.stars.into())); + item.insert("gq".into(), opt_int(row.gq)); + item.insert("dp".into(), opt_int(row.dp)); + item.insert("low_confidence".into(), Value::Bool(row.low_confidence)); item.insert("inheritance".into(), Value::Str(x.inheritance.clone())); item.insert("condition".into(), Value::Str(x.condition.clone())); if row.combined_allele != "." { @@ -74,6 +246,21 @@ impl Carrier { }; items.push(item); aside.push(sev.is_some()); + if row.low_confidence { + low.insert((g.to_owned(), key.clone())); + } + if sev.is_none() && x.inheritance == "AR" && copies == 1 && ploidy == 2 { + hets.entry(g.to_owned()).or_default().push(( + Het { + key: key.clone(), + gt: gt.clone(), + ps: gt_field(r, "PS"), + joined: joined_keys(r), + low: row.low_confidence, + }, + items.len() - 1, + )); + } // A record with no alt copy called is no hit to pair. if copies > 0 && sev.is_none_or(|s| s.kind.as_deref() == Some("hypomorph")) { variants.push(( @@ -95,17 +282,39 @@ impl Carrier { } } } + for list in hets.values() { + // The same record twice (a duplicate line) is one allele. + let mut seen = HashSet::new(); + let distinct: Vec = list + .iter() + .filter(|(h, _)| seen.insert(h.key.clone())) + .map(|(h, _)| h.clone()) + .collect(); + let Some((word, why)) = het_pair(&distinct) else { + continue; + }; + for (_, at) in list { + let item = &mut items[*at]; + if let Some(w) = &word { + item.insert("pair".into(), Value::Str(w.clone())); + } + item.insert("phase".into(), Value::Str(why.clone())); + } + } let spans: Spans = genes .iter() .map(|(g, x)| (g.clone(), x.span.clone())) .collect(); let (dels, read, unread) = gene_deletions(deletions, &spans); let vs: Vec = variants.iter().map(|(v, _)| v.clone()).collect(); - let found = two_hits(&vs, &dels); + let found = two_hits_with(&vs, &dels, |v| { + low.contains(&(v.gene.clone(), v.key.clone())) + }); for (v, at) in &variants { if let Some(t) = found.hemi.get(&(v.gene.clone(), v.key.clone())) { let item = &mut items[*at]; item.insert("genotype".into(), Value::Str("hemizygous".into())); + item.insert("zygosity".into(), Value::Str("hemizygous".into())); item.insert( "hemizygous".into(), Value::Str(format!("called homozygous inside {t}")), @@ -124,10 +333,17 @@ impl Carrier { Value::Object(m) }) .collect(); - let (mut carriers, mut set_aside) = (Vec::new(), Vec::new()); + let (mut carriers, mut both, mut set_aside) = (Vec::new(), Vec::new(), Vec::new()); for (item, a) in items.into_iter().zip(aside) { + let zyg = match item.get("zygosity") { + Some(Value::Str(z)) => z.clone(), + _ => String::new(), + }; if a { set_aside.push(Value::Object(item)); + } else if matches!(zyg.as_str(), "hom" | "hemizygous") { + // No unchanged copy left: not the pattern of a carrier. + both.push(Value::Object(item)); } else { carriers.push(Value::Object(item)); } @@ -137,6 +353,7 @@ impl Carrier { ("genes_on_list", Value::Int(genes.len() as i128)), ("list", Value::Str("assets/carrier_genes.tsv".into())), ("carriers", Value::Array(carriers)), + ("hom_or_hemizygous", Value::Array(both)), ("set_aside", Value::Array(set_aside)), ( "two_hits", diff --git a/rust/crates/og-summary/src/collect/two_hits.rs b/rust/crates/og-summary/src/collect/two_hits.rs index 3841788ac..0e273ddef 100644 --- a/rust/crates/og-summary/src/collect/two_hits.rs +++ b/rust/crates/og-summary/src/collect/two_hits.rs @@ -76,6 +76,9 @@ pub enum Verdict { Biallelic, /// Phase unknown, or the calls disagree: possibly both copies. PossiblyBiallelic, + /// A pair that would count, but the small variant's call is below + /// step 06's call floor: confirm the call first. + LowConfidence, /// Both on the same copy: no second hit. Cis, } @@ -85,6 +88,7 @@ impl Verdict { match self { Verdict::Biallelic => "biallelic", Verdict::PossiblyBiallelic => "possibly biallelic", + Verdict::LowConfidence => "possibly biallelic (low-confidence call)", Verdict::Cis => "cis", } } @@ -229,12 +233,23 @@ pub struct TwoHits { /// The genes hit twice. pub fn two_hits(variants: &[Variant], dels: &HashMap>) -> TwoHits { + two_hits_with(variants, dels, |_| false) +} + +/// [`two_hits`], where a pair built on a variant `low` calls low +/// confidence (below step 06's call floor) is never more than +/// [`Verdict::LowConfidence`]. +pub fn two_hits_with( + variants: &[Variant], + dels: &HashMap>, + low: impl Fn(&Variant) -> bool, +) -> TwoHits { let mut out = TwoHits::default(); let mut best: HashMap<(String, VKey), Verdict> = HashMap::new(); for v in variants { let k = (v.gene.clone(), v.key.clone()); for dl in dels.get(&v.gene).map_or(&[][..], Vec::as_slice) { - let (verdict, why) = pair_phase(dl, v); + let (mut verdict, mut why) = pair_phase(dl, v); if verdict == Verdict::Biallelic && why.starts_with("the variant is called homozygous") { out.hemi.insert(k.clone(), dl.text.clone()); @@ -242,6 +257,13 @@ pub fn two_hits(variants: &[Variant], dels: &HashMap>) -> if verdict == Verdict::Cis { continue; } + if low(v) { + verdict = Verdict::LowConfidence; + why = format!( + "the variant's call is below the call floor (low confidence), so confirm it \ + first; {why}" + ); + } let e = Entry { gene: v.gene.clone(), verdict, diff --git a/rust/crates/og-summary/tests/i411_carrier_confidence.rs b/rust/crates/og-summary/tests/i411_carrier_confidence.rs new file mode 100644 index 000000000..54c716aaf --- /dev/null +++ b/rust/crates/og-summary/tests/i411_carrier_confidence.rs @@ -0,0 +1,335 @@ +//! The carrier list keeps each hit's call quality and zygosity, and counts +//! two hits in one gene as copies. +//! +//! The list used to judge every hit at GQ 30 and DP 10, whatever floor the +//! hits file states, and it dropped the low-confidence mark the ClinVar +//! section shows for the same row. It listed a homozygous or hemizygous +//! P/LP row as a carrier beside the heterozygous ones, two different +//! heterozygous hits of one recessive gene as two plain carrier rows, and a +//! deletion plus a low-confidence call as a confident two-hit gene. These +//! cases run the list on synthetic hits with the shipped +//! `assets/carrier_genes.tsv`. + +use indexmap::IndexMap; +use og_summary::collect::carrier::Carrier; +use og_summary::collect::clinvar::{Floor, HitRecords, HitsVcf}; +use og_summary::collect::two_hits::{DeletionInputs, SvRow}; +use pycompat::json::Value; + +const ASSETS: &str = concat!(env!("CARGO_MANIFEST_DIR"), "/../../../assets"); + +// MUTYH and CFTR spans in assets/carrier_genes.tsv: chr1:45329163-45340893 +// and chr7:117287120-117715971. MUTYH is on the ACMG SF list, CFTR is not. +const MUTYH_A: (&str, i128, &str, &str) = ("chr1", 45_331_556, "C", "T"); +const CFTR_A: (&str, i128, &str, &str) = ("chr7", 117_559_590, "ATCT", "A"); +const CFTR_B: (&str, i128, &str, &str) = ("chr7", 117_587_806, "G", "T"); +const OTC_A: (&str, i128, &str, &str) = ("chrX", 38_400_000, "C", "T"); + +/// One step 06 hit: Pathogenic with 2 stars, the FORMAT values given (GT +/// first), and `info` added to INFO. +fn hit( + site: (&str, i128, &str, &str), + gene: &str, + fmt: &str, + sample: &str, + info: &str, +) -> Vec { + let info = format!( + "GENEINFO={gene}:1;CLNSIG=Pathogenic;\ + CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts{info}" + ); + [ + site.0, + &site.1.to_string(), + ".", + site.2, + site.3, + ".", + "PASS", + &info, + fmt, + sample, + ] + .iter() + .map(|s| (*s).to_owned()) + .collect() +} + +/// A hit with good call quality (GQ 50, DP 30). +fn good(site: (&str, i128, &str, &str), gene: &str, gt: &str, ps: Option<&str>) -> Vec { + match ps { + Some(p) => hit(site, gene, "GT:GQ:DP:PS", &format!("{gt}:50:30:{p}"), ""), + None => hit(site, gene, "GT:GQ:DP", &format!("{gt}:50:30"), ""), + } +} + +fn no_deletions() -> DeletionInputs { + DeletionInputs { + annotsv: Ok(None), + step35: Ok(None), + } +} + +/// A class 5 MUTYH deletion, chr1:45335000-45337000, GT and PS as given. +fn mutyh_deletion(gt: &str, ps: Option<&str>) -> DeletionInputs { + DeletionInputs { + annotsv: Ok(Some(vec![SvRow { + sv: "chr1:45335000-45337000".into(), + sv_type: Some("DEL".into()), + gt: Some(gt.into()), + ps: ps.map(str::to_owned), + acmg_class: Some("5".into()), + genes: vec!["MUTYH".into()], + caller: Some("manta".into()), + support: None, + common: false, + }])), + step35: Ok(None), + } +} + +fn list(hits: Vec>, dels: &DeletionInputs) -> IndexMap { + let h: Result = Ok((Floor::default(), hits)); + obj(Carrier::read(ASSETS, &h, dels).unwrap().to_json()) +} + +fn obj(v: Value) -> IndexMap { + match v { + Value::Object(m) => m, + x => panic!("{x:?}"), + } +} + +fn rows<'a>(m: &'a IndexMap, k: &str) -> Vec<&'a IndexMap> { + let Some(Value::Array(a)) = m.get(k) else { + panic!("{k}: {m:?}") + }; + a.iter() + .map(|x| match x { + Value::Object(o) => o, + _ => panic!("{x:?}"), + }) + .collect() +} + +fn s<'a>(m: &'a IndexMap, k: &str) -> &'a str { + match m.get(k) { + Some(Value::Str(x)) => x, + x => panic!("{k}: {x:?} in {m:?}"), + } +} + +fn of<'a>(m: &'a IndexMap, k: &str, gene: &str) -> Vec<&'a IndexMap> { + rows(m, k) + .into_iter() + .filter(|r| s(r, "gene") == gene) + .collect() +} + +#[test] +fn a_weak_call_keeps_its_low_confidence_mark() { + let c = list( + vec![hit(MUTYH_A, "MUTYH", "GT:GQ:DP", "0/1:1:1", "")], + &no_deletions(), + ); + let r = of(&c, "carriers", "MUTYH"); + assert_eq!(r.len(), 1, "{c:?}"); + assert_eq!( + r[0].get("low_confidence"), + Some(&Value::Bool(true)), + "{r:?}" + ); + assert_eq!(r[0].get("gq"), Some(&Value::Int(1))); + assert_eq!(r[0].get("dp"), Some(&Value::Int(1))); + assert_eq!(s(r[0], "zygosity"), "het"); + + let c = list(vec![good(MUTYH_A, "MUTYH", "0/1", None)], &no_deletions()); + let r = of(&c, "carriers", "MUTYH"); + assert_eq!( + r[0].get("low_confidence"), + Some(&Value::Bool(false)), + "{r:?}" + ); +} + +#[test] +fn the_hits_file_floor_judges_the_carrier_rows() { + let dir = std::env::temp_dir().join(format!("og-i411-carrier-floor-{}", std::process::id())); + std::fs::create_dir_all(&dir).unwrap(); + let path = dir.join("S_clinvar_hits.vcf"); + let rec = hit(MUTYH_A, "MUTYH", "GT:GQ:DP", "0/1:35:20", "").join("\t"); + std::fs::write( + &path, + format!( + "##fileformat=VCFv4.2\n##PGP_CALL_FLOOR=GQ=40,DP=15\n\ + #CHROM\tPOS\tID\tREF\tALT\tQUAL\tFILTER\tINFO\tFORMAT\tS\n{rec}\n" + ), + ) + .unwrap(); + let p = path.to_string_lossy().into_owned(); + let vcf = HitsVcf::read(p.clone(), p); + std::fs::remove_dir_all(&dir).unwrap(); + assert_eq!(vcf.read.as_ref().unwrap().0, Floor { gq: 40, dp: 15 }); + let c = obj(Carrier::read(ASSETS, &vcf.read, &no_deletions()) + .unwrap() + .to_json()); + let r = of(&c, "carriers", "MUTYH"); + assert_eq!(r.len(), 1, "{c:?}"); + assert_eq!( + r[0].get("low_confidence"), + Some(&Value::Bool(true)), + "GQ 35 is below the file's floor of GQ 40: {r:?}" + ); +} + +#[test] +fn a_homozygous_or_hemizygous_row_is_no_carrier() { + let c = list( + vec![ + good(CFTR_A, "CFTR", "1/1", None), + good(OTC_A, "OTC", "1", None), + good(MUTYH_A, "MUTYH", "0/1", None), + ], + &no_deletions(), + ); + let carriers: Vec<&str> = rows(&c, "carriers").iter().map(|r| s(r, "gene")).collect(); + assert_eq!(carriers, ["MUTYH"], "{c:?}"); + let both: Vec<(&str, &str)> = rows(&c, "hom_or_hemizygous") + .iter() + .map(|r| (s(r, "gene"), s(r, "zygosity"))) + .collect(); + assert_eq!(both, [("CFTR", "hom"), ("OTC", "hemizygous")]); +} + +#[test] +fn a_homozygous_call_inside_a_deletion_is_listed_hemizygous_apart() { + let inside = ("chr1", 45_336_000, "G", "A"); + let c = list( + vec![good(inside, "MUTYH", "1/1", None)], + &mutyh_deletion("0/1", None), + ); + assert!(of(&c, "carriers", "MUTYH").is_empty(), "{c:?}"); + let r = of(&c, "hom_or_hemizygous", "MUTYH"); + assert_eq!(r.len(), 1, "{c:?}"); + assert_eq!(s(r[0], "genotype"), "hemizygous"); + assert_eq!(s(r[0], "zygosity"), "hemizygous"); +} + +#[test] +fn two_unphased_hets_in_one_recessive_gene_are_possible_two_hits() { + let c = list( + vec![ + good(CFTR_A, "CFTR", "0/1", None), + good(CFTR_B, "CFTR", "0/1", None), + ], + &no_deletions(), + ); + let r = of(&c, "carriers", "CFTR"); + assert_eq!(r.len(), 2, "{c:?}"); + for x in r { + assert_eq!(s(x, "pair"), "possible two hits", "{x:?}"); + assert!(s(x, "phase").starts_with("phase unknown"), "{x:?}"); + } +} + +#[test] +fn read_backed_phase_decides_two_hits_or_one_copy() { + let trans = list( + vec![ + good(CFTR_A, "CFTR", "0|1", Some("9")), + good(CFTR_B, "CFTR", "1|0", Some("9")), + ], + &no_deletions(), + ); + for x in of(&trans, "carriers", "CFTR") { + assert_eq!(s(x, "pair"), "two hits", "{x:?}"); + assert!(s(x, "phase").contains("phase set 9"), "{x:?}"); + } + let cis = list( + vec![ + good(CFTR_A, "CFTR", "0|1", Some("9")), + good(CFTR_B, "CFTR", "0|1", Some("9")), + ], + &no_deletions(), + ); + for x in of(&cis, "carriers", "CFTR") { + assert!(x.get("pair").is_none(), "a cis pair is one copy: {x:?}"); + assert!( + s(x, "phase").starts_with("two heterozygous variants in cis"), + "{x:?}" + ); + } + // A phased GT without a phase set says nothing about the other call. + let no_ps = list( + vec![ + good(CFTR_A, "CFTR", "0|1", None), + good(CFTR_B, "CFTR", "1|0", None), + ], + &no_deletions(), + ); + for x in of(&no_ps, "carriers", "CFTR") { + assert_eq!(s(x, "pair"), "possible two hits", "{x:?}"); + } +} + +#[test] +fn a_low_confidence_call_makes_two_hits_only_possible() { + let c = list( + vec![ + good(CFTR_A, "CFTR", "0|1", Some("9")), + hit(CFTR_B, "CFTR", "GT:GQ:DP:PS", "1|0:5:4:9", ""), + ], + &no_deletions(), + ); + for x in of(&c, "carriers", "CFTR") { + assert_eq!( + s(x, "pair"), + "possible two hits (low-confidence call)", + "{x:?}" + ); + } +} + +#[test] +fn a_combined_allele_and_its_part_are_one_allele() { + let joined = format!( + ";PGP_JOINED_FROM={}:{}:{}:{}|chr7:117559600:G:A", + CFTR_A.0, CFTR_A.1, CFTR_A.2, CFTR_A.3 + ); + let c = list( + vec![ + good(CFTR_A, "CFTR", "0/1", None), + hit(CFTR_B, "CFTR", "GT:GQ:DP", "0/1:50:30", &joined), + ], + &no_deletions(), + ); + for x in of(&c, "carriers", "CFTR") { + assert!(x.get("pair").is_none(), "{x:?}"); + assert!(x.get("phase").is_none(), "{x:?}"); + } +} + +fn two_hit_verdict(c: &IndexMap, gene: &str) -> String { + let Some(Value::Object(t)) = c.get("two_hits") else { + panic!("{c:?}") + }; + let g = rows(t, "genes"); + let g: Vec<_> = g.into_iter().filter(|r| s(r, "gene") == gene).collect(); + assert_eq!(g.len(), 1, "{t:?}"); + s(g[0], "verdict").to_owned() +} + +#[test] +fn a_deletion_plus_a_low_confidence_call_is_only_possibly_biallelic() { + let dels = mutyh_deletion("1|0", Some("5")); + let sure = list(vec![good(MUTYH_A, "MUTYH", "0|1", Some("5"))], &dels); + assert_eq!(two_hit_verdict(&sure, "MUTYH"), "biallelic"); + let weak = list( + vec![hit(MUTYH_A, "MUTYH", "GT:GQ:DP:PS", "0|1:12:6:5", "")], + &dels, + ); + assert_eq!( + two_hit_verdict(&weak, "MUTYH"), + "possibly biallelic (low-confidence call)" + ); +} diff --git a/tests/parity/golden/summary-collect/all-history/all-history.json b/tests/parity/golden/summary-collect/all-history/all-history.json index 6df9f687b..6dd6f2188 100644 --- a/tests/parity/golden/summary-collect/all-history/all-history.json +++ b/tests/parity/golden/summary-collect/all-history/all-history.json @@ -12795,8 +12795,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -12804,8 +12808,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -12813,8 +12821,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -12822,8 +12834,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -12832,37 +12848,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy", "hemizygous": "called homozygous inside one SMN1 copy (Parascopy, step 35)" @@ -12873,8 +12907,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", diff --git a/tests/parity/golden/summary-collect/all-nf/all-nf.json b/tests/parity/golden/summary-collect/all-nf/all-nf.json index 700cb8ce2..b72d542d4 100644 --- a/tests/parity/golden/summary-collect/all-nf/all-nf.json +++ b/tests/parity/golden/summary-collect/all-nf/all-nf.json @@ -12604,8 +12604,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -12613,8 +12617,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -12622,8 +12630,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -12631,8 +12643,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -12641,37 +12657,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hom", + "zygosity": "hom", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy" } @@ -12681,8 +12715,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", @@ -12693,8 +12731,8 @@ "genes": [ { "gene": "CFTR", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "CFTR_del deletion, 1 of 2 copies (read depth, step 35)", "variant": "chr7:117559590 ATCT>A", "genotype": "het", diff --git a/tests/parity/golden/summary-collect/all/all.json b/tests/parity/golden/summary-collect/all/all.json index 467431b39..d3f14cfe2 100644 --- a/tests/parity/golden/summary-collect/all/all.json +++ b/tests/parity/golden/summary-collect/all/all.json @@ -12800,8 +12800,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -12809,8 +12813,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -12818,8 +12826,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -12827,8 +12839,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -12837,37 +12853,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy", "hemizygous": "called homozygous inside one SMN1 copy (Parascopy, step 35)" @@ -12878,8 +12912,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", diff --git a/tests/parity/golden/summary-collect/cb-full/cb-full.json b/tests/parity/golden/summary-collect/cb-full/cb-full.json index 86fc5522d..bb8c3eff3 100644 --- a/tests/parity/golden/summary-collect/cb-full/cb-full.json +++ b/tests/parity/golden/summary-collect/cb-full/cb-full.json @@ -378,8 +378,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -387,8 +391,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -396,8 +404,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -405,8 +417,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -415,37 +431,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy", "hemizygous": "called homozygous inside one SMN1 copy (Parascopy, step 35)" @@ -456,8 +490,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", @@ -468,8 +506,8 @@ "genes": [ { "gene": "CFTR", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "CFTR_del deletion, 1 of 2 copies (read depth, step 35)", "variant": "chr7:117559590 ATCT>A", "genotype": "het", @@ -479,8 +517,8 @@ }, { "gene": "GJB2", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "DEL chr13:20180000-20200000 (AnnotSV class 4, Manta)", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", diff --git a/tests/parity/golden/summary-collect/cb-nf/cb-nf.json b/tests/parity/golden/summary-collect/cb-nf/cb-nf.json index ea2911faa..5bbe94c9a 100644 --- a/tests/parity/golden/summary-collect/cb-nf/cb-nf.json +++ b/tests/parity/golden/summary-collect/cb-nf/cb-nf.json @@ -259,8 +259,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -268,8 +272,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -277,8 +285,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -286,8 +298,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -296,37 +312,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hom", + "zygosity": "hom", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy" } @@ -336,8 +370,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", @@ -348,8 +386,8 @@ "genes": [ { "gene": "CFTR", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "CFTR_del deletion, 1 of 2 copies (read depth, step 35)", "variant": "chr7:117559590 ATCT>A", "genotype": "het", diff --git a/tests/parity/golden/summary-collect/cb-nfbad/cb-nfbad.json b/tests/parity/golden/summary-collect/cb-nfbad/cb-nfbad.json index 76b421bcc..366a2d0d9 100644 --- a/tests/parity/golden/summary-collect/cb-nfbad/cb-nfbad.json +++ b/tests/parity/golden/summary-collect/cb-nfbad/cb-nfbad.json @@ -259,8 +259,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -268,8 +272,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -277,8 +285,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -286,8 +298,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -296,37 +312,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hom", + "zygosity": "hom", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy" } @@ -336,8 +370,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", diff --git a/tests/parity/golden/summary-collect/cb-notbi/cb-notbi.json b/tests/parity/golden/summary-collect/cb-notbi/cb-notbi.json index c7668ea8a..2217746a0 100644 --- a/tests/parity/golden/summary-collect/cb-notbi/cb-notbi.json +++ b/tests/parity/golden/summary-collect/cb-notbi/cb-notbi.json @@ -259,8 +259,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -268,8 +272,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -277,8 +285,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -286,8 +298,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -296,37 +312,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hom", + "zygosity": "hom", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy" } @@ -336,8 +370,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", diff --git a/tests/parity/golden/summary-collect/cb-quoted-dosage/cb-quoted-dosage.json b/tests/parity/golden/summary-collect/cb-quoted-dosage/cb-quoted-dosage.json index 86fc5522d..bb8c3eff3 100644 --- a/tests/parity/golden/summary-collect/cb-quoted-dosage/cb-quoted-dosage.json +++ b/tests/parity/golden/summary-collect/cb-quoted-dosage/cb-quoted-dosage.json @@ -378,8 +378,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -387,8 +391,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -396,8 +404,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -405,8 +417,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -415,37 +431,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy", "hemizygous": "called homozygous inside one SMN1 copy (Parascopy, step 35)" @@ -456,8 +490,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", @@ -468,8 +506,8 @@ "genes": [ { "gene": "CFTR", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "CFTR_del deletion, 1 of 2 copies (read depth, step 35)", "variant": "chr7:117559590 ATCT>A", "genotype": "het", @@ -479,8 +517,8 @@ }, { "gene": "GJB2", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "DEL chr13:20180000-20200000 (AnnotSV class 4, Manta)", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", diff --git a/tests/parity/golden/summary-collect/cb-quoted-interval/cb-quoted-interval.json b/tests/parity/golden/summary-collect/cb-quoted-interval/cb-quoted-interval.json index 86fc5522d..bb8c3eff3 100644 --- a/tests/parity/golden/summary-collect/cb-quoted-interval/cb-quoted-interval.json +++ b/tests/parity/golden/summary-collect/cb-quoted-interval/cb-quoted-interval.json @@ -378,8 +378,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -387,8 +391,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -396,8 +404,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -405,8 +417,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -415,37 +431,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy", "hemizygous": "called homozygous inside one SMN1 copy (Parascopy, step 35)" @@ -456,8 +490,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", @@ -468,8 +506,8 @@ "genes": [ { "gene": "CFTR", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "CFTR_del deletion, 1 of 2 copies (read depth, step 35)", "variant": "chr7:117559590 ATCT>A", "genotype": "het", @@ -479,8 +517,8 @@ }, { "gene": "GJB2", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "DEL chr13:20180000-20200000 (AnnotSV class 4, Manta)", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", diff --git a/tests/parity/golden/summary-collect/cb-quoted-smn/cb-quoted-smn.json b/tests/parity/golden/summary-collect/cb-quoted-smn/cb-quoted-smn.json index 86fc5522d..bb8c3eff3 100644 --- a/tests/parity/golden/summary-collect/cb-quoted-smn/cb-quoted-smn.json +++ b/tests/parity/golden/summary-collect/cb-quoted-smn/cb-quoted-smn.json @@ -378,8 +378,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -387,8 +391,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -396,8 +404,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -405,8 +417,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -415,37 +431,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy", "hemizygous": "called homozygous inside one SMN1 copy (Parascopy, step 35)" @@ -456,8 +490,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", @@ -468,8 +506,8 @@ "genes": [ { "gene": "CFTR", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "CFTR_del deletion, 1 of 2 copies (read depth, step 35)", "variant": "chr7:117559590 ATCT>A", "genotype": "het", @@ -479,8 +517,8 @@ }, { "gene": "GJB2", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "DEL chr13:20180000-20200000 (AnnotSV class 4, Manta)", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", diff --git a/tests/parity/golden/summary-collect/cb-unicode-contig/cb-unicode-contig.json b/tests/parity/golden/summary-collect/cb-unicode-contig/cb-unicode-contig.json index 86fc5522d..bb8c3eff3 100644 --- a/tests/parity/golden/summary-collect/cb-unicode-contig/cb-unicode-contig.json +++ b/tests/parity/golden/summary-collect/cb-unicode-contig/cb-unicode-contig.json @@ -378,8 +378,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -387,8 +391,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -396,8 +404,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -405,8 +417,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -415,37 +431,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy", "hemizygous": "called homozygous inside one SMN1 copy (Parascopy, step 35)" @@ -456,8 +490,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", @@ -468,8 +506,8 @@ "genes": [ { "gene": "CFTR", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "CFTR_del deletion, 1 of 2 copies (read depth, step 35)", "variant": "chr7:117559590 ATCT>A", "genotype": "het", @@ -479,8 +517,8 @@ }, { "gene": "GJB2", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "DEL chr13:20180000-20200000 (AnnotSV class 4, Manta)", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", diff --git a/tests/schema/summary.schema.json b/tests/schema/summary.schema.json index db8383557..04a17dd07 100644 --- a/tests/schema/summary.schema.json +++ b/tests/schema/summary.schema.json @@ -55,6 +55,99 @@ "type": "string" } } + }, + "carrier_row": { + "type": "object", + "required": [ + "gene", + "variant", + "genotype", + "zygosity", + "significance", + "stars", + "gq", + "dp", + "low_confidence", + "inheritance", + "condition" + ], + "properties": { + "gene": { + "type": "string" + }, + "variant": { + "type": "string" + }, + "genotype": { + "type": "string" + }, + "zygosity": { + "enum": [ + "het", + "hom", + "hemizygous", + "unknown" + ] + }, + "significance": { + "type": "string" + }, + "stars": { + "enum": [ + 0, + 1, + 2, + 3, + 4 + ] + }, + "gq": { + "type": [ + "integer", + "null" + ] + }, + "dp": { + "type": [ + "integer", + "null" + ] + }, + "low_confidence": { + "type": "boolean" + }, + "inheritance": { + "type": "string" + }, + "condition": { + "type": "string" + }, + "combined_allele": { + "type": "string" + }, + "kind": { + "type": [ + "string", + "null" + ] + }, + "name": { + "type": "string" + }, + "hemizygous": { + "type": "string" + }, + "pair": { + "enum": [ + "two hits", + "possible two hits", + "possible two hits (low-confidence call)" + ] + }, + "phase": { + "type": "string" + } + } } }, "type": "object", @@ -1408,6 +1501,90 @@ } ] }, + "carrier": { + "allOf": [ + { + "$ref": "#/definitions/section" + }, + { + "properties": { + "data": { + "type": "object", + "properties": { + "unavailable": { + "type": "string" + }, + "genes_on_list": { + "type": "integer", + "minimum": 0 + }, + "list": { + "type": "string" + }, + "carriers": { + "type": "array", + "items": { + "$ref": "#/definitions/carrier_row" + } + }, + "hom_or_hemizygous": { + "type": "array", + "items": { + "$ref": "#/definitions/carrier_row" + } + }, + "set_aside": { + "type": "array", + "items": { + "$ref": "#/definitions/carrier_row" + } + }, + "two_hits": { + "type": "object", + "properties": { + "genes": { + "type": "array", + "items": { + "type": "object", + "required": [ + "gene", + "verdict", + "why", + "deletion", + "variant", + "genotype" + ], + "properties": { + "verdict": { + "enum": [ + "biallelic", + "possibly biallelic", + "possibly biallelic (low-confidence call)" + ] + } + } + } + }, + "deletions_read": { + "type": "array", + "items": { + "type": "string" + } + }, + "deletions_not_read": { + "type": "array", + "items": { + "type": "string" + } + } + } + } + } + } + } + } + ] + }, "cpsr": { "allOf": [ { From f1d31c88fad8d9911dff0ef60c675a548dad8926 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Fri, 20 Nov 2026 22:59:02 +0100 Subject: [PATCH 05/38] docs(carrier): say what each carrier row carries and when a row is no carrier Bead: clin-15 Bead: clin-19 --- CHANGELOG.md | 1 + docs/results/secondary-findings.md | 3 +++ 2 files changed, 4 insertions(+) diff --git a/CHANGELOG.md b/CHANGELOG.md index 893fff178..e4a0853bf 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,6 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`, and the report's carrier count leaves it out; the ClinVar table still shows it. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. A pair that rests on a low-confidence call is at most `possible two hits (low-confidence call)`, and a deletion plus a low-confidence call in one gene reads `possibly biallelic (low-confidence call)` under `two_hits`. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - The live site's family page and its pedigree drawing are now built by `og live family`, in Rust. `bin/owngenome_live_family.py` asks `og` for a family's state, its `family.json`, the list of files it serves and `pedigree.svg`, and no longer reads the family's tables itself; `bin/pedigree_svg.py` and `bin/family_report.py` are gone. The page shows the same thing: `family.json` and the drawing were compared with the old code on the demo family and the test families, field by field and number by number, and matched. The live site therefore needs `og` (`scripts/setup.sh --og` installs it); without it a family's `family.json` answers 500, its `pedigree.svg` answers 503, and the run list marks each family unreadable. A family file that cannot be read still gives no page and an unreadable family. - The local genome viewer runs on `og` and no longer needs `python3` on the host. `scripts/owngenome-view.sh` starts `og view serve` (through `bin/og`, or `OG`), which serves the same page, config and byte ranges on 127.0.0.1 as `assets/viewer/serve.py` did. Two requests it answered before are now refused. A locus whose end comes before its start (`chr1:13000-12000`) stops the script with exit 2 and the reason, instead of opening a view igv.js cannot show. A request with a `Forwarded`, `X-Forwarded-*` or `X-Real-IP` header gets 403: the viewer has no password, so a reverse proxy in front of it would hand the sample to anyone who reaches the proxy; an ssh port forward still works. The default SV track is now Manta's diploid SVs (step 4), else step 22's consensus, which keeps only the calls two callers agree on. `docs/viewer.md` says that every account on the machine can reach 127.0.0.1. No option of the script, file or output name changes; `og view serve` takes the flags `serve.py` took, plus `--assets`, the page's folder. The live site's viewer also opens Manta's diploid SVs first; the rest of it is unchanged until its server moves to `og`. Part of #411 (plat-11, plat-12). - Step 22's SV consensus no longer counts a record a caller did not call as a second caller. Before, every PASS record went to SURVIVOR, so a PASS Delly record genotyped `0/0`, a Delly call whose sample filter (`FT`) says `LowQual`, or a CNVpytor segment no quality rule had read sat beside a Manta-only call and made it read "2 callers". A new verb, `og sv survivor-prep --caller NAME IN OUT`, now writes each caller's input for both the script and the Nextflow `SURVIVOR_PREP`, in place of the bcftools and awk they each carried. A record votes when its FILTER and its sample `FT` are `PASS` or `.` and its genotype is not reference only (`0/0`, `0|0`, haploid `0`, `0/.`); a no-call (`./.`) and a sites-only record still vote. A CNVpytor call votes when its e-value is below 0.01 and its share of MAPQ 0 reads below 0.5, the rule step 05 already applies when it adds CNVpytor's calls; the VCF step 22 makes from CNVpytor's table now carries the table's e-value, `q0` and `pN` as `pytorP1`, `pytorQ0` and `pytorPN`, so the rule reads both inputs. A header without `GT` or without these tags no longer matters. Step 18's closing hint and `docs/18-cnvpytor.md` gave e-value below 0.05 and size over 1 kb; they now give the same rule. What changes in the output: `sv_merged/inputs/.vcf` holds only the records that vote, and the consensus can hold fewer records. No file, column or option is renamed or removed. Part of #411 (sv-05, sv-06, sv-09, sv-10, sv-11, sv-40). diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index 28ef4721d..ebfe7287d 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,6 +14,8 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`, the carrier count leaves it out, and the ClinVar table still shows it. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. When one of the two is a low-confidence call, the pair is at most `possible two hits (low-confidence call)`. The reports do not show these fields yet. + **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: - a dominant gene (BRCA1, LDLR, MYH7 and most others): one pathogenic or likely pathogenic variant is reported; @@ -27,6 +29,7 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta - **biallelic** when the reads show the two hits on different copies. Either the hit is called homozygous inside the deletion, so it sits on the one copy left (the line and the carrier list call it hemizygous; if the deletion is a false call, the hit is homozygous and both copies still carry it), or both calls carry read-backed phase (a `|` genotype with the same phase set, PS) on different copies. A low-expression (hypomorph) allele called homozygous inside a deletion is only **possibly biallelic**: it causes disease with a null allele only if the deletion is real, so confirm the deletion (array or MLPA); - **possibly biallelic** otherwise: the phase is unknown. Most short-read calls carry no phase, so this is the usual line. Step 05's checked table keeps no genotype column yet, and step 35's counts have no phase, so in a pipeline run a deletion pairs as possibly biallelic unless the hit is called homozygous inside it. A parent's genome (step 38, [family analysis](../multi-sample.md#family-analysis-step-38-opt-in)) or long reads can settle it; +- **possibly biallelic (low-confidence call)** when the pair would count but the small variant's call is below step 6's call floor (its `low_confidence` mark): confirm the call first; - no line when read-backed phase puts both on the same copy (cis): the other copy is intact. Examples: an exon deletion of MUTYH plus a pathogenic MUTYH variant; three alpha-globin genes plus an HBA2 point variant; one SMN1 copy plus an SMN1 variant (short reads place few SMN1 variants reliably, so check with a targeted test); and the 1q21.1 deletion plus one of the two RBM8A low-expression alleles (c.-21G>A, rs139428292, or c.67+32G>C, rs201779890), the cause of TAR syndrome (thrombocytopenia with absent radius; Albers et al., Nat Genet 2012;44(4):435-439, PMID 22366785). On its own an RBM8A low-expression allele stays set aside. The [couple screen](../39-couple.md) (step 39) applies the same pairing between partners: a hypomorph allele of the list in one partner and a full loss of function in the same gene in the other (a ClinVar pathogenic variant, a Delly deletion) is a shared gene with its risk for a child; the allele in both partners, or in one alone, stays set aside. In the secondary-findings card a called deletion counts as one of the two variants a recessive gene needs, unless read-backed phase puts it on the variant's copy. The line under the carrier list names the deletion callers it read and the ones it could not read. A deletion AnnotSV ranks below class 4 is not counted. From 070d77906ea4dc16ebc8c5793917a7c8e8964785 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Fri, 20 Nov 2026 23:39:24 +0100 Subject: [PATCH 06/38] fix(chip): warn when the contamination estimate runs without gnomAD, or not at all FilterMutectCalls weighs each allele by its population frequency, which Mutect2 takes from gnomAD's germline resource. On public data (HG002 with HG005's reads mixed in) the estimate removed 31 of 35 PASS calls with gnomAD and none without it. The step now warns in that case, and main.nf warns on the console without --chip_common_sites and with it but without --chip_germline_resource, since a task's stderr is not shown. The docs say the estimate needs gnomAD too and give the measurement. Bead: trait-62 --- CHANGELOG.md | 2 +- docs/49-chip.md | 4 ++-- main.nf | 2 ++ scripts/49-chip.sh | 7 ++++++- tests/fake-docker/i411-chip-contamination.sh | 19 ++++++++++++++++++- 5 files changed, 29 insertions(+), 5 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index 7a4a48b57..adaedb583 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- Step 49 (CHIP) now gives FilterMutectCalls a contamination estimate. Before, it filtered Mutect2's calls without one, so another person's DNA in the sample, whose alleles sit at a low VAF, could pass as a small clone and read `chip`. When step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` is installed with its `.tbi`, `scripts/49-chip.sh` and the Nextflow `CHIP_MUTECT2` run GetPileupSummaries at its 59,295 sites across the genome and CalculateContamination, and pass `--contamination-table` and `--tumor-segmentation` to FilterMutectCalls. The pileups do not stop at the CHIP exons, which hold only 8 of those sites, too few for an estimate. A call that contamination explains is then marked `contamination` by FilterMutectCalls and reads `filtered`. Without the VCF the log says there is no contamination estimate. A new optional parameter, `--chip_common_sites`, gives the VCF to the Nextflow pipeline, and `run-all.sh` passes it when the file is installed. The bash step also keeps `chip/_chip_contamination.table`. No column, option or file name changes. Part of #411 (trait-62). +- Step 49 (CHIP) now gives FilterMutectCalls a contamination estimate. Before, it filtered Mutect2's calls without one, so another person's DNA in the sample, whose alleles sit at a low VAF, could pass as a small clone and read `chip`. When step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` is installed with its `.tbi`, `scripts/49-chip.sh` and the Nextflow `CHIP_MUTECT2` run GetPileupSummaries at its 59,295 sites across the genome and CalculateContamination, and pass `--contamination-table` and `--tumor-segmentation` to FilterMutectCalls. The pileups do not stop at the CHIP exons, which hold only 8 of those sites, too few for an estimate. A call that contamination explains is then marked `contamination` by FilterMutectCalls and reads `filtered`. FilterMutectCalls weighs each allele by its gnomAD population frequency, so the estimate does its work only with `somatic/af-only-gnomad.hg38.vcf.gz` installed too. Without the common-sites VCF the log says there is no contamination estimate, and with it but without gnomAD the log warns that the estimate changes few calls. A new optional parameter, `--chip_common_sites`, gives the VCF to the Nextflow pipeline, and `run-all.sh` passes it when the file is installed. The bash step also keeps `chip/_chip_contamination.table`. No column, option or file name changes. Part of #411 (trait-62). - The live site's family page and its pedigree drawing are now built by `og live family`, in Rust. `bin/owngenome_live_family.py` asks `og` for a family's state, its `family.json`, the list of files it serves and `pedigree.svg`, and no longer reads the family's tables itself; `bin/pedigree_svg.py` and `bin/family_report.py` are gone. The page shows the same thing: `family.json` and the drawing were compared with the old code on the demo family and the test families, field by field and number by number, and matched. The live site therefore needs `og` (`scripts/setup.sh --og` installs it); without it a family's `family.json` answers 500, its `pedigree.svg` answers 503, and the run list marks each family unreadable. A family file that cannot be read still gives no page and an unreadable family. - The local genome viewer runs on `og` and no longer needs `python3` on the host. `scripts/owngenome-view.sh` starts `og view serve` (through `bin/og`, or `OG`), which serves the same page, config and byte ranges on 127.0.0.1 as `assets/viewer/serve.py` did. Two requests it answered before are now refused. A locus whose end comes before its start (`chr1:13000-12000`) stops the script with exit 2 and the reason, instead of opening a view igv.js cannot show. A request with a `Forwarded`, `X-Forwarded-*` or `X-Real-IP` header gets 403: the viewer has no password, so a reverse proxy in front of it would hand the sample to anyone who reaches the proxy; an ssh port forward still works. The default SV track is now Manta's diploid SVs (step 4), else step 22's consensus, which keeps only the calls two callers agree on. `docs/viewer.md` says that every account on the machine can reach 127.0.0.1. No option of the script, file or output name changes; `og view serve` takes the flags `serve.py` took, plus `--assets`, the page's folder. The live site's viewer also opens Manta's diploid SVs first; the rest of it is unchanged until its server moves to `og`. Part of #411 (plat-11, plat-12). - Step 22's SV consensus no longer counts a record a caller did not call as a second caller. Before, every PASS record went to SURVIVOR, so a PASS Delly record genotyped `0/0`, a Delly call whose sample filter (`FT`) says `LowQual`, or a CNVpytor segment no quality rule had read sat beside a Manta-only call and made it read "2 callers". A new verb, `og sv survivor-prep --caller NAME IN OUT`, now writes each caller's input for both the script and the Nextflow `SURVIVOR_PREP`, in place of the bcftools and awk they each carried. A record votes when its FILTER and its sample `FT` are `PASS` or `.` and its genotype is not reference only (`0/0`, `0|0`, haploid `0`, `0/.`); a no-call (`./.`) and a sites-only record still vote. A CNVpytor call votes when its e-value is below 0.01 and its share of MAPQ 0 reads below 0.5, the rule step 05 already applies when it adds CNVpytor's calls; the VCF step 22 makes from CNVpytor's table now carries the table's e-value, `q0` and `pN` as `pytorP1`, `pytorQ0` and `pytorPN`, so the rule reads both inputs. A header without `GT` or without these tags no longer matters. Step 18's closing hint and `docs/18-cnvpytor.md` gave e-value below 0.05 and size over 1 kb; they now give the same rule. What changes in the output: `sv_merged/inputs/.vcf` holds only the records that vote, and the consensus can hold fewer records. No file, column or option is renamed or removed. Part of #411 (sv-05, sv-06, sv-09, sv-10, sv-11, sv-40). diff --git a/docs/49-chip.md b/docs/49-chip.md index 35ff6cf00..cbd547d2c 100644 --- a/docs/49-chip.md +++ b/docs/49-chip.md @@ -30,7 +30,7 @@ Pinned in `versions.env`; [Image versions](versions.md) lists the current tags. - the reference with its `.fai` and `.dict` - Ensembl's GRCh38 gene annotation, `reference/ensembl/Homo_sapiens.GRCh38..chr.gff3.gz` (`ENSEMBL_GFF_RELEASE` in `versions.env`, about 110 MB). Install it once with `./scripts/setup.sh --chip-data "${GENOME_DIR}"`; it is checked against `ENSEMBL_GFF_SHA256`. - Optional, and the same files as [step 29](29-mutect2-somatic.md): gnomAD's AF-only germline resource `somatic/af-only-gnomad.hg38.vcf.gz` and a panel of normals `somatic/1000g_pon.hg38.vcf.gz`, each with its `.tbi`. Without gnomAD, inherited variants are left out by their VAF only. -- Optional, and recommended: step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` with its `.tbi` ([step 29](29-mutect2-somatic.md) says how to download it). With it the step estimates how much of the sample is another person's DNA and FilterMutectCalls reads that estimate. Without it the log says there is no contamination estimate, and a contaminant's alleles can pass as a small clone. +- Optional, and recommended together with gnomAD: step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` with its `.tbi` ([step 29](29-mutect2-somatic.md) says how to download it). With it the step estimates how much of the sample is another person's DNA and FilterMutectCalls reads that estimate. Without it the log says there is no contamination estimate, and a contaminant's alleles can pass as a small clone. With it but without gnomAD the log warns that the estimate changes few calls (step 2 below says why). ## Command @@ -44,7 +44,7 @@ With `run-all.sh`: `TOOLS=...,chip`. It is opt-in, so a run lists step 49 only w ## How it decides 1. For each gene of `assets/chip_genes.tsv` the step takes the transcript Ensembl tags `MANE_Select`, and calls inside its coding exons, 10 bases wider on each side so the splice donor and acceptor sites are in. That is 162 exons and about 35 kb with Ensembl 116. -2. Mutect2 calls in tumour-only mode, with the read orientation model, and with gnomAD and the panel of normals when they are installed. With the common-sites VCF, GetPileupSummaries counts the reads at every one of its 59,295 sites across the genome, CalculateContamination estimates from them how much of the sample is another person's DNA, and FilterMutectCalls gets that estimate (`--contamination-table`). Another person's DNA adds its own alleles at a low VAF, the VAF of a small clone; with the estimate, FilterMutectCalls marks a call that contamination explains `contamination`, and the call reads `filtered`. The pileups do not stop at the CHIP exons, as step 29's do at its intervals: the exons hold 8 of the 59,295 sites, too few for an estimate. Step 33's VerifyBamID2 gives a second, separate estimate (FREEMIX). +2. Mutect2 calls in tumour-only mode, with the read orientation model, and with gnomAD and the panel of normals when they are installed. With the common-sites VCF, GetPileupSummaries counts the reads at every one of its 59,295 sites across the genome, CalculateContamination estimates from them how much of the sample is another person's DNA, and FilterMutectCalls gets that estimate (`--contamination-table`). Another person's DNA adds its own alleles at a low VAF, the VAF of a small clone; with the estimate, FilterMutectCalls marks a call that contamination explains `contamination`, and the call reads `filtered`. The pileups do not stop at the CHIP exons, as step 29's do at its intervals: the exons hold 8 of the 59,295 sites, too few for an estimate. FilterMutectCalls weighs each allele by its population frequency, which Mutect2 takes from gnomAD, so the estimate does its work only with gnomAD installed too. On public data (GIAB's HG002 reads with HG005's reads mixed in, 19,365 of 209,006 reads, over DNMT3A, SF3B1 and IDH1 and 450 windows around common sites on chr2), CalculateContamination read 0.147 (error 0.023) for the mix and 0.006 for HG002 alone. With gnomAD, the mix had 35 PASS calls without the estimate and 4 with it, as many as HG002 alone; without gnomAD the estimate removed none of them. Step 33's VerifyBamID2 gives a second, separate estimate (FREEMIX). 3. Each call that changes the protein is put in the gene's class from the table: | Gene | Counted | Source (PMID) | diff --git a/main.nf b/main.nf index 14a300106..4f8b92b6c 100644 --- a/main.nf +++ b/main.nf @@ -1081,6 +1081,8 @@ workflow { def common = params.chip_common_sites // the contamination estimate FilterMutectCalls reads def chip_common = common ? file(common, checkIfExists: true) : [] def chip_common_index = common ? file("${common}.tbi", checkIfExists: true) : [] + if (!common) log.warn "chip: no --chip_common_sites, so FilterMutectCalls runs without a contamination estimate and another person's DNA in the sample can pass as a small clone (docs/49-chip.md)." + else if (!germ) log.warn "chip: --chip_common_sites without --chip_germline_resource: FilterMutectCalls has no population frequency to weigh the contamination estimate by, so it changes few calls (docs/49-chip.md)." ch_vcf .map { meta, _vcf, _idx -> [meta.id, meta] } .join(ch_bam.map { meta, _bam, _bai -> [meta.id, true] }, remainder: true) diff --git a/scripts/49-chip.sh b/scripts/49-chip.sh index b7f412ab1..c5c2950d9 100755 --- a/scripts/49-chip.sh +++ b/scripts/49-chip.sh @@ -94,7 +94,9 @@ FILTER=(gatk FilterMutectCalls -R "${REF_FASTA_C}" -V "$(cpath "${P}_unfiltered. # small clone. CalculateContamination estimates that share from the reads at # every site of the common-sites VCF, across the genome: the CHIP exons hold # only 8 of its 59,295 sites, too few for an estimate. FilterMutectCalls then -# marks the calls contamination explains. +# marks the calls contamination explains. It weighs each allele by its +# population frequency, which Mutect2 takes from gnomAD: without gnomAD the +# estimate changes few calls. rm -f "${P}_contamination.table" "${P}_segments.table" if [ -f "$COMMON_VCF" ] && [ -f "${COMMON_VCF}.tbi" ]; then echo " contamination estimate: common sites ${COMMON_VCF}" @@ -103,6 +105,9 @@ if [ -f "$COMMON_VCF" ] && [ -f "${COMMON_VCF}.tbi" ]; then run_in --cpus 2 --memory 4g "$GATK_IMAGE" gatk CalculateContamination -I "$(cpath "${P}_pileups.table")" \ --tumor-segmentation "$(cpath "${P}_segments.table")" -O "$(cpath "${P}_contamination.table")" FILTER+=(--contamination-table "$(cpath "${P}_contamination.table")" --tumor-segmentation "$(cpath "${P}_segments.table")") + if [ ! -f "$GNOMAD_VCF" ] || [ ! -f "${GNOMAD_VCF}.tbi" ]; then + echo " WARNING: the contamination estimate without gnomAD's germline resource: FilterMutectCalls has no population frequency to weigh it by, so it changes few calls (docs/49-chip.md)." + fi else echo " no common-sites VCF (${COMMON_VCF}): no contamination estimate, so another person's DNA in the sample can pass as a small clone (docs/49-chip.md says how to install it)." fi diff --git a/tests/fake-docker/i411-chip-contamination.sh b/tests/fake-docker/i411-chip-contamination.sh index cbed00513..80d215f48 100755 --- a/tests/fake-docker/i411-chip-contamination.sh +++ b/tests/fake-docker/i411-chip-contamination.sh @@ -4,7 +4,8 @@ # site of that VCF (not only inside the CHIP exons), CalculateContamination, then # FilterMutectCalls with --contamination-table and --tumor-segmentation. # Without the VCF, or without its .tbi, there is no estimate and the log says -# so. The Nextflow CHIP_MUTECT2 runs the same commands: its script block, run +# so; with it but without gnomAD's germline resource the log warns that the +# estimate changes few calls. The Nextflow CHIP_MUTECT2 runs the same commands: its script block, run # here with a fake gatk, passes the table when it gets --chip_common_sites and # not without it; main.nf hands it the file, and run-all.sh passes the VCF # under somatic/ to the pipeline only with its .tbi. @@ -61,6 +62,16 @@ awk '/ CalculateContamination / { c = NR } / FilterMutectCalls / { f = NR } END || fail "FilterMutectCalls ran before CalculateContamination" output_lacks chip-common 'no contamination estimate' output_has chip-common 'contamination estimate: common sites ' +output_has chip-common 'WARNING: the contamination estimate without gnomAD' +# With gnomAD's germline resource too: Mutect2 reads it and the warning goes. +printf 'placeholder\n' > "${G}/somatic/af-only-gnomad.hg38.vcf.gz" +printf 'placeholder\n' > "${G}/somatic/af-only-gnomad.hg38.vcf.gz.tbi" +: > "$FAKE_DOCKER_LOG" +run_expect 0 chip-common-gnomad "${SCRIPTS}/49-chip.sh" sample1 +docker_log_has '^run image=[^ ]*gatk.* Mutect2 .*--germline-resource /genome/somatic/af-only-gnomad\.hg38\.vcf\.gz' "Mutect2 did not get gnomAD" +docker_log_has "^run image=[^ ]*gatk.* FilterMutectCalls .*--contamination-table ${C}_contamination\\.table" "FilterMutectCalls with gnomAD did not get the contamination table" +output_lacks chip-common-gnomad 'without gnomAD' +rm -f "${G}/somatic/af-only-gnomad.hg38.vcf.gz" "${G}/somatic/af-only-gnomad.hg38.vcf.gz.tbi" # The VCF without its .tbi is not used. rm -f "${COMMON}.tbi" @@ -119,6 +130,12 @@ if grep -qE 'GetPileupSummaries|CalculateContamination|--contamination-table' "$ fail "CHIP_MUTECT2 estimated contamination without --chip_common_sites" fi grep -q 'no --chip_common_sites' "${NFW}/out.txt" || fail "CHIP_MUTECT2 without common sites does not say it has no estimate" +# main.nf warns on the console (a task's stderr stays in its work directory) +# without the common sites, and with them but without gnomAD. +grep -qF 'if (!common) log.warn "chip: no --chip_common_sites, so FilterMutectCalls runs without a contamination estimate' "${REPO_ROOT}/main.nf" \ + || fail "main.nf does not warn when chip runs without --chip_common_sites" +grep -qF 'else if (!germ) log.warn "chip: --chip_common_sites without --chip_germline_resource' "${REPO_ROOT}/main.nf" \ + || fail "main.nf does not warn when the contamination estimate runs without gnomAD" # main.nf hands the module the file and its index, in the order of its inputs. grep -qF 'def chip_common = common ? file(common, checkIfExists: true) : []' "${REPO_ROOT}/main.nf" \ || fail "main.nf does not read --chip_common_sites" From 0da2276e9e984c937062743bc269ef7c30e160bc Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 01:25:47 +0100 Subject: [PATCH 07/38] test(chip): verify the module input order for common sites Check the positional binding of the common-sites VCF and index. List the optional VCF in the Nextflow guide. Bead: trait-62 --- docs/nextflow.md | 6 +++--- tests/fake-docker/i411-chip-contamination.sh | 19 +++++++++++++++++++ 2 files changed, 22 insertions(+), 3 deletions(-) diff --git a/docs/nextflow.md b/docs/nextflow.md index a4538387e..cbaa93168 100644 --- a/docs/nextflow.md +++ b/docs/nextflow.md @@ -63,9 +63,9 @@ nextflow run main.nf \ # --tools '...,parascopy' + --parascopy_data (setup.sh --parascopy-data; docs/35-paralogs.md) # --tools '...,bloodtype' no data to install; RhD needs the BAM (docs/41-bloodtype.md) # --tools '...,lpa' no data to install; needs the BAM (docs/46-lpa.md) -# --tools '...,chip' + --chip_gff (setup.sh --chip-data), optional --chip_germline_resource -# and --chip_pon (each with its .tbi beside it); needs the BAM -# (docs/49-chip.md) +# --tools '...,chip' + --chip_gff (setup.sh --chip-data), optional --chip_germline_resource, +# --chip_pon, and --chip_common_sites (each with its .tbi beside it). +# Needs the BAM (docs/49-chip.md). # --tools '...,archaic' + --archaic_data (setup.sh --archaic), --archaic_pop, --hla_genes for the # genes of each segment (docs/43-archaic.md) # --tools '...,ancient' + --ancient_panel (setup.sh --ancient-panel); reads the gVCF, so a sample diff --git a/tests/fake-docker/i411-chip-contamination.sh b/tests/fake-docker/i411-chip-contamination.sh index 80d215f48..5edeb9e5b 100755 --- a/tests/fake-docker/i411-chip-contamination.sh +++ b/tests/fake-docker/i411-chip-contamination.sh @@ -141,6 +141,25 @@ grep -qF 'def chip_common = common ? file(common, checkIfExists: true) : [ || fail "main.nf does not read --chip_common_sites" grep -qF 'chip_pon, chip_pon_index, chip_common, chip_common_index)' "${REPO_ROOT}/main.nf" \ || fail "main.nf does not pass the common sites to CHIP_MUTECT2" +# The rendered script substitutes the VCF directly, so check the positional +# binding of the VCF and its index in the module's input declarations too. +awk ' + /^process CHIP_MUTECT2[[:space:]]*\{/ { in_process = 1 } + in_process && /^}/ { exit } + in_process && /^[[:space:]]*input:/ { in_input = 1; next } + in_input && /^[[:space:]]*output:/ { exit } + in_input { + sub(/[[:space:]]*\/\/.*/, "") + gsub(/^[[:space:]]+|[[:space:]]+$/, "") + if (two_back == "path(pon_index)" && previous == "path(common)" && $0 == "path(common_index)") { + found = 1 + exit + } + two_back = previous + previous = $0 + } + END { exit !found } +' "$MOD" || fail "CHIP_MUTECT2 does not take the common sites and their index after the panel of normals" # --- run-all.sh -------------------------------------------------------------------------- # TOOLS=chip passes the installed common-sites VCF to the pipeline, only with its .tbi. From 799d247ae3a8fe4d0f0c04a253eba4ae0807e432 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 11:22:10 +0100 Subject: [PATCH 08/38] fix(carrier): keep showing rows with no unchanged copy in both reports and on the live page Moving homozygous and hemizygous P/LP rows from `carriers` to `hom_or_hemizygous` left every consumer reading only `carriers`. The live page lost its act finding for such a row ("two changed copies", "the only copy changed"), and a gene left with a homozygous row fell to a plain ClinVar review finding. Both reports dropped the row from the carrier block. The live page (finding rows, the carrier panel and its headline) now reads both lists. Both report renderers (og-render and render_report.py, still step 24's) print each such row on its own line in the carrier block, "two changed copies" or "the only copy changed", "not the pattern of a carrier", and the block's first line counts it apart from the carriers. The report-render parity cases whose summary holds such rows get goldens for the new lines. The two CFTR pair tests now assert their row count, so they cannot pass with no row. Bead: clin-15 Bead: clin-19 --- CHANGELOG.md | 2 +- bin/live_results.py | 7 +- bin/owngenome_live.py | 2 +- bin/render_report.py | 7 + docs/results/secondary-findings.md | 2 +- rust/crates/og-render/src/sections/carrier.rs | 29 +- rust/crates/og-render/tests/clinical.rs | 36 +- .../tests/i411_carrier_confidence.rs | 2 + .../report-render/all-history/all-history.txt | 552 ++++++++++++++ .../golden/report-render/all-nf/all-nf.html | 710 ++++++++++++++++++ .../golden/report-render/all-nf/all-nf.txt | 371 +++++++++ tests/parity/golden/report-render/all/all.txt | 514 +++++++++++++ .../golden/report-render/cb-full/cb-full.html | 599 +++++++++++++++ .../golden/report-render/cb-full/cb-full.txt | 272 +++++++ .../golden/report-render/cb-nf/cb-nf.html | 545 ++++++++++++++ .../golden/report-render/cb-nf/cb-nf.txt | 230 ++++++ .../report-render/cb-nfbad/cb-nfbad.html | 477 ++++++++++++ .../report-render/cb-nfbad/cb-nfbad.txt | 143 ++++ .../report-render/cb-notbi/cb-notbi.html | 474 ++++++++++++ .../report-render/cb-notbi/cb-notbi.txt | 139 ++++ .../cb-quoted-dosage/cb-quoted-dosage.html | 599 +++++++++++++++ .../cb-quoted-dosage/cb-quoted-dosage.txt | 272 +++++++ .../cb-quoted-interval.html | 599 +++++++++++++++ .../cb-quoted-interval/cb-quoted-interval.txt | 272 +++++++ .../cb-quoted-smn/cb-quoted-smn.html | 599 +++++++++++++++ .../cb-quoted-smn/cb-quoted-smn.txt | 272 +++++++ .../cb-unicode-contig/cb-unicode-contig.html | 599 +++++++++++++++ .../cb-unicode-contig/cb-unicode-contig.txt | 272 +++++++ .../m-clinical-escape/m-clinical-escape.html | 599 +++++++++++++++ .../m-clinical-escape/m-clinical-escape.txt | 272 +++++++ .../m-clinical-stale/m-clinical-stale.html | 619 +++++++++++++++ .../m-clinical-stale/m-clinical-stale.txt | 285 +++++++ .../m-clinvar-freq-note.html | 599 +++++++++++++++ .../m-clinvar-freq-note.txt | 272 +++++++ .../m-clinvar-many/m-clinvar-many.html | 643 ++++++++++++++++ .../m-clinvar-many/m-clinvar-many.txt | 405 ++++++++++ .../m-clinvar-none/m-clinvar-none.html | 565 ++++++++++++++ .../m-clinvar-none/m-clinvar-none.txt | 229 ++++++ .../m-couple-empty/m-couple-empty.html | 608 +++++++++++++++ .../m-couple-empty/m-couple-empty.txt | 277 +++++++ .../report-render/m-couple/m-couple.html | 610 +++++++++++++++ .../report-render/m-couple/m-couple.txt | 279 +++++++ .../m-cpsr-none/m-cpsr-none.html | 584 ++++++++++++++ .../report-render/m-cpsr-none/m-cpsr-none.txt | 256 +++++++ .../m-cpsr-noown/m-cpsr-noown.html | 589 +++++++++++++++ .../m-cpsr-noown/m-cpsr-noown.txt | 262 +++++++ .../report-render/m-sf-notes/m-sf-notes.html | 600 +++++++++++++++ .../report-render/m-sf-notes/m-sf-notes.txt | 273 +++++++ .../m-since-clinical/m-since-clinical.html | 599 +++++++++++++++ .../m-since-clinical/m-since-clinical.txt | 275 +++++++ .../m-slivar-phase/m-slivar-phase.html | 575 ++++++++++++++ .../m-slivar-phase/m-slivar-phase.txt | 252 +++++++ .../m-slivar-unphased/m-slivar-unphased.html | 573 ++++++++++++++ .../m-slivar-unphased/m-slivar-unphased.txt | 250 ++++++ 54 files changed, 19938 insertions(+), 9 deletions(-) create mode 100644 tests/parity/golden/report-render/all-history/all-history.txt create mode 100644 tests/parity/golden/report-render/all-nf/all-nf.html create mode 100644 tests/parity/golden/report-render/all-nf/all-nf.txt create mode 100644 tests/parity/golden/report-render/all/all.txt create mode 100644 tests/parity/golden/report-render/cb-full/cb-full.html create mode 100644 tests/parity/golden/report-render/cb-full/cb-full.txt create mode 100644 tests/parity/golden/report-render/cb-nf/cb-nf.html create mode 100644 tests/parity/golden/report-render/cb-nf/cb-nf.txt create mode 100644 tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html create mode 100644 tests/parity/golden/report-render/cb-nfbad/cb-nfbad.txt create mode 100644 tests/parity/golden/report-render/cb-notbi/cb-notbi.html create mode 100644 tests/parity/golden/report-render/cb-notbi/cb-notbi.txt create mode 100644 tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html create mode 100644 tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt create mode 100644 tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html create mode 100644 tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt create mode 100644 tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html create mode 100644 tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt create mode 100644 tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html create mode 100644 tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt create mode 100644 tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html create mode 100644 tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt create mode 100644 tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html create mode 100644 tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt create mode 100644 tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html create mode 100644 tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt create mode 100644 tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html create mode 100644 tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt create mode 100644 tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html create mode 100644 tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt create mode 100644 tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html create mode 100644 tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt create mode 100644 tests/parity/golden/report-render/m-couple/m-couple.html create mode 100644 tests/parity/golden/report-render/m-couple/m-couple.txt create mode 100644 tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html create mode 100644 tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt create mode 100644 tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html create mode 100644 tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt create mode 100644 tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html create mode 100644 tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt create mode 100644 tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html create mode 100644 tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt create mode 100644 tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html create mode 100644 tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt create mode 100644 tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html create mode 100644 tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt diff --git a/CHANGELOG.md b/CHANGELOG.md index e4a0853bf..392d1d3a3 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`, and the report's carrier count leaves it out; the ClinVar table still shows it. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. A pair that rests on a low-confidence call is at most `possible two hits (low-confidence call)`, and a deletion plus a low-confidence call in one gene reads `possibly biallelic (low-confidence call)` under `two_hits`. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. A pair that rests on a low-confidence call is at most `possible two hits (low-confidence call)`, and a deletion plus a low-confidence call in one gene reads `possibly biallelic (low-confidence call)` under `two_hits`. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - The live site's family page and its pedigree drawing are now built by `og live family`, in Rust. `bin/owngenome_live_family.py` asks `og` for a family's state, its `family.json`, the list of files it serves and `pedigree.svg`, and no longer reads the family's tables itself; `bin/pedigree_svg.py` and `bin/family_report.py` are gone. The page shows the same thing: `family.json` and the drawing were compared with the old code on the demo family and the test families, field by field and number by number, and matched. The live site therefore needs `og` (`scripts/setup.sh --og` installs it); without it a family's `family.json` answers 500, its `pedigree.svg` answers 503, and the run list marks each family unreadable. A family file that cannot be read still gives no page and an unreadable family. - The local genome viewer runs on `og` and no longer needs `python3` on the host. `scripts/owngenome-view.sh` starts `og view serve` (through `bin/og`, or `OG`), which serves the same page, config and byte ranges on 127.0.0.1 as `assets/viewer/serve.py` did. Two requests it answered before are now refused. A locus whose end comes before its start (`chr1:13000-12000`) stops the script with exit 2 and the reason, instead of opening a view igv.js cannot show. A request with a `Forwarded`, `X-Forwarded-*` or `X-Real-IP` header gets 403: the viewer has no password, so a reverse proxy in front of it would hand the sample to anyone who reaches the proxy; an ssh port forward still works. The default SV track is now Manta's diploid SVs (step 4), else step 22's consensus, which keeps only the calls two callers agree on. `docs/viewer.md` says that every account on the machine can reach 127.0.0.1. No option of the script, file or output name changes; `og view serve` takes the flags `serve.py` took, plus `--assets`, the page's folder. The live site's viewer also opens Manta's diploid SVs first; the rest of it is unchanged until its server moves to `og`. Part of #411 (plat-11, plat-12). - Step 22's SV consensus no longer counts a record a caller did not call as a second caller. Before, every PASS record went to SURVIVOR, so a PASS Delly record genotyped `0/0`, a Delly call whose sample filter (`FT`) says `LowQual`, or a CNVpytor segment no quality rule had read sat beside a Manta-only call and made it read "2 callers". A new verb, `og sv survivor-prep --caller NAME IN OUT`, now writes each caller's input for both the script and the Nextflow `SURVIVOR_PREP`, in place of the bcftools and awk they each carried. A record votes when its FILTER and its sample `FT` are `PASS` or `.` and its genotype is not reference only (`0/0`, `0|0`, haploid `0`, `0/.`); a no-call (`./.`) and a sites-only record still vote. A CNVpytor call votes when its e-value is below 0.01 and its share of MAPQ 0 reads below 0.5, the rule step 05 already applies when it adds CNVpytor's calls; the VCF step 22 makes from CNVpytor's table now carries the table's e-value, `q0` and `pN` as `pytorP1`, `pytorQ0` and `pytorPN`, so the rule reads both inputs. A header without `GT` or without these tags no longer matters. Step 18's closing hint and `docs/18-cnvpytor.md` gave e-value below 0.05 and size over 1 kb; they now give the same rule. What changes in the output: `sv_merged/inputs/.vcf` holds only the records that vote, and the consensus can hold fewer records. No file, column or option is renamed or removed. Part of #411 (sv-05, sv-06, sv-09, sv-10, sv-11, sv-40). diff --git a/bin/live_results.py b/bin/live_results.py index 975b8a6ff..ef7614200 100644 --- a/bin/live_results.py +++ b/bin/live_results.py @@ -374,7 +374,7 @@ def a_carrier(S, s): if d.get("unavailable"): return {"lines": rr.carrier_lines(d), "attention": True} rows = [[c.get("gene"), c.get("variant"), c.get("genotype"), c.get("significance"), c.get("stars"), - c.get("inheritance"), c.get("condition")] for c in d.get("carriers") or []] + c.get("inheritance"), c.get("condition")] for c in (d.get("carriers") or []) + (d.get("hom_or_hemizygous") or [])] two = (d.get("two_hits") or {}).get("genes") or [] return {"facts": [["Genes on the carrier list", d.get("genes_on_list")], ["Carrier findings", len(rows)], ["Genes with two hits", ", ".join(g if isinstance(g, str) else g.get("gene", ".") for g in two) @@ -833,7 +833,7 @@ def gene(x): return g if isinstance(g, str) else None sf_genes = {gene(x) for x in _items(sf.get("clinvar_hits")) if isinstance(x, dict)} car = _data(S, "carrier") - carrier_genes = {gene(c) for c in _items(car.get("carriers")) if isinstance(c, dict)} + carrier_genes = {gene(c) for c in _items(car.get("carriers")) + _items(car.get("hom_or_hemizygous")) if isinstance(c, dict)} th = car.get("two_hits") if isinstance(car.get("two_hits"), dict) else {} two_hit = {gene(g) for g in _items(th.get("genes"))} - {None} # 1. ACMG secondary findings: the gene's own reporting rule already said "report". The report's own @@ -943,7 +943,8 @@ def gene(x): "A ranking to bring to a clinical geneticist, not a diagnosis.", gene=x.get("gene"), evidence=[["Score", x.get("exomiser_score")], ["Inheritance", x.get("moi")]])) # 7. Carriers: one changed copy in a gene of the carrier list, and the couple screen. - for c in _items(car.get("carriers")): + # A row with no unchanged copy (hom_or_hemizygous) takes the branch below that says it is not a carrier. + for c in _items(car.get("carriers")) + _items(car.get("hom_or_hemizygous")): with _Row(out, "carrier-list", "act"): if c.get("gene") in two_hit: continue diff --git a/bin/owngenome_live.py b/bin/owngenome_live.py index c970ac660..d09815bd1 100755 --- a/bin/owngenome_live.py +++ b/bin/owngenome_live.py @@ -299,7 +299,7 @@ def _h_clinvar(d, summary): def _h_carrier(d, summary): lines = _rr().carrier_lines(d) - return lines[0], bool(d.get("carriers")) + return lines[0], bool(d.get("carriers") or d.get("hom_or_hemizygous")) def _h_couple(d, summary): diff --git a/bin/render_report.py b/bin/render_report.py index a339af688..26cf32ef9 100755 --- a/bin/render_report.py +++ b/bin/render_report.py @@ -2025,13 +2025,20 @@ def carrier_lines(c): """The sample's own carrier list (no partner), the same in both reports.""" if c.get("unavailable"): return [f"Carrier list: not made, {c['unavailable']}"] + both = c.get("hom_or_hemizygous") or [] # no unchanged copy: listed apart, not counted as carriers lines = [f"Carrier list ({c['genes_on_list']} genes): {len(c['carriers'])} finding(s)" + + (f", {len(both)} with no unchanged copy" if both else "") + (f", {len(c['set_aside'])} set aside" if c["set_aside"] else "")] def hemi(x): return f" ({x['hemizygous']})" if x.get("hemizygous") else "" for x in c["carriers"]: lines.append(f"{x['gene']} ({x['condition']}; {x['inheritance']}): {x['variant']} {x['genotype']}{hemi(x)}, " f"ClinVar {x['significance']}") + for x in both: + lines.append(f"{x['gene']} ({x['condition']}; {x['inheritance']}): {x['variant']} {x['genotype']}{hemi(x)}, " + f"ClinVar {x['significance']}: " + + ("two changed copies" if x["genotype"] == "hom" else "the only copy changed") + + ", not the pattern of a carrier") for x in c["set_aside"]: lines.append(f"Set aside: {x['gene']} {x['variant']} {x['genotype']}{hemi(x)}: {x['name']} is a {x['kind']} " "allele, not a carrier finding on its own") diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index ebfe7287d..419965724 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,7 +14,7 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. -Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`, the carrier count leaves it out, and the ClinVar table still shows it. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. When one of the two is a low-confidence call, the pair is at most `possible two hits (low-confidence call)`. The reports do not show these fields yet. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. When one of the two is a low-confidence call, the pair is at most `possible two hits (low-confidence call)`. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: diff --git a/rust/crates/og-render/src/sections/carrier.rs b/rust/crates/og-render/src/sections/carrier.rs index ffaf982a4..d0dde8dc8 100644 --- a/rust/crates/og-render/src/sections/carrier.rs +++ b/rust/crates/og-render/src/sections/carrier.rs @@ -1,5 +1,6 @@ //! The sample's own carrier list (no partner): the ClinVar P/LP hits in -//! the genes of `assets/carrier_genes.tsv`, the hypomorph and +//! the genes of `assets/carrier_genes.tsv`, the rows with no unchanged copy +//! (`hom_or_hemizygous`, never counted as carriers), the hypomorph and //! pseudodeficiency alleles set aside, and the two-hit genes //! ([`super::two_hits`]). @@ -27,12 +28,21 @@ pub fn lines(c: &D<'_>) -> Result, Malformed> { )]); } let carriers = c.at("carriers")?.items()?; + // Homozygous or hemizygous: no unchanged copy, so listed apart and never + // counted as a carrier. A summary written before the list has none. + let both = match c.opt("hom_or_hemizygous")? { + Some(b) => b.items()?, + None => Vec::new(), + }; let set_aside = c.at("set_aside")?; let mut head = format!( "Carrier list ({} genes): {} finding(s)", c.s("genes_on_list")?, carriers.len() ); + if !both.is_empty() { + head += &format!(", {} with no unchanged copy", both.len()); + } if set_aside.truthy() { head += &format!(", {} set aside", set_aside.len()?); } @@ -49,6 +59,23 @@ pub fn lines(c: &D<'_>) -> Result, Malformed> { x.s("significance")? )); } + for x in &both { + let copies = if x.at("genotype")?.is("hom") { + "two changed copies" + } else { + "the only copy changed" + }; + out.push(format!( + "{} ({}; {}): {} {}{}, ClinVar {}: {copies}, not the pattern of a carrier", + x.s("gene")?, + x.s("condition")?, + x.s("inheritance")?, + x.s("variant")?, + x.s("genotype")?, + hemi(x)?, + x.s("significance")? + )); + } for x in set_aside.items()? { out.push(format!( "Set aside: {} {} {}{}: {} is a {} allele, not a carrier finding on its own", diff --git a/rust/crates/og-render/tests/clinical.rs b/rust/crates/og-render/tests/clinical.rs index a235a8eea..3c94eecaa 100644 --- a/rust/crates/og-render/tests/clinical.rs +++ b/rust/crates/og-render/tests/clinical.rs @@ -923,8 +923,18 @@ fn both_reports_print_the_two_hit_line_and_the_hemizygous_genotype() { let (txt, html) = reports(&collect(&d)); assert!(txt.contains("Biallelic: MUTYH")); assert!(html.contains("Biallelic: MUTYH")); - // The hit has no unchanged copy, so the summary lists it apart from the - // carriers (hom_or_hemizygous); the two-hit line still names it. + // The hit has no unchanged copy: the summary lists it apart from the + // carriers (hom_or_hemizygous), and both reports still print it in the + // carrier block, with the hemizygous note, and not as a carrier. + assert!(html.contains("hemizygous (called homozygous inside DEL")); + assert!(txt.contains("hemizygous (called homozygous inside DEL")); + for r in [&txt, &html] { + assert!(r.contains("1 finding(s), 1 with no unchanged copy"), "{r}"); + assert!( + r.contains("the only copy changed, not the pattern of a carrier"), + "{r}" + ); + } assert!( html.replace(">", ">") .contains("chr1:45336000 G>A hemizygous") @@ -934,6 +944,28 @@ fn both_reports_print_the_two_hit_line_and_the_hemizygous_genotype() { assert!(html.contains("biallelic with DEL chr1:45335000-45337000")); } +/// A homozygous P/LP row has no unchanged copy: the carrier block lists it +/// apart from the carriers and does not count it as one. +#[test] +fn a_homozygous_row_is_listed_apart_from_the_carriers() { + let t = Dir::new("hom-apart"); + let d = sample(&t, "hom", &[hit(SNV, "MUTYH", "1/1", None)], None); + let c = carrier_of(&d); + let lines = carrier::lines(&D::new(&c, "carrier")).unwrap(); + assert!( + lines[0].contains("0 finding(s), 1 with no unchanged copy"), + "{lines:?}" + ); + let line: Vec<&String> = lines.iter().filter(|x| x.starts_with("MUTYH (")).collect(); + assert_eq!(line.len(), 1, "{lines:?}"); + assert!(line[0].contains(" hom, ClinVar "), "{}", line[0]); + assert!( + line[0].ends_with(": two changed copies, not the pattern of a carrier"), + "{}", + line[0] + ); +} + /// test_cross_engine_biallelic.py check 10. #[test] fn two_hit_edges() { diff --git a/rust/crates/og-summary/tests/i411_carrier_confidence.rs b/rust/crates/og-summary/tests/i411_carrier_confidence.rs index 54c716aaf..45d2a84b6 100644 --- a/rust/crates/og-summary/tests/i411_carrier_confidence.rs +++ b/rust/crates/og-summary/tests/i411_carrier_confidence.rs @@ -281,6 +281,7 @@ fn a_low_confidence_call_makes_two_hits_only_possible() { ], &no_deletions(), ); + assert_eq!(of(&c, "carriers", "CFTR").len(), 2, "{c:?}"); for x in of(&c, "carriers", "CFTR") { assert_eq!( s(x, "pair"), @@ -303,6 +304,7 @@ fn a_combined_allele_and_its_part_are_one_allele() { ], &no_deletions(), ); + assert_eq!(of(&c, "carriers", "CFTR").len(), 2, "{c:?}"); for x in of(&c, "carriers", "CFTR") { assert!(x.get("pair").is_none(), "{x:?}"); assert!(x.get("phase").is_none(), "{x:?}"); diff --git a/tests/parity/golden/report-render/all-history/all-history.txt b/tests/parity/golden/report-render/all-history/all-history.txt new file mode 100644 index 000000000..764ee1013 --- /dev/null +++ b/tests/parity/golden/report-render/all-history/all-history.txt @@ -0,0 +1,552 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC + Database re-check: 2021-03-05 00:00:00 UTC: ClinVar newer-release +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Quality control +--- + [New since 2021-01-01 00:00 UTC] + Mean depth: 31.2x + Alignment: 1000 reads in, 1000 primary records in the BAM + Inferred sex: male + Declared sex: male + Sex from the reads (somalier): male (declared and measured sex agree) + Contamination (VerifyBamID2 FREEMIX): 0.0010 (warning above ) + Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error. + +## Genes This Genome Could Not Read Reliably +--- + [New since 2021-01-01 00:00 UTC] + 217 of the 1572 hard-to-read genes of assets/callability_genes.tsv were read: 90% or more of their bases had 10 or more reads of mapping quality 20 or more. + Not read, and no other step calls them (1301): OR4F5 (17%), OR4F29 (33%), OR4F16 (50%), AGRN (67%), ATAD3B (0%), MMP23B (0%), CDK11B (17%), SLC35E2B (33%), CDK11A (50%), TTC34 (67%), RPL22 (83%), MASP2 (0%), NPPA (17%), KIAA2013 (33%), PRAMEF1 (50%), PRAMEF11 (67%), HNRNPCL1 (83%), PRAMEF4 (0%), PRAMEF10 (17%), PRAMEF7 (33%), PRAMEF6 (50%), PRAMEF27 (67%), HNRNPCL3 (83%), HNRNPCL2 (0%), PRAMEF26 (17%), HNRNPCL4 (33%), PRAMEF9 (50%), PRAMEF13 (67%), PRAMEF18 (83%), PRAMEF8 (0%), PRAMEF33 (17%), PRAMEF15 (33%), PRAMEF14 (50%), PRAMEF19 (67%), PRAMEF17 (83%), CELA2B (0%), CLCNKA (17%), CLCNKB (33%), NBPF1 (50%), CROCC (67%), AKR7L (83%), NBPF3 (0%), CELA3B (17%), CELA3A (33%), HMGCL (50%), CNR2 (67%), RSRP1 (83%), PIGV (17%), XKR8 (33%), BMP8A (50%), BMP8B (67%), OXCT2 (83%), CYP4Z1 (0%), CYP4A22 (17%), GBP1 (33%), SETSIP (50%), AGL (67%), EXTL2 (83%), AMY2A (0%), NBPF4 (67%), NBPF6 (83%), LRIG2 (17%), VANGL1 (33%), IGSF3 (50%), SEC22B (83%), NBPF26 (0%), NOTCH2NLR (17%), PPIAL4A (33%), FAM72B (50%), SRGAP2C (67%), H3-7 (83%), PPIAL4E (0%), NBPF15 (17%), PPIAL4F (33%), SRGAP2B (50%), FAM72D (67%), PPIAL4D (83%), GPR89A (0%), RBM8A (17%), NBPF10 (33%), NOTCH2NLA (50%), PPIAL4H (67%), NBPF12 (83%), NBPF11 (0%), PPIAL4G (17%), NBPF14 (33%), NOTCH2NLB (50%), NUDT4B (67%), PDE4DIP (83%), NOTCH2NLC (0%), NBPF19 (17%), PPIAL4C (33%), H2BC18 (67%), H3C13 (83%), H3C14 (0%), H2AC18 (17%), H2AC19 (33%), H3C15 (50%), H4C15 (67%), HRNR (83%), LCE3E (0%), LCE3D (17%), S100A8 (33%), S100A7A (50%), S100A7 (67%), FLAD1 (83%), MTX1 (0%), HCN3 (33%), FCRL5 (50%), HSPA6 (83%), FCGR2B (33%), HSD17B7 (50%), CD247 (67%), XCL2 (83%), PRG4 (0%), PTPRC (50%), PPP1R12B (67%), KISS1 (83%), SRGAP2 (0%), CR1 (17%), CR1L (33%), ZC3H11B (50%), LBR (67%), LEFTY2 (83%), OR2T33 (0%), OR2T7 (17%), OR2T2 (33%), OR2T3 (50%), OR2T5 (67%), OR2G6 (83%), OR2T34 (0%), OR2T11 (17%), OR2T35 (33%), OR2T27 (50%), SNTG2 (67%), TPO (83%), KLF11 (0%), CCDC121 (17%), ABCG8 (33%), PCBP1 (50%), NAT8 (67%), C2orf78 (83%), CD8B (0%), RGPD1 (17%), PLGLB1 (33%), PLGLB2 (50%), RGPD2 (67%), RPIA (83%), TEKT4 (0%), FAHD2A (17%), TRIM43B (33%), TRIM43 (50%), ANKRD36C (67%), GPAT2 (83%), ANKRD36 (0%), ANKRD36B (17%), RGPD3 (33%), RGPD4 (50%), RANBP2 (67%), RGPD5 (83%), MALL (0%), MTLN (17%), LIMS4 (33%), RGPD6 (50%), ANAPC1 (67%), RGPD8 (83%), FOXD4L1 (0%), RABL2A (17%), RAB6C (33%), POTEF (50%), CCDC74B (67%), SMPD4 (83%), TUBA3E (0%), POTEI (17%), CFC1B (33%), CFC1 (50%), POTEJ (67%), PLEKHB2 (83%), RAB6D (0%), MZT2A (17%), TUBA3D (33%), CCDC74A (50%), ANKRD30BL (67%), NOSTRIN (83%), IFT70B (0%), CASP10 (17%), ALPP (33%), ALPG (50%), UGT1A6 (67%), UGT1A5 (83%), UGT1A3 (0%), MLPH (17%), OR6B2 (33%), AQP12B (50%), AQP12A (67%), ANO7 (83%), CHL1 (0%), EMC3 (17%), FANCD2 (33%), DAZL (50%), ZNF35 (67%), LZTFL1 (83%), MST1 (0%), MST1R (17%), HYAL1 (33%), FRG2C (50%), ZNF717 (67%), OR5H6 (0%), ROPN1 (17%), ROPN1B (33%), RPN1 (50%), ALG1L2 (67%), BFSP2 (83%), PRR23B (0%), SOX2 (17%), EIF2B5 (33%), KNG1 (50%), TM4SF19 (67%), ZNF595 (83%), PDE6B (0%), GAK (17%), FGFRL1 (33%), RNF212 (50%), UVSSA (67%), DOK7 (83%), HMX1 (0%), FAM90A26 (17%), USP17L10 (33%), USP17L11 (50%), USP17L12 (67%), USP17L13 (83%), USP17L17 (0%), USP17L18 (17%), USP17L19 (33%), USP17L20 (50%), USP17L21 (67%), USP17L22 (83%), USP17L24 (0%), USP17L25 (17%), USP17L26 (33%), USP17L5 (50%), USP17L27 (67%), USP17L28 (83%), USP17L30 (0%), DEFB131A (17%), DRD5 (33%), UGT2B10 (83%), UGT2B28 (0%), UGT2A1 (17%), UGT2A2 (33%), HTN3 (50%), HTN1 (67%), AFP (83%), PIGY (0%), PYURF (17%), CISD2 (33%), SLC9B1 (50%), KLHL2 (0%), GK3 (17%), HPF1 (33%), PDLIM3 (50%), FAT1 (67%), FRG1 (83%), FRG2 (0%), DUX4 (17%), SDHA (33%), PDCD6 (50%), ZDHHC11B (67%), ZDHHC11 (83%), TERT (0%), SLC6A3 (17%), TAF11L2 (33%), TAF11L3 (50%), TAF11L4 (67%), TAF11L5 (83%), TAF11L7 (0%), TAF11L8 (17%), TAF11L9 (33%), TAF11L10 (50%), TAF11L11 (67%), TAF11L12 (83%), TAF11L14 (0%), EMB (17%), MARVELD2 (33%), SERF1B (67%), NAIP (17%), SKIC3 (50%), LIX1 (67%), SAR1B (83%), DND1 (0%), PCDHA10 (17%), PCDHB7 (33%), PCDHB8 (50%), PCDHB11 (67%), PCDHB12 (83%), PPP1R2B (0%), NPM1 (17%), THOC3 (33%), SIMC1 (50%), FAM153A (67%), FAM153CP (83%), FLT4 (0%), OR4F3 (17%), DUSP22 (33%), TUBB2A (50%), H2AC13 (67%), H2AC14 (83%), OR2J1 (0%), OR2J2 (17%), HLA-G (33%), HLA-A (50%), MICA (67%), MICB (83%), ZBTB12 (17%), PBX2 (83%), HLA-DRB1 (0%), GSTA2 (17%), GSTA1 (33%), GSTA5 (50%), PRIM2 (67%), FKBP1C (83%), SLC17A5 (0%), SEC63 (17%), OR2A4 (33%), CTAGE9 (50%), PCMT1 (67%), RAET1G (83%), ULBP1 (0%), RAET1L (17%), ULBP3 (33%), SLC22A1 (50%), SMOC2 (83%), RBAK-RBAKDN (0%), RBAK (17%), SLC29A4 (33%), FSCN1 (50%), OCM (67%), CCZ1 (83%), RSPH10B2 (17%), CCZ1B (33%), NOD1 (50%), FKBP9 (67%), DPY19L1 (83%), SEPTIN7 (0%), SPDYE1 (17%), PPIA (33%), CDC14C (50%), PSPH (67%), CCT6A (83%), ZNF716 (0%), ZNF727 (17%), ZNF735 (33%), ZNF736 (50%), GUSB (67%), RABGEF1 (83%), TYW1 (0%), SPDYE21 (17%), TYW1B (33%), POM121 (50%), TRIM74 (67%), SPDYE8 (83%), SPDYE9 (0%), SPDYE10 (17%), NSUN5 (33%), TRIM50 (50%), CLIP2 (67%), GTF2IRD2 (0%), SPDYE12 (17%), CASTOR2 (33%), GTF2IRD2B (50%), SPDYE13 (67%), SPDYE14 (83%), TRIM73 (0%), POM121C (17%), SPDYE5 (33%), DTX2 (50%), UPK3B (67%), SPDYE16 (83%), SPDYE17 (0%), SPDYE18 (17%), STEAP1 (33%), ASNS (50%), OCM2 (67%), CYP3A7-CYP3A51P (83%), CYP3A4 (0%), STAG3 (17%), PVRIG (33%), SPDYE3 (50%), SAP25 (67%), ZAN (83%), MUC12 (0%), SPDYE6 (17%), POLR2J (33%), RASA4B (50%), POLR2J3 (67%), UPK3BL2 (83%), RASA4 (0%), UPK3BL1 (17%), POLR2J3-UPK3BL2 (33%), SPDYE2B (50%), POLR2J2 (67%), LAMB1 (83%), METTL2B (0%), KLF14 (17%), AKR1B10 (33%), AKR1B15 (50%), BRAF (67%), TRBV9 (83%), PRSS2 (0%), CTAGE15 (17%), TCAF2 (33%), TCAF2C (50%), CTAGE6 (67%), OR2F2 (83%), CTAGE4 (0%), OR2A42 (17%), OR2A7 (33%), CTAGE8 (50%), OR2A1 (67%), ARHGEF5 (83%), ACTR3C (0%), KMT2C (17%), ACTR3B (33%), OR4F21 (50%), FBXO25 (67%), ARHGEF10 (83%), FAM90A15 (17%), FAM90A3 (33%), FAM90A13 (50%), FAM90A5 (67%), FAM90A20 (83%), USP17L1 (0%), USP17L4 (17%), ZNF705G (33%), DEFB108C (50%), DEFB4B (67%), DEFB103B (83%), DEFB104B (0%), DEFB106B (17%), DEFB105B (33%), DEFB107B (50%), PRR23D1 (67%), FAM90A7 (83%), FAM90A23 (0%), FAM90A14 (17%), FAM90A18 (33%), FAM90A16 (50%), FAM90A8 (67%), FAM90A17 (83%), FAM90A9 (0%), FAM90A10 (17%), PRR23D2 (33%), DEFB107A (50%), DEFB105A (67%), DEFB106A (83%), SPAG11A (0%), DEFB103A (17%), DEFB4A (33%), ZNF705B (50%), USP17L8 (67%), USP17L3 (83%), FAM90A11 (0%), FAM90A24 (17%), FAM90A12 (33%), SLC35G5 (50%), DEFB130B (67%), ZNF705D (83%), USP17L2 (0%), DEFB109D (17%), FAM86B1 (33%), DEFB130A (50%), FAM86B2 (67%), RBPMS (83%), IMPA1 (0%), SLC10A5 (17%), CDH17 (33%), CYP11B1 (50%), CYP11B2 (67%), GPIHBP1 (83%), WASHC1 (0%), FOXD4 (17%), ZNG1A (33%), KCNV2 (50%), RLN2 (67%), RLN1 (83%), IFNA21 (0%), IFNA4 (17%), IFNA7 (33%), IFNA10 (50%), IFNA16 (67%), IFNA17 (83%), IFNA13 (0%), IFNA1 (17%), ANKRD18B (33%), PRSS3 (50%), GALT (67%), SPATA31F1 (83%), CNTNAP3 (0%), SPATA31A1 (17%), FOXD4L6 (33%), ZNG1F (50%), CNTNAP3B (67%), SPATA31A6 (83%), SPATA31A7 (0%), CNTNAP3C (17%), FOXD4L5 (33%), ZNG1E (50%), FOXD4L4 (67%), ZNF658 (83%), ANKRD20A1 (0%), ZNG1C (17%), FOXD4L3 (33%), PGM5 (50%), FXN (67%), TJP2 (83%), SPATA31D4 (0%), SPATA31D3 (17%), SPATA31D1 (33%), KIF27 (50%), SPATA31C1 (67%), SPATA31C2 (83%), SLC71A2 (0%), NUTM2G (17%), CTSV (33%), OR13C5 (50%), OR13C2 (67%), OR13C9 (83%), POLE3 (0%), ORM1 (17%), ORM2 (33%), SLC27A4 (50%), PKN3 (67%), ABO (0%), LCN1 (17%), OBP2A (33%), SOHLH1 (50%), INPP5E (67%), AJM1 (83%), GRIN1 (0%), TUBB8 (17%), AKR1C1 (33%), AKR1C2 (50%), DCLRE1C (67%), MRC1 (83%), ANKRD30A (0%), ZNF33A (17%), ZNF37A (33%), PLD5P1 (50%), ZNF33B (67%), BMS1 (83%), AGAP4 (0%), TIMM23 (17%), ANTXRL (33%), ANXA8L1 (50%), NPY4R (67%), GPRIN2 (83%), PTPN20 (0%), ANXA8 (17%), FAM25G (33%), AGAP9 (50%), SYT15B (67%), NPY4R2 (83%), PARG (0%), TIMM23B (17%), TIMM23B-AGAP6 (33%), AGAP6 (50%), WASHC2A (67%), ASAH2B (83%), EIF5AL1 (0%), NUTM2B (17%), NUTM2E (33%), TMEM254 (50%), PLAC9 (67%), ADIRF (83%), NUTM2A (0%), NUTM2D (17%), PAPSS2 (33%), PTEN (50%), LIPN (67%), BTRC (83%), SFR1 (0%), DHX32 (17%), FANK1 (33%), ECHS1 (50%), SPRN (67%), FRG2B (83%), SCGB1C1 (0%), IFITM3 (17%), DRD4 (33%), DEAF1 (50%), KRTAP5-2 (83%), KRTAP5-4 (0%), MRPL23 (17%), H19 (33%), SSU72L5 (50%), SSU72L2 (67%), SSU72L4 (83%), SSU72L1 (0%), OR51A4 (17%), OR51A2 (33%), HBG1 (50%), OR10A5 (67%), MRGPRX4 (83%), MDK (0%), SPI1 (17%), OR4C3 (33%), OR4C5 (50%), OR4A47 (67%), TRIM51G (83%), TRIM64C (0%), FOLH1 (17%), OR4C13 (33%), OR4C12 (50%), OR4C45 (67%), OR4C46 (83%), OR4A5 (0%), TRIM48 (17%), OR4A15 (33%), TRIM51 (50%), OR5F1 (67%), OR8H2 (83%), OR5M8 (0%), OR9G1 (17%), OR1S2 (33%), OR1S1 (50%), GLYATL1B (67%), PGA3 (83%), B3GAT3 (0%), ESRRA (17%), SLC22A12 (33%), RBM4B (50%), TPCN2 (67%), FGF3 (83%), KRTAP5-8 (0%), KRTAP5-10 (17%), KRTAP5-11 (33%), XNDC1N-ZNF705EP-ALG1L9P (50%), DEFB108B (67%), XNDC1N (83%), INTS4 (0%), NOX4 (17%), TRIM77 (33%), TRIM49 (50%), TRIM64B (67%), TRIM49D1 (83%), TRIM64 (0%), TRIM49C (17%), UBTFL1 (33%), CARD16 (50%), HSPA8 (67%), OR8B2 (83%), TMEM45B (0%), CD4 (17%), PEX5 (33%), APOBEC1 (50%), GDF3 (67%), NANOG (83%), FAM90A1 (0%), PRH1 (33%), PRR4 (50%), PRH2 (67%), TAS2R14 (83%), TAS2R31 (0%), TAS2R46 (17%), TAS2R43 (33%), TAS2R30 (50%), PRB4 (67%), PRB1 (83%), DDX11 (0%), H3-5 (17%), ALG10 (33%), ALG10B (50%), TUBA1B (67%), COX14 (83%), NACA (50%), DPY19L2 (67%), HNF1A (83%), HPD (0%), HCAR2 (17%), HCAR3 (33%), P2RX2 (50%), PGAM5 (67%), GOLGA3 (83%), C1QTNF9B (0%), C1QTNF9 (17%), PARP4 (33%), PABPC3 (50%), MRPS31 (67%), HNRNPA1L2 (83%), PRR20C (0%), PRR20B (17%), PRR20D (33%), PRR20E (50%), F7 (67%), PROZ (83%), POTEM (0%), POTEG (17%), OR11H2 (33%), OR4N2 (50%), OR4Q3 (67%), OR4M1 (83%), RNASE3 (0%), RNASE2 (17%), OR10G2 (33%), DHRS4 (50%), DHRS4L2 (67%), ARF6 (83%), ACOT2 (0%), NDUFB1 (17%), JAG2 (33%), BTBD6 (50%), IGHV3-21 (67%), GOLGA6L6 (83%), POTEB3 (0%), LINC02203 (17%), OR4M2B (33%), OR4N4C (50%), POTEB (67%), OR4M2-OT1 (83%), OR4N4 (0%), GOLGA6L22 (17%), GOLGA6L1 (33%), GOLGA6L26 (50%), GOLGA8S (67%), GOLGA6L2 (83%), HERC2 (0%), GOLGA6L24 (17%), GOLGA8F (33%), GOLGA8G (50%), GOLGA6L25 (67%), GOLGA8M (83%), GOLGA8J (0%), GOLGA8T (17%), GOLGA8R (50%), GOLGA8Q (67%), GOLGA8H (83%), GOLGA8O (0%), GOLGA8N (17%), GOLGA8A (33%), GOLGA8B (50%), NANOGP8 (67%), NDUFAF1 (83%), CKMT1B (0%), CATSPER2 (33%), CKMT1A (50%), TERB2 (67%), LDHAL6B (0%), GOLGA6B (17%), GOLGA6A (33%), ISLR2 (50%), GOLGA6C (67%), GOLGA6D (83%), ADAMTS7 (0%), EFL1 (17%), SAXO2 (33%), GOLGA6L10 (50%), GOLGA6L9 (67%), WHAMM (83%), OR4F4 (0%), MPG (17%), HBM (33%), AXIN1 (83%), SSTR5 (0%), TPSD1 (50%), GNPTG (67%), UNKL (83%), PKD1 (0%), PDPK1 (17%), EEF2KMT (33%), NPIPA3 (50%), NPIPA2 (67%), NOMO1 (83%), PDXDC1 (0%), RRN3 (17%), NPIPA5 (33%), MPV17L (50%), NOMO3 (67%), NPIPA6 (83%), NPIPA8 (0%), NPIPA9 (17%), NOMO2 (33%), SMG1 (50%), IQCK (67%), ACSM5 (83%), ACSM2B (0%), NPIPB3 (17%), NPIPB4 (50%), NPIPB5 (67%), NPIPB6 (83%), NPIPB7 (0%), SULT1A2 (17%), NPIPB8 (50%), EIF3C (67%), NPIPB9 (83%), NPIPB11 (0%), BOLA2-SMG1P6 (17%), BOLA2 (33%), SLX1B (50%), SULT1A4 (67%), NPIPB12 (83%), SLX1A (0%), SULT1A3 (17%), NPIPB13 (33%), PHKG2 (50%), VKORC1 (67%), KRABD5 (83%), TP53TG3 (0%), TP53TG3C (17%), TP53TG3E (33%), TP53TG3B (50%), TP53TG3F (67%), CCNYL1B (83%), CES1 (0%), MT1M (17%), MATCAP1 (33%), HSD11B2 (50%), CLEC18A (67%), PDPR (83%), EXOSC6 (0%), HPR (50%), NPIPB15 (67%), CLEC18B (83%), CA5A (0%), ZNF469 (17%), CDH15 (33%), ANKRD11 (50%), MC1R (67%), PRDM7 (83%), ABR (0%), SERPINF2 (17%), SRR (33%), OR1D5 (50%), P2RX5 (67%), ALOX15 (83%), ENO3 (0%), USP6 (17%), SLC35G6 (33%), ALOXE3 (50%), HES7 (67%), CDRT15 (83%), FBXW10B (0%), TRIM16 (17%), ZNF286A-TBC1D26 (33%), ZNF286A (50%), TBC1D26 (67%), UBB (83%), ATPAF2 (0%), EVPLL (17%), LGALS9C (33%), TBC1D28 (50%), FOXO3B (67%), FBXW10 (83%), GRAP (0%), GRAPL (17%), LGALS9B (33%), CDRT15L2 (50%), MEIS3P2 (67%), MAP2K3 (83%), KCNJ18 (0%), LGALS9 (17%), FOXN1 (33%), SUZ12 (50%), LRRC37B (67%), SLC35G3 (83%), CCL4 (0%), TBC1D3B (17%), CCL4L2 (50%), TBC1D3I (67%), TBC1D3G (83%), TBC1D3F (0%), TBC1D3K (17%), TBC1D3L (33%), TBC1D3D (50%), TBC1D3C (67%), TBC1D3E (83%), MRPL45 (0%), KRTAP1-1 (17%), KRTAP4-7 (33%), KRTAP4-8 (50%), KRTAP4-16 (67%), KRTAP4-9 (83%), KRTAP4-12 (0%), KRTAP9-7 (17%), KRT14 (33%), KRT16 (50%), KRT17 (67%), HSD17B1 (83%), G6PC3 (0%), ARHGAP27 (17%), PLEKHM1 (33%), ARL17B (50%), LRRC37A (67%), ARL17A (83%), NSF (0%), NPEPPS (17%), HOXB8 (33%), GIP (50%), DHX40 (67%), RPS6KB1 (83%), METTL2A (0%), TLK2 (17%), CSH2 (33%), GH2 (50%), CSH1 (67%), CSHL1 (83%), LRRC37A3 (0%), C17orf58 (17%), AMZ2 (33%), TMC6 (50%), CANT1 (67%), RNF213 (83%), ARL16 (0%), TUBB8B (17%), TYMS (33%), SLC35G4 (50%), POTEC (67%), ANKRD30B (83%), SLC25A52 (0%), KATNAL2 (17%), SERPINB4 (33%), SERPINB3 (50%), GALR1 (67%), CTDP1 (83%), BSG (0%), HCN2 (17%), KISS1R (33%), STK11 (50%), TCF3 (67%), ABHD17A (83%), GIPC3 (0%), TBXA2R (17%), CREB3L3 (33%), RFX2 (50%), C3 (67%), MBD3L2B (83%), MBD3L4 (0%), MBD3L2 (17%), STXBP2 (33%), TYK2 (50%), ZNF799 (67%), ZNF443 (83%), CYP4F3 (0%), CYP4F12 (17%), OR10H2 (33%), CALR3 (50%), MYO9B (67%), INSL3 (83%), ZNF738 (0%), ZNF100 (17%), ZNF208 (33%), ZNF676 (50%), ZNF729 (67%), ZNF492 (83%), ZNF728 (0%), RHPN2 (17%), GPI (33%), ZNF302 (50%), ZNF181 (67%), FFAR3 (83%), COX6B1 (0%), LGALS7 (17%), LGALS7B (33%), IFNL3 (50%), IFNL4 (67%), IFNL2 (83%), CYP2A7 (17%), CYP2G1P (33%), CYP2A13 (67%), CYP2F1 (83%), PSG8 (0%), PSG1 (17%), PSG6 (33%), PSG7 (50%), PSG11 (67%), PSG2 (83%), PSG4 (0%), PSG9 (17%), ETHE1 (50%), ZNF285 (67%), APOC1 (83%), APOC4 (0%), BLOC1S3 (17%), DMPK (33%), FUT1 (50%), BAX (67%), LHB (83%), CGB3 (0%), CGB2 (17%), CGB1 (33%), CGB5 (50%), CGB8 (67%), CGB7 (83%), PNKP (0%), SIGLEC16 (17%), KLK4 (33%), ETFB (50%), ZNF808 (67%), ZNF600 (83%), ZNF468 (0%), VN1R4 (17%), FAM90A27P (33%), ZNF765 (50%), ZNF761 (67%), ZNF813 (83%), PRKCG (0%), MBOAT7 (17%), LILRA6 (33%), LILRB2 (50%), LAIR1 (67%), LAIR2 (83%), LILRB1 (0%), KIR3DL3 (17%), KIR2DL3 (33%), KIR2DL1 (50%), KIR2DL4 (67%), KIR3DL1 (83%), KIR3DL2 (0%), NLRP7 (17%), NLRP2 (33%), GP6 (50%), TNNT1 (67%), TNNI3 (83%), RFPL4A (0%), RFPL4AL1 (17%), ZNF419 (33%), ZNF773 (50%), ZNF587B (67%), ZNF814 (83%), ZNF417 (0%), SLC27A5 (17%), SIRPB1 (33%), CST4 (50%), CST1 (67%), CST2 (83%), PLAGL2 (0%), SEMG1 (17%), PLTP (33%), CHRNA4 (50%), EEF1A2 (67%), PTK6 (83%), MYT1 (0%), PCMTD2 (17%), TPTE (33%), POTED (50%), KRTAP21-1 (67%), SMIM11 (83%), SMIM34 (0%), KCNE1 (17%), CBR3 (33%), NDUFV3 (50%), CBS (67%), U2AF1 (83%), SIK1 (0%), HSF2BP (17%), H2BC12L (33%), TRAPPC10 (50%), PWP2 (67%), GATD3 (83%), DNMT3L (0%), KRTAP10-1 (17%), KRTAP10-2 (33%), KRTAP10-4 (50%), KRTAP10-5 (67%), KRTAP10-6 (83%), KRTAP10-8 (0%), KRTAP10-9 (17%), KRTAP10-10 (33%), KRTAP12-2 (50%), KRTAP12-1 (67%), COL18A1 (83%), OR11H1 (0%), POTEH (17%), CCT8L2 (33%), USP18 (50%), GGTLC3 (67%), TMEM191B (83%), FAM246B (0%), DGCR6 (17%), PRODH (33%), FAM246C (50%), CCDC188 (67%), RTN4R (83%), TUBA3FP (0%), LRRC74B (17%), FAM246A (33%), RIMBP3B (50%), HIC2 (67%), TMEM191C (83%), GGTLC2 (0%), IGLL1 (17%), DRICH1 (33%), GSTT2B (50%), DDTL (67%), GSTT2 (83%), RFPL1 (0%), C22orf42 (17%), RFPL3 (33%), APOBEC3D (83%), APOBEC3H (0%), ATF4 (17%), NDUFA6 (33%), CYP2D7 (67%), RRP7A (83%), CYB5R3 (0%), A4GALT (17%), TTLL1 (33%), MLC1 (50%), TUBGCP6 (67%), ACR (83%), XG (0%), GYG2 (17%), ARSD (33%), MXRA5 (50%), PRKX (67%), VCX3A (83%), VCX2 (0%), VCX3B (17%), FAM9A (33%), FAM9C (50%), SUPT20HL2 (67%), SUPT20HL1 (83%), MAGEB6 (0%), DCAF8L1 (17%), FAM47B (33%), H2AL1Q (50%), FAM47C (67%), H2AL3 (83%), SPACA5B (0%), SSX5 (17%), SSX1 (33%), SSX3 (50%), SSX4 (67%), SSX4B (83%), GAGE12J (0%), GAGE13 (17%), GAGE2E (33%), GAGE12B (50%), GAGE12C (67%), GAGE12D (83%), GAGE12F (0%), GAGE12G (17%), GAGE12H (33%), GAGE2A (50%), GAGE1 (67%), CENPVL3 (83%), CENPVL1 (0%), MAGED4B (17%), MAGED4 (33%), XAGE1A (50%), XAGE1B (67%), SSX7 (83%), SSX2B (0%), SPANXN5 (17%), XAGE5 (33%), XAGE3 (50%), FAM156B (67%), FAM156A (83%), SPIN2B (0%), SPIN2A (17%), ZXDA (33%), CXorf49 (50%), CXorf49B (67%), DMRTC1B (83%), FAM236D (0%), DMRTC1 (17%), FAM236C (33%), FAM236A (50%), PABPC1L2B (67%), PABPC1L2A (83%), TGIF2LX (0%), PCDH11X (17%), TCEAL6 (33%), TCP11X1 (50%), NXF2 (67%), NXF2B (83%), RAB40AL (0%), TMSB15B (17%), H2BW1 (33%), H2BW2 (50%), TMSB15C (67%), PSMD10 (83%), CT47C1 (0%), RHOXF2B (17%), RHOXF2 (33%), CT47B1 (50%), CT47A12 (67%), CT47A11 (83%), CT47A9 (0%), CT47A8 (17%), CT47A7 (33%), CT47A6 (50%), CT47A5 (67%), CT47A4 (83%), CT47A2 (0%), CT47A1 (17%), RTL8B (33%), RTL8C (50%), RTL8A (67%), SMIM10L2B (83%), CT55 (0%), ETDA (17%), SMIM10L2A (33%), CT45A1 (50%), CT45A3 (67%), CT45A5 (83%), CT45A2 (0%), CT45A7 (17%), CT45A8 (33%), CT45A9 (50%), CT45A10 (67%), SAGE1 (83%), SPANXC (0%), SPANXA1 (17%), SPANXA2 (33%), SPANXD (50%), MAGEC1 (67%), SPANXN3 (83%), UBE2NL (0%), SPANXN1 (17%), CXorf51B (33%), CXorf51A (50%), EOLA1 (67%), HSFX3 (83%), HSFX2 (0%), HSFX1 (17%), MAGEA9 (33%), EOLA2 (50%), HSFX4 (67%), MAGEA3 (83%), MAGEA2B (0%), CSAG1 (17%), MAGEA12 (33%), MAGEA2 (50%), CSAG3 (67%), MAGEA6 (83%), PWWP4 (0%), SLC6A8 (17%), BCAP31 (33%), OPN1LW (50%), OPN1MW (67%), OPN1MW2 (83%), TEX28 (0%), CTAG1A (17%), CTAG1B (33%), CTAG2 (50%), H2AB1 (67%), F8A1 (83%), F8A2 (0%), F8A3 (17%), H2AB3 (33%), IL9R (50%), WASH6P (67%), TGIF2LY (not on this reference), PCDH11Y (not on this reference), TSPY2 (not on this reference), TSPY4 (not on this reference), TSPY8 (not on this reference), TSPY3 (not on this reference), TSPY1 (not on this reference), TSPY9 (not on this reference), TSPY10 (not on this reference), VCY (not on this reference), VCY1B (not on this reference), CDY2B (not on this reference), CDY2A (not on this reference), HSFY1 (not on this reference), HSFY2 (not on this reference), RBMY1B (not on this reference), RBMY1A1 (not on this reference), RBMY1D (not on this reference), RBMY1E (not on this reference), RBMY1F (not on this reference), RBMY1J (not on this reference), BPY2 (not on this reference), DAZ1 (not on this reference), DAZ2 (not on this reference), CDY1B (not on this reference), BPY2B (not on this reference), DAZ3 (not on this reference), DAZ4 (not on this reference), BPY2C (not on this reference), CDY1 (not on this reference), C4B_2 (not on this reference), GSTT1 (not on this reference), GSTTP2 (not on this reference), GTF2H2C_2 (not on this reference), HLA-DRB3 (not on this reference), HLA-DRB4 (not on this reference), KIR2DL2 (not on this reference), KIR2DL5A (not on this reference), KIR2DL5B (not on this reference), KIR2DS1 (not on this reference), KIR2DS2 (not on this reference), KIR2DS3 (not on this reference), KIR2DS5 (not on this reference), KIR3DS1 (not on this reference), LILRA3 (not on this reference), OR8U8 (not on this reference), OR8U9 (not on this reference), OR9G9 (not on this reference), TAS2R45 (not on this reference) + Not read here, called by a step of their own (54): RHCE (0%) by parascopy, AMY1A (17%) by parascopy, AMY1B (33%) by parascopy, AMY1C (50%) by parascopy, GSTM1 (0%) by pypgx, NOTCH2 (67%) by parascopy, FCGR1A (50%) by parascopy, GBA1 (17%) by parascopy, FCGR2A (67%) by parascopy, FCGR2C (0%) by parascopy, FCGR3B (17%) by parascopy, CFHR3 (17%) by parascopy, CFHR1 (33%) by parascopy, PROS1 (83%) by parascopy, UGT2B17 (50%) by pypgx, UGT2B15 (67%) by pypgx, GYPE (67%) by parascopy, GYPB (83%) by parascopy, GTF2H2C (50%) by parascopy, SMN2 (83%) by parascopy, SMN1 (0%) by parascopy, GTF2H2 (33%) by parascopy, HSPA1B (0%) by parascopy, C4A (33%) by parascopy, C4B (50%) by parascopy, CYP21A2 (67%) by cn_loci:CYP21A2, LPA (67%) by cn_loci:LPA_KIV2, PMS2 (0%) by parascopy, GTF2I (83%) by parascopy, DEFA1B (0%) by parascopy, CEL (83%) by parascopy, MUC5B (67%) by parascopy, KLRC2 (17%) by parascopy, KRT6B (0%) by parascopy, KRT6C (17%) by parascopy, KRT6A (33%) by parascopy, CHRFAM7A (33%) by parascopy, STRC (17%) by parascopy, SORD (83%) by parascopy, HBA2 (50%) by cn_loci:HBA, HBA1 (67%) by cn_loci:HBA, TPSB2 (17%) by parascopy, TPSAB1 (33%) by parascopy, OTOA (33%) by parascopy, SULT1A1 (33%) by pypgx, HYDIN (17%) by parascopy, HP (33%) by cn_loci:HP, CCL3L3 (33%) by cn_loci:CCL3L1, CYP2A6 (0%) by pypgx, CYP2B6 (50%) by pypgx, CD177 (33%) by parascopy, APOBEC3A (50%) by parascopy, APOBEC3B (67%) by parascopy, CYP2D6 (50%) by pypgx + A gene listed as not read could not be read reliably: too few of its reads were placed on it with confidence, so a 'no finding' in it says nothing. A gene with a caller of its own is left to that caller's section. + +## Variant Calling (DeepVariant) +--- + [New since 2021-01-01 00:00 UTC] + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + [New since 2021-01-01 00:00 UTC] + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: 2021-03-01 + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + [New since 2021-01-01 00:00 UTC] + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 0 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + [New since 2021-01-01 00:00 UTC] + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of 2021-03-01 + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + [New since 2021-01-01 00:00 UTC] + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + [New since 2021-01-01 00:00 UTC] + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + [New since 2021-01-01 00:00 UTC] + [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/str_intermediate_ranges.tsv'] +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + [New since 2021-01-01 00:00 UTC] + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + [New since 2021-01-01 00:00 UTC] + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + [New since 2021-01-01 00:00 UTC] + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + [New since 2021-01-01 00:00 UTC] + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + [New since 2021-01-01 00:00 UTC] + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + [New since 2021-01-01 00:00 UTC] + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); Parascopy's SMN1 count (step 35); not read: step 35's HBA1/HBA2 count: not called + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + [New since 2021-01-01 00:00 UTC] + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + [New since 2021-01-01 00:00 UTC] + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + [New since 2021-01-01 00:00 UTC] + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + [New since 2021-01-01 00:00 UTC] + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + [New since 2021-01-01 00:00 UTC] + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + [New since 2021-01-01 00:00 UTC] + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + [New since 2021-01-01 00:00 UTC] + PharmCAT (step 36's call) not run + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## HLA Typing (T1K) +--- + [New since 2021-01-01 00:00 UTC] + [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/hla_alleles.tsv'] +## Locityper Second Opinion at Hard Loci (step 53) +--- + [New since 2021-01-01 00:00 UTC] + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08) did not run + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K's KIR pass (step 08, KIR=true) gave no call + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32): *1/*2; Cyrius (step 21): *2/*1 + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + [New since 2021-01-01 00:00 UTC] + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + [New since 2021-01-01 00:00 UTC] + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + [New since 2021-01-01 00:00 UTC] + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + [New since 2021-01-01 00:00 UTC] + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + [New since 2021-01-01 00:00 UTC] + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + [New since 2021-01-01 00:00 UTC] + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + [New since 2021-01-01 00:00 UTC] + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + [New since 2021-01-01 00:00 UTC] + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + [New since 2021-01-01 00:00 UTC] + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + [New since 2021-01-01 00:00 UTC] + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Short not available (not available/not available variants matched) PGS1 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + [New since 2021-01-01 00:00 UTC] + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + [New since 2021-01-01 00:00 UTC] + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + [New since 2021-01-01 00:00 UTC] + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Steps Not Run +--- + All major steps completed. + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +Run manifest: run_manifest.tsv (pipeline commit unknown, 1 images) +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/all-nf/all-nf.html b/tests/parity/golden/report-render/all-nf/all-nf.html new file mode 100644 index 000000000..992c7e6ee --- /dev/null +++ b/tests/parity/golden/report-render/all-nf/all-nf.html @@ -0,0 +1,710 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/all-nf/all-nf.txt b/tests/parity/golden/report-render/all-nf/all-nf.txt new file mode 100644 index 000000000..8e75283d2 --- /dev/null +++ b/tests/parity/golden/report-render/all-nf/all-nf.txt @@ -0,0 +1,371 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Quality control +--- + Mean depth: nanx + Inferred sex: female + Declared sex: female + Sex from the reads (somalier): male (declared and measured sex agree) + Contamination (VerifyBamID2 FREEMIX): 0.0010 (warning above ) + Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error. + +## Genes This Genome Could Not Read Reliably +--- + 217 of the 1572 hard-to-read genes of assets/callability_genes.tsv were read: 90% or more of their bases had 10 or more reads of mapping quality 20 or more. + Not read, and no other step calls them (1301): OR4F5 (17%), OR4F29 (33%), OR4F16 (50%), AGRN (67%), ATAD3B (0%), MMP23B (0%), CDK11B (17%), SLC35E2B (33%), CDK11A (50%), TTC34 (67%), RPL22 (83%), MASP2 (0%), NPPA (17%), KIAA2013 (33%), PRAMEF1 (50%), PRAMEF11 (67%), HNRNPCL1 (83%), PRAMEF4 (0%), PRAMEF10 (17%), PRAMEF7 (33%), PRAMEF6 (50%), PRAMEF27 (67%), HNRNPCL3 (83%), HNRNPCL2 (0%), PRAMEF26 (17%), HNRNPCL4 (33%), PRAMEF9 (50%), PRAMEF13 (67%), PRAMEF18 (83%), PRAMEF8 (0%), PRAMEF33 (17%), PRAMEF15 (33%), PRAMEF14 (50%), PRAMEF19 (67%), PRAMEF17 (83%), CELA2B (0%), CLCNKA (17%), CLCNKB (33%), NBPF1 (50%), CROCC (67%), AKR7L (83%), NBPF3 (0%), CELA3B (17%), CELA3A (33%), HMGCL (50%), CNR2 (67%), RSRP1 (83%), PIGV (17%), XKR8 (33%), BMP8A (50%), BMP8B (67%), OXCT2 (83%), CYP4Z1 (0%), CYP4A22 (17%), GBP1 (33%), SETSIP (50%), AGL (67%), EXTL2 (83%), AMY2A (0%), NBPF4 (67%), NBPF6 (83%), LRIG2 (17%), VANGL1 (33%), IGSF3 (50%), SEC22B (83%), NBPF26 (0%), NOTCH2NLR (17%), PPIAL4A (33%), FAM72B (50%), SRGAP2C (67%), H3-7 (83%), PPIAL4E (0%), NBPF15 (17%), PPIAL4F (33%), SRGAP2B (50%), FAM72D (67%), PPIAL4D (83%), GPR89A (0%), RBM8A (17%), NBPF10 (33%), NOTCH2NLA (50%), PPIAL4H (67%), NBPF12 (83%), NBPF11 (0%), PPIAL4G (17%), NBPF14 (33%), NOTCH2NLB (50%), NUDT4B (67%), PDE4DIP (83%), NOTCH2NLC (0%), NBPF19 (17%), PPIAL4C (33%), H2BC18 (67%), H3C13 (83%), H3C14 (0%), H2AC18 (17%), H2AC19 (33%), H3C15 (50%), H4C15 (67%), HRNR (83%), LCE3E (0%), LCE3D (17%), S100A8 (33%), S100A7A (50%), S100A7 (67%), FLAD1 (83%), MTX1 (0%), HCN3 (33%), FCRL5 (50%), HSPA6 (83%), FCGR2B (33%), HSD17B7 (50%), CD247 (67%), XCL2 (83%), PRG4 (0%), PTPRC (50%), PPP1R12B (67%), KISS1 (83%), SRGAP2 (0%), CR1 (17%), CR1L (33%), ZC3H11B (50%), LBR (67%), LEFTY2 (83%), OR2T33 (0%), OR2T7 (17%), OR2T2 (33%), OR2T3 (50%), OR2T5 (67%), OR2G6 (83%), OR2T34 (0%), OR2T11 (17%), OR2T35 (33%), OR2T27 (50%), SNTG2 (67%), TPO (83%), KLF11 (0%), CCDC121 (17%), ABCG8 (33%), PCBP1 (50%), NAT8 (67%), C2orf78 (83%), CD8B (0%), RGPD1 (17%), PLGLB1 (33%), PLGLB2 (50%), RGPD2 (67%), RPIA (83%), TEKT4 (0%), FAHD2A (17%), TRIM43B (33%), TRIM43 (50%), ANKRD36C (67%), GPAT2 (83%), ANKRD36 (0%), ANKRD36B (17%), RGPD3 (33%), RGPD4 (50%), RANBP2 (67%), RGPD5 (83%), MALL (0%), MTLN (17%), LIMS4 (33%), RGPD6 (50%), ANAPC1 (67%), RGPD8 (83%), FOXD4L1 (0%), RABL2A (17%), RAB6C (33%), POTEF (50%), CCDC74B (67%), SMPD4 (83%), TUBA3E (0%), POTEI (17%), CFC1B (33%), CFC1 (50%), POTEJ (67%), PLEKHB2 (83%), RAB6D (0%), MZT2A (17%), TUBA3D (33%), CCDC74A (50%), ANKRD30BL (67%), NOSTRIN (83%), IFT70B (0%), CASP10 (17%), ALPP (33%), ALPG (50%), UGT1A6 (67%), UGT1A5 (83%), UGT1A3 (0%), MLPH (17%), OR6B2 (33%), AQP12B (50%), AQP12A (67%), ANO7 (83%), CHL1 (0%), EMC3 (17%), FANCD2 (33%), DAZL (50%), ZNF35 (67%), LZTFL1 (83%), MST1 (0%), MST1R (17%), HYAL1 (33%), FRG2C (50%), ZNF717 (67%), OR5H6 (0%), ROPN1 (17%), ROPN1B (33%), RPN1 (50%), ALG1L2 (67%), BFSP2 (83%), PRR23B (0%), SOX2 (17%), EIF2B5 (33%), KNG1 (50%), TM4SF19 (67%), ZNF595 (83%), PDE6B (0%), GAK (17%), FGFRL1 (33%), RNF212 (50%), UVSSA (67%), DOK7 (83%), HMX1 (0%), FAM90A26 (17%), USP17L10 (33%), USP17L11 (50%), USP17L12 (67%), USP17L13 (83%), USP17L17 (0%), USP17L18 (17%), USP17L19 (33%), USP17L20 (50%), USP17L21 (67%), USP17L22 (83%), USP17L24 (0%), USP17L25 (17%), USP17L26 (33%), USP17L5 (50%), USP17L27 (67%), USP17L28 (83%), USP17L30 (0%), DEFB131A (17%), DRD5 (33%), UGT2B10 (83%), UGT2B28 (0%), UGT2A1 (17%), UGT2A2 (33%), HTN3 (50%), HTN1 (67%), AFP (83%), PIGY (0%), PYURF (17%), CISD2 (33%), SLC9B1 (50%), KLHL2 (0%), GK3 (17%), HPF1 (33%), PDLIM3 (50%), FAT1 (67%), FRG1 (83%), FRG2 (0%), DUX4 (17%), SDHA (33%), PDCD6 (50%), ZDHHC11B (67%), ZDHHC11 (83%), TERT (0%), SLC6A3 (17%), TAF11L2 (33%), TAF11L3 (50%), TAF11L4 (67%), TAF11L5 (83%), TAF11L7 (0%), TAF11L8 (17%), TAF11L9 (33%), TAF11L10 (50%), TAF11L11 (67%), TAF11L12 (83%), TAF11L14 (0%), EMB (17%), MARVELD2 (33%), SERF1B (67%), NAIP (17%), SKIC3 (50%), LIX1 (67%), SAR1B (83%), DND1 (0%), PCDHA10 (17%), PCDHB7 (33%), PCDHB8 (50%), PCDHB11 (67%), PCDHB12 (83%), PPP1R2B (0%), NPM1 (17%), THOC3 (33%), SIMC1 (50%), FAM153A (67%), FAM153CP (83%), FLT4 (0%), OR4F3 (17%), DUSP22 (33%), TUBB2A (50%), H2AC13 (67%), H2AC14 (83%), OR2J1 (0%), OR2J2 (17%), HLA-G (33%), HLA-A (50%), MICA (67%), MICB (83%), ZBTB12 (17%), PBX2 (83%), HLA-DRB1 (0%), GSTA2 (17%), GSTA1 (33%), GSTA5 (50%), PRIM2 (67%), FKBP1C (83%), SLC17A5 (0%), SEC63 (17%), OR2A4 (33%), CTAGE9 (50%), PCMT1 (67%), RAET1G (83%), ULBP1 (0%), RAET1L (17%), ULBP3 (33%), SLC22A1 (50%), SMOC2 (83%), RBAK-RBAKDN (0%), RBAK (17%), SLC29A4 (33%), FSCN1 (50%), OCM (67%), CCZ1 (83%), RSPH10B2 (17%), CCZ1B (33%), NOD1 (50%), FKBP9 (67%), DPY19L1 (83%), SEPTIN7 (0%), SPDYE1 (17%), PPIA (33%), CDC14C (50%), PSPH (67%), CCT6A (83%), ZNF716 (0%), ZNF727 (17%), ZNF735 (33%), ZNF736 (50%), GUSB (67%), RABGEF1 (83%), TYW1 (0%), SPDYE21 (17%), TYW1B (33%), POM121 (50%), TRIM74 (67%), SPDYE8 (83%), SPDYE9 (0%), SPDYE10 (17%), NSUN5 (33%), TRIM50 (50%), CLIP2 (67%), GTF2IRD2 (0%), SPDYE12 (17%), CASTOR2 (33%), GTF2IRD2B (50%), SPDYE13 (67%), SPDYE14 (83%), TRIM73 (0%), POM121C (17%), SPDYE5 (33%), DTX2 (50%), UPK3B (67%), SPDYE16 (83%), SPDYE17 (0%), SPDYE18 (17%), STEAP1 (33%), ASNS (50%), OCM2 (67%), CYP3A7-CYP3A51P (83%), CYP3A4 (0%), STAG3 (17%), PVRIG (33%), SPDYE3 (50%), SAP25 (67%), ZAN (83%), MUC12 (0%), SPDYE6 (17%), POLR2J (33%), RASA4B (50%), POLR2J3 (67%), UPK3BL2 (83%), RASA4 (0%), UPK3BL1 (17%), POLR2J3-UPK3BL2 (33%), SPDYE2B (50%), POLR2J2 (67%), LAMB1 (83%), METTL2B (0%), KLF14 (17%), AKR1B10 (33%), AKR1B15 (50%), BRAF (67%), TRBV9 (83%), PRSS2 (0%), CTAGE15 (17%), TCAF2 (33%), TCAF2C (50%), CTAGE6 (67%), OR2F2 (83%), CTAGE4 (0%), OR2A42 (17%), OR2A7 (33%), CTAGE8 (50%), OR2A1 (67%), ARHGEF5 (83%), ACTR3C (0%), KMT2C (17%), ACTR3B (33%), OR4F21 (50%), FBXO25 (67%), ARHGEF10 (83%), FAM90A15 (17%), FAM90A3 (33%), FAM90A13 (50%), FAM90A5 (67%), FAM90A20 (83%), USP17L1 (0%), USP17L4 (17%), ZNF705G (33%), DEFB108C (50%), DEFB4B (67%), DEFB103B (83%), DEFB104B (0%), DEFB106B (17%), DEFB105B (33%), DEFB107B (50%), PRR23D1 (67%), FAM90A7 (83%), FAM90A23 (0%), FAM90A14 (17%), FAM90A18 (33%), FAM90A16 (50%), FAM90A8 (67%), FAM90A17 (83%), FAM90A9 (0%), FAM90A10 (17%), PRR23D2 (33%), DEFB107A (50%), DEFB105A (67%), DEFB106A (83%), SPAG11A (0%), DEFB103A (17%), DEFB4A (33%), ZNF705B (50%), USP17L8 (67%), USP17L3 (83%), FAM90A11 (0%), FAM90A24 (17%), FAM90A12 (33%), SLC35G5 (50%), DEFB130B (67%), ZNF705D (83%), USP17L2 (0%), DEFB109D (17%), FAM86B1 (33%), DEFB130A (50%), FAM86B2 (67%), RBPMS (83%), IMPA1 (0%), SLC10A5 (17%), CDH17 (33%), CYP11B1 (50%), CYP11B2 (67%), GPIHBP1 (83%), WASHC1 (0%), FOXD4 (17%), ZNG1A (33%), KCNV2 (50%), RLN2 (67%), RLN1 (83%), IFNA21 (0%), IFNA4 (17%), IFNA7 (33%), IFNA10 (50%), IFNA16 (67%), IFNA17 (83%), IFNA13 (0%), IFNA1 (17%), ANKRD18B (33%), PRSS3 (50%), GALT (67%), SPATA31F1 (83%), CNTNAP3 (0%), SPATA31A1 (17%), FOXD4L6 (33%), ZNG1F (50%), CNTNAP3B (67%), SPATA31A6 (83%), SPATA31A7 (0%), CNTNAP3C (17%), FOXD4L5 (33%), ZNG1E (50%), FOXD4L4 (67%), ZNF658 (83%), ANKRD20A1 (0%), ZNG1C (17%), FOXD4L3 (33%), PGM5 (50%), FXN (67%), TJP2 (83%), SPATA31D4 (0%), SPATA31D3 (17%), SPATA31D1 (33%), KIF27 (50%), SPATA31C1 (67%), SPATA31C2 (83%), SLC71A2 (0%), NUTM2G (17%), CTSV (33%), OR13C5 (50%), OR13C2 (67%), OR13C9 (83%), POLE3 (0%), ORM1 (17%), ORM2 (33%), SLC27A4 (50%), PKN3 (67%), ABO (0%), LCN1 (17%), OBP2A (33%), SOHLH1 (50%), INPP5E (67%), AJM1 (83%), GRIN1 (0%), TUBB8 (17%), AKR1C1 (33%), AKR1C2 (50%), DCLRE1C (67%), MRC1 (83%), ANKRD30A (0%), ZNF33A (17%), ZNF37A (33%), PLD5P1 (50%), ZNF33B (67%), BMS1 (83%), AGAP4 (0%), TIMM23 (17%), ANTXRL (33%), ANXA8L1 (50%), NPY4R (67%), GPRIN2 (83%), PTPN20 (0%), ANXA8 (17%), FAM25G (33%), AGAP9 (50%), SYT15B (67%), NPY4R2 (83%), PARG (0%), TIMM23B (17%), TIMM23B-AGAP6 (33%), AGAP6 (50%), WASHC2A (67%), ASAH2B (83%), EIF5AL1 (0%), NUTM2B (17%), NUTM2E (33%), TMEM254 (50%), PLAC9 (67%), ADIRF (83%), NUTM2A (0%), NUTM2D (17%), PAPSS2 (33%), PTEN (50%), LIPN (67%), BTRC (83%), SFR1 (0%), DHX32 (17%), FANK1 (33%), ECHS1 (50%), SPRN (67%), FRG2B (83%), SCGB1C1 (0%), IFITM3 (17%), DRD4 (33%), DEAF1 (50%), KRTAP5-2 (83%), KRTAP5-4 (0%), MRPL23 (17%), H19 (33%), SSU72L5 (50%), SSU72L2 (67%), SSU72L4 (83%), SSU72L1 (0%), OR51A4 (17%), OR51A2 (33%), HBG1 (50%), OR10A5 (67%), MRGPRX4 (83%), MDK (0%), SPI1 (17%), OR4C3 (33%), OR4C5 (50%), OR4A47 (67%), TRIM51G (83%), TRIM64C (0%), FOLH1 (17%), OR4C13 (33%), OR4C12 (50%), OR4C45 (67%), OR4C46 (83%), OR4A5 (0%), TRIM48 (17%), OR4A15 (33%), TRIM51 (50%), OR5F1 (67%), OR8H2 (83%), OR5M8 (0%), OR9G1 (17%), OR1S2 (33%), OR1S1 (50%), GLYATL1B (67%), PGA3 (83%), B3GAT3 (0%), ESRRA (17%), SLC22A12 (33%), RBM4B (50%), TPCN2 (67%), FGF3 (83%), KRTAP5-8 (0%), KRTAP5-10 (17%), KRTAP5-11 (33%), XNDC1N-ZNF705EP-ALG1L9P (50%), DEFB108B (67%), XNDC1N (83%), INTS4 (0%), NOX4 (17%), TRIM77 (33%), TRIM49 (50%), TRIM64B (67%), TRIM49D1 (83%), TRIM64 (0%), TRIM49C (17%), UBTFL1 (33%), CARD16 (50%), HSPA8 (67%), OR8B2 (83%), TMEM45B (0%), CD4 (17%), PEX5 (33%), APOBEC1 (50%), GDF3 (67%), NANOG (83%), FAM90A1 (0%), PRH1 (33%), PRR4 (50%), PRH2 (67%), TAS2R14 (83%), TAS2R31 (0%), TAS2R46 (17%), TAS2R43 (33%), TAS2R30 (50%), PRB4 (67%), PRB1 (83%), DDX11 (0%), H3-5 (17%), ALG10 (33%), ALG10B (50%), TUBA1B (67%), COX14 (83%), NACA (50%), DPY19L2 (67%), HNF1A (83%), HPD (0%), HCAR2 (17%), HCAR3 (33%), P2RX2 (50%), PGAM5 (67%), GOLGA3 (83%), C1QTNF9B (0%), C1QTNF9 (17%), PARP4 (33%), PABPC3 (50%), MRPS31 (67%), HNRNPA1L2 (83%), PRR20C (0%), PRR20B (17%), PRR20D (33%), PRR20E (50%), F7 (67%), PROZ (83%), POTEM (0%), POTEG (17%), OR11H2 (33%), OR4N2 (50%), OR4Q3 (67%), OR4M1 (83%), RNASE3 (0%), RNASE2 (17%), OR10G2 (33%), DHRS4 (50%), DHRS4L2 (67%), ARF6 (83%), ACOT2 (0%), NDUFB1 (17%), JAG2 (33%), BTBD6 (50%), IGHV3-21 (67%), GOLGA6L6 (83%), POTEB3 (0%), LINC02203 (17%), OR4M2B (33%), OR4N4C (50%), POTEB (67%), OR4M2-OT1 (83%), OR4N4 (0%), GOLGA6L22 (17%), GOLGA6L1 (33%), GOLGA6L26 (50%), GOLGA8S (67%), GOLGA6L2 (83%), HERC2 (0%), GOLGA6L24 (17%), GOLGA8F (33%), GOLGA8G (50%), GOLGA6L25 (67%), GOLGA8M (83%), GOLGA8J (0%), GOLGA8T (17%), GOLGA8R (50%), GOLGA8Q (67%), GOLGA8H (83%), GOLGA8O (0%), GOLGA8N (17%), GOLGA8A (33%), GOLGA8B (50%), NANOGP8 (67%), NDUFAF1 (83%), CKMT1B (0%), CATSPER2 (33%), CKMT1A (50%), TERB2 (67%), LDHAL6B (0%), GOLGA6B (17%), GOLGA6A (33%), ISLR2 (50%), GOLGA6C (67%), GOLGA6D (83%), ADAMTS7 (0%), EFL1 (17%), SAXO2 (33%), GOLGA6L10 (50%), GOLGA6L9 (67%), WHAMM (83%), OR4F4 (0%), MPG (17%), HBM (33%), AXIN1 (83%), SSTR5 (0%), TPSD1 (50%), GNPTG (67%), UNKL (83%), PKD1 (0%), PDPK1 (17%), EEF2KMT (33%), NPIPA3 (50%), NPIPA2 (67%), NOMO1 (83%), PDXDC1 (0%), RRN3 (17%), NPIPA5 (33%), MPV17L (50%), NOMO3 (67%), NPIPA6 (83%), NPIPA8 (0%), NPIPA9 (17%), NOMO2 (33%), SMG1 (50%), IQCK (67%), ACSM5 (83%), ACSM2B (0%), NPIPB3 (17%), NPIPB4 (50%), NPIPB5 (67%), NPIPB6 (83%), NPIPB7 (0%), SULT1A2 (17%), NPIPB8 (50%), EIF3C (67%), NPIPB9 (83%), NPIPB11 (0%), BOLA2-SMG1P6 (17%), BOLA2 (33%), SLX1B (50%), SULT1A4 (67%), NPIPB12 (83%), SLX1A (0%), SULT1A3 (17%), NPIPB13 (33%), PHKG2 (50%), VKORC1 (67%), KRABD5 (83%), TP53TG3 (0%), TP53TG3C (17%), TP53TG3E (33%), TP53TG3B (50%), TP53TG3F (67%), CCNYL1B (83%), CES1 (0%), MT1M (17%), MATCAP1 (33%), HSD11B2 (50%), CLEC18A (67%), PDPR (83%), EXOSC6 (0%), HPR (50%), NPIPB15 (67%), CLEC18B (83%), CA5A (0%), ZNF469 (17%), CDH15 (33%), ANKRD11 (50%), MC1R (67%), PRDM7 (83%), ABR (0%), SERPINF2 (17%), SRR (33%), OR1D5 (50%), P2RX5 (67%), ALOX15 (83%), ENO3 (0%), USP6 (17%), SLC35G6 (33%), ALOXE3 (50%), HES7 (67%), CDRT15 (83%), FBXW10B (0%), TRIM16 (17%), ZNF286A-TBC1D26 (33%), ZNF286A (50%), TBC1D26 (67%), UBB (83%), ATPAF2 (0%), EVPLL (17%), LGALS9C (33%), TBC1D28 (50%), FOXO3B (67%), FBXW10 (83%), GRAP (0%), GRAPL (17%), LGALS9B (33%), CDRT15L2 (50%), MEIS3P2 (67%), MAP2K3 (83%), KCNJ18 (0%), LGALS9 (17%), FOXN1 (33%), SUZ12 (50%), LRRC37B (67%), SLC35G3 (83%), CCL4 (0%), TBC1D3B (17%), CCL4L2 (50%), TBC1D3I (67%), TBC1D3G (83%), TBC1D3F (0%), TBC1D3K (17%), TBC1D3L (33%), TBC1D3D (50%), TBC1D3C (67%), TBC1D3E (83%), MRPL45 (0%), KRTAP1-1 (17%), KRTAP4-7 (33%), KRTAP4-8 (50%), KRTAP4-16 (67%), KRTAP4-9 (83%), KRTAP4-12 (0%), KRTAP9-7 (17%), KRT14 (33%), KRT16 (50%), KRT17 (67%), HSD17B1 (83%), G6PC3 (0%), ARHGAP27 (17%), PLEKHM1 (33%), ARL17B (50%), LRRC37A (67%), ARL17A (83%), NSF (0%), NPEPPS (17%), HOXB8 (33%), GIP (50%), DHX40 (67%), RPS6KB1 (83%), METTL2A (0%), TLK2 (17%), CSH2 (33%), GH2 (50%), CSH1 (67%), CSHL1 (83%), LRRC37A3 (0%), C17orf58 (17%), AMZ2 (33%), TMC6 (50%), CANT1 (67%), RNF213 (83%), ARL16 (0%), TUBB8B (17%), TYMS (33%), SLC35G4 (50%), POTEC (67%), ANKRD30B (83%), SLC25A52 (0%), KATNAL2 (17%), SERPINB4 (33%), SERPINB3 (50%), GALR1 (67%), CTDP1 (83%), BSG (0%), HCN2 (17%), KISS1R (33%), STK11 (50%), TCF3 (67%), ABHD17A (83%), GIPC3 (0%), TBXA2R (17%), CREB3L3 (33%), RFX2 (50%), C3 (67%), MBD3L2B (83%), MBD3L4 (0%), MBD3L2 (17%), STXBP2 (33%), TYK2 (50%), ZNF799 (67%), ZNF443 (83%), CYP4F3 (0%), CYP4F12 (17%), OR10H2 (33%), CALR3 (50%), MYO9B (67%), INSL3 (83%), ZNF738 (0%), ZNF100 (17%), ZNF208 (33%), ZNF676 (50%), ZNF729 (67%), ZNF492 (83%), ZNF728 (0%), RHPN2 (17%), GPI (33%), ZNF302 (50%), ZNF181 (67%), FFAR3 (83%), COX6B1 (0%), LGALS7 (17%), LGALS7B (33%), IFNL3 (50%), IFNL4 (67%), IFNL2 (83%), CYP2A7 (17%), CYP2G1P (33%), CYP2A13 (67%), CYP2F1 (83%), PSG8 (0%), PSG1 (17%), PSG6 (33%), PSG7 (50%), PSG11 (67%), PSG2 (83%), PSG4 (0%), PSG9 (17%), ETHE1 (50%), ZNF285 (67%), APOC1 (83%), APOC4 (0%), BLOC1S3 (17%), DMPK (33%), FUT1 (50%), BAX (67%), LHB (83%), CGB3 (0%), CGB2 (17%), CGB1 (33%), CGB5 (50%), CGB8 (67%), CGB7 (83%), PNKP (0%), SIGLEC16 (17%), KLK4 (33%), ETFB (50%), ZNF808 (67%), ZNF600 (83%), ZNF468 (0%), VN1R4 (17%), FAM90A27P (33%), ZNF765 (50%), ZNF761 (67%), ZNF813 (83%), PRKCG (0%), MBOAT7 (17%), LILRA6 (33%), LILRB2 (50%), LAIR1 (67%), LAIR2 (83%), LILRB1 (0%), KIR3DL3 (17%), KIR2DL3 (33%), KIR2DL1 (50%), KIR2DL4 (67%), KIR3DL1 (83%), KIR3DL2 (0%), NLRP7 (17%), NLRP2 (33%), GP6 (50%), TNNT1 (67%), TNNI3 (83%), RFPL4A (0%), RFPL4AL1 (17%), ZNF419 (33%), ZNF773 (50%), ZNF587B (67%), ZNF814 (83%), ZNF417 (0%), SLC27A5 (17%), SIRPB1 (33%), CST4 (50%), CST1 (67%), CST2 (83%), PLAGL2 (0%), SEMG1 (17%), PLTP (33%), CHRNA4 (50%), EEF1A2 (67%), PTK6 (83%), MYT1 (0%), PCMTD2 (17%), TPTE (33%), POTED (50%), KRTAP21-1 (67%), SMIM11 (83%), SMIM34 (0%), KCNE1 (17%), CBR3 (33%), NDUFV3 (50%), CBS (67%), U2AF1 (83%), SIK1 (0%), HSF2BP (17%), H2BC12L (33%), TRAPPC10 (50%), PWP2 (67%), GATD3 (83%), DNMT3L (0%), KRTAP10-1 (17%), KRTAP10-2 (33%), KRTAP10-4 (50%), KRTAP10-5 (67%), KRTAP10-6 (83%), KRTAP10-8 (0%), KRTAP10-9 (17%), KRTAP10-10 (33%), KRTAP12-2 (50%), KRTAP12-1 (67%), COL18A1 (83%), OR11H1 (0%), POTEH (17%), CCT8L2 (33%), USP18 (50%), GGTLC3 (67%), TMEM191B (83%), FAM246B (0%), DGCR6 (17%), PRODH (33%), FAM246C (50%), CCDC188 (67%), RTN4R (83%), TUBA3FP (0%), LRRC74B (17%), FAM246A (33%), RIMBP3B (50%), HIC2 (67%), TMEM191C (83%), GGTLC2 (0%), IGLL1 (17%), DRICH1 (33%), GSTT2B (50%), DDTL (67%), GSTT2 (83%), RFPL1 (0%), C22orf42 (17%), RFPL3 (33%), APOBEC3D (83%), APOBEC3H (0%), ATF4 (17%), NDUFA6 (33%), CYP2D7 (67%), RRP7A (83%), CYB5R3 (0%), A4GALT (17%), TTLL1 (33%), MLC1 (50%), TUBGCP6 (67%), ACR (83%), XG (0%), GYG2 (17%), ARSD (33%), MXRA5 (50%), PRKX (67%), VCX3A (83%), VCX2 (0%), VCX3B (17%), FAM9A (33%), FAM9C (50%), SUPT20HL2 (67%), SUPT20HL1 (83%), MAGEB6 (0%), DCAF8L1 (17%), FAM47B (33%), H2AL1Q (50%), FAM47C (67%), H2AL3 (83%), SPACA5B (0%), SSX5 (17%), SSX1 (33%), SSX3 (50%), SSX4 (67%), SSX4B (83%), GAGE12J (0%), GAGE13 (17%), GAGE2E (33%), GAGE12B (50%), GAGE12C (67%), GAGE12D (83%), GAGE12F (0%), GAGE12G (17%), GAGE12H (33%), GAGE2A (50%), GAGE1 (67%), CENPVL3 (83%), CENPVL1 (0%), MAGED4B (17%), MAGED4 (33%), XAGE1A (50%), XAGE1B (67%), SSX7 (83%), SSX2B (0%), SPANXN5 (17%), XAGE5 (33%), XAGE3 (50%), FAM156B (67%), FAM156A (83%), SPIN2B (0%), SPIN2A (17%), ZXDA (33%), CXorf49 (50%), CXorf49B (67%), DMRTC1B (83%), FAM236D (0%), DMRTC1 (17%), FAM236C (33%), FAM236A (50%), PABPC1L2B (67%), PABPC1L2A (83%), TGIF2LX (0%), PCDH11X (17%), TCEAL6 (33%), TCP11X1 (50%), NXF2 (67%), NXF2B (83%), RAB40AL (0%), TMSB15B (17%), H2BW1 (33%), H2BW2 (50%), TMSB15C (67%), PSMD10 (83%), CT47C1 (0%), RHOXF2B (17%), RHOXF2 (33%), CT47B1 (50%), CT47A12 (67%), CT47A11 (83%), CT47A9 (0%), CT47A8 (17%), CT47A7 (33%), CT47A6 (50%), CT47A5 (67%), CT47A4 (83%), CT47A2 (0%), CT47A1 (17%), RTL8B (33%), RTL8C (50%), RTL8A (67%), SMIM10L2B (83%), CT55 (0%), ETDA (17%), SMIM10L2A (33%), CT45A1 (50%), CT45A3 (67%), CT45A5 (83%), CT45A2 (0%), CT45A7 (17%), CT45A8 (33%), CT45A9 (50%), CT45A10 (67%), SAGE1 (83%), SPANXC (0%), SPANXA1 (17%), SPANXA2 (33%), SPANXD (50%), MAGEC1 (67%), SPANXN3 (83%), UBE2NL (0%), SPANXN1 (17%), CXorf51B (33%), CXorf51A (50%), EOLA1 (67%), HSFX3 (83%), HSFX2 (0%), HSFX1 (17%), MAGEA9 (33%), EOLA2 (50%), HSFX4 (67%), MAGEA3 (83%), MAGEA2B (0%), CSAG1 (17%), MAGEA12 (33%), MAGEA2 (50%), CSAG3 (67%), MAGEA6 (83%), PWWP4 (0%), SLC6A8 (17%), BCAP31 (33%), OPN1LW (50%), OPN1MW (67%), OPN1MW2 (83%), TEX28 (0%), CTAG1A (17%), CTAG1B (33%), CTAG2 (50%), H2AB1 (67%), F8A1 (83%), F8A2 (0%), F8A3 (17%), H2AB3 (33%), IL9R (50%), WASH6P (67%), TGIF2LY (not on this reference), PCDH11Y (not on this reference), TSPY2 (not on this reference), TSPY4 (not on this reference), TSPY8 (not on this reference), TSPY3 (not on this reference), TSPY1 (not on this reference), TSPY9 (not on this reference), TSPY10 (not on this reference), VCY (not on this reference), VCY1B (not on this reference), CDY2B (not on this reference), CDY2A (not on this reference), HSFY1 (not on this reference), HSFY2 (not on this reference), RBMY1B (not on this reference), RBMY1A1 (not on this reference), RBMY1D (not on this reference), RBMY1E (not on this reference), RBMY1F (not on this reference), RBMY1J (not on this reference), BPY2 (not on this reference), DAZ1 (not on this reference), DAZ2 (not on this reference), CDY1B (not on this reference), BPY2B (not on this reference), DAZ3 (not on this reference), DAZ4 (not on this reference), BPY2C (not on this reference), CDY1 (not on this reference), C4B_2 (not on this reference), GSTT1 (not on this reference), GSTTP2 (not on this reference), GTF2H2C_2 (not on this reference), HLA-DRB3 (not on this reference), HLA-DRB4 (not on this reference), KIR2DL2 (not on this reference), KIR2DL5A (not on this reference), KIR2DL5B (not on this reference), KIR2DS1 (not on this reference), KIR2DS2 (not on this reference), KIR2DS3 (not on this reference), KIR2DS5 (not on this reference), KIR3DS1 (not on this reference), LILRA3 (not on this reference), OR8U8 (not on this reference), OR8U9 (not on this reference), OR9G9 (not on this reference), TAS2R45 (not on this reference) + Not read here, called by a step of their own (54): RHCE (0%) by parascopy, AMY1A (17%) by parascopy, AMY1B (33%) by parascopy, AMY1C (50%) by parascopy, GSTM1 (0%) by pypgx, NOTCH2 (67%) by parascopy, FCGR1A (50%) by parascopy, GBA1 (17%) by parascopy, FCGR2A (67%) by parascopy, FCGR2C (0%) by parascopy, FCGR3B (17%) by parascopy, CFHR3 (17%) by parascopy, CFHR1 (33%) by parascopy, PROS1 (83%) by parascopy, UGT2B17 (50%) by pypgx, UGT2B15 (67%) by pypgx, GYPE (67%) by parascopy, GYPB (83%) by parascopy, GTF2H2C (50%) by parascopy, SMN2 (83%) by parascopy, SMN1 (0%) by parascopy, GTF2H2 (33%) by parascopy, HSPA1B (0%) by parascopy, C4A (33%) by parascopy, C4B (50%) by parascopy, CYP21A2 (67%) by cn_loci:CYP21A2, LPA (67%) by cn_loci:LPA_KIV2, PMS2 (0%) by parascopy, GTF2I (83%) by parascopy, DEFA1B (0%) by parascopy, CEL (83%) by parascopy, MUC5B (67%) by parascopy, KLRC2 (17%) by parascopy, KRT6B (0%) by parascopy, KRT6C (17%) by parascopy, KRT6A (33%) by parascopy, CHRFAM7A (33%) by parascopy, STRC (17%) by parascopy, SORD (83%) by parascopy, HBA2 (50%) by cn_loci:HBA, HBA1 (67%) by cn_loci:HBA, TPSB2 (17%) by parascopy, TPSAB1 (33%) by parascopy, OTOA (33%) by parascopy, SULT1A1 (33%) by pypgx, HYDIN (17%) by parascopy, HP (33%) by cn_loci:HP, CCL3L3 (33%) by cn_loci:CCL3L1, CYP2A6 (0%) by pypgx, CYP2B6 (50%) by pypgx, CD177 (33%) by parascopy, APOBEC3A (50%) by parascopy, APOBEC3B (67%) by parascopy, CYP2D6 (50%) by pypgx + A gene listed as not read could not be read reliably: too few of its reads were placed on it with confidence, so a 'no finding' in it says nothing. A gene with a caller of its own is left to that caller's section. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + gnomAD AF: unknown for every hit (no VEP output (step 13) in this folder) + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF unknown + call: low-confidence call (GQ 15, DP 30): check the reads + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF unknown + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF unknown + call: low-confidence call (GQ 40, DP 5): check the reads + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 6 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 0 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (FINAL_CLASSIFICATION): + Pathogenic: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 0 + P/LP rows below the depth floor (DP below 8): 0 + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: . + No gene passed Exomiser's filters with a variant that fits a mode of inheritance. + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Mobile Element Insertions (step 50) +--- + Insertions called: 0 (none) + FKTN SVA (F; AR): callable (depth 30, seen) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/str_intermediate_ranges.tsv'] +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: not assessed + . + VNtyper's coverage check: . + . + . + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 1 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 0 + ClinVar and gnomAD: not annotated (mito/S_chrM_annotated.tsv is older than the chrM calls: rerun step 20) + Confirmed disease variants (assets/mito_confirmed.tsv): 1 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + Large deletions: not looked for (no deletion table (mito/_chrM_deletions.tsv): step 20 ran before it looked for large deletions, eKLIPse wrote no table (see the step's log), or the Nextflow MITO_DELETIONS task failed (see the Nextflow log)) + mtDNA copy number: not counted (no copy-number table (mito/_mtdna_copies.tsv): step 20 ran before it counted mtDNA copies, or the Nextflow MITO_DELETIONS task failed (see the Nextflow log)) + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats: too little depth + . + KIV-2 4925G>A null allele (rs1484919544): not assessed + LPA KIV-2 4925G>A: not assessed, step 46 wrote no S_lpa_kiv2_4925.tsv (a run from before this reader, or the check did not run). + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: . (not read) + Not determined: neither the KIV-2 count nor the two risk variants could be read. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + No CHIP call. + No CHIP gene has the depth to find a clone: no result either way. + Too shallow or not on the reference: DNMT3A. + 0 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Not assessed: too shallow + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hom, ClinVar Pathogenic: two changed copies, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); not read: step 35's HBA1/HBA2 count: not assessed: S_hba_copy_number.tsv has no status row; Parascopy's SMN1 count: not resolved + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: x (called) + SMN1 by both tools: Paraphase no call, Parascopy no row covers SMN1 exon 7: no comparison: one of them has no call + Variants on phased haplotypes: 0 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: no row covers exon 7 + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: no row covers exon 7 + SMN1 and SMN2 together (agCN) at exon 7: . (quality ., filter .) + Reading: SMN1 and SMN2 not assessed: no model: no carrier reading + HBA1 and HBA2 together (alpha-globin genes, from depth): not assessed: S_hba_copy_number.tsv has no status row + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: vcf/B.report.json (PharmCAT version unknown) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + [STALE: from an earlier run (2019-06-01 12:30 UTC); step 27 was not run in the run of 2020-01-01 00:00 UTC] + Genes with a non-normal phenotype: 0 More than one possible result: 0 Not called: 1 Called without a function phenotype (no drug guidance): 0 + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) not called + pypgx *1/*2 + Cyrius *1/*2 (not usable: Filter LowQ) + pypgx and Cyrius agree: fewer than two usable calls + Probable (one caller: pypgx): *1/*2, Normal Metabolizer; not passed to PharmCAT, so no drug guidance rests on it + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## HLA Typing (T1K) +--- + [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/hla_alleles.tsv'] +## Locityper Second Opinion at Hard Loci (step 53) +--- + [STALE: from an earlier run (2019-06-01 12:30 UTC); step 53 was skipped in the run of 2020-01-01 00:00 UTC] + Loci called: 3 of 3; passing the authors' filter: 3 + HLA-DRB1 Locityper: h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: T1K (step 08) did not run + HLA-DQB1 Locityper: h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: T1K (step 08) did not run + CYP2D6 Locityper: h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: pypgx (step 32): *1/*2; Cyrius (step 21): *1/*2 (not usable: Filter LowQ) + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Mitochondrial Haplogroup +--- + [STALE: from an earlier run (2019-06-01 12:30 UTC); step 12 was skipped in the run of 2020-01-01 00:00 UTC] + Haplogroup: U5a + Contamination (haplocheck): not checked (needs step 20's Mutect2 chrM calls) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/U5a + YFull MTree: https://www.yfull.com/mtree/U5a/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: insufficient markers (. markers, QC-score .) + +## Y Placement on the Current Public Tree +--- + Branch: no branch has a derived call (level ., .) + Path SNPs: . derived, . ancestral, . no call; . SNPs called at depth . or more + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Runs of Homozygosity +--- + Segments: 1 Total: 7.0 MB Largest: 7.0 MB + Autosomal ROH > 5MB: 1 + chr2:10000001-17000000 7.0MB + F_ROH: 0.0294 (7.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 0 No genotype at the position: 1 Other allele: 0 + Not read (no genotype in the gVCF): rs10455872 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + +## Polygenic Risk Scores +--- + [STALE: from an earlier run (2019-06-01 12:30 UTC); step 25 was failed (exit 2) in the run of 2020-01-01 00:00 UTC] + X (/ variants matched) PGS1 + Raw score only: no ancestry reference panel was installed, so there is no percentile and the sum cannot be compared with anyone (scripts/setup.sh --ancestry-panel adds it). Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 334 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 61,873; depth unknown (no total_reads or read_lengths in the summary): not checked + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: not assessed (no human depth) + No read on any of the 1 viral genomes. + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Steps Not Run +--- + - Mosaic loss of chromosome Y or X + - Variant calling + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Delly) + - Y-STR markers (HipSTR) + - Blood groups (predicted) + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - HBA1/HBA2 copy number (alpha-thalassaemia deletions): neither step 35's read-depth count (short reads) nor step 35b (Paraphase, PacBio HiFi) made a call + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/all/all.txt b/tests/parity/golden/report-render/all/all.txt new file mode 100644 index 000000000..117f1c19f --- /dev/null +++ b/tests/parity/golden/report-render/all/all.txt @@ -0,0 +1,514 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Quality control +--- + Mean depth: 31.2x + Alignment: 1000 reads in, 1000 primary records in the BAM + Inferred sex: male + Declared sex: male + Sex from the reads (somalier): male (declared and measured sex agree) + Contamination (VerifyBamID2 FREEMIX): 0.0010 (warning above ) + Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error. + +## Genes This Genome Could Not Read Reliably +--- + 217 of the 1572 hard-to-read genes of assets/callability_genes.tsv were read: 90% or more of their bases had 10 or more reads of mapping quality 20 or more. + Not read, and no other step calls them (1301): OR4F5 (17%), OR4F29 (33%), OR4F16 (50%), AGRN (67%), ATAD3B (0%), MMP23B (0%), CDK11B (17%), SLC35E2B (33%), CDK11A (50%), TTC34 (67%), RPL22 (83%), MASP2 (0%), NPPA (17%), KIAA2013 (33%), PRAMEF1 (50%), PRAMEF11 (67%), HNRNPCL1 (83%), PRAMEF4 (0%), PRAMEF10 (17%), PRAMEF7 (33%), PRAMEF6 (50%), PRAMEF27 (67%), HNRNPCL3 (83%), HNRNPCL2 (0%), PRAMEF26 (17%), HNRNPCL4 (33%), PRAMEF9 (50%), PRAMEF13 (67%), PRAMEF18 (83%), PRAMEF8 (0%), PRAMEF33 (17%), PRAMEF15 (33%), PRAMEF14 (50%), PRAMEF19 (67%), PRAMEF17 (83%), CELA2B (0%), CLCNKA (17%), CLCNKB (33%), NBPF1 (50%), CROCC (67%), AKR7L (83%), NBPF3 (0%), CELA3B (17%), CELA3A (33%), HMGCL (50%), CNR2 (67%), RSRP1 (83%), PIGV (17%), XKR8 (33%), BMP8A (50%), BMP8B (67%), OXCT2 (83%), CYP4Z1 (0%), CYP4A22 (17%), GBP1 (33%), SETSIP (50%), AGL (67%), EXTL2 (83%), AMY2A (0%), NBPF4 (67%), NBPF6 (83%), LRIG2 (17%), VANGL1 (33%), IGSF3 (50%), SEC22B (83%), NBPF26 (0%), NOTCH2NLR (17%), PPIAL4A (33%), FAM72B (50%), SRGAP2C (67%), H3-7 (83%), PPIAL4E (0%), NBPF15 (17%), PPIAL4F (33%), SRGAP2B (50%), FAM72D (67%), PPIAL4D (83%), GPR89A (0%), RBM8A (17%), NBPF10 (33%), NOTCH2NLA (50%), PPIAL4H (67%), NBPF12 (83%), NBPF11 (0%), PPIAL4G (17%), NBPF14 (33%), NOTCH2NLB (50%), NUDT4B (67%), PDE4DIP (83%), NOTCH2NLC (0%), NBPF19 (17%), PPIAL4C (33%), H2BC18 (67%), H3C13 (83%), H3C14 (0%), H2AC18 (17%), H2AC19 (33%), H3C15 (50%), H4C15 (67%), HRNR (83%), LCE3E (0%), LCE3D (17%), S100A8 (33%), S100A7A (50%), S100A7 (67%), FLAD1 (83%), MTX1 (0%), HCN3 (33%), FCRL5 (50%), HSPA6 (83%), FCGR2B (33%), HSD17B7 (50%), CD247 (67%), XCL2 (83%), PRG4 (0%), PTPRC (50%), PPP1R12B (67%), KISS1 (83%), SRGAP2 (0%), CR1 (17%), CR1L (33%), ZC3H11B (50%), LBR (67%), LEFTY2 (83%), OR2T33 (0%), OR2T7 (17%), OR2T2 (33%), OR2T3 (50%), OR2T5 (67%), OR2G6 (83%), OR2T34 (0%), OR2T11 (17%), OR2T35 (33%), OR2T27 (50%), SNTG2 (67%), TPO (83%), KLF11 (0%), CCDC121 (17%), ABCG8 (33%), PCBP1 (50%), NAT8 (67%), C2orf78 (83%), CD8B (0%), RGPD1 (17%), PLGLB1 (33%), PLGLB2 (50%), RGPD2 (67%), RPIA (83%), TEKT4 (0%), FAHD2A (17%), TRIM43B (33%), TRIM43 (50%), ANKRD36C (67%), GPAT2 (83%), ANKRD36 (0%), ANKRD36B (17%), RGPD3 (33%), RGPD4 (50%), RANBP2 (67%), RGPD5 (83%), MALL (0%), MTLN (17%), LIMS4 (33%), RGPD6 (50%), ANAPC1 (67%), RGPD8 (83%), FOXD4L1 (0%), RABL2A (17%), RAB6C (33%), POTEF (50%), CCDC74B (67%), SMPD4 (83%), TUBA3E (0%), POTEI (17%), CFC1B (33%), CFC1 (50%), POTEJ (67%), PLEKHB2 (83%), RAB6D (0%), MZT2A (17%), TUBA3D (33%), CCDC74A (50%), ANKRD30BL (67%), NOSTRIN (83%), IFT70B (0%), CASP10 (17%), ALPP (33%), ALPG (50%), UGT1A6 (67%), UGT1A5 (83%), UGT1A3 (0%), MLPH (17%), OR6B2 (33%), AQP12B (50%), AQP12A (67%), ANO7 (83%), CHL1 (0%), EMC3 (17%), FANCD2 (33%), DAZL (50%), ZNF35 (67%), LZTFL1 (83%), MST1 (0%), MST1R (17%), HYAL1 (33%), FRG2C (50%), ZNF717 (67%), OR5H6 (0%), ROPN1 (17%), ROPN1B (33%), RPN1 (50%), ALG1L2 (67%), BFSP2 (83%), PRR23B (0%), SOX2 (17%), EIF2B5 (33%), KNG1 (50%), TM4SF19 (67%), ZNF595 (83%), PDE6B (0%), GAK (17%), FGFRL1 (33%), RNF212 (50%), UVSSA (67%), DOK7 (83%), HMX1 (0%), FAM90A26 (17%), USP17L10 (33%), USP17L11 (50%), USP17L12 (67%), USP17L13 (83%), USP17L17 (0%), USP17L18 (17%), USP17L19 (33%), USP17L20 (50%), USP17L21 (67%), USP17L22 (83%), USP17L24 (0%), USP17L25 (17%), USP17L26 (33%), USP17L5 (50%), USP17L27 (67%), USP17L28 (83%), USP17L30 (0%), DEFB131A (17%), DRD5 (33%), UGT2B10 (83%), UGT2B28 (0%), UGT2A1 (17%), UGT2A2 (33%), HTN3 (50%), HTN1 (67%), AFP (83%), PIGY (0%), PYURF (17%), CISD2 (33%), SLC9B1 (50%), KLHL2 (0%), GK3 (17%), HPF1 (33%), PDLIM3 (50%), FAT1 (67%), FRG1 (83%), FRG2 (0%), DUX4 (17%), SDHA (33%), PDCD6 (50%), ZDHHC11B (67%), ZDHHC11 (83%), TERT (0%), SLC6A3 (17%), TAF11L2 (33%), TAF11L3 (50%), TAF11L4 (67%), TAF11L5 (83%), TAF11L7 (0%), TAF11L8 (17%), TAF11L9 (33%), TAF11L10 (50%), TAF11L11 (67%), TAF11L12 (83%), TAF11L14 (0%), EMB (17%), MARVELD2 (33%), SERF1B (67%), NAIP (17%), SKIC3 (50%), LIX1 (67%), SAR1B (83%), DND1 (0%), PCDHA10 (17%), PCDHB7 (33%), PCDHB8 (50%), PCDHB11 (67%), PCDHB12 (83%), PPP1R2B (0%), NPM1 (17%), THOC3 (33%), SIMC1 (50%), FAM153A (67%), FAM153CP (83%), FLT4 (0%), OR4F3 (17%), DUSP22 (33%), TUBB2A (50%), H2AC13 (67%), H2AC14 (83%), OR2J1 (0%), OR2J2 (17%), HLA-G (33%), HLA-A (50%), MICA (67%), MICB (83%), ZBTB12 (17%), PBX2 (83%), HLA-DRB1 (0%), GSTA2 (17%), GSTA1 (33%), GSTA5 (50%), PRIM2 (67%), FKBP1C (83%), SLC17A5 (0%), SEC63 (17%), OR2A4 (33%), CTAGE9 (50%), PCMT1 (67%), RAET1G (83%), ULBP1 (0%), RAET1L (17%), ULBP3 (33%), SLC22A1 (50%), SMOC2 (83%), RBAK-RBAKDN (0%), RBAK (17%), SLC29A4 (33%), FSCN1 (50%), OCM (67%), CCZ1 (83%), RSPH10B2 (17%), CCZ1B (33%), NOD1 (50%), FKBP9 (67%), DPY19L1 (83%), SEPTIN7 (0%), SPDYE1 (17%), PPIA (33%), CDC14C (50%), PSPH (67%), CCT6A (83%), ZNF716 (0%), ZNF727 (17%), ZNF735 (33%), ZNF736 (50%), GUSB (67%), RABGEF1 (83%), TYW1 (0%), SPDYE21 (17%), TYW1B (33%), POM121 (50%), TRIM74 (67%), SPDYE8 (83%), SPDYE9 (0%), SPDYE10 (17%), NSUN5 (33%), TRIM50 (50%), CLIP2 (67%), GTF2IRD2 (0%), SPDYE12 (17%), CASTOR2 (33%), GTF2IRD2B (50%), SPDYE13 (67%), SPDYE14 (83%), TRIM73 (0%), POM121C (17%), SPDYE5 (33%), DTX2 (50%), UPK3B (67%), SPDYE16 (83%), SPDYE17 (0%), SPDYE18 (17%), STEAP1 (33%), ASNS (50%), OCM2 (67%), CYP3A7-CYP3A51P (83%), CYP3A4 (0%), STAG3 (17%), PVRIG (33%), SPDYE3 (50%), SAP25 (67%), ZAN (83%), MUC12 (0%), SPDYE6 (17%), POLR2J (33%), RASA4B (50%), POLR2J3 (67%), UPK3BL2 (83%), RASA4 (0%), UPK3BL1 (17%), POLR2J3-UPK3BL2 (33%), SPDYE2B (50%), POLR2J2 (67%), LAMB1 (83%), METTL2B (0%), KLF14 (17%), AKR1B10 (33%), AKR1B15 (50%), BRAF (67%), TRBV9 (83%), PRSS2 (0%), CTAGE15 (17%), TCAF2 (33%), TCAF2C (50%), CTAGE6 (67%), OR2F2 (83%), CTAGE4 (0%), OR2A42 (17%), OR2A7 (33%), CTAGE8 (50%), OR2A1 (67%), ARHGEF5 (83%), ACTR3C (0%), KMT2C (17%), ACTR3B (33%), OR4F21 (50%), FBXO25 (67%), ARHGEF10 (83%), FAM90A15 (17%), FAM90A3 (33%), FAM90A13 (50%), FAM90A5 (67%), FAM90A20 (83%), USP17L1 (0%), USP17L4 (17%), ZNF705G (33%), DEFB108C (50%), DEFB4B (67%), DEFB103B (83%), DEFB104B (0%), DEFB106B (17%), DEFB105B (33%), DEFB107B (50%), PRR23D1 (67%), FAM90A7 (83%), FAM90A23 (0%), FAM90A14 (17%), FAM90A18 (33%), FAM90A16 (50%), FAM90A8 (67%), FAM90A17 (83%), FAM90A9 (0%), FAM90A10 (17%), PRR23D2 (33%), DEFB107A (50%), DEFB105A (67%), DEFB106A (83%), SPAG11A (0%), DEFB103A (17%), DEFB4A (33%), ZNF705B (50%), USP17L8 (67%), USP17L3 (83%), FAM90A11 (0%), FAM90A24 (17%), FAM90A12 (33%), SLC35G5 (50%), DEFB130B (67%), ZNF705D (83%), USP17L2 (0%), DEFB109D (17%), FAM86B1 (33%), DEFB130A (50%), FAM86B2 (67%), RBPMS (83%), IMPA1 (0%), SLC10A5 (17%), CDH17 (33%), CYP11B1 (50%), CYP11B2 (67%), GPIHBP1 (83%), WASHC1 (0%), FOXD4 (17%), ZNG1A (33%), KCNV2 (50%), RLN2 (67%), RLN1 (83%), IFNA21 (0%), IFNA4 (17%), IFNA7 (33%), IFNA10 (50%), IFNA16 (67%), IFNA17 (83%), IFNA13 (0%), IFNA1 (17%), ANKRD18B (33%), PRSS3 (50%), GALT (67%), SPATA31F1 (83%), CNTNAP3 (0%), SPATA31A1 (17%), FOXD4L6 (33%), ZNG1F (50%), CNTNAP3B (67%), SPATA31A6 (83%), SPATA31A7 (0%), CNTNAP3C (17%), FOXD4L5 (33%), ZNG1E (50%), FOXD4L4 (67%), ZNF658 (83%), ANKRD20A1 (0%), ZNG1C (17%), FOXD4L3 (33%), PGM5 (50%), FXN (67%), TJP2 (83%), SPATA31D4 (0%), SPATA31D3 (17%), SPATA31D1 (33%), KIF27 (50%), SPATA31C1 (67%), SPATA31C2 (83%), SLC71A2 (0%), NUTM2G (17%), CTSV (33%), OR13C5 (50%), OR13C2 (67%), OR13C9 (83%), POLE3 (0%), ORM1 (17%), ORM2 (33%), SLC27A4 (50%), PKN3 (67%), ABO (0%), LCN1 (17%), OBP2A (33%), SOHLH1 (50%), INPP5E (67%), AJM1 (83%), GRIN1 (0%), TUBB8 (17%), AKR1C1 (33%), AKR1C2 (50%), DCLRE1C (67%), MRC1 (83%), ANKRD30A (0%), ZNF33A (17%), ZNF37A (33%), PLD5P1 (50%), ZNF33B (67%), BMS1 (83%), AGAP4 (0%), TIMM23 (17%), ANTXRL (33%), ANXA8L1 (50%), NPY4R (67%), GPRIN2 (83%), PTPN20 (0%), ANXA8 (17%), FAM25G (33%), AGAP9 (50%), SYT15B (67%), NPY4R2 (83%), PARG (0%), TIMM23B (17%), TIMM23B-AGAP6 (33%), AGAP6 (50%), WASHC2A (67%), ASAH2B (83%), EIF5AL1 (0%), NUTM2B (17%), NUTM2E (33%), TMEM254 (50%), PLAC9 (67%), ADIRF (83%), NUTM2A (0%), NUTM2D (17%), PAPSS2 (33%), PTEN (50%), LIPN (67%), BTRC (83%), SFR1 (0%), DHX32 (17%), FANK1 (33%), ECHS1 (50%), SPRN (67%), FRG2B (83%), SCGB1C1 (0%), IFITM3 (17%), DRD4 (33%), DEAF1 (50%), KRTAP5-2 (83%), KRTAP5-4 (0%), MRPL23 (17%), H19 (33%), SSU72L5 (50%), SSU72L2 (67%), SSU72L4 (83%), SSU72L1 (0%), OR51A4 (17%), OR51A2 (33%), HBG1 (50%), OR10A5 (67%), MRGPRX4 (83%), MDK (0%), SPI1 (17%), OR4C3 (33%), OR4C5 (50%), OR4A47 (67%), TRIM51G (83%), TRIM64C (0%), FOLH1 (17%), OR4C13 (33%), OR4C12 (50%), OR4C45 (67%), OR4C46 (83%), OR4A5 (0%), TRIM48 (17%), OR4A15 (33%), TRIM51 (50%), OR5F1 (67%), OR8H2 (83%), OR5M8 (0%), OR9G1 (17%), OR1S2 (33%), OR1S1 (50%), GLYATL1B (67%), PGA3 (83%), B3GAT3 (0%), ESRRA (17%), SLC22A12 (33%), RBM4B (50%), TPCN2 (67%), FGF3 (83%), KRTAP5-8 (0%), KRTAP5-10 (17%), KRTAP5-11 (33%), XNDC1N-ZNF705EP-ALG1L9P (50%), DEFB108B (67%), XNDC1N (83%), INTS4 (0%), NOX4 (17%), TRIM77 (33%), TRIM49 (50%), TRIM64B (67%), TRIM49D1 (83%), TRIM64 (0%), TRIM49C (17%), UBTFL1 (33%), CARD16 (50%), HSPA8 (67%), OR8B2 (83%), TMEM45B (0%), CD4 (17%), PEX5 (33%), APOBEC1 (50%), GDF3 (67%), NANOG (83%), FAM90A1 (0%), PRH1 (33%), PRR4 (50%), PRH2 (67%), TAS2R14 (83%), TAS2R31 (0%), TAS2R46 (17%), TAS2R43 (33%), TAS2R30 (50%), PRB4 (67%), PRB1 (83%), DDX11 (0%), H3-5 (17%), ALG10 (33%), ALG10B (50%), TUBA1B (67%), COX14 (83%), NACA (50%), DPY19L2 (67%), HNF1A (83%), HPD (0%), HCAR2 (17%), HCAR3 (33%), P2RX2 (50%), PGAM5 (67%), GOLGA3 (83%), C1QTNF9B (0%), C1QTNF9 (17%), PARP4 (33%), PABPC3 (50%), MRPS31 (67%), HNRNPA1L2 (83%), PRR20C (0%), PRR20B (17%), PRR20D (33%), PRR20E (50%), F7 (67%), PROZ (83%), POTEM (0%), POTEG (17%), OR11H2 (33%), OR4N2 (50%), OR4Q3 (67%), OR4M1 (83%), RNASE3 (0%), RNASE2 (17%), OR10G2 (33%), DHRS4 (50%), DHRS4L2 (67%), ARF6 (83%), ACOT2 (0%), NDUFB1 (17%), JAG2 (33%), BTBD6 (50%), IGHV3-21 (67%), GOLGA6L6 (83%), POTEB3 (0%), LINC02203 (17%), OR4M2B (33%), OR4N4C (50%), POTEB (67%), OR4M2-OT1 (83%), OR4N4 (0%), GOLGA6L22 (17%), GOLGA6L1 (33%), GOLGA6L26 (50%), GOLGA8S (67%), GOLGA6L2 (83%), HERC2 (0%), GOLGA6L24 (17%), GOLGA8F (33%), GOLGA8G (50%), GOLGA6L25 (67%), GOLGA8M (83%), GOLGA8J (0%), GOLGA8T (17%), GOLGA8R (50%), GOLGA8Q (67%), GOLGA8H (83%), GOLGA8O (0%), GOLGA8N (17%), GOLGA8A (33%), GOLGA8B (50%), NANOGP8 (67%), NDUFAF1 (83%), CKMT1B (0%), CATSPER2 (33%), CKMT1A (50%), TERB2 (67%), LDHAL6B (0%), GOLGA6B (17%), GOLGA6A (33%), ISLR2 (50%), GOLGA6C (67%), GOLGA6D (83%), ADAMTS7 (0%), EFL1 (17%), SAXO2 (33%), GOLGA6L10 (50%), GOLGA6L9 (67%), WHAMM (83%), OR4F4 (0%), MPG (17%), HBM (33%), AXIN1 (83%), SSTR5 (0%), TPSD1 (50%), GNPTG (67%), UNKL (83%), PKD1 (0%), PDPK1 (17%), EEF2KMT (33%), NPIPA3 (50%), NPIPA2 (67%), NOMO1 (83%), PDXDC1 (0%), RRN3 (17%), NPIPA5 (33%), MPV17L (50%), NOMO3 (67%), NPIPA6 (83%), NPIPA8 (0%), NPIPA9 (17%), NOMO2 (33%), SMG1 (50%), IQCK (67%), ACSM5 (83%), ACSM2B (0%), NPIPB3 (17%), NPIPB4 (50%), NPIPB5 (67%), NPIPB6 (83%), NPIPB7 (0%), SULT1A2 (17%), NPIPB8 (50%), EIF3C (67%), NPIPB9 (83%), NPIPB11 (0%), BOLA2-SMG1P6 (17%), BOLA2 (33%), SLX1B (50%), SULT1A4 (67%), NPIPB12 (83%), SLX1A (0%), SULT1A3 (17%), NPIPB13 (33%), PHKG2 (50%), VKORC1 (67%), KRABD5 (83%), TP53TG3 (0%), TP53TG3C (17%), TP53TG3E (33%), TP53TG3B (50%), TP53TG3F (67%), CCNYL1B (83%), CES1 (0%), MT1M (17%), MATCAP1 (33%), HSD11B2 (50%), CLEC18A (67%), PDPR (83%), EXOSC6 (0%), HPR (50%), NPIPB15 (67%), CLEC18B (83%), CA5A (0%), ZNF469 (17%), CDH15 (33%), ANKRD11 (50%), MC1R (67%), PRDM7 (83%), ABR (0%), SERPINF2 (17%), SRR (33%), OR1D5 (50%), P2RX5 (67%), ALOX15 (83%), ENO3 (0%), USP6 (17%), SLC35G6 (33%), ALOXE3 (50%), HES7 (67%), CDRT15 (83%), FBXW10B (0%), TRIM16 (17%), ZNF286A-TBC1D26 (33%), ZNF286A (50%), TBC1D26 (67%), UBB (83%), ATPAF2 (0%), EVPLL (17%), LGALS9C (33%), TBC1D28 (50%), FOXO3B (67%), FBXW10 (83%), GRAP (0%), GRAPL (17%), LGALS9B (33%), CDRT15L2 (50%), MEIS3P2 (67%), MAP2K3 (83%), KCNJ18 (0%), LGALS9 (17%), FOXN1 (33%), SUZ12 (50%), LRRC37B (67%), SLC35G3 (83%), CCL4 (0%), TBC1D3B (17%), CCL4L2 (50%), TBC1D3I (67%), TBC1D3G (83%), TBC1D3F (0%), TBC1D3K (17%), TBC1D3L (33%), TBC1D3D (50%), TBC1D3C (67%), TBC1D3E (83%), MRPL45 (0%), KRTAP1-1 (17%), KRTAP4-7 (33%), KRTAP4-8 (50%), KRTAP4-16 (67%), KRTAP4-9 (83%), KRTAP4-12 (0%), KRTAP9-7 (17%), KRT14 (33%), KRT16 (50%), KRT17 (67%), HSD17B1 (83%), G6PC3 (0%), ARHGAP27 (17%), PLEKHM1 (33%), ARL17B (50%), LRRC37A (67%), ARL17A (83%), NSF (0%), NPEPPS (17%), HOXB8 (33%), GIP (50%), DHX40 (67%), RPS6KB1 (83%), METTL2A (0%), TLK2 (17%), CSH2 (33%), GH2 (50%), CSH1 (67%), CSHL1 (83%), LRRC37A3 (0%), C17orf58 (17%), AMZ2 (33%), TMC6 (50%), CANT1 (67%), RNF213 (83%), ARL16 (0%), TUBB8B (17%), TYMS (33%), SLC35G4 (50%), POTEC (67%), ANKRD30B (83%), SLC25A52 (0%), KATNAL2 (17%), SERPINB4 (33%), SERPINB3 (50%), GALR1 (67%), CTDP1 (83%), BSG (0%), HCN2 (17%), KISS1R (33%), STK11 (50%), TCF3 (67%), ABHD17A (83%), GIPC3 (0%), TBXA2R (17%), CREB3L3 (33%), RFX2 (50%), C3 (67%), MBD3L2B (83%), MBD3L4 (0%), MBD3L2 (17%), STXBP2 (33%), TYK2 (50%), ZNF799 (67%), ZNF443 (83%), CYP4F3 (0%), CYP4F12 (17%), OR10H2 (33%), CALR3 (50%), MYO9B (67%), INSL3 (83%), ZNF738 (0%), ZNF100 (17%), ZNF208 (33%), ZNF676 (50%), ZNF729 (67%), ZNF492 (83%), ZNF728 (0%), RHPN2 (17%), GPI (33%), ZNF302 (50%), ZNF181 (67%), FFAR3 (83%), COX6B1 (0%), LGALS7 (17%), LGALS7B (33%), IFNL3 (50%), IFNL4 (67%), IFNL2 (83%), CYP2A7 (17%), CYP2G1P (33%), CYP2A13 (67%), CYP2F1 (83%), PSG8 (0%), PSG1 (17%), PSG6 (33%), PSG7 (50%), PSG11 (67%), PSG2 (83%), PSG4 (0%), PSG9 (17%), ETHE1 (50%), ZNF285 (67%), APOC1 (83%), APOC4 (0%), BLOC1S3 (17%), DMPK (33%), FUT1 (50%), BAX (67%), LHB (83%), CGB3 (0%), CGB2 (17%), CGB1 (33%), CGB5 (50%), CGB8 (67%), CGB7 (83%), PNKP (0%), SIGLEC16 (17%), KLK4 (33%), ETFB (50%), ZNF808 (67%), ZNF600 (83%), ZNF468 (0%), VN1R4 (17%), FAM90A27P (33%), ZNF765 (50%), ZNF761 (67%), ZNF813 (83%), PRKCG (0%), MBOAT7 (17%), LILRA6 (33%), LILRB2 (50%), LAIR1 (67%), LAIR2 (83%), LILRB1 (0%), KIR3DL3 (17%), KIR2DL3 (33%), KIR2DL1 (50%), KIR2DL4 (67%), KIR3DL1 (83%), KIR3DL2 (0%), NLRP7 (17%), NLRP2 (33%), GP6 (50%), TNNT1 (67%), TNNI3 (83%), RFPL4A (0%), RFPL4AL1 (17%), ZNF419 (33%), ZNF773 (50%), ZNF587B (67%), ZNF814 (83%), ZNF417 (0%), SLC27A5 (17%), SIRPB1 (33%), CST4 (50%), CST1 (67%), CST2 (83%), PLAGL2 (0%), SEMG1 (17%), PLTP (33%), CHRNA4 (50%), EEF1A2 (67%), PTK6 (83%), MYT1 (0%), PCMTD2 (17%), TPTE (33%), POTED (50%), KRTAP21-1 (67%), SMIM11 (83%), SMIM34 (0%), KCNE1 (17%), CBR3 (33%), NDUFV3 (50%), CBS (67%), U2AF1 (83%), SIK1 (0%), HSF2BP (17%), H2BC12L (33%), TRAPPC10 (50%), PWP2 (67%), GATD3 (83%), DNMT3L (0%), KRTAP10-1 (17%), KRTAP10-2 (33%), KRTAP10-4 (50%), KRTAP10-5 (67%), KRTAP10-6 (83%), KRTAP10-8 (0%), KRTAP10-9 (17%), KRTAP10-10 (33%), KRTAP12-2 (50%), KRTAP12-1 (67%), COL18A1 (83%), OR11H1 (0%), POTEH (17%), CCT8L2 (33%), USP18 (50%), GGTLC3 (67%), TMEM191B (83%), FAM246B (0%), DGCR6 (17%), PRODH (33%), FAM246C (50%), CCDC188 (67%), RTN4R (83%), TUBA3FP (0%), LRRC74B (17%), FAM246A (33%), RIMBP3B (50%), HIC2 (67%), TMEM191C (83%), GGTLC2 (0%), IGLL1 (17%), DRICH1 (33%), GSTT2B (50%), DDTL (67%), GSTT2 (83%), RFPL1 (0%), C22orf42 (17%), RFPL3 (33%), APOBEC3D (83%), APOBEC3H (0%), ATF4 (17%), NDUFA6 (33%), CYP2D7 (67%), RRP7A (83%), CYB5R3 (0%), A4GALT (17%), TTLL1 (33%), MLC1 (50%), TUBGCP6 (67%), ACR (83%), XG (0%), GYG2 (17%), ARSD (33%), MXRA5 (50%), PRKX (67%), VCX3A (83%), VCX2 (0%), VCX3B (17%), FAM9A (33%), FAM9C (50%), SUPT20HL2 (67%), SUPT20HL1 (83%), MAGEB6 (0%), DCAF8L1 (17%), FAM47B (33%), H2AL1Q (50%), FAM47C (67%), H2AL3 (83%), SPACA5B (0%), SSX5 (17%), SSX1 (33%), SSX3 (50%), SSX4 (67%), SSX4B (83%), GAGE12J (0%), GAGE13 (17%), GAGE2E (33%), GAGE12B (50%), GAGE12C (67%), GAGE12D (83%), GAGE12F (0%), GAGE12G (17%), GAGE12H (33%), GAGE2A (50%), GAGE1 (67%), CENPVL3 (83%), CENPVL1 (0%), MAGED4B (17%), MAGED4 (33%), XAGE1A (50%), XAGE1B (67%), SSX7 (83%), SSX2B (0%), SPANXN5 (17%), XAGE5 (33%), XAGE3 (50%), FAM156B (67%), FAM156A (83%), SPIN2B (0%), SPIN2A (17%), ZXDA (33%), CXorf49 (50%), CXorf49B (67%), DMRTC1B (83%), FAM236D (0%), DMRTC1 (17%), FAM236C (33%), FAM236A (50%), PABPC1L2B (67%), PABPC1L2A (83%), TGIF2LX (0%), PCDH11X (17%), TCEAL6 (33%), TCP11X1 (50%), NXF2 (67%), NXF2B (83%), RAB40AL (0%), TMSB15B (17%), H2BW1 (33%), H2BW2 (50%), TMSB15C (67%), PSMD10 (83%), CT47C1 (0%), RHOXF2B (17%), RHOXF2 (33%), CT47B1 (50%), CT47A12 (67%), CT47A11 (83%), CT47A9 (0%), CT47A8 (17%), CT47A7 (33%), CT47A6 (50%), CT47A5 (67%), CT47A4 (83%), CT47A2 (0%), CT47A1 (17%), RTL8B (33%), RTL8C (50%), RTL8A (67%), SMIM10L2B (83%), CT55 (0%), ETDA (17%), SMIM10L2A (33%), CT45A1 (50%), CT45A3 (67%), CT45A5 (83%), CT45A2 (0%), CT45A7 (17%), CT45A8 (33%), CT45A9 (50%), CT45A10 (67%), SAGE1 (83%), SPANXC (0%), SPANXA1 (17%), SPANXA2 (33%), SPANXD (50%), MAGEC1 (67%), SPANXN3 (83%), UBE2NL (0%), SPANXN1 (17%), CXorf51B (33%), CXorf51A (50%), EOLA1 (67%), HSFX3 (83%), HSFX2 (0%), HSFX1 (17%), MAGEA9 (33%), EOLA2 (50%), HSFX4 (67%), MAGEA3 (83%), MAGEA2B (0%), CSAG1 (17%), MAGEA12 (33%), MAGEA2 (50%), CSAG3 (67%), MAGEA6 (83%), PWWP4 (0%), SLC6A8 (17%), BCAP31 (33%), OPN1LW (50%), OPN1MW (67%), OPN1MW2 (83%), TEX28 (0%), CTAG1A (17%), CTAG1B (33%), CTAG2 (50%), H2AB1 (67%), F8A1 (83%), F8A2 (0%), F8A3 (17%), H2AB3 (33%), IL9R (50%), WASH6P (67%), TGIF2LY (not on this reference), PCDH11Y (not on this reference), TSPY2 (not on this reference), TSPY4 (not on this reference), TSPY8 (not on this reference), TSPY3 (not on this reference), TSPY1 (not on this reference), TSPY9 (not on this reference), TSPY10 (not on this reference), VCY (not on this reference), VCY1B (not on this reference), CDY2B (not on this reference), CDY2A (not on this reference), HSFY1 (not on this reference), HSFY2 (not on this reference), RBMY1B (not on this reference), RBMY1A1 (not on this reference), RBMY1D (not on this reference), RBMY1E (not on this reference), RBMY1F (not on this reference), RBMY1J (not on this reference), BPY2 (not on this reference), DAZ1 (not on this reference), DAZ2 (not on this reference), CDY1B (not on this reference), BPY2B (not on this reference), DAZ3 (not on this reference), DAZ4 (not on this reference), BPY2C (not on this reference), CDY1 (not on this reference), C4B_2 (not on this reference), GSTT1 (not on this reference), GSTTP2 (not on this reference), GTF2H2C_2 (not on this reference), HLA-DRB3 (not on this reference), HLA-DRB4 (not on this reference), KIR2DL2 (not on this reference), KIR2DL5A (not on this reference), KIR2DL5B (not on this reference), KIR2DS1 (not on this reference), KIR2DS2 (not on this reference), KIR2DS3 (not on this reference), KIR2DS5 (not on this reference), KIR3DS1 (not on this reference), LILRA3 (not on this reference), OR8U8 (not on this reference), OR8U9 (not on this reference), OR9G9 (not on this reference), TAS2R45 (not on this reference) + Not read here, called by a step of their own (54): RHCE (0%) by parascopy, AMY1A (17%) by parascopy, AMY1B (33%) by parascopy, AMY1C (50%) by parascopy, GSTM1 (0%) by pypgx, NOTCH2 (67%) by parascopy, FCGR1A (50%) by parascopy, GBA1 (17%) by parascopy, FCGR2A (67%) by parascopy, FCGR2C (0%) by parascopy, FCGR3B (17%) by parascopy, CFHR3 (17%) by parascopy, CFHR1 (33%) by parascopy, PROS1 (83%) by parascopy, UGT2B17 (50%) by pypgx, UGT2B15 (67%) by pypgx, GYPE (67%) by parascopy, GYPB (83%) by parascopy, GTF2H2C (50%) by parascopy, SMN2 (83%) by parascopy, SMN1 (0%) by parascopy, GTF2H2 (33%) by parascopy, HSPA1B (0%) by parascopy, C4A (33%) by parascopy, C4B (50%) by parascopy, CYP21A2 (67%) by cn_loci:CYP21A2, LPA (67%) by cn_loci:LPA_KIV2, PMS2 (0%) by parascopy, GTF2I (83%) by parascopy, DEFA1B (0%) by parascopy, CEL (83%) by parascopy, MUC5B (67%) by parascopy, KLRC2 (17%) by parascopy, KRT6B (0%) by parascopy, KRT6C (17%) by parascopy, KRT6A (33%) by parascopy, CHRFAM7A (33%) by parascopy, STRC (17%) by parascopy, SORD (83%) by parascopy, HBA2 (50%) by cn_loci:HBA, HBA1 (67%) by cn_loci:HBA, TPSB2 (17%) by parascopy, TPSAB1 (33%) by parascopy, OTOA (33%) by parascopy, SULT1A1 (33%) by pypgx, HYDIN (17%) by parascopy, HP (33%) by cn_loci:HP, CCL3L3 (33%) by cn_loci:CCL3L1, CYP2A6 (0%) by pypgx, CYP2B6 (50%) by pypgx, CD177 (33%) by parascopy, APOBEC3A (50%) by parascopy, APOBEC3B (67%) by parascopy, CYP2D6 (50%) by pypgx + A gene listed as not read could not be read reliably: too few of its reads were placed on it with confidence, so a 'no finding' in it says nothing. A gene with a caller of its own is left to that caller's section. + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: 2026-10-01 + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 0 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: 20250901; step 6 used the ClinVar file of 2026-10-01 + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/str_intermediate_ranges.tsv'] +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); Parascopy's SMN1 count (step 35); not read: step 35's HBA1/HBA2 count: not called + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) not run + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## HLA Typing (T1K) +--- + [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/hla_alleles.tsv'] +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08) did not run + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K's KIR pass (step 08, KIR=true) gave no call + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32): *1/*2; Cyrius (step 21): *2/*1 + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Short not available (not available/not available variants matched) PGS1 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Steps Not Run +--- + All major steps completed. + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +Run manifest: run_manifest.tsv (pipeline commit unknown, 0 images) +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-full/cb-full.html b/tests/parity/golden/report-render/cb-full/cb-full.html new file mode 100644 index 000000000..2b8e65bf0 --- /dev/null +++ b/tests/parity/golden/report-render/cb-full/cb-full.html @@ -0,0 +1,599 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/cb-full/cb-full.txt b/tests/parity/golden/report-render/cb-full/cb-full.txt new file mode 100644 index 000000000..c58e566d8 --- /dev/null +++ b/tests/parity/golden/report-render/cb-full/cb-full.txt @@ -0,0 +1,272 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-nf/cb-nf.html b/tests/parity/golden/report-render/cb-nf/cb-nf.html new file mode 100644 index 000000000..508ad2473 --- /dev/null +++ b/tests/parity/golden/report-render/cb-nf/cb-nf.html @@ -0,0 +1,545 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
ClinVar file dateunknown
+

gnomAD AF: unknown for every hit (no VEP output (step 13) in this folder)

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualityViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF unknownlow-confidence call (GQ 15, DP 30): check the readschr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownchr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF unknownchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF unknownlow-confidence call (GQ 40, DP 5): check the readschr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownchr3:15645186
chr2100AGhet...0gnomAD AF unknownchr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownchrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants6
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenicchr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 0

+

P/LP rows below the depth floor (DP below 8): 0

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hom, ClinVar Pathogenic: two changed copies, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); not read: step 35's HBA1/HBA2 count: not called; Parascopy's SMN1 count: not resolved

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copiesno SMN1 table (step 35 wrote no SMN copy-number table)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copiesno SMN1 table (step 35 wrote no SMN copy-number table)
+
SMN1 and SMN2 together (agCN) at exon 7. (quality ., filter .)
+
Readingno SMN1 table (step 35 wrote no SMN copy-number table): no carrier reading
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:07 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Stale · file date 2019-06-01 12:30 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
STALE: from an earlier run (2019-06-01 12:30 UTC); step 27 was skipped in the run of 2020-01-01 00:00 UTC
+
StatusStale
+
Genes with a non-normal phenotype0
+
Genes with more than one possible result0
+
Genes not called1
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
CPIC drug-gene recommendations: STALE: from an earlier run (2019-06-01 12:30 UTC); step 27 was skipped in the run of 2020-01-01 00:00 UTC
+
PharmCAT (step 36's call)not called
+
pypgx*1/*2
+
Cyrius*1/*2 (not usable: Filter LowQ)
+
pypgx and Cyrius agreefewer than two usable calls
+
Probable (one caller: pypgx)*1/*2, Normal Metabolizer; not passed to PharmCAT, so no drug guidance rests on it
+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • SV consensus merge
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • HBA1/HBA2 copy number (alpha-thalassaemia deletions): neither step 35's read-depth count (short reads) nor step 35b (Paraphase, PacBio HiFi) made a call
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/cb-nf/cb-nf.txt b/tests/parity/golden/report-render/cb-nf/cb-nf.txt new file mode 100644 index 000000000..e3baa4d56 --- /dev/null +++ b/tests/parity/golden/report-render/cb-nf/cb-nf.txt @@ -0,0 +1,230 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + gnomAD AF: unknown for every hit (no VEP output (step 13) in this folder) + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF unknown + call: low-confidence call (GQ 15, DP 30): check the reads + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF unknown + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF unknown + call: low-confidence call (GQ 40, DP 5): check the reads + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 6 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 0 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (FINAL_CLASSIFICATION): + Pathogenic: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 0 + P/LP rows below the depth floor (DP below 8): 0 + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hom, ClinVar Pathogenic: two changed copies, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); not read: step 35's HBA1/HBA2 count: not called; Parascopy's SMN1 count: not resolved + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: no SMN1 table (step 35 wrote no SMN copy-number table) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: no SMN1 table (step 35 wrote no SMN copy-number table) + SMN1 and SMN2 together (agCN) at exon 7: . (quality ., filter .) + Reading: no SMN1 table (step 35 wrote no SMN copy-number table): no carrier reading + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: vcf/B.report.json (PharmCAT version unknown) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + [STALE: from an earlier run (2019-06-01 12:30 UTC); step 27 was skipped in the run of 2020-01-01 00:00 UTC] + Genes with a non-normal phenotype: 0 More than one possible result: 0 Not called: 1 Called without a function phenotype (no drug guidance): 0 + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) not called + pypgx *1/*2 + Cyrius *1/*2 (not usable: Filter LowQ) + pypgx and Cyrius agree: fewer than two usable calls + Probable (one caller: pypgx): *1/*2, Normal Metabolizer; not passed to PharmCAT, so no drug guidance rests on it + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - SV consensus merge + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - HBA1/HBA2 copy number (alpha-thalassaemia deletions): neither step 35's read-depth count (short reads) nor step 35b (Paraphase, PacBio HiFi) made a call + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html new file mode 100644 index 000000000..095c42ff2 --- /dev/null +++ b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html @@ -0,0 +1,477 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
ClinVar file dateunknown
+

gnomAD AF: unknown for every hit (no VEP output (step 13) in this folder)

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualityViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF unknownlow-confidence call (GQ 15, DP 30): check the readschr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownchr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF unknownchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF unknownlow-confidence call (GQ 40, DP 5): check the readschr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownchr3:15645186
chr2100AGhet...0gnomAD AF unknownchr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownchrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Failed · link to this section

+
could not be read: S_clinical.vcf.gz: Compressed file ended before the end-of-stream marker was reached
+
StatusUnreadable
+
+
+
+
+

Cancer Predisposition

+

Step 17 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hom, ClinVar Pathogenic: two changed copies, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Two hits across callers (a deletion plus a variant on the other copy): none found; deletions read from no caller; not read: AnnotSV (step 05): no table; step 35's interval table: none; step 35's HBA1/HBA2 count: not assessed: S_hba_copy_number.tsv has no status row; Parascopy's SMN1 count: not resolved

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copiesno SMN1 table (step 35 wrote no SMN copy-number table)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copiesno SMN1 table (step 35 wrote no SMN copy-number table)
+
SMN1 and SMN2 together (agCN) at exon 7. (quality ., filter .)
+
Readingno SMN1 table (step 35 wrote no SMN copy-number table): no carrier reading
+
HBA1 and HBA2 together (alpha-globin genes, from depth)not assessed: S_hba_copy_number.tsv has no status row
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
GenesCopies together (agCN)Reading
rhd4 (1 region(s), quality 40 or more, filter PASS).
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)not assessed (step 35's <id>_cn_intervals.tsv is not in this run's output)
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

CYP2D6 Across Callers

+

Steps 32, 21 · Not run · link to this section

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)not run
+
pypgxnot run
+
Cyriusnot run
+
pypgx and Cyrius agreefewer than two usable calls
+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • PharmCAT
  • +
  • CPIC drug-gene recommendations
  • +
  • pypgx
  • +
  • Cyrius (CYP2D6)
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • SV consensus merge
  • +
  • Structural variants, class 4 and 5 (AnnotSV)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
  • Cancer predisposition (CPSR)
  • +
  • Variant prioritization (slivar)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • HBA1/HBA2 copy number (alpha-thalassaemia deletions): neither step 35's read-depth count (short reads) nor step 35b (Paraphase, PacBio HiFi) made a call
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.txt b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.txt new file mode 100644 index 000000000..45a9a2042 --- /dev/null +++ b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.txt @@ -0,0 +1,143 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + gnomAD AF: unknown for every hit (no VEP output (step 13) in this folder) + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF unknown + call: low-confidence call (GQ 15, DP 30): check the reads + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF unknown + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF unknown + call: low-confidence call (GQ 40, DP 5): check the reads + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + [could not be read: S_clinical.vcf.gz: Compressed file ended before the end-of-stream marker was reached] +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hom, ClinVar Pathogenic: two changed copies, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Two hits across callers (a deletion plus a variant on the other copy): none found; deletions read from no caller; not read: AnnotSV (step 05): no table; step 35's interval table: none; step 35's HBA1/HBA2 count: not assessed: S_hba_copy_number.tsv has no status row; Parascopy's SMN1 count: not resolved + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: no SMN1 table (step 35 wrote no SMN copy-number table) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: no SMN1 table (step 35 wrote no SMN copy-number table) + SMN1 and SMN2 together (agCN) at exon 7: . (quality ., filter .) + Reading: no SMN1 table (step 35 wrote no SMN copy-number table): no carrier reading + HBA1 and HBA2 together (alpha-globin genes, from depth): not assessed: S_hba_copy_number.tsv has no status row + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + rhd (agCN): 4 (1 region(s), quality 40 or more, filter PASS) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): not assessed (step 35's _cn_intervals.tsv is not in this run's output) + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - PharmCAT + - CPIC drug-gene recommendations + - pypgx + - Cyrius (CYP2D6) + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - SV consensus merge + - Structural variants, class 4 and 5 (AnnotSV) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + - Cancer predisposition (CPSR) + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - HBA1/HBA2 copy number (alpha-thalassaemia deletions): neither step 35's read-depth count (short reads) nor step 35b (Paraphase, PacBio HiFi) made a call + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-notbi/cb-notbi.html b/tests/parity/golden/report-render/cb-notbi/cb-notbi.html new file mode 100644 index 000000000..bd1e0f5a4 --- /dev/null +++ b/tests/parity/golden/report-render/cb-notbi/cb-notbi.html @@ -0,0 +1,474 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
ClinVar file dateunknown
+

gnomAD AF: unknown for every hit (vep/S_vep.vcf.gz has no .tbi index)

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualityViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF unknownlow-confidence call (GQ 15, DP 30): check the readschr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownchr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF unknownchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF unknownlow-confidence call (GQ 40, DP 5): check the readschr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownchr3:15645186
chr2100AGhet...0gnomAD AF unknownchr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownchrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Cancer Predisposition

+

Step 17 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hom, ClinVar Pathogenic: two changed copies, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Two hits across callers (a deletion plus a variant on the other copy): none found; deletions read from step 35's HBA1/HBA2 count; not read: AnnotSV (step 05): no table; step 35's interval table: none; Parascopy's SMN1 count: not resolved

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copiesno SMN1 table (step 35 wrote no SMN copy-number table)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copiesno SMN1 table (step 35 wrote no SMN copy-number table)
+
SMN1 and SMN2 together (agCN) at exon 7. (quality ., filter .)
+
Readingno SMN1 table (step 35 wrote no SMN copy-number table): no carrier reading
+
HBA1 and HBA2 together (alpha-globin genes, from depth)0 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)not assessed (step 35's <id>_cn_intervals.tsv is not in this run's output)
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

CYP2D6 Across Callers

+

Steps 32, 21 · Not run · link to this section

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)not run
+
pypgxnot run
+
Cyriusnot run
+
pypgx and Cyrius agreefewer than two usable calls
+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • PharmCAT
  • +
  • CPIC drug-gene recommendations
  • +
  • pypgx
  • +
  • Cyrius (CYP2D6)
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • SV consensus merge
  • +
  • Structural variants, class 4 and 5 (AnnotSV)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
  • Cancer predisposition (CPSR)
  • +
  • Clinical variant filter
  • +
  • Variant prioritization (slivar)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/cb-notbi/cb-notbi.txt b/tests/parity/golden/report-render/cb-notbi/cb-notbi.txt new file mode 100644 index 000000000..05cd3b868 --- /dev/null +++ b/tests/parity/golden/report-render/cb-notbi/cb-notbi.txt @@ -0,0 +1,139 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + gnomAD AF: unknown for every hit (vep/S_vep.vcf.gz has no .tbi index) + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF unknown + call: low-confidence call (GQ 15, DP 30): check the reads + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF unknown + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF unknown + call: low-confidence call (GQ 40, DP 5): check the reads + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hom, ClinVar Pathogenic: two changed copies, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Two hits across callers (a deletion plus a variant on the other copy): none found; deletions read from step 35's HBA1/HBA2 count; not read: AnnotSV (step 05): no table; step 35's interval table: none; Parascopy's SMN1 count: not resolved + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: no SMN1 table (step 35 wrote no SMN copy-number table) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: no SMN1 table (step 35 wrote no SMN copy-number table) + SMN1 and SMN2 together (agCN) at exon 7: . (quality ., filter .) + Reading: no SMN1 table (step 35 wrote no SMN copy-number table): no carrier reading + HBA1 and HBA2 together (alpha-globin genes, from depth): 0 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): not assessed (step 35's _cn_intervals.tsv is not in this run's output) + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - PharmCAT + - CPIC drug-gene recommendations + - pypgx + - Cyrius (CYP2D6) + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - SV consensus merge + - Structural variants, class 4 and 5 (AnnotSV) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html new file mode 100644 index 000000000..9b65c885e --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html @@ -0,0 +1,599 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's dosage table has no row)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt new file mode 100644 index 000000000..c8c4cd456 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt @@ -0,0 +1,272 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's dosage table has no row) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html new file mode 100644 index 000000000..2b8e65bf0 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html @@ -0,0 +1,599 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt new file mode 100644 index 000000000..c58e566d8 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt @@ -0,0 +1,272 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html new file mode 100644 index 000000000..2b8e65bf0 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html @@ -0,0 +1,599 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt new file mode 100644 index 000000000..c58e566d8 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt @@ -0,0 +1,272 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html new file mode 100644 index 000000000..2b8e65bf0 --- /dev/null +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html @@ -0,0 +1,599 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt new file mode 100644 index 000000000..c58e566d8 --- /dev/null +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt @@ -0,0 +1,272 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html new file mode 100644 index 000000000..ea96a3396 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html @@ -0,0 +1,599 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetA<&>'"Pathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
<b>chr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (x <y> & z; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt new file mode 100644 index 000000000..4999e7724 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt @@ -0,0 +1,272 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + A<&>'" chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (x & z; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html new file mode 100644 index 000000000..1b14657dc --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html @@ -0,0 +1,619 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Stale · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
STALE: note of clinvar <&>
+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+
STALE: note of clinvar <&>
+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+
STALE: note of clinvar <&>
+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Stale · file date 2021-03-04 05:06 UTC · link to this section

+
STALE: note of clinical <&>
+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+
STALE: note of clinical <&>
+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Stale · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
STALE: note of cpsr <&>
+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Stale · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
STALE: note of slivar <&>
+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Stale · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+
STALE: note of carrier <&>
+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

Couple Carrier Screen

+

Step 39 · Stale · file date 2021-03-04 05:06 UTC · link to this section

+

A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

+
STALE: note of couple <&>
+

Partner: P<2>. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

+

Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P<2>: c.350G>A (LP)

+

X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P<2>: .

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt new file mode 100644 index 000000000..4eb83c790 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt @@ -0,0 +1,285 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + [STALE: note of clinvar <&>] + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + [STALE: note of clinical <&>] + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + [STALE: note of cpsr <&>] + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + [STALE: note of slivar <&>] + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + [STALE: note of carrier <&>] + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + [STALE: note of couple <&>] + Partner: P<2>. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P<2>: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P<2>: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html new file mode 100644 index 000000000..c3dd1efab --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html @@ -0,0 +1,599 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below None or DP below None), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF: unknown for every hit (no VEP output)

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt new file mode 100644 index 000000000..1c3ca852d --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt @@ -0,0 +1,272 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below None or DP below None), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF: unknown for every hit (no VEP output) + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html new file mode 100644 index 000000000..58196ec46 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html @@ -0,0 +1,643 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 12 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 50 of 60)

+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

Hit at a known lab-construct site past the first 50: MUTYH chr1:45331556 C>T het: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)

+

Hit at a known lab-construct site past the first 50: SMN1 chr5:70951946 C>T hom: known lab-construct site (pcDNA3): clipped <x> (3 of 4 alt reads and 0 of 10 ref reads clipped at an exon edge)

+

Hit at a known lab-construct site past the first 50: BTD chr3:15645186 G>C het: known lab-construct site (EGFP): clear (0 of 4 alt reads and 0 of 10 ref reads clipped at an exon edge)

+

Hit at a known lab-construct site past the first 50: . chr2:100 A>G het: known lab-construct site (lentiviral): not checked

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt new file mode 100644 index 000000000..00d39ed94 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt @@ -0,0 +1,405 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 12 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + Hits at a known lab-construct site past the first 50: + MUTYH chr1:45331556 C>T het: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + SMN1 chr5:70951946 C>T hom: known lab-construct site (pcDNA3): clipped (3 of 4 alt reads and 0 of 10 ref reads clipped at an exon edge) + BTD chr3:15645186 G>C het: known lab-construct site (EGFP): clear (0 of 4 alt reads and 0 of 10 ref reads clipped at an exon edge) + . chr2:100 A>G het: known lab-construct site (lentiviral): not checked + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html new file mode 100644 index 000000000..3f4d1b994 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html @@ -0,0 +1,565 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches0
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Hits at a known lab-construct site (check the reads)1
+
ClinVar file dateunknown
+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

cDNA scan of every exon: not run: no BAM

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt new file mode 100644 index 000000000..e226fb54c --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt @@ -0,0 +1,229 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 0 + ClinVar file date: unknown + cDNA scan of every exon: not run: no BAM + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html new file mode 100644 index 000000000..724d393bf --- /dev/null +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html @@ -0,0 +1,608 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

Couple Carrier Screen

+

Step 39 · Complete · link to this section

+

A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

+

Partner: the partner. Genes where both carry a change: 0; X-linked findings: 0; genes where only one partner carries a change: 0

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt new file mode 100644 index 000000000..cf635f8f2 --- /dev/null +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt @@ -0,0 +1,277 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + Partner: the partner. Genes where both carry a change: 0; X-linked findings: 0; genes where only one partner carries a change: 0 + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-couple/m-couple.html b/tests/parity/golden/report-render/m-couple/m-couple.html new file mode 100644 index 000000000..9fdc8d823 --- /dev/null +++ b/tests/parity/golden/report-render/m-couple/m-couple.html @@ -0,0 +1,610 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

Couple Carrier Screen

+

Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

+

Partner: P<2>. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

+

Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P<2>: c.350G>A (LP)

+

X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P<2>: .

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-couple/m-couple.txt b/tests/parity/golden/report-render/m-couple/m-couple.txt new file mode 100644 index 000000000..28201efd1 --- /dev/null +++ b/tests/parity/golden/report-render/m-couple/m-couple.txt @@ -0,0 +1,279 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + Partner: P<2>. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P<2>: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P<2>: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html new file mode 100644 index 000000000..6ccc716bc --- /dev/null +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html @@ -0,0 +1,584 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportNo HTML
+
+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt new file mode 100644 index 000000000..e4b96e531 --- /dev/null +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt @@ -0,0 +1,256 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html new file mode 100644 index 000000000..d14bf055a --- /dev/null +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html @@ -0,0 +1,589 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

The classification table has no CPSR_CLASSIFICATION column, so no disagreement can be shown.

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+
+

Files of this step, beside this report: CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt new file mode 100644 index 000000000..76d23ae17 --- /dev/null +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt @@ -0,0 +1,262 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification table has no CLASSIFICATION column. + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + The classification table has no CPSR_CLASSIFICATION column, so no disagreement can be shown. + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html new file mode 100644 index 000000000..d7767564b --- /dev/null +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html @@ -0,0 +1,600 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

carrier list <unreadable>

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt new file mode 100644 index 000000000..0bf737190 --- /dev/null +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt @@ -0,0 +1,273 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, ? genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 2 weak call(s), 1 of unknown frequency), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + carrier list + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html new file mode 100644 index 000000000..49510cbee --- /dev/null +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html @@ -0,0 +1,599 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt new file mode 100644 index 000000000..1af75d23f --- /dev/null +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt @@ -0,0 +1,275 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + [New since 2026-01-01T00:00:00Z] + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + [New since 2026-01-01T00:00:00Z] + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + [New since 2026-01-01T00:00:00Z] + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html new file mode 100644 index 000000000..cdeb54184 --- /dev/null +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html @@ -0,0 +1,575 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown2.5 / 1 / 1
+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt new file mode 100644 index 000000000..3d8614b73 --- /dev/null +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt @@ -0,0 +1,252 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 2.5 trans, 1 cis, 1 unknown of 26 pairs + ... 2.5 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html new file mode 100644 index 000000000..ea6d778ae --- /dev/null +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html @@ -0,0 +1,573 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt new file mode 100644 index 000000000..14371953d --- /dev/null +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt @@ -0,0 +1,250 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + (Candidates only: unphased single-sample data. See docs/31-slivar.md) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ From e2737d8240440249e9ec3218b5db8478d0e78dd6 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 11:59:37 +0100 Subject: [PATCH 09/38] test(personal-data): allow the synthetic LPA genotypes of the all report goldens The report-render goldens of the all and all-history cases print the LPA section of the synthetic corpus summary, whose two risk-allele lines read as an rsID with a genotype. They are invented test data: allow those two lines in those goldens only. Bead: clin-15 --- scripts/ci/check-personal-data.sh | 2 ++ 1 file changed, 2 insertions(+) diff --git a/scripts/ci/check-personal-data.sh b/scripts/ci/check-personal-data.sh index a51191031..152153072 100755 --- a/scripts/ci/check-personal-data.sh +++ b/scripts/ci/check-personal-data.sh @@ -156,6 +156,8 @@ tests/smoke/commands.tsv HTT at 19/45 repeats tests/smoke/commands.tsv ATXN3 at 22/24 repeats rust/crates/og-facts/tests/facts.rs "rs2231142 G/G" rust/crates/og-facts/tests/facts.rs "rs9923231 C/C" +tests/parity/golden/report-render/all*/all*.txt rs10455872: A/G (1 risk allele) +tests/parity/golden/report-render/all*/all*.txt rs3798220: T|C (1 risk allele) ' # Whole files that are not scanned (glob), with the reason. Keep this list From f631b3c8fe27732b4d333d004808793e39c4277a Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 13:41:26 +0100 Subject: [PATCH 10/38] test(parity): fix the time of the report corpus, so its goldens hold on every run A collected summary carries the minute og summary collect ran (generated_utc), and both reports print it. The report-render goldens of the cases with a row in hom_or_hemizygous therefore failed on the next day's run. report-corpus.sh now writes one fixed time into every collected summary (sed on that one line, so a summary that holds NaN or Infinity on purpose stays as it is), and the goldens are written again from og run inside the checkout, as CI runs it: the all and all-nf summaries now read their repeat tables, as on CI. The pinned oracle matches the old og on every other output (299 of 301; the other 2 are the committed viral golden), and no new golden is stale. The all and all-history text goldens also print the corpus's invented repeat sizes: allow those two lines too. Bead: clin-15 --- scripts/ci/check-personal-data.sh | 2 + tests/parity/gen/report-corpus.sh | 7 ++ .../report-render/all-history/all-history.txt | 72 +++++++++++++++++-- .../golden/report-render/all-nf/all-nf.html | 51 ++++++++++--- .../golden/report-render/all-nf/all-nf.txt | 55 ++++++++++++-- tests/parity/golden/report-render/all/all.txt | 72 +++++++++++++++++-- .../golden/report-render/cb-full/cb-full.html | 2 +- .../golden/report-render/cb-full/cb-full.txt | 2 +- .../golden/report-render/cb-nf/cb-nf.html | 2 +- .../golden/report-render/cb-nf/cb-nf.txt | 2 +- .../report-render/cb-nfbad/cb-nfbad.html | 2 +- .../report-render/cb-nfbad/cb-nfbad.txt | 2 +- .../report-render/cb-notbi/cb-notbi.html | 2 +- .../report-render/cb-notbi/cb-notbi.txt | 2 +- .../cb-quoted-dosage/cb-quoted-dosage.html | 2 +- .../cb-quoted-dosage/cb-quoted-dosage.txt | 2 +- .../cb-quoted-interval.html | 2 +- .../cb-quoted-interval/cb-quoted-interval.txt | 2 +- .../cb-quoted-smn/cb-quoted-smn.html | 2 +- .../cb-quoted-smn/cb-quoted-smn.txt | 2 +- .../cb-unicode-contig/cb-unicode-contig.html | 2 +- .../cb-unicode-contig/cb-unicode-contig.txt | 2 +- .../m-clinical-escape/m-clinical-escape.html | 2 +- .../m-clinical-escape/m-clinical-escape.txt | 2 +- .../m-clinical-stale/m-clinical-stale.html | 2 +- .../m-clinical-stale/m-clinical-stale.txt | 2 +- .../m-clinvar-freq-note.html | 2 +- .../m-clinvar-freq-note.txt | 2 +- .../m-clinvar-many/m-clinvar-many.html | 2 +- .../m-clinvar-many/m-clinvar-many.txt | 2 +- .../m-clinvar-none/m-clinvar-none.html | 2 +- .../m-clinvar-none/m-clinvar-none.txt | 2 +- .../m-couple-empty/m-couple-empty.html | 2 +- .../m-couple-empty/m-couple-empty.txt | 2 +- .../report-render/m-couple/m-couple.html | 2 +- .../report-render/m-couple/m-couple.txt | 2 +- .../m-cpsr-none/m-cpsr-none.html | 2 +- .../report-render/m-cpsr-none/m-cpsr-none.txt | 2 +- .../m-cpsr-noown/m-cpsr-noown.html | 2 +- .../m-cpsr-noown/m-cpsr-noown.txt | 2 +- .../report-render/m-sf-notes/m-sf-notes.html | 2 +- .../report-render/m-sf-notes/m-sf-notes.txt | 2 +- .../m-since-clinical/m-since-clinical.html | 2 +- .../m-since-clinical/m-since-clinical.txt | 2 +- .../m-slivar-phase/m-slivar-phase.html | 2 +- .../m-slivar-phase/m-slivar-phase.txt | 2 +- .../m-slivar-unphased/m-slivar-unphased.html | 2 +- .../m-slivar-unphased/m-slivar-unphased.txt | 2 +- 48 files changed, 276 insertions(+), 67 deletions(-) diff --git a/scripts/ci/check-personal-data.sh b/scripts/ci/check-personal-data.sh index 152153072..e62535b1f 100755 --- a/scripts/ci/check-personal-data.sh +++ b/scripts/ci/check-personal-data.sh @@ -158,6 +158,8 @@ rust/crates/og-facts/tests/facts.rs "rs2231142 G/G" rust/crates/og-facts/tests/facts.rs "rs9923231 C/C" tests/parity/golden/report-render/all*/all*.txt rs10455872: A/G (1 risk allele) tests/parity/golden/report-render/all*/all*.txt rs3798220: T|C (1 risk allele) +tests/parity/golden/report-render/all*/all*.txt HTT 17/20 normal,normal +tests/parity/golden/report-render/all*/all*.txt ATXN1 30/37 not sized ' # Whole files that are not scanned (glob), with the reason. Keep this list diff --git a/tests/parity/gen/report-corpus.sh b/tests/parity/gen/report-corpus.sh index cc4519b69..059db202d 100644 --- a/tests/parity/gen/report-corpus.sh +++ b/tests/parity/gen/report-corpus.sh @@ -67,6 +67,13 @@ while IFS=$'\t' read -r case inputs args; do done (cd "$dir" && "$og" summary collect "${keep[@]}" --out "../../${case}.json" > /dev/null 2>&1) \ || rm -f "${case}.json" + # The time of writing, fixed, so a report-render golden of a collected + # summary (or of a change of one) stays true on every run. + if [ -s "${case}.json" ]; then + # sed, not jq: a summary may hold NaN or Infinity on purpose. + sed -E 's/^( *"generated_utc": )"[^"]*"/\1"2026-01-02 03:04 UTC"/' "${case}.json" > "${case}.json.t" + mv "${case}.json.t" "${case}.json" + fi done < folders/cases.tsv rm -rf folders diff --git a/tests/parity/golden/report-render/all-history/all-history.txt b/tests/parity/golden/report-render/all-history/all-history.txt index 764ee1013..3198ce5c2 100644 --- a/tests/parity/golden/report-render/all-history/all-history.txt +++ b/tests/parity/golden/report-render/all-history/all-history.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC Database re-check: 2021-03-05 00:00:00 UTC: ClinVar newer-release ================================================================================ @@ -183,7 +183,36 @@ ## Repeat Expansions (ExpansionHunter) --- [New since 2021-01-01 00:00 UTC] - [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/str_intermediate_ranges.tsv'] + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + ## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) --- [New since 2021-01-01 00:00 UTC] @@ -369,15 +398,48 @@ ## HLA Typing (T1K) --- [New since 2021-01-01 00:00 UTC] - [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/hla_alleles.tsv'] + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + ## Locityper Second Opinion at Hard Loci (step 53) --- [New since 2021-01-01 00:00 UTC] Loci called: 4 of 5; passing the authors' filter: 3 HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) - primary: T1K (step 08) did not run + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) - primary: T1K's KIR pass (step 08, KIR=true) gave no call + primary: T1K KIR pass (step 08): 1 genes typed CYP2D6 Locityper: not called: low depth primary: pypgx (step 32): *1/*2; Cyrius (step 21): *2/*1 FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) diff --git a/tests/parity/golden/report-render/all-nf/all-nf.html b/tests/parity/golden/report-render/all-nf/all-nf.html index 992c7e6ee..5905f7e3a 100644 --- a/tests/parity/golden/report-render/all-nf/all-nf.html +++ b/tests/parity/golden/report-render/all-nf/all-nf.html @@ -122,7 +122,7 @@

Contents

  • Variant prioritization
  • Symptom-driven ranking
  • Mobile element insertions
  • -
  • Repeat expansions
  • +
  • Repeat expansions
  • MUC1 repeat (ADTKD)
  • Mitochondrial variants
  • Lp(a)
  • @@ -141,7 +141,7 @@

    Contents

  • PharmCAT
  • CPIC recommendations
  • pypgx, Cyrius and CYP2D6
  • -
  • HLA typing
  • +
  • HLA typing
  • Locityper second opinion
  • @@ -176,7 +176,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown @@ -349,9 +349,17 @@

    Mobile Element Insertions

    Repeat Expansions

    -

    Step 09 · Failed · link to this section

    -
    could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/str_intermediate_ranges.tsv'
    -
    StatusUnreadable
    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)older than ExpansionHunter's result: rerun step 9b
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG12-5T/TG12-5T
    +

    5T: 2 copys with the 5T poly-T tract, TG12 on the 5T copies. 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. R117H was not read (no step 42 traits row for rs78655421 was called), so whether it sits on the 5T copy is not known. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*28/TA9
    +

    *28/TA9 (TA7/TA9, 8/10 TA units as ExpansionHunter counts them): a TA length outside TA5 to TA8 is not a named allele here, so its function is not read and it is not compared with PharmCAT (step 7). (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +
    LocusRepeat CountStrangerNotes
    HTTnot in output
    FMR1not in output
    C9ORF72not in output
    ATXN1not in output
    DMPKnot in output
    CFTR_T5/5
    CFTR_TG12/12
    UGT1A18/10
    @@ -531,9 +539,32 @@

    CYP2D6 Across Callers

    HLA Typing

    -

    Step 08 · Failed · link to this section

    -
    could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/hla_alleles.tsv'
    -
    StatusUnreadable
    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-DQA1DQA1*03:01 (quality 0) / DQA1*01:01 (quality 30); low confidence (T1K quality 0 or below)
    +
    HLA-DQB1DQB1*02:01 (quality 40)
    +
    HLA-DRB1DRB1*04:01 (quality 40) / DRB1*07:01 (quality 40)
    +

    Coeliac DQ: not determined (HLA-DQA1 low confidence)

    +

    DQB1*02 copies: 2

    +

    DRB1*04:01 present: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    A*31:01 not determined (HLA-A not typed): carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    B*15:02 not determined (HLA-B not typed): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B not typed): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B not typed): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B not typed): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +

    C*06:02 not determined (HLA-C not typed): psoriasis (Nair 2006, Am J Hum Genet)

    +
    HLA databaseunknown
    +
    OptiType checknot compared: OptiType did not run: no class I reads
    +

    too few KIR reads

    @@ -543,7 +574,7 @@

    Locityper Second Opinion at Hard Loci

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    STALE: from an earlier run (2019-06-01 12:30 UTC); step 53 was skipped in the run of 2020-01-01 00:00 UTC
    Loci called3 of 3 (3 pass the filter)
    -
    LocusLocityperFilterPrimary caller
    HLA-DRB1h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passT1K (step 08) did not run
    HLA-DQB1h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passT1K (step 08) did not run
    CYP2D6h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passpypgx (step 32): *1/*2; Cyrius (step 21): *1/*2 (not usable: Filter LowQ)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passT1K (step 08): DRB1*04:01/DRB1*07:01
    HLA-DQB1h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passT1K (step 08): DQB1*02:01
    CYP2D6h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passpypgx (step 32): *1/*2; Cyrius (step 21): *1/*2 (not usable: Filter LowQ)
    diff --git a/tests/parity/golden/report-render/all-nf/all-nf.txt b/tests/parity/golden/report-render/all-nf/all-nf.txt index 8e75283d2..41062aeaf 100644 --- a/tests/parity/golden/report-render/all-nf/all-nf.txt +++ b/tests/parity/golden/report-render/all-nf/all-nf.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ @@ -130,7 +130,25 @@ ## Repeat Expansions (ExpansionHunter) --- - [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/str_intermediate_ranges.tsv'] + Loci in output: 3 + Stranger's result is older than ExpansionHunter's: rerun step 9b. No locus is marked as normal or expanded. + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG12-5T/TG12-5T + 5T: 2 copys with the 5T poly-T tract, TG12 on the 5T copies. 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. R117H was not read (no step 42 traits row for rs78655421 was called), so whether it sits on the 5T copy is not known. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *28/TA9 + *28/TA9 (TA7/TA9, 8/10 TA units as ExpansionHunter counts them): a TA length outside TA5 to TA8 is not a named allele here, so its function is not read and it is not compared with PharmCAT (step 7). (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Every locus (key loci first): repeat count, Stranger status, notes + HTT not in output - + FMR1 not in output - + C9ORF72 not in output - + ATXN1 not in output - + DMPK not in output - + CFTR_T 5/5 - + CFTR_TG 12/12 - + UGT1A1 8/10 - + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + ## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) --- Result: not assessed @@ -264,15 +282,42 @@ ## HLA Typing (T1K) --- - [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/hla_alleles.tsv'] + HLA-DQA1 DQA1*03:01 (quality 0) / DQA1*01:01 (quality 30); low confidence (T1K quality 0 or below) + HLA-DQB1 DQB1*02:01 (quality 40) + HLA-DRB1 DRB1*04:01 (quality 40) / DRB1*07:01 (quality 40) + Coeliac DQ: not determined (HLA-DQA1 low confidence) + DQB1*02 copies: 2 + DRB1*04:01 present: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + A*31:01 not determined (HLA-A not typed): carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + B*15:02 not determined (HLA-B not typed): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B not typed): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B not typed): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B not typed): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + C*06:02 not determined (HLA-C not typed): psoriasis (Nair 2006, Am J Hum Genet) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + not compared: OptiType did not run: no class I reads + KIR genes (T1K, KIR=true): + too few KIR reads + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + ## Locityper Second Opinion at Hard Loci (step 53) --- [STALE: from an earlier run (2019-06-01 12:30 UTC); step 53 was skipped in the run of 2020-01-01 00:00 UTC] Loci called: 3 of 3; passing the authors' filter: 3 HLA-DRB1 Locityper: h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass) - primary: T1K (step 08) did not run + primary: T1K (step 08): DRB1*04:01/DRB1*07:01 HLA-DQB1 Locityper: h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass) - primary: T1K (step 08) did not run + primary: T1K (step 08): DQB1*02:01 CYP2D6 Locityper: h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass) primary: pypgx (step 32): *1/*2; Cyrius (step 21): *1/*2 (not usable: Filter LowQ) A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. diff --git a/tests/parity/golden/report-render/all/all.txt b/tests/parity/golden/report-render/all/all.txt index 117f1c19f..15cb06ab0 100644 --- a/tests/parity/golden/report-render/all/all.txt +++ b/tests/parity/golden/report-render/all/all.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ @@ -173,7 +173,36 @@ ## Repeat Expansions (ExpansionHunter) --- - [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/str_intermediate_ranges.tsv'] + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + ## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) --- Result: negative @@ -345,14 +374,47 @@ ## HLA Typing (T1K) --- - [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/hla_alleles.tsv'] + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: IPD-IMGT/HLA 3.60 extra + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + ## Locityper Second Opinion at Hard Loci (step 53) --- Loci called: 4 of 5; passing the authors' filter: 3 HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) - primary: T1K (step 08) did not run + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) - primary: T1K's KIR pass (step 08, KIR=true) gave no call + primary: T1K KIR pass (step 08): 1 genes typed CYP2D6 Locityper: not called: low depth primary: pypgx (step 32): *1/*2; Cyrius (step 21): *2/*1 FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) diff --git a/tests/parity/golden/report-render/cb-full/cb-full.html b/tests/parity/golden/report-render/cb-full/cb-full.html index 2b8e65bf0..ff5a242ab 100644 --- a/tests/parity/golden/report-render/cb-full/cb-full.html +++ b/tests/parity/golden/report-render/cb-full/cb-full.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/cb-full/cb-full.txt b/tests/parity/golden/report-render/cb-full/cb-full.txt index c58e566d8..af8d4a1ba 100644 --- a/tests/parity/golden/report-render/cb-full/cb-full.txt +++ b/tests/parity/golden/report-render/cb-full/cb-full.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/cb-nf/cb-nf.html b/tests/parity/golden/report-render/cb-nf/cb-nf.html index 508ad2473..8ce72db92 100644 --- a/tests/parity/golden/report-render/cb-nf/cb-nf.html +++ b/tests/parity/golden/report-render/cb-nf/cb-nf.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/cb-nf/cb-nf.txt b/tests/parity/golden/report-render/cb-nf/cb-nf.txt index e3baa4d56..ac7d9b88a 100644 --- a/tests/parity/golden/report-render/cb-nf/cb-nf.txt +++ b/tests/parity/golden/report-render/cb-nf/cb-nf.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html index 095c42ff2..7c8f6da4b 100644 --- a/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html +++ b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.txt b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.txt index 45a9a2042..957ddacbc 100644 --- a/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.txt +++ b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC ================================================================================ ################################################################################ diff --git a/tests/parity/golden/report-render/cb-notbi/cb-notbi.html b/tests/parity/golden/report-render/cb-notbi/cb-notbi.html index bd1e0f5a4..e3365b996 100644 --- a/tests/parity/golden/report-render/cb-notbi/cb-notbi.html +++ b/tests/parity/golden/report-render/cb-notbi/cb-notbi.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/cb-notbi/cb-notbi.txt b/tests/parity/golden/report-render/cb-notbi/cb-notbi.txt index 05cd3b868..7e2fb7d86 100644 --- a/tests/parity/golden/report-render/cb-notbi/cb-notbi.txt +++ b/tests/parity/golden/report-render/cb-notbi/cb-notbi.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC ================================================================================ ################################################################################ diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html index 9b65c885e..152e83fc3 100644 --- a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt index c8c4cd456..0786439a6 100644 --- a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html index 2b8e65bf0..ff5a242ab 100644 --- a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt index c58e566d8..af8d4a1ba 100644 --- a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html index 2b8e65bf0..ff5a242ab 100644 --- a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt index c58e566d8..af8d4a1ba 100644 --- a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html index 2b8e65bf0..ff5a242ab 100644 --- a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt index c58e566d8..af8d4a1ba 100644 --- a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html index ea96a3396..9a5a4da4b 100644 --- a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt index 4999e7724..89954e3ab 100644 --- a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html index 1b14657dc..5b67b1e82 100644 --- a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html @@ -162,7 +162,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt index 4eb83c790..620915c00 100644 --- a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html index c3dd1efab..3f5ba65f4 100644 --- a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt index 1c3ca852d..508a4358d 100644 --- a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html index 58196ec46..a0751b532 100644 --- a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt index 00d39ed94..4eb79e3bb 100644 --- a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html index 3f4d1b994..daa7ea1e7 100644 --- a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt index e226fb54c..532a16449 100644 --- a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html index 724d393bf..6d2304010 100644 --- a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html @@ -162,7 +162,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt index cf635f8f2..5706ec222 100644 --- a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-couple/m-couple.html b/tests/parity/golden/report-render/m-couple/m-couple.html index 9fdc8d823..84b4d55f4 100644 --- a/tests/parity/golden/report-render/m-couple/m-couple.html +++ b/tests/parity/golden/report-render/m-couple/m-couple.html @@ -162,7 +162,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-couple/m-couple.txt b/tests/parity/golden/report-render/m-couple/m-couple.txt index 28201efd1..c64a44a24 100644 --- a/tests/parity/golden/report-render/m-couple/m-couple.txt +++ b/tests/parity/golden/report-render/m-couple/m-couple.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html index 6ccc716bc..7a8558199 100644 --- a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt index e4b96e531..9711220ee 100644 --- a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html index d14bf055a..f4f6722cb 100644 --- a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt index 76d23ae17..4d5a6fddf 100644 --- a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html index d7767564b..850ef691a 100644 --- a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt index 0bf737190..e4986aedf 100644 --- a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html index 49510cbee..c91ecc749 100644 --- a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt index 1af75d23f..59ab75868 100644 --- a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html index cdeb54184..f827bbc4f 100644 --- a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt index 3d8614b73..5eccfc04b 100644 --- a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html index ea6d778ae..07a81c6e0 100644 --- a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt index 14371953d..06eb71fe4 100644 --- a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ From 6059508132ae43190bf3a066592f788f3798ef28 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 16:53:57 +0100 Subject: [PATCH 11/38] fix(sf): cap a secondary-findings pair that rests on a low-confidence call The SF card called two_hits(), so a class 4/5 deletion plus a P/LP call below step 06's call floor read 'biallelic' there, while the carrier list of the same report read it as possibly biallelic (low-confidence call). Two phased hets of which one is a low-confidence call also read 'biallelic' with no mark. Each counted allele now carries its low_confidence mark. The deletion rule goes through two_hits_with, and a pair whose proof needs a low-confidence call reads 'possibly biallelic (low-confidence call)'. A confident homozygous call or a confident pair stays 'biallelic'. Bead: clin-19 --- rust/crates/og-summary/src/collect/acmg.rs | 65 +- .../tests/i411_carrier_confidence.rs | 95 +- .../report-render/all-history/all-history.txt | 55 + .../golden/report-render/all-nf/all-nf.html | 1464 +++++++++++++++++ .../golden/report-render/all-nf/all-nf.txt | 29 + tests/parity/golden/report-render/all/all.txt | 48 + .../golden/report-render/cb-full/cb-full.html | 99 ++ .../golden/report-render/cb-full/cb-full.txt | 21 + .../golden/report-render/cb-nf/cb-nf.html | 81 + .../golden/report-render/cb-nf/cb-nf.txt | 4 + .../report-render/cb-nfbad/cb-nfbad.html | 47 + .../report-render/cb-notbi/cb-notbi.html | 47 + .../cb-quoted-dosage/cb-quoted-dosage.html | 99 ++ .../cb-quoted-dosage/cb-quoted-dosage.txt | 21 + .../cb-quoted-interval.html | 99 ++ .../cb-quoted-interval/cb-quoted-interval.txt | 21 + .../cb-quoted-smn/cb-quoted-smn.html | 99 ++ .../cb-quoted-smn/cb-quoted-smn.txt | 21 + .../cb-unicode-contig/cb-unicode-contig.html | 99 ++ .../cb-unicode-contig/cb-unicode-contig.txt | 21 + .../m-clinical-escape/m-clinical-escape.html | 100 ++ .../m-clinical-escape/m-clinical-escape.txt | 21 + .../m-clinical-stale/m-clinical-stale.html | 100 ++ .../m-clinical-stale/m-clinical-stale.txt | 21 + .../m-clinvar-freq-note.html | 99 ++ .../m-clinvar-freq-note.txt | 21 + .../m-clinvar-many/m-clinvar-many.html | 99 ++ .../m-clinvar-many/m-clinvar-many.txt | 21 + .../m-clinvar-none/m-clinvar-none.html | 94 ++ .../m-clinvar-none/m-clinvar-none.txt | 21 + .../m-couple-empty/m-couple-empty.html | 99 ++ .../m-couple-empty/m-couple-empty.txt | 21 + .../report-render/m-couple/m-couple.html | 100 ++ .../report-render/m-couple/m-couple.txt | 21 + .../m-cpsr-none/m-cpsr-none.html | 97 ++ .../report-render/m-cpsr-none/m-cpsr-none.txt | 21 + .../m-cpsr-noown/m-cpsr-noown.html | 99 ++ .../m-cpsr-noown/m-cpsr-noown.txt | 21 + .../report-render/m-sf-notes/m-sf-notes.html | 99 ++ .../report-render/m-sf-notes/m-sf-notes.txt | 21 + .../m-since-clinical/m-since-clinical.html | 99 ++ .../m-since-clinical/m-since-clinical.txt | 21 + .../m-slivar-phase/m-slivar-phase.html | 79 + .../m-slivar-phase/m-slivar-phase.txt | 21 + .../m-slivar-unphased/m-slivar-unphased.html | 99 ++ .../m-slivar-unphased/m-slivar-unphased.txt | 21 + 46 files changed, 4058 insertions(+), 13 deletions(-) diff --git a/rust/crates/og-summary/src/collect/acmg.rs b/rust/crates/og-summary/src/collect/acmg.rs index c2f58b970..01f50c511 100644 --- a/rust/crates/og-summary/src/collect/acmg.rs +++ b/rust/crates/og-summary/src/collect/acmg.rs @@ -29,7 +29,7 @@ use super::clinvar::{ }; use super::text::{self, digits, format_map, gt_field, info_map}; use super::two_hits::{ - DeletionInputs, Entry, Spans, Variant, Verdict, gene_deletions, phase_haps, two_hits, + DeletionInputs, Entry, Spans, Variant, Verdict, gene_deletions, phase_haps, two_hits_with, }; use indexmap::IndexMap; use pycompat::json::Value; @@ -439,8 +439,9 @@ struct Cand { } /// One distinct variant of a gene as the verdict counts it: its alt -/// copies, ploidy, GT and phase set, and whether it stands for a combined -/// allele and its parts. +/// copies, ploidy, GT and phase set, whether it stands for a combined +/// allele and its parts, and whether a call of it is below step 06's call +/// floor (low confidence). #[derive(Debug, Clone, PartialEq)] struct Allele { copies: usize, @@ -448,6 +449,7 @@ struct Allele { gt: String, ps: Option, combined: bool, + low: bool, } impl Allele { @@ -458,6 +460,7 @@ impl Allele { gt: String::new(), ps: None, combined: false, + low: false, } } @@ -618,15 +621,39 @@ fn sf_verdicts( }; out.insert(k.clone(), why); } + // The count again without the low-confidence calls: a pair that needs + // one of them is only possible until the call is confirmed. + let firm: IndexMap = kept + .iter() + .filter(|(_, a)| !a.low) + .map(|(k, a)| (k.clone(), a.clone())) + .collect(); + let (n_firm, proof_firm, _) = copies_hit(&firm); + let low = |why: String| { + ( + Verdict::LowConfidence.word(), + format!( + "a call it rests on is below the call floor (low confidence), so confirm it \ + first; {why}" + ), + ) + }; let pair = (counted && n >= 2).then(|| match (proof, deletion) { - (Some(p), _) => ("biallelic", p), + (Some(p), _) => match proof_firm { + Some(f) => ("biallelic", f), + None => low(p), + }, (None, Some(e)) => (e.verdict.word(), format!("with {}: {}", e.deletion, e.why)), - (None, None) => ( - Verdict::PossiblyBiallelic.word(), - "phase unknown: no read-backed phase links the variants, so they may sit on the \ - same copy (cis)" - .to_owned(), - ), + (None, None) => { + let why = "phase unknown: no read-backed phase links the variants, so they may sit \ + on the same copy (cis)" + .to_owned(); + if n_firm >= 2 { + (Verdict::PossiblyBiallelic.word(), why) + } else { + low(why) + } + } }); let hypo: Vec<&str> = out .iter() @@ -950,9 +977,11 @@ fn tier(i: &Inputs) -> Result, String> { // allele's own call stands for its parts. let (own, folded): (Vec<&Cand>, Vec<&Cand>) = small.iter().copied().partition(|x| unit(x) == x.key); + // A step 06 hit below its call floor (the ClinVar row's low_confidence). + let is_low = |x: &Cand| matches!(x.fields.get("low_confidence"), Some(Value::Bool(true))); for x in &own { let p = if x.ploidy == 0 { 2 } else { x.ploidy }; - alleles + let a = alleles .entry(x.gene.clone()) .or_default() .entry(x.key.clone()) @@ -961,6 +990,7 @@ fn tier(i: &Inputs) -> Result, String> { ps: x.ps.clone(), ..Allele::of(x.copies, p) }); + a.low |= is_low(x); } for x in &folded { let p = if x.ploidy == 0 { 2 } else { x.ploidy }; @@ -975,6 +1005,7 @@ fn tier(i: &Inputs) -> Result, String> { }); a.copies = a.copies.max(x.copies); a.combined = true; + a.low |= is_low(x); } for x in &svs { alleles @@ -1021,7 +1052,17 @@ fn tier(i: &Inputs) -> Result, String> { }); } } - let found = two_hits(&variants, &dels); + let low: HashSet<(String, Key)> = own + .iter() + .filter(|x| is_low(x)) + .filter_map(|x| match &x.key { + AKey::Small(k) => Some((x.gene.clone(), k.clone())), + _ => None, + }) + .collect(); + let found = two_hits_with(&variants, &dels, |v| { + low.contains(&(v.gene.clone(), v.key.clone())) + }); let mut two: HashMap<(String, Key), String> = HashMap::new(); for g in found.entries.keys() { if matches!(rules[g].report_if.as_str(), "biallelic" | "hemizygous") { diff --git a/rust/crates/og-summary/tests/i411_carrier_confidence.rs b/rust/crates/og-summary/tests/i411_carrier_confidence.rs index 45d2a84b6..4676e850a 100644 --- a/rust/crates/og-summary/tests/i411_carrier_confidence.rs +++ b/rust/crates/og-summary/tests/i411_carrier_confidence.rs @@ -8,9 +8,12 @@ //! heterozygous hits of one recessive gene as two plain carrier rows, and a //! deletion plus a low-confidence call as a confident two-hit gene. These //! cases run the list on synthetic hits with the shipped -//! `assets/carrier_genes.tsv`. +//! `assets/carrier_genes.tsv`. The last cases run the ACMG SF card on the +//! same hits (`assets/acmg_sf.tsv`): a pair that rests on a low-confidence +//! call reads the same there. use indexmap::IndexMap; +use og_summary::collect::acmg::{Inputs, acmg_sf}; use og_summary::collect::carrier::Carrier; use og_summary::collect::clinvar::{Floor, HitRecords, HitsVcf}; use og_summary::collect::two_hits::{DeletionInputs, SvRow}; @@ -21,6 +24,7 @@ const ASSETS: &str = concat!(env!("CARGO_MANIFEST_DIR"), "/../../../assets"); // MUTYH and CFTR spans in assets/carrier_genes.tsv: chr1:45329163-45340893 // and chr7:117287120-117715971. MUTYH is on the ACMG SF list, CFTR is not. const MUTYH_A: (&str, i128, &str, &str) = ("chr1", 45_331_556, "C", "T"); +const MUTYH_B: (&str, i128, &str, &str) = ("chr1", 45_332_803, "T", "C"); const CFTR_A: (&str, i128, &str, &str) = ("chr7", 117_559_590, "ATCT", "A"); const CFTR_B: (&str, i128, &str, &str) = ("chr7", 117_587_806, "G", "T"); const OTC_A: (&str, i128, &str, &str) = ("chrX", 38_400_000, "C", "T"); @@ -335,3 +339,92 @@ fn a_deletion_plus_a_low_confidence_call_is_only_possibly_biallelic() { "possibly biallelic (low-confidence call)" ); } + +/// The ACMG SF card on step 06's hits alone (no clinical VCF). +fn sf(hits: Vec>, dels: &DeletionInputs) -> IndexMap { + let h: Result = Ok((Floor::default(), hits)); + obj(acmg_sf(&Inputs { + assets: ASSETS, + hits: Some(&h), + clinical: None, + deletions: dels, + }) + .unwrap()) +} + +/// The `pair` word of each reported ClinVar row of `gene` on the SF card. +fn sf_pairs(c: &IndexMap, gene: &str) -> Vec { + let r = of(c, "clinvar_hits", gene); + assert!(!r.is_empty(), "{c:?}"); + r.iter().map(|x| s(x, "pair").to_owned()).collect() +} + +#[test] +fn the_sf_card_caps_a_deletion_pair_on_a_low_confidence_call() { + let dels = mutyh_deletion("1|0", Some("9")); + let weak = sf( + vec![hit(MUTYH_A, "MUTYH", "GT:GQ:DP:PS", "0|1:5:4:9", "")], + &dels, + ); + assert_eq!( + sf_pairs(&weak, "MUTYH"), + ["possibly biallelic (low-confidence call)"] + ); + let sure = sf(vec![good(MUTYH_A, "MUTYH", "0|1", Some("9"))], &dels); + assert_eq!(sf_pairs(&sure, "MUTYH"), ["biallelic"]); +} + +#[test] +fn the_sf_card_caps_a_phased_pair_on_a_low_confidence_call() { + let weak = sf( + vec![ + good(MUTYH_A, "MUTYH", "0|1", Some("9")), + hit(MUTYH_B, "MUTYH", "GT:GQ:DP:PS", "1|0:5:4:9", ""), + ], + &no_deletions(), + ); + let low = "possibly biallelic (low-confidence call)"; + assert_eq!(sf_pairs(&weak, "MUTYH"), [low, low]); + for x in of(&weak, "clinvar_hits", "MUTYH") { + assert!(s(x, "phase").contains("low confidence"), "{x:?}"); + } + // Unphased, one of them weak: the same mark. + let unphased = sf( + vec![ + good(MUTYH_A, "MUTYH", "0/1", None), + hit(MUTYH_B, "MUTYH", "GT:GQ:DP", "0/1:5:4", ""), + ], + &no_deletions(), + ); + assert_eq!(sf_pairs(&unphased, "MUTYH"), [low, low]); + // Both confident: biallelic, and possibly biallelic unphased. + let sure = sf( + vec![ + good(MUTYH_A, "MUTYH", "0|1", Some("9")), + good(MUTYH_B, "MUTYH", "1|0", Some("9")), + ], + &no_deletions(), + ); + assert_eq!(sf_pairs(&sure, "MUTYH"), ["biallelic", "biallelic"]); + let open = sf( + vec![ + good(MUTYH_A, "MUTYH", "0/1", None), + good(MUTYH_B, "MUTYH", "0/1", None), + ], + &no_deletions(), + ); + assert_eq!( + sf_pairs(&open, "MUTYH"), + ["possibly biallelic", "possibly biallelic"] + ); + // A confident homozygous call proves both copies on its own; a weak + // second variant does not weaken that. + let hom = sf( + vec![ + good(MUTYH_A, "MUTYH", "1/1", None), + hit(MUTYH_B, "MUTYH", "GT:GQ:DP", "0/1:5:4", ""), + ], + &no_deletions(), + ); + assert_eq!(sf_pairs(&hom, "MUTYH"), ["biallelic", "biallelic"]); +} diff --git a/tests/parity/golden/report-render/all-history/all-history.txt b/tests/parity/golden/report-render/all-history/all-history.txt index 3198ce5c2..84e4a5c3e 100644 --- a/tests/parity/golden/report-render/all-history/all-history.txt +++ b/tests/parity/golden/report-render/all-history/all-history.txt @@ -173,6 +173,45 @@ chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt +## Structural Variants (Manta) +--- + [New since 2021-01-01 00:00 UTC] + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + [New since 2021-01-01 00:00 UTC] + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + [New since 2021-01-01 00:00 UTC] + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band) + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + [New since 2021-01-01 00:00 UTC] + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + [New since 2021-01-01 00:00 UTC] + Class 4-5 SVs: 3 (single caller: 1; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: 2 callers (manta, delly) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: 3 callers (manta, delly, tiddit, caller 4) + DEL 9:1-100 class 4 G9 support: single caller (tiddit) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ## Mobile Element Insertions (step 50) --- Insertions called: 3 (ALU 2, L1 1) @@ -272,6 +311,13 @@ 1 other protein changes listed, not counted: chip/S_chip.tsv. Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. +## Mosaic loss of chromosome Y or X +--- + [New since 2021-01-01 00:00 UTC] + chrY or chrX: not detected above 10% (None) + From depth: estimated share of the cells that lost one X 2.0% (95% range -1.0% to 5.0%); None to autosome depth ratio 0.980, 1.0 expected + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + ## Mosaic Chromosomal Alterations (MoChA, step 51) --- [New since 2021-01-01 00:00 UTC] @@ -595,6 +641,15 @@ HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. +## Raw-Data Export (23andMe v5 layout) +--- + [New since 2021-01-01 00:00 UTC] + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + ## Steps Not Run --- All major steps completed. diff --git a/tests/parity/golden/report-render/all-nf/all-nf.html b/tests/parity/golden/report-render/all-nf/all-nf.html index 5905f7e3a..56196d55f 100644 --- a/tests/parity/golden/report-render/all-nf/all-nf.html +++ b/tests/parity/golden/report-render/all-nf/all-nf.html @@ -121,12 +121,14 @@

    Contents

  • Cancer predisposition
  • Variant prioritization
  • Symptom-driven ranking
  • +
  • Structural variants
  • Mobile element insertions
  • Repeat expansions
  • MUC1 repeat (ADTKD)
  • Mitochondrial variants
  • Lp(a)
  • Clonal haematopoiesis
  • +
  • Mosaic loss of chromosome Y or X
  • Mosaic chromosomal alterations
  • @@ -162,6 +164,7 @@

    Contents

  • Other and exports
    1. Viral DNA
    2. +
    3. Raw-data export
  • What this report leaves out @@ -170,6 +173,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -229,6 +233,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -337,6 +342,27 @@

    Symptom-Driven Ranking (Exomiser)

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Copy number (CNVpytor): STALE: from an earlier run (2019-06-01 12:30 UTC); step 18 was skipped (opt-in) in the run of 2020-01-01 00:00 UTC
    +
    SV consensus merge: STALE: from an earlier run (2019-06-01 12:30 UTC); step 22 was failed (exit 1) in the run of 2020-01-01 00:00 UTC
    +
    Manta SVs (total / PASS)0 / 0
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVs2
    +
    CNVpytor significant (e-val < 0.01)2
    +
    CNVpytor significant after filters1 (left out: 1 on chrY of a declared female)
    +
    Consensus SVs (2+ callers)1
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +
    StatusComplete
    +

    Class 4-5 SVs: 0

    +
    +

    Mobile Element Insertions

    @@ -380,6 +406,7 @@

    MUC1 VNTR Frameshifts (VNtyper)

    Mitochondrial Analysis

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4
    chrM variants (PASS)1
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    Length heteroplasmy in the D-loop poly-C tracts0
    @@ -417,6 +444,13 @@

    Clonal Haematopoiesis (CHIP)

    0 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    @@ -620,6 +654,7 @@

    Runs of Homozygosity

    Step 11 · Complete · file date 2019-06-01 12:30 UTC · link to this section

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000CFTR chr7:117559590 ATCT>A: Pathogenic, 4 stars, het, low-confidence callBRCA1,NBR2 chr17:43057100 C>T: Pathogenic, 3 stars, hetHFE chr6:26092913 G>A: Pathogenic, 3 stars, hetMUTYH chr1:45331556 C>T: Pathogenic, 2 stars, hetHBA1 chr16:176700 G>A: Pathogenic, 2 stars, hetSMN1 chr5:70951946 C>T: Pathogenic, 2 stars, homGJB2 chr13:20189473 C>T: Likely pathogenic, 1 star, one copy, other copy not called ref (1/.), low-confidence callBTD chr3:15645186 G>C: Pathogenic/Likely pathogenic, 1 star, het. chr2:100 A>G: ., 0 stars, hetGLA chrX:101398000 C>T: Pathogenic, 0 stars, 1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar call
    StatusComplete
    ROH total7.0 MB
    ROH largest segment7.0 MB
    @@ -684,6 +719,16 @@

    Viral DNA in the Unmapped Reads

    No read on any viral genome.

    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 10 of 10 (100.0%); '--' at 0

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/. and consumer_export/.

    +
    +
    @@ -723,6 +768,1425 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/all-nf/all-nf.txt b/tests/parity/golden/report-render/all-nf/all-nf.txt index 41062aeaf..7bf9c546c 100644 --- a/tests/parity/golden/report-render/all-nf/all-nf.txt +++ b/tests/parity/golden/report-render/all-nf/all-nf.txt @@ -122,6 +122,28 @@ No gene passed Exomiser's filters with a variant that fits a mode of inheritance. A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt +## Structural Variants (Manta) +--- + Total SVs: 0 PASS: 0 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Copy Number Variants (CNVpytor) +--- + [STALE: from an earlier run (2019-06-01 12:30 UTC); step 18 was skipped (opt-in) in the run of 2020-01-01 00:00 UTC] + Total CNVs: 2 (2 deletions, 0 duplications) + Significant (e-val < 0.01): 2 + Significant after filters: 1 (left out: 1 on chrY of a declared female) + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + [STALE: from an earlier run (2019-06-01 12:30 UTC); step 22 was failed (exit 1) in the run of 2020-01-01 00:00 UTC] + Consensus SVs (2+ callers): 1 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 0 + ## Mobile Element Insertions (step 50) --- Insertions called: 0 (none) @@ -387,6 +409,13 @@ No read on any of the 1 viral genomes. From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 10 of 10 (100.0%); '--' at 0 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/. and consumer_export/. + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + ## Steps Not Run --- - Mosaic loss of chromosome Y or X diff --git a/tests/parity/golden/report-render/all/all.txt b/tests/parity/golden/report-render/all/all.txt index 15cb06ab0..9e0859df8 100644 --- a/tests/parity/golden/report-render/all/all.txt +++ b/tests/parity/golden/report-render/all/all.txt @@ -164,6 +164,40 @@ chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band) + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 1; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: 2 callers (manta, delly) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: 3 callers (manta, delly, tiddit, caller 4) + DEL 9:1-100 class 4 G9 support: single caller (tiddit) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ## Mobile Element Insertions (step 50) --- Insertions called: 3 (ALU 2, L1 1) @@ -258,6 +292,12 @@ 1 other protein changes listed, not counted: chip/S_chip.tsv. Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. +## Mosaic loss of chromosome Y or X +--- + chrY or chrX: not detected above 10% (None) + From depth: estimated share of the cells that lost one X 2.0% (95% range -1.0% to 5.0%); None to autosome depth ratio 0.980, 1.0 expected + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + ## Mosaic Chromosomal Alterations (MoChA, step 51) --- Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) @@ -557,6 +597,14 @@ HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + ## Steps Not Run --- All major steps completed. diff --git a/tests/parity/golden/report-render/cb-full/cb-full.html b/tests/parity/golden/report-render/cb-full/cb-full.html index ff5a242ab..588864b73 100644 --- a/tests/parity/golden/report-render/cb-full/cb-full.html +++ b/tests/parity/golden/report-render/cb-full/cb-full.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -335,6 +339,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -349,6 +376,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -581,6 +615,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/cb-full/cb-full.txt b/tests/parity/golden/report-render/cb-full/cb-full.txt index af8d4a1ba..ab3502a3c 100644 --- a/tests/parity/golden/report-render/cb-full/cb-full.txt +++ b/tests/parity/golden/report-render/cb-full/cb-full.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/cb-nf/cb-nf.html b/tests/parity/golden/report-render/cb-nf/cb-nf.html index 8ce72db92..b2cce9090 100644 --- a/tests/parity/golden/report-render/cb-nf/cb-nf.html +++ b/tests/parity/golden/report-render/cb-nf/cb-nf.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -298,6 +302,23 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)N/A
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +
    StatusComplete
    +

    Class 4-5 SVs: 0

    +
    +

    Repeat Expansions

    @@ -312,6 +333,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -527,6 +555,59 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/cb-nf/cb-nf.txt b/tests/parity/golden/report-render/cb-nf/cb-nf.txt index ac7d9b88a..0f027956a 100644 --- a/tests/parity/golden/report-render/cb-nf/cb-nf.txt +++ b/tests/parity/golden/report-render/cb-nf/cb-nf.txt @@ -96,6 +96,10 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 0 + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html index 7c8f6da4b..2af4f1ca0 100644 --- a/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html +++ b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -248,6 +252,18 @@

    Variant Prioritization (slivar)

    StatusNot run
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Not run · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)N/A
    +
    +

    Repeat Expansions

    @@ -262,6 +278,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -459,6 +482,30 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/cb-notbi/cb-notbi.html b/tests/parity/golden/report-render/cb-notbi/cb-notbi.html index e3365b996..13029d9b6 100644 --- a/tests/parity/golden/report-render/cb-notbi/cb-notbi.html +++ b/tests/parity/golden/report-render/cb-notbi/cb-notbi.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -247,6 +251,18 @@

    Variant Prioritization (slivar)

    StatusNot run
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Not run · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)N/A
    +
    +

    Repeat Expansions

    @@ -261,6 +277,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -456,6 +479,30 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html index 152e83fc3..ea9891284 100644 --- a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -335,6 +339,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -349,6 +376,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -581,6 +615,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt index 0786439a6..e4af1140f 100644 --- a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html index ff5a242ab..588864b73 100644 --- a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -335,6 +339,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -349,6 +376,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -581,6 +615,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt index af8d4a1ba..ab3502a3c 100644 --- a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html index ff5a242ab..588864b73 100644 --- a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -335,6 +339,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -349,6 +376,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -581,6 +615,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt index af8d4a1ba..ab3502a3c 100644 --- a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html index ff5a242ab..4730e2e56 100644 --- a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -335,6 +339,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHsingle caller (Manta)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -349,6 +376,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -581,6 +615,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt index af8d4a1ba..9c2957b3a 100644 --- a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: single caller (Manta) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html index 9a5a4da4b..d0d716b1f 100644 --- a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -335,6 +339,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -349,6 +376,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -581,6 +615,72 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt index 89954e3ab..9cfb76642 100644 --- a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html index 5b67b1e82..afd02899a 100644 --- a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -156,6 +158,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -202,6 +205,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    STALE: note of clinvar <&>
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    @@ -343,6 +347,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -357,6 +384,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -601,6 +635,72 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt index 620915c00..549dba951 100644 --- a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt @@ -132,6 +132,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html index 3f5ba65f4..71cb39891 100644 --- a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below None or DP below None: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below None or DP below None), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -335,6 +339,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -349,6 +376,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -581,6 +615,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt index 508a4358d..14a79ff24 100644 --- a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html index a0751b532..ece70cbb1 100644 --- a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A, BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A, BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A, BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A, BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A and more3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T, MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T, MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T, MUTYH chr1:45331556 C>T and more2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C, BTD chr3:15645186 G>C, BTD chr3:15645186 G>C, BTD chr3:15645186 G>C, BTD chr3:15645186 G>C, BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T, . chr2:100 A>G, GLA chrX:101398000 C>T, . chr2:100 A>G, GLA chrX:101398000 C>T, . chr2:100 A>G, GLA chrX:101398000 C>T, . chr2:100 A>G, GLA chrX:101398000 C>T and more0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -379,6 +383,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -393,6 +420,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -625,6 +659,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt index 4eb79e3bb..351fd3e65 100644 --- a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt @@ -261,6 +261,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html index daa7ea1e7..fed6ce1e6 100644 --- a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars3 stars22 stars: 3 hits with 2 review stars2 stars31 star: 1 hit with 1 review star1 star10 stars: 2 hits with 0 review stars0 stars2
    ClinVar matches0
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    Hits at a known lab-construct site (check the reads)1
    @@ -301,6 +305,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -315,6 +342,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -547,6 +581,66 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt index 532a16449..2775a2396 100644 --- a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt @@ -85,6 +85,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html index 6d2304010..d514f6db5 100644 --- a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -156,6 +158,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -202,6 +205,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -336,6 +340,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -350,6 +377,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -590,6 +624,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt index 5706ec222..1a6242848 100644 --- a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-couple/m-couple.html b/tests/parity/golden/report-render/m-couple/m-couple.html index 84b4d55f4..27436ddd2 100644 --- a/tests/parity/golden/report-render/m-couple/m-couple.html +++ b/tests/parity/golden/report-render/m-couple/m-couple.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -156,6 +158,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -202,6 +205,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -336,6 +340,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -350,6 +377,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -592,6 +626,72 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-couple/m-couple.txt b/tests/parity/golden/report-render/m-couple/m-couple.txt index c64a44a24..3dde7aea9 100644 --- a/tests/parity/golden/report-render/m-couple/m-couple.txt +++ b/tests/parity/golden/report-render/m-couple/m-couple.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html index 7a8558199..e2d8c5fcf 100644 --- a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -320,6 +324,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -334,6 +361,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -566,6 +600,69 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt index 9711220ee..c73177061 100644 --- a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt @@ -112,6 +112,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html index f4f6722cb..d7820497d 100644 --- a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -325,6 +329,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -339,6 +366,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -571,6 +605,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt index 4d5a6fddf..5e016d16b 100644 --- a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt @@ -118,6 +118,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html index 850ef691a..70e52e743 100644 --- a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -336,6 +340,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -350,6 +377,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -582,6 +616,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt index e4986aedf..fd8beca52 100644 --- a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt @@ -129,6 +129,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html index c91ecc749..f49fdfd65 100644 --- a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -335,6 +339,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -349,6 +376,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -581,6 +615,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt index 59ab75868..4f105b67d 100644 --- a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt @@ -130,6 +130,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html index f827bbc4f..d0f1fb5bb 100644 --- a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -311,6 +315,29 @@

    Variant Prioritization (slivar)

    Pairs in trans / cis / unknown2.5 / 1 / 1
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -325,6 +352,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -557,6 +591,51 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt index 5eccfc04b..b17cbd9a6 100644 --- a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt @@ -108,6 +108,27 @@ ... 2.5 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html index 07a81c6e0..511f859c6 100644 --- a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -309,6 +313,29 @@

    Variant Prioritization (slivar)

    Compound het candidates4 variants, 2 genes
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -323,6 +350,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -555,6 +589,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt index 06eb71fe4..e96760679 100644 --- a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt @@ -106,6 +106,27 @@ Compound het candidates: 4 variants across 2 genes (Candidates only: unphased single-sample data. See docs/31-slivar.md) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ From fa5f6e622da5a0394aa60a1ff4da6d5d14460725 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 16:53:57 +0100 Subject: [PATCH 12/38] fix(live): flag the carrier headline of og live serve for hom or hemizygous rows The Python server flags a sample whose carrier list holds only homozygous or hemizygous rows (a man with only a GLA row). og live serve read only 'carriers', so it gave such a sample no attention flag. Bead: clin-15 --- rust/crates/og-live/src/state.rs | 38 +++++++++++++++++++++++++++++++- 1 file changed, 37 insertions(+), 1 deletion(-) diff --git a/rust/crates/og-live/src/state.rs b/rust/crates/og-live/src/state.rs index ac2f54208..b9d0d187b 100644 --- a/rust/crates/og-live/src/state.rs +++ b/rust/crates/og-live/src/state.rs @@ -375,7 +375,10 @@ fn line_of(key: &str, sm: &Summary) -> Result, bool)>, Ma positive(&n)?, ) } - "carrier" => (Some(first(sec::carrier::lines(&d)?)?), flag("carriers")), + "carrier" => ( + Some(first(sec::carrier::lines(&d)?)?), + flag("carriers") || flag("hom_or_hemizygous"), + ), "couple" => ( with_note(&sec::couple::lines(&d)?, COUPLE_NOTE), flag("shared") || flag("x_linked"), @@ -1143,6 +1146,39 @@ mod tests { assert_eq!(utc_seconds(""), None); } + /// The carrier headline of a summary whose carrier section is `data`. + fn carrier_headline(data: &str) -> (String, &'static str) { + let sec = format!(r#"{{"state": "ok", "title": "Carrier list", "data": {data}}}"#); + let summary = og_render::model::Summary::parse(&format!( + r#"{{"databases": {{}}, "sections": {{"carrier": {sec}}}}}"# + )) + .unwrap(); + let raw = pycompat::json::loads(&sec).unwrap(); + headline("carrier", Some(&raw), &summary).unwrap() + } + + #[test] + fn a_carrier_list_of_only_hom_or_hemizygous_rows_asks_for_attention() { + // A man with only a hemizygous GLA row: no carrier, but no unchanged + // copy either, so the headline asks for attention as the Python + // server's does (bin/owngenome_live.py, _h_carrier). + let gla = r#"{"gene": "GLA", "condition": "Fabry disease", "inheritance": "XL", + "variant": "chrX:101398000 C>T", "genotype": "hemizygous", "zygosity": "hemizygous", + "significance": "Pathogenic", "gq": 50, "dp": 30, "low_confidence": false}"#; + let only = carrier_headline(&format!( + r#"{{"genes_on_list": 3, "carriers": [], "hom_or_hemizygous": [{gla}], "set_aside": []}}"# + )); + assert_eq!(only.1, "attention", "{}", only.0); + assert!(only.0.contains("1 with no unchanged copy"), "{}", only.0); + let none = carrier_headline( + r#"{"genes_on_list": 3, "carriers": [], "hom_or_hemizygous": [], "set_aside": []}"#, + ); + assert_eq!(none.1, "info", "{}", none.0); + // A summary written before the list existed reads as before. + let old = carrier_headline(r#"{"genes_on_list": 3, "carriers": [], "set_aside": []}"#); + assert_eq!(old.1, "info", "{}", old.0); + } + #[test] fn a_note_joined_as_two_sentences() { let l = |a: &[&str]| a.iter().map(|x| (*x).to_owned()).collect::>(); From 4df2db0b9ef7078c0bce056a634dc3f238d5a83e Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 16:53:57 +0100 Subject: [PATCH 13/38] test(parity): whole-report goldens for the carrier cases The report-render cases now compare whole reports. The 24 cases whose summary holds a homozygous or hemizygous carrier row get whole-report goldens; each differs from the oracle only in the carrier block. The docs and the changelog say what the SF card now does with a pair on a low-confidence call. Bead: clin-15, clin-19 --- CHANGELOG.md | 2 +- docs/results/secondary-findings.md | 4 ++-- 2 files changed, 3 insertions(+), 3 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index dac5c8073..49d46fa12 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. A pair that rests on a low-confidence call is at most `possible two hits (low-confidence call)`, and a deletion plus a low-confidence call in one gene reads `possibly biallelic (low-confidence call)` under `two_hits`. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. A pair that rests on a low-confidence call is at most `possible two hits (low-confidence call)`, and a deletion plus a low-confidence call in one gene reads `possibly biallelic (low-confidence call)` under `two_hits`. The secondary-findings card applies the same cap: its `pair` for a gene whose pair needs a low-confidence call (a deletion plus that call, or two heterozygous variants, phased or not) is `possibly biallelic (low-confidence call)`, and so is the card's two-hit line for that deletion. A confident homozygous call or a confident pair stays `biallelic`. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - One section that cannot be written no longer stops the whole report. Step 24, the Nextflow `HTML_REPORT` module and `scripts/generate-report.sh` ran `bin/render_report.py`, and a section whose data it could not read stopped it with a Python error: the run got no text report and no HTML report at all. The three now run `og report render` (`rust/crates/og-render`), so no Python runs for the reports. A section that cannot be written says so in its own place, `[could not be read: ...]` in the text report and an Unreadable card in the HTML report, and every other section is still written; `og report render` prints one `WARNING` line on stderr that counts and names those parts, and still exits 0. A panic inside a section writer counts the same way, so the release build now unwinds on a panic (`rust/Cargo.toml`); a panic anywhere else still aborts og at once, through the panic hook og installs first. A search index or charts file that cannot be made is written empty and named in the same `WARNING` line. On the 164 report-render parity summaries (154 before, and 10 new ones that reach each state of the mosaic sex-loss, raw-data export and structural-variant sections) both reports are byte for byte the Python's, whole, with two changes on purpose: a gene the ACMG card names is listed once in the closing gene list, not twice (the `acmg_sf` section repeats the card the clinical section holds), and a run whose BAM has no unplaced unmapped reads says the viral screen was not assessed instead of "no read". The checks of `tests/test_render_report.py` are cargo tests (`rust/og/tests/report_checks.rs`, and `rust/crates/og-render/tests/section_failure.rs` for a section that panics), and the Python file is gone. `bin/render_report.py`, `bin/report_charts.py` and `bin/results_index.py` stay only for the Python live site. - The reads drawing on a live finding page now says what it is before it is shown. It is the same nine bars on every finding, but its label read "The reads at " above it and only a caption after it said it was a sketch, so it looked like the person's own reads. The label now reads "Where to look at the reads: . An illustration, not your reads.", and the link to the real reads in the genome viewer stays. In the public demo, which has no reads, every offer of reads said so only after the click: the finding page's link, a card's "See the reads at" link, a chart mark's link and a search hit's "reads at " link opened a page saying the demo has none, and the map's card button and reads pill opened a panel saying so. They now read "Reads: not in the demo": the links are plain text, and the map's buttons still open the panel that says why. On any site, the map's reads panel, which opens under the map and often below the screen, now scrolls into view when it opens. The browser check `rust/crates/og-browser/tests/rv_live_reads_sketch_label.rs` builds the demo and checks all of it. No option, output or file name changes. - `og live serve` serves the live site from the one static `og` binary, in Rust: the home, run and family pages, `state.json` and its headlines, the event stream, the run files, the map, `/metrics` and the search, charts, ops and re-check plugins, with the same policy on every answer. It has no login yet, so it serves loopback only and refuses the password, TLS and proxy options with exit 2; `scripts/owngenome-live.sh` still starts the Python server ([Watch a Run Live](docs/live-site.md)). `bin/owngenome_recheck.py`, the shim that ran `og recheck`, is gone: call `bin/og recheck`. The Python checks of the site that `og live serve` now answers moved to `cargo test -p og-live`. diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index 419965724..4f5d52a17 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,12 +14,12 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. -Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. When one of the two is a low-confidence call, the pair is at most `possible two hits (low-confidence call)`. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. When one of the two is a low-confidence call, the pair is at most `possible two hits (low-confidence call)`, as the secondary-findings card caps the same pair at `possibly biallelic (low-confidence call)`. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: - a dominant gene (BRCA1, LDLR, MYH7 and most others): one pathogenic or likely pathogenic variant is reported; -- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; +- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. A pair that needs a call below step 6's call floor (its `low_confidence` mark) is `possibly biallelic (low-confidence call)`: confirm that call first. A confident homozygous call, or a confident pair, keeps `biallelic` even when another variant of the gene is a low-confidence call. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; - HFE: only homozygous p.Cys282Tyr. A heterozygous p.Cys282Tyr or a homozygous p.His63Asp is not reported; - X-linked: GLA (Fabry disease) and OTC are reported in a hemizygous male and a heterozygous female alike. ABCD1 (X-linked adrenoleukodystrophy) is reported hemizygous, homozygous or with two heterozygous variants, never for one heterozygous variant; - BTD with p.Asp444His: reported as partial, not profound, biotinidase deficiency; From 9a27ad7a83ea0214ec86986af00f0fe8b37eff41 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 18:05:27 +0100 Subject: [PATCH 14/38] fix(nextflow): stop the clinical filter crashing on REVEL and AlphaMissense scores written as text Bead: nf-vcfanno-ops --- CHANGELOG.md | 2 + modules/local/vcfanno/main.nf | 9 +- scripts/ci/e2e-case-paths.tsv | 1 + scripts/ci/e2e-case-times.tsv | 1 + .../e2e/i411-nf-vcfanno-ops-1-score-tiers.sh | 139 ++++++++++++++++++ tests/test_vcfanno_toml.sh | 38 +++++ 6 files changed, 186 insertions(+), 4 deletions(-) create mode 100755 tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh create mode 100755 tests/test_vcfanno_toml.sh diff --git a/CHANGELOG.md b/CHANGELOG.md index 4ac2445c2..68e5bece4 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -503,6 +503,8 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n - `og` runs natively on a Mac that hosts the live site, so the genome map works there too. `scripts/setup.sh --og` and each release now also make `og-darwin-arm64` and `og-darwin-x86_64`, and `bin/og` runs them on macOS. They are built without the new cargo feature `bam` (on by default, so the Linux builds are unchanged): the BAM tools say so and exit 2 there. `rust/og.sh check` refuses a stale macOS binary, and a release's `SHA256SUMS` lists all four. +- Nextflow vcfanno now writes CADD, REVEL and AlphaMissense scores as floating-point INFO fields, matching step 30. The clinical filter can compare them with its numeric thresholds. + ## Releases - 1.0.0 (not released yet): [docs/releases/v1.0.0.md](docs/releases/v1.0.0.md) diff --git a/modules/local/vcfanno/main.nf b/modules/local/vcfanno/main.nf index 18a433a3e..f43dce628 100644 --- a/modules/local/vcfanno/main.nf +++ b/modules/local/vcfanno/main.nf @@ -49,6 +49,7 @@ process VCFANNO { task.ext.when == null || task.ext.when script: + // Match step 30. The max op writes TSV scores as Float for numeric filters. def toml = "" if (cadd_snv) { toml += """ @@ -56,7 +57,7 @@ process VCFANNO { file="${cadd_snv}" columns=[6] names=["CADD_PHRED"] -ops=["self"] +ops=["max"] """ } if (cadd_indel) { @@ -65,7 +66,7 @@ ops=["self"] file="${cadd_indel}" columns=[6] names=["CADD_PHRED_indel"] -ops=["self"] +ops=["max"] """ } if (spliceai_snv) { @@ -92,7 +93,7 @@ ops=["self"] file="${revel}" columns=[5] names=["REVEL"] -ops=["self"] +ops=["max"] """ } if (alphamissense) { @@ -101,7 +102,7 @@ ops=["self"] file="${alphamissense}" columns=[9,10] names=["AM_pathogenicity","AM_class"] -ops=["self","self"] +ops=["max","self"] """ } if (!toml) { diff --git a/scripts/ci/e2e-case-paths.tsv b/scripts/ci/e2e-case-paths.tsv index 1241a5e03..a4808c80d 100644 --- a/scripts/ci/e2e-case-paths.tsv +++ b/scripts/ci/e2e-case-paths.tsv @@ -110,6 +110,7 @@ hba-short-read-accuracy-1-nf-report assets/acmg_sf.tsv assets/callability_genes. hla-second-caller-1-bash assets/pgx_genes.tsv assets/stub/db/hla.dat assets/stub/db/kir.dat bin/cn_loci.tsv bin/og bin/render_report.py scripts/08-hla-typing.sh scripts/24-html-report.sh scripts/32-pypgx.sh scripts/36-pgx-consensus.sh scripts/ci/fake-docker/lib.sh scripts/validate-setup.sh hla-second-caller-2-nextflow assets/acmg_sf.tsv assets/callability_genes.tsv assets/carrier_genes.tsv assets/mito_confirmed.tsv assets/pgx_genes.tsv assets/stub/db/hla.dat assets/stub/db/kir.dat assets/stub/sample.vcf.gz bin/cn_loci.tsv bin/collect_summary.py bin/og bin/render_report.py bin/results_index.py modules/local/hla_typing/* modules/local/html_report/* modules/local/pgx_consensus/* modules/local/pharmcat/* modules/local/t1k_build/* modules/local/vcf_precheck/* scripts/07-pharmacogenomics.sh scripts/08-hla-typing.sh scripts/21-cyrius.sh scripts/24-html-report.sh scripts/32-pypgx.sh scripts/36-pgx-consensus.sh scripts/ci/fake-docker/lib.sh scripts/cyrius-constraints.txt scripts/setup.sh scripts/validate-setup.sh i411-callability-overlap-1-mates modules/local/mosdepth/* scripts/16b-mosdepth.sh scripts/lib/common.sh +i411-nf-vcfanno-ops-1-score-tiers bin/og modules/local/clinical_filter/* modules/local/vcfanno/* scripts/30-vcfanno.sh ibd-segments-1 assets/families.example.tsv assets/par_grch38.bed assets/pedigree.example.tsv assets/stub/pedigree.tsv bin/og rust/crates/og-dev/src/fixture.rs scripts/38-family.sh scripts/ci/fake-docker/lib.sh scripts/setup.sh live-server-1-weblog assets/live/* assets/viewer/index.html bin/live_results.py bin/og bin/owngenome_live.py bin/owngenome_live_results.py bin/render_report.py bin/run_state.py modules/local/roh/* modules/local/vcf_precheck/* rust/crates/og-dev/src/fixture.rs scripts/11-roh-analysis.sh scripts/ci/fake-docker/lib.sh scripts/validate-setup.sh lpa-1 assets/acmg_sf.tsv assets/callability_genes.tsv assets/carrier_genes.tsv assets/mito_confirmed.tsv assets/par_grch38.bed assets/stub/sample.vcf.gz bin/cn_loci.tsv bin/collect_summary.py bin/og bin/render_report.py bin/results_index.py modules/local/deepvariant/* modules/local/html_report/* modules/local/lpa/* modules/local/vcf_precheck/* scripts/24-html-report.sh scripts/46-lpa.sh scripts/ci/fake-docker/lib.sh scripts/validate-setup.sh diff --git a/scripts/ci/e2e-case-times.tsv b/scripts/ci/e2e-case-times.tsv index ab5d048e2..4bf109c17 100644 --- a/scripts/ci/e2e-case-times.tsv +++ b/scripts/ci/e2e-case-times.tsv @@ -106,6 +106,7 @@ hba-short-read-accuracy-1-nf-report shard 111 - hla-second-caller-1-bash shard 482 - hla-second-caller-2-nextflow shard 188 hla-second-caller-1-bash i411-callability-overlap-1-mates shard 40 - +i411-nf-vcfanno-ops-1-score-tiers shard 37 - ibd-segments-1 shard 239 - live-server-1-weblog shard 18 - lpa-1 shard 42 - diff --git a/tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh b/tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh new file mode 100755 index 000000000..2b9be6bb2 --- /dev/null +++ b/tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh @@ -0,0 +1,139 @@ +#!/usr/bin/env bash +# Run all six synthetic score tracks through both annotation paths and feed +# the Nextflow output into CLINICAL_FILTER. Only the high scores select hits. +# shellcheck source=lib.sh +. "$(dirname "$0")/lib.sh" + +command -v nextflow >/dev/null || { fail "nextflow is not on PATH"; finish; } +WORK=$(mktemp -d "${CASE_TMP}/run.XXXXXX") || { fail "cannot create the case directory"; finish; } +GENOME_DIR="${WORK}/genome" +S=VCFANNO_TEST +P="${WORK}/project" +VEP="${S}/vep/${S}_vep.vcf" +ANNOT="${GENOME_DIR}/annotations" + +( + set -e + mkdir -p "${GENOME_DIR}/${S}/vep" "$ANNOT" "$P/bin/.og" + cp "${REPO}/bin/og" "$P/bin/" + cp "${REPO}"/bin/.og/og-linux-* "$P/bin/.og/" + + # Use synthetic CSQ entries with LOW impact so that an impact tier cannot + # pick any record by itself. + { + cat <<'VCF' +##fileformat=VCFv4.2 +##contig= +##INFO= +##FORMAT= +VCF + printf '#CHROM\tPOS\tID\tREF\tALT\tQUAL\tFILTER\tINFO\tFORMAT\t%s\n' "$S" + printf 'chr1\t%s\t%s\tA\t%s\t.\tPASS\tCSQ=%s|%s|LOW|TESTGENE|TX1|0.001\tGT\t0/1\n' \ + 101 cadd_snv C C synonymous_variant \ + 202 cadd_indel AT T intron_variant \ + 303 revel G G missense_variant \ + 404 alphamissense T T missense_variant \ + 505 cadd_below AAG AG intron_variant \ + 550 missense_below G G missense_variant \ + 606 spliceai_snv C C intron_variant \ + 707 spliceai_indel AT T intron_variant + } > "${GENOME_DIR}/${VEP}" + + printf '#Chrom\tPos\tRef\tAlt\tRawScore\tPHRED\n1\t101\tA\tC\t3.1\t25\n' \ + > "$ANNOT/whole_genome_SNVs.tsv" + printf '#Chrom\tPos\tRef\tAlt\tRawScore\tPHRED\n1\t202\tA\tAT\t3.2\t26\n1\t505\tA\tAAG\t1.1\t10\n' \ + > "$ANNOT/gnomad.genomes.r4.0.indel.tsv" + printf '%s\n' \ + $'#chr\tpos\tref\talt\tREVEL' \ + $'chr1\t303\tA\tG\t0.9' \ + $'chr1\t404\tA\tT\t0.1' \ + $'chr1\t550\tA\tG\t0.2' > "$ANNOT/revel_grch38.tsv" + printf '%s\n' \ + $'#CHROM\tPOS\tREF\tALT\tgenome\tuniprot_id\ttranscript_id\tprotein_variant\tam_pathogenicity\tam_class' \ + $'chr1\t303\tA\tG\thg38\tPTEST\tTX1\tA1G\t0.1\tlikely_benign' \ + $'chr1\t404\tA\tT\thg38\tPTEST\tTX1\tA2T\t0.9\tlikely_pathogenic' \ + $'chr1\t550\tA\tG\thg38\tPTEST\tTX1\tA3G\t0.2\tlikely_benign' > "$ANNOT/AlphaMissense_hg38.tsv" + + splice_track() { + printf '##fileformat=VCFv4.2\n##contig=\n' + printf '##INFO=\n' + printf '#CHROM\tPOS\tID\tREF\tALT\tQUAL\tFILTER\tINFO\n' + printf '1\t%s\t.\tA\t%s\t.\tPASS\tSpliceAI=%s|TESTGENE|0.3|0|0|0|1|0|0|0\n' "$1" "$2" "$2" + } + splice_track 606 C > "$ANNOT/spliceai_scores.masked.snv.hg38.vcf" + splice_track 707 AT > "$ANNOT/spliceai_scores.masked.indel.hg38.vcf" + + docker run --rm --user "$(id -u):$(id -g)" --network none \ + -v "${GENOME_DIR}:/genome" -w /genome "$GATK_IMAGE" bash -ec ' + for file in annotations/*.tsv; do + bgzip -c "$file" > "$file.gz" + tabix -s 1 -b 2 -e 2 "$file.gz" + done + for file in annotations/*.vcf "$1"; do + bgzip -c "$file" > "$file.gz" + tabix -p vcf "$file.gz" + done + ' bash "$VEP" +) +setup_rc=$? + +[ "$setup_rc" -eq 0 ] || { fail "could not prepare the synthetic VCF and score tables"; finish; } + +cat > "$P/main.nf" < file("${ANNOT}/\$name") } + VCFANNO(channel.of([[id: '${S}'], input, file("\${input}.tbi")]), + tracks[0], file("\${tracks[0]}.tbi"), tracks[1], file("\${tracks[1]}.tbi"), + tracks[2], file("\${tracks[2]}.tbi"), tracks[3], file("\${tracks[3]}.tbi"), + tracks[4], file("\${tracks[4]}.tbi"), tracks[5], file("\${tracks[5]}.tbi")) + VCFANNO_INDEX(VCFANNO.out.vcf) + CLINICAL_FILTER(VCFANNO_INDEX.out.vcf.join(VCFANNO_INDEX.out.vcf_index)) +} +NF +cat > "$P/nextflow.config" <&1 | tee "$STEP_LOG" +NF_RC=${PIPESTATUS[0]} +check_eq "VCFANNO, VCFANNO_INDEX and CLINICAL_FILTER exit 0" "$NF_RC" 0 +[ "$NF_RC" -eq 0 ] || finish + +clinical="nextflow/${S}/clinical/${S}" +check_eq "CLINICAL_FILTER selects the six high-score records and excludes the two low-score records" \ + "$(bcf query -f '%ID\n' "${clinical}_clinical.vcf.gz" | paste -sd, -)" \ + cadd_snv,cadd_indel,revel,alphamissense,spliceai_snv,spliceai_indel +check_eq "CLINICAL_FILTER reports one row per high-score hit" \ + "$(awk 'END {print NR - 1}' "${GENOME_DIR}/${clinical}_clinical_summary.tsv")" 6 + +run_step 30-vcfanno.sh "$S" +check_step_exit 30-vcfanno.sh + +info_types() { + bcf view -h "$1" | sed -nE 's/^##INFO= "$TMP/bash.toml" +extract_annotations "${2:-$ROOT/modules/local/vcfanno/main.nf}" > "$TMP/nextflow.toml" +diff -u "$TMP/bash.toml" "$TMP/nextflow.toml" +echo "Step 30 and Nextflow configure the same vcfanno tracks and operations." From 12341ab9c2c9f634d040e26f95035973759dd189 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 18:14:45 +0100 Subject: [PATCH 15/38] fix(carrier): give the carrier list and the SF card one answer beside a weak call The two cards capped different pairs when a gene held a low-confidence call. The carrier list capped a pair whenever any of its hets was weak, so a confident phased pair beside a weak third het read "possible two hits (low-confidence call)". The secondary-findings card capped only a pair whose proof needed the weak call. Commit 60595081 also said a confident pair stays biallelic beside a low-confidence call. That was false for a confident deletion pair: the card gave it the low-confidence word, while the same row's two-hit line said biallelic. And a combined allele lost its confidence when any one of its calls was weak. Both cards now count a gene's hits twice, with every call and with the confident calls alone: - A pair the confident calls prove is "two hits" on the list and "biallelic" on the card, whatever weak call sits beside it. - On the card, a confident deletion pair that is biallelic or possibly biallelic is used before the low-confidence cap. - A pair that only a weak call proves gets the low-confidence word. - Hits of unknown phase are "possible two hits" and "possibly biallelic" when two of them are confident. Two confident unphased hets plus a weak homozygous call now read "possibly biallelic" on the card, as the carrier list already said. - An allele counts the copies its confident calls give (a count, not a flag), so a combined allele that one confident call proves stays firm. The carrier list counts a combined allele the same way. No reported or not-reported decision moves; only `pair` and `phase` change. A new test runs MUTYH, which is on both lists, through both cards over 25 shapes of hits and requires the same answer from both. Bead: clin-19 --- CHANGELOG.md | 2 +- docs/results/secondary-findings.md | 4 +- rust/crates/og-summary/src/collect/acmg.rs | 70 ++- rust/crates/og-summary/src/collect/carrier.rs | 160 ++++--- .../tests/i411_carrier_confidence.rs | 416 +++++++++++++++++- 5 files changed, 560 insertions(+), 92 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index 49d46fa12..20770e5b6 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. A pair that rests on a low-confidence call is at most `possible two hits (low-confidence call)`, and a deletion plus a low-confidence call in one gene reads `possibly biallelic (low-confidence call)` under `two_hits`. The secondary-findings card applies the same cap: its `pair` for a gene whose pair needs a low-confidence call (a deletion plus that call, or two heterozygous variants, phased or not) is `possibly biallelic (low-confidence call)`, and so is the card's two-hit line for that deletion. A confident homozygous call or a confident pair stays `biallelic`. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. A pair that only a low-confidence call proves is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. Hits of unknown phase are `possible two hits` and `possibly biallelic` when two of them are confident, and the low-confidence word otherwise. A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is. So a gene on both lists gets the same answer on both. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - One section that cannot be written no longer stops the whole report. Step 24, the Nextflow `HTML_REPORT` module and `scripts/generate-report.sh` ran `bin/render_report.py`, and a section whose data it could not read stopped it with a Python error: the run got no text report and no HTML report at all. The three now run `og report render` (`rust/crates/og-render`), so no Python runs for the reports. A section that cannot be written says so in its own place, `[could not be read: ...]` in the text report and an Unreadable card in the HTML report, and every other section is still written; `og report render` prints one `WARNING` line on stderr that counts and names those parts, and still exits 0. A panic inside a section writer counts the same way, so the release build now unwinds on a panic (`rust/Cargo.toml`); a panic anywhere else still aborts og at once, through the panic hook og installs first. A search index or charts file that cannot be made is written empty and named in the same `WARNING` line. On the 164 report-render parity summaries (154 before, and 10 new ones that reach each state of the mosaic sex-loss, raw-data export and structural-variant sections) both reports are byte for byte the Python's, whole, with two changes on purpose: a gene the ACMG card names is listed once in the closing gene list, not twice (the `acmg_sf` section repeats the card the clinical section holds), and a run whose BAM has no unplaced unmapped reads says the viral screen was not assessed instead of "no read". The checks of `tests/test_render_report.py` are cargo tests (`rust/og/tests/report_checks.rs`, and `rust/crates/og-render/tests/section_failure.rs` for a section that panics), and the Python file is gone. `bin/render_report.py`, `bin/report_charts.py` and `bin/results_index.py` stay only for the Python live site. - The reads drawing on a live finding page now says what it is before it is shown. It is the same nine bars on every finding, but its label read "The reads at " above it and only a caption after it said it was a sketch, so it looked like the person's own reads. The label now reads "Where to look at the reads: . An illustration, not your reads.", and the link to the real reads in the genome viewer stays. In the public demo, which has no reads, every offer of reads said so only after the click: the finding page's link, a card's "See the reads at" link, a chart mark's link and a search hit's "reads at " link opened a page saying the demo has none, and the map's card button and reads pill opened a panel saying so. They now read "Reads: not in the demo": the links are plain text, and the map's buttons still open the panel that says why. On any site, the map's reads panel, which opens under the map and often below the screen, now scrolls into view when it opens. The browser check `rust/crates/og-browser/tests/rv_live_reads_sketch_label.rs` builds the demo and checks all of it. No option, output or file name changes. - `og live serve` serves the live site from the one static `og` binary, in Rust: the home, run and family pages, `state.json` and its headlines, the event stream, the run files, the map, `/metrics` and the search, charts, ops and re-check plugins, with the same policy on every answer. It has no login yet, so it serves loopback only and refuses the password, TLS and proxy options with exit 2; `scripts/owngenome-live.sh` still starts the Python server ([Watch a Run Live](docs/live-site.md)). `bin/owngenome_recheck.py`, the shim that ran `og recheck`, is gone: call `bin/og recheck`. The Python checks of the site that `og live serve` now answers moved to `cargo test -p og-live`. diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index 4f5d52a17..5c075e3f3 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,12 +14,12 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. -Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. When one of the two is a low-confidence call, the pair is at most `possible two hits (low-confidence call)`, as the secondary-findings card caps the same pair at `possibly biallelic (low-confidence call)`. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. A pair that only a low-confidence call proves is `possible two hits (low-confidence call)`. Hits of unknown phase are `possible two hits` when two of them are confident, and the low-confidence word otherwise. A combined allele counts as confident when any call of it is. The secondary-findings card below counts the same way, so a gene on both lists gets the same answer: its `biallelic` is `two hits` here, and its `possibly biallelic (low-confidence call)` is `possible two hits (low-confidence call)`. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: - a dominant gene (BRCA1, LDLR, MYH7 and most others): one pathogenic or likely pathogenic variant is reported; -- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. A pair that needs a call below step 6's call floor (its `low_confidence` mark) is `possibly biallelic (low-confidence call)`: confirm that call first. A confident homozygous call, or a confident pair, keeps `biallelic` even when another variant of the gene is a low-confidence call. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; +- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. The card counts the variants twice, with every call and with the confident calls alone. A pair that needs a call below step 6's call floor (its `low_confidence` mark) is `possibly biallelic (low-confidence call)`: confirm that call first. A confident homozygous call, a confident pair or a confident deletion pair keeps `biallelic` even when another variant of the gene is a low-confidence call, and two confident variants of unknown phase stay `possibly biallelic`. A combined allele counts as confident when any call of it is. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; - HFE: only homozygous p.Cys282Tyr. A heterozygous p.Cys282Tyr or a homozygous p.His63Asp is not reported; - X-linked: GLA (Fabry disease) and OTC are reported in a hemizygous male and a heterozygous female alike. ABCD1 (X-linked adrenoleukodystrophy) is reported hemizygous, homozygous or with two heterozygous variants, never for one heterozygous variant; - BTD with p.Asp444His: reported as partial, not profound, biotinidase deficiency; diff --git a/rust/crates/og-summary/src/collect/acmg.rs b/rust/crates/og-summary/src/collect/acmg.rs index 01f50c511..760784756 100644 --- a/rust/crates/og-summary/src/collect/acmg.rs +++ b/rust/crates/og-summary/src/collect/acmg.rs @@ -440,8 +440,8 @@ struct Cand { /// One distinct variant of a gene as the verdict counts it: its alt /// copies, ploidy, GT and phase set, whether it stands for a combined -/// allele and its parts, and whether a call of it is below step 06's call -/// floor (low confidence). +/// allele and its parts, and the alt copies its confident calls give (`firm`: +/// 0 when every call of it is below step 06's call floor, low confidence). #[derive(Debug, Clone, PartialEq)] struct Allele { copies: usize, @@ -449,7 +449,7 @@ struct Allele { gt: String, ps: Option, combined: bool, - low: bool, + firm: usize, } impl Allele { @@ -460,7 +460,7 @@ impl Allele { gt: String::new(), ps: None, combined: false, - low: false, + firm: 0, } } @@ -621,12 +621,23 @@ fn sf_verdicts( }; out.insert(k.clone(), why); } - // The count again without the low-confidence calls: a pair that needs - // one of them is only possible until the call is confirmed. + // The count again with only the copies confident calls give: a pair + // that needs a low-confidence call is only possible until the call is + // confirmed. A small allele no confident call gives drops out; one whose + // confident calls give fewer copies than it counts loses its phase too, + // as that came from the low call. A deletion counts as it is: its pair + // is judged by `two_hits_with`. let firm: IndexMap = kept .iter() - .filter(|(_, a)| !a.low) - .map(|(k, a)| (k.clone(), a.clone())) + .filter(|(k, a)| !matches!(k, AKey::Small(_)) || a.firm > 0) + .map(|(k, a)| { + let mut f = a.clone(); + if matches!(k, AKey::Small(_)) && a.firm < a.copies { + f.copies = a.firm; + f.ps = None; + } + (k.clone(), f) + }) .collect(); let (n_firm, proof_firm, _) = copies_hit(&firm); let low = |why: String| { @@ -638,21 +649,28 @@ fn sf_verdicts( ), ) }; - let pair = (counted && n >= 2).then(|| match (proof, deletion) { - (Some(p), _) => match proof_firm { - Some(f) => ("biallelic", f), - None => low(p), - }, - (None, Some(e)) => (e.verdict.word(), format!("with {}: {}", e.deletion, e.why)), - (None, None) => { - let why = "phase unknown: no read-backed phase links the variants, so they may sit \ - on the same copy (cis)" - .to_owned(); - if n_firm >= 2 { - (Verdict::PossiblyBiallelic.word(), why) - } else { - low(why) + let unknown = || { + "phase unknown: no read-backed phase links the variants, so they may sit on the same \ + copy (cis)" + .to_owned() + }; + // The best the evidence gives: a confident proof, then the deletion pair + // when it is at least possibly biallelic (`two_hits_with` already lowers + // a pair on a low call), then a proof that needs a low call, then the + // copies counted with phase unknown. + let pair = (counted && n >= 2).then(|| { + let del = deletion.map(|e| (e.verdict, format!("with {}: {}", e.deletion, e.why))); + match (proof_firm, proof, del) { + (Some(f), _, _) => ("biallelic", f), + (None, _, Some((v @ (Verdict::Biallelic | Verdict::PossiblyBiallelic), why))) => { + (v.word(), why) } + (None, Some(p), Some(_)) => low(p), + (None, Some(_), None) if n_firm >= 2 => (Verdict::PossiblyBiallelic.word(), unknown()), + (None, Some(p), None) => low(p), + (None, None, Some((v, why))) => (v.word(), why), + (None, None, None) if n_firm >= 2 => (Verdict::PossiblyBiallelic.word(), unknown()), + (None, None, None) => low(unknown()), } }); let hypo: Vec<&str> = out @@ -990,7 +1008,9 @@ fn tier(i: &Inputs) -> Result, String> { ps: x.ps.clone(), ..Allele::of(x.copies, p) }); - a.low |= is_low(x); + if !is_low(x) { + a.firm = a.firm.max(x.copies); + } } for x in &folded { let p = if x.ploidy == 0 { 2 } else { x.ploidy }; @@ -1005,7 +1025,9 @@ fn tier(i: &Inputs) -> Result, String> { }); a.copies = a.copies.max(x.copies); a.combined = true; - a.low |= is_low(x); + if !is_low(x) { + a.firm = a.firm.max(x.copies); + } } for x in &svs { alleles diff --git a/rust/crates/og-summary/src/collect/carrier.rs b/rust/crates/og-summary/src/collect/carrier.rs index bafa8a8cd..e77b26c36 100644 --- a/rust/crates/og-summary/src/collect/carrier.rs +++ b/rust/crates/og-summary/src/collect/carrier.rs @@ -14,7 +14,9 @@ //! heterozygous hits in one recessive gene are counted as copies, the way //! the secondary-findings card counts them: read-backed phase on different //! copies is two hits, phase unknown is possible two hits, both on one copy -//! is one hit. +//! is one hit. A pair that needs a low-confidence call is possible two hits +//! (low-confidence call); a pair the confident calls prove alone keeps its +//! word, whatever weak call sits beside it. use super::assets::carrier_genes; use super::clinvar::{ @@ -82,7 +84,11 @@ fn joined_keys(r: &[String]) -> Vec { /// How two or more different heterozygous hits of one gene pair up: the /// pair word (`two hits`, `possible two hits`, none when they sit on one /// copy) and why. `None` when fewer than two distinct alleles are left -/// once a combined allele and its parts count once. +/// once a combined allele and its parts count once. The hets are counted +/// twice, all of them and the confident ones alone: two hits when the +/// confident ones prove it, the low-confidence word when only all of them +/// do, and with phase unknown, possible two hits when the confident ones +/// still count two copies. fn het_pair(hets: &[Het]) -> Option<(Option, String)> { // A combined allele and its parts count once, under the combined // allele, when its call is phased or at most one part is here; an @@ -102,79 +108,105 @@ fn het_pair(hets: &[Het]) -> Option<(Option, String)> { if kept.len() < 2 { return None; } - let mut n = 0; - let mut sets: IndexMap<&str, (BTreeSet, usize)> = IndexMap::new(); - let mut halves: IndexMap<(&str, i128), (BTreeSet, usize)> = IndexMap::new(); - for h in &kept { - if let Some((ps, hs)) = h.phased() { - let s = sets.entry(ps).or_default(); - s.0.extend(hs); - s.1 += 1; - } else if let Some(i) = h.half() { - let s = halves.entry((h.key.0.as_str(), h.key.1)).or_default(); - s.0.insert(i); - s.1 += 1; - } else { - n += 1; - } - } - let mut proof: Option = None; - let mut cis: Option<&str> = None; - for (ps, (h, count)) in &sets { - n += h.len(); - if h.len() >= 2 { - proof.get_or_insert_with(|| { - format!( - "in trans: read-backed phase puts them on different copies (phase set {ps})" - ) - }); - } else if *count >= 2 { - cis.get_or_insert(ps); + // A kept allele is firm when a call of it is confident: its own, or a + // call folded into it (a part under its combined allele, or an unphased + // combined allele under its first part), as the secondary-findings card + // counts it. + let mut firm: HashSet<&VarKey> = kept.iter().filter(|h| !h.low).map(|h| &h.key).collect(); + for h in hets.iter().filter(|h| !h.joined.is_empty()) { + if gone.contains(&h.key) { + if !h.low { + firm.extend(h.joined.iter().find(|k| present.contains(k))); + } + } else if hets.iter().any(|p| !p.low && h.joined.contains(&p.key)) { + firm.insert(&h.key); } } - for ((chrom, pos), (h, count)) in &halves { - if h.len() >= 2 { - n += 2 + count - h.len(); - proof.get_or_insert_with(|| { - format!("in trans: the two alt alleles of one call at {chrom}:{pos}") - }); - } else { - n += count; + // The copies a set of hets hits: the count, the proof of two copies if a + // call gives one, and the first phase set holding two or more of them on + // one copy (cis). + let count = |hs: &[&Het]| -> (usize, Option, Option) { + let mut n = 0; + let mut sets: IndexMap<&str, (BTreeSet, usize)> = IndexMap::new(); + let mut halves: IndexMap<(&str, i128), (BTreeSet, usize)> = IndexMap::new(); + for h in hs { + if let Some((ps, s)) = h.phased() { + let e = sets.entry(ps).or_default(); + e.0.extend(s); + e.1 += 1; + } else if let Some(i) = h.half() { + let e = halves.entry((h.key.0.as_str(), h.key.1)).or_default(); + e.0.insert(i); + e.1 += 1; + } else { + n += 1; + } } - } - let (word, why) = match (proof, cis) { - (Some(p), _) => ("two hits", p), - (None, _) if n >= 2 => ( - "possible two hits", - "phase unknown: no read-backed phase links the variants, so they may sit on the same \ - copy (cis)" - .to_owned(), - ), - (None, Some(ps)) => { - return Some(( - None, - format!( - "two heterozygous variants in cis: read-backed phase puts them on the same \ - copy (phase set {ps}), so one copy is hit" - ), - )); + let mut proof: Option = None; + let mut cis: Option = None; + for (ps, (h, count)) in &sets { + n += h.len(); + if h.len() >= 2 { + proof.get_or_insert_with(|| { + format!( + "in trans: read-backed phase puts them on different copies (phase set {ps})" + ) + }); + } else if *count >= 2 { + cis.get_or_insert_with(|| (*ps).to_owned()); + } } - (None, None) => { - return Some(( - None, - "the variants sit on one copy, so one copy is hit".to_owned(), - )); + for ((chrom, pos), (h, count)) in &halves { + if h.len() >= 2 { + n += 2 + count - h.len(); + proof.get_or_insert_with(|| { + format!("in trans: the two alt alleles of one call at {chrom}:{pos}") + }); + } else { + n += count; + } } + (n, proof, cis) }; - if kept.iter().any(|h| h.low) { - return Some(( + let (n, proof, cis) = count(&kept); + let sure: Vec<&Het> = kept + .iter() + .copied() + .filter(|h| firm.contains(&h.key)) + .collect(); + let (n_firm, proof_firm, _) = count(&sure); + // A pair that needs a low-confidence call is only possible until the + // call is confirmed. + let low = |why: String| { + Some(( Some("possible two hits (low-confidence call)".to_owned()), format!( "a call below the call floor (low confidence) is one of them, so confirm it first; {why}" ), - )); + )) + }; + let unknown = "phase unknown: no read-backed phase links the variants, so they may sit on the \ + same copy (cis)" + .to_owned(); + match (proof_firm, proof, cis) { + (Some(f), _, _) => Some((Some("two hits".to_owned()), f)), + (None, Some(p), _) => low(p), + (None, None, _) if n >= 2 && n_firm >= 2 => { + Some((Some("possible two hits".to_owned()), unknown)) + } + (None, None, _) if n >= 2 => low(unknown), + (None, None, Some(ps)) => Some(( + None, + format!( + "two heterozygous variants in cis: read-backed phase puts them on the same copy \ + (phase set {ps}), so one copy is hit" + ), + )), + (None, None, None) => Some(( + None, + "the variants sit on one copy, so one copy is hit".to_owned(), + )), } - Some((Some(word.to_owned()), why)) } impl Carrier { diff --git a/rust/crates/og-summary/tests/i411_carrier_confidence.rs b/rust/crates/og-summary/tests/i411_carrier_confidence.rs index 4676e850a..e050bca86 100644 --- a/rust/crates/og-summary/tests/i411_carrier_confidence.rs +++ b/rust/crates/og-summary/tests/i411_carrier_confidence.rs @@ -10,7 +10,9 @@ //! cases run the list on synthetic hits with the shipped //! `assets/carrier_genes.tsv`. The last cases run the ACMG SF card on the //! same hits (`assets/acmg_sf.tsv`): a pair that rests on a low-confidence -//! call reads the same there. +//! call reads the same there, a low-confidence call beside a confident pair +//! leaves it as it is, and MUTYH, on both lists, gets the same answer from +//! both cards over each shape of hits. use indexmap::IndexMap; use og_summary::collect::acmg::{Inputs, acmg_sf}; @@ -28,6 +30,9 @@ const MUTYH_B: (&str, i128, &str, &str) = ("chr1", 45_332_803, "T", "C"); const CFTR_A: (&str, i128, &str, &str) = ("chr7", 117_559_590, "ATCT", "A"); const CFTR_B: (&str, i128, &str, &str) = ("chr7", 117_587_806, "G", "T"); const OTC_A: (&str, i128, &str, &str) = ("chrX", 38_400_000, "C", "T"); +// A third MUTYH and CFTR site, outside the test deletion. +const MUTYH_C: (&str, i128, &str, &str) = ("chr1", 45_334_000, "G", "A"); +const CFTR_C: (&str, i128, &str, &str) = ("chr7", 117_600_000, "C", "T"); /// One step 06 hit: Pathogenic with 2 stars, the FORMAT values given (GT /// first), and `info` added to INFO. @@ -295,6 +300,88 @@ fn a_low_confidence_call_makes_two_hits_only_possible() { } } +/// A hit below the default call floor (GQ 5, DP 4), PS added when given. +fn weak(site: (&str, i128, &str, &str), gene: &str, gt: &str, ps: Option<&str>) -> Vec { + match ps { + Some(p) => hit(site, gene, "GT:GQ:DP:PS", &format!("{gt}:5:4:{p}"), ""), + None => hit(site, gene, "GT:GQ:DP", &format!("{gt}:5:4"), ""), + } +} + +/// The `pair` word of the carrier rows of `gene`, one per row. +fn carrier_pairs(c: &IndexMap, gene: &str) -> Vec> { + of(c, "carriers", gene) + .iter() + .map(|x| match x.get("pair") { + Some(Value::Str(p)) => Some(p.clone()), + _ => None, + }) + .collect() +} + +#[test] +fn a_weak_third_het_leaves_a_confident_phased_pair_two_hits() { + // Unphased, in the pair's phase set, or on the other copy: the + // confident pair proves two copies by itself. + for third in [ + weak(CFTR_C, "CFTR", "0/1", None), + weak(CFTR_C, "CFTR", "0|1", Some("9")), + weak(CFTR_C, "CFTR", "1|0", Some("9")), + ] { + let c = list( + vec![ + good(CFTR_A, "CFTR", "0|1", Some("9")), + good(CFTR_B, "CFTR", "1|0", Some("9")), + third, + ], + &no_deletions(), + ); + let p = carrier_pairs(&c, "CFTR"); + assert_eq!(p.len(), 3, "{c:?}"); + for x in &p { + assert_eq!(x.as_deref(), Some("two hits"), "{c:?}"); + } + for x in of(&c, "carriers", "CFTR") { + assert!(s(x, "phase").starts_with("in trans"), "{x:?}"); + } + } +} + +#[test] +fn a_weak_third_het_leaves_two_confident_unphased_hets_possible_two_hits() { + let c = list( + vec![ + good(CFTR_A, "CFTR", "0/1", None), + good(CFTR_B, "CFTR", "0/1", None), + weak(CFTR_C, "CFTR", "0/1", None), + ], + &no_deletions(), + ); + let p = carrier_pairs(&c, "CFTR"); + assert_eq!(p.len(), 3, "{c:?}"); + for x in &p { + assert_eq!(x.as_deref(), Some("possible two hits"), "no low cap: {c:?}"); + } + // One confident het and two weak ones: any pair rests on a weak call, + // so the cap stays (the two-het case is + // a_low_confidence_call_makes_two_hits_only_possible). + let c = list( + vec![ + good(CFTR_A, "CFTR", "0/1", None), + weak(CFTR_B, "CFTR", "0/1", None), + weak(CFTR_C, "CFTR", "0/1", None), + ], + &no_deletions(), + ); + for x in carrier_pairs(&c, "CFTR") { + assert_eq!( + x.as_deref(), + Some("possible two hits (low-confidence call)"), + "{c:?}" + ); + } +} + #[test] fn a_combined_allele_and_its_part_are_one_allele() { let joined = format!( @@ -428,3 +515,330 @@ fn the_sf_card_caps_a_phased_pair_on_a_low_confidence_call() { ); assert_eq!(sf_pairs(&hom, "MUTYH"), ["biallelic", "biallelic"]); } + +/// The rank of a pair word, strongest first, on either card. +fn rank(word: &str) -> Option { + match word { + "biallelic" | "two hits" => Some(0), + "possibly biallelic" | "possible two hits" => Some(1), + "possibly biallelic (low-confidence call)" | "possible two hits (low-confidence call)" => { + Some(2) + } + _ => None, + } +} + +const WORDS: [&str; 3] = [ + "biallelic", + "possibly biallelic", + "possibly biallelic (low-confidence call)", +]; + +/// The reported rows of `gene` whose pair is weaker than the pair their own +/// `two_hit` line names. None should be: the gene's pair is the best of its +/// pairs. +fn rows_weaker_than_their_two_hit(c: &IndexMap, gene: &str) -> Vec { + let mut bad = Vec::new(); + for x in of(c, "clinvar_hits", gene) { + let (Some(Value::Str(t)), Some(Value::Str(p))) = (x.get("two_hit"), x.get("pair")) else { + continue; + }; + if let Some(own) = WORDS.iter().rev().find(|w| t.starts_with(*w)) + && rank(p) > rank(own) + { + bad.push(format!("pair {p} is weaker than its own two_hit {t}")); + } + } + bad +} + +fn assert_rows_agree(c: &IndexMap, gene: &str) { + let bad = rows_weaker_than_their_two_hit(c, gene); + assert!(bad.is_empty(), "{bad:?}: {c:?}"); +} + +#[test] +fn a_weak_call_beside_a_confident_deletion_pair_leaves_it_biallelic() { + let dels = mutyh_deletion("1|0", Some("9")); + // E6a: a weak homozygous call; E6b: the weak call on the deletion's + // copy, in the same phase set. + for weak_call in [ + weak(MUTYH_B, "MUTYH", "1/1", None), + weak(MUTYH_B, "MUTYH", "1|0", Some("9")), + ] { + let c = sf( + vec![good(MUTYH_A, "MUTYH", "0|1", Some("9")), weak_call], + &dels, + ); + assert_eq!(sf_pairs(&c, "MUTYH"), ["biallelic", "biallelic"], "{c:?}"); + let sure = &of(&c, "clinvar_hits", "MUTYH")[0]; + assert!( + s(sure, "two_hit").starts_with("biallelic with DEL"), + "{sure:?}" + ); + assert_rows_agree(&c, "MUTYH"); + } +} + +#[test] +fn a_combined_allele_a_confident_call_proves_is_firm() { + // A combined allele phased on one copy, its part on the same copy, and a + // third het on the other copy. One of the combined call and its part is + // weak; the other is confident, so the pair is proven. + let joined = format!( + ";PGP_JOINED_FROM={}:{}:{}:{}|chr1:45331560:G:A", + MUTYH_A.0, MUTYH_A.1, MUTYH_A.2, MUTYH_A.3 + ); + let combined = |gq: u32, dp: u32| { + hit( + MUTYH_B, + "MUTYH", + "GT:GQ:DP:PS", + &format!("0|1:{gq}:{dp}:9"), + &joined, + ) + }; + // E4a: the combined call confident, its part weak. + let e4a = sf( + vec![ + combined(50, 30), + weak(MUTYH_A, "MUTYH", "0|1", Some("9")), + good(MUTYH_C, "MUTYH", "1|0", Some("9")), + ], + &no_deletions(), + ); + assert_eq!(sf_pairs(&e4a, "MUTYH"), ["biallelic"; 3], "{e4a:?}"); + // E4b: the combined call weak, its part confident. + let e4b = sf( + vec![ + combined(5, 4), + good(MUTYH_A, "MUTYH", "0|1", Some("9")), + good(MUTYH_C, "MUTYH", "1|0", Some("9")), + ], + &no_deletions(), + ); + assert_eq!(sf_pairs(&e4b, "MUTYH"), ["biallelic"; 3], "{e4b:?}"); +} + +#[test] +fn a_weak_hom_beside_two_confident_unphased_hets_is_possibly_biallelic() { + // E3c: the confident pair alone is possibly biallelic, as the carrier + // list says for the same hets; the weak homozygous call does not lower + // it to the low-confidence word. + let c = sf( + vec![ + good(MUTYH_A, "MUTYH", "0/1", None), + good(MUTYH_C, "MUTYH", "0/1", None), + weak(MUTYH_B, "MUTYH", "1/1", None), + ], + &no_deletions(), + ); + assert_eq!(sf_pairs(&c, "MUTYH"), ["possibly biallelic"; 3], "{c:?}"); +} + +/// The carrier list's answer for a gene, in the SF card's words: the best of +/// its het pair, its deletion pair and its homozygous or hemizygous rows (a +/// low-confidence one only possibly so). `None` when none of them says two +/// copies may be hit. +fn carrier_answer(c: &IndexMap, gene: &str) -> Option<&'static str> { + let mut best: Option = None; + let mut take = |r: Option| { + if let Some(r) = r { + best = Some(best.map_or(r, |b| b.min(r))); + } + }; + for x in of(c, "carriers", gene) { + if let Some(Value::Str(p)) = x.get("pair") { + take(Some(rank(p).unwrap_or_else(|| panic!("{p}")))); + } + } + for x in of(c, "hom_or_hemizygous", gene) { + let low = x.get("low_confidence") == Some(&Value::Bool(true)); + take(Some(if low { 2 } else { 0 })); + } + let Some(Value::Object(t)) = c.get("two_hits") else { + panic!("{c:?}") + }; + for x in rows(t, "genes") + .into_iter() + .filter(|r| s(r, "gene") == gene) + { + take(rank(s(x, "verdict"))); + } + best.map(|b| WORDS[b]) +} + +/// The SF card's answer for a gene: the one pair word of its reported rows. +fn sf_answer(c: &IndexMap, gene: &str) -> Option<&'static str> { + let words: std::collections::BTreeSet = of(c, "clinvar_hits", gene) + .iter() + .filter_map(|x| match x.get("pair") { + Some(Value::Str(p)) => Some(p.clone()), + _ => None, + }) + .collect(); + assert!(words.len() <= 1, "one pair per gene: {c:?}"); + let w = words.into_iter().next()?; + rank(&w).map(|r| WORDS[r]) +} + +#[test] +fn the_carrier_list_and_the_sf_card_agree_on_a_gene_on_both_lists() { + let (a, b, cc) = (MUTYH_A, MUTYH_B, MUTYH_C); + let g = |site, gt, ps| good(site, "MUTYH", gt, ps); + let w = |site, gt, ps| weak(site, "MUTYH", gt, ps); + let joined = format!( + ";PGP_JOINED_FROM={}:{}:{}:{}|chr1:45331560:G:A", + a.0, a.1, a.2, a.3 + ); + let combined = |q: &str| hit(b, "MUTYH", "GT:GQ:DP:PS", &format!("0|1:{q}:9"), &joined); + let del = || mutyh_deletion("1|0", Some("9")); + let none = no_deletions; + let p9 = Some("9"); + let bi = Some("biallelic"); + let maybe = Some("possibly biallelic"); + let low = Some("possibly biallelic (low-confidence call)"); + #[allow(clippy::type_complexity)] + let shapes: Vec<(&str, Vec>, DeletionInputs, Option<&str>)> = vec![ + ("confident hom", vec![g(a, "1/1", None)], none(), bi), + ("weak hom", vec![w(a, "1/1", None)], none(), low), + ( + "confident phased pair", + vec![g(a, "0|1", p9), g(b, "1|0", p9)], + none(), + bi, + ), + ( + "confident unphased pair", + vec![g(a, "0/1", None), g(b, "0/1", None)], + none(), + maybe, + ), + ( + "confident cis pair", + vec![g(a, "0|1", p9), g(b, "0|1", p9)], + none(), + None, + ), + ("weak het alone", vec![w(a, "0/1", None)], none(), None), + ( + "E1 confident hom + weak het", + vec![g(a, "1/1", None), w(b, "0/1", None)], + none(), + bi, + ), + ( + "E2a confident phased pair + weak unphased third", + vec![g(a, "0|1", p9), g(b, "1|0", p9), w(cc, "0/1", None)], + none(), + bi, + ), + ( + "E2b confident phased pair + weak third in the phase set", + vec![g(a, "0|1", p9), g(b, "1|0", p9), w(cc, "0|1", p9)], + none(), + bi, + ), + ( + "E2c confident phased pair + weak hom", + vec![g(a, "0|1", p9), g(b, "1|0", p9), w(cc, "1/1", None)], + none(), + bi, + ), + ( + "E3a confident + weak phased pair", + vec![g(a, "0|1", p9), w(b, "1|0", p9)], + none(), + low, + ), + ( + "E3b confident + weak unphased hets", + vec![g(a, "0/1", None), w(b, "0/1", None)], + none(), + low, + ), + ( + "E3c two confident unphased hets + weak hom", + vec![g(a, "0/1", None), g(cc, "0/1", None), w(b, "1/1", None)], + none(), + maybe, + ), + ( + "E3d two confident unphased hets + weak het", + vec![g(a, "0/1", None), g(cc, "0/1", None), w(b, "0/1", None)], + none(), + maybe, + ), + ( + "E3e two weak hets", + vec![w(a, "0/1", None), w(b, "0/1", None)], + none(), + low, + ), + ( + "E3f confident het + weak hom", + vec![g(a, "0/1", None), w(b, "1/1", None)], + none(), + low, + ), + ( + "E4a combined confident, part weak, third in trans", + vec![combined("50:30"), w(a, "0|1", p9), g(cc, "1|0", p9)], + none(), + bi, + ), + ( + "E4b combined weak, part confident, third in trans", + vec![combined("5:4"), g(a, "0|1", p9), g(cc, "1|0", p9)], + none(), + bi, + ), + ( + "E5a deletion + confident het in trans", + vec![g(a, "0|1", p9)], + del(), + bi, + ), + ( + "E5b deletion + weak het in trans", + vec![w(a, "0|1", p9)], + del(), + low, + ), + ( + "E6a deletion + confident het + weak hom", + vec![g(a, "0|1", p9), w(b, "1/1", None)], + del(), + bi, + ), + ( + "E6b deletion + confident het + weak het in cis with it", + vec![g(a, "0|1", p9), w(b, "1|0", p9)], + del(), + bi, + ), + ( + "E6c unphased deletion + confident het + weak hom", + vec![g(a, "0/1", None), w(b, "1/1", None)], + mutyh_deletion("0/1", None), + maybe, + ), + ("deletion alone", vec![], del(), None), + ("nothing", vec![], none(), None), + ]; + let mut wrong = Vec::new(); + for (label, hits, dels, want) in shapes { + let carrier = list(hits.clone(), &dels); + let card = sf(hits, &dels); + // The whole output of both cards, for a before/after diff. + eprintln!("DUMP {label}\tSF {card:?}\tCARRIER {carrier:?}"); + let (x, y) = (sf_answer(&card, "MUTYH"), carrier_answer(&carrier, "MUTYH")); + if x != want || y != want { + wrong.push(format!("{label}: want {want:?}, SF {x:?}, carrier {y:?}")); + } + for b in rows_weaker_than_their_two_hit(&card, "MUTYH") { + wrong.push(format!("{label}: {b}")); + } + } + assert!(wrong.is_empty(), "{}", wrong.join("\n")); +} From a857c8c2074734ddfd8f8a8421445039a476cbef Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 18:22:48 +0100 Subject: [PATCH 16/38] test(report): check the reason the reports give for an unknown SV support With step 22's consensus set and an SV whose support is null, both reports must say the consensus cannot tell, never that it did not run, in the AnnotSV rows and in the secondary-findings SV rows, and the AnnotSV count line must count the unknown rows. Without the consensus the old text stays. Red on the code before the fix: the header lacks "not known: 1" and the row says "no step 22 consensus". Bead: sv-01 --- .../og-render/tests/i411_sv_support_text.rs | 192 ++++++++++++++++++ 1 file changed, 192 insertions(+) create mode 100644 rust/crates/og-render/tests/i411_sv_support_text.rs diff --git a/rust/crates/og-render/tests/i411_sv_support_text.rs b/rust/crates/og-render/tests/i411_sv_support_text.rs new file mode 100644 index 000000000..f7809f035 --- /dev/null +++ b/rust/crates/og-render/tests/i411_sv_support_text.rs @@ -0,0 +1,192 @@ +//! The reports give the right reason when an SV's caller support is not +//! known (#411 sv-01). +//! +//! `og summary collect` writes an SV's `support` as `null` in two cases: +//! step 22's consensus did not run, or it ran and cannot tell (an `SV_VCF` +//! run's `sv_vcf` rows, a row with no record ID, an ID in two events, a +//! vote with no readable ID). The reports gave both the reason "no step 22 +//! consensus", so a user whose step 22 did run read that it did not. The +//! AnnotSV header counted only single-caller rows, so with the consensus +//! set and every row unknown it read "single caller: 0". +//! +//! Now the AnnotSV section's `consensus` field picks the reason, in the +//! AnnotSV block and in the secondary-findings rows, and the header counts +//! the unknown rows when the consensus ran. Without the consensus the old +//! text stays. + +use og_render::escape::e; +use og_render::model::Summary; +use og_render::sections::{acmg_sf, annotsv}; +use og_render::{html, text}; + +const CANNOT_TELL: &str = "not known (step 22's consensus cannot tell)"; +const NO_CONSENSUS: &str = "not known (no step 22 consensus)"; + +/// A summary with an AnnotSV section of two class 4-5 SVs (one seen by one +/// caller, one whose support is `second`) and an SF tier with one +/// structural row whose support is null. `consensus` is the AnnotSV +/// section's `consensus` field, as JSON. +fn summary(consensus: &str, second: &str) -> Summary { + Summary::parse(&summary_json(consensus, second, true)).expect("a summary") +} + +/// The summary's JSON; without `with_annotsv` it has no AnnotSV section. +fn summary_json(consensus: &str, second: &str, with_annotsv: bool) -> String { + let annotsv = format!( + r#""annotsv": {{"title": "Structural Variants, Class 4 and 5 (AnnotSV)", "state": "ok", "step": "05", + "source": "annotsv/S1_sv_class4_5_checked.tsv", "file_date": "2026-11-21 11:00:00", "note": null, + "data": {{"count": 2, "consensus": {consensus}, "consensus_note": null, "single_caller": 1, + "exon_edge": 0, "exon_edge_checked": true, "common": 0, "downgraded": [], "rows": [ + {{"type": "DEL", "sv": "chr1:1000-5000", "acmg_class": "5", "genes": ["G1"], "caller": "manta", + "support": 1, "support_callers": ["manta"], "exon_edge": "no", "population_af": null}}, + {{"type": "DUP", "sv": "chr2:2000-9000", "acmg_class": "4", "genes": ["G2"], "caller": "sv_vcf", + "support": {second}, "support_callers": ["manta", "delly"], "exon_edge": "no", "population_af": null}}]}}}},"# + ); + let annotsv = if with_annotsv { annotsv.as_str() } else { "" }; + format!( + r#"{{ + "schema_version": 2, "sample": "S1", "generated_utc": "2026-11-21 12:00 UTC", + "run": {{"started_utc": "2026-11-21 10:00 UTC", "declared_sex": "female"}}, + "databases": {{"clinvar_release": "2026-10-01", "cpsr_clinvar_release": null, "hla_database": null}}, + "manifest": [], + "sections": {{ + {annotsv} + "clinical": {{"title": "Clinical Variant Filter", "state": "ok", "step": "23", + "source": "clinical/S1_clinical.tsv", "file_date": "2026-11-21 11:00:00", "note": null, + "data": {{"variants": 3, "acmg_sf": {{"version": "SF v3.3", "genes_on_list": 84, "clinvar_hits": [], + "high_impact": [], "structural_checked": true, "structural": [ + {{"gene": "G1", "variant": "DEL chr1:1000-5000", "acmg_class": "5", "caller": "sv_vcf", "support": null}}]}}}}}} + }}, + "cyp2d6": null, "not_run": [], "not_assessed": [] +}}"# + ) +} + +/// The block of section `sid` in the HTML report. +fn frame<'a>(page: &'a str, sid: &str) -> &'a str { + page.split_once(&format!("id=\"{sid}\">")) + .map_or("", |(_, rest)| { + rest.split("").next().unwrap_or("") + }) +} + +/// Both reports, text and HTML. +fn reports(s: &Summary) -> (String, String) { + ( + text::report(s).expect("the text report"), + html::report(s).expect("the HTML report"), + ) +} + +/// The consensus ran: a null support is one it cannot tell, in the AnnotSV +/// rows, the header and the SF row; "no step 22 consensus" is gone. +#[test] +fn a_consensus_that_cannot_tell_says_so() { + let s = summary(r#""sv_merged/S1_sv_consensus.vcf.gz""#, "null"); + let (txt, page) = reports(&s); + + let head = " Class 4-5 SVs: 2 (single caller: 1, not known: 1; deletions on exon edges: 0; common: 0)"; + assert!(txt.lines().any(|l| l == head), "{txt}"); + assert!( + txt.lines().any( + |l| l.starts_with(" DUP chr2:2000-9000 class 4 G2 support: ") + && l.ends_with(CANNOT_TELL) + ), + "{txt}" + ); + assert!( + txt.contains("G1 DEL chr1:1000-5000 . AnnotSV class 5, caller support not known (step 22's consensus cannot tell)"), + "{txt}" + ); + // The consensus ran, so its "did not run" note is not there either. + assert!(!txt.contains("did not run"), "{txt}"); + + let sv = frame(&page, "structural-variants"); + assert!(sv.contains(&format!("{}", e(CANNOT_TELL))), "{sv}"); + assert!( + sv.contains(&*e( + "single caller: 1, not known: 1; deletions on exon edges: 0" + )), + "{sv}" + ); + let clinical = frame(&page, "clinical-filter"); + assert!( + clinical.contains(&*e( + "AnnotSV class 5, caller support not known (step 22's consensus cannot tell)" + )), + "{clinical}" + ); + for (name, report) in [("text", txt.as_str()), ("HTML", page.as_str())] { + assert!( + !report.contains("no step 22 consensus"), + "the {name} report still says the consensus did not run:\n{report}" + ); + } +} + +/// The consensus ran and saw every row: the header has no unknown count. +#[test] +fn a_consensus_that_saw_every_row_adds_no_unknown_count() { + let s = summary(r#""sv_merged/S1_sv_consensus.vcf.gz""#, "2"); + let lines = + annotsv::lines(&og_render::sections::clinvar::D::of(&s.section("annotsv"))).unwrap(); + assert_eq!( + lines[0], + "Class 4-5 SVs: 2 (single caller: 1; deletions on exon edges: 0; common: 0)" + ); + let (txt, _) = reports(&s); + assert!(txt.contains("support: 2 callers (manta, delly)"), "{txt}"); +} + +/// No consensus: the old reason stays everywhere, with the note that says +/// step 22 did not run, and the header reads "not known" as before. +#[test] +fn without_the_consensus_the_old_reason_stays() { + let s = summary("null", "null"); + let (txt, page) = reports(&s); + + let head = + " Class 4-5 SVs: 2 (single caller: not known; deletions on exon edges: 0; common: 0)"; + assert!(txt.lines().any(|l| l == head), "{txt}"); + assert!( + txt.lines().any( + |l| l.starts_with(" DUP chr2:2000-9000 class 4 G2 support: ") + && l.ends_with(NO_CONSENSUS) + ), + "{txt}" + ); + assert!( + txt.contains("G1 DEL chr1:1000-5000 . AnnotSV class 5, caller support not known (no step 22 consensus)"), + "{txt}" + ); + assert!(txt.contains("step 22's consensus did not run"), "{txt}"); + let sv = frame(&page, "structural-variants"); + assert!( + sv.contains(&format!("{}", e(NO_CONSENSUS))), + "{sv}" + ); + for (name, report) in [("text", txt.as_str()), ("HTML", page.as_str())] { + assert!( + !report.contains("cannot tell"), + "the {name} report gives the consensus's reason without a consensus:\n{report}" + ); + } +} + +/// The SF rows read the AnnotSV section's flag: with no AnnotSV section at +/// all, the old reason stays. +#[test] +fn sf_rows_without_an_annotsv_section_keep_the_old_reason() { + let s = Summary::parse(&summary_json( + r#""sv_merged/S1_sv_consensus.vcf.gz""#, + "null", + false, + )) + .expect("a summary"); + let txt = acmg_sf::text(&s).unwrap().join("\n"); + assert!( + txt.contains("AnnotSV class 5, caller support not known (no step 22 consensus)"), + "{txt}" + ); + assert!(!txt.contains("cannot tell"), "{txt}"); +} From f91075bd714b2166839ad9002e9ad492aaf70588 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 18:22:48 +0100 Subject: [PATCH 17/38] fix(report): give the right reason when step 22's consensus cannot tell an SV's support og summary collect writes an SV's support as null when step 22's consensus ran but cannot tell (an SV_VCF run's rows, a row with no ID, an ID in two events, a vote with no readable ID). Both renderers still said "not known (no step 22 consensus)" for every null, and the AnnotSV count line read "single caller: 0". The AnnotSV section's consensus flag now picks the reason in the AnnotSV rows and the secondary-findings SV rows, and the count line adds ", not known: M" when the consensus ran. bin/render_report.py and bin/live_results.py change the same lines for the live site. The pinned Python oracle prints the old reason, so the 50 report-render cases that show it get whole-report goldens. report-corpus.sh pins each collected summary's generated_utc so those goldens stay stable (the same hunk as the carrier-confidence lane). Bead: sv-01 --- CHANGELOG.md | 1 + bin/live_results.py | 4 +- bin/render_report.py | 18 +- docs/05-annotsv.md | 2 +- rust/crates/og-render/src/sections/acmg_sf.rs | 27 +- rust/crates/og-render/src/sections/annotsv.rs | 42 +- tests/parity/gen/report-corpus.sh | 7 + .../report-render/a-escape/a-escape.html | 920 +++++++++++++++++ .../report-render/a-escape/a-escape.txt | 439 +++++++++ .../report-render/a-failed/a-failed.html | 860 ++++++++++++++++ .../report-render/a-failed/a-failed.txt | 405 ++++++++ .../golden/report-render/a-full/a-full.html | 922 +++++++++++++++++ .../golden/report-render/a-full/a-full.txt | 441 +++++++++ .../report-render/a-missing/a-missing.html | 813 +++++++++++++++ .../report-render/a-missing/a-missing.txt | 373 +++++++ .../a-no-painting/a-no-painting.html | 919 +++++++++++++++++ .../a-no-painting/a-no-painting.txt | 440 +++++++++ .../report-render/a-numbers/a-numbers.txt | 441 +++++++++ .../report-render/a-painting/a-painting.html | 923 +++++++++++++++++ .../report-render/a-painting/a-painting.txt | 442 +++++++++ .../report-render/a-partial/a-partial.html | 884 +++++++++++++++++ .../report-render/a-partial/a-partial.txt | 389 ++++++++ .../report-render/a-prs-raw/a-prs-raw.html | 921 +++++++++++++++++ .../report-render/a-prs-raw/a-prs-raw.txt | 441 +++++++++ .../report-render/a-prs-sex/a-prs-sex.html | 923 +++++++++++++++++ .../report-render/a-prs-sex/a-prs-sex.txt | 442 +++++++++ .../golden/report-render/a-since/a-since.html | 922 +++++++++++++++++ .../golden/report-render/a-since/a-since.txt | 444 +++++++++ .../golden/report-render/a-stale/a-stale.html | 930 ++++++++++++++++++ .../golden/report-render/a-stale/a-stale.txt | 449 +++++++++ .../a-unreadable/a-unreadable.html | 860 ++++++++++++++++ .../a-unreadable/a-unreadable.txt | 397 ++++++++ .../report-render/a-y-calls/a-y-calls.html | 909 +++++++++++++++++ .../report-render/a-y-calls/a-y-calls.txt | 424 ++++++++ .../report-render/all-history/all-history.txt | 669 +++++++++++++ tests/parity/golden/report-render/all/all.txt | 624 ++++++++++++ .../c-float--inf/c-float--inf.txt | 411 ++++++++ .../report-render/c-float-inf/c-float-inf.txt | 418 ++++++++ .../report-render/c-float-nan/c-float-nan.txt | 407 ++++++++ .../golden/report-render/c-full/c-full.txt | 442 +++++++++ .../golden/report-render/cb-full/cb-full.html | 698 +++++++++++++ .../golden/report-render/cb-full/cb-full.txt | 293 ++++++ .../cb-no-assets/cb-no-assets.html | 672 +++++++++++++ .../cb-no-assets/cb-no-assets.txt | 266 +++++ .../cb-quoted-dosage/cb-quoted-dosage.html | 698 +++++++++++++ .../cb-quoted-dosage/cb-quoted-dosage.txt | 293 ++++++ .../cb-quoted-interval.html | 698 +++++++++++++ .../cb-quoted-interval/cb-quoted-interval.txt | 293 ++++++ .../cb-quoted-smn/cb-quoted-smn.html | 698 +++++++++++++ .../cb-quoted-smn/cb-quoted-smn.txt | 293 ++++++ .../cb-unicode-contig/cb-unicode-contig.html | 698 +++++++++++++ .../cb-unicode-contig/cb-unicode-contig.txt | 293 ++++++ .../m-clinical-escape/m-clinical-escape.html | 699 +++++++++++++ .../m-clinical-escape/m-clinical-escape.txt | 293 ++++++ .../m-clinical-failed/m-clinical-failed.html | 564 +++++++++++ .../m-clinical-failed/m-clinical-failed.txt | 186 ++++ .../m-clinical-stale/m-clinical-stale.html | 719 ++++++++++++++ .../m-clinical-stale/m-clinical-stale.txt | 306 ++++++ .../m-clinical-unreadable.html | 564 +++++++++++ .../m-clinical-unreadable.txt | 179 ++++ .../m-clinvar-freq-note.html | 698 +++++++++++++ .../m-clinvar-freq-note.txt | 293 ++++++ .../m-clinvar-many/m-clinvar-many.html | 742 ++++++++++++++ .../m-clinvar-many/m-clinvar-many.txt | 426 ++++++++ .../m-clinvar-none/m-clinvar-none.html | 659 +++++++++++++ .../m-clinvar-none/m-clinvar-none.txt | 250 +++++ .../m-couple-empty/m-couple-empty.html | 707 +++++++++++++ .../m-couple-empty/m-couple-empty.txt | 298 ++++++ .../report-render/m-couple/m-couple.html | 710 +++++++++++++ .../report-render/m-couple/m-couple.txt | 300 ++++++ .../m-cpsr-none/m-cpsr-none.html | 681 +++++++++++++ .../report-render/m-cpsr-none/m-cpsr-none.txt | 277 ++++++ .../m-cpsr-noown/m-cpsr-noown.html | 688 +++++++++++++ .../m-cpsr-noown/m-cpsr-noown.txt | 283 ++++++ .../report-render/m-sf-notes/m-sf-notes.html | 699 +++++++++++++ .../report-render/m-sf-notes/m-sf-notes.txt | 294 ++++++ .../m-since-clinical/m-since-clinical.html | 698 +++++++++++++ .../m-since-clinical/m-since-clinical.txt | 296 ++++++ .../m-slivar-phase/m-slivar-phase.html | 654 ++++++++++++ .../m-slivar-phase/m-slivar-phase.txt | 273 +++++ .../m-slivar-unphased/m-slivar-unphased.html | 672 +++++++++++++ .../m-slivar-unphased/m-slivar-unphased.txt | 271 +++++ .../s-consumer-reasons.html | 922 +++++++++++++++++ .../s-consumer-reasons/s-consumer-reasons.txt | 441 +++++++++ .../s-consumer-stale/s-consumer-stale.html | 922 +++++++++++++++++ .../s-consumer-stale/s-consumer-stale.txt | 441 +++++++++ .../s-sexloss-chrx/s-sexloss-chrx.html | 925 +++++++++++++++++ .../s-sexloss-chrx/s-sexloss-chrx.txt | 447 +++++++++ .../s-sexloss-detected.html | 925 +++++++++++++++++ .../s-sexloss-detected/s-sexloss-detected.txt | 447 +++++++++ .../s-sexloss-failed/s-sexloss-failed.html | 923 +++++++++++++++++ .../s-sexloss-failed/s-sexloss-failed.txt | 445 +++++++++ .../s-sexloss-gain-stale.html | 925 +++++++++++++++++ .../s-sexloss-gain-stale.txt | 447 +++++++++ .../s-sexloss-not-estimated.html | 924 +++++++++++++++++ .../s-sexloss-not-estimated.txt | 446 +++++++++ .../s-sexloss-odd/s-sexloss-odd.html | 925 +++++++++++++++++ .../s-sexloss-odd/s-sexloss-odd.txt | 447 +++++++++ .../report-render/s-sv-stale/s-sv-stale.html | 926 +++++++++++++++++ .../report-render/s-sv-stale/s-sv-stale.txt | 445 +++++++++ 100 files changed, 53314 insertions(+), 26 deletions(-) create mode 100644 tests/parity/golden/report-render/a-escape/a-escape.html create mode 100644 tests/parity/golden/report-render/a-escape/a-escape.txt create mode 100644 tests/parity/golden/report-render/a-failed/a-failed.html create mode 100644 tests/parity/golden/report-render/a-failed/a-failed.txt create mode 100644 tests/parity/golden/report-render/a-full/a-full.html create mode 100644 tests/parity/golden/report-render/a-full/a-full.txt create mode 100644 tests/parity/golden/report-render/a-missing/a-missing.html create mode 100644 tests/parity/golden/report-render/a-missing/a-missing.txt create mode 100644 tests/parity/golden/report-render/a-no-painting/a-no-painting.html create mode 100644 tests/parity/golden/report-render/a-no-painting/a-no-painting.txt create mode 100644 tests/parity/golden/report-render/a-numbers/a-numbers.txt create mode 100644 tests/parity/golden/report-render/a-painting/a-painting.html create mode 100644 tests/parity/golden/report-render/a-painting/a-painting.txt create mode 100644 tests/parity/golden/report-render/a-partial/a-partial.html create mode 100644 tests/parity/golden/report-render/a-partial/a-partial.txt create mode 100644 tests/parity/golden/report-render/a-prs-raw/a-prs-raw.html create mode 100644 tests/parity/golden/report-render/a-prs-raw/a-prs-raw.txt create mode 100644 tests/parity/golden/report-render/a-prs-sex/a-prs-sex.html create mode 100644 tests/parity/golden/report-render/a-prs-sex/a-prs-sex.txt create mode 100644 tests/parity/golden/report-render/a-since/a-since.html create mode 100644 tests/parity/golden/report-render/a-since/a-since.txt create mode 100644 tests/parity/golden/report-render/a-stale/a-stale.html create mode 100644 tests/parity/golden/report-render/a-stale/a-stale.txt create mode 100644 tests/parity/golden/report-render/a-unreadable/a-unreadable.html create mode 100644 tests/parity/golden/report-render/a-unreadable/a-unreadable.txt create mode 100644 tests/parity/golden/report-render/a-y-calls/a-y-calls.html create mode 100644 tests/parity/golden/report-render/a-y-calls/a-y-calls.txt create mode 100644 tests/parity/golden/report-render/all-history/all-history.txt create mode 100644 tests/parity/golden/report-render/all/all.txt create mode 100644 tests/parity/golden/report-render/c-float--inf/c-float--inf.txt create mode 100644 tests/parity/golden/report-render/c-float-inf/c-float-inf.txt create mode 100644 tests/parity/golden/report-render/c-float-nan/c-float-nan.txt create mode 100644 tests/parity/golden/report-render/c-full/c-full.txt create mode 100644 tests/parity/golden/report-render/cb-full/cb-full.html create mode 100644 tests/parity/golden/report-render/cb-full/cb-full.txt create mode 100644 tests/parity/golden/report-render/cb-no-assets/cb-no-assets.html create mode 100644 tests/parity/golden/report-render/cb-no-assets/cb-no-assets.txt create mode 100644 tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html create mode 100644 tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt create mode 100644 tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html create mode 100644 tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt create mode 100644 tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html create mode 100644 tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt create mode 100644 tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html create mode 100644 tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt create mode 100644 tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html create mode 100644 tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt create mode 100644 tests/parity/golden/report-render/m-clinical-failed/m-clinical-failed.html create mode 100644 tests/parity/golden/report-render/m-clinical-failed/m-clinical-failed.txt create mode 100644 tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html create mode 100644 tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt create mode 100644 tests/parity/golden/report-render/m-clinical-unreadable/m-clinical-unreadable.html create mode 100644 tests/parity/golden/report-render/m-clinical-unreadable/m-clinical-unreadable.txt create mode 100644 tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html create mode 100644 tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt create mode 100644 tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html create mode 100644 tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt create mode 100644 tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html create mode 100644 tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt create mode 100644 tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html create mode 100644 tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt create mode 100644 tests/parity/golden/report-render/m-couple/m-couple.html create mode 100644 tests/parity/golden/report-render/m-couple/m-couple.txt create mode 100644 tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html create mode 100644 tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt create mode 100644 tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html create mode 100644 tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt create mode 100644 tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html create mode 100644 tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt create mode 100644 tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html create mode 100644 tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt create mode 100644 tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html create mode 100644 tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt create mode 100644 tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html create mode 100644 tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt create mode 100644 tests/parity/golden/report-render/s-consumer-reasons/s-consumer-reasons.html create mode 100644 tests/parity/golden/report-render/s-consumer-reasons/s-consumer-reasons.txt create mode 100644 tests/parity/golden/report-render/s-consumer-stale/s-consumer-stale.html create mode 100644 tests/parity/golden/report-render/s-consumer-stale/s-consumer-stale.txt create mode 100644 tests/parity/golden/report-render/s-sexloss-chrx/s-sexloss-chrx.html create mode 100644 tests/parity/golden/report-render/s-sexloss-chrx/s-sexloss-chrx.txt create mode 100644 tests/parity/golden/report-render/s-sexloss-detected/s-sexloss-detected.html create mode 100644 tests/parity/golden/report-render/s-sexloss-detected/s-sexloss-detected.txt create mode 100644 tests/parity/golden/report-render/s-sexloss-failed/s-sexloss-failed.html create mode 100644 tests/parity/golden/report-render/s-sexloss-failed/s-sexloss-failed.txt create mode 100644 tests/parity/golden/report-render/s-sexloss-gain-stale/s-sexloss-gain-stale.html create mode 100644 tests/parity/golden/report-render/s-sexloss-gain-stale/s-sexloss-gain-stale.txt create mode 100644 tests/parity/golden/report-render/s-sexloss-not-estimated/s-sexloss-not-estimated.html create mode 100644 tests/parity/golden/report-render/s-sexloss-not-estimated/s-sexloss-not-estimated.txt create mode 100644 tests/parity/golden/report-render/s-sexloss-odd/s-sexloss-odd.html create mode 100644 tests/parity/golden/report-render/s-sexloss-odd/s-sexloss-odd.txt create mode 100644 tests/parity/golden/report-render/s-sv-stale/s-sv-stale.html create mode 100644 tests/parity/golden/report-render/s-sv-stale/s-sv-stale.txt diff --git a/CHANGELOG.md b/CHANGELOG.md index 66ce46e0e..e676a7222 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -25,6 +25,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n - The local genome viewer runs on `og` and no longer needs `python3` on the host. `scripts/owngenome-view.sh` starts `og view serve` (through `bin/og`, or `OG`), which serves the same page, config and byte ranges on 127.0.0.1 as `assets/viewer/serve.py` did. Two requests it answered before are now refused. A locus whose end comes before its start (`chr1:13000-12000`) stops the script with exit 2 and the reason, instead of opening a view igv.js cannot show. A request with a `Forwarded`, `X-Forwarded-*` or `X-Real-IP` header gets 403: the viewer has no password, so a reverse proxy in front of it would hand the sample to anyone who reaches the proxy; an ssh port forward still works. The default SV track is now Manta's diploid SVs (step 4), else step 22's consensus, which keeps only the calls two callers agree on. `docs/viewer.md` says that every account on the machine can reach 127.0.0.1. No option of the script, file or output name changes; `og view serve` takes the flags `serve.py` took, plus `--assets`, the page's folder. The live site's viewer also opens Manta's diploid SVs first; the rest of it is unchanged until its server moves to `og`. Part of #411 (plat-11, plat-12). - Step 22's SV consensus no longer counts a record a caller did not call as a second caller. Before, every PASS record went to SURVIVOR, so a PASS Delly record genotyped `0/0`, a Delly call whose sample filter (`FT`) says `LowQual`, or a CNVpytor segment no quality rule had read sat beside a Manta-only call and made it read "2 callers". A new verb, `og sv survivor-prep --caller NAME IN OUT`, now writes each caller's input for both the script and the Nextflow `SURVIVOR_PREP`, in place of the bcftools and awk they each carried. A record votes when its FILTER and its sample `FT` are `PASS` or `.` and its genotype is not reference only (`0/0`, `0|0`, haploid `0`, `0/.`); a no-call (`./.`) and a sites-only record still vote. A CNVpytor call votes when its e-value is below 0.01 and its share of MAPQ 0 reads below 0.5, the rule step 05 already applies when it adds CNVpytor's calls; the VCF step 22 makes from CNVpytor's table now carries the table's e-value, `q0` and `pN` as `pytorP1`, `pytorQ0` and `pytorPN`, so the rule reads both inputs. A header without `GT` or without these tags no longer matters. Step 18's closing hint and `docs/18-cnvpytor.md` gave e-value below 0.05 and size over 1 kb; they now give the same rule. What changes in the output: `sv_merged/inputs/.vcf` holds only the records that vote, and the consensus can hold fewer records. No file, column or option is renamed or removed. Part of #411 (sv-05, sv-06, sv-09, sv-10, sv-11, sv-40). - A class 4 or 5 SV gets support from more than one caller only from the step 22 consensus event that lists its own record: same contig and SV type, its caller voting in `SUPP_VEC`, and its original record ID in that caller's `FORMAT/ID`. Before, the nearest consensus record within 1,000 bp lent its callers, whatever its type or filter, so a filtered call, a call of the other type or an unrelated call nearby made a Manta-only call read "2 callers". A row that no event lists shows as single caller, when the consensus names every vote of its caller. When the consensus cannot tell, the support is now "not known": `Support` and `Support_callers` are empty in `_sv_class4_5_checked.tsv`, and `support` is `null` in `summary.json`. That happens when the row has no record ID, its caller is not a consensus column (`sv_vcf` rows of an `SV_VCF` run), its ID is in two events, or a vote of its caller has no readable ID (CNVpytor calls when step 22 made CNVpytor's VCF from its table). `og sv add-callers` now keeps Delly's `RDCN` on each Delly call it adds (`FORMAT GT:RDCN` and the `##FORMAT=` header line), so `Depth_support` reads the depth that step checked: `yes` for a call over 1,000 bp it kept. A Delly call over 1,000 bp with no `RDCN`, from a VCF not written by Delly 2.x, now reads `unknown` instead of `yes` and keeps its class; step 05's log line counts it apart from `not checked`. No column, option or file name changes. Part of #411 (sv-01, sv-08, sv-03) and follow-up to #542. +- The reports no longer say step 22 did not run when it did. Step 22's consensus leaves an SV's caller support "not known" when it cannot tell: an `SV_VCF` run's `sv_vcf` rows, a row with no record ID, an ID in two events, or a vote with no readable ID. Both reports still gave those SVs the reason "not known (no step 22 consensus)", and the AnnotSV count line read "single caller: 0", as if every SV had two callers. When the AnnotSV section's `consensus` is set, the AnnotSV rows and the secondary-findings SV rows now say "not known (step 22's consensus cannot tell)", and the count line adds the unknown ones, as in `single caller: 0, not known: 3`. Without the consensus the old text stays. The Python live site (`bin/render_report.py`, `bin/live_results.py`) writes the same text. No file, key or option changes; only the report text does. The pinned Python oracle still prints the old reason, so the 50 report-render parity cases that show it now have goldens. Part of #411 (sv-01), follow-up to #566. - The callability section of `summary.json` now says, for each gene a step of its own calls, whether that step ran. A gene such as SMN1, CYP2D6, HBA1, LPA or RHD that step 16b did not read is listed under `not_read_owned` with its owner, and it read as handed to that step even when the step never ran for the sample, so its coverage stood alone as the answer. Each entry gains two fields: `owner_step` (`35`, `32`, `46` or `41`) and `owner_status` (`ran`; `not run` when that step wrote no file of its own for the gene in the sample folder, a Parascopy gene being judged by its own table in `assets/paralog_loci.tsv`; or `from an earlier run` when that file is older than the last run and the step was not `ok` in it, the rule that makes a section stale). Fields are only added; none is renamed or removed, and the reports do not show them yet. The share keeps its four decimals (0.8988 stays 0.8988). Part of #411 (clin-25). - Step 10 (telomere content) always reads the GRCh38 chromosome bands now. When `reference/cytoBand.hg38.txt` was missing, `scripts/10-telomere-hunter.sh` warned and ran TelomereHunter without `-b`, so it sorted reads by its own hg19 band ends on GRCh38 positions; the Nextflow module did the same whenever `--cytoband` was not set, which is the default. The script now installs the copy the repository ships (`assets/reference/cytoBand.hg38.txt`) before it runs, and the pipeline passes that copy when `--cytoband` is not set. The step also moves from TelomereHunter 1.1.0, Python 2.7 code, to its maintained successor TelomereHunter2 1.0.12 (`TELOMEREHUNTER_IMAGE`, `quay.io/biocontainers/telomerehunter2`). On the image test's input both give the same `tel_content` (5347.255643 with 1,100 planted telomeric reads, 5337.585253 with 1,098), so earlier values stay comparable. THREADS now sets its worker count (`-c`), and the container gets a higher open-file limit, which it needs on a BAM with many contigs. Output change: `telomere///_summary.tsv` keeps its name, but its columns follow TelomereHunter2 (`tel_content` third, `intratelomeric_reads`, `tel_read_count`, `read_lengths`, plus three read-class counts). `summary.json` and the reports read both layouts by name and do not change. The docs no longer describe the value as an age measure: `tests/test_telomere_wording.sh` fails when a file that describes step 10 does. Part of #411 (trait-46, trait-47, trait-48, trait-49). - Step 25 and the Nextflow `PRS_SUMMARY` withhold a score's percentile when the genotypes pgsc_calc scored list variants only. Every site such a VCF leaves out adds nothing to the sum, so the sum leans away from the panel's sums, which come from complete genotypes, and the percentile was not comparable. Each score keeps its raw sum. Its `Percentile` is `NA`, its `Effect` is empty, and a new column before `Input`, `Percentile_Note`, says `percentile withheld: the input lists variants only`. The decision reads the genotypes, not the kind of input: at least one genotyped position in five must be a reference call (0/0), the rule step 26b applies to the panel's sites. Genotypes from a gVCF and chip VCFs from `scripts/chip-to-vcf.sh`, which list their reference calls, keep their percentiles. `og prs table` takes the genotypes with a new option, `--target VCF`, and prints the NOTE that step 25 printed before; the NOTE now follows the genotypes too, so a gVCF without reference blocks at the score positions gets it. `og summary collect` passes the note on as `percentile_note`. When every percentile was withheld, both reports say "Percentile withheld: the input lists variants only" and why, and the summary's `not_assessed` list says the percentiles were withheld, in place of the lines for a run without the panel, which told the user to install a panel the run had used. The output gains one column; no column, option or file name changes. diff --git a/bin/live_results.py b/bin/live_results.py index 975b8a6ff..3f235d411 100644 --- a/bin/live_results.py +++ b/bin/live_results.py @@ -250,7 +250,7 @@ def a_structural(S, s): ["Consensus SVs (2+ callers)", sv.get("consensus", ".")], ["AnnotSV class 4 and 5", av.get("count", ".")]] rows = [[x.get("type"), x.get("sv"), x.get("gt"), x.get("length"), x.get("acmg_class"), - rr.annotsv_genes_text(x) if x.get("genes") is not None else ".", rr.annotsv_support_text(x), + rr.annotsv_genes_text(x) if x.get("genes") is not None else ".", rr.annotsv_support_text(x, av.get("consensus")), "; ".join(rr.annotsv_flags(x)) if "exon_edge" in x else "."] for x in av.get("rows") or []] return {"facts": facts, "table": table(["Type", "Where", "Genotype", "Length", "Class", "Genes", "Support", @@ -889,7 +889,7 @@ def gene(x): f"A {x.get('type') or 'structural change'} of {abs(int(num(x.get('length')) or 0)):,} bases that " f"AnnotSV ranks class {x.get('acmg_class')}. Short reads can misplace large changes: confirm it.", gene=(x.get("genes") or [None])[0], detail=x.get("sv"), - evidence=[["Class", x.get("acmg_class")], ["Callers", rr.annotsv_support_text(x)], + evidence=[["Class", x.get("acmg_class")], ["Callers", rr.annotsv_support_text(x, _data(S, "annotsv").get("consensus"))], ["Genotype", x.get("gt")]], viewer=str(x.get("sv") or "").replace(" ", "") or None)) # 6. Repeat expansions outside Stranger's "normal", or in an intermediate zone. for l in _items(_data(S, "expansions").get("loci")): diff --git a/bin/render_report.py b/bin/render_report.py index fa3496b4f..d13fedd1b 100755 --- a/bin/render_report.py +++ b/bin/render_report.py @@ -836,9 +836,9 @@ def comphet_phase_html(d): "those calls are listed apart with the reason and are not counted here.") -def annotsv_support_text(x): +def annotsv_support_text(x, consensus=None): if x["support"] is None: - return "not known (no step 22 consensus)" + return "not known (step 22's consensus cannot tell)" if consensus else "not known (no step 22 consensus)" if x["support"] == 1: return f"single caller ({x['caller']})" return f"{x['support']} callers ({', '.join(x['support_callers'])})" @@ -874,7 +874,7 @@ def annotsv_lines(d): """Step 05's class 4-5 lines, the same in both reports.""" head = f"Class 4-5 SVs: {d['count']}" if d["count"]: - head += (f" (single caller: {d['single_caller'] if d['consensus'] else 'not known'}; deletions on exon edges: " + head += (f" (single caller: {str(d['single_caller']) + (f', not known: {m}' if (m := sum(x['support'] is None for x in d.get('rows') or [])) else '') if d['consensus'] else 'not known'}; deletions on exon edges: " f"{d['exon_edge'] if d['exon_edge_checked'] else 'not checked'}; common: {d['common']})") lines = [head] if d.get("downgraded"): @@ -1343,7 +1343,7 @@ def head(key, title=None): w(f" {line}") for x in d["rows"]: w(f" {x['type']:<4} {x['sv']} class {x['acmg_class']} {annotsv_genes_text(x)} " - f"support: {annotsv_support_text(x)}") + f"support: {annotsv_support_text(x, d['consensus'])}") for f in annotsv_flags(x): w(f" {f}") if d.get("downgraded"): @@ -1553,7 +1553,7 @@ def head(key, title=None): f"{len(sf['clinvar_hits'])} ClinVar P/LP, {high_rare(sf)} rare HIGH impact" + high_apart(sf) + (f", {len(sf['structural'])} class 4/5 SV(s)" if sf.get("structural_checked") else "") + (f", {len(sf['not_reported'])} not reported by the gene's rule" if sf.get("not_reported") else "")) - for g, v, z, ev in sf_rows(sf): + for g, v, z, ev in sf_rows(sf, (S.get("annotsv", MISSING).get("data") or {}).get("consensus")): w(f" {g:<8} {v} {z} {ev}") for line in sf_apart_lines(sf): w(f" {line}") @@ -1991,7 +1991,7 @@ def paralogs_unchecked(S): "change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.") -def sf_rows(sf): +def sf_rows(sf, consensus=None): """The secondary findings as (gene, variant, genotype, evidence) rows, the same in both reports: ClinVar hits, rare HIGH-impact records, then class 4 and 5 SVs.""" @@ -2004,7 +2004,7 @@ def extra(x): for x in sf["high_impact"]] def support(x): if x["support"] is None: - return "caller support not known (no step 22 consensus)" + return "caller support not known (step 22's consensus cannot tell)" if consensus else "caller support not known (no step 22 consensus)" return f"single caller ({x['caller']})" if x["support"] == 1 else f"{x['support']} callers" rows += [(x["gene"], x["variant"], ".", f"AnnotSV class {x['acmg_class']}, {support(x)}" + (f"; through {x['via']}" if x.get("via") else "") + extra(x)) for x in sf.get("structural", [])] @@ -2843,7 +2843,7 @@ def a(key, lines): if av.get("rows"): body.append(f" {VIEWER_TH}" + "".join(f"" - f"" + f"" f"{viewer_td_of(x['sv'])}" for x in av["rows"]) + "
    SVClassGenesCallersChecks
    {E(x['type'] + ' ' + x['sv'])}{E(x['acmg_class'])}{E(annotsv_genes_text(x))}{E(annotsv_support_text(x))}{E(annotsv_genes_text(x))}{E(annotsv_support_text(x, av['consensus']))}{E('; '.join(annotsv_flags(x)) or 'none')}
    ") @@ -3062,7 +3062,7 @@ def a(key, lines): if sf and (sf["clinvar_hits"] or sf["high_impact"] or sf.get("structural") or sf.get("not_reported") or sf.get("unavailable")): rows = "".join(f"{E(g)}{E(v)}{E(z)}{E(ev)}{viewer_td_of(v)}\n" - for g, v, z, ev in sf_rows(sf)) + for g, v, z, ev in sf_rows(sf, (S.get("annotsv", MISSING).get("data") or {}).get("consensus"))) a("clinical", card(S["clinical"], f"Secondary-Findings Genes ({sf['version']})", [" ", f" {VIEWER_TH}", rows.rstrip("\n"), "
    GeneVariantGenotypeEvidence
    "] diff --git a/docs/05-annotsv.md b/docs/05-annotsv.md index fc4be32a3..df211c79d 100644 --- a/docs/05-annotsv.md +++ b/docs/05-annotsv.md @@ -135,7 +135,7 @@ The reports (`og summary collect`) read each SV's support from step 22's consens - its ID is a member of two events; - or the consensus holds a vote of its caller without a readable ID. This covers the CNVpytor calls when step 22 made CNVpytor's VCF from its table, which writes no record IDs. It also covers a consensus without `FORMAT/ID`; SURVIVOR 1.0.7 always writes it, so only a file made another way lacks it. -Without the consensus file the support is "not known" too. `og sv postfilter --consensus` adds the same `Support` and `Support_callers` columns to the table, both empty when the support is not known. +Without the consensus file the support is "not known" too. `og sv postfilter --consensus` adds the same `Support` and `Support_callers` columns to the table, both empty when the support is not known. The reports give the reason: "not known (step 22's consensus cannot tell)" when the consensus ran, "not known (no step 22 consensus)" when it did not. When the consensus ran, the section's count line adds how many SVs it could not tell, as in `single caller: 2, not known: 3`. Both reports list every class 4 and 5 SV in a section of their own, with its support, the exon-edge flag and the frequency. The bash report (`scripts/24-html-report.sh`, which `run-all.sh` runs) reads the table from the sample folder. The Nextflow `HTML_REPORT` gets the table from `ANNOTSV` and, with `survivor_merge` in `--tools`, the consensus, so a report written by `nextflow run` alone has the same section. A report of a run without AnnotSV lists it under the steps not run. diff --git a/rust/crates/og-render/src/sections/acmg_sf.rs b/rust/crates/og-render/src/sections/acmg_sf.rs index 800535851..7128de9a3 100644 --- a/rust/crates/og-render/src/sections/acmg_sf.rs +++ b/rust/crates/og-render/src/sections/acmg_sf.rs @@ -9,6 +9,7 @@ use pycompat::fmt::ljust; use crate::model::{Card, Cell, HtmlPart, Inline, Layout, Line, Malformed, Summary, Table}; use crate::notes::ACMG_NOTE; +use crate::sections::annotsv::unknown_reason; use crate::sections::clinvar::{D, viewer_of}; use crate::{html, text}; @@ -73,9 +74,21 @@ fn extra(x: &D<'_>) -> Result { Ok(out) } +/// Whether step 22's consensus ran, as the AnnotSV section says: then an +/// SV whose support is not known is one the consensus cannot tell. +pub fn consensus_ran(s: &Summary) -> Result { + let sec = s.section("annotsv"); + let d = D::of(&sec); + if d.is_none() { + return Ok(false); + } + d.flag("consensus") +} + /// The secondary findings as rows, the same in both reports: ClinVar hits, -/// rare HIGH-impact records, then class 4 and 5 SVs. -pub fn rows(sf: &D<'_>) -> Result, Malformed> { +/// rare HIGH-impact records, then class 4 and 5 SVs. `consensus` is +/// [`consensus_ran`]. +pub fn rows(sf: &D<'_>, consensus: bool) -> Result, Malformed> { let mut out = Vec::new(); for x in sf.at("clinvar_hits")?.items()? { let low = if x.flag("low_confidence")? { @@ -111,7 +124,7 @@ pub fn rows(sf: &D<'_>) -> Result, Malformed> { for x in sv.items()? { let support = x.at("support")?; let support = if support.is_none() { - "caller support not known (no step 22 consensus)".to_owned() + format!("caller support not known ({})", unknown_reason(consensus)) } else if support.is_num(1) { format!("single caller ({})", x.s("caller")?) } else { @@ -223,7 +236,7 @@ pub fn text(s: &Summary) -> Result, Malformed> { line += &format!(", {} not reported by the gene's rule", nr.len()?); } w.push(line); - for (g, v, z, ev) in rows(&sf)? { + for (g, v, z, ev) in rows(&sf, consensus_ran(s)?)? { w.push(format!(" {} {v} {z} {ev}", ljust(&g, 8))); } for line in apart_lines(&sf)? { @@ -270,7 +283,7 @@ fn counts_card(d: &D<'_>) -> Result { } /// The SF card, when the tier lists anything or says why it could not. -fn sf_card(sf: &D<'_>) -> Result, Malformed> { +fn sf_card(sf: &D<'_>, consensus: bool) -> Result, Malformed> { let shown = sf.at("clinvar_hits")?.truthy() || sf.at("high_impact")?.truthy() || sf.flag("structural")? @@ -280,7 +293,7 @@ fn sf_card(sf: &D<'_>) -> Result, Malformed> { return Ok(None); } let mut cells = Vec::new(); - for (g, v, z, ev) in rows(sf)? { + for (g, v, z, ev) in rows(sf, consensus)? { let at = viewer_of(&v)?; cells.push(vec![ Cell::Text(g), @@ -318,7 +331,7 @@ pub fn html(s: &Summary) -> Result { let d = D::of(&sec); let mut cards = vec![html::card(&sec, counts_card(&d)?)?]; if let Some(sf) = d.opt("acmg_sf")? - && let Some(card) = sf_card(&sf)? + && let Some(card) = sf_card(&sf, consensus_ran(s)?)? { cards.push(html::card(&sec, card)?); } diff --git a/rust/crates/og-render/src/sections/annotsv.rs b/rust/crates/og-render/src/sections/annotsv.rs index 37caf236a..b3594cdf9 100644 --- a/rust/crates/og-render/src/sections/annotsv.rs +++ b/rust/crates/og-render/src/sections/annotsv.rs @@ -17,11 +17,21 @@ use crate::{html, text}; const TITLE: &str = "Structural Variants, Class 4 and 5 (AnnotSV)"; -/// How many callers saw the SV. -pub fn support_text(x: &D<'_>) -> Result { +/// Why an SV's caller support is not known: step 22's consensus ran +/// (`consensus`, the section's flag) and cannot tell, or it did not run. +pub fn unknown_reason(consensus: bool) -> &'static str { + if consensus { + "step 22's consensus cannot tell" + } else { + "no step 22 consensus" + } +} + +/// How many callers saw the SV; `consensus` is the section's flag. +pub fn support_text(x: &D<'_>, consensus: bool) -> Result { let s = x.at("support")?; if s.is_none() { - return Ok("not known (no step 22 consensus)".to_owned()); + return Ok(format!("not known ({})", unknown_reason(consensus))); } if s.is_num(1) { return Ok(format!("single caller ({})", x.s("caller")?)); @@ -115,7 +125,23 @@ pub fn lines(d: &D<'_>) -> Result, Malformed> { if count.truthy() { let consensus = d.at("consensus")?.truthy(); let single = if consensus { - d.s("single_caller")? + // The consensus ran, but a row it cannot tell has no support: + // count those apart, so "single caller: 0" never reads as + // "every SV had two callers". + let mut unknown = 0; + if let Some(rows) = d.opt("rows")? { + for x in rows.items()? { + if x.at("support")?.is_none() { + unknown += 1; + } + } + } + let single = d.s("single_caller")?; + if unknown > 0 { + format!("{single}, not known: {unknown}") + } else { + single + } } else { "not known".to_owned() }; @@ -158,6 +184,7 @@ pub fn text(s: &Summary) -> Result, Malformed> { } let d = D::of(&s.section("annotsv")); w.extend(lines(&d)?.iter().map(|l| format!(" {l}"))); + let consensus = d.at("consensus")?.truthy(); for x in d.at("rows")?.items()? { w.push(format!( " {} {} class {} {} support: {}", @@ -165,7 +192,7 @@ pub fn text(s: &Summary) -> Result, Malformed> { x.s("sv")?, x.s("acmg_class")?, genes_text(&x)?, - support_text(&x)? + support_text(&x, consensus)? )); for f in flags(&x)? { w.push(format!(" {f}")); @@ -215,6 +242,7 @@ pub fn html(s: &Summary) -> Result { } let rows = d.opt("rows")?; if let Some(rows) = &rows { + let consensus = d.at("consensus")?.truthy(); let mut cells = Vec::new(); for x in rows.items()? { let checks = flags(&x)?.join("; "); @@ -222,7 +250,7 @@ pub fn html(s: &Summary) -> Result { Cell::Text(sv_cell(&x)?), Cell::Text(x.s("acmg_class")?), Cell::Text(genes_text(&x)?), - Cell::Text(support_text(&x)?), + Cell::Text(support_text(&x, consensus)?), Cell::Text(if checks.is_empty() { "none".to_owned() } else { @@ -338,7 +366,7 @@ mod tests { DEL chr1:1000-50005A<B, C&D, G1 and 1 more\ 2 callers (manta, delly)on exon edges: exon 2; benign-set AF 0.001 (gnomAD); \ rule R1: loss <of> function & more{}\ - INS chr3:74no genenot known (no step 22 consensus)\ + INS chr3:74no genenot known (step 22's consensus cannot tell)\ none{}", viewer("chr1:1000-5000"), viewer("chr3:7") diff --git a/tests/parity/gen/report-corpus.sh b/tests/parity/gen/report-corpus.sh index 29ca21a4e..48577cd07 100644 --- a/tests/parity/gen/report-corpus.sh +++ b/tests/parity/gen/report-corpus.sh @@ -70,6 +70,13 @@ while IFS=$'\t' read -r case inputs args; do done (cd "$dir" && "$og" summary collect "${keep[@]}" --out "../../${case}.json" > /dev/null 2>&1) \ || rm -f "${case}.json" + # The time of writing, fixed, so a report-render golden of a collected + # summary (or of a change of one) stays true on every run. + if [ -s "${case}.json" ]; then + # sed, not jq: a summary may hold NaN or Infinity on purpose. + sed -E 's/^( *"generated_utc": )"[^"]*"/\1"2026-01-02 03:04 UTC"/' "${case}.json" > "${case}.json.t" + mv "${case}.json.t" "${case}.json" + fi done < folders/cases.tsv rm -rf folders diff --git a/tests/parity/golden/report-render/a-escape/a-escape.html b/tests/parity/golden/report-render/a-escape/a-escape.html new file mode 100644 index 000000000..d817fa0f8 --- /dev/null +++ b/tests/parity/golden/report-render/a-escape/a-escape.html @@ -0,0 +1,920 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West <Eurasia>95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ <b>W</b> ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest <Eurasia>: Continental groups: 95% (bootstrap range 93% to 97%)West <Eurasia>95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH<b>&"x'
    +
    Contamination (haplocheck)YES, two mtDNA haplogroups in the reads (another person's DNA?) (level 0.4<)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/"><script>alert(1)</script> (opens a website; the address carries the haplogroup)
    +
    <i>YFull</i> & cohttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/"x"&y/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1<R>1M1&M2
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS<393>13high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    chr1:1-2 <GENE>

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_<BA>2000 BCESpainA & B10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    C<A>D & "x"PGS0000180.5100/12075 (EUR)HR <1.5>
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100C<A>D & "x" (PGS000018): 75 (EUR)C<A>D & "x" (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/a-escape/a-escape.txt b/tests/parity/golden/report-render/a-escape/a-escape.txt new file mode 100644 index 000000000..f26fcffa2 --- /dev/null +++ b/tests/parity/golden/report-render/a-escape/a-escape.txt @@ -0,0 +1,439 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H&"x' + Contamination (haplocheck): YES, two mtDNA haplogroups in the reads (another person's DNA?) (level 0.4<) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/"> + YFull & co: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/"x"&y/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS<393> 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + chr1:1-2 + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_ (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CD & "x" 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR <1.5> + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-failed/a-failed.html b/tests/parity/golden/report-render/a-failed/a-failed.html new file mode 100644 index 000000000..c27e3035e --- /dev/null +++ b/tests/parity/golden/report-render/a-failed/a-failed.html @@ -0,0 +1,860 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: why: <b>&'"
    +
    StatusFailed
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: why: <b>&'"
    +
    StatusFailed
    +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: why: <b>&'"
    +
    StatusFailed
    +
    +
    +

    Y Placement on the Current Public Tree

    +
    FAILED: why: <b>&'"
    +
    StatusFailed
    +
    +
    +

    Y-STR Markers (HipSTR)

    +
    FAILED: why: <b>&'"
    +
    StatusFailed
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: why: <b>&'"
    +
    StatusFailed
    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: why: <b>&'"
    +
    StatusFailed
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/a-failed/a-failed.txt b/tests/parity/golden/report-render/a-failed/a-failed.txt new file mode 100644 index 000000000..2f9cfb1e9 --- /dev/null +++ b/tests/parity/golden/report-render/a-failed/a-failed.txt @@ -0,0 +1,405 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + [FAILED: why: &'"] + +## Mitochondrial Haplogroup +--- + [FAILED: why: &'"] + +## Y-Chromosome Haplogroup (Yleaf) +--- + [FAILED: why: &'"] + +## Y Placement on the Current Public Tree +--- + [FAILED: why: &'"] + +## Y-STR Markers (HipSTR) +--- + [FAILED: why: &'"] + +## Archaic Ancestry (IBDmix, step 43) +--- + [FAILED: why: &'"] + +## Ancient Populations (AADR PCA, step 44) +--- + [FAILED: why: &'"] + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + [FAILED: why: &'"] + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-full/a-full.html b/tests/parity/golden/report-render/a-full/a-full.html new file mode 100644 index 000000000..09bcbdeff --- /dev/null +++ b/tests/parity/golden/report-render/a-full/a-full.html @@ -0,0 +1,922 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/a-full/a-full.txt b/tests/parity/golden/report-render/a-full/a-full.txt new file mode 100644 index 000000000..cec992442 --- /dev/null +++ b/tests/parity/golden/report-render/a-full/a-full.txt @@ -0,0 +1,441 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-missing/a-missing.html b/tests/parity/golden/report-render/a-missing/a-missing.html new file mode 100644 index 000000000..45dc102e4 --- /dev/null +++ b/tests/parity/golden/report-render/a-missing/a-missing.html @@ -0,0 +1,813 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/a-missing/a-missing.txt b/tests/parity/golden/report-render/a-missing/a-missing.txt new file mode 100644 index 000000000..05acd591c --- /dev/null +++ b/tests/parity/golden/report-render/a-missing/a-missing.txt @@ -0,0 +1,373 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-no-painting/a-no-painting.html b/tests/parity/golden/report-render/a-no-painting/a-no-painting.html new file mode 100644 index 000000000..1696f1a8b --- /dev/null +++ b/tests/parity/golden/report-render/a-no-painting/a-no-painting.html @@ -0,0 +1,919 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/a-no-painting/a-no-painting.txt b/tests/parity/golden/report-render/a-no-painting/a-no-painting.txt new file mode 100644 index 000000000..2c6e0aff7 --- /dev/null +++ b/tests/parity/golden/report-render/a-no-painting/a-no-painting.txt @@ -0,0 +1,440 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Chromosome painting: none (no chromosome long enough) + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-numbers/a-numbers.txt b/tests/parity/golden/report-render/a-numbers/a-numbers.txt new file mode 100644 index 000000000..27583c4bc --- /dev/null +++ b/tests/parity/golden/report-render/a-numbers/a-numbers.txt @@ -0,0 +1,441 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 100% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R 2.0D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + 1 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (51.2 Mb in 120 segments) + Denisovan: 0.01% (0.0 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5.5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + 7 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.25 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-painting/a-painting.html b/tests/parity/golden/report-render/a-painting/a-painting.html new file mode 100644 index 000000000..68deafaeb --- /dev/null +++ b/tests/parity/golden/report-render/a-painting/a-painting.html @@ -0,0 +1,923 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/a-painting/a-painting.txt b/tests/parity/golden/report-render/a-painting/a-painting.txt new file mode 100644 index 000000000..dae609fbd --- /dev/null +++ b/tests/parity/golden/report-render/a-painting/a-painting.txt @@ -0,0 +1,442 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Wide 0% (0% to 6%) + Left out of the model: Oceania (continental and regional group), Papua (regional group), Odd (name) (x group), Plain. The panel has fewer than 12 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting, share of the painted genome: Africa 30%, West Eurasia 70% + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-partial/a-partial.html b/tests/parity/golden/report-render/a-partial/a-partial.html new file mode 100644 index 000000000..781b98035 --- /dev/null +++ b/tests/parity/golden/report-render/a-partial/a-partial.html @@ -0,0 +1,884 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/a-partial/a-partial.txt b/tests/parity/golden/report-render/a-partial/a-partial.txt new file mode 100644 index 000000000..f89aa2bcf --- /dev/null +++ b/tests/parity/golden/report-render/a-partial/a-partial.txt @@ -0,0 +1,389 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- +## Mitochondrial Haplogroup +--- +## Y-Chromosome Haplogroup (Yleaf) +--- +## Y Placement on the Current Public Tree +--- +## Y-STR Markers (HipSTR) +--- +## Archaic Ancestry (IBDmix, step 43) +--- +## Ancient Populations (AADR PCA, step 44) +--- +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-prs-raw/a-prs-raw.html b/tests/parity/golden/report-render/a-prs-raw/a-prs-raw.html new file mode 100644 index 000000000..b11b722a4 --- /dev/null +++ b/tests/parity/golden/report-render/a-prs-raw/a-prs-raw.html @@ -0,0 +1,921 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/a-prs-raw/a-prs-raw.txt b/tests/parity/golden/report-render/a-prs-raw/a-prs-raw.txt new file mode 100644 index 000000000..0d6b1b11b --- /dev/null +++ b/tests/parity/golden/report-render/a-prs-raw/a-prs-raw.txt @@ -0,0 +1,441 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 + T2D 0.1 (10/20 variants matched) PGS000014 + Raw score only: no ancestry reference panel was installed, so there is no percentile and the sum cannot be compared with anyone (scripts/setup.sh --ancestry-panel adds it). Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-prs-sex/a-prs-sex.html b/tests/parity/golden/report-render/a-prs-sex/a-prs-sex.html new file mode 100644 index 000000000..5d440c4d2 --- /dev/null +++ b/tests/parity/golden/report-render/a-prs-sex/a-prs-sex.html @@ -0,0 +1,923 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/a-prs-sex/a-prs-sex.txt b/tests/parity/golden/report-render/a-prs-sex/a-prs-sex.txt new file mode 100644 index 000000000..d8bda9460 --- /dev/null +++ b/tests/parity/golden/report-render/a-prs-sex/a-prs-sex.txt @@ -0,0 +1,442 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + Prostate 1 (5/6 variants matched) PGS2 not applicable to the declared sex (male-specific score) + Breast 2 (7/9 variants matched) PGS3 percentile 40 (AFR) no published OR or HR for AFR + Height 3 (1/2 variants matched) PGS4 percentile 60 (AFR) no published OR or HR for AFR; evaluated in EUR, AFR + Percentile: where the score falls among the AFR samples of the reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. Rows on chrX were left out, because the sample's sex was not given: PGS3 (3). Give the sex to score them (docs/25-prs.md). No sex was declared, so these sex-specific scores are shown for any sex: PGS3 (female). Give the sex to mark a score of the other sex not applicable (docs/25-prs.md). + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-since/a-since.html b/tests/parity/golden/report-render/a-since/a-since.html new file mode 100644 index 000000000..30277ba22 --- /dev/null +++ b/tests/parity/golden/report-render/a-since/a-since.html @@ -0,0 +1,922 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/a-since/a-since.txt b/tests/parity/golden/report-render/a-since/a-since.txt new file mode 100644 index 000000000..470d96bc1 --- /dev/null +++ b/tests/parity/golden/report-render/a-since/a-since.txt @@ -0,0 +1,444 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + [New since 2026-01-01T00:00:00Z] + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + [New since 2026-01-01T00:00:00Z] + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + [New since 2026-01-01T00:00:00Z] + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-stale/a-stale.html b/tests/parity/golden/report-render/a-stale/a-stale.html new file mode 100644 index 000000000..82b0ab21e --- /dev/null +++ b/tests/parity/golden/report-render/a-stale/a-stale.html @@ -0,0 +1,930 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/a-stale/a-stale.txt b/tests/parity/golden/report-render/a-stale/a-stale.txt new file mode 100644 index 000000000..b7889214f --- /dev/null +++ b/tests/parity/golden/report-render/a-stale/a-stale.txt @@ -0,0 +1,449 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + [STALE: why: &'"] + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + [STALE: why: &'"] + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + [STALE: why: &'"] + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + [STALE: why: &'"] + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + [STALE: why: &'"] + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + [STALE: why: &'"] + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + [STALE: why: &'"] + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + [STALE: why: &'"] + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-unreadable/a-unreadable.html b/tests/parity/golden/report-render/a-unreadable/a-unreadable.html new file mode 100644 index 000000000..48103d733 --- /dev/null +++ b/tests/parity/golden/report-render/a-unreadable/a-unreadable.html @@ -0,0 +1,860 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: why: <b>&'"
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: why: <b>&'"
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: why: <b>&'"
    +
    StatusUnreadable
    +
    +
    +

    Y Placement on the Current Public Tree

    +
    could not be read: why: <b>&'"
    +
    StatusUnreadable
    +
    +
    +

    Y-STR Markers (HipSTR)

    +
    could not be read: why: <b>&'"
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: why: <b>&'"
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: why: <b>&'"
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/a-unreadable/a-unreadable.txt b/tests/parity/golden/report-render/a-unreadable/a-unreadable.txt new file mode 100644 index 000000000..58e5b48cb --- /dev/null +++ b/tests/parity/golden/report-render/a-unreadable/a-unreadable.txt @@ -0,0 +1,397 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + [could not be read: why: &'"] +## Mitochondrial Haplogroup +--- + [could not be read: why: &'"] +## Y-Chromosome Haplogroup (Yleaf) +--- + [could not be read: why: &'"] +## Y Placement on the Current Public Tree +--- + [could not be read: why: &'"] +## Y-STR Markers (HipSTR) +--- + [could not be read: why: &'"] +## Archaic Ancestry (IBDmix, step 43) +--- + [could not be read: why: &'"] +## Ancient Populations (AADR PCA, step 44) +--- + [could not be read: why: &'"] +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + [could not be read: why: &'"] +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-y-calls/a-y-calls.html b/tests/parity/golden/report-render/a-y-calls/a-y-calls.html new file mode 100644 index 000000000..f1b84a346 --- /dev/null +++ b/tests/parity/golden/report-render/a-y-calls/a-y-calls.html @@ -0,0 +1,909 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)not checked (needs step 20's Mutect2 chrM calls)
    +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +

    Ancestral inside the terminal branch: M1,M2

    +

    Ancestral on the path, outvoted by the SNPs below it: None

    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + +
    #Ancient groupDatesCountryPlacePeople
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/a-y-calls/a-y-calls.txt b/tests/parity/golden/report-render/a-y-calls/a-y-calls.txt new file mode 100644 index 000000000..734f14e56 --- /dev/null +++ b/tests/parity/golden/report-render/a-y-calls/a-y-calls.txt @@ -0,0 +1,424 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): not checked (needs step 20's Mutect2 chrM calls) + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + Ancestral inside the terminal branch: M1,M2 + Ancestral on the path, outvoted by the SNPs below it: None + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/all-history/all-history.txt b/tests/parity/golden/report-render/all-history/all-history.txt new file mode 100644 index 000000000..ef251f96e --- /dev/null +++ b/tests/parity/golden/report-render/all-history/all-history.txt @@ -0,0 +1,669 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC + Database re-check: 2021-03-05 00:00:00 UTC: ClinVar newer-release +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Quality control +--- + [New since 2021-01-01 00:00 UTC] + Mean depth: 31.2x + Alignment: 1000 reads in, 1000 primary records in the BAM + Inferred sex: male + Declared sex: male + Sex from the reads (somalier): male (declared and measured sex agree) + Contamination (VerifyBamID2 FREEMIX): 0.0010 (warning above ) + Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error. + +## Genes This Genome Could Not Read Reliably +--- + [New since 2021-01-01 00:00 UTC] + 217 of the 1572 hard-to-read genes of assets/callability_genes.tsv were read: 90% or more of their bases had 10 or more reads of mapping quality 20 or more. + Not read, and no other step calls them (1301): OR4F5 (17%), OR4F29 (33%), OR4F16 (50%), AGRN (67%), ATAD3B (0%), MMP23B (0%), CDK11B (17%), SLC35E2B (33%), CDK11A (50%), TTC34 (67%), RPL22 (83%), MASP2 (0%), NPPA (17%), KIAA2013 (33%), PRAMEF1 (50%), PRAMEF11 (67%), HNRNPCL1 (83%), PRAMEF4 (0%), PRAMEF10 (17%), PRAMEF7 (33%), PRAMEF6 (50%), PRAMEF27 (67%), HNRNPCL3 (83%), HNRNPCL2 (0%), PRAMEF26 (17%), HNRNPCL4 (33%), PRAMEF9 (50%), PRAMEF13 (67%), PRAMEF18 (83%), PRAMEF8 (0%), PRAMEF33 (17%), PRAMEF15 (33%), PRAMEF14 (50%), PRAMEF19 (67%), PRAMEF17 (83%), CELA2B (0%), CLCNKA (17%), CLCNKB (33%), NBPF1 (50%), CROCC (67%), AKR7L (83%), NBPF3 (0%), CELA3B (17%), CELA3A (33%), HMGCL (50%), CNR2 (67%), RSRP1 (83%), PIGV (17%), XKR8 (33%), BMP8A (50%), BMP8B (67%), OXCT2 (83%), CYP4Z1 (0%), CYP4A22 (17%), GBP1 (33%), SETSIP (50%), AGL (67%), EXTL2 (83%), AMY2A (0%), NBPF4 (67%), NBPF6 (83%), LRIG2 (17%), VANGL1 (33%), IGSF3 (50%), SEC22B (83%), NBPF26 (0%), NOTCH2NLR (17%), PPIAL4A (33%), FAM72B (50%), SRGAP2C (67%), H3-7 (83%), PPIAL4E (0%), NBPF15 (17%), PPIAL4F (33%), SRGAP2B (50%), FAM72D (67%), PPIAL4D (83%), GPR89A (0%), RBM8A (17%), NBPF10 (33%), NOTCH2NLA (50%), PPIAL4H (67%), NBPF12 (83%), NBPF11 (0%), PPIAL4G (17%), NBPF14 (33%), NOTCH2NLB (50%), NUDT4B (67%), PDE4DIP (83%), NOTCH2NLC (0%), NBPF19 (17%), PPIAL4C (33%), H2BC18 (67%), H3C13 (83%), H3C14 (0%), H2AC18 (17%), H2AC19 (33%), H3C15 (50%), H4C15 (67%), HRNR (83%), LCE3E (0%), LCE3D (17%), S100A8 (33%), S100A7A (50%), S100A7 (67%), FLAD1 (83%), MTX1 (0%), HCN3 (33%), FCRL5 (50%), HSPA6 (83%), FCGR2B (33%), HSD17B7 (50%), CD247 (67%), XCL2 (83%), PRG4 (0%), PTPRC (50%), PPP1R12B (67%), KISS1 (83%), SRGAP2 (0%), CR1 (17%), CR1L (33%), ZC3H11B (50%), LBR (67%), LEFTY2 (83%), OR2T33 (0%), OR2T7 (17%), OR2T2 (33%), OR2T3 (50%), OR2T5 (67%), OR2G6 (83%), OR2T34 (0%), OR2T11 (17%), OR2T35 (33%), OR2T27 (50%), SNTG2 (67%), TPO (83%), KLF11 (0%), CCDC121 (17%), ABCG8 (33%), PCBP1 (50%), NAT8 (67%), C2orf78 (83%), CD8B (0%), RGPD1 (17%), PLGLB1 (33%), PLGLB2 (50%), RGPD2 (67%), RPIA (83%), TEKT4 (0%), FAHD2A (17%), TRIM43B (33%), TRIM43 (50%), ANKRD36C (67%), GPAT2 (83%), ANKRD36 (0%), ANKRD36B (17%), RGPD3 (33%), RGPD4 (50%), RANBP2 (67%), RGPD5 (83%), MALL (0%), MTLN (17%), LIMS4 (33%), RGPD6 (50%), ANAPC1 (67%), RGPD8 (83%), FOXD4L1 (0%), RABL2A (17%), RAB6C (33%), POTEF (50%), CCDC74B (67%), SMPD4 (83%), TUBA3E (0%), POTEI (17%), CFC1B (33%), CFC1 (50%), POTEJ (67%), PLEKHB2 (83%), RAB6D (0%), MZT2A (17%), TUBA3D (33%), CCDC74A (50%), ANKRD30BL (67%), NOSTRIN (83%), IFT70B (0%), CASP10 (17%), ALPP (33%), ALPG (50%), UGT1A6 (67%), UGT1A5 (83%), UGT1A3 (0%), MLPH (17%), OR6B2 (33%), AQP12B (50%), AQP12A (67%), ANO7 (83%), CHL1 (0%), EMC3 (17%), FANCD2 (33%), DAZL (50%), ZNF35 (67%), LZTFL1 (83%), MST1 (0%), MST1R (17%), HYAL1 (33%), FRG2C (50%), ZNF717 (67%), OR5H6 (0%), ROPN1 (17%), ROPN1B (33%), RPN1 (50%), ALG1L2 (67%), BFSP2 (83%), PRR23B (0%), SOX2 (17%), EIF2B5 (33%), KNG1 (50%), TM4SF19 (67%), ZNF595 (83%), PDE6B (0%), GAK (17%), FGFRL1 (33%), RNF212 (50%), UVSSA (67%), DOK7 (83%), HMX1 (0%), FAM90A26 (17%), USP17L10 (33%), USP17L11 (50%), USP17L12 (67%), USP17L13 (83%), USP17L17 (0%), USP17L18 (17%), USP17L19 (33%), USP17L20 (50%), USP17L21 (67%), USP17L22 (83%), USP17L24 (0%), USP17L25 (17%), USP17L26 (33%), USP17L5 (50%), USP17L27 (67%), USP17L28 (83%), USP17L30 (0%), DEFB131A (17%), DRD5 (33%), UGT2B10 (83%), UGT2B28 (0%), UGT2A1 (17%), UGT2A2 (33%), HTN3 (50%), HTN1 (67%), AFP (83%), PIGY (0%), PYURF (17%), CISD2 (33%), SLC9B1 (50%), KLHL2 (0%), GK3 (17%), HPF1 (33%), PDLIM3 (50%), FAT1 (67%), FRG1 (83%), FRG2 (0%), DUX4 (17%), SDHA (33%), PDCD6 (50%), ZDHHC11B (67%), ZDHHC11 (83%), TERT (0%), SLC6A3 (17%), TAF11L2 (33%), TAF11L3 (50%), TAF11L4 (67%), TAF11L5 (83%), TAF11L7 (0%), TAF11L8 (17%), TAF11L9 (33%), TAF11L10 (50%), TAF11L11 (67%), TAF11L12 (83%), TAF11L14 (0%), EMB (17%), MARVELD2 (33%), SERF1B (67%), NAIP (17%), SKIC3 (50%), LIX1 (67%), SAR1B (83%), DND1 (0%), PCDHA10 (17%), PCDHB7 (33%), PCDHB8 (50%), PCDHB11 (67%), PCDHB12 (83%), PPP1R2B (0%), NPM1 (17%), THOC3 (33%), SIMC1 (50%), FAM153A (67%), FAM153CP (83%), FLT4 (0%), OR4F3 (17%), DUSP22 (33%), TUBB2A (50%), H2AC13 (67%), H2AC14 (83%), OR2J1 (0%), OR2J2 (17%), HLA-G (33%), HLA-A (50%), MICA (67%), MICB (83%), ZBTB12 (17%), PBX2 (83%), HLA-DRB1 (0%), GSTA2 (17%), GSTA1 (33%), GSTA5 (50%), PRIM2 (67%), FKBP1C (83%), SLC17A5 (0%), SEC63 (17%), OR2A4 (33%), CTAGE9 (50%), PCMT1 (67%), RAET1G (83%), ULBP1 (0%), RAET1L (17%), ULBP3 (33%), SLC22A1 (50%), SMOC2 (83%), RBAK-RBAKDN (0%), RBAK (17%), SLC29A4 (33%), FSCN1 (50%), OCM (67%), CCZ1 (83%), RSPH10B2 (17%), CCZ1B (33%), NOD1 (50%), FKBP9 (67%), DPY19L1 (83%), SEPTIN7 (0%), SPDYE1 (17%), PPIA (33%), CDC14C (50%), PSPH (67%), CCT6A (83%), ZNF716 (0%), ZNF727 (17%), ZNF735 (33%), ZNF736 (50%), GUSB (67%), RABGEF1 (83%), TYW1 (0%), SPDYE21 (17%), TYW1B (33%), POM121 (50%), TRIM74 (67%), SPDYE8 (83%), SPDYE9 (0%), SPDYE10 (17%), NSUN5 (33%), TRIM50 (50%), CLIP2 (67%), GTF2IRD2 (0%), SPDYE12 (17%), CASTOR2 (33%), GTF2IRD2B (50%), SPDYE13 (67%), SPDYE14 (83%), TRIM73 (0%), POM121C (17%), SPDYE5 (33%), DTX2 (50%), UPK3B (67%), SPDYE16 (83%), SPDYE17 (0%), SPDYE18 (17%), STEAP1 (33%), ASNS (50%), OCM2 (67%), CYP3A7-CYP3A51P (83%), CYP3A4 (0%), STAG3 (17%), PVRIG (33%), SPDYE3 (50%), SAP25 (67%), ZAN (83%), MUC12 (0%), SPDYE6 (17%), POLR2J (33%), RASA4B (50%), POLR2J3 (67%), UPK3BL2 (83%), RASA4 (0%), UPK3BL1 (17%), POLR2J3-UPK3BL2 (33%), SPDYE2B (50%), POLR2J2 (67%), LAMB1 (83%), METTL2B (0%), KLF14 (17%), AKR1B10 (33%), AKR1B15 (50%), BRAF (67%), TRBV9 (83%), PRSS2 (0%), CTAGE15 (17%), TCAF2 (33%), TCAF2C (50%), CTAGE6 (67%), OR2F2 (83%), CTAGE4 (0%), OR2A42 (17%), OR2A7 (33%), CTAGE8 (50%), OR2A1 (67%), ARHGEF5 (83%), ACTR3C (0%), KMT2C (17%), ACTR3B (33%), OR4F21 (50%), FBXO25 (67%), ARHGEF10 (83%), FAM90A15 (17%), FAM90A3 (33%), FAM90A13 (50%), FAM90A5 (67%), FAM90A20 (83%), USP17L1 (0%), USP17L4 (17%), ZNF705G (33%), DEFB108C (50%), DEFB4B (67%), DEFB103B (83%), DEFB104B (0%), DEFB106B (17%), DEFB105B (33%), DEFB107B (50%), PRR23D1 (67%), FAM90A7 (83%), FAM90A23 (0%), FAM90A14 (17%), FAM90A18 (33%), FAM90A16 (50%), FAM90A8 (67%), FAM90A17 (83%), FAM90A9 (0%), FAM90A10 (17%), PRR23D2 (33%), DEFB107A (50%), DEFB105A (67%), DEFB106A (83%), SPAG11A (0%), DEFB103A (17%), DEFB4A (33%), ZNF705B (50%), USP17L8 (67%), USP17L3 (83%), FAM90A11 (0%), FAM90A24 (17%), FAM90A12 (33%), SLC35G5 (50%), DEFB130B (67%), ZNF705D (83%), USP17L2 (0%), DEFB109D (17%), FAM86B1 (33%), DEFB130A (50%), FAM86B2 (67%), RBPMS (83%), IMPA1 (0%), SLC10A5 (17%), CDH17 (33%), CYP11B1 (50%), CYP11B2 (67%), GPIHBP1 (83%), WASHC1 (0%), FOXD4 (17%), ZNG1A (33%), KCNV2 (50%), RLN2 (67%), RLN1 (83%), IFNA21 (0%), IFNA4 (17%), IFNA7 (33%), IFNA10 (50%), IFNA16 (67%), IFNA17 (83%), IFNA13 (0%), IFNA1 (17%), ANKRD18B (33%), PRSS3 (50%), GALT (67%), SPATA31F1 (83%), CNTNAP3 (0%), SPATA31A1 (17%), FOXD4L6 (33%), ZNG1F (50%), CNTNAP3B (67%), SPATA31A6 (83%), SPATA31A7 (0%), CNTNAP3C (17%), FOXD4L5 (33%), ZNG1E (50%), FOXD4L4 (67%), ZNF658 (83%), ANKRD20A1 (0%), ZNG1C (17%), FOXD4L3 (33%), PGM5 (50%), FXN (67%), TJP2 (83%), SPATA31D4 (0%), SPATA31D3 (17%), SPATA31D1 (33%), KIF27 (50%), SPATA31C1 (67%), SPATA31C2 (83%), SLC71A2 (0%), NUTM2G (17%), CTSV (33%), OR13C5 (50%), OR13C2 (67%), OR13C9 (83%), POLE3 (0%), ORM1 (17%), ORM2 (33%), SLC27A4 (50%), PKN3 (67%), ABO (0%), LCN1 (17%), OBP2A (33%), SOHLH1 (50%), INPP5E (67%), AJM1 (83%), GRIN1 (0%), TUBB8 (17%), AKR1C1 (33%), AKR1C2 (50%), DCLRE1C (67%), MRC1 (83%), ANKRD30A (0%), ZNF33A (17%), ZNF37A (33%), PLD5P1 (50%), ZNF33B (67%), BMS1 (83%), AGAP4 (0%), TIMM23 (17%), ANTXRL (33%), ANXA8L1 (50%), NPY4R (67%), GPRIN2 (83%), PTPN20 (0%), ANXA8 (17%), FAM25G (33%), AGAP9 (50%), SYT15B (67%), NPY4R2 (83%), PARG (0%), TIMM23B (17%), TIMM23B-AGAP6 (33%), AGAP6 (50%), WASHC2A (67%), ASAH2B (83%), EIF5AL1 (0%), NUTM2B (17%), NUTM2E (33%), TMEM254 (50%), PLAC9 (67%), ADIRF (83%), NUTM2A (0%), NUTM2D (17%), PAPSS2 (33%), PTEN (50%), LIPN (67%), BTRC (83%), SFR1 (0%), DHX32 (17%), FANK1 (33%), ECHS1 (50%), SPRN (67%), FRG2B (83%), SCGB1C1 (0%), IFITM3 (17%), DRD4 (33%), DEAF1 (50%), KRTAP5-2 (83%), KRTAP5-4 (0%), MRPL23 (17%), H19 (33%), SSU72L5 (50%), SSU72L2 (67%), SSU72L4 (83%), SSU72L1 (0%), OR51A4 (17%), OR51A2 (33%), HBG1 (50%), OR10A5 (67%), MRGPRX4 (83%), MDK (0%), SPI1 (17%), OR4C3 (33%), OR4C5 (50%), OR4A47 (67%), TRIM51G (83%), TRIM64C (0%), FOLH1 (17%), OR4C13 (33%), OR4C12 (50%), OR4C45 (67%), OR4C46 (83%), OR4A5 (0%), TRIM48 (17%), OR4A15 (33%), TRIM51 (50%), OR5F1 (67%), OR8H2 (83%), OR5M8 (0%), OR9G1 (17%), OR1S2 (33%), OR1S1 (50%), GLYATL1B (67%), PGA3 (83%), B3GAT3 (0%), ESRRA (17%), SLC22A12 (33%), RBM4B (50%), TPCN2 (67%), FGF3 (83%), KRTAP5-8 (0%), KRTAP5-10 (17%), KRTAP5-11 (33%), XNDC1N-ZNF705EP-ALG1L9P (50%), DEFB108B (67%), XNDC1N (83%), INTS4 (0%), NOX4 (17%), TRIM77 (33%), TRIM49 (50%), TRIM64B (67%), TRIM49D1 (83%), TRIM64 (0%), TRIM49C (17%), UBTFL1 (33%), CARD16 (50%), HSPA8 (67%), OR8B2 (83%), TMEM45B (0%), CD4 (17%), PEX5 (33%), APOBEC1 (50%), GDF3 (67%), NANOG (83%), FAM90A1 (0%), PRH1 (33%), PRR4 (50%), PRH2 (67%), TAS2R14 (83%), TAS2R31 (0%), TAS2R46 (17%), TAS2R43 (33%), TAS2R30 (50%), PRB4 (67%), PRB1 (83%), DDX11 (0%), H3-5 (17%), ALG10 (33%), ALG10B (50%), TUBA1B (67%), COX14 (83%), NACA (50%), DPY19L2 (67%), HNF1A (83%), HPD (0%), HCAR2 (17%), HCAR3 (33%), P2RX2 (50%), PGAM5 (67%), GOLGA3 (83%), C1QTNF9B (0%), C1QTNF9 (17%), PARP4 (33%), PABPC3 (50%), MRPS31 (67%), HNRNPA1L2 (83%), PRR20C (0%), PRR20B (17%), PRR20D (33%), PRR20E (50%), F7 (67%), PROZ (83%), POTEM (0%), POTEG (17%), OR11H2 (33%), OR4N2 (50%), OR4Q3 (67%), OR4M1 (83%), RNASE3 (0%), RNASE2 (17%), OR10G2 (33%), DHRS4 (50%), DHRS4L2 (67%), ARF6 (83%), ACOT2 (0%), NDUFB1 (17%), JAG2 (33%), BTBD6 (50%), IGHV3-21 (67%), GOLGA6L6 (83%), POTEB3 (0%), LINC02203 (17%), OR4M2B (33%), OR4N4C (50%), POTEB (67%), OR4M2-OT1 (83%), OR4N4 (0%), GOLGA6L22 (17%), GOLGA6L1 (33%), GOLGA6L26 (50%), GOLGA8S (67%), GOLGA6L2 (83%), HERC2 (0%), GOLGA6L24 (17%), GOLGA8F (33%), GOLGA8G (50%), GOLGA6L25 (67%), GOLGA8M (83%), GOLGA8J (0%), GOLGA8T (17%), GOLGA8R (50%), GOLGA8Q (67%), GOLGA8H (83%), GOLGA8O (0%), GOLGA8N (17%), GOLGA8A (33%), GOLGA8B (50%), NANOGP8 (67%), NDUFAF1 (83%), CKMT1B (0%), CATSPER2 (33%), CKMT1A (50%), TERB2 (67%), LDHAL6B (0%), GOLGA6B (17%), GOLGA6A (33%), ISLR2 (50%), GOLGA6C (67%), GOLGA6D (83%), ADAMTS7 (0%), EFL1 (17%), SAXO2 (33%), GOLGA6L10 (50%), GOLGA6L9 (67%), WHAMM (83%), OR4F4 (0%), MPG (17%), HBM (33%), AXIN1 (83%), SSTR5 (0%), TPSD1 (50%), GNPTG (67%), UNKL (83%), PKD1 (0%), PDPK1 (17%), EEF2KMT (33%), NPIPA3 (50%), NPIPA2 (67%), NOMO1 (83%), PDXDC1 (0%), RRN3 (17%), NPIPA5 (33%), MPV17L (50%), NOMO3 (67%), NPIPA6 (83%), NPIPA8 (0%), NPIPA9 (17%), NOMO2 (33%), SMG1 (50%), IQCK (67%), ACSM5 (83%), ACSM2B (0%), NPIPB3 (17%), NPIPB4 (50%), NPIPB5 (67%), NPIPB6 (83%), NPIPB7 (0%), SULT1A2 (17%), NPIPB8 (50%), EIF3C (67%), NPIPB9 (83%), NPIPB11 (0%), BOLA2-SMG1P6 (17%), BOLA2 (33%), SLX1B (50%), SULT1A4 (67%), NPIPB12 (83%), SLX1A (0%), SULT1A3 (17%), NPIPB13 (33%), PHKG2 (50%), VKORC1 (67%), KRABD5 (83%), TP53TG3 (0%), TP53TG3C (17%), TP53TG3E (33%), TP53TG3B (50%), TP53TG3F (67%), CCNYL1B (83%), CES1 (0%), MT1M (17%), MATCAP1 (33%), HSD11B2 (50%), CLEC18A (67%), PDPR (83%), EXOSC6 (0%), HPR (50%), NPIPB15 (67%), CLEC18B (83%), CA5A (0%), ZNF469 (17%), CDH15 (33%), ANKRD11 (50%), MC1R (67%), PRDM7 (83%), ABR (0%), SERPINF2 (17%), SRR (33%), OR1D5 (50%), P2RX5 (67%), ALOX15 (83%), ENO3 (0%), USP6 (17%), SLC35G6 (33%), ALOXE3 (50%), HES7 (67%), CDRT15 (83%), FBXW10B (0%), TRIM16 (17%), ZNF286A-TBC1D26 (33%), ZNF286A (50%), TBC1D26 (67%), UBB (83%), ATPAF2 (0%), EVPLL (17%), LGALS9C (33%), TBC1D28 (50%), FOXO3B (67%), FBXW10 (83%), GRAP (0%), GRAPL (17%), LGALS9B (33%), CDRT15L2 (50%), MEIS3P2 (67%), MAP2K3 (83%), KCNJ18 (0%), LGALS9 (17%), FOXN1 (33%), SUZ12 (50%), LRRC37B (67%), SLC35G3 (83%), CCL4 (0%), TBC1D3B (17%), CCL4L2 (50%), TBC1D3I (67%), TBC1D3G (83%), TBC1D3F (0%), TBC1D3K (17%), TBC1D3L (33%), TBC1D3D (50%), TBC1D3C (67%), TBC1D3E (83%), MRPL45 (0%), KRTAP1-1 (17%), KRTAP4-7 (33%), KRTAP4-8 (50%), KRTAP4-16 (67%), KRTAP4-9 (83%), KRTAP4-12 (0%), KRTAP9-7 (17%), KRT14 (33%), KRT16 (50%), KRT17 (67%), HSD17B1 (83%), G6PC3 (0%), ARHGAP27 (17%), PLEKHM1 (33%), ARL17B (50%), LRRC37A (67%), ARL17A (83%), NSF (0%), NPEPPS (17%), HOXB8 (33%), GIP (50%), DHX40 (67%), RPS6KB1 (83%), METTL2A (0%), TLK2 (17%), CSH2 (33%), GH2 (50%), CSH1 (67%), CSHL1 (83%), LRRC37A3 (0%), C17orf58 (17%), AMZ2 (33%), TMC6 (50%), CANT1 (67%), RNF213 (83%), ARL16 (0%), TUBB8B (17%), TYMS (33%), SLC35G4 (50%), POTEC (67%), ANKRD30B (83%), SLC25A52 (0%), KATNAL2 (17%), SERPINB4 (33%), SERPINB3 (50%), GALR1 (67%), CTDP1 (83%), BSG (0%), HCN2 (17%), KISS1R (33%), STK11 (50%), TCF3 (67%), ABHD17A (83%), GIPC3 (0%), TBXA2R (17%), CREB3L3 (33%), RFX2 (50%), C3 (67%), MBD3L2B (83%), MBD3L4 (0%), MBD3L2 (17%), STXBP2 (33%), TYK2 (50%), ZNF799 (67%), ZNF443 (83%), CYP4F3 (0%), CYP4F12 (17%), OR10H2 (33%), CALR3 (50%), MYO9B (67%), INSL3 (83%), ZNF738 (0%), ZNF100 (17%), ZNF208 (33%), ZNF676 (50%), ZNF729 (67%), ZNF492 (83%), ZNF728 (0%), RHPN2 (17%), GPI (33%), ZNF302 (50%), ZNF181 (67%), FFAR3 (83%), COX6B1 (0%), LGALS7 (17%), LGALS7B (33%), IFNL3 (50%), IFNL4 (67%), IFNL2 (83%), CYP2A7 (17%), CYP2G1P (33%), CYP2A13 (67%), CYP2F1 (83%), PSG8 (0%), PSG1 (17%), PSG6 (33%), PSG7 (50%), PSG11 (67%), PSG2 (83%), PSG4 (0%), PSG9 (17%), ETHE1 (50%), ZNF285 (67%), APOC1 (83%), APOC4 (0%), BLOC1S3 (17%), DMPK (33%), FUT1 (50%), BAX (67%), LHB (83%), CGB3 (0%), CGB2 (17%), CGB1 (33%), CGB5 (50%), CGB8 (67%), CGB7 (83%), PNKP (0%), SIGLEC16 (17%), KLK4 (33%), ETFB (50%), ZNF808 (67%), ZNF600 (83%), ZNF468 (0%), VN1R4 (17%), FAM90A27P (33%), ZNF765 (50%), ZNF761 (67%), ZNF813 (83%), PRKCG (0%), MBOAT7 (17%), LILRA6 (33%), LILRB2 (50%), LAIR1 (67%), LAIR2 (83%), LILRB1 (0%), KIR3DL3 (17%), KIR2DL3 (33%), KIR2DL1 (50%), KIR2DL4 (67%), KIR3DL1 (83%), KIR3DL2 (0%), NLRP7 (17%), NLRP2 (33%), GP6 (50%), TNNT1 (67%), TNNI3 (83%), RFPL4A (0%), RFPL4AL1 (17%), ZNF419 (33%), ZNF773 (50%), ZNF587B (67%), ZNF814 (83%), ZNF417 (0%), SLC27A5 (17%), SIRPB1 (33%), CST4 (50%), CST1 (67%), CST2 (83%), PLAGL2 (0%), SEMG1 (17%), PLTP (33%), CHRNA4 (50%), EEF1A2 (67%), PTK6 (83%), MYT1 (0%), PCMTD2 (17%), TPTE (33%), POTED (50%), KRTAP21-1 (67%), SMIM11 (83%), SMIM34 (0%), KCNE1 (17%), CBR3 (33%), NDUFV3 (50%), CBS (67%), U2AF1 (83%), SIK1 (0%), HSF2BP (17%), H2BC12L (33%), TRAPPC10 (50%), PWP2 (67%), GATD3 (83%), DNMT3L (0%), KRTAP10-1 (17%), KRTAP10-2 (33%), KRTAP10-4 (50%), KRTAP10-5 (67%), KRTAP10-6 (83%), KRTAP10-8 (0%), KRTAP10-9 (17%), KRTAP10-10 (33%), KRTAP12-2 (50%), KRTAP12-1 (67%), COL18A1 (83%), OR11H1 (0%), POTEH (17%), CCT8L2 (33%), USP18 (50%), GGTLC3 (67%), TMEM191B (83%), FAM246B (0%), DGCR6 (17%), PRODH (33%), FAM246C (50%), CCDC188 (67%), RTN4R (83%), TUBA3FP (0%), LRRC74B (17%), FAM246A (33%), RIMBP3B (50%), HIC2 (67%), TMEM191C (83%), GGTLC2 (0%), IGLL1 (17%), DRICH1 (33%), GSTT2B (50%), DDTL (67%), GSTT2 (83%), RFPL1 (0%), C22orf42 (17%), RFPL3 (33%), APOBEC3D (83%), APOBEC3H (0%), ATF4 (17%), NDUFA6 (33%), CYP2D7 (67%), RRP7A (83%), CYB5R3 (0%), A4GALT (17%), TTLL1 (33%), MLC1 (50%), TUBGCP6 (67%), ACR (83%), XG (0%), GYG2 (17%), ARSD (33%), MXRA5 (50%), PRKX (67%), VCX3A (83%), VCX2 (0%), VCX3B (17%), FAM9A (33%), FAM9C (50%), SUPT20HL2 (67%), SUPT20HL1 (83%), MAGEB6 (0%), DCAF8L1 (17%), FAM47B (33%), H2AL1Q (50%), FAM47C (67%), H2AL3 (83%), SPACA5B (0%), SSX5 (17%), SSX1 (33%), SSX3 (50%), SSX4 (67%), SSX4B (83%), GAGE12J (0%), GAGE13 (17%), GAGE2E (33%), GAGE12B (50%), GAGE12C (67%), GAGE12D (83%), GAGE12F (0%), GAGE12G (17%), GAGE12H (33%), GAGE2A (50%), GAGE1 (67%), CENPVL3 (83%), CENPVL1 (0%), MAGED4B (17%), MAGED4 (33%), XAGE1A (50%), XAGE1B (67%), SSX7 (83%), SSX2B (0%), SPANXN5 (17%), XAGE5 (33%), XAGE3 (50%), FAM156B (67%), FAM156A (83%), SPIN2B (0%), SPIN2A (17%), ZXDA (33%), CXorf49 (50%), CXorf49B (67%), DMRTC1B (83%), FAM236D (0%), DMRTC1 (17%), FAM236C (33%), FAM236A (50%), PABPC1L2B (67%), PABPC1L2A (83%), TGIF2LX (0%), PCDH11X (17%), TCEAL6 (33%), TCP11X1 (50%), NXF2 (67%), NXF2B (83%), RAB40AL (0%), TMSB15B (17%), H2BW1 (33%), H2BW2 (50%), TMSB15C (67%), PSMD10 (83%), CT47C1 (0%), RHOXF2B (17%), RHOXF2 (33%), CT47B1 (50%), CT47A12 (67%), CT47A11 (83%), CT47A9 (0%), CT47A8 (17%), CT47A7 (33%), CT47A6 (50%), CT47A5 (67%), CT47A4 (83%), CT47A2 (0%), CT47A1 (17%), RTL8B (33%), RTL8C (50%), RTL8A (67%), SMIM10L2B (83%), CT55 (0%), ETDA (17%), SMIM10L2A (33%), CT45A1 (50%), CT45A3 (67%), CT45A5 (83%), CT45A2 (0%), CT45A7 (17%), CT45A8 (33%), CT45A9 (50%), CT45A10 (67%), SAGE1 (83%), SPANXC (0%), SPANXA1 (17%), SPANXA2 (33%), SPANXD (50%), MAGEC1 (67%), SPANXN3 (83%), UBE2NL (0%), SPANXN1 (17%), CXorf51B (33%), CXorf51A (50%), EOLA1 (67%), HSFX3 (83%), HSFX2 (0%), HSFX1 (17%), MAGEA9 (33%), EOLA2 (50%), HSFX4 (67%), MAGEA3 (83%), MAGEA2B (0%), CSAG1 (17%), MAGEA12 (33%), MAGEA2 (50%), CSAG3 (67%), MAGEA6 (83%), PWWP4 (0%), SLC6A8 (17%), BCAP31 (33%), OPN1LW (50%), OPN1MW (67%), OPN1MW2 (83%), TEX28 (0%), CTAG1A (17%), CTAG1B (33%), CTAG2 (50%), H2AB1 (67%), F8A1 (83%), F8A2 (0%), F8A3 (17%), H2AB3 (33%), IL9R (50%), WASH6P (67%), TGIF2LY (not on this reference), PCDH11Y (not on this reference), TSPY2 (not on this reference), TSPY4 (not on this reference), TSPY8 (not on this reference), TSPY3 (not on this reference), TSPY1 (not on this reference), TSPY9 (not on this reference), TSPY10 (not on this reference), VCY (not on this reference), VCY1B (not on this reference), CDY2B (not on this reference), CDY2A (not on this reference), HSFY1 (not on this reference), HSFY2 (not on this reference), RBMY1B (not on this reference), RBMY1A1 (not on this reference), RBMY1D (not on this reference), RBMY1E (not on this reference), RBMY1F (not on this reference), RBMY1J (not on this reference), BPY2 (not on this reference), DAZ1 (not on this reference), DAZ2 (not on this reference), CDY1B (not on this reference), BPY2B (not on this reference), DAZ3 (not on this reference), DAZ4 (not on this reference), BPY2C (not on this reference), CDY1 (not on this reference), C4B_2 (not on this reference), GSTT1 (not on this reference), GSTTP2 (not on this reference), GTF2H2C_2 (not on this reference), HLA-DRB3 (not on this reference), HLA-DRB4 (not on this reference), KIR2DL2 (not on this reference), KIR2DL5A (not on this reference), KIR2DL5B (not on this reference), KIR2DS1 (not on this reference), KIR2DS2 (not on this reference), KIR2DS3 (not on this reference), KIR2DS5 (not on this reference), KIR3DS1 (not on this reference), LILRA3 (not on this reference), OR8U8 (not on this reference), OR8U9 (not on this reference), OR9G9 (not on this reference), TAS2R45 (not on this reference) + Not read here, called by a step of their own (54): RHCE (0%) by parascopy, AMY1A (17%) by parascopy, AMY1B (33%) by parascopy, AMY1C (50%) by parascopy, GSTM1 (0%) by pypgx, NOTCH2 (67%) by parascopy, FCGR1A (50%) by parascopy, GBA1 (17%) by parascopy, FCGR2A (67%) by parascopy, FCGR2C (0%) by parascopy, FCGR3B (17%) by parascopy, CFHR3 (17%) by parascopy, CFHR1 (33%) by parascopy, PROS1 (83%) by parascopy, UGT2B17 (50%) by pypgx, UGT2B15 (67%) by pypgx, GYPE (67%) by parascopy, GYPB (83%) by parascopy, GTF2H2C (50%) by parascopy, SMN2 (83%) by parascopy, SMN1 (0%) by parascopy, GTF2H2 (33%) by parascopy, HSPA1B (0%) by parascopy, C4A (33%) by parascopy, C4B (50%) by parascopy, CYP21A2 (67%) by cn_loci:CYP21A2, LPA (67%) by cn_loci:LPA_KIV2, PMS2 (0%) by parascopy, GTF2I (83%) by parascopy, DEFA1B (0%) by parascopy, CEL (83%) by parascopy, MUC5B (67%) by parascopy, KLRC2 (17%) by parascopy, KRT6B (0%) by parascopy, KRT6C (17%) by parascopy, KRT6A (33%) by parascopy, CHRFAM7A (33%) by parascopy, STRC (17%) by parascopy, SORD (83%) by parascopy, HBA2 (50%) by cn_loci:HBA, HBA1 (67%) by cn_loci:HBA, TPSB2 (17%) by parascopy, TPSAB1 (33%) by parascopy, OTOA (33%) by parascopy, SULT1A1 (33%) by pypgx, HYDIN (17%) by parascopy, HP (33%) by cn_loci:HP, CCL3L3 (33%) by cn_loci:CCL3L1, CYP2A6 (0%) by pypgx, CYP2B6 (50%) by pypgx, CD177 (33%) by parascopy, APOBEC3A (50%) by parascopy, APOBEC3B (67%) by parascopy, CYP2D6 (50%) by pypgx + A gene listed as not read could not be read reliably: too few of its reads were placed on it with confidence, so a 'no finding' in it says nothing. A gene with a caller of its own is left to that caller's section. + +## Variant Calling (DeepVariant) +--- + [New since 2021-01-01 00:00 UTC] + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + [New since 2021-01-01 00:00 UTC] + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: 2021-03-01 + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + [New since 2021-01-01 00:00 UTC] + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 0 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + [New since 2021-01-01 00:00 UTC] + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of 2021-03-01 + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + [New since 2021-01-01 00:00 UTC] + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + [New since 2021-01-01 00:00 UTC] + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + [New since 2021-01-01 00:00 UTC] + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + [New since 2021-01-01 00:00 UTC] + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + [New since 2021-01-01 00:00 UTC] + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band) + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + [New since 2021-01-01 00:00 UTC] + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + [New since 2021-01-01 00:00 UTC] + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + [New since 2021-01-01 00:00 UTC] + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + [New since 2021-01-01 00:00 UTC] + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + [New since 2021-01-01 00:00 UTC] + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + [New since 2021-01-01 00:00 UTC] + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + [New since 2021-01-01 00:00 UTC] + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic loss of chromosome Y or X +--- + [New since 2021-01-01 00:00 UTC] + chrY or chrX: not detected above 10% (None) + From depth: estimated share of the cells that lost one X 2.0% (95% range -1.0% to 5.0%); None to autosome depth ratio 0.980, 1.0 expected + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + [New since 2021-01-01 00:00 UTC] + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + [New since 2021-01-01 00:00 UTC] + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); Parascopy's SMN1 count (step 35); not read: step 35's HBA1/HBA2 count: not called + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + [New since 2021-01-01 00:00 UTC] + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + [New since 2021-01-01 00:00 UTC] + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + [New since 2021-01-01 00:00 UTC] + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + [New since 2021-01-01 00:00 UTC] + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + [New since 2021-01-01 00:00 UTC] + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + [New since 2021-01-01 00:00 UTC] + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + [New since 2021-01-01 00:00 UTC] + PharmCAT (step 36's call) not run + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## HLA Typing (T1K) +--- + [New since 2021-01-01 00:00 UTC] + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + [New since 2021-01-01 00:00 UTC] + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32): *1/*2; Cyrius (step 21): *2/*1 + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + [New since 2021-01-01 00:00 UTC] + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + [New since 2021-01-01 00:00 UTC] + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + [New since 2021-01-01 00:00 UTC] + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + [New since 2021-01-01 00:00 UTC] + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + [New since 2021-01-01 00:00 UTC] + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + [New since 2021-01-01 00:00 UTC] + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + [New since 2021-01-01 00:00 UTC] + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + [New since 2021-01-01 00:00 UTC] + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + [New since 2021-01-01 00:00 UTC] + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + [New since 2021-01-01 00:00 UTC] + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Short not available (not available/not available variants matched) PGS1 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + [New since 2021-01-01 00:00 UTC] + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + [New since 2021-01-01 00:00 UTC] + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + [New since 2021-01-01 00:00 UTC] + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + [New since 2021-01-01 00:00 UTC] + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + All major steps completed. + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +Run manifest: run_manifest.tsv (pipeline commit unknown, 1 images) +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/all/all.txt b/tests/parity/golden/report-render/all/all.txt new file mode 100644 index 000000000..e2600a51d --- /dev/null +++ b/tests/parity/golden/report-render/all/all.txt @@ -0,0 +1,624 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Quality control +--- + Mean depth: 31.2x + Alignment: 1000 reads in, 1000 primary records in the BAM + Inferred sex: male + Declared sex: male + Sex from the reads (somalier): male (declared and measured sex agree) + Contamination (VerifyBamID2 FREEMIX): 0.0010 (warning above ) + Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error. + +## Genes This Genome Could Not Read Reliably +--- + 217 of the 1572 hard-to-read genes of assets/callability_genes.tsv were read: 90% or more of their bases had 10 or more reads of mapping quality 20 or more. + Not read, and no other step calls them (1301): OR4F5 (17%), OR4F29 (33%), OR4F16 (50%), AGRN (67%), ATAD3B (0%), MMP23B (0%), CDK11B (17%), SLC35E2B (33%), CDK11A (50%), TTC34 (67%), RPL22 (83%), MASP2 (0%), NPPA (17%), KIAA2013 (33%), PRAMEF1 (50%), PRAMEF11 (67%), HNRNPCL1 (83%), PRAMEF4 (0%), PRAMEF10 (17%), PRAMEF7 (33%), PRAMEF6 (50%), PRAMEF27 (67%), HNRNPCL3 (83%), HNRNPCL2 (0%), PRAMEF26 (17%), HNRNPCL4 (33%), PRAMEF9 (50%), PRAMEF13 (67%), PRAMEF18 (83%), PRAMEF8 (0%), PRAMEF33 (17%), PRAMEF15 (33%), PRAMEF14 (50%), PRAMEF19 (67%), PRAMEF17 (83%), CELA2B (0%), CLCNKA (17%), CLCNKB (33%), NBPF1 (50%), CROCC (67%), AKR7L (83%), NBPF3 (0%), CELA3B (17%), CELA3A (33%), HMGCL (50%), CNR2 (67%), RSRP1 (83%), PIGV (17%), XKR8 (33%), BMP8A (50%), BMP8B (67%), OXCT2 (83%), CYP4Z1 (0%), CYP4A22 (17%), GBP1 (33%), SETSIP (50%), AGL (67%), EXTL2 (83%), AMY2A (0%), NBPF4 (67%), NBPF6 (83%), LRIG2 (17%), VANGL1 (33%), IGSF3 (50%), SEC22B (83%), NBPF26 (0%), NOTCH2NLR (17%), PPIAL4A (33%), FAM72B (50%), SRGAP2C (67%), H3-7 (83%), PPIAL4E (0%), NBPF15 (17%), PPIAL4F (33%), SRGAP2B (50%), FAM72D (67%), PPIAL4D (83%), GPR89A (0%), RBM8A (17%), NBPF10 (33%), NOTCH2NLA (50%), PPIAL4H (67%), NBPF12 (83%), NBPF11 (0%), PPIAL4G (17%), NBPF14 (33%), NOTCH2NLB (50%), NUDT4B (67%), PDE4DIP (83%), NOTCH2NLC (0%), NBPF19 (17%), PPIAL4C (33%), H2BC18 (67%), H3C13 (83%), H3C14 (0%), H2AC18 (17%), H2AC19 (33%), H3C15 (50%), H4C15 (67%), HRNR (83%), LCE3E (0%), LCE3D (17%), S100A8 (33%), S100A7A (50%), S100A7 (67%), FLAD1 (83%), MTX1 (0%), HCN3 (33%), FCRL5 (50%), HSPA6 (83%), FCGR2B (33%), HSD17B7 (50%), CD247 (67%), XCL2 (83%), PRG4 (0%), PTPRC (50%), PPP1R12B (67%), KISS1 (83%), SRGAP2 (0%), CR1 (17%), CR1L (33%), ZC3H11B (50%), LBR (67%), LEFTY2 (83%), OR2T33 (0%), OR2T7 (17%), OR2T2 (33%), OR2T3 (50%), OR2T5 (67%), OR2G6 (83%), OR2T34 (0%), OR2T11 (17%), OR2T35 (33%), OR2T27 (50%), SNTG2 (67%), TPO (83%), KLF11 (0%), CCDC121 (17%), ABCG8 (33%), PCBP1 (50%), NAT8 (67%), C2orf78 (83%), CD8B (0%), RGPD1 (17%), PLGLB1 (33%), PLGLB2 (50%), RGPD2 (67%), RPIA (83%), TEKT4 (0%), FAHD2A (17%), TRIM43B (33%), TRIM43 (50%), ANKRD36C (67%), GPAT2 (83%), ANKRD36 (0%), ANKRD36B (17%), RGPD3 (33%), RGPD4 (50%), RANBP2 (67%), RGPD5 (83%), MALL (0%), MTLN (17%), LIMS4 (33%), RGPD6 (50%), ANAPC1 (67%), RGPD8 (83%), FOXD4L1 (0%), RABL2A (17%), RAB6C (33%), POTEF (50%), CCDC74B (67%), SMPD4 (83%), TUBA3E (0%), POTEI (17%), CFC1B (33%), CFC1 (50%), POTEJ (67%), PLEKHB2 (83%), RAB6D (0%), MZT2A (17%), TUBA3D (33%), CCDC74A (50%), ANKRD30BL (67%), NOSTRIN (83%), IFT70B (0%), CASP10 (17%), ALPP (33%), ALPG (50%), UGT1A6 (67%), UGT1A5 (83%), UGT1A3 (0%), MLPH (17%), OR6B2 (33%), AQP12B (50%), AQP12A (67%), ANO7 (83%), CHL1 (0%), EMC3 (17%), FANCD2 (33%), DAZL (50%), ZNF35 (67%), LZTFL1 (83%), MST1 (0%), MST1R (17%), HYAL1 (33%), FRG2C (50%), ZNF717 (67%), OR5H6 (0%), ROPN1 (17%), ROPN1B (33%), RPN1 (50%), ALG1L2 (67%), BFSP2 (83%), PRR23B (0%), SOX2 (17%), EIF2B5 (33%), KNG1 (50%), TM4SF19 (67%), ZNF595 (83%), PDE6B (0%), GAK (17%), FGFRL1 (33%), RNF212 (50%), UVSSA (67%), DOK7 (83%), HMX1 (0%), FAM90A26 (17%), USP17L10 (33%), USP17L11 (50%), USP17L12 (67%), USP17L13 (83%), USP17L17 (0%), USP17L18 (17%), USP17L19 (33%), USP17L20 (50%), USP17L21 (67%), USP17L22 (83%), USP17L24 (0%), USP17L25 (17%), USP17L26 (33%), USP17L5 (50%), USP17L27 (67%), USP17L28 (83%), USP17L30 (0%), DEFB131A (17%), DRD5 (33%), UGT2B10 (83%), UGT2B28 (0%), UGT2A1 (17%), UGT2A2 (33%), HTN3 (50%), HTN1 (67%), AFP (83%), PIGY (0%), PYURF (17%), CISD2 (33%), SLC9B1 (50%), KLHL2 (0%), GK3 (17%), HPF1 (33%), PDLIM3 (50%), FAT1 (67%), FRG1 (83%), FRG2 (0%), DUX4 (17%), SDHA (33%), PDCD6 (50%), ZDHHC11B (67%), ZDHHC11 (83%), TERT (0%), SLC6A3 (17%), TAF11L2 (33%), TAF11L3 (50%), TAF11L4 (67%), TAF11L5 (83%), TAF11L7 (0%), TAF11L8 (17%), TAF11L9 (33%), TAF11L10 (50%), TAF11L11 (67%), TAF11L12 (83%), TAF11L14 (0%), EMB (17%), MARVELD2 (33%), SERF1B (67%), NAIP (17%), SKIC3 (50%), LIX1 (67%), SAR1B (83%), DND1 (0%), PCDHA10 (17%), PCDHB7 (33%), PCDHB8 (50%), PCDHB11 (67%), PCDHB12 (83%), PPP1R2B (0%), NPM1 (17%), THOC3 (33%), SIMC1 (50%), FAM153A (67%), FAM153CP (83%), FLT4 (0%), OR4F3 (17%), DUSP22 (33%), TUBB2A (50%), H2AC13 (67%), H2AC14 (83%), OR2J1 (0%), OR2J2 (17%), HLA-G (33%), HLA-A (50%), MICA (67%), MICB (83%), ZBTB12 (17%), PBX2 (83%), HLA-DRB1 (0%), GSTA2 (17%), GSTA1 (33%), GSTA5 (50%), PRIM2 (67%), FKBP1C (83%), SLC17A5 (0%), SEC63 (17%), OR2A4 (33%), CTAGE9 (50%), PCMT1 (67%), RAET1G (83%), ULBP1 (0%), RAET1L (17%), ULBP3 (33%), SLC22A1 (50%), SMOC2 (83%), RBAK-RBAKDN (0%), RBAK (17%), SLC29A4 (33%), FSCN1 (50%), OCM (67%), CCZ1 (83%), RSPH10B2 (17%), CCZ1B (33%), NOD1 (50%), FKBP9 (67%), DPY19L1 (83%), SEPTIN7 (0%), SPDYE1 (17%), PPIA (33%), CDC14C (50%), PSPH (67%), CCT6A (83%), ZNF716 (0%), ZNF727 (17%), ZNF735 (33%), ZNF736 (50%), GUSB (67%), RABGEF1 (83%), TYW1 (0%), SPDYE21 (17%), TYW1B (33%), POM121 (50%), TRIM74 (67%), SPDYE8 (83%), SPDYE9 (0%), SPDYE10 (17%), NSUN5 (33%), TRIM50 (50%), CLIP2 (67%), GTF2IRD2 (0%), SPDYE12 (17%), CASTOR2 (33%), GTF2IRD2B (50%), SPDYE13 (67%), SPDYE14 (83%), TRIM73 (0%), POM121C (17%), SPDYE5 (33%), DTX2 (50%), UPK3B (67%), SPDYE16 (83%), SPDYE17 (0%), SPDYE18 (17%), STEAP1 (33%), ASNS (50%), OCM2 (67%), CYP3A7-CYP3A51P (83%), CYP3A4 (0%), STAG3 (17%), PVRIG (33%), SPDYE3 (50%), SAP25 (67%), ZAN (83%), MUC12 (0%), SPDYE6 (17%), POLR2J (33%), RASA4B (50%), POLR2J3 (67%), UPK3BL2 (83%), RASA4 (0%), UPK3BL1 (17%), POLR2J3-UPK3BL2 (33%), SPDYE2B (50%), POLR2J2 (67%), LAMB1 (83%), METTL2B (0%), KLF14 (17%), AKR1B10 (33%), AKR1B15 (50%), BRAF (67%), TRBV9 (83%), PRSS2 (0%), CTAGE15 (17%), TCAF2 (33%), TCAF2C (50%), CTAGE6 (67%), OR2F2 (83%), CTAGE4 (0%), OR2A42 (17%), OR2A7 (33%), CTAGE8 (50%), OR2A1 (67%), ARHGEF5 (83%), ACTR3C (0%), KMT2C (17%), ACTR3B (33%), OR4F21 (50%), FBXO25 (67%), ARHGEF10 (83%), FAM90A15 (17%), FAM90A3 (33%), FAM90A13 (50%), FAM90A5 (67%), FAM90A20 (83%), USP17L1 (0%), USP17L4 (17%), ZNF705G (33%), DEFB108C (50%), DEFB4B (67%), DEFB103B (83%), DEFB104B (0%), DEFB106B (17%), DEFB105B (33%), DEFB107B (50%), PRR23D1 (67%), FAM90A7 (83%), FAM90A23 (0%), FAM90A14 (17%), FAM90A18 (33%), FAM90A16 (50%), FAM90A8 (67%), FAM90A17 (83%), FAM90A9 (0%), FAM90A10 (17%), PRR23D2 (33%), DEFB107A (50%), DEFB105A (67%), DEFB106A (83%), SPAG11A (0%), DEFB103A (17%), DEFB4A (33%), ZNF705B (50%), USP17L8 (67%), USP17L3 (83%), FAM90A11 (0%), FAM90A24 (17%), FAM90A12 (33%), SLC35G5 (50%), DEFB130B (67%), ZNF705D (83%), USP17L2 (0%), DEFB109D (17%), FAM86B1 (33%), DEFB130A (50%), FAM86B2 (67%), RBPMS (83%), IMPA1 (0%), SLC10A5 (17%), CDH17 (33%), CYP11B1 (50%), CYP11B2 (67%), GPIHBP1 (83%), WASHC1 (0%), FOXD4 (17%), ZNG1A (33%), KCNV2 (50%), RLN2 (67%), RLN1 (83%), IFNA21 (0%), IFNA4 (17%), IFNA7 (33%), IFNA10 (50%), IFNA16 (67%), IFNA17 (83%), IFNA13 (0%), IFNA1 (17%), ANKRD18B (33%), PRSS3 (50%), GALT (67%), SPATA31F1 (83%), CNTNAP3 (0%), SPATA31A1 (17%), FOXD4L6 (33%), ZNG1F (50%), CNTNAP3B (67%), SPATA31A6 (83%), SPATA31A7 (0%), CNTNAP3C (17%), FOXD4L5 (33%), ZNG1E (50%), FOXD4L4 (67%), ZNF658 (83%), ANKRD20A1 (0%), ZNG1C (17%), FOXD4L3 (33%), PGM5 (50%), FXN (67%), TJP2 (83%), SPATA31D4 (0%), SPATA31D3 (17%), SPATA31D1 (33%), KIF27 (50%), SPATA31C1 (67%), SPATA31C2 (83%), SLC71A2 (0%), NUTM2G (17%), CTSV (33%), OR13C5 (50%), OR13C2 (67%), OR13C9 (83%), POLE3 (0%), ORM1 (17%), ORM2 (33%), SLC27A4 (50%), PKN3 (67%), ABO (0%), LCN1 (17%), OBP2A (33%), SOHLH1 (50%), INPP5E (67%), AJM1 (83%), GRIN1 (0%), TUBB8 (17%), AKR1C1 (33%), AKR1C2 (50%), DCLRE1C (67%), MRC1 (83%), ANKRD30A (0%), ZNF33A (17%), ZNF37A (33%), PLD5P1 (50%), ZNF33B (67%), BMS1 (83%), AGAP4 (0%), TIMM23 (17%), ANTXRL (33%), ANXA8L1 (50%), NPY4R (67%), GPRIN2 (83%), PTPN20 (0%), ANXA8 (17%), FAM25G (33%), AGAP9 (50%), SYT15B (67%), NPY4R2 (83%), PARG (0%), TIMM23B (17%), TIMM23B-AGAP6 (33%), AGAP6 (50%), WASHC2A (67%), ASAH2B (83%), EIF5AL1 (0%), NUTM2B (17%), NUTM2E (33%), TMEM254 (50%), PLAC9 (67%), ADIRF (83%), NUTM2A (0%), NUTM2D (17%), PAPSS2 (33%), PTEN (50%), LIPN (67%), BTRC (83%), SFR1 (0%), DHX32 (17%), FANK1 (33%), ECHS1 (50%), SPRN (67%), FRG2B (83%), SCGB1C1 (0%), IFITM3 (17%), DRD4 (33%), DEAF1 (50%), KRTAP5-2 (83%), KRTAP5-4 (0%), MRPL23 (17%), H19 (33%), SSU72L5 (50%), SSU72L2 (67%), SSU72L4 (83%), SSU72L1 (0%), OR51A4 (17%), OR51A2 (33%), HBG1 (50%), OR10A5 (67%), MRGPRX4 (83%), MDK (0%), SPI1 (17%), OR4C3 (33%), OR4C5 (50%), OR4A47 (67%), TRIM51G (83%), TRIM64C (0%), FOLH1 (17%), OR4C13 (33%), OR4C12 (50%), OR4C45 (67%), OR4C46 (83%), OR4A5 (0%), TRIM48 (17%), OR4A15 (33%), TRIM51 (50%), OR5F1 (67%), OR8H2 (83%), OR5M8 (0%), OR9G1 (17%), OR1S2 (33%), OR1S1 (50%), GLYATL1B (67%), PGA3 (83%), B3GAT3 (0%), ESRRA (17%), SLC22A12 (33%), RBM4B (50%), TPCN2 (67%), FGF3 (83%), KRTAP5-8 (0%), KRTAP5-10 (17%), KRTAP5-11 (33%), XNDC1N-ZNF705EP-ALG1L9P (50%), DEFB108B (67%), XNDC1N (83%), INTS4 (0%), NOX4 (17%), TRIM77 (33%), TRIM49 (50%), TRIM64B (67%), TRIM49D1 (83%), TRIM64 (0%), TRIM49C (17%), UBTFL1 (33%), CARD16 (50%), HSPA8 (67%), OR8B2 (83%), TMEM45B (0%), CD4 (17%), PEX5 (33%), APOBEC1 (50%), GDF3 (67%), NANOG (83%), FAM90A1 (0%), PRH1 (33%), PRR4 (50%), PRH2 (67%), TAS2R14 (83%), TAS2R31 (0%), TAS2R46 (17%), TAS2R43 (33%), TAS2R30 (50%), PRB4 (67%), PRB1 (83%), DDX11 (0%), H3-5 (17%), ALG10 (33%), ALG10B (50%), TUBA1B (67%), COX14 (83%), NACA (50%), DPY19L2 (67%), HNF1A (83%), HPD (0%), HCAR2 (17%), HCAR3 (33%), P2RX2 (50%), PGAM5 (67%), GOLGA3 (83%), C1QTNF9B (0%), C1QTNF9 (17%), PARP4 (33%), PABPC3 (50%), MRPS31 (67%), HNRNPA1L2 (83%), PRR20C (0%), PRR20B (17%), PRR20D (33%), PRR20E (50%), F7 (67%), PROZ (83%), POTEM (0%), POTEG (17%), OR11H2 (33%), OR4N2 (50%), OR4Q3 (67%), OR4M1 (83%), RNASE3 (0%), RNASE2 (17%), OR10G2 (33%), DHRS4 (50%), DHRS4L2 (67%), ARF6 (83%), ACOT2 (0%), NDUFB1 (17%), JAG2 (33%), BTBD6 (50%), IGHV3-21 (67%), GOLGA6L6 (83%), POTEB3 (0%), LINC02203 (17%), OR4M2B (33%), OR4N4C (50%), POTEB (67%), OR4M2-OT1 (83%), OR4N4 (0%), GOLGA6L22 (17%), GOLGA6L1 (33%), GOLGA6L26 (50%), GOLGA8S (67%), GOLGA6L2 (83%), HERC2 (0%), GOLGA6L24 (17%), GOLGA8F (33%), GOLGA8G (50%), GOLGA6L25 (67%), GOLGA8M (83%), GOLGA8J (0%), GOLGA8T (17%), GOLGA8R (50%), GOLGA8Q (67%), GOLGA8H (83%), GOLGA8O (0%), GOLGA8N (17%), GOLGA8A (33%), GOLGA8B (50%), NANOGP8 (67%), NDUFAF1 (83%), CKMT1B (0%), CATSPER2 (33%), CKMT1A (50%), TERB2 (67%), LDHAL6B (0%), GOLGA6B (17%), GOLGA6A (33%), ISLR2 (50%), GOLGA6C (67%), GOLGA6D (83%), ADAMTS7 (0%), EFL1 (17%), SAXO2 (33%), GOLGA6L10 (50%), GOLGA6L9 (67%), WHAMM (83%), OR4F4 (0%), MPG (17%), HBM (33%), AXIN1 (83%), SSTR5 (0%), TPSD1 (50%), GNPTG (67%), UNKL (83%), PKD1 (0%), PDPK1 (17%), EEF2KMT (33%), NPIPA3 (50%), NPIPA2 (67%), NOMO1 (83%), PDXDC1 (0%), RRN3 (17%), NPIPA5 (33%), MPV17L (50%), NOMO3 (67%), NPIPA6 (83%), NPIPA8 (0%), NPIPA9 (17%), NOMO2 (33%), SMG1 (50%), IQCK (67%), ACSM5 (83%), ACSM2B (0%), NPIPB3 (17%), NPIPB4 (50%), NPIPB5 (67%), NPIPB6 (83%), NPIPB7 (0%), SULT1A2 (17%), NPIPB8 (50%), EIF3C (67%), NPIPB9 (83%), NPIPB11 (0%), BOLA2-SMG1P6 (17%), BOLA2 (33%), SLX1B (50%), SULT1A4 (67%), NPIPB12 (83%), SLX1A (0%), SULT1A3 (17%), NPIPB13 (33%), PHKG2 (50%), VKORC1 (67%), KRABD5 (83%), TP53TG3 (0%), TP53TG3C (17%), TP53TG3E (33%), TP53TG3B (50%), TP53TG3F (67%), CCNYL1B (83%), CES1 (0%), MT1M (17%), MATCAP1 (33%), HSD11B2 (50%), CLEC18A (67%), PDPR (83%), EXOSC6 (0%), HPR (50%), NPIPB15 (67%), CLEC18B (83%), CA5A (0%), ZNF469 (17%), CDH15 (33%), ANKRD11 (50%), MC1R (67%), PRDM7 (83%), ABR (0%), SERPINF2 (17%), SRR (33%), OR1D5 (50%), P2RX5 (67%), ALOX15 (83%), ENO3 (0%), USP6 (17%), SLC35G6 (33%), ALOXE3 (50%), HES7 (67%), CDRT15 (83%), FBXW10B (0%), TRIM16 (17%), ZNF286A-TBC1D26 (33%), ZNF286A (50%), TBC1D26 (67%), UBB (83%), ATPAF2 (0%), EVPLL (17%), LGALS9C (33%), TBC1D28 (50%), FOXO3B (67%), FBXW10 (83%), GRAP (0%), GRAPL (17%), LGALS9B (33%), CDRT15L2 (50%), MEIS3P2 (67%), MAP2K3 (83%), KCNJ18 (0%), LGALS9 (17%), FOXN1 (33%), SUZ12 (50%), LRRC37B (67%), SLC35G3 (83%), CCL4 (0%), TBC1D3B (17%), CCL4L2 (50%), TBC1D3I (67%), TBC1D3G (83%), TBC1D3F (0%), TBC1D3K (17%), TBC1D3L (33%), TBC1D3D (50%), TBC1D3C (67%), TBC1D3E (83%), MRPL45 (0%), KRTAP1-1 (17%), KRTAP4-7 (33%), KRTAP4-8 (50%), KRTAP4-16 (67%), KRTAP4-9 (83%), KRTAP4-12 (0%), KRTAP9-7 (17%), KRT14 (33%), KRT16 (50%), KRT17 (67%), HSD17B1 (83%), G6PC3 (0%), ARHGAP27 (17%), PLEKHM1 (33%), ARL17B (50%), LRRC37A (67%), ARL17A (83%), NSF (0%), NPEPPS (17%), HOXB8 (33%), GIP (50%), DHX40 (67%), RPS6KB1 (83%), METTL2A (0%), TLK2 (17%), CSH2 (33%), GH2 (50%), CSH1 (67%), CSHL1 (83%), LRRC37A3 (0%), C17orf58 (17%), AMZ2 (33%), TMC6 (50%), CANT1 (67%), RNF213 (83%), ARL16 (0%), TUBB8B (17%), TYMS (33%), SLC35G4 (50%), POTEC (67%), ANKRD30B (83%), SLC25A52 (0%), KATNAL2 (17%), SERPINB4 (33%), SERPINB3 (50%), GALR1 (67%), CTDP1 (83%), BSG (0%), HCN2 (17%), KISS1R (33%), STK11 (50%), TCF3 (67%), ABHD17A (83%), GIPC3 (0%), TBXA2R (17%), CREB3L3 (33%), RFX2 (50%), C3 (67%), MBD3L2B (83%), MBD3L4 (0%), MBD3L2 (17%), STXBP2 (33%), TYK2 (50%), ZNF799 (67%), ZNF443 (83%), CYP4F3 (0%), CYP4F12 (17%), OR10H2 (33%), CALR3 (50%), MYO9B (67%), INSL3 (83%), ZNF738 (0%), ZNF100 (17%), ZNF208 (33%), ZNF676 (50%), ZNF729 (67%), ZNF492 (83%), ZNF728 (0%), RHPN2 (17%), GPI (33%), ZNF302 (50%), ZNF181 (67%), FFAR3 (83%), COX6B1 (0%), LGALS7 (17%), LGALS7B (33%), IFNL3 (50%), IFNL4 (67%), IFNL2 (83%), CYP2A7 (17%), CYP2G1P (33%), CYP2A13 (67%), CYP2F1 (83%), PSG8 (0%), PSG1 (17%), PSG6 (33%), PSG7 (50%), PSG11 (67%), PSG2 (83%), PSG4 (0%), PSG9 (17%), ETHE1 (50%), ZNF285 (67%), APOC1 (83%), APOC4 (0%), BLOC1S3 (17%), DMPK (33%), FUT1 (50%), BAX (67%), LHB (83%), CGB3 (0%), CGB2 (17%), CGB1 (33%), CGB5 (50%), CGB8 (67%), CGB7 (83%), PNKP (0%), SIGLEC16 (17%), KLK4 (33%), ETFB (50%), ZNF808 (67%), ZNF600 (83%), ZNF468 (0%), VN1R4 (17%), FAM90A27P (33%), ZNF765 (50%), ZNF761 (67%), ZNF813 (83%), PRKCG (0%), MBOAT7 (17%), LILRA6 (33%), LILRB2 (50%), LAIR1 (67%), LAIR2 (83%), LILRB1 (0%), KIR3DL3 (17%), KIR2DL3 (33%), KIR2DL1 (50%), KIR2DL4 (67%), KIR3DL1 (83%), KIR3DL2 (0%), NLRP7 (17%), NLRP2 (33%), GP6 (50%), TNNT1 (67%), TNNI3 (83%), RFPL4A (0%), RFPL4AL1 (17%), ZNF419 (33%), ZNF773 (50%), ZNF587B (67%), ZNF814 (83%), ZNF417 (0%), SLC27A5 (17%), SIRPB1 (33%), CST4 (50%), CST1 (67%), CST2 (83%), PLAGL2 (0%), SEMG1 (17%), PLTP (33%), CHRNA4 (50%), EEF1A2 (67%), PTK6 (83%), MYT1 (0%), PCMTD2 (17%), TPTE (33%), POTED (50%), KRTAP21-1 (67%), SMIM11 (83%), SMIM34 (0%), KCNE1 (17%), CBR3 (33%), NDUFV3 (50%), CBS (67%), U2AF1 (83%), SIK1 (0%), HSF2BP (17%), H2BC12L (33%), TRAPPC10 (50%), PWP2 (67%), GATD3 (83%), DNMT3L (0%), KRTAP10-1 (17%), KRTAP10-2 (33%), KRTAP10-4 (50%), KRTAP10-5 (67%), KRTAP10-6 (83%), KRTAP10-8 (0%), KRTAP10-9 (17%), KRTAP10-10 (33%), KRTAP12-2 (50%), KRTAP12-1 (67%), COL18A1 (83%), OR11H1 (0%), POTEH (17%), CCT8L2 (33%), USP18 (50%), GGTLC3 (67%), TMEM191B (83%), FAM246B (0%), DGCR6 (17%), PRODH (33%), FAM246C (50%), CCDC188 (67%), RTN4R (83%), TUBA3FP (0%), LRRC74B (17%), FAM246A (33%), RIMBP3B (50%), HIC2 (67%), TMEM191C (83%), GGTLC2 (0%), IGLL1 (17%), DRICH1 (33%), GSTT2B (50%), DDTL (67%), GSTT2 (83%), RFPL1 (0%), C22orf42 (17%), RFPL3 (33%), APOBEC3D (83%), APOBEC3H (0%), ATF4 (17%), NDUFA6 (33%), CYP2D7 (67%), RRP7A (83%), CYB5R3 (0%), A4GALT (17%), TTLL1 (33%), MLC1 (50%), TUBGCP6 (67%), ACR (83%), XG (0%), GYG2 (17%), ARSD (33%), MXRA5 (50%), PRKX (67%), VCX3A (83%), VCX2 (0%), VCX3B (17%), FAM9A (33%), FAM9C (50%), SUPT20HL2 (67%), SUPT20HL1 (83%), MAGEB6 (0%), DCAF8L1 (17%), FAM47B (33%), H2AL1Q (50%), FAM47C (67%), H2AL3 (83%), SPACA5B (0%), SSX5 (17%), SSX1 (33%), SSX3 (50%), SSX4 (67%), SSX4B (83%), GAGE12J (0%), GAGE13 (17%), GAGE2E (33%), GAGE12B (50%), GAGE12C (67%), GAGE12D (83%), GAGE12F (0%), GAGE12G (17%), GAGE12H (33%), GAGE2A (50%), GAGE1 (67%), CENPVL3 (83%), CENPVL1 (0%), MAGED4B (17%), MAGED4 (33%), XAGE1A (50%), XAGE1B (67%), SSX7 (83%), SSX2B (0%), SPANXN5 (17%), XAGE5 (33%), XAGE3 (50%), FAM156B (67%), FAM156A (83%), SPIN2B (0%), SPIN2A (17%), ZXDA (33%), CXorf49 (50%), CXorf49B (67%), DMRTC1B (83%), FAM236D (0%), DMRTC1 (17%), FAM236C (33%), FAM236A (50%), PABPC1L2B (67%), PABPC1L2A (83%), TGIF2LX (0%), PCDH11X (17%), TCEAL6 (33%), TCP11X1 (50%), NXF2 (67%), NXF2B (83%), RAB40AL (0%), TMSB15B (17%), H2BW1 (33%), H2BW2 (50%), TMSB15C (67%), PSMD10 (83%), CT47C1 (0%), RHOXF2B (17%), RHOXF2 (33%), CT47B1 (50%), CT47A12 (67%), CT47A11 (83%), CT47A9 (0%), CT47A8 (17%), CT47A7 (33%), CT47A6 (50%), CT47A5 (67%), CT47A4 (83%), CT47A2 (0%), CT47A1 (17%), RTL8B (33%), RTL8C (50%), RTL8A (67%), SMIM10L2B (83%), CT55 (0%), ETDA (17%), SMIM10L2A (33%), CT45A1 (50%), CT45A3 (67%), CT45A5 (83%), CT45A2 (0%), CT45A7 (17%), CT45A8 (33%), CT45A9 (50%), CT45A10 (67%), SAGE1 (83%), SPANXC (0%), SPANXA1 (17%), SPANXA2 (33%), SPANXD (50%), MAGEC1 (67%), SPANXN3 (83%), UBE2NL (0%), SPANXN1 (17%), CXorf51B (33%), CXorf51A (50%), EOLA1 (67%), HSFX3 (83%), HSFX2 (0%), HSFX1 (17%), MAGEA9 (33%), EOLA2 (50%), HSFX4 (67%), MAGEA3 (83%), MAGEA2B (0%), CSAG1 (17%), MAGEA12 (33%), MAGEA2 (50%), CSAG3 (67%), MAGEA6 (83%), PWWP4 (0%), SLC6A8 (17%), BCAP31 (33%), OPN1LW (50%), OPN1MW (67%), OPN1MW2 (83%), TEX28 (0%), CTAG1A (17%), CTAG1B (33%), CTAG2 (50%), H2AB1 (67%), F8A1 (83%), F8A2 (0%), F8A3 (17%), H2AB3 (33%), IL9R (50%), WASH6P (67%), TGIF2LY (not on this reference), PCDH11Y (not on this reference), TSPY2 (not on this reference), TSPY4 (not on this reference), TSPY8 (not on this reference), TSPY3 (not on this reference), TSPY1 (not on this reference), TSPY9 (not on this reference), TSPY10 (not on this reference), VCY (not on this reference), VCY1B (not on this reference), CDY2B (not on this reference), CDY2A (not on this reference), HSFY1 (not on this reference), HSFY2 (not on this reference), RBMY1B (not on this reference), RBMY1A1 (not on this reference), RBMY1D (not on this reference), RBMY1E (not on this reference), RBMY1F (not on this reference), RBMY1J (not on this reference), BPY2 (not on this reference), DAZ1 (not on this reference), DAZ2 (not on this reference), CDY1B (not on this reference), BPY2B (not on this reference), DAZ3 (not on this reference), DAZ4 (not on this reference), BPY2C (not on this reference), CDY1 (not on this reference), C4B_2 (not on this reference), GSTT1 (not on this reference), GSTTP2 (not on this reference), GTF2H2C_2 (not on this reference), HLA-DRB3 (not on this reference), HLA-DRB4 (not on this reference), KIR2DL2 (not on this reference), KIR2DL5A (not on this reference), KIR2DL5B (not on this reference), KIR2DS1 (not on this reference), KIR2DS2 (not on this reference), KIR2DS3 (not on this reference), KIR2DS5 (not on this reference), KIR3DS1 (not on this reference), LILRA3 (not on this reference), OR8U8 (not on this reference), OR8U9 (not on this reference), OR9G9 (not on this reference), TAS2R45 (not on this reference) + Not read here, called by a step of their own (54): RHCE (0%) by parascopy, AMY1A (17%) by parascopy, AMY1B (33%) by parascopy, AMY1C (50%) by parascopy, GSTM1 (0%) by pypgx, NOTCH2 (67%) by parascopy, FCGR1A (50%) by parascopy, GBA1 (17%) by parascopy, FCGR2A (67%) by parascopy, FCGR2C (0%) by parascopy, FCGR3B (17%) by parascopy, CFHR3 (17%) by parascopy, CFHR1 (33%) by parascopy, PROS1 (83%) by parascopy, UGT2B17 (50%) by pypgx, UGT2B15 (67%) by pypgx, GYPE (67%) by parascopy, GYPB (83%) by parascopy, GTF2H2C (50%) by parascopy, SMN2 (83%) by parascopy, SMN1 (0%) by parascopy, GTF2H2 (33%) by parascopy, HSPA1B (0%) by parascopy, C4A (33%) by parascopy, C4B (50%) by parascopy, CYP21A2 (67%) by cn_loci:CYP21A2, LPA (67%) by cn_loci:LPA_KIV2, PMS2 (0%) by parascopy, GTF2I (83%) by parascopy, DEFA1B (0%) by parascopy, CEL (83%) by parascopy, MUC5B (67%) by parascopy, KLRC2 (17%) by parascopy, KRT6B (0%) by parascopy, KRT6C (17%) by parascopy, KRT6A (33%) by parascopy, CHRFAM7A (33%) by parascopy, STRC (17%) by parascopy, SORD (83%) by parascopy, HBA2 (50%) by cn_loci:HBA, HBA1 (67%) by cn_loci:HBA, TPSB2 (17%) by parascopy, TPSAB1 (33%) by parascopy, OTOA (33%) by parascopy, SULT1A1 (33%) by pypgx, HYDIN (17%) by parascopy, HP (33%) by cn_loci:HP, CCL3L3 (33%) by cn_loci:CCL3L1, CYP2A6 (0%) by pypgx, CYP2B6 (50%) by pypgx, CD177 (33%) by parascopy, APOBEC3A (50%) by parascopy, APOBEC3B (67%) by parascopy, CYP2D6 (50%) by pypgx + A gene listed as not read could not be read reliably: too few of its reads were placed on it with confidence, so a 'no finding' in it says nothing. A gene with a caller of its own is left to that caller's section. + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: 2026-10-01 + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 0 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: 20250901; step 6 used the ClinVar file of 2026-10-01 + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band) + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic loss of chromosome Y or X +--- + chrY or chrX: not detected above 10% (None) + From depth: estimated share of the cells that lost one X 2.0% (95% range -1.0% to 5.0%); None to autosome depth ratio 0.980, 1.0 expected + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); Parascopy's SMN1 count (step 35); not read: step 35's HBA1/HBA2 count: not called + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) not run + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: IPD-IMGT/HLA 3.60 extra + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32): *1/*2; Cyrius (step 21): *2/*1 + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Short not available (not available/not available variants matched) PGS1 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + All major steps completed. + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +Run manifest: run_manifest.tsv (pipeline commit unknown, 0 images) +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/c-float--inf/c-float--inf.txt b/tests/parity/golden/report-render/c-float--inf/c-float--inf.txt new file mode 100644 index 000000000..16d839961 --- /dev/null +++ b/tests/parity/golden/report-render/c-float--inf/c-float--inf.txt @@ -0,0 +1,411 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 1 (1 deletions, 0 duplications) + Significant (e-val < 0.01): 1 + Significant after filters: 1; no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 1 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 0 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 0 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 1 + m.3243A>G (MT-TL1) AF -inf filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level -inf% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + No CHIP gene has the depth to find a clone: no result either way. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality -inf, filter PASS), not resolved: no comparison: one of them has no call + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality -inf, filter PASS), not resolved + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality *, filter PASS), not resolved + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality -inf, filter PASS) + Reading: SMN1 not resolved (quality under 20 or filter not PASS): no carrier reading + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality -inf, filter PASS); chr7:5980001-5990000 3 (quality -inf, filter LowQual): no region with a whole copy number, filter PASS and quality 20 or more + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01 (quality -inf) / A*01:01 (quality -inf); low confidence (T1K quality 0 or below), not passed to PharmCAT + Coeliac DQ: not determined (HLA-DQA1 not typed; HLA-DQB1 not typed) + DQB1*02 copies: not determined + A*31:01 not determined (HLA-A low confidence): carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + B*15:02 not determined (HLA-B not typed): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B not typed): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B not typed): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B not typed): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + C*06:02 not determined (HLA-C not typed): psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 not determined (HLA-DQB1 not typed): narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 not determined (HLA-DRB1 not typed): multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08) did not run + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + [could not be read: S_roh.txt has a run of length -inf] +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Short not available (not available/not available variants matched) PGS1 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40; depth unknown (no total_reads or read_lengths in the summary): not checked + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/c-float-inf/c-float-inf.txt b/tests/parity/golden/report-render/c-float-inf/c-float-inf.txt new file mode 100644 index 000000000..2a49c2e2c --- /dev/null +++ b/tests/parity/golden/report-render/c-float-inf/c-float-inf.txt @@ -0,0 +1,418 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 1 (1 deletions, 0 duplications) + Significant (e-val < 0.01): 0 + Significant after filters: 0; no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 1 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 0 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 0 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 1 + m.3243A>G (MT-TL1) AF inf filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level inf% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level inf% + m.301_399del (99 bp) level inf% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + No CHIP gene has the depth to find a clone: no result either way. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality inf, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality inf, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality *, filter PASS), not resolved + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality inf, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality inf, filter PASS); chr7:5980001-5990000 3 (quality inf, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01 (quality inf) / A*01:01 (quality inf) + Coeliac DQ: not determined (HLA-DQA1 not typed; HLA-DQB1 not typed) + DQB1*02 copies: not determined + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + B*15:02 not determined (HLA-B not typed): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B not typed): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B not typed): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B not typed): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + C*06:02 not determined (HLA-C not typed): psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 not determined (HLA-DQB1 not typed): narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 not determined (HLA-DRB1 not typed): multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08) did not run + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia inf% (inf% to inf%) + Africa inf% (inf% to inf%) + Regional groups (fraction, bootstrap range): + Iberia inf% (inf% to inf%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + [could not be read: S_roh.txt has a run of length inf] +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Short not available (not available/not available variants matched) PGS1 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40; depth unknown (no total_reads or read_lengths in the summary): not checked + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/c-float-nan/c-float-nan.txt b/tests/parity/golden/report-render/c-float-nan/c-float-nan.txt new file mode 100644 index 000000000..0a44d80db --- /dev/null +++ b/tests/parity/golden/report-render/c-float-nan/c-float-nan.txt @@ -0,0 +1,407 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 1 (1 deletions, 0 duplications) + Significant (e-val < 0.01): 1 + Significant after filters: 1; no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 1 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 0 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 0 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 1 + m.3243A>G (MT-TL1) AF nan filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level nan% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + [could not be read: ValueError: cannot convert float NaN to integer] +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality nan, filter PASS), not resolved: no comparison: one of them has no call + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality nan, filter PASS), not resolved + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality *, filter PASS), not resolved + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality nan, filter PASS) + Reading: SMN1 not resolved (quality under 20 or filter not PASS): no carrier reading + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality nan, filter PASS); chr7:5980001-5990000 3 (quality nan, filter LowQual): no region with a whole copy number, filter PASS and quality 20 or more + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01 (quality nan) / A*01:01 (quality nan) + Coeliac DQ: not determined (HLA-DQA1 not typed; HLA-DQB1 not typed) + DQB1*02 copies: not determined + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + B*15:02 not determined (HLA-B not typed): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B not typed): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B not typed): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B not typed): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + C*06:02 not determined (HLA-C not typed): psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 not determined (HLA-DQB1 not typed): narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 not determined (HLA-DRB1 not typed): multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08) did not run + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + [could not be read: S_roh.txt has a run of length nan] +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Short not available (not available/not available variants matched) PGS1 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40; depth unknown (no total_reads or read_lengths in the summary): not checked + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/c-full/c-full.txt b/tests/parity/golden/report-render/c-full/c-full.txt new file mode 100644 index 000000000..613ed2877 --- /dev/null +++ b/tests/parity/golden/report-render/c-full/c-full.txt @@ -0,0 +1,442 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Short not available (not available/not available variants matched) PGS1 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-full/cb-full.html b/tests/parity/golden/report-render/cb-full/cb-full.html new file mode 100644 index 000000000..7d6bb92a9 --- /dev/null +++ b/tests/parity/golden/report-render/cb-full/cb-full.html @@ -0,0 +1,698 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/cb-full/cb-full.txt b/tests/parity/golden/report-render/cb-full/cb-full.txt new file mode 100644 index 000000000..94b2ba22f --- /dev/null +++ b/tests/parity/golden/report-render/cb-full/cb-full.txt @@ -0,0 +1,293 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-no-assets/cb-no-assets.html b/tests/parity/golden/report-render/cb-no-assets/cb-no-assets.html new file mode 100644 index 000000000..6872ae388 --- /dev/null +++ b/tests/parity/golden/report-render/cb-no-assets/cb-no-assets.html @@ -0,0 +1,672 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + +
    GeneVariantGenotypeEvidenceViewer
    +

    Secondary findings: not assessed, acmg_sf.tsv is not in nowhere: the report needs the repository's assets/ folder (render_report.py --assets)

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list: not made, carrier_genes.tsv is not in nowhere: the report needs the repository's assets/ folder (render_report.py --assets)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/cb-no-assets/cb-no-assets.txt b/tests/parity/golden/report-render/cb-no-assets/cb-no-assets.txt new file mode 100644 index 000000000..c8e940efc --- /dev/null +++ b/tests/parity/golden/report-render/cb-no-assets/cb-no-assets.txt @@ -0,0 +1,266 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary findings: not assessed, acmg_sf.tsv is not in nowhere: the report needs the repository's assets/ folder (render_report.py --assets) + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list: not made, carrier_genes.tsv is not in nowhere: the report needs the repository's assets/ folder (render_report.py --assets) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html new file mode 100644 index 000000000..e9a5fbb73 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html @@ -0,0 +1,698 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's dosage table has no row)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt new file mode 100644 index 000000000..2d4f39b53 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt @@ -0,0 +1,293 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's dosage table has no row) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html new file mode 100644 index 000000000..7d6bb92a9 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html @@ -0,0 +1,698 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt new file mode 100644 index 000000000..94b2ba22f --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt @@ -0,0 +1,293 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html new file mode 100644 index 000000000..7d6bb92a9 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html @@ -0,0 +1,698 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt new file mode 100644 index 000000000..94b2ba22f --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt @@ -0,0 +1,293 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html new file mode 100644 index 000000000..7d6bb92a9 --- /dev/null +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html @@ -0,0 +1,698 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt new file mode 100644 index 000000000..94b2ba22f --- /dev/null +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt @@ -0,0 +1,293 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html new file mode 100644 index 000000000..8faaf8ce0 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html @@ -0,0 +1,699 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetA<&>'"Pathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    <b>chr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (x <y> & z; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt new file mode 100644 index 000000000..c4237beb3 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt @@ -0,0 +1,293 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + A<&>'" chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (x & z; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinical-failed/m-clinical-failed.html b/tests/parity/golden/report-render/m-clinical-failed/m-clinical-failed.html new file mode 100644 index 000000000..f71d180af --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-failed/m-clinical-failed.html @@ -0,0 +1,564 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Genes This Genome Could Not Read Reliably

    +

    Step 16b · Failed · link to this section

    +
    FAILED: note of callability <&>
    +
    StatusFailed
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: note of clinvar <&>
    +
    StatusFailed
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: note of clinical <&>
    +
    StatusFailed
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +
    FAILED: note of clinical <&>
    +
    StatusFailed
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: note of cpsr <&>
    +
    StatusFailed
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: note of slivar <&>
    +
    StatusFailed
    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: note of carrier <&>
    +
    StatusFailed
    +
    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: note of couple <&>
    +
    StatusFailed
    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-clinical-failed/m-clinical-failed.txt b/tests/parity/golden/report-render/m-clinical-failed/m-clinical-failed.txt new file mode 100644 index 000000000..5d4901536 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-failed/m-clinical-failed.txt @@ -0,0 +1,186 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Genes This Genome Could Not Read Reliably +--- + [FAILED: note of callability <&>] + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + [FAILED: note of clinvar <&>] + +## Clinical Variant Filter +--- + [FAILED: note of clinical <&>] + +## Cancer Predisposition Screening (CPSR) +--- + [FAILED: note of cpsr <&>] + +## Variant Prioritization (slivar) +--- + [FAILED: note of slivar <&>] + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + [FAILED: note of carrier <&>] + +## Couple Carrier Screen (step 39) +--- + [FAILED: note of couple <&>] + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html new file mode 100644 index 000000000..f7824baab --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html @@ -0,0 +1,719 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    STALE: note of clinvar <&>
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    +
    STALE: note of clinvar <&>
    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    +
    STALE: note of clinvar <&>
    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +
    STALE: note of clinical <&>
    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    +
    STALE: note of clinical <&>
    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    STALE: note of cpsr <&>
    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    STALE: note of slivar <&>
    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +
    STALE: note of carrier <&>
    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +
    STALE: note of couple <&>
    +

    Partner: P<2>. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P<2>: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P<2>: .

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt new file mode 100644 index 000000000..e34bf5c21 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt @@ -0,0 +1,306 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + [STALE: note of clinvar <&>] + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + [STALE: note of clinical <&>] + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + [STALE: note of cpsr <&>] + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + [STALE: note of slivar <&>] + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + [STALE: note of carrier <&>] + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + [STALE: note of couple <&>] + Partner: P<2>. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P<2>: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P<2>: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinical-unreadable/m-clinical-unreadable.html b/tests/parity/golden/report-render/m-clinical-unreadable/m-clinical-unreadable.html new file mode 100644 index 000000000..5460283e0 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-unreadable/m-clinical-unreadable.html @@ -0,0 +1,564 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Genes This Genome Could Not Read Reliably

    +

    Step 16b · Failed · link to this section

    +
    could not be read: note of callability <&>
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: note of clinvar <&>
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: note of clinical <&>
    +
    StatusUnreadable
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +
    could not be read: note of clinical <&>
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: note of cpsr <&>
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: note of slivar <&>
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: note of carrier <&>
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: note of couple <&>
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-clinical-unreadable/m-clinical-unreadable.txt b/tests/parity/golden/report-render/m-clinical-unreadable/m-clinical-unreadable.txt new file mode 100644 index 000000000..44596563f --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-unreadable/m-clinical-unreadable.txt @@ -0,0 +1,179 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Genes This Genome Could Not Read Reliably +--- + [could not be read: note of callability <&>] +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + [could not be read: note of clinvar <&>] +## Clinical Variant Filter +--- + [could not be read: note of clinical <&>] +## Cancer Predisposition Screening (CPSR) +--- + [could not be read: note of cpsr <&>] +## Variant Prioritization (slivar) +--- + [could not be read: note of slivar <&>] +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + [could not be read: note of carrier <&>] +## Couple Carrier Screen (step 39) +--- + [could not be read: note of couple <&>] +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html new file mode 100644 index 000000000..fe45fe133 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html @@ -0,0 +1,698 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below None or DP below None: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below None or DP below None), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF: unknown for every hit (no VEP output)

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt new file mode 100644 index 000000000..ded5b0175 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt @@ -0,0 +1,293 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below None or DP below None), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF: unknown for every hit (no VEP output) + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html new file mode 100644 index 000000000..77f14856c --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html @@ -0,0 +1,742 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A, BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A, BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A, BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A, BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A and more3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T, MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T, MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T, MUTYH chr1:45331556 C>T and more2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C, BTD chr3:15645186 G>C, BTD chr3:15645186 G>C, BTD chr3:15645186 G>C, BTD chr3:15645186 G>C, BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T, . chr2:100 A>G, GLA chrX:101398000 C>T, . chr2:100 A>G, GLA chrX:101398000 C>T, . chr2:100 A>G, GLA chrX:101398000 C>T, . chr2:100 A>G, GLA chrX:101398000 C>T and more0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 12 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 50 of 60)

    + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    Hit at a known lab-construct site past the first 50: MUTYH chr1:45331556 C>T het: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)

    +

    Hit at a known lab-construct site past the first 50: SMN1 chr5:70951946 C>T hom: known lab-construct site (pcDNA3): clipped <x> (3 of 4 alt reads and 0 of 10 ref reads clipped at an exon edge)

    +

    Hit at a known lab-construct site past the first 50: BTD chr3:15645186 G>C het: known lab-construct site (EGFP): clear (0 of 4 alt reads and 0 of 10 ref reads clipped at an exon edge)

    +

    Hit at a known lab-construct site past the first 50: . chr2:100 A>G het: known lab-construct site (lentiviral): not checked

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt new file mode 100644 index 000000000..6c35ceac1 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt @@ -0,0 +1,426 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 12 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + Hits at a known lab-construct site past the first 50: + MUTYH chr1:45331556 C>T het: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + SMN1 chr5:70951946 C>T hom: known lab-construct site (pcDNA3): clipped (3 of 4 alt reads and 0 of 10 ref reads clipped at an exon edge) + BTD chr3:15645186 G>C het: known lab-construct site (EGFP): clear (0 of 4 alt reads and 0 of 10 ref reads clipped at an exon edge) + . chr2:100 A>G het: known lab-construct site (lentiviral): not checked + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html new file mode 100644 index 000000000..d635a5050 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html @@ -0,0 +1,659 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars3 stars22 stars: 3 hits with 2 review stars2 stars31 star: 1 hit with 1 review star1 star10 stars: 2 hits with 0 review stars0 stars2
    +
    ClinVar matches0
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Hits at a known lab-construct site (check the reads)1
    +
    ClinVar file dateunknown
    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    cDNA scan of every exon: not run: no BAM

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt new file mode 100644 index 000000000..c7056e920 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt @@ -0,0 +1,250 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 0 + ClinVar file date: unknown + cDNA scan of every exon: not run: no BAM + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html new file mode 100644 index 000000000..3b396cf6f --- /dev/null +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html @@ -0,0 +1,707 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: the partner. Genes where both carry a change: 0; X-linked findings: 0; genes where only one partner carries a change: 0

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt new file mode 100644 index 000000000..901ce6cc7 --- /dev/null +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt @@ -0,0 +1,298 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + Partner: the partner. Genes where both carry a change: 0; X-linked findings: 0; genes where only one partner carries a change: 0 + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-couple/m-couple.html b/tests/parity/golden/report-render/m-couple/m-couple.html new file mode 100644 index 000000000..d866af2b6 --- /dev/null +++ b/tests/parity/golden/report-render/m-couple/m-couple.html @@ -0,0 +1,710 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P<2>. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P<2>: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P<2>: .

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-couple/m-couple.txt b/tests/parity/golden/report-render/m-couple/m-couple.txt new file mode 100644 index 000000000..dfd48d62c --- /dev/null +++ b/tests/parity/golden/report-render/m-couple/m-couple.txt @@ -0,0 +1,300 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + Partner: P<2>. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P<2>: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P<2>: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html new file mode 100644 index 000000000..88a023be6 --- /dev/null +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html @@ -0,0 +1,681 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportNo HTML
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt new file mode 100644 index 000000000..438e209b2 --- /dev/null +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt @@ -0,0 +1,277 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html new file mode 100644 index 000000000..158a4f7c6 --- /dev/null +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html @@ -0,0 +1,688 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    The classification table has no CPSR_CLASSIFICATION column, so no disagreement can be shown.

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +
    +

    Files of this step, beside this report: CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt new file mode 100644 index 000000000..9e9ae40ff --- /dev/null +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt @@ -0,0 +1,283 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification table has no CLASSIFICATION column. + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + The classification table has no CPSR_CLASSIFICATION column, so no disagreement can be shown. + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html new file mode 100644 index 000000000..25128ef05 --- /dev/null +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html @@ -0,0 +1,699 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    carrier list <unreadable>

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt new file mode 100644 index 000000000..2ed7ebc29 --- /dev/null +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt @@ -0,0 +1,294 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, ? genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 2 weak call(s), 1 of unknown frequency), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + carrier list + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html new file mode 100644 index 000000000..f3204a08b --- /dev/null +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html @@ -0,0 +1,698 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt new file mode 100644 index 000000000..760948d7d --- /dev/null +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt @@ -0,0 +1,296 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + [New since 2026-01-01T00:00:00Z] + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + [New since 2026-01-01T00:00:00Z] + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + [New since 2026-01-01T00:00:00Z] + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html new file mode 100644 index 000000000..3fec4ad98 --- /dev/null +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html @@ -0,0 +1,654 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown2.5 / 1 / 1
    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt new file mode 100644 index 000000000..2e036d5f3 --- /dev/null +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt @@ -0,0 +1,273 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 2.5 trans, 1 cis, 1 unknown of 26 pairs + ... 2.5 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html new file mode 100644 index 000000000..475f4c332 --- /dev/null +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html @@ -0,0 +1,672 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt new file mode 100644 index 000000000..39e44dd84 --- /dev/null +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt @@ -0,0 +1,271 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + (Candidates only: unphased single-sample data. See docs/31-slivar.md) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-consumer-reasons/s-consumer-reasons.html b/tests/parity/golden/report-render/s-consumer-reasons/s-consumer-reasons.html new file mode 100644 index 000000000..234b3b3d1 --- /dev/null +++ b/tests/parity/golden/report-render/s-consumer-reasons/s-consumer-reasons.html @@ -0,0 +1,922 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 1234

    +

    Files: consumer_export/S_23andme.txt and consumer_export/S_ancestry.txt

    +

    '--' because: low <depth> 9; zeta 5; alpha 5; one 1

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/s-consumer-reasons/s-consumer-reasons.txt b/tests/parity/golden/report-render/s-consumer-reasons/s-consumer-reasons.txt new file mode 100644 index 000000000..e1d9a0da8 --- /dev/null +++ b/tests/parity/golden/report-render/s-consumer-reasons/s-consumer-reasons.txt @@ -0,0 +1,441 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 1234 + Files: consumer_export/S_23andme.txt and consumer_export/S_ancestry.txt + '--' because: low 9; zeta 5; alpha 5; one 1 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-consumer-stale/s-consumer-stale.html b/tests/parity/golden/report-render/s-consumer-stale/s-consumer-stale.html new file mode 100644 index 000000000..2390dc042 --- /dev/null +++ b/tests/parity/golden/report-render/s-consumer-stale/s-consumer-stale.html @@ -0,0 +1,922 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/s-consumer-stale/s-consumer-stale.txt b/tests/parity/golden/report-render/s-consumer-stale/s-consumer-stale.txt new file mode 100644 index 000000000..0768ecf09 --- /dev/null +++ b/tests/parity/golden/report-render/s-consumer-stale/s-consumer-stale.txt @@ -0,0 +1,441 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + [STALE: older export] + Sites with a genotype: 590000 of 0; '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-sexloss-chrx/s-sexloss-chrx.html b/tests/parity/golden/report-render/s-sexloss-chrx/s-sexloss-chrx.html new file mode 100644 index 000000000..8dfd4400b --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-chrx/s-sexloss-chrx.html @@ -0,0 +1,925 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/s-sexloss-chrx/s-sexloss-chrx.txt b/tests/parity/golden/report-render/s-sexloss-chrx/s-sexloss-chrx.txt new file mode 100644 index 000000000..33e86cf31 --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-chrx/s-sexloss-chrx.txt @@ -0,0 +1,447 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic loss of chromosome Y or X +--- + chrX: detected (allele fraction & depth) + From chrX allele fractions at 40 heterozygous sites: 12.5% (95% range 10.0% to ?) + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-sexloss-detected/s-sexloss-detected.html b/tests/parity/golden/report-render/s-sexloss-detected/s-sexloss-detected.html new file mode 100644 index 000000000..32486a829 --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-detected/s-sexloss-detected.html @@ -0,0 +1,925 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/s-sexloss-detected/s-sexloss-detected.txt b/tests/parity/golden/report-render/s-sexloss-detected/s-sexloss-detected.txt new file mode 100644 index 000000000..dc23c55e8 --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-detected/s-sexloss-detected.txt @@ -0,0 +1,447 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic loss of chromosome Y or X +--- + chrY: detected (depth below the floor) + From depth: estimated share of the cells that lost the Y 28.8% (95% range 25.0% to 33.0%); chrY to autosome depth ratio 0.712, None expected + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-sexloss-failed/s-sexloss-failed.html b/tests/parity/golden/report-render/s-sexloss-failed/s-sexloss-failed.html new file mode 100644 index 000000000..584a23f25 --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-failed/s-sexloss-failed.html @@ -0,0 +1,923 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/s-sexloss-failed/s-sexloss-failed.txt b/tests/parity/golden/report-render/s-sexloss-failed/s-sexloss-failed.txt new file mode 100644 index 000000000..f2d16991d --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-failed/s-sexloss-failed.txt @@ -0,0 +1,445 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic loss of chromosome Y or X +--- + [FAILED: step 33 failed] + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-sexloss-gain-stale/s-sexloss-gain-stale.html b/tests/parity/golden/report-render/s-sexloss-gain-stale/s-sexloss-gain-stale.html new file mode 100644 index 000000000..fdbc32688 --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-gain-stale/s-sexloss-gain-stale.html @@ -0,0 +1,925 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/s-sexloss-gain-stale/s-sexloss-gain-stale.txt b/tests/parity/golden/report-render/s-sexloss-gain-stale/s-sexloss-gain-stale.txt new file mode 100644 index 000000000..b6b834a71 --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-gain-stale/s-sexloss-gain-stale.txt @@ -0,0 +1,447 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic loss of chromosome Y or X +--- + [STALE: from an older run ] + chrY: an extra copy, not a loss (depth above 1) + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-sexloss-not-estimated/s-sexloss-not-estimated.html b/tests/parity/golden/report-render/s-sexloss-not-estimated/s-sexloss-not-estimated.html new file mode 100644 index 000000000..8f53ca88d --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-not-estimated/s-sexloss-not-estimated.html @@ -0,0 +1,924 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/s-sexloss-not-estimated/s-sexloss-not-estimated.txt b/tests/parity/golden/report-render/s-sexloss-not-estimated/s-sexloss-not-estimated.txt new file mode 100644 index 000000000..1c67f391b --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-not-estimated/s-sexloss-not-estimated.txt @@ -0,0 +1,446 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic loss of chromosome Y or X +--- + chrY: not estimated (too few reads on chrY) + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-sexloss-odd/s-sexloss-odd.html b/tests/parity/golden/report-render/s-sexloss-odd/s-sexloss-odd.html new file mode 100644 index 000000000..5ef547d91 --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-odd/s-sexloss-odd.html @@ -0,0 +1,925 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/s-sexloss-odd/s-sexloss-odd.txt b/tests/parity/golden/report-render/s-sexloss-odd/s-sexloss-odd.txt new file mode 100644 index 000000000..4b3646409 --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-odd/s-sexloss-odd.txt @@ -0,0 +1,447 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic loss of chromosome Y or X +--- + chrY or chrX: maybe (None) + From depth: estimated share of the cells that lost one X 5.0% (95% range ? to ?); to autosome depth ratio ?, None expected + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-sv-stale/s-sv-stale.html b/tests/parity/golden/report-render/s-sv-stale/s-sv-stale.html new file mode 100644 index 000000000..4c449b1c8 --- /dev/null +++ b/tests/parity/golden/report-render/s-sv-stale/s-sv-stale.html @@ -0,0 +1,926 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/s-sv-stale/s-sv-stale.txt b/tests/parity/golden/report-render/s-sv-stale/s-sv-stale.txt new file mode 100644 index 000000000..98dc7c892 --- /dev/null +++ b/tests/parity/golden/report-render/s-sv-stale/s-sv-stale.txt @@ -0,0 +1,445 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + [STALE: why: &'"] + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + [STALE: why: &'"] + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + [STALE: why: &'"] + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + [STALE: why: &'"] + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ From 44d3398bb1a6a43847dad652f93ef24cae52721b Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 18:23:52 +0100 Subject: [PATCH 18/38] ci(personal-data): allow the corpus's made-up genotypes in report-render goldens The whole-report goldens of the c-full, all and a-/s- report-render cases print the made-up lipoprotein(a) genotypes and repeat sizes of the summary-collect corpus. The scan read them as personal data. Allow those four lines under tests/parity/golden/report-render only. Bead: sv-01 --- scripts/ci/check-personal-data.sh | 4 ++++ 1 file changed, 4 insertions(+) diff --git a/scripts/ci/check-personal-data.sh b/scripts/ci/check-personal-data.sh index a51191031..828d86e18 100755 --- a/scripts/ci/check-personal-data.sh +++ b/scripts/ci/check-personal-data.sh @@ -146,6 +146,10 @@ CONTRIBUTING.md /mnt/user\|internal-host\|/home/ CONTRIBUTING.md (`/mnt/user/`, `/home/username/`, etc.) modules/local/cyrius/main.nf ${prefix}\\t*1/*1\\tPASS tests/fake-docker/reports-stale-step.sh sample1\t*1/*1\tPASS +tests/parity/golden/report-render/*/* rs10455872: A/G (1 risk allele) +tests/parity/golden/report-render/*/* rs3798220: T|C (1 risk allele) +tests/parity/golden/report-render/*/* HTT 17/20 normal,normal +tests/parity/golden/report-render/*/* ATXN1 30/37 not sized tests/test_collect_summary.py S\t*1/*4\tPASS tests/test_collect_summary.py strec("HTT", "17/30" tests/test_collect_summary.py strec("C9ORF72", "2/8" From 966083d43b5553b1a72eed42e83cc905b5449aeb Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 19:13:54 +0100 Subject: [PATCH 19/38] test(e2e): compress the score-tier tables with the bcftools image, not the 9 GB GATK one GATK_IMAGE is pulled lazily, so the shard that ran this case pulled about 9 GB to bgzip five small tables. The bcftools image is cached and ships bgzip and tabix. --- tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh b/tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh index 2b9be6bb2..da9e86244 100755 --- a/tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh +++ b/tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh @@ -64,7 +64,7 @@ VCF splice_track 707 AT > "$ANNOT/spliceai_scores.masked.indel.hg38.vcf" docker run --rm --user "$(id -u):$(id -g)" --network none \ - -v "${GENOME_DIR}:/genome" -w /genome "$GATK_IMAGE" bash -ec ' + -v "${GENOME_DIR}:/genome" -w /genome "${BCFTOOLS_HTTPS_IMAGE:?}" bash -ec ' for file in annotations/*.tsv; do bgzip -c "$file" > "$file.gz" tabix -s 1 -b 2 -e 2 "$file.gz" From f059dc31578059b5041d68ae1b507491877bb7aa Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 19:20:26 +0100 Subject: [PATCH 20/38] fix(report): count an SV row without a support key as not known The new count line read each row's support with d["support"] (Python) and at("support") (og-render). A live-site summary whose rows have no support key then raised, and the live site dropped the structural card: tests/test_owngenome_live_family.py counted 0 flagged cards where it expects 1. Both now count a missing key as not known, the same as null. Bead: sv-01 --- bin/render_report.py | 2 +- rust/crates/og-render/src/sections/annotsv.rs | 4 ++-- .../og-render/tests/i411_sv_support_text.rs | 18 ++++++++++++++++++ 3 files changed, 21 insertions(+), 3 deletions(-) diff --git a/bin/render_report.py b/bin/render_report.py index d13fedd1b..625de561c 100755 --- a/bin/render_report.py +++ b/bin/render_report.py @@ -874,7 +874,7 @@ def annotsv_lines(d): """Step 05's class 4-5 lines, the same in both reports.""" head = f"Class 4-5 SVs: {d['count']}" if d["count"]: - head += (f" (single caller: {str(d['single_caller']) + (f', not known: {m}' if (m := sum(x['support'] is None for x in d.get('rows') or [])) else '') if d['consensus'] else 'not known'}; deletions on exon edges: " + head += (f" (single caller: {str(d['single_caller']) + (f', not known: {m}' if (m := sum(x.get('support') is None for x in d.get('rows') or [])) else '') if d['consensus'] else 'not known'}; deletions on exon edges: " f"{d['exon_edge'] if d['exon_edge_checked'] else 'not checked'}; common: {d['common']})") lines = [head] if d.get("downgraded"): diff --git a/rust/crates/og-render/src/sections/annotsv.rs b/rust/crates/og-render/src/sections/annotsv.rs index b3594cdf9..88b1948e0 100644 --- a/rust/crates/og-render/src/sections/annotsv.rs +++ b/rust/crates/og-render/src/sections/annotsv.rs @@ -127,11 +127,11 @@ pub fn lines(d: &D<'_>) -> Result, Malformed> { let single = if consensus { // The consensus ran, but a row it cannot tell has no support: // count those apart, so "single caller: 0" never reads as - // "every SV had two callers". + // "every SV had two callers". A row without the key counts too. let mut unknown = 0; if let Some(rows) = d.opt("rows")? { for x in rows.items()? { - if x.at("support")?.is_none() { + if x.get("support")?.is_none_or(|v| v.is_none()) { unknown += 1; } } diff --git a/rust/crates/og-render/tests/i411_sv_support_text.rs b/rust/crates/og-render/tests/i411_sv_support_text.rs index f7809f035..2bdc4f3fa 100644 --- a/rust/crates/og-render/tests/i411_sv_support_text.rs +++ b/rust/crates/og-render/tests/i411_sv_support_text.rs @@ -190,3 +190,21 @@ fn sf_rows_without_an_annotsv_section_keep_the_old_reason() { ); assert!(!txt.contains("cannot tell"), "{txt}"); } + +/// A row with no `support` key (a summary written by hand, or an older +/// one) counts as not known: the count line still comes out. +#[test] +fn a_row_without_a_support_key_counts_as_not_known() { + let s = Summary::parse( + r#"{"sections": {"annotsv": {"state": "ok", "data": {"count": 1, "consensus": 1, + "single_caller": 0, "exon_edge_checked": false, "exon_edge": 0, "common": 0, + "rows": [{"sv": "chr17:1-2", "type": "DEL", "acmg_class": 5, "genes": ["G"]}]}}}}"#, + ) + .expect("a summary"); + let lines = + annotsv::lines(&og_render::sections::clinvar::D::of(&s.section("annotsv"))).unwrap(); + assert_eq!( + lines[0], + "Class 4-5 SVs: 1 (single caller: 0, not known: 1; deletions on exon edges: not checked; common: 0)" + ); +} From 87f194a8ebe3452e12653675679dd007a28d99c4 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 20:15:57 +0100 Subject: [PATCH 21/38] fix(carrier): let only confident calls give the phase of a two-copy pair Two confident hets of unknown phase beside a weak het in trans with one of them read "possible two hits (low-confidence call)" on the carrier list but "possibly biallelic" on the secondary-findings card. The card checked two confident copies of unknown phase before the low cap; the list capped first. The list now takes the same step in the same order. A combined allele that is confident only through a folded part kept the GT and phase set of its own weak call, so both cards could call a pair biallelic that the confident calls do not prove. Each allele is now counted with the GT and phase set of the confident call that makes it confident, on both cards. On the card's deletion path a weak combined allele with a confident part is no longer marked low when the confident calls give its copies, and it pairs with the deletion by that confident call's phase. New shapes in the agreement test: R1, R1b, R1c (the list now says possible two hits), R2 and R3d (the card now says possibly biallelic, with its two-hit line), R3 (both now say possibly), and R6 and R7, which keep the low word on both cards. Bead: clin-19 --- rust/crates/og-summary/src/collect/acmg.rs | 63 ++++++++++++++----- rust/crates/og-summary/src/collect/carrier.rs | 42 ++++++++----- .../tests/i411_carrier_confidence.rs | 52 +++++++++++++++ 3 files changed, 129 insertions(+), 28 deletions(-) diff --git a/rust/crates/og-summary/src/collect/acmg.rs b/rust/crates/og-summary/src/collect/acmg.rs index 760784756..5547f8533 100644 --- a/rust/crates/og-summary/src/collect/acmg.rs +++ b/rust/crates/og-summary/src/collect/acmg.rs @@ -441,7 +441,8 @@ struct Cand { /// One distinct variant of a gene as the verdict counts it: its alt /// copies, ploidy, GT and phase set, whether it stands for a combined /// allele and its parts, and the alt copies its confident calls give (`firm`: -/// 0 when every call of it is below step 06's call floor, low confidence). +/// 0 when every call of it is below step 06's call floor, low confidence), +/// with the GT and phase set of the confident call that gives them. #[derive(Debug, Clone, PartialEq)] struct Allele { copies: usize, @@ -450,6 +451,8 @@ struct Allele { ps: Option, combined: bool, firm: usize, + firm_gt: String, + firm_ps: Option, } impl Allele { @@ -461,6 +464,18 @@ impl Allele { ps: None, combined: false, firm: 0, + firm_gt: String::new(), + firm_ps: None, + } + } + + /// Count a confident call of this allele: the most copies one gives, + /// with that call's GT and phase set. + fn confirm(&mut self, copies: usize, gt: &str, ps: &Option) { + if copies > self.firm { + self.firm = copies; + self.firm_gt = gt.to_owned(); + self.firm_ps = ps.clone(); } } @@ -625,16 +640,23 @@ fn sf_verdicts( // that needs a low-confidence call is only possible until the call is // confirmed. A small allele no confident call gives drops out; one whose // confident calls give fewer copies than it counts loses its phase too, - // as that came from the low call. A deletion counts as it is: its pair - // is judged by `two_hits_with`. + // as that came from the low call; any other takes the GT and phase set + // of the confident call, so a phase only a low call gives proves + // nothing. A deletion counts as it is: its pair is judged by + // `two_hits_with`. let firm: IndexMap = kept .iter() .filter(|(k, a)| !matches!(k, AKey::Small(_)) || a.firm > 0) .map(|(k, a)| { let mut f = a.clone(); - if matches!(k, AKey::Small(_)) && a.firm < a.copies { - f.copies = a.firm; - f.ps = None; + if matches!(k, AKey::Small(_)) { + if a.firm < a.copies { + f.copies = a.firm; + f.ps = None; + } else { + f.gt = a.firm_gt.clone(); + f.ps = a.firm_ps.clone(); + } } (k.clone(), f) }) @@ -654,10 +676,11 @@ fn sf_verdicts( copy (cis)" .to_owned() }; - // The best the evidence gives: a confident proof, then the deletion pair + // The best the evidence gives: a confident proof; then the deletion pair // when it is at least possibly biallelic (`two_hits_with` already lowers - // a pair on a low call), then a proof that needs a low call, then the - // copies counted with phase unknown. + // a pair on a low call); then, with no deletion pair, two confident + // copies of unknown phase; then the low word for a pair that needs a + // low call. let pair = (counted && n >= 2).then(|| { let del = deletion.map(|e| (e.verdict, format!("with {}: {}", e.deletion, e.why))); match (proof_firm, proof, del) { @@ -1009,7 +1032,7 @@ fn tier(i: &Inputs) -> Result, String> { ..Allele::of(x.copies, p) }); if !is_low(x) { - a.firm = a.firm.max(x.copies); + a.confirm(x.copies, &x.gt, &x.ps); } } for x in &folded { @@ -1026,7 +1049,7 @@ fn tier(i: &Inputs) -> Result, String> { a.copies = a.copies.max(x.copies); a.combined = true; if !is_low(x) { - a.firm = a.firm.max(x.copies); + a.confirm(x.copies, &x.gt, &x.ps); } } for x in &svs { @@ -1047,12 +1070,24 @@ fn tier(i: &Inputs) -> Result, String> { ), }; let (dels, _, _) = gene_deletions(i.deletions, &spans); + // The confident call of a small allele whose own call is low, when it + // gives as many copies: a combined allele counts as confident when any + // call of it is, and its pair with a deletion then rests on that call's + // GT and phase set, not on the low call's. + let confirmed = |x: &Cand| { + alleles + .get(&x.gene) + .and_then(|a| a.get(&x.key)) + .filter(|a| is_low(x) && a.firm >= x.copies) + .map(|a| (a.firm_gt.clone(), a.firm_ps.clone())) + }; let mut seen = HashSet::new(); let mut variants = Vec::new(); for x in &own { let AKey::Small(k) = &x.key else { continue }; let pseudo = rules[&x.gene].severity_kind(k) == Some("pseudodeficiency"); if !pseudo && seen.insert((x.gene.clone(), k.clone())) { + let (gt, ps) = confirmed(x).unwrap_or_else(|| (x.gt.clone(), x.ps.clone())); variants.push(Variant { gene: x.gene.clone(), key: k.clone(), @@ -1068,15 +1103,15 @@ fn tier(i: &Inputs) -> Result, String> { }, copies: x.copies, ploidy: if x.ploidy == 0 { 2 } else { x.ploidy }, - gt: x.gt.clone(), - ps: x.ps.clone(), + gt, + ps, allele: None, }); } } let low: HashSet<(String, Key)> = own .iter() - .filter(|x| is_low(x)) + .filter(|x| is_low(x) && confirmed(x).is_none()) .filter_map(|x| match &x.key { AKey::Small(k) => Some((x.gene.clone(), k.clone())), _ => None, diff --git a/rust/crates/og-summary/src/collect/carrier.rs b/rust/crates/og-summary/src/collect/carrier.rs index e77b26c36..98a411a12 100644 --- a/rust/crates/og-summary/src/collect/carrier.rs +++ b/rust/crates/og-summary/src/collect/carrier.rs @@ -26,7 +26,7 @@ use super::text::{self, gt_field}; use super::two_hits::{DeletionInputs, Spans, Variant, gene_deletions, phase_haps, two_hits_with}; use indexmap::IndexMap; use pycompat::json::Value; -use std::collections::{BTreeSet, HashSet}; +use std::collections::{BTreeSet, HashMap, HashSet}; /// The section's data: the list, or why it could not be made. #[derive(Debug, Clone, PartialEq)] @@ -86,9 +86,10 @@ fn joined_keys(r: &[String]) -> Vec { /// copy) and why. `None` when fewer than two distinct alleles are left /// once a combined allele and its parts count once. The hets are counted /// twice, all of them and the confident ones alone: two hits when the -/// confident ones prove it, the low-confidence word when only all of them -/// do, and with phase unknown, possible two hits when the confident ones -/// still count two copies. +/// confident ones prove it; else possible two hits when the confident ones +/// still count two copies of unknown phase, whatever a low-confidence call +/// adds; else the low-confidence word when a pair needs a low-confidence +/// call. fn het_pair(hets: &[Het]) -> Option<(Option, String)> { // A combined allele and its parts count once, under the combined // allele, when its call is phased or at most one part is here; an @@ -111,15 +112,22 @@ fn het_pair(hets: &[Het]) -> Option<(Option, String)> { // A kept allele is firm when a call of it is confident: its own, or a // call folded into it (a part under its combined allele, or an unphased // combined allele under its first part), as the secondary-findings card - // counts it. - let mut firm: HashSet<&VarKey> = kept.iter().filter(|h| !h.low).map(|h| &h.key).collect(); + // counts it. The confident count takes that call's GT and phase set: a + // phase only a low-confidence call gives proves nothing. + let mut firm: HashMap<&VarKey, &Het> = kept + .iter() + .filter(|h| !h.low) + .map(|h| (&h.key, *h)) + .collect(); for h in hets.iter().filter(|h| !h.joined.is_empty()) { if gone.contains(&h.key) { - if !h.low { - firm.extend(h.joined.iter().find(|k| present.contains(k))); + if !h.low + && let Some(k) = h.joined.iter().find(|k| present.contains(k)) + { + firm.entry(k).or_insert(h); } - } else if hets.iter().any(|p| !p.low && h.joined.contains(&p.key)) { - firm.insert(&h.key); + } else if let Some(p) = hets.iter().find(|p| !p.low && h.joined.contains(&p.key)) { + firm.entry(&h.key).or_insert(p); } } // The copies a set of hets hits: the count, the proof of two copies if a @@ -169,12 +177,17 @@ fn het_pair(hets: &[Het]) -> Option<(Option, String)> { (n, proof, cis) }; let (n, proof, cis) = count(&kept); - let sure: Vec<&Het> = kept + let sure: Vec = kept .iter() - .copied() - .filter(|h| firm.contains(&h.key)) + .filter_map(|h| { + firm.get(&h.key).map(|c| Het { + gt: c.gt.clone(), + ps: c.ps.clone(), + ..(*h).clone() + }) + }) .collect(); - let (n_firm, proof_firm, _) = count(&sure); + let (n_firm, proof_firm, _) = count(&sure.iter().collect::>()); // A pair that needs a low-confidence call is only possible until the // call is confirmed. let low = |why: String| { @@ -190,6 +203,7 @@ fn het_pair(hets: &[Het]) -> Option<(Option, String)> { .to_owned(); match (proof_firm, proof, cis) { (Some(f), _, _) => Some((Some("two hits".to_owned()), f)), + (None, Some(_), _) if n_firm >= 2 => Some((Some("possible two hits".to_owned()), unknown)), (None, Some(p), _) => low(p), (None, None, _) if n >= 2 && n_firm >= 2 => { Some((Some("possible two hits".to_owned()), unknown)) diff --git a/rust/crates/og-summary/tests/i411_carrier_confidence.rs b/rust/crates/og-summary/tests/i411_carrier_confidence.rs index e050bca86..2ee6f9575 100644 --- a/rust/crates/og-summary/tests/i411_carrier_confidence.rs +++ b/rust/crates/og-summary/tests/i411_carrier_confidence.rs @@ -692,6 +692,10 @@ fn the_carrier_list_and_the_sf_card_agree_on_a_gene_on_both_lists() { a.0, a.1, a.2, a.3 ); let combined = |q: &str| hit(b, "MUTYH", "GT:GQ:DP:PS", &format!("0|1:{q}:9"), &joined); + // The same combined allele, unphased and weak. + let combined_open = || hit(b, "MUTYH", "GT:GQ:DP", "0/1:5:4", &joined); + // A second alt allele at MUTYH_A's position, for a split call there. + let a2 = (a.0, a.1, a.2, "G"); let del = || mutyh_deletion("1|0", Some("9")); let none = no_deletions; let p9 = Some("9"); @@ -823,6 +827,54 @@ fn the_carrier_list_and_the_sf_card_agree_on_a_gene_on_both_lists() { mutyh_deletion("0/1", None), maybe, ), + ( + "R1 confident het + weak het in trans with it + confident unphased het", + vec![g(a, "0|1", p9), w(b, "1|0", p9), g(cc, "0/1", None)], + none(), + maybe, + ), + ( + "R1b confident het + weak het in trans with it + confident het in another phase set", + vec![g(a, "0|1", p9), w(b, "1|0", p9), g(cc, "1|0", Some("7"))], + none(), + maybe, + ), + ( + "R1c confident half call + weak half call at one position + confident het", + vec![g(a, "1/.", None), w(a2, "./1", None), g(cc, "0/1", None)], + none(), + maybe, + ), + ( + "R2 weak unphased combined, confident part + unphased deletion", + vec![combined_open(), g(a, "0/1", None)], + mutyh_deletion("0/1", None), + maybe, + ), + ( + "R3 weak phased combined, confident unphased part, third in trans by the weak phase", + vec![combined("5:4"), g(a, "0/1", None), g(cc, "1|0", p9)], + none(), + maybe, + ), + ( + "R3d weak phased combined, confident unphased part, deletion in trans by the weak phase", + vec![combined("5:4"), g(a, "0/1", None)], + del(), + maybe, + ), + ( + "R6 confident cis pair + weak het in trans", + vec![g(a, "0|1", p9), g(b, "0|1", p9), w(cc, "1|0", p9)], + none(), + low, + ), + ( + "R7 deletion in cis with a confident het + weak het in trans", + vec![g(a, "1|0", p9), w(b, "0|1", p9)], + del(), + low, + ), ("deletion alone", vec![], del(), None), ("nothing", vec![], none(), None), ]; From 6ec4394f5ea15ab9c80e51f73cd7fa3698d04e41 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 20:15:57 +0100 Subject: [PATCH 22/38] docs(carrier): say where the carrier list and the SF card agree The docs and the changelog said a gene on both lists gets the same answer. That holds for a recessive gene the SF card counts by two copies, and only at the gene level: on the carrier list the answer is the best of `pair`, the `two_hits` verdict and the homozygous rows, and `pair` counts heterozygous hits only. Say so, and name the new rule for two confident copies of unknown phase. Bead: clin-19 --- CHANGELOG.md | 2 +- docs/results/secondary-findings.md | 4 ++-- 2 files changed, 3 insertions(+), 3 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index 20770e5b6..fccca7cc2 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. A pair that only a low-confidence call proves is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. Hits of unknown phase are `possible two hits` and `possibly biallelic` when two of them are confident, and the low-confidence word otherwise. A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is. So a gene on both lists gets the same answer on both. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer: on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - One section that cannot be written no longer stops the whole report. Step 24, the Nextflow `HTML_REPORT` module and `scripts/generate-report.sh` ran `bin/render_report.py`, and a section whose data it could not read stopped it with a Python error: the run got no text report and no HTML report at all. The three now run `og report render` (`rust/crates/og-render`), so no Python runs for the reports. A section that cannot be written says so in its own place, `[could not be read: ...]` in the text report and an Unreadable card in the HTML report, and every other section is still written; `og report render` prints one `WARNING` line on stderr that counts and names those parts, and still exits 0. A panic inside a section writer counts the same way, so the release build now unwinds on a panic (`rust/Cargo.toml`); a panic anywhere else still aborts og at once, through the panic hook og installs first. A search index or charts file that cannot be made is written empty and named in the same `WARNING` line. On the 164 report-render parity summaries (154 before, and 10 new ones that reach each state of the mosaic sex-loss, raw-data export and structural-variant sections) both reports are byte for byte the Python's, whole, with two changes on purpose: a gene the ACMG card names is listed once in the closing gene list, not twice (the `acmg_sf` section repeats the card the clinical section holds), and a run whose BAM has no unplaced unmapped reads says the viral screen was not assessed instead of "no read". The checks of `tests/test_render_report.py` are cargo tests (`rust/og/tests/report_checks.rs`, and `rust/crates/og-render/tests/section_failure.rs` for a section that panics), and the Python file is gone. `bin/render_report.py`, `bin/report_charts.py` and `bin/results_index.py` stay only for the Python live site. - The reads drawing on a live finding page now says what it is before it is shown. It is the same nine bars on every finding, but its label read "The reads at " above it and only a caption after it said it was a sketch, so it looked like the person's own reads. The label now reads "Where to look at the reads: . An illustration, not your reads.", and the link to the real reads in the genome viewer stays. In the public demo, which has no reads, every offer of reads said so only after the click: the finding page's link, a card's "See the reads at" link, a chart mark's link and a search hit's "reads at " link opened a page saying the demo has none, and the map's card button and reads pill opened a panel saying so. They now read "Reads: not in the demo": the links are plain text, and the map's buttons still open the panel that says why. On any site, the map's reads panel, which opens under the map and often below the screen, now scrolls into view when it opens. The browser check `rust/crates/og-browser/tests/rv_live_reads_sketch_label.rs` builds the demo and checks all of it. No option, output or file name changes. - `og live serve` serves the live site from the one static `og` binary, in Rust: the home, run and family pages, `state.json` and its headlines, the event stream, the run files, the map, `/metrics` and the search, charts, ops and re-check plugins, with the same policy on every answer. It has no login yet, so it serves loopback only and refuses the password, TLS and proxy options with exit 2; `scripts/owngenome-live.sh` still starts the Python server ([Watch a Run Live](docs/live-site.md)). `bin/owngenome_recheck.py`, the shim that ran `og recheck`, is gone: call `bin/og recheck`. The Python checks of the site that `og live serve` now answers moved to `cargo test -p og-live`. diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index 5c075e3f3..17ae9a6c0 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,12 +14,12 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. -Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. A pair that only a low-confidence call proves is `possible two hits (low-confidence call)`. Hits of unknown phase are `possible two hits` when two of them are confident, and the low-confidence word otherwise. A combined allele counts as confident when any call of it is. The secondary-findings card below counts the same way, so a gene on both lists gets the same answer: its `biallelic` is `two hits` here, and its `possibly biallelic (low-confidence call)` is `possible two hits (low-confidence call)`. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: - a dominant gene (BRCA1, LDLR, MYH7 and most others): one pathogenic or likely pathogenic variant is reported; -- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. The card counts the variants twice, with every call and with the confident calls alone. A pair that needs a call below step 6's call floor (its `low_confidence` mark) is `possibly biallelic (low-confidence call)`: confirm that call first. A confident homozygous call, a confident pair or a confident deletion pair keeps `biallelic` even when another variant of the gene is a low-confidence call, and two confident variants of unknown phase stay `possibly biallelic`. A combined allele counts as confident when any call of it is. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; +- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. The card counts the variants twice, with every call and with the confident calls alone. A pair that needs a call below step 6's call floor (its `low_confidence` mark) is `possibly biallelic (low-confidence call)`: confirm that call first. A confident homozygous call, a confident pair or a confident deletion pair keeps `biallelic` even when another variant of the gene is a low-confidence call, and two confident variants of unknown phase stay `possibly biallelic`, even when a low-confidence call would prove the pair. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; - HFE: only homozygous p.Cys282Tyr. A heterozygous p.Cys282Tyr or a homozygous p.His63Asp is not reported; - X-linked: GLA (Fabry disease) and OTC are reported in a hemizygous male and a heterozygous female alike. ABCD1 (X-linked adrenoleukodystrophy) is reported hemizygous, homozygous or with two heterozygous variants, never for one heterozygous variant; - BTD with p.Asp444His: reported as partial, not profound, biotinidase deficiency; From 327a7c34578151b6017c5f0eca7b2bbbffba0e1d Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 20:36:22 +0100 Subject: [PATCH 23/38] fix(live): give the live site's secondary-findings rows the consensus reason too bin/live_results.py called sf_rows without the AnnotSV consensus in the clinical-filter table and in the findings list, so those rows still said "no step 22 consensus" after step 22 ran, next to AnnotSV rows that said it cannot tell. Both now pass the consensus, as the AnnotSV rows do. The parity README names the new golden cases and the generated_utc pin, and the two repeat-size allow lines cover only the text goldens. Bead: sv-01 --- bin/live_results.py | 4 ++-- scripts/ci/check-personal-data.sh | 4 ++-- tests/parity/README.md | 2 +- 3 files changed, 5 insertions(+), 5 deletions(-) diff --git a/bin/live_results.py b/bin/live_results.py index 3f235d411..78c59d1bc 100644 --- a/bin/live_results.py +++ b/bin/live_results.py @@ -202,7 +202,7 @@ def a_clinical_filter(S, s): if sf.get("unavailable"): # Not assessed is never zero findings: the report's sentence instead of the counts. return {"facts": facts, "lines": rr.sf_apart_lines(sf), "attention": True} - rows = [[r[0], r[1], r[2], r[3]] for r in rr.sf_rows(sf)] if sf else [] + rows = [[r[0], r[1], r[2], r[3]] for r in rr.sf_rows(sf, _data(S, "annotsv").get("consensus"))] if sf else [] high = f"{rr.high_rare(sf)}{rr.high_apart(sf)}" if sf.get("high_impact_checked") else "not checked" facts += [[f"{sf.get('version') or 'ACMG SF'}: ClinVar P/LP in its genes", len(sf.get("clinvar_hits") or [])], ["High-impact rare variants in its genes", high]] @@ -840,7 +840,7 @@ def gene(x): # rows (rr.sf_rows): one it cannot read costs this rule, never the rest. sf_list = [] with _Row(out, "clinical-filter", "act"): - sf_list = rr.sf_rows(sf) if sf and not sf.get("unavailable") else [] + sf_list = rr.sf_rows(sf, _data(S, "annotsv").get("consensus")) if sf and not sf.get("unavailable") else [] for r in sf_list: with _Row(out, "clinical-filter", "act"): out.append(_f("act", "clinical-filter", ("sf", r[0], r[1]), f"Secondary finding in {r[0]}", diff --git a/scripts/ci/check-personal-data.sh b/scripts/ci/check-personal-data.sh index 828d86e18..78ebe099e 100755 --- a/scripts/ci/check-personal-data.sh +++ b/scripts/ci/check-personal-data.sh @@ -148,8 +148,8 @@ modules/local/cyrius/main.nf ${prefix}\\t*1/*1\\tPASS tests/fake-docker/reports-stale-step.sh sample1\t*1/*1\tPASS tests/parity/golden/report-render/*/* rs10455872: A/G (1 risk allele) tests/parity/golden/report-render/*/* rs3798220: T|C (1 risk allele) -tests/parity/golden/report-render/*/* HTT 17/20 normal,normal -tests/parity/golden/report-render/*/* ATXN1 30/37 not sized +tests/parity/golden/report-render/*/*.txt HTT 17/20 normal,normal +tests/parity/golden/report-render/*/*.txt ATXN1 30/37 not sized tests/test_collect_summary.py S\t*1/*4\tPASS tests/test_collect_summary.py strec("HTT", "17/30" tests/test_collect_summary.py strec("C9ORF72", "2/8" diff --git a/tests/parity/README.md b/tests/parity/README.md index 60e49dea2..78ed842a3 100644 --- a/tests/parity/README.md +++ b/tests/parity/README.md @@ -49,4 +49,4 @@ duplicate records, TAS2R38 phase blocks, phase-site VCFs and catalog refusals. The oracle adapter maps the three Rust verbs to the old flags. The Python report keeps only the metadata and table reader listed in `remnants.tsv`. -The `report-render` cases render the summaries that `gen/report-corpus.sh` writes: each summary-collect folder collected whole by `og summary collect`, and changes of a few of those summaries made with `jq`. Both reports are compared whole, byte for byte, against `bin/render_report.py`'s: every section, the charts and the closing gene list. The generator's `oracle.sh` reads a null PRS count as og's "not available", and its copy of `results_index.py` leaves out the `acmg_sf` section as og's index does. Six summaries whose PRS scores the Python's HTML report cannot render run as text-only cases. One case, `m-optin-viral-na`, is compared with its committed goldens instead: og's viral line differs from the Python's on purpose there. The Python still runs, so a golden it matches fails as stale. +The `report-render` cases render the summaries that `gen/report-corpus.sh` writes: each summary-collect folder collected whole by `og summary collect`, and changes of a few of those summaries made with `jq`. Both reports are compared whole, byte for byte, against `bin/render_report.py`'s: every section, the charts and the closing gene list. The generator's `oracle.sh` reads a null PRS count as og's "not available", and its copy of `results_index.py` leaves out the `acmg_sf` section as og's index does. Six summaries whose PRS scores the Python's HTML report cannot render run as text-only cases. Cases where og's report differs from the Python's on purpose are compared with their committed goldens instead: `m-optin-viral-na` for its viral line, and the cases that show the SV support reason of a consensus that cannot tell. `report-corpus.sh` fixes each summary's `generated_utc`, so those goldens stay stable. The Python still runs, so a golden it matches fails as stale. From ff501c3c7cf8f1305c49a70590500574dbb9a52a Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 21:54:02 +0100 Subject: [PATCH 24/38] fix(carrier): let no weak call make an allele firm or give it a phase A HIGH-impact record of the clinical VCF for the same variant made a weak call count as confident on the secondary-findings card, because the card read only step 06's low_confidence mark. With the record's phase set it proved a pair biallelic from a weak phase alone, and beside a deletion it cleared the low-confidence word. The card now also treats a call whose HIGH-impact record has weak_call as low confidence. The carrier list paired a weak combined allele with a deletion by the weak row's own GT and phase set, while the card used its confident part. The list now pairs it the same way: by the first confident row of the same allele with as many copies. The card dropped the phase of a combined allele whose confident call gives fewer copies than the weak one, although that phase came from the confident call. Every small allele now counts with the copies, GT and phase set of its confident call. The agreement test gains eight shapes (H1, H2, H3p, H5, X4, X4b, X9b, X10); each fails on the previous head. Part of #411 (clin-19). --- CHANGELOG.md | 2 +- docs/results/secondary-findings.md | 6 +- rust/crates/og-summary/src/collect/acmg.rs | 39 +++--- rust/crates/og-summary/src/collect/carrier.rs | 30 +++- .../tests/i411_carrier_confidence.rs | 131 +++++++++++++++++- 5 files changed, 178 insertions(+), 30 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index fccca7cc2..99f1521ce 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer: on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. On the card a low-confidence call is one below step 06's call floor or a weak HIGH-impact call (`weak_call`). A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and it then counts with the copies, GT and phase set of that confident call, beside a deletion too. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer when the hits file and the clinical VCF state the same call floor, apart from one rare deletion shape where the card is more cautious: on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - One section that cannot be written no longer stops the whole report. Step 24, the Nextflow `HTML_REPORT` module and `scripts/generate-report.sh` ran `bin/render_report.py`, and a section whose data it could not read stopped it with a Python error: the run got no text report and no HTML report at all. The three now run `og report render` (`rust/crates/og-render`), so no Python runs for the reports. A section that cannot be written says so in its own place, `[could not be read: ...]` in the text report and an Unreadable card in the HTML report, and every other section is still written; `og report render` prints one `WARNING` line on stderr that counts and names those parts, and still exits 0. A panic inside a section writer counts the same way, so the release build now unwinds on a panic (`rust/Cargo.toml`); a panic anywhere else still aborts og at once, through the panic hook og installs first. A search index or charts file that cannot be made is written empty and named in the same `WARNING` line. On the 164 report-render parity summaries (154 before, and 10 new ones that reach each state of the mosaic sex-loss, raw-data export and structural-variant sections) both reports are byte for byte the Python's, whole, with two changes on purpose: a gene the ACMG card names is listed once in the closing gene list, not twice (the `acmg_sf` section repeats the card the clinical section holds), and a run whose BAM has no unplaced unmapped reads says the viral screen was not assessed instead of "no read". The checks of `tests/test_render_report.py` are cargo tests (`rust/og/tests/report_checks.rs`, and `rust/crates/og-render/tests/section_failure.rs` for a section that panics), and the Python file is gone. `bin/render_report.py`, `bin/report_charts.py` and `bin/results_index.py` stay only for the Python live site. - The reads drawing on a live finding page now says what it is before it is shown. It is the same nine bars on every finding, but its label read "The reads at " above it and only a caption after it said it was a sketch, so it looked like the person's own reads. The label now reads "Where to look at the reads: . An illustration, not your reads.", and the link to the real reads in the genome viewer stays. In the public demo, which has no reads, every offer of reads said so only after the click: the finding page's link, a card's "See the reads at" link, a chart mark's link and a search hit's "reads at " link opened a page saying the demo has none, and the map's card button and reads pill opened a panel saying so. They now read "Reads: not in the demo": the links are plain text, and the map's buttons still open the panel that says why. On any site, the map's reads panel, which opens under the map and often below the screen, now scrolls into view when it opens. The browser check `rust/crates/og-browser/tests/rv_live_reads_sketch_label.rs` builds the demo and checks all of it. No option, output or file name changes. - `og live serve` serves the live site from the one static `og` binary, in Rust: the home, run and family pages, `state.json` and its headlines, the event stream, the run files, the map, `/metrics` and the search, charts, ops and re-check plugins, with the same policy on every answer. It has no login yet, so it serves loopback only and refuses the password, TLS and proxy options with exit 2; `scripts/owngenome-live.sh` still starts the Python server ([Watch a Run Live](docs/live-site.md)). `bin/owngenome_recheck.py`, the shim that ran `og recheck`, is gone: call `bin/og recheck`. The Python checks of the site that `og live serve` now answers moved to `cargo test -p og-live`. diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index 17ae9a6c0..79dd76dd5 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,12 +14,12 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. -Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call, in `pair` and beside a deletion in `two_hits`. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. One rare shape reads more cautiously on the card: a weak homozygous call of a combined allele, a confident heterozygous call of a part of it and a deletion give the low-confidence word there and `possibly biallelic` here. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The card also reads the HIGH-impact calls of the clinical VCF, and the list does not. So when the hits file and the clinical VCF state different call floors, a call can be low confidence on the list and confident on the card. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: - a dominant gene (BRCA1, LDLR, MYH7 and most others): one pathogenic or likely pathogenic variant is reported; -- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. The card counts the variants twice, with every call and with the confident calls alone. A pair that needs a call below step 6's call floor (its `low_confidence` mark) is `possibly biallelic (low-confidence call)`: confirm that call first. A confident homozygous call, a confident pair or a confident deletion pair keeps `biallelic` even when another variant of the gene is a low-confidence call, and two confident variants of unknown phase stay `possibly biallelic`, even when a low-confidence call would prove the pair. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; +- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. The card counts the variants twice, with every call and with the confident calls alone. A pair that needs a low-confidence call is `possibly biallelic (low-confidence call)`: confirm that call first. A low-confidence call is one below step 6's call floor (its `low_confidence` mark), or a weak HIGH-impact call (a HIGH-impact record's `weak_call` mark: below the clinical call floor, or an allele balance out of range). A confident homozygous call, a confident pair or a confident deletion pair keeps `biallelic` even when another variant of the gene is a low-confidence call, and two confident variants of unknown phase stay `possibly biallelic`, even when a low-confidence call would prove the pair. A combined allele counts as confident when any call of it is. Then it counts with the copies, GT and phase set of that confident call. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; - HFE: only homozygous p.Cys282Tyr. A heterozygous p.Cys282Tyr or a homozygous p.His63Asp is not reported; - X-linked: GLA (Fabry disease) and OTC are reported in a hemizygous male and a heterozygous female alike. ABCD1 (X-linked adrenoleukodystrophy) is reported hemizygous, homozygous or with two heterozygous variants, never for one heterozygous variant; - BTD with p.Asp444His: reported as partial, not profound, biotinidase deficiency; @@ -29,7 +29,7 @@ Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, - **biallelic** when the reads show the two hits on different copies. Either the hit is called homozygous inside the deletion, so it sits on the one copy left (the line and the carrier list call it hemizygous; if the deletion is a false call, the hit is homozygous and both copies still carry it), or both calls carry read-backed phase (a `|` genotype with the same phase set, PS) on different copies. A low-expression (hypomorph) allele called homozygous inside a deletion is only **possibly biallelic**: it causes disease with a null allele only if the deletion is real, so confirm the deletion (array or MLPA); - **possibly biallelic** otherwise: the phase is unknown. Most short-read calls carry no phase, so this is the usual line. Step 05's checked table keeps no genotype column yet, and step 35's counts have no phase, so in a pipeline run a deletion pairs as possibly biallelic unless the hit is called homozygous inside it. A parent's genome (step 38, [family analysis](../multi-sample.md#family-analysis-step-38-opt-in)) or long reads can settle it; -- **possibly biallelic (low-confidence call)** when the pair would count but the small variant's call is below step 6's call floor (its `low_confidence` mark): confirm the call first; +- **possibly biallelic (low-confidence call)** when the pair would count but the small variant's call is low confidence: below step 6's call floor (its `low_confidence` mark), or on the card also a weak HIGH-impact call. Confirm the call first. A low-confidence call of a combined allele pairs by a confident call of the same allele (the combined call or a part of it) when that call gives as many copies, with that call's GT and phase set; - no line when read-backed phase puts both on the same copy (cis): the other copy is intact. Examples: an exon deletion of MUTYH plus a pathogenic MUTYH variant; three alpha-globin genes plus an HBA2 point variant; one SMN1 copy plus an SMN1 variant (short reads place few SMN1 variants reliably, so check with a targeted test); and the 1q21.1 deletion plus one of the two RBM8A low-expression alleles (c.-21G>A, rs139428292, or c.67+32G>C, rs201779890), the cause of TAR syndrome (thrombocytopenia with absent radius; Albers et al., Nat Genet 2012;44(4):435-439, PMID 22366785). On its own an RBM8A low-expression allele stays set aside. The [couple screen](../39-couple.md) (step 39) applies the same pairing between partners: a hypomorph allele of the list in one partner and a full loss of function in the same gene in the other (a ClinVar pathogenic variant, a Delly deletion) is a shared gene with its risk for a child; the allele in both partners, or in one alone, stays set aside. In the secondary-findings card a called deletion counts as one of the two variants a recessive gene needs, unless read-backed phase puts it on the variant's copy. The line under the carrier list names the deletion callers it read and the ones it could not read. A deletion AnnotSV ranks below class 4 is not counted. diff --git a/rust/crates/og-summary/src/collect/acmg.rs b/rust/crates/og-summary/src/collect/acmg.rs index 5547f8533..831b6270c 100644 --- a/rust/crates/og-summary/src/collect/acmg.rs +++ b/rust/crates/og-summary/src/collect/acmg.rs @@ -441,8 +441,9 @@ struct Cand { /// One distinct variant of a gene as the verdict counts it: its alt /// copies, ploidy, GT and phase set, whether it stands for a combined /// allele and its parts, and the alt copies its confident calls give (`firm`: -/// 0 when every call of it is below step 06's call floor, low confidence), -/// with the GT and phase set of the confident call that gives them. +/// 0 when every call of it is low confidence: below step 06's call floor, or +/// a weak HIGH-impact call), with the GT and phase set of the confident call +/// that gives them. #[derive(Debug, Clone, PartialEq)] struct Allele { copies: usize, @@ -638,25 +639,19 @@ fn sf_verdicts( } // The count again with only the copies confident calls give: a pair // that needs a low-confidence call is only possible until the call is - // confirmed. A small allele no confident call gives drops out; one whose - // confident calls give fewer copies than it counts loses its phase too, - // as that came from the low call; any other takes the GT and phase set - // of the confident call, so a phase only a low call gives proves - // nothing. A deletion counts as it is: its pair is judged by - // `two_hits_with`. + // confirmed. A small allele no confident call gives drops out; any other + // takes the copies, GT and phase set of the confident call that gives + // them, so a phase only a low call gives proves nothing. A deletion + // counts as it is: its pair is judged by `two_hits_with`. let firm: IndexMap = kept .iter() .filter(|(k, a)| !matches!(k, AKey::Small(_)) || a.firm > 0) .map(|(k, a)| { let mut f = a.clone(); if matches!(k, AKey::Small(_)) { - if a.firm < a.copies { - f.copies = a.firm; - f.ps = None; - } else { - f.gt = a.firm_gt.clone(); - f.ps = a.firm_ps.clone(); - } + f.copies = a.firm; + f.gt = a.firm_gt.clone(); + f.ps = a.firm_ps.clone(); } (k.clone(), f) }) @@ -666,8 +661,8 @@ fn sf_verdicts( ( Verdict::LowConfidence.word(), format!( - "a call it rests on is below the call floor (low confidence), so confirm it \ - first; {why}" + "a call it rests on is low confidence (below the call floor, or a weak \ + HIGH-impact call), so confirm it first; {why}" ), ) }; @@ -1018,8 +1013,14 @@ fn tier(i: &Inputs) -> Result, String> { // allele's own call stands for its parts. let (own, folded): (Vec<&Cand>, Vec<&Cand>) = small.iter().copied().partition(|x| unit(x) == x.key); - // A step 06 hit below its call floor (the ClinVar row's low_confidence). - let is_low = |x: &Cand| matches!(x.fields.get("low_confidence"), Some(Value::Bool(true))); + // A low-confidence call: a step 06 hit below its call floor (the + // ClinVar row's low_confidence), or a weak HIGH-impact call (its + // weak_call: the clinical call floor or allele balance). Neither makes + // its allele firm. + let is_low = |x: &Cand| { + matches!(x.fields.get("low_confidence"), Some(Value::Bool(true))) + || matches!(x.fields.get("weak_call"), Some(Value::Bool(true))) + }; for x in &own { let p = if x.ploidy == 0 { 2 } else { x.ploidy }; let a = alleles diff --git a/rust/crates/og-summary/src/collect/carrier.rs b/rust/crates/og-summary/src/collect/carrier.rs index 98a411a12..ce1184778 100644 --- a/rust/crates/og-summary/src/collect/carrier.rs +++ b/rust/crates/og-summary/src/collect/carrier.rs @@ -246,6 +246,8 @@ impl Carrier { // Which list each item is on: carriers (false) or set aside (true). let mut aside: Vec = Vec::new(); let mut variants: Vec<(Variant, usize)> = Vec::new(); + // The parts of each variant's combined allele, by the same index. + let mut vjoined: Vec> = Vec::new(); let mut low: HashSet<(String, VarKey)> = HashSet::new(); // The heterozygous carrier hits of each recessive gene, with the // items they are. @@ -325,6 +327,7 @@ impl Carrier { }, items.len() - 1, )); + vjoined.push(joined_keys(r)); } } } @@ -352,9 +355,32 @@ impl Carrier { .map(|(g, x)| (g.clone(), x.span.clone())) .collect(); let (dels, read, unread) = gene_deletions(deletions, &spans); - let vs: Vec = variants.iter().map(|(v, _)| v.clone()).collect(); + // A low-confidence row pairs with a deletion by a confident call of + // its combined allele, as the secondary-findings card counts it: the + // first confident row of the gene, with as many copies, that is a + // part of it or that it is a part of. That row's GT and phase set + // stand for it, and the pair no longer needs a low-confidence call. + let mut vs: Vec = variants.iter().map(|(v, _)| v.clone()).collect(); + let mut low_pair = low.clone(); + let is_low = |v: &Variant| low.contains(&(v.gene.clone(), v.key.clone())); + for (i, (v, _)) in variants.iter().enumerate() { + if !is_low(v) { + continue; + } + let sure = variants.iter().enumerate().find(|(j, (c, _))| { + c.gene == v.gene + && !is_low(c) + && c.copies >= v.copies + && (vjoined[i].contains(&c.key) || vjoined[*j].contains(&v.key)) + }); + if let Some((_, (c, _))) = sure { + vs[i].gt = c.gt.clone(); + vs[i].ps = c.ps.clone(); + low_pair.remove(&(v.gene.clone(), v.key.clone())); + } + } let found = two_hits_with(&vs, &dels, |v| { - low.contains(&(v.gene.clone(), v.key.clone())) + low_pair.contains(&(v.gene.clone(), v.key.clone())) }); for (v, at) in &variants { if let Some(t) = found.hemi.get(&(v.gene.clone(), v.key.clone())) { diff --git a/rust/crates/og-summary/tests/i411_carrier_confidence.rs b/rust/crates/og-summary/tests/i411_carrier_confidence.rs index 2ee6f9575..eb40fc17b 100644 --- a/rust/crates/og-summary/tests/i411_carrier_confidence.rs +++ b/rust/crates/og-summary/tests/i411_carrier_confidence.rs @@ -12,10 +12,11 @@ //! same hits (`assets/acmg_sf.tsv`): a pair that rests on a low-confidence //! call reads the same there, a low-confidence call beside a confident pair //! leaves it as it is, and MUTYH, on both lists, gets the same answer from -//! both cards over each shape of hits. +//! both cards over each shape of hits, some with a HIGH-impact record of +//! the clinical VCF beside the hit on the card. use indexmap::IndexMap; -use og_summary::collect::acmg::{Inputs, acmg_sf}; +use og_summary::collect::acmg::{ClinicalVcf, HighRecord, Inputs, acmg_sf}; use og_summary::collect::carrier::Carrier; use og_summary::collect::clinvar::{Floor, HitRecords, HitsVcf}; use og_summary::collect::two_hits::{DeletionInputs, SvRow}; @@ -429,16 +430,65 @@ fn a_deletion_plus_a_low_confidence_call_is_only_possibly_biallelic() { /// The ACMG SF card on step 06's hits alone (no clinical VCF). fn sf(hits: Vec>, dels: &DeletionInputs) -> IndexMap { + sf_with_high(hits, Vec::new(), dels) +} + +/// The ACMG SF card on step 06's hits plus a clinical VCF whose only +/// HIGH-impact records are `high` (none: no clinical VCF). +fn sf_with_high( + hits: Vec>, + high: Vec<(Site, HighRecord)>, + dels: &DeletionInputs, +) -> IndexMap { let h: Result = Ok((Floor::default(), hits)); + let clinical: Option> = (!high.is_empty()).then(|| { + Ok(ClinicalVcf { + records: high.len(), + high: Ok(high + .into_iter() + .map(|(s, r)| ((s.0.to_owned(), s.1, s.2.to_owned(), s.3.to_owned()), r)) + .collect()), + }) + }); obj(acmg_sf(&Inputs { assets: ASSETS, hits: Some(&h), - clinical: None, + clinical: clinical.as_ref(), deletions: dels, }) .unwrap()) } +type Site = (&'static str, i128, &'static str, &'static str); + +/// A HIGH-impact MUTYH stop-gain record of the clinical VCF for the hit at +/// `site`, with the hit's own GT and phase set, as a real run gives it, +/// called weak (GQ 5, DP 4) or confident (GQ 50, DP 30). +fn high(site: Site, gt: &str, ps: Option<&str>, weak: bool) -> (Site, HighRecord) { + let (gq, dp) = if weak { (5, 4) } else { (50, 30) }; + ( + site, + HighRecord { + genotype: gt.to_owned(), + ps: ps.map(str::to_owned), + genes: [("MUTYH".to_owned(), "stop_gained".to_owned())] + .into_iter() + .collect(), + transcript: "MANE", + frequency: "rare", + weak, + why: if weak { + vec!["GQ 5 < 30".to_owned(), "DP 4 < 10".to_owned()] + } else { + Vec::new() + }, + gq: Some(gq), + dp: Some(dp), + ad: None, + }, + ) +} + /// The `pair` word of each reported ClinVar row of `gene` on the SF card. fn sf_pairs(c: &IndexMap, gene: &str) -> Vec { let r = of(c, "clinvar_hits", gene); @@ -694,6 +744,8 @@ fn the_carrier_list_and_the_sf_card_agree_on_a_gene_on_both_lists() { let combined = |q: &str| hit(b, "MUTYH", "GT:GQ:DP:PS", &format!("0|1:{q}:9"), &joined); // The same combined allele, unphased and weak. let combined_open = || hit(b, "MUTYH", "GT:GQ:DP", "0/1:5:4", &joined); + // The same combined allele, called homozygous and weak. + let combined_hom = || hit(b, "MUTYH", "GT:GQ:DP", "1/1:5:4", &joined); // A second alt allele at MUTYH_A's position, for a split call there. let a2 = (a.0, a.1, a.2, "G"); let del = || mutyh_deletion("1|0", Some("9")); @@ -877,11 +929,80 @@ fn the_carrier_list_and_the_sf_card_agree_on_a_gene_on_both_lists() { ), ("deletion alone", vec![], del(), None), ("nothing", vec![], none(), None), + ( + "X4 weak hom combined, confident part, third in trans with the part", + vec![combined_hom(), g(a, "0|1", p9), g(cc, "1|0", p9)], + none(), + bi, + ), + ( + "X4b confident combined, weak hom part, third in trans with the combined", + vec![combined("50:30"), w(a, "1/1", None), g(cc, "1|0", p9)], + none(), + bi, + ), + ( + "X9b weak unphased combined, confident part in cis with the deletion", + vec![combined_open(), g(a, "0|1", p9)], + mutyh_deletion("0|1", p9), + None, + ), + ( + "X10 weak phased combined, confident part in cis with the deletion", + vec![combined("5:4"), g(a, "1|0", p9)], + del(), + None, + ), ]; + // The same weak calls with a HIGH-impact record of the variant on the + // card, weak too (its GT and phase set the call's own): the record is + // no confident call of it. + let hw = |site, gt, ps| high(site, gt, ps, true); + #[allow(clippy::type_complexity)] + let with_high: Vec<( + &str, + Vec>, + Vec<(Site, HighRecord)>, + DeletionInputs, + Option<&str>, + )> = vec![ + ( + "H1 weak het with a weak HIGH record + confident unphased het", + vec![w(a, "0/1", None), g(cc, "0/1", None)], + vec![hw(a, "0/1", None)], + none(), + low, + ), + ( + "H2 weak het with a weak HIGH record + unphased deletion", + vec![w(a, "0/1", None)], + vec![hw(a, "0/1", None)], + mutyh_deletion("0/1", None), + low, + ), + ( + "H3p weak het with a weak HIGH record, in trans with a confident het by its own phase", + vec![w(a, "0|1", p9), g(b, "1|0", p9)], + vec![hw(a, "0|1", p9)], + none(), + low, + ), + ( + "H5 two weak hets with weak HIGH records", + vec![w(a, "0/1", None), w(b, "0/1", None)], + vec![hw(a, "0/1", None), hw(b, "0/1", None)], + none(), + low, + ), + ]; + let all = shapes + .into_iter() + .map(|(l, h, d, w)| (l, h, Vec::new(), d, w)) + .chain(with_high); let mut wrong = Vec::new(); - for (label, hits, dels, want) in shapes { + for (label, hits, records, dels, want) in all { let carrier = list(hits.clone(), &dels); - let card = sf(hits, &dels); + let card = sf_with_high(hits, records, &dels); // The whole output of both cards, for a before/after diff. eprintln!("DUMP {label}\tSF {card:?}\tCARRIER {carrier:?}"); let (x, y) = (sf_answer(&card, "MUTYH"), carrier_answer(&carrier, "MUTYH")); From ae476dbe1fb6c93cbae472246204d8ab04c908f4 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 22:00:48 +0100 Subject: [PATCH 25/38] docs(carrier): name the weak HIGH-impact call where the two lists differ A HIGH-impact record is weak on a skewed allele balance too, not only below the clinical call floor. Such a call is now low confidence on the secondary-findings card and confident on the carrier list, even when both files state the same floor. The changelog and the results page said the two lists agree whenever the floors match; they now name this case. Part of #411 (clin-19). --- CHANGELOG.md | 2 +- docs/results/secondary-findings.md | 2 +- 2 files changed, 2 insertions(+), 2 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index 99f1521ce..43cde4eae 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. On the card a low-confidence call is one below step 06's call floor or a weak HIGH-impact call (`weak_call`). A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and it then counts with the copies, GT and phase set of that confident call, beside a deletion too. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer when the hits file and the clinical VCF state the same call floor, apart from one rare deletion shape where the card is more cautious: on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. On the card a low-confidence call is one below step 06's call floor or a weak HIGH-impact call (`weak_call`). A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and it then counts with the copies, GT and phase set of that confident call, beside a deletion too. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer, apart from one rare deletion shape where the card is more cautious and from a call the card judges by its HIGH-impact record (another call floor in the clinical VCF, or an allele balance out of range): on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - One section that cannot be written no longer stops the whole report. Step 24, the Nextflow `HTML_REPORT` module and `scripts/generate-report.sh` ran `bin/render_report.py`, and a section whose data it could not read stopped it with a Python error: the run got no text report and no HTML report at all. The three now run `og report render` (`rust/crates/og-render`), so no Python runs for the reports. A section that cannot be written says so in its own place, `[could not be read: ...]` in the text report and an Unreadable card in the HTML report, and every other section is still written; `og report render` prints one `WARNING` line on stderr that counts and names those parts, and still exits 0. A panic inside a section writer counts the same way, so the release build now unwinds on a panic (`rust/Cargo.toml`); a panic anywhere else still aborts og at once, through the panic hook og installs first. A search index or charts file that cannot be made is written empty and named in the same `WARNING` line. On the 164 report-render parity summaries (154 before, and 10 new ones that reach each state of the mosaic sex-loss, raw-data export and structural-variant sections) both reports are byte for byte the Python's, whole, with two changes on purpose: a gene the ACMG card names is listed once in the closing gene list, not twice (the `acmg_sf` section repeats the card the clinical section holds), and a run whose BAM has no unplaced unmapped reads says the viral screen was not assessed instead of "no read". The checks of `tests/test_render_report.py` are cargo tests (`rust/og/tests/report_checks.rs`, and `rust/crates/og-render/tests/section_failure.rs` for a section that panics), and the Python file is gone. `bin/render_report.py`, `bin/report_charts.py` and `bin/results_index.py` stay only for the Python live site. - The reads drawing on a live finding page now says what it is before it is shown. It is the same nine bars on every finding, but its label read "The reads at " above it and only a caption after it said it was a sketch, so it looked like the person's own reads. The label now reads "Where to look at the reads: . An illustration, not your reads.", and the link to the real reads in the genome viewer stays. In the public demo, which has no reads, every offer of reads said so only after the click: the finding page's link, a card's "See the reads at" link, a chart mark's link and a search hit's "reads at " link opened a page saying the demo has none, and the map's card button and reads pill opened a panel saying so. They now read "Reads: not in the demo": the links are plain text, and the map's buttons still open the panel that says why. On any site, the map's reads panel, which opens under the map and often below the screen, now scrolls into view when it opens. The browser check `rust/crates/og-browser/tests/rv_live_reads_sketch_label.rs` builds the demo and checks all of it. No option, output or file name changes. - `og live serve` serves the live site from the one static `og` binary, in Rust: the home, run and family pages, `state.json` and its headlines, the event stream, the run files, the map, `/metrics` and the search, charts, ops and re-check plugins, with the same policy on every answer. It has no login yet, so it serves loopback only and refuses the password, TLS and proxy options with exit 2; `scripts/owngenome-live.sh` still starts the Python server ([Watch a Run Live](docs/live-site.md)). `bin/owngenome_recheck.py`, the shim that ran `og recheck`, is gone: call `bin/og recheck`. The Python checks of the site that `og live serve` now answers moved to `cargo test -p og-live`. diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index 79dd76dd5..4a6128366 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,7 +14,7 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. -Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call, in `pair` and beside a deletion in `two_hits`. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. One rare shape reads more cautiously on the card: a weak homozygous call of a combined allele, a confident heterozygous call of a part of it and a deletion give the low-confidence word there and `possibly biallelic` here. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The card also reads the HIGH-impact calls of the clinical VCF, and the list does not. So when the hits file and the clinical VCF state different call floors, a call can be low confidence on the list and confident on the card. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call, in `pair` and beside a deletion in `two_hits`. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. One rare shape reads more cautiously on the card: a weak homozygous call of a combined allele, a confident heterozygous call of a part of it and a deletion give the low-confidence word there and `possibly biallelic` here. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The card also reads the HIGH-impact calls of the clinical VCF, and the list does not. So a call can be low confidence on one list and confident on the other: when the hits file and the clinical VCF state different call floors, or when the allele balance of a HIGH-impact call is out of range (then it is low confidence on the card only). The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: From 4299bb37ed317b7cf9bf65a4f9dc0ad8058ccd69 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 23:10:59 +0100 Subject: [PATCH 26/38] docs(carrier): name the real split between the two lists, not allele balance The docs said a HIGH-impact call weak on allele balance is low confidence on the card only. It never lowers a hit whose ClinVar row is confident, so that split does not exist. The real one is the HIGH-impact call of a part of a combined allele, which makes the allele confident on the card while the list marks it low confidence. Bead: clin-19 --- CHANGELOG.md | 2 +- docs/results/secondary-findings.md | 4 ++-- 2 files changed, 3 insertions(+), 3 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index 43cde4eae..dbf8af6e9 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. On the card a low-confidence call is one below step 06's call floor or a weak HIGH-impact call (`weak_call`). A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and it then counts with the copies, GT and phase set of that confident call, beside a deletion too. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer, apart from one rare deletion shape where the card is more cautious and from a call the card judges by its HIGH-impact record (another call floor in the clinical VCF, or an allele balance out of range): on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. On the card a low-confidence call is one below step 06's call floor or a weak HIGH-impact call (`weak_call`). A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and it then counts with the copies, GT and phase set of that confident call, beside a deletion too. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer, apart from one rare deletion shape where the card is more cautious and from a call the card judges by its HIGH-impact record (a lower call floor in the clinical VCF, or a HIGH-impact call of a part of a combined allele): on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - One section that cannot be written no longer stops the whole report. Step 24, the Nextflow `HTML_REPORT` module and `scripts/generate-report.sh` ran `bin/render_report.py`, and a section whose data it could not read stopped it with a Python error: the run got no text report and no HTML report at all. The three now run `og report render` (`rust/crates/og-render`), so no Python runs for the reports. A section that cannot be written says so in its own place, `[could not be read: ...]` in the text report and an Unreadable card in the HTML report, and every other section is still written; `og report render` prints one `WARNING` line on stderr that counts and names those parts, and still exits 0. A panic inside a section writer counts the same way, so the release build now unwinds on a panic (`rust/Cargo.toml`); a panic anywhere else still aborts og at once, through the panic hook og installs first. A search index or charts file that cannot be made is written empty and named in the same `WARNING` line. On the 164 report-render parity summaries (154 before, and 10 new ones that reach each state of the mosaic sex-loss, raw-data export and structural-variant sections) both reports are byte for byte the Python's, whole, with two changes on purpose: a gene the ACMG card names is listed once in the closing gene list, not twice (the `acmg_sf` section repeats the card the clinical section holds), and a run whose BAM has no unplaced unmapped reads says the viral screen was not assessed instead of "no read". The checks of `tests/test_render_report.py` are cargo tests (`rust/og/tests/report_checks.rs`, and `rust/crates/og-render/tests/section_failure.rs` for a section that panics), and the Python file is gone. `bin/render_report.py`, `bin/report_charts.py` and `bin/results_index.py` stay only for the Python live site. - The reads drawing on a live finding page now says what it is before it is shown. It is the same nine bars on every finding, but its label read "The reads at " above it and only a caption after it said it was a sketch, so it looked like the person's own reads. The label now reads "Where to look at the reads: . An illustration, not your reads.", and the link to the real reads in the genome viewer stays. In the public demo, which has no reads, every offer of reads said so only after the click: the finding page's link, a card's "See the reads at" link, a chart mark's link and a search hit's "reads at " link opened a page saying the demo has none, and the map's card button and reads pill opened a panel saying so. They now read "Reads: not in the demo": the links are plain text, and the map's buttons still open the panel that says why. On any site, the map's reads panel, which opens under the map and often below the screen, now scrolls into view when it opens. The browser check `rust/crates/og-browser/tests/rv_live_reads_sketch_label.rs` builds the demo and checks all of it. No option, output or file name changes. - `og live serve` serves the live site from the one static `og` binary, in Rust: the home, run and family pages, `state.json` and its headlines, the event stream, the run files, the map, `/metrics` and the search, charts, ops and re-check plugins, with the same policy on every answer. It has no login yet, so it serves loopback only and refuses the password, TLS and proxy options with exit 2; `scripts/owngenome-live.sh` still starts the Python server ([Watch a Run Live](docs/live-site.md)). `bin/owngenome_recheck.py`, the shim that ran `og recheck`, is gone: call `bin/og recheck`. The Python checks of the site that `og live serve` now answers moved to `cargo test -p og-live`. diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index 4a6128366..742dabaa3 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,12 +14,12 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. -Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call, in `pair` and beside a deletion in `two_hits`. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. One rare shape reads more cautiously on the card: a weak homozygous call of a combined allele, a confident heterozygous call of a part of it and a deletion give the low-confidence word there and `possibly biallelic` here. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The card also reads the HIGH-impact calls of the clinical VCF, and the list does not. So a call can be low confidence on one list and confident on the other: when the hits file and the clinical VCF state different call floors, or when the allele balance of a HIGH-impact call is out of range (then it is low confidence on the card only). The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call, in `pair` and beside a deletion in `two_hits`. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. One rare shape reads more cautiously on the card: a weak homozygous call of a combined allele, a confident heterozygous call of a part of it and a deletion give the low-confidence word there and `possibly biallelic` here. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The card also reads the HIGH-impact calls of the clinical VCF, and the list does not. So the card can count a call the list does not have: a HIGH-impact variant that is no ClinVar hit, or the HIGH-impact call of a part of a combined allele, which makes that allele confident on the card while the list marks it low confidence. When the clinical VCF states a lower call floor than the hits file, a call can also be low confidence on the list and confident on the card. A HIGH-impact call that is weak on allele balance alone never lowers a hit whose ClinVar row is confident. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: - a dominant gene (BRCA1, LDLR, MYH7 and most others): one pathogenic or likely pathogenic variant is reported; -- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. The card counts the variants twice, with every call and with the confident calls alone. A pair that needs a low-confidence call is `possibly biallelic (low-confidence call)`: confirm that call first. A low-confidence call is one below step 6's call floor (its `low_confidence` mark), or a weak HIGH-impact call (a HIGH-impact record's `weak_call` mark: below the clinical call floor, or an allele balance out of range). A confident homozygous call, a confident pair or a confident deletion pair keeps `biallelic` even when another variant of the gene is a low-confidence call, and two confident variants of unknown phase stay `possibly biallelic`, even when a low-confidence call would prove the pair. A combined allele counts as confident when any call of it is. Then it counts with the copies, GT and phase set of that confident call. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; +- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. The card counts the variants twice, with every call and with the confident calls alone. A pair that needs a low-confidence call is `possibly biallelic (low-confidence call)`: confirm that call first. A low-confidence call is one below step 6's call floor (its `low_confidence` mark), or a weak HIGH-impact call (a HIGH-impact record's `weak_call` mark: below the clinical call floor, or an allele balance out of range). A variant counts as confident when any call of it is: its ClinVar row or its HIGH-impact record. A confident homozygous call, a confident pair or a confident deletion pair keeps `biallelic` even when another variant of the gene is a low-confidence call, and two confident variants of unknown phase stay `possibly biallelic`, even when a low-confidence call would prove the pair. A combined allele counts as confident when any call of it is. Then it counts with the copies, GT and phase set of that confident call. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; - HFE: only homozygous p.Cys282Tyr. A heterozygous p.Cys282Tyr or a homozygous p.His63Asp is not reported; - X-linked: GLA (Fabry disease) and OTC are reported in a hemizygous male and a heterozygous female alike. ABCD1 (X-linked adrenoleukodystrophy) is reported hemizygous, homozygous or with two heterozygous variants, never for one heterozygous variant; - BTD with p.Asp444His: reported as partial, not profound, biotinidase deficiency; From 366365f3c799da69469395c245a3b76a4533b67f Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 23:10:59 +0100 Subject: [PATCH 27/38] fix(carrier): let a phased combined allele lend no phase to its weak part The carrier list rescued a weak part by its confident combined allele in every case. The card counts a part through its combined allele only when that allele is unphased and the part is its first part present, so a phased combined allele inside a deletion made its weak part just outside it read biallelic on the list. The SF card's deletion pair on a weak HIGH-impact call also blamed the call floor; it now names both kinds of low-confidence call. Bead: clin-19 --- rust/crates/og-summary/src/collect/acmg.rs | 14 ++++- rust/crates/og-summary/src/collect/carrier.rs | 22 ++++++- .../tests/i411_carrier_confidence.rs | 58 +++++++++++++++++++ 3 files changed, 90 insertions(+), 4 deletions(-) diff --git a/rust/crates/og-summary/src/collect/acmg.rs b/rust/crates/og-summary/src/collect/acmg.rs index 831b6270c..7a4e6d4a9 100644 --- a/rust/crates/og-summary/src/collect/acmg.rs +++ b/rust/crates/og-summary/src/collect/acmg.rs @@ -1118,9 +1118,21 @@ fn tier(i: &Inputs) -> Result, String> { _ => None, }) .collect(); - let found = two_hits_with(&variants, &dels, |v| { + let mut found = two_hits_with(&variants, &dels, |v| { low.contains(&(v.gene.clone(), v.key.clone())) }); + // The card's low calls include a weak HIGH-impact call, so its pairs + // name both kinds, as its own low-confidence word does. + let (floor, either) = ( + "the variant's call is below the call floor (low confidence)", + "the variant's call is low confidence (below the call floor, or a weak HIGH-impact call)", + ); + for e in found.entries.values_mut() { + e.why = e.why.replacen(floor, either, 1); + } + for t in found.pairs.values_mut() { + *t = t.replacen(floor, either, 1); + } let mut two: HashMap<(String, Key), String> = HashMap::new(); for g in found.entries.keys() { if matches!(rules[g].report_if.as_str(), "biallelic" | "hemizygous") { diff --git a/rust/crates/og-summary/src/collect/carrier.rs b/rust/crates/og-summary/src/collect/carrier.rs index ce1184778..59c87a738 100644 --- a/rust/crates/og-summary/src/collect/carrier.rs +++ b/rust/crates/og-summary/src/collect/carrier.rs @@ -358,11 +358,26 @@ impl Carrier { // A low-confidence row pairs with a deletion by a confident call of // its combined allele, as the secondary-findings card counts it: the // first confident row of the gene, with as many copies, that is a - // part of it or that it is a part of. That row's GT and phase set - // stand for it, and the pair no longer needs a low-confidence call. + // part of it, or an unphased combined allele whose first part present + // it is (the card counts such an allele under that part). A phased + // combined allele stands for its parts, so it never lends them its + // phase. That row's GT and phase set stand for it, and the pair no + // longer needs a low-confidence call. let mut vs: Vec = variants.iter().map(|(v, _)| v.clone()).collect(); let mut low_pair = low.clone(); let is_low = |v: &Variant| low.contains(&(v.gene.clone(), v.key.clone())); + let phased = |v: &Variant| { + v.ps.as_deref().is_some_and(|p| !p.is_empty()) + && phase_haps(Some(&v.gt)).is_some_and(|h| !h.is_empty()) + }; + // The first part of combined row `j` present among the gene's + // variants, in `PGP_JOINED_FROM` order. + let first_part = |j: usize| { + let g = &variants[j].0.gene; + vjoined[j] + .iter() + .find(|k| variants.iter().any(|(x, _)| &x.gene == g && &x.key == *k)) + }; for (i, (v, _)) in variants.iter().enumerate() { if !is_low(v) { continue; @@ -371,7 +386,8 @@ impl Carrier { c.gene == v.gene && !is_low(c) && c.copies >= v.copies - && (vjoined[i].contains(&c.key) || vjoined[*j].contains(&v.key)) + && (vjoined[i].contains(&c.key) + || (!phased(c) && first_part(*j) == Some(&v.key))) }); if let Some((_, (c, _))) = sure { vs[i].gt = c.gt.clone(); diff --git a/rust/crates/og-summary/tests/i411_carrier_confidence.rs b/rust/crates/og-summary/tests/i411_carrier_confidence.rs index eb40fc17b..a81913c93 100644 --- a/rust/crates/og-summary/tests/i411_carrier_confidence.rs +++ b/rust/crates/og-summary/tests/i411_carrier_confidence.rs @@ -489,6 +489,16 @@ fn high(site: Site, gt: &str, ps: Option<&str>, weak: bool) -> (Site, HighRecord ) } +/// The same HIGH-impact record with good GQ and DP, weak on its allele +/// balance alone (5 alt reads of 30 on a heterozygote). +fn high_ab(site: Site, gt: &str, ps: Option<&str>) -> (Site, HighRecord) { + let (s, mut r) = high(site, gt, ps, false); + r.weak = true; + r.why = vec!["alt reads 0.17 of the depth on a heterozygote".to_owned()]; + r.ad = Some("25,5".to_owned()); + (s, r) +} + /// The `pair` word of each reported ClinVar row of `gene` on the SF card. fn sf_pairs(c: &IndexMap, gene: &str) -> Vec { let r = of(c, "clinvar_hits", gene); @@ -511,6 +521,29 @@ fn the_sf_card_caps_a_deletion_pair_on_a_low_confidence_call() { assert_eq!(sf_pairs(&sure, "MUTYH"), ["biallelic"]); } +/// A HIGH-impact call weak on its allele balance alone is low confidence on +/// the card, and its deletion pair says so without blaming the call floor. +#[test] +fn the_sf_card_names_a_weak_high_impact_call_in_its_deletion_pair() { + let card = sf_with_high( + Vec::new(), + vec![high_ab(MUTYH_A, "0/1", None)], + &mutyh_deletion("0/1", None), + ); + let r = of(&card, "high_impact", "MUTYH"); + assert_eq!(r.len(), 1, "{card:?}"); + assert_eq!(s(r[0], "pair"), "possibly biallelic (low-confidence call)"); + let either = "low confidence (below the call floor, or a weak HIGH-impact call)"; + for k in ["phase", "two_hit"] { + let t = s(r[0], k); + assert!(t.contains(either), "{k}: {t}"); + assert!( + !t.contains("below the call floor (low confidence)"), + "{k}: {t}" + ); + } +} + #[test] fn the_sf_card_caps_a_phased_pair_on_a_low_confidence_call() { let weak = sf( @@ -748,6 +781,18 @@ fn the_carrier_list_and_the_sf_card_agree_on_a_gene_on_both_lists() { let combined_hom = || hit(b, "MUTYH", "GT:GQ:DP", "1/1:5:4", &joined); // A second alt allele at MUTYH_A's position, for a split call there. let a2 = (a.0, a.1, a.2, "G"); + // A confident phased combined allele at chr1:45336998, inside the test + // deletion, whose second part sits at chr1:45337002, just past its end. + let edge = ("chr1", 45_337_002, "C", "T"); + let straddle = || { + hit( + ("chr1", 45_336_998, "ATGCC", "GTGCT"), + "MUTYH", + "GT:GQ:DP:PS", + "0|1:50:30:9", + ";PGP_JOINED_FROM=chr1:45336998:A:G|chr1:45337002:C:T", + ) + }; let del = || mutyh_deletion("1|0", Some("9")); let none = no_deletions; let p9 = Some("9"); @@ -953,6 +998,12 @@ fn the_carrier_list_and_the_sf_card_agree_on_a_gene_on_both_lists() { del(), None, ), + ( + "N13 confident phased combined inside the deletion, weak part just outside it, deletion in trans", + vec![straddle(), w(edge, "0/1", None)], + del(), + maybe, + ), ]; // The same weak calls with a HIGH-impact record of the variant on the // card, weak too (its GT and phase set the call's own): the record is @@ -994,6 +1045,13 @@ fn the_carrier_list_and_the_sf_card_agree_on_a_gene_on_both_lists() { none(), low, ), + ( + "N1 confident het with a HIGH record weak on allele balance alone + confident unphased het", + vec![g(a, "0/1", None), g(cc, "0/1", None)], + vec![high_ab(a, "0/1", None)], + none(), + maybe, + ), ]; let all = shapes .into_iter() From a1b27b3df8851da4b637b3947b06c43988de656b Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 23:17:35 +0100 Subject: [PATCH 28/38] test(parity): regenerate 38 report-render goldens on main's SV support text Main now prints the SV caller support as main's code words it ("caller support not known (no step 22 consensus)" and the like), so the 38 report goldens this PR adds no longer matched og. Each file is og's own output from the merged tree; oracle-diff summary-collect report-render agrees on all 1097 items, and no summary-collect golden moved. Bead: clin-19 --- .../report-render/all-history/all-history.txt | 10 +++++----- tests/parity/golden/report-render/all/all.txt | 10 +++++----- .../golden/report-render/cb-full/cb-full.html | 8 ++++---- .../golden/report-render/cb-full/cb-full.txt | 18 +++++++++--------- .../cb-quoted-dosage/cb-quoted-dosage.html | 8 ++++---- .../cb-quoted-dosage/cb-quoted-dosage.txt | 18 +++++++++--------- .../cb-quoted-interval/cb-quoted-interval.html | 8 ++++---- .../cb-quoted-interval/cb-quoted-interval.txt | 18 +++++++++--------- .../cb-quoted-smn/cb-quoted-smn.html | 8 ++++---- .../cb-quoted-smn/cb-quoted-smn.txt | 18 +++++++++--------- .../cb-unicode-contig/cb-unicode-contig.html | 8 ++++---- .../cb-unicode-contig/cb-unicode-contig.txt | 18 +++++++++--------- .../m-clinical-escape/m-clinical-escape.html | 8 ++++---- .../m-clinical-escape/m-clinical-escape.txt | 18 +++++++++--------- .../m-clinical-stale/m-clinical-stale.html | 8 ++++---- .../m-clinical-stale/m-clinical-stale.txt | 18 +++++++++--------- .../m-clinvar-freq-note.html | 8 ++++---- .../m-clinvar-freq-note.txt | 18 +++++++++--------- .../m-clinvar-many/m-clinvar-many.html | 8 ++++---- .../m-clinvar-many/m-clinvar-many.txt | 18 +++++++++--------- .../m-clinvar-none/m-clinvar-none.html | 8 ++++---- .../m-clinvar-none/m-clinvar-none.txt | 18 +++++++++--------- .../m-couple-empty/m-couple-empty.html | 8 ++++---- .../m-couple-empty/m-couple-empty.txt | 18 +++++++++--------- .../report-render/m-couple/m-couple.html | 8 ++++---- .../golden/report-render/m-couple/m-couple.txt | 18 +++++++++--------- .../report-render/m-cpsr-none/m-cpsr-none.html | 8 ++++---- .../report-render/m-cpsr-none/m-cpsr-none.txt | 18 +++++++++--------- .../m-cpsr-noown/m-cpsr-noown.html | 8 ++++---- .../m-cpsr-noown/m-cpsr-noown.txt | 18 +++++++++--------- .../report-render/m-sf-notes/m-sf-notes.html | 8 ++++---- .../report-render/m-sf-notes/m-sf-notes.txt | 18 +++++++++--------- .../m-since-clinical/m-since-clinical.html | 8 ++++---- .../m-since-clinical/m-since-clinical.txt | 18 +++++++++--------- .../m-slivar-phase/m-slivar-phase.html | 8 ++++---- .../m-slivar-phase/m-slivar-phase.txt | 18 +++++++++--------- .../m-slivar-unphased/m-slivar-unphased.html | 8 ++++---- .../m-slivar-unphased/m-slivar-unphased.txt | 18 +++++++++--------- 38 files changed, 244 insertions(+), 244 deletions(-) diff --git a/tests/parity/golden/report-render/all-history/all-history.txt b/tests/parity/golden/report-render/all-history/all-history.txt index 84e4a5c3e..d6f60827b 100644 --- a/tests/parity/golden/report-render/all-history/all-history.txt +++ b/tests/parity/golden/report-render/all-history/all-history.txt @@ -200,13 +200,13 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- [New since 2021-01-01 00:00 UTC] - Class 4-5 SVs: 3 (single caller: 1; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 3 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:1100-5100 class 5 GENE1, GENE2 support: 2 callers (manta, delly) + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (no step 22 consensus) on exon edges: exon 2 benign-set AF 0.001 (gnomAD) - DUP 2:150-880 class 4 GENE3 support: 3 callers (manta, delly, tiddit, caller 4) - DEL 9:1-100 class 4 G9 support: single caller (tiddit) + DUP 2:150-880 class 4 GENE3 support: not known (no step 22 consensus) + DEL 9:1-100 class 4 G9 support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) @@ -611,7 +611,7 @@ CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) T2D 0.1 (10/20 variants matched) PGS000014 Short not available (not available/not available variants matched) PGS1 - Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. ## Blood Groups (predicted from the genome) --- diff --git a/tests/parity/golden/report-render/all/all.txt b/tests/parity/golden/report-render/all/all.txt index 9e0859df8..03c715856 100644 --- a/tests/parity/golden/report-render/all/all.txt +++ b/tests/parity/golden/report-render/all/all.txt @@ -186,13 +186,13 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 3 (single caller: 1; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 3 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:1100-5100 class 5 GENE1, GENE2 support: 2 callers (manta, delly) + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (no step 22 consensus) on exon edges: exon 2 benign-set AF 0.001 (gnomAD) - DUP 2:150-880 class 4 GENE3 support: 3 callers (manta, delly, tiddit, caller 4) - DEL 9:1-100 class 4 G9 support: single caller (tiddit) + DUP 2:150-880 class 4 GENE3 support: not known (no step 22 consensus) + DEL 9:1-100 class 4 G9 support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) @@ -570,7 +570,7 @@ CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) T2D 0.1 (10/20 variants matched) PGS000014 Short not available (not available/not available variants matched) PGS1 - Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. ## Blood Groups (predicted from the genome) --- diff --git a/tests/parity/golden/report-render/cb-full/cb-full.html b/tests/parity/golden/report-render/cb-full/cb-full.html index 588864b73..da5f01318 100644 --- a/tests/parity/golden/report-render/cb-full/cb-full.html +++ b/tests/parity/golden/report-render/cb-full/cb-full.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gained
    chr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -354,9 +354,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/cb-full/cb-full.txt b/tests/parity/golden/report-render/cb-full/cb-full.txt index ab3502a3c..2f2125230 100644 --- a/tests/parity/golden/report-render/cb-full/cb-full.txt +++ b/tests/parity/golden/report-render/cb-full/cb-full.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html index ea9891284..50c6f17ac 100644 --- a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -354,9 +354,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt index e4af1140f..4dd70693e 100644 --- a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html index 588864b73..da5f01318 100644 --- a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -354,9 +354,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt index ab3502a3c..2f2125230 100644 --- a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html index 588864b73..da5f01318 100644 --- a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -354,9 +354,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt index ab3502a3c..2f2125230 100644 --- a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html index 4730e2e56..da5f01318 100644 --- a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -354,9 +354,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 6; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHsingle caller (Manta)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt index 9c2957b3a..2f2125230 100644 --- a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 6; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: single caller (Manta) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html index d0d716b1f..98d967d9f 100644 --- a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -354,9 +354,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt index 9cfb76642..a02bc03a9 100644 --- a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html index afd02899a..81656e7a8 100644 --- a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html @@ -278,8 +278,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -362,9 +362,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt index 549dba951..f5910ef77 100644 --- a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt @@ -74,8 +74,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -138,16 +138,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html index 71cb39891..4c7f69b36 100644 --- a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -354,9 +354,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt index 14a79ff24..7be47c40d 100644 --- a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html index ece70cbb1..14fb3370b 100644 --- a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html @@ -316,8 +316,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -398,9 +398,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt index 351fd3e65..06b41f0b8 100644 --- a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt @@ -205,8 +205,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -267,16 +267,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html index fed6ce1e6..3001a07f3 100644 --- a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html @@ -238,8 +238,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -320,9 +320,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt index 2775a2396..680f40fdb 100644 --- a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt @@ -29,8 +29,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -91,16 +91,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html index d514f6db5..d42c0df81 100644 --- a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html @@ -273,8 +273,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -355,9 +355,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt index 1a6242848..201e3c3f5 100644 --- a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-couple/m-couple.html b/tests/parity/golden/report-render/m-couple/m-couple.html index 27436ddd2..0e4f04cec 100644 --- a/tests/parity/golden/report-render/m-couple/m-couple.html +++ b/tests/parity/golden/report-render/m-couple/m-couple.html @@ -273,8 +273,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -355,9 +355,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-couple/m-couple.txt b/tests/parity/golden/report-render/m-couple/m-couple.txt index 3dde7aea9..68ba48448 100644 --- a/tests/parity/golden/report-render/m-couple/m-couple.txt +++ b/tests/parity/golden/report-render/m-couple/m-couple.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html index e2d8c5fcf..b88e3b02f 100644 --- a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -339,9 +339,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt index c73177061..41b647e7b 100644 --- a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -118,16 +118,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html index d7820497d..563d5b2c4 100644 --- a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -344,9 +344,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt index 5e016d16b..c560033c8 100644 --- a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -124,16 +124,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html index 70e52e743..70a31868e 100644 --- a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -355,9 +355,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt index fd8beca52..732c94735 100644 --- a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -135,16 +135,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html index f49fdfd65..0b2e84ba7 100644 --- a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -354,9 +354,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt index 4f105b67d..a28702b2e 100644 --- a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt @@ -73,8 +73,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -136,16 +136,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html index d0f1fb5bb..eb10ee6a1 100644 --- a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -330,9 +330,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt index b17cbd9a6..58d139a78 100644 --- a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -114,16 +114,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html index 511f859c6..47607470f 100644 --- a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -328,9 +328,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt index e96760679..dcdbe1688 100644 --- a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -112,16 +112,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) From 7a6a81d6590198d5154812778e160ffcc2a99081 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 00:04:07 +0100 Subject: [PATCH 29/38] ci(e2e): weigh prs-3-panel-measure at 2900 s only on a run that is not traced A traced run skips the panel measure (measure_on in its file, #572), so its shard should not be planned around 2900 seconds of work that never runs. --- .github/workflows/e2e.yml | 13 +++++++------ docs/testing.md | 2 +- 2 files changed, 8 insertions(+), 7 deletions(-) diff --git a/.github/workflows/e2e.yml b/.github/workflows/e2e.yml index 7f1af299c..028f13ce9 100644 --- a/.github/workflows/e2e.yml +++ b/.github/workflows/e2e.yml @@ -119,12 +119,13 @@ env: E2E_SHARDS: 6 # Times that replace scripts/ci/e2e-case-times.tsv's for this run # (scripts/ci/e2e-shards.sh). prs-3-panel-measure measures the 1000 Genomes - # panel only on a run dispatched on a branch other than main (measure_on in - # its file), where it took 2684 to 3452 s (median 2900, runs 44488552622, - # 44616213787 and 44790003535 on the geiresx fork); elsewhere it takes 0 s, - # as the table says. Without this its shard got a full share of other cases - # on top and finished last. Set here, so every job of a run splits alike. - E2E_SECONDS: ${{ github.event_name == 'workflow_dispatch' && github.ref != 'refs/heads/main' && 'prs-3-panel-measure=2900' || '' }} + # panel only on a run dispatched on a branch other than main and not traced + # (measure_on in its file), where it took 2684 to 3452 s (median 2900, runs + # 44488552622, 44616213787 and 44790003535 on the geiresx fork); elsewhere it + # takes 0 s, as the table says. Without this its shard got a full share of + # other cases on top and finished last. Set here, so every job of a run + # splits alike. + E2E_SECONDS: ${{ github.event_name == 'workflow_dispatch' && github.ref != 'refs/heads/main' && !inputs.trace && 'prs-3-panel-measure=2900' || '' }} concurrency: group: ${{ github.workflow }}-${{ github.event_name }}-${{ github.ref }} diff --git a/docs/testing.md b/docs/testing.md index f5d53322f..71fcec1ff 100644 --- a/docs/testing.md +++ b/docs/testing.md @@ -77,7 +77,7 @@ You can build it yourself on Linux with Docker, `bgzip`, `tabix` and about 10 GB In CI the cases run in parallel legs, each case at most once: a pull request runs only the cases it can affect ([Which cases a pull request runs](#which-cases-a-pull-request-runs)), main and the monthly run run them all. On 2026-11-02 the 130 cases took 230 minutes one after another on one runner (run 41390434697), against a 300-minute job limit. Now: - `e2e-plan` splits the cases with [`scripts/ci/e2e-shards.sh`](https://github.com/GeiserX/OwnGenome/blob/main/scripts/ci/e2e-shards.sh). The leg `e2e base` runs the cases of stage `base` in [`scripts/ci/e2e-case-times.tsv`](https://github.com/GeiserX/OwnGenome/blob/main/scripts/ci/e2e-case-times.tsv) (every numbered case: the fixture check, setup validation, alignment, DeepVariant, GATK, the single steps on HG002, the reports and the Nextflow run; and `bash-step-08-hla`), because most other cases read what those wrote. Every other picked case goes to one of the shard legs (`e2e shard 1`, `e2e shard 2`, ...). A full run uses all `E2E_SHARDS` (6) legs. For picked cases, `e2e-shards.sh count` sets how many: the cases' total seconds divided by the heaviest group's seconds (the critical path, since a group is never split) or by 900 seconds when that is larger, rounded down, plus one more leg when the rest is 900 seconds or more, and never more than `E2E_SHARDS` (6). A shard leg spends 18 to 20 minutes on top of its cases (pulling images, fetching and unpacking the base outputs, the parity checks and the uploads; run 41847167444), so a leg with less than 15 minutes of cases costs more runner time than it saves in wall time. With every case that rule gives 4 or 5 legs, and that is why a full run does not use it: the runner's disk, not time, is what a leg runs out of. With 5 legs, shards of 30 and 37 cases filled one runner's disk until the runner itself died (run 41995851301, shard 3), while 6 legs passed on the same main (run 41995719742). -- The table holds each case's median time on the passing runs of nine e2e runs of 2026-11-04 (41766267038, 41767270253, 41773233871, 41774860458, 41779067613, 41790595358, 41799741941, 41807346887 and 41821518376), and its `needs`: the non-base cases whose outputs it reads. The needs were written from what each case says it reads (its header and its checks) and from the cases that failed in a split run without them (run 41455829120). A case and every case it needs, followed through, form a group that stays in one shard, in name order. Groups go to the least loaded shard, heaviest first. Every case needs a row: `e2e-shards.sh check`, which `tests/test_e2e_shards.sh` runs on the real table in the unit tests, fails and names each case without one. The split itself still runs a case with no row, as a 300-second case that needs nothing, so add the row with the case's measured seconds from its first passing run. A case whose cost depends on the run gets its time for that run from `E2E_SECONDS` (`CASE=SECONDS ...`), which `e2e.yml` sets for every job of the run, so they all split alike: `prs-3-panel-measure` measures the 1000 Genomes panel only on a run dispatched on a branch other than main, where it took 2684 to 3452 seconds (median 2900), and takes 0 seconds elsewhere, as its row says. Before, a dispatched run gave its shard a full share of other cases on top of those 48 minutes, and that shard finished last in 12 of 18 runs. `e2e-shards.sh seconds` prints the time each case is weighed by, and the plan job's summary names any time `E2E_SECONDS` replaced. +- The table holds each case's median time on the passing runs of nine e2e runs of 2026-11-04 (41766267038, 41767270253, 41773233871, 41774860458, 41779067613, 41790595358, 41799741941, 41807346887 and 41821518376), and its `needs`: the non-base cases whose outputs it reads. The needs were written from what each case says it reads (its header and its checks) and from the cases that failed in a split run without them (run 41455829120). A case and every case it needs, followed through, form a group that stays in one shard, in name order. Groups go to the least loaded shard, heaviest first. Every case needs a row: `e2e-shards.sh check`, which `tests/test_e2e_shards.sh` runs on the real table in the unit tests, fails and names each case without one. The split itself still runs a case with no row, as a 300-second case that needs nothing, so add the row with the case's measured seconds from its first passing run. A case whose cost depends on the run gets its time for that run from `E2E_SECONDS` (`CASE=SECONDS ...`), which `e2e.yml` sets for every job of the run, so they all split alike: `prs-3-panel-measure` measures the 1000 Genomes panel only on a run dispatched on a branch other than main and not traced, where it took 2684 to 3452 seconds (median 2900), and takes 0 seconds elsewhere, as its row says. Before, a dispatched run gave its shard a full share of other cases on top of those 48 minutes, and that shard finished last in 12 of 18 runs. `e2e-shards.sh seconds` prints the time each case is weighed by, and the plan job's summary names any time `E2E_SECONDS` replaced. - The job `og` builds `og` once, for the runners only (`OG_ARCHES=x86_64`, no macOS binaries; see `rust/og.sh`), and hands it to every leg as the artifact `og-e2e`. Guard's `rust` job and the Rust workflow's `images` job still build all four binaries. The base leg does not wait for `og` to start: it mounts the spare disk, frees disk, sets up Docker, Java and Nextflow, restores the image cache and pulls the images while `og` builds, and only then waits for `og-e2e` (step "Wait for og"). A shard leg finds the artifact at once. When the job `og` ends without it, the leg stops. - The base leg runs first. It packs every file its cases wrote or changed (at its absolute path, with owners, modes and times) and uploads it as the artifact `e2e-base`, kept for 3 days so that "Re-run failed jobs" the next day still finds it. The shard legs start only after it passed (`needs:`), so a shard never holds a runner while it waits: when many runs share the account's runners, shards that started early and waited took the runners the base legs needed (run 41506673662 had three shards running and its base leg still queued). Each shard fetches the artifact, tried up to five times, takes the base leg's work area, unpacks the archive there, deletes it (about 4 GB the cases need) and runs its cases. When the base leg fails, the shards are skipped and `e2e` is red. - The shard that holds `nextflow-from-fastq-2-nextflow` and the one that holds `nextflow-hardening-2-nf` run the parity checks; the plan fails when either case runs and the case before it in its pair is in a different shard. From 8befa62284e7180cd3316fc62d6c180eea943c3b Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 00:04:07 +0100 Subject: [PATCH 30/38] docs(prs): say the panel measure adds 35 to 80 minutes, as its case says --- docs/25-prs.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/25-prs.md b/docs/25-prs.md index c7c437ff7..b6ffd767c 100644 --- a/docs/25-prs.md +++ b/docs/25-prs.md @@ -179,7 +179,7 @@ The panel is pgsc_calc's 1000 Genomes database, `pgsc_1000G_v1.tar.zst` (`PGSC_P | Memory | 7.3 to 7.6 GB at the peak for the whole machine; the largest task, 6.9 to 7.1 GB (plink2 scoring the panel's own samples, and the panel's variant filter) | | Time | 20 to 30 minutes for the run, on 4 CPUs | -That run scored PGS000018 alone and fits a 16 GB machine; the default scores need more ([Memory](#memory)). It does not fit the 14 GB of disk a GitHub-hosted runner guarantees, and its download takes 13 to 31 minutes on a runner, so the panel stays opt-in (`setup.sh --ancestry-panel`), and the tests on every pull request project the fixture sample onto the PGS Catalog's 268 MB synthetic panel instead (`tests/e2e/prs-2-ancestry.sh`). The 1000 Genomes run above repeats on an E2E run dispatched on a branch other than main and not traced (or with `PGSC_MEASURE=1`): it adds about 40 minutes, which a dispatched run of main keeps for its other cases. +That run scored PGS000018 alone and fits a 16 GB machine; the default scores need more ([Memory](#memory)). It does not fit the 14 GB of disk a GitHub-hosted runner guarantees, and its download takes 13 to 31 minutes on a runner, so the panel stays opt-in (`setup.sh --ancestry-panel`), and the tests on every pull request project the fixture sample onto the PGS Catalog's 268 MB synthetic panel instead (`tests/e2e/prs-2-ancestry.sh`). The 1000 Genomes run above repeats on an E2E run dispatched on a branch other than main and not traced (or with `PGSC_MEASURE=1`): it adds 35 to 80 minutes, which a dispatched run of main keeps for its other cases. ## Interpreting Results From f6578120f55d6ecf451d564fa889f00c1430ab78 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 00:13:53 +0100 Subject: [PATCH 31/38] test(parity): regenerate report-render goldens for #559 with #571 #559 (carrier confidence) and #571 (SV support reason) each added the same 38 report-render goldens, each written by its own og. On the merged tree og prints both changes, so the 38 files are og's output on this tip: every line of each comes from one of the two sides, and oracle-diff now agrees on all 1097 summary-collect and report-render items (38 differed before). --- .../golden/report-render/all-history/all-history.txt | 6 +++--- tests/parity/golden/report-render/all/all.txt | 6 +++--- tests/parity/golden/report-render/cb-full/cb-full.html | 10 +++++----- tests/parity/golden/report-render/cb-full/cb-full.txt | 10 +++++----- .../cb-quoted-dosage/cb-quoted-dosage.html | 10 +++++----- .../cb-quoted-dosage/cb-quoted-dosage.txt | 10 +++++----- .../cb-quoted-interval/cb-quoted-interval.html | 10 +++++----- .../cb-quoted-interval/cb-quoted-interval.txt | 10 +++++----- .../report-render/cb-quoted-smn/cb-quoted-smn.html | 10 +++++----- .../report-render/cb-quoted-smn/cb-quoted-smn.txt | 10 +++++----- .../cb-unicode-contig/cb-unicode-contig.html | 10 +++++----- .../cb-unicode-contig/cb-unicode-contig.txt | 10 +++++----- .../m-clinical-escape/m-clinical-escape.html | 10 +++++----- .../m-clinical-escape/m-clinical-escape.txt | 10 +++++----- .../m-clinical-stale/m-clinical-stale.html | 10 +++++----- .../m-clinical-stale/m-clinical-stale.txt | 10 +++++----- .../m-clinvar-freq-note/m-clinvar-freq-note.html | 10 +++++----- .../m-clinvar-freq-note/m-clinvar-freq-note.txt | 10 +++++----- .../report-render/m-clinvar-many/m-clinvar-many.html | 10 +++++----- .../report-render/m-clinvar-many/m-clinvar-many.txt | 10 +++++----- .../report-render/m-clinvar-none/m-clinvar-none.html | 10 +++++----- .../report-render/m-clinvar-none/m-clinvar-none.txt | 10 +++++----- .../report-render/m-couple-empty/m-couple-empty.html | 10 +++++----- .../report-render/m-couple-empty/m-couple-empty.txt | 10 +++++----- .../parity/golden/report-render/m-couple/m-couple.html | 10 +++++----- .../parity/golden/report-render/m-couple/m-couple.txt | 10 +++++----- .../golden/report-render/m-cpsr-none/m-cpsr-none.html | 10 +++++----- .../golden/report-render/m-cpsr-none/m-cpsr-none.txt | 10 +++++----- .../report-render/m-cpsr-noown/m-cpsr-noown.html | 10 +++++----- .../golden/report-render/m-cpsr-noown/m-cpsr-noown.txt | 10 +++++----- .../golden/report-render/m-sf-notes/m-sf-notes.html | 10 +++++----- .../golden/report-render/m-sf-notes/m-sf-notes.txt | 10 +++++----- .../m-since-clinical/m-since-clinical.html | 10 +++++----- .../m-since-clinical/m-since-clinical.txt | 10 +++++----- .../report-render/m-slivar-phase/m-slivar-phase.html | 10 +++++----- .../report-render/m-slivar-phase/m-slivar-phase.txt | 10 +++++----- .../m-slivar-unphased/m-slivar-unphased.html | 10 +++++----- .../m-slivar-unphased/m-slivar-unphased.txt | 10 +++++----- 38 files changed, 186 insertions(+), 186 deletions(-) diff --git a/tests/parity/golden/report-render/all-history/all-history.txt b/tests/parity/golden/report-render/all-history/all-history.txt index ef251f96e..5f802f3b4 100644 --- a/tests/parity/golden/report-render/all-history/all-history.txt +++ b/tests/parity/golden/report-render/all-history/all-history.txt @@ -332,15 +332,15 @@ ## Carrier List (this sample) --- [New since 2021-01-01 00:00 UTC] - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); Parascopy's SMN1 count (step 35); not read: step 35's HBA1/HBA2 count: not called diff --git a/tests/parity/golden/report-render/all/all.txt b/tests/parity/golden/report-render/all/all.txt index e2600a51d..9eb954616 100644 --- a/tests/parity/golden/report-render/all/all.txt +++ b/tests/parity/golden/report-render/all/all.txt @@ -310,15 +310,15 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); Parascopy's SMN1 count (step 35); not read: step 35's HBA1/HBA2 count: not called diff --git a/tests/parity/golden/report-render/cb-full/cb-full.html b/tests/parity/golden/report-render/cb-full/cb-full.html index 7d6bb92a9..452a35b3b 100644 --- a/tests/parity/golden/report-render/cb-full/cb-full.html +++ b/tests/parity/golden/report-render/cb-full/cb-full.html @@ -394,18 +394,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/cb-full/cb-full.txt b/tests/parity/golden/report-render/cb-full/cb-full.txt index 94b2ba22f..06a377aea 100644 --- a/tests/parity/golden/report-render/cb-full/cb-full.txt +++ b/tests/parity/golden/report-render/cb-full/cb-full.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html index e9a5fbb73..788cb4191 100644 --- a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html @@ -394,18 +394,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt index 2d4f39b53..3f5176dea 100644 --- a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html index 7d6bb92a9..452a35b3b 100644 --- a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html @@ -394,18 +394,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt index 94b2ba22f..06a377aea 100644 --- a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html index 7d6bb92a9..452a35b3b 100644 --- a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html @@ -394,18 +394,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt index 94b2ba22f..06a377aea 100644 --- a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html index 7d6bb92a9..452a35b3b 100644 --- a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html @@ -394,18 +394,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt index 94b2ba22f..06a377aea 100644 --- a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html index 8faaf8ce0..a922e0a52 100644 --- a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html @@ -394,18 +394,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (x <y> & z; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt index c4237beb3..a4ece0c48 100644 --- a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (x & z; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html index f7824baab..3cac70c83 100644 --- a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html @@ -403,18 +403,18 @@

    Carrier List (this sample)

    Step 06 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    STALE: note of carrier <&>
    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt index e34bf5c21..82d31461c 100644 --- a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt @@ -160,18 +160,18 @@ ## Carrier List (this sample) --- [STALE: note of carrier <&>] - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html index fe45fe133..4f5be96f6 100644 --- a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html @@ -394,18 +394,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt index ded5b0175..4be3275d9 100644 --- a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html index 77f14856c..065ab269f 100644 --- a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html @@ -438,18 +438,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt index 6c35ceac1..77cc1df16 100644 --- a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt @@ -288,18 +288,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html index d635a5050..dc636873b 100644 --- a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html @@ -360,18 +360,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt index c7056e920..d72ad6faa 100644 --- a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt @@ -112,18 +112,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html index 3b396cf6f..20e2e619b 100644 --- a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html @@ -395,18 +395,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt index 901ce6cc7..a08eaea38 100644 --- a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-couple/m-couple.html b/tests/parity/golden/report-render/m-couple/m-couple.html index d866af2b6..f35955562 100644 --- a/tests/parity/golden/report-render/m-couple/m-couple.html +++ b/tests/parity/golden/report-render/m-couple/m-couple.html @@ -395,18 +395,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-couple/m-couple.txt b/tests/parity/golden/report-render/m-couple/m-couple.txt index dfd48d62c..13230ddce 100644 --- a/tests/parity/golden/report-render/m-couple/m-couple.txt +++ b/tests/parity/golden/report-render/m-couple/m-couple.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html index 88a023be6..70e8f7f78 100644 --- a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html @@ -379,18 +379,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt index 438e209b2..ff0b41d4c 100644 --- a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt @@ -139,18 +139,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html index 158a4f7c6..7159d4e8f 100644 --- a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html @@ -384,18 +384,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt index 9e9ae40ff..d0e48bfc5 100644 --- a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt @@ -145,18 +145,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html index 25128ef05..7c9a9dd25 100644 --- a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html @@ -395,18 +395,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt index 2ed7ebc29..8ece36f9b 100644 --- a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt @@ -156,18 +156,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html index f3204a08b..b6856ca65 100644 --- a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html @@ -394,18 +394,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt index 760948d7d..0ee19e856 100644 --- a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt @@ -158,18 +158,18 @@ ## Carrier List (this sample) --- [New since 2026-01-01T00:00:00Z] - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html index 3fec4ad98..34f4965b7 100644 --- a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html @@ -370,18 +370,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt index 2e036d5f3..c801d0115 100644 --- a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt @@ -135,18 +135,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html index 475f4c332..4bddb1ce6 100644 --- a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html @@ -368,18 +368,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt index 39e44dd84..f70473f5a 100644 --- a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt @@ -133,18 +133,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way From cc4b811fd2470afc1d0913cb677196f60e78f144 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 00:50:56 +0100 Subject: [PATCH 32/38] docs(carrier): name the deletion-straddle shape where the SF card is more cautious --- CHANGELOG.md | 2 +- docs/results/secondary-findings.md | 2 +- 2 files changed, 2 insertions(+), 2 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index c1071d80f..b4d7fcd81 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -5,7 +5,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased - The E2E run dispatched on a batch of pull requests finishes sooner, with every case and check it ran before. The shard split now weighs `prs-3-panel-measure` at its measured 2900 seconds on a run dispatched on a branch (`E2E_SECONDS`), where it measures the 1000 Genomes panel, so its shard no longer gets a full share of other cases on top. The base leg sets up while `og` builds, and the job `og` builds only the Linux x86_64 binary the legs run (`OG_ARCHES`, `OG_DARWIN_ARCHES` in `rust/og.sh`); Guard's `rust` job still builds all four on every pull request, as does the Rust `images` job when it runs. The nightly Rust run, which is the `streams` job only, now builds only `og-linux-x86_64`, the binary it runs. Container Test runs at most 8 smoke rows at once, so a change to every image no longer takes the runners the E2E legs wait for. The jobs that only build `og --release` lose their Rust cache, which did not speed them up, and Guard's `rust` job saves its cache on main only, so the E2E image and data caches fit the 10 GB budget. -- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. On the card a low-confidence call is one below step 06's call floor or a weak HIGH-impact call (`weak_call`). A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and it then counts with the copies, GT and phase set of that confident call, beside a deletion too. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer, apart from one rare deletion shape where the card is more cautious and from a call the card judges by its HIGH-impact record (a lower call floor in the clinical VCF, or a HIGH-impact call of a part of a combined allele): on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. On the card a low-confidence call is one below step 06's call floor or a weak HIGH-impact call (`weak_call`). A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and it then counts with the copies, GT and phase set of that confident call, beside a deletion too. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer, apart from rare deletion shapes where the card is more cautious (a combined allele across a deletion's end) and from a call the card judges by its HIGH-impact record (a lower call floor in the clinical VCF, or a HIGH-impact call of a part of a combined allele): on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - A step you selected that produced nothing now says so. A report-only Nextflow step (TelomereHunter, VNtyper, the CHIP genes and the others in `nextflow.config`) is dropped when it fails, after one retry when the exit was a memory kill. Its section had no file, so the report listed it as not run, the same as a step nobody asked for. `HTML_REPORT` now records the run's `--tools` list, and `og summary collect` lists selected sections with no file under Steps Not Run as "(selected, no result)", with a note naming the tool and the step. Y haplogroup, Y tree placement, and Y-STR markers get this label only for samples declared male. `summary.json` gets a new top-level list, `selected_no_result`, with those section keys. It is present only when the run recorded its tool list, so a bash run's summary is unchanged. The section's state stays `missing`. - One section that cannot be written no longer stops the whole report. Step 24, the Nextflow `HTML_REPORT` module and `scripts/generate-report.sh` ran `bin/render_report.py`, and a section whose data it could not read stopped it with a Python error: the run got no text report and no HTML report at all. The three now run `og report render` (`rust/crates/og-render`), so no Python runs for the reports. A section that cannot be written says so in its own place, `[could not be read: ...]` in the text report and an Unreadable card in the HTML report, and every other section is still written; `og report render` prints one `WARNING` line on stderr that counts and names those parts, and still exits 0. A panic inside a section writer counts the same way, so the release build now unwinds on a panic (`rust/Cargo.toml`); a panic anywhere else still aborts og at once, through the panic hook og installs first. A search index or charts file that cannot be made is written empty and named in the same `WARNING` line. On the 164 report-render parity summaries (154 before, and 10 new ones that reach each state of the mosaic sex-loss, raw-data export and structural-variant sections) both reports are byte for byte the Python's, whole, with two changes on purpose: a gene the ACMG card names is listed once in the closing gene list, not twice (the `acmg_sf` section repeats the card the clinical section holds), and a run whose BAM has no unplaced unmapped reads says the viral screen was not assessed instead of "no read". The checks of `tests/test_render_report.py` are cargo tests (`rust/og/tests/report_checks.rs`, and `rust/crates/og-render/tests/section_failure.rs` for a section that panics), and the Python file is gone. `bin/render_report.py`, `bin/report_charts.py` and `bin/results_index.py` stay only for the Python live site. - Nextflow's `docker` profile now runs each task as you, as the step scripts do, not as root. Before, every task ran with `--user root:root`, so a file a task wrote outside its work directory, beside an input under `GENOME_DIR`, stayed root's (Nextflow's `docker.fixOwnership` gives back only the work directory). Tasks now run with `-u` and your UID and GID, with `HOME=/tmp`. `CPSR` and `CNVPYTOR` still run as root, with `HOME=/root` as before: PCGR has not been shown to run unprivileged, which is why step 17 runs it as root too, and the CNVpytor module copies its resources into its image. A file those two write outside their work directory stays root's. The ids are written as bash's `${UID}:${GROUPS}`, which have no space. The PRS module, which hands the run's options on to pgsc_calc, now also drops a user flag with its whole value: a config's common `-u $(id -u):$(id -g)` gave pgsc_calc a stray `-g)` before. pgsc_calc's containers now also get `HOME=/tmp`. A sample folder written by an older run can hold root-owned files that a task running as you cannot overwrite: [troubleshooting](docs/troubleshooting.md#permission-denied-writing-to-mounted-volumes) gives the `chown` that takes it back. `tests/test_prs_runopts.sh` checks the profile's user and the PRS module's user flag drop, and the e2e case `prs-runopts-and-trace-1` checks the docker run line of every task of a stub run. diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index 742dabaa3..921caad0f 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,7 +14,7 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. -Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call, in `pair` and beside a deletion in `two_hits`. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. One rare shape reads more cautiously on the card: a weak homozygous call of a combined allele, a confident heterozygous call of a part of it and a deletion give the low-confidence word there and `possibly biallelic` here. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The card also reads the HIGH-impact calls of the clinical VCF, and the list does not. So the card can count a call the list does not have: a HIGH-impact variant that is no ClinVar hit, or the HIGH-impact call of a part of a combined allele, which makes that allele confident on the card while the list marks it low confidence. When the clinical VCF states a lower call floor than the hits file, a call can also be low confidence on the list and confident on the card. A HIGH-impact call that is weak on allele balance alone never lowers a hit whose ClinVar row is confident. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call, in `pair` and beside a deletion in `two_hits`. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. Rare shapes read more cautiously on the card. A combined allele that starts inside a deletion and ends past it, in trans with it by read-backed phase, is `possibly biallelic` there, because the card judges it at its start, a heterozygous call inside the deletion. Here its part past the deletion makes it `biallelic` in `two_hits`. A weak homozygous call of a combined allele, a confident heterozygous call of a part of it and a deletion give the low-confidence word there and `possibly biallelic` here. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The card also reads the HIGH-impact calls of the clinical VCF, and the list does not. So the card can count a call the list does not have: a HIGH-impact variant that is no ClinVar hit, or the HIGH-impact call of a part of a combined allele, which makes that allele confident on the card while the list marks it low confidence. When the clinical VCF states a lower call floor than the hits file, a call can also be low confidence on the list and confident on the card. A HIGH-impact call that is weak on allele balance alone never lowers a hit whose ClinVar row is confident. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: From 23eb52aff7e08525164eb4a99bf315e0fbc561d1 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 00:50:56 +0100 Subject: [PATCH 33/38] ci(e2e): say the panel measure time applies only on a run that is not traced --- scripts/ci/e2e-case-times.tsv | 5 +++-- 1 file changed, 3 insertions(+), 2 deletions(-) diff --git a/scripts/ci/e2e-case-times.tsv b/scripts/ci/e2e-case-times.tsv index 71ca018c4..630ff747c 100644 --- a/scripts/ci/e2e-case-times.tsv +++ b/scripts/ci/e2e-case-times.tsv @@ -18,8 +18,9 @@ # times again and prints a new file in its summary; its traced needs are an # upper bound to check by hand (docs/testing.md). # prs-3-panel-measure takes 0 s except on a run dispatched on a branch other -# than main, where it measures the 1000 Genomes panel for about 2900 s; there -# .github/workflows/e2e.yml gives it that time through E2E_SECONDS. +# than main and not traced, where it measures the 1000 Genomes panel for about +# 2900 s; there .github/workflows/e2e.yml gives it that time through +# E2E_SECONDS. 01-fixture base 17 - 10-validate-setup base 7 - 20-align-02 base 116 - From 9184fd454f2bb8664575edecd30e1bada1c64f94 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 01:01:39 +0100 Subject: [PATCH 34/38] test(live): carry the results veil and SMN1 agreement cases Bead: plat-31 Bead: D1 Bead: D14 --- rust/crates/og-live/tests/results_veil.rs | 175 ++++++++++++++++++++++ 1 file changed, 175 insertions(+) create mode 100644 rust/crates/og-live/tests/results_veil.rs diff --git a/rust/crates/og-live/tests/results_veil.rs b/rust/crates/og-live/tests/results_veil.rs new file mode 100644 index 000000000..fa9ed8c08 --- /dev/null +++ b/rust/crates/og-live/tests/results_veil.rs @@ -0,0 +1,175 @@ +use pycompat::json::{Value, loads}; +use std::{ + fs, + path::PathBuf, + sync::atomic::{AtomicUsize, Ordering}, +}; + +fn input(summary: &str) -> PathBuf { + static COUNTER: AtomicUsize = AtomicUsize::new(0); + let path = std::env::temp_dir().join(format!( + "og-results-test-{}-{}.json", + std::process::id(), + COUNTER.fetch_add(1, Ordering::Relaxed) + )); + fs::write(&path, summary).unwrap(); + path +} + +fn results(summary: &str, mode: &[&str]) -> Value { + let path = input(summary); + let mut args = vec![path.to_string_lossy().into_owned()]; + args.extend(mode.iter().map(|arg| (*arg).to_owned())); + let mut out = Vec::new(); + let mut err = Vec::new(); + let code = og_live::results::cli(&args, &mut out, &mut err); + fs::remove_file(path).unwrap(); + assert_eq!(code, 0, "{}", String::from_utf8_lossy(&err)); + loads(&String::from_utf8(out).unwrap()).unwrap() +} + +fn field<'a>(doc: &'a Value, path: &[&str]) -> &'a Value { + path.iter().fold(doc, |node, key| { + let Value::Object(object) = node else { + panic!("expected object at {key}") + }; + object + .get(*key) + .unwrap_or_else(|| panic!("missing key {key}")) + }) +} + +fn text_list(values: &[Option<&str>]) -> Value { + Value::Array( + values + .iter() + .map(|item| item.map_or(Value::Null, |text| Value::Str(text.into()))) + .collect(), + ) +} + +const CLOSED: &str = r#"{ + "sample":"TEST", + "sections":{ + "clinical":{"state":"ok","data":{"acmg_sf":{"clinvar_hits":[ + {"gene":"GENE1","variant":"chr2:110 A>G","genotype":"het","significance":"Pathogenic"} + ],"high_impact":[]}}}, + "clinvar":{"state":"ok","data":{"count":3,"hits":[ + {"gene":"GENE1","chrom":"chr2","pos":110,"ref":"A","alt":"G","stars":2}, + {"gene":"GENE1","chrom":"chr2","pos":130,"ref":"C","alt":"T","stars":1}, + {"gene":"GENE2","chrom":"chr3","pos":7,"ref":"T","alt":"C","stars":1} + ],"deep_intronic":[ + {"gene":"GENE1","chrom":"chr2","pos":123,"ref":"A","alt":"T","call":"het"}, + {"gene":"GENE2","chrom":"chr3","pos":8,"ref":"C","alt":"A","call":"het"} + ]}}, + "annotsv":{"state":"ok","data":{"consensus":true,"count":1,"rows":[ + {"type":"DEL","sv":"chr2:100-200","length":100,"acmg_class":"5","genes":["GENE1"],"support":null} + ]}}, + "exomiser":{"state":"ok","data":{"genes":[{"gene":"GENE1","rank":1},{"gene":"GENE2","rank":2}]}}, + "chip":{"state":"ok","data":{"genes":[{"gene":"GENE1","mean_depth":75,"detection_limit_vaf":0.06}], + "calls":[{"gene":"GENE2","vaf":0.08},{"gene":"GENE1","vaf":0.12}]}}, + "carrier":{"state":"ok","data":{"two_hits":{"genes":["SMN1"]}}}, + "paralogs":{"state":"ok","data":{"genes":[{"gene":"SMN1","copy_number":1,"status":"called"}, + {"gene":"SMN2","copy_number":2,"status":"called"}]}}, + "parascopy":{"state":"ok","data":{"smn1":{"text":"1","cn":1},"smn1_marker":{"status":"not assessed"}}} + } +}"#; + +#[test] +fn veil_distinguishes_exact_loci_spans_and_unrelated_rows() { + let doc = results(CLOSED, &[]); + let veil = field(&doc, &["veil"]); + let sf = Some("sf-gene1-chr2-110-a-g"); + let sv = Some("sv-chr2-100-200"); + assert_eq!( + field(veil, &["rows", "clinvar"]), + &text_list(&[sf, sf, None]) + ); + assert_eq!( + field(veil, &["viewer", "clinvar"]), + &text_list(&[sf, sf, None]) + ); + assert_eq!( + field(veil, &["rows", "structural-variants"]), + &text_list(&[sv]) + ); + assert_eq!(field(veil, &["rows", "exomiser"]), &text_list(&[sf, None])); + assert_eq!(field(veil, &["lines", "clinvar"]), &text_list(&[sf, None])); + assert_eq!( + field(veil, &["findings", "exomiser-gene1"]), + &Value::Str(sf.unwrap().into()) + ); + assert!(matches!(field(veil, &["marks", "genome"]), Value::Object(m) if !m.is_empty())); + assert!(matches!(field(veil, &["spans"]), Value::Array(a) if a.len() >= 3)); +} + +#[test] +fn veil_tags_widget_items_facts_and_closed_lead() { + let doc = results(CLOSED, &[]); + let veil = field(&doc, &["veil"]); + assert_eq!( + field(veil, &["widget", "chip"]), + &text_list(&[None, Some("sf-gene1-chr2-110-a-g")]) + ); + assert_eq!( + field(veil, &["widget", "paralogs"]), + &text_list(&[Some("two-hits-smn1"), None]) + ); + assert_eq!( + field(veil, &["facts", "paralogs"]), + &text_list(&[Some("two-hits-smn1"), Some("two-hits-smn1")]) + ); + let overview = results(CLOSED, &["--overview"]); + assert!(matches!(field(&overview, &["lead_closed"]), Value::Str(t) + if t.contains("closed until opened on purpose") && !t.contains("GENE1"))); + let Value::Array(top) = field(&overview, &["top"]) else { + panic!("missing top") + }; + assert!( + !top.iter() + .any(|f| field(f, &["id"]) == &Value::Str("exomiser-gene1".into())) + ); +} + +#[test] +fn no_act_has_no_tags_and_gene_only_closes_the_viewer_link() { + let base = r#"{"sections":{"clinvar":{"state":"ok","data":{"hits":[ + {"gene":"GENE1","chrom":"chr1","pos":7} + ]}}}}"#; + assert_eq!(field(&results(base, &[]), &["veil"]), &loads("{}").unwrap()); + let with_gene_only = base.replace( + r#""sections":{"#, + r#""sections":{ + "carrier":{"state":"ok","data":{"two_hits":{"genes":["GENE1"]}}},"#, + ); + let doc = results(&with_gene_only, &[]); + assert_eq!( + field(&doc, &["veil", "viewer", "clinvar"]), + &text_list(&[Some("two-hits-gene1")]) + ); +} + +#[test] +fn discordant_smn1_counts_use_the_report_verdict_without_carrier_finding() { + let doc = results( + r#"{"sections":{ + "paralogs":{"state":"ok","data":{"genes":[{"gene":"SMN1","copy_number":1,"status":"called","detail":"."}], + "smn1":{"agree":"disagree","paraphase":1,"parascopy":{"text":"2","cn":2}}}}, + "parascopy":{"state":"ok","data":{"smn1":{"text":"2","cn":2}}} + }}"#, + &[], + ); + let Value::Array(findings) = field(&doc, &["findings"]) else { + panic!("missing findings") + }; + assert!( + !findings + .iter() + .any(|f| field(f, &["id"]) == &Value::Str("smn1".into())) + ); + assert!( + pycompat::json::dumps(&doc, &Default::default()) + .unwrap() + .contains("they DISAGREE: check both before using either") + ); +} From cde3382a31c0f5c9e277eafaa7d7ead1078fa494 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 01:21:54 +0100 Subject: [PATCH 35/38] feat(live): build the results journal from the Rust report Bead: plat-31 Bead: D1 Bead: D14 --- CHANGELOG.md | 1 + rust/crates/og-live/src/headlines.rs | 248 ++++- rust/crates/og-live/src/results/clinical.rs | 467 ++++++++ rust/crates/og-live/src/results/clinvar.rs | 185 +++ rust/crates/og-live/src/results/lineage.rs | 175 +++ rust/crates/og-live/src/results/mod.rs | 1114 ++++++++++++++++++- rust/crates/og-live/src/results/pgx.rs | 161 +++ rust/crates/og-live/src/results/qc.rs | 164 +++ rust/crates/og-live/src/results/sv.rs | 542 +++++++++ rust/crates/og-live/src/results/traits.rs | 159 +++ rust/crates/og-live/src/server.rs | 3 +- rust/crates/og-live/src/veil.rs | 309 ++++- rust/crates/og-live/src/widgets.rs | 182 ++- rust/crates/og-live/tests/results_veil.rs | 10 +- 14 files changed, 3700 insertions(+), 20 deletions(-) create mode 100644 rust/crates/og-live/src/results/clinical.rs create mode 100644 rust/crates/og-live/src/results/clinvar.rs create mode 100644 rust/crates/og-live/src/results/lineage.rs create mode 100644 rust/crates/og-live/src/results/pgx.rs create mode 100644 rust/crates/og-live/src/results/qc.rs create mode 100644 rust/crates/og-live/src/results/sv.rs create mode 100644 rust/crates/og-live/src/results/traits.rs diff --git a/CHANGELOG.md b/CHANGELOG.md index b4d7fcd81..bc7e8dc93 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,6 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased +- `og live results` builds the live site's cards and findings from `summary.json` and shares wording and caveats with the Rust report. `og live serve` uses it for the results page. When Paraphase and Parascopy disagree on SMN1, the live card shows the report's warning and the journal makes no SMN1 carrier finding. - The E2E run dispatched on a batch of pull requests finishes sooner, with every case and check it ran before. The shard split now weighs `prs-3-panel-measure` at its measured 2900 seconds on a run dispatched on a branch (`E2E_SECONDS`), where it measures the 1000 Genomes panel, so its shard no longer gets a full share of other cases on top. The base leg sets up while `og` builds, and the job `og` builds only the Linux x86_64 binary the legs run (`OG_ARCHES`, `OG_DARWIN_ARCHES` in `rust/og.sh`); Guard's `rust` job still builds all four on every pull request, as does the Rust `images` job when it runs. The nightly Rust run, which is the `streams` job only, now builds only `og-linux-x86_64`, the binary it runs. Container Test runs at most 8 smoke rows at once, so a change to every image no longer takes the runners the E2E legs wait for. The jobs that only build `og --release` lose their Rust cache, which did not speed them up, and Guard's `rust` job saves its cache on main only, so the E2E image and data caches fit the 10 GB budget. - The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. On the card a low-confidence call is one below step 06's call floor or a weak HIGH-impact call (`weak_call`). A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and it then counts with the copies, GT and phase set of that confident call, beside a deletion too. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer, apart from rare deletion shapes where the card is more cautious (a combined allele across a deletion's end) and from a call the card judges by its HIGH-impact record (a lower call floor in the clinical VCF, or a HIGH-impact call of a part of a combined allele): on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - A step you selected that produced nothing now says so. A report-only Nextflow step (TelomereHunter, VNtyper, the CHIP genes and the others in `nextflow.config`) is dropped when it fails, after one retry when the exit was a memory kill. Its section had no file, so the report listed it as not run, the same as a step nobody asked for. `HTML_REPORT` now records the run's `--tools` list, and `og summary collect` lists selected sections with no file under Steps Not Run as "(selected, no result)", with a note naming the tool and the step. Y haplogroup, Y tree placement, and Y-STR markers get this label only for samples declared male. `summary.json` gets a new top-level list, `selected_no_result`, with those section keys. It is present only when the run recorded its tool list, so a bash run's summary is unchanged. The section's state stays `missing`. diff --git a/rust/crates/og-live/src/headlines.rs b/rust/crates/og-live/src/headlines.rs index 8757bbc4d..6a0f210ee 100644 --- a/rust/crates/og-live/src/headlines.rs +++ b/rust/crates/og-live/src/headlines.rs @@ -1,2 +1,246 @@ -//! The headlines of a results page. Empty until its unit of the 1.0.0 plan -//! lands. +//! The journal lead and the home page's open and closed versions. + +use crate::results::{Finding, Level, data, list, str_val, string, text, val}; +use crate::state::{get, obj, s}; +use og_render::model::{Summary, truthy}; +use pycompat::{fmt::fixed, json::Value}; +use std::collections::BTreeSet; + +pub(crate) struct LeadPart { + pub text: String, + bold: bool, + pub names_act: bool, +} + +impl LeadPart { + fn new(text: impl Into, bold: bool) -> Self { + Self { + text: text.into(), + bold, + names_act: false, + } + } + + pub(crate) fn json(self) -> Value { + let mut part = vec![s(&self.text), Value::Bool(self.bold)]; + if self.names_act { + part.push(s("act")); + } + Value::Array(part) + } +} + +fn screened(summary: &Summary) -> bool { + ["clinvar", "clinical", "cpsr"] + .iter() + .any(|key| summary.section(key).state.ran()) +} + +fn names(found: &[&Finding], limit: usize) -> String { + let mut titles = found + .iter() + .take(limit) + .map(|f| f.title.as_str()) + .collect::>(); + let Some(last) = titles.pop() else { + return String::new(); + }; + let mut names = if titles.is_empty() { + last.to_owned() + } else { + format!("{} and {last}", titles.join(", ")) + }; + if found.len() > limit { + names.push_str(&format!(", and {} more", found.len() - limit)); + } + names +} + +fn count(n: usize, one: &str, many: &str, capitalize: bool) -> String { + let word = [ + "zero", "one", "two", "three", "four", "five", "six", "seven", "eight", "nine", + ] + .get(n) + .map_or_else(|| n.to_string(), |word| (*word).to_owned()); + let mut text = format!("{word} {}", if n == 1 { one } else { many }); + if capitalize { + text[..1].make_ascii_uppercase(); + } + text +} + +pub(crate) fn lead(summary: &Summary, found: &[Finding]) -> Vec { + let by = |lv| found.iter().filter(|f| f.level == lv).collect::>(); + let mut lead = Vec::new(); + let trust = by(Level::Trust); + if !trust.is_empty() { + lead.push(LeadPart::new("Read the data-quality section first: ", true)); + lead.push(LeadPart::new(format!("{}. ", names(&trust, 3)), false)); + } + let act = by(Level::Act); + if !act.is_empty() { + lead.push(LeadPart::new( + "Of everything this genome was screened for, ", + false, + )); + lead.push(LeadPart::new( + format!( + "{} go to a doctor", + count(act.len(), "finding should", "findings should", false) + ), + true, + )); + lead.push(LeadPart { + text: format!(": {}. ", names(&act, 3)), + bold: false, + names_act: true, + }); + } else if screened(summary) { + lead.push(LeadPart::new( + "No finding in what these steps assessed needs a doctor; ", + true, + )); + lead.push(LeadPart::new( + "sections 8 and 9 say what they do not see. ", + false, + )); + } else { + lead.push(LeadPart::new( + "The clinical screens have no result yet; ", + true, + )); + lead.push(LeadPart::new( + "section 9 lists the steps that did not run. ", + false, + )); + } + let medicine = by(Level::Medicine); + if !medicine.is_empty() { + let genes = medicine + .iter() + .filter(|f| truthy(&f.gene)) + .map(|f| text(&f.gene)) + .collect::>() + .into_iter() + .collect::>(); + let verb = if medicine.len() == 1 { "bears" } else { "bear" }; + lead.push(LeadPart::new( + count(medicine.len(), "medicine result", "medicine results", true), + true, + )); + lead.push(LeadPart::new( + format!( + " {verb} on how drugs work ({}): tell whoever prescribes. ", + genes.join(", ") + ), + false, + )); + } + let carrier = by(Level::Carrier); + if !carrier.is_empty() { + lead.push(LeadPart::new( + format!("A carrier of {}", names(&carrier, 2)), + true, + )); + lead.push(LeadPart::new( + ": carriers are not affected; it matters when a partner carries the same gene. ", + false, + )); + } + let review = by(Level::Review); + if !review.is_empty() { + lead.push(LeadPart::new( + format!( + "{} worth a look", + count(review.len(), "result is", "results are", true) + ), + true, + )); + lead.push(LeadPart::new(format!(": {}. ", names(&review, 3)), false)); + } + let coverage = data(summary, "coverage"); + let qc = data(summary, "sample_qc"); + if trust.is_empty() + && let Some(depth) = match val(coverage, "mean_depth") { + Value::Int(n) => Some(*n as f64), + Value::Float(n) => Some(*n), + Value::Bool(n) => Some(f64::from(u8::from(*n))), + _ => None, + } + { + let checked = string(qc, "contamination") == "ok" && string(qc, "sex_check") == "ok"; + let note = if checked { + "the identity and contamination checks raised no flag." + } else { + "the identity and contamination checks have no result here: section 5 says why." + }; + lead.push(LeadPart::new( + format!("Mean depth {}×; {note}", fixed(depth, 1)), + false, + )); + } + if let Some(last) = lead.last_mut() { + last.text.truncate(last.text.trim_end().len()); + } + lead +} + +fn closed_segment(t: &str) -> String { + const CLOSED: &str = "closed until opened on purpose"; + if t.trim_start().starts_with(':') { + return format!(": {CLOSED}. "); + } + if let Some((start, end)) = t.find('(').zip(t.rfind(')')).filter(|(a, b)| a < b) { + return format!("{}({CLOSED}){}", &t[..start], &t[end + 1..]); + } + if let Some((start, _)) = t.split_once(" of ") { + return format!("{start} result, {CLOSED}"); + } + format!("{CLOSED}. ") +} + +pub(crate) fn overview(summary: &Summary, doc: &Value) -> Value { + let veil = val(doc, "veil"); + let named = val(veil, "findings"); + let mut top: Vec<_> = list(val(doc, "findings")) + .iter() + .filter(|f| string(f, "level") != "info" && get(named, string(f, "id")).is_none()) + .collect(); + top.sort_by_key(|f| match string(f, "level") { + "trust" => 0, + "act" => 1, + "medicine" => 2, + "review" => 3, + _ => 4, + }); + let tags = list(val(veil, "lead")); + let mut lead = String::new(); + let mut closed = String::new(); + for (i, part) in list(val(doc, "lead")).iter().map(list).enumerate() { + let text = part.first().map_or("", str_val); + lead.push_str(text); + if part.get(2).is_some_and(|x| str_val(x) == "act") { + closed.push_str(": closed until opened on purpose. "); + } else if tags.get(i).is_some_and(truthy) { + closed.push_str(&closed_segment(text)); + } else { + closed.push_str(text); + } + } + obj([ + ("attention", val(doc, "attention").clone()), + ("levels", val(doc, "levels").clone()), + ("screened", Value::Bool(screened(summary))), + ( + "top", + Value::Array( + top.into_iter() + .take(4) + .map(|f| obj(["id", "level", "title"].map(|key| (key, val(f, key).clone())))) + .collect(), + ), + ), + ("lead", s(&lead)), + ("lead_closed", s(&closed)), + ]) +} diff --git a/rust/crates/og-live/src/results/clinical.rs b/rust/crates/og-live/src/results/clinical.rs new file mode 100644 index 000000000..822029f03 --- /dev/null +++ b/rust/crates/og-live/src/results/clinical.rs @@ -0,0 +1,467 @@ +use super::clinvar::text_or_null; +use super::*; +use crate::widgets; +use og_render::sections::{acmg_sf, carrier, clinvar::D, comphet, cpsr, parascopy, smn1, two_hits}; + +fn sf_rows(summary: &Summary, sf: &Value) -> Read> { + if !truthy(sf) || truthy(val(sf, "unavailable")) { + return Ok(Vec::new()); + } + let consensus = truthy(val(data(summary, "annotsv"), "consensus")); + acmg_sf::rows(&D::new(sf, "clinical.acmg_sf"), consensus) +} + +fn carrier_rows(carrier: &Value) -> impl Iterator { + rows(val(carrier, "carriers")) + .iter() + .chain(rows(val(carrier, "hom_or_hemizygous"))) +} + +fn two_hit_genes(carrier: &Value) -> impl Iterator { + rows(val(val(carrier, "two_hits"), "genes")) + .iter() + .map(|g| { + if matches!(g, Value::Str(_)) { + g + } else { + val(g, "gene") + } + }) + .filter(|g| matches!(g, Value::Str(_))) +} + +fn smn1_pair(summary: &Summary) -> &Value { + val(data(summary, "paralogs"), "smn1") +} + +pub(super) fn card(id: &str, summary: &Summary) -> Read { + let mut out = Adapter::default(); + match id { + "clinical-filter" => { + let d = summary.section("clinical").data; + let sf = val(d, "acmg_sf"); + let bi = val(d, "by_impact"); + out.fact( + "Variants after the clinical filter", + cell(val(d, "variants")), + ); + out.fact( + "By impact (high / moderate / low)", + ["HIGH", "MODERATE", "LOW"] + .map(|k| default(bi, k, "0")) + .join(" / "), + ); + out.fact("Genes", cell(val(d, "genes"))); + let record = D::new(sf, "clinical.acmg_sf"); + if truthy(val(sf, "unavailable")) { + out.lines = acmg_sf::apart_lines(&record)?; + out.attention = true; + } else { + let rows = sf_rows(summary, sf)? + .into_iter() + .map(|(gene, variant, kind, rule)| { + [gene, variant, kind, rule] + .into_iter() + .map(|t| cell(&s(&t))) + .collect() + }) + .collect(); + out.table(&["Gene", "Variant", "Kind", "Rule"], rows); + let high = if truthy(val(sf, "high_impact_checked")) { + format!( + "{}{}", + acmg_sf::high_rare(&record)?, + acmg_sf::high_apart(&record)? + ) + } else { + "not checked".into() + }; + let version = text_or(val(sf, "version"), "ACMG SF"); + out.fact( + format!("{version}: ClinVar P/LP in its genes"), + list(val(sf, "clinvar_hits")).len().to_string(), + ); + out.fact("High-impact rare variants in its genes", high); + out.attention = ["clinvar_hits", "high_impact", "structural"] + .iter() + .any(|k| truthy(val(sf, k))); + } + } + "cpsr" => { + let sec = summary.section("cpsr"); + let d = sec.data; + out.fact( + "CPSR report", + if truthy(val(d, "html_report")) { + "Ran" + } else { + "No HTML" + }, + ); + for (k, v) in fields(val(d, "classification")) { + out.fact(k.replace('_', " "), cell(v)); + } + let rows = array(d, "plp")? + .iter() + .map(|x| { + let mut r = row(x, &["gene", "variant", "final"]); + r.push(text_or(val(x, "clinvar"), ".")); + r.push( + if truthy(val(x, "low_confidence")) { + "low confidence" + } else { + "." + } + .into(), + ); + r + }) + .collect(); + out.table(&["Gene", "Variant", "Final class", "ClinVar", "Call"], rows); + let dbs = summary.get("databases").unwrap_or(&Value::Null); + out.lines = cpsr::lines(&D::of(&sec), &D::new(dbs, "databases"))?; + out.links = vec!["cpsr"]; + } + "slivar" => { + let sec = summary.section("slivar"); + let d = sec.data; + out.facts( + d, + &[ + ("Prioritized variants", "prioritized"), + ("Compound-het candidate variants", "compound_het_variants"), + ("Compound-het candidate genes", "compound_het_genes"), + ], + ); + if get(d, "compound_het_phase").is_some() { + out.lines = comphet::phase_text(&D::of(&sec))?; + } + } + "exomiser" => { + let d = summary.section("exomiser").data; + let terms = array(d, "terms")? + .iter() + .map(|t| format!("{} ({})", text(val(t, "label")), text(val(t, "id")))) + .collect::>() + .join(", "); + out.fact("Symptoms searched", text_or(&s(&terms), "none")); + let mut hits = Vec::new(); + for g in array(d, "genes")? { + object_row(g)?; + let variants = array(g, "variants")?; + let entries = if variants.is_empty() { + &[Value::Null] + } else { + variants + }; + for v in entries { + let mut r = row(g, &["rank", "gene", "moi", "exomiser_score"]); + r.push(if truthy(val(v, "hgvs")) { + cell(val(v, "hgvs")) + } else { + cell(val(v, "variant")) + }); + r.extend(row(v, &["genotype", "acmg", "disease"])); + hits.push(r); + } + } + out.table( + &[ + "Rank", + "Gene", + "Inheritance", + "Score", + "Variant", + "Genotype", + "ACMG", + "Disease", + ], + hits, + ); + } + "carrier-list" => { + let sec = summary.section("carrier"); + let d = sec.data; + if truthy(val(d, "unavailable")) { + out.lines = carrier::lines(&D::of(&sec))?; + out.attention = true; + } else { + let calls = array(d, "carriers")? + .iter() + .chain(array(d, "hom_or_hemizygous")?); + let rows: Vec<_> = calls + .map(|c| { + row( + c, + &[ + "gene", + "variant", + "genotype", + "significance", + "stars", + "inheritance", + "condition", + ], + ) + }) + .collect(); + out.fact("Genes on the carrier list", cell(val(d, "genes_on_list"))); + out.fact("Carrier findings", rows.len().to_string()); + let two = val(d, "two_hits"); + let genes = array(two, "genes")?; + let genes_text = genes + .iter() + .map(|g| match g { + Value::Str(t) => t.clone(), + _ => default(g, "gene", "."), + }) + .collect::>() + .join(", "); + out.fact("Genes with two hits", text_or(&s(&genes_text), "none")); + out.table( + &[ + "Gene", + "Variant", + "Genotype", + "Significance", + "Stars", + "Inheritance", + "Condition", + ], + rows, + ); + let two = D::new(two, "carrier.two_hits"); + out.lines = two_hits::lines(Some(&two))?; + out.attention = !genes.is_empty(); + } + } + "couple" => { + let d = summary.section("couple").data; + out.fact("Partner", cell(val(d, "partner"))); + let shared = array(d, "shared")?; + let x_linked = array(d, "x_linked")?; + out.fact("Genes where both carry a change", shared.len().to_string()); + out.fact("X-linked findings", x_linked.len().to_string()); + out.fact( + "Genes where only one partner carries a change", + format!( + "{}, unless the other partner carries something the screen does not see", + default(d, "one_partner", "0") + ), + ); + let rows = [("Both carry", shared), ("X-linked", x_linked)] + .into_iter() + .flat_map(|(label, items)| { + items.iter().map(move |x| { + let mut r = vec![label.to_owned()]; + r.extend(row( + x, + &["gene", "condition", "risk", "own", "partner_findings"], + )); + r + }) + }) + .collect(); + out.table( + &[ + "Result", + "Gene", + "Condition", + "Chance for a child", + "This person", + "Partner", + ], + rows, + ); + } + "paralogs" => { + let parascopy = summary.section("parascopy"); + let pc = data(summary, "parascopy"); + if parascopy.state.ran() { + out.lines = parascopy::text_lines(¶scopy)?; + if truthy(val(pc, "smn1_marker")) { + out.fact("SMN1 copies", default(val(pc, "smn1"), "text", ".")); + out.fact( + "SMN1 g.27134T>G silent-carrier marker", + smn1::marker_state(val(pc, "smn1_marker"))?, + ); + } + } + let p = data(summary, "paralogs"); + if string(smn1_pair(summary), "agree") == "disagree" + && let Some(verdict) = smn1::smn1_text(smn1_pair(summary))? + { + out.lines.push(format!("SMN1 by both tools: {verdict}")); + } + let genes = array(p, "genes")?; + out.fields_table( + &["Gene", "Copies", "Status", "Detail"], + genes, + &["gene", "copy_number", "status", "detail"], + ); + out.extra("widget", widgets::copies(genes, pc)); + } + _ => unreachable!(), + } + Ok(out) +} + +pub(super) fn clinical_findings<'a>( + summary: &'a Summary, + found: &mut Vec, +) -> Vec<&'a Value> { + let sf = val(data(summary, "clinical"), "acmg_sf"); + let car = data(summary, "carrier"); + let sf_excluded = rows(val(sf, "clinvar_hits")) + .iter() + .filter(|x| matches!(x, Value::Object(_))) + .map(|x| val(x, "gene")); + let carrier_excluded = carrier_rows(car) + .filter(|x| matches!(x, Value::Object(_))) + .map(|x| val(x, "gene")); + let two_hit: BTreeSet<_> = two_hit_genes(car) + .map(str_val) + .filter(|g| !g.is_empty()) + .collect(); + match sf_rows(summary, sf) { + Ok(rows) => { + for (gene, variant, genotype, why) in rows { + found.push(Finding::new(Level::Act, "clinical-filter", &["sf", &gene, &variant], + format!("Secondary finding in {gene}"), + format!("A change in {gene} that the ACMG secondary-findings list reports: {why}.")) + .gene(&s(&gene)).detail(format!("{gene} {variant} {}", if genotype == "." { "" } else { &genotype })) + .evidence("Variant", &s(&variant)).evidence("Genotype", &s(&genotype)).evidence("Why it is reported", &s(&why))); + } + } + Err(err) => found.push(unreadable( + "clinical-filter", + Level::Act, + found.len(), + error_kind(&err), + )), + } + for x in rows(val(data(summary, "cpsr"), "plp")) { + add_row(found, "cpsr", Level::Act, || { + object_row(x)?; + let gene = val(x, "gene"); + let variant = val(x, "variant"); + Ok(Some(Finding::new(Level::Act, "cpsr", &["cpsr", &text_or_null(gene), &text_or_null(variant)], + format!("Cancer predisposition ({})", text(gene)), + format!("CPSR grades this change in {} as {}: it can raise the risk of some cancers. It is not a diagnosis of cancer.", + text(gene), text(val(x, "final")))).gene(gene) + .detail(format!("{} {}", text(gene), text(variant))) + .evidence_fields(x, &[("Class", "final"), ("ClinVar", "clinvar")]) + .evidence("Call", &if truthy(val(x, "low_confidence")) { s("low confidence") } else { Value::Null }))) + }); + } + for gene in two_hit { + found.push(Finding::new(Level::Act, "carrier-list", &["two-hits", gene], format!("Two changes in {gene}"), + format!("Two changes were found in {gene}, a gene where it takes two to cause the condition. Whether they sit on different copies decides whether it matters.")) + .gene(&s(gene))); + } + sf_excluded + .chain(carrier_excluded) + .chain(two_hit_genes(car)) + .collect() +} + +pub(super) fn family_findings(summary: &Summary, found: &mut Vec) { + let car = data(summary, "carrier"); + let paired: Vec<_> = two_hit_genes(car).collect(); + for c in carrier_rows(car) { + add_row(found, "carrier-list", Level::Act, || { + object_row(c)?; + let gene = val(c, "gene"); + if paired.contains(&gene) { + return Ok(None); + } + let g = text(gene); + let variant = val(c, "variant"); + let gt = text_or(val(c, "genotype"), ""); + let condition = val(c, "condition"); + let key = ["carrier", &text_or_null(gene), &text_or_null(variant)]; + let evidence = [ + ("Significance", "significance"), + ("Stars", "stars"), + ("Inheritance", "inheritance"), + ]; + let finding = if matches!(gt.as_str(), "hom" | "hemizygous") { + let (title, copies) = if gt == "hom" { + ("two changed copies", "two changed copies") + } else { + ("the only copy changed", "no unchanged copy") + }; + Finding::new(Level::Act, "carrier-list", &key, format!("{}: {title}", text_or(condition, &g)), + format!("This genome has {copies} of {g}, a gene of {} ({}). That is not the pattern of a carrier: a doctor or genetic counsellor reads it.", + text_or(condition, "a condition on the carrier list"), text_or(val(c, "inheritance"), "inheritance not given"))) + .detail(format!("{g} {} {gt}", text_or(variant, ""))).evidence("Genotype", &s(>)) + } else { + let title = if truthy(condition) { + format!("{} carrier", text(condition)) + } else { + format!("Carrier in {g}") + }; + Finding::new(Level::Carrier, "carrier-list", &key, title, + format!("A carrier has one changed copy of a gene where it takes two to cause the condition. This genome has one changed copy of {g}: a carrier, not affected.")) + .detail(format!("{g} {}", text_or(variant, ""))) + }; + Ok(Some(finding.gene(gene).evidence_fields(c, &evidence))) + }); + } + let cp = data(summary, "couple"); + for key in ["shared", "x_linked"] { + for x in rows(val(cp, key)) { + add_row(found, "couple", Level::Review, || { + object_row(x)?; + let gene = val(x, "gene"); + let g = text(gene); + let label = if key == "shared" { + format!("Both partners carry {g}") + } else { + format!("X-linked finding in {g}") + }; + Ok(Some( + Finding::new( + Level::Carrier, + "couple", + &["couple", key, &text_or_null(gene)], + label, + format!( + "{}: {} for each pregnancy, with {}.", + text_or(val(x, "condition"), &g), + text_or(val(x, "risk"), "see the couple screen"), + text(val(cp, "partner")) + ), + ) + .gene(gene) + .evidence("Chance for a child", val(x, "risk")) + .evidence("Partner", val(cp, "partner")), + )) + }); + } + } + add_row(found, "paralogs", Level::Review, || { + let pair = smn1_pair(summary); + if string(pair, "agree") == "disagree" && smn1::smn1_text(pair)?.is_some() { + return Ok(None); + } + let mut called = None; + for g in array(data(summary, "paralogs"), "genes")? { + object_row(g)?; + if string(g, "gene") == "SMN1" && string(g, "status") == "called" && called.is_none() { + called = Some(val(g, "copy_number")); + } + } + let (one, by) = if let Some(cn) = called { + (text(cn) == "1", "Paraphase") + } else { + ( + num(Some(val(val(data(summary, "parascopy"), "smn1"), "cn"))) == Some(1.0), + "Parascopy", + ) + }; + Ok(one.then(|| Finding::new(Level::Carrier, "paralogs", &["smn1"], "Spinal muscular atrophy carrier (SMN1)", + "One copy of SMN1 where most people have two: a carrier of spinal muscular atrophy, not affected.") + .gene(&s("SMN1")).evidence("SMN1 copies", &s("1")).evidence("Called by", &s(by)))) + }); +} diff --git a/rust/crates/og-live/src/results/clinvar.rs b/rust/crates/og-live/src/results/clinvar.rs new file mode 100644 index 000000000..645f6b1f6 --- /dev/null +++ b/rust/crates/og-live/src/results/clinvar.rs @@ -0,0 +1,185 @@ +use super::*; +use og_render::sections::{ + cdna, cdna_scan, + clinvar::{self, D, HITS_SHOWN}, + deep_intronic, +}; + +fn variant(h: &Value) -> String { + format!( + "{}:{} {}>{}", + text(val(h, "chrom")), + text(val(h, "pos")), + text(val(h, "ref")), + text(val(h, "alt")) + ) +} + +fn locus(h: &Value) -> String { + format!("{}:{}", text(val(h, "chrom")), text(val(h, "pos"))) +} + +fn stars(h: &Value, empty: &str) -> Read { + let stars = match val(h, "stars") { + v if !truthy(v) => 0, + Value::Int(n) => *n, + Value::Float(n) if n.is_finite() => *n as i128, + Value::Bool(n) => i128::from(*n), + Value::Str(s) => s + .trim() + .parse() + .map_err(|_| Malformed("stars is not an integer".into()))?, + _ => return Err(Malformed("stars is not an integer".into())), + }; + Ok(if stars <= 0 { + empty.into() + } else { + "★".repeat(stars.min(1000) as usize) + }) +} + +fn call(h: &D<'_>) -> Read { + let mut parts = Vec::new(); + let call = clinvar::call_text(h)?; + if !call.is_empty() { + parts.push(call); + } + if h.has("cdna") { + parts.push(format!("reads: {}", cdna::cdna_text(h)?)); + } + let combined = clinvar::combined_cell(h)?; + if !combined.is_empty() { + parts.push(combined); + } + Ok(if parts.is_empty() { + ".".into() + } else { + parts.join("; ") + }) +} + +fn frequency(h: &D<'_>) -> Read { + let frequency = clinvar::af_text(h)?; + Ok(if frequency.is_empty() { + "frequency unknown".into() + } else { + frequency + }) +} + +pub(super) fn card(summary: &Summary) -> Read { + let sec = summary.section("clinvar"); + let d = sec.data; + let mut out = Adapter::default(); + out.fact("P/LP matches", default(d, "count", "0")); + let by = val(d, "by_stars"); + out.fact( + "By review stars (4/3/2/1/0)", + ["4", "3", "2", "1", "0"] + .map(|n| default(by, n, "0")) + .join(" / "), + ); + let dbs = summary.get("databases").unwrap_or(&Value::Null); + out.fact( + "ClinVar file date", + text_or(val(dbs, "clinvar_release"), "unknown"), + ); + if let Some(n) = get(d, "low_confidence") { + let f = val(d, "call_floor"); + out.fact( + format!( + "Low-confidence calls (GQ below {} or DP below {}), not counted", + text(val(f, "GQ")), + text(val(f, "DP")) + ), + cell(n), + ); + } + let hits = array(d, "hits")?; + let mut table = Vec::new(); + let mut viewer = Vec::new(); + for h in hits.iter().take(HITS_SHOWN) { + object_row(h)?; + let hit = D::new(h, "ClinVar hit"); + table.push(vec![ + cell(val(h, "gene")), + variant(h), + cell(val(h, "genotype")), + cell(val(h, "significance")), + stars(h, "0")?, + frequency(&hit)?, + call(&hit)?, + ]); + viewer.push(locus(h)); + } + out.table( + &[ + "Gene", + "Variant", + "Genotype", + "Significance", + "Stars", + "Frequency", + "Call", + ], + table, + ); + out.extra("viewer", strings(viewer)); + if let Some(line) = clinvar::freq_line(&D::of(&sec))? { + out.lines.push(line); + } + out.lines.extend(cdna_scan::lines(&sec)?); + for x in array(d, "deep_intronic")? { + out.lines.push(format!( + "Known deep intronic site (always reported): {} {} {}: {}", + text(val(x, "gene")), + text(val(x, "hgvs")), + variant(x), + deep_intronic::call(&D::new(x, "deep intronic site"))? + )); + } + Ok(out) +} + +pub(super) fn findings(summary: &Summary, excluded: &[&Value], found: &mut Vec) { + for h in rows(val(data(summary, "clinvar"), "hits")) + .iter() + .take(HITS_SHOWN) + { + add_row(found, "clinvar", Level::Review, || { + object_row(h)?; + let gene = val(h, "gene"); + if excluded.contains(&gene) { + return Ok(None); + } + let d = D::new(h, "ClinVar hit"); + let significance = val(h, "significance"); + let genotype = val(h, "genotype"); + let copies = match str_val(genotype) { + "hom" => "two copies".into(), + "het" => "one copy".into(), + _ => text_or(genotype, "genotype not given"), + }; + let key = ["gene", "chrom", "pos", "ref", "alt"].map(|k| text_or_null(val(h, k))); + let mut finding = Finding::new(Level::Review, "clinvar", + &["clinvar", &key[0], &key[1], &key[2], &key[3], &key[4]], + format!("{} change in {}", text_or(significance, "Pathogenic"), text(gene)), + format!("ClinVar lists this change in {} as {}; this genome has {copies}. Whether it matters depends on how the gene is inherited: a genetic counsellor reads it with the rest of this report.", + text(gene), text_or(significance, "").to_lowercase())) + .gene(gene).detail(format!("{} {} {}", text(gene), variant(h), text_or(genotype, ""))) + .evidence("Significance", significance).evidence("ClinVar review", &s(&stars(h, "0 stars")?)) + .evidence("Genotype", genotype).evidence("Frequency", &s(&frequency(&d)?)) + .evidence("Call", &s(&call(&d)?)).viewer(locus(h)); + finding.af = val(h, "af").clone(); + Ok(Some(finding)) + }); + } +} + +pub(super) fn text_or_null(v: &Value) -> String { + if matches!(v, Value::Null) { + String::new() + } else { + text(v) + } +} diff --git a/rust/crates/og-live/src/results/lineage.rs b/rust/crates/og-live/src/results/lineage.rs new file mode 100644 index 000000000..54e177dbe --- /dev/null +++ b/rust/crates/og-live/src/results/lineage.rs @@ -0,0 +1,175 @@ +use super::*; +use crate::widgets; +use og_render::sections::{ancestry_fine, archaic, haplogroups, roh}; +use pycompat::fmt::fixed; + +fn share(v: &Value) -> String { + num(Some(v)).map_or_else(|| ".".to_owned(), |n| format!("{}%", fixed(n * 100.0, 0))) +} + +fn explore(d: &Value) -> Read { + Ok(Value::Array( + array(d, "explore")? + .iter() + .map(|x| { + obj([ + ("name", val(x, "name").clone()), + ("url", val(x, "url").clone()), + ]) + }) + .collect(), + )) +} + +// Historical summaries may hold raw SVG instead of the base64 used by the collector. +fn base64(bytes: &[u8]) -> String { + let alphabet = b"ABCDEFGHIJKLMNOPQRSTUVWXYZabcdefghijklmnopqrstuvwxyz0123456789+/"; + let mut result = String::with_capacity(bytes.len().div_ceil(3) * 4); + for chunk in bytes.chunks(3) { + let first = chunk[0]; + let second = chunk.get(1).copied().unwrap_or(0); + let third = chunk.get(2).copied().unwrap_or(0); + result.push(char::from(alphabet[usize::from(first >> 2)])); + result.push(char::from( + alphabet[usize::from((first & 3) << 4 | second >> 4)], + )); + result.push(if chunk.len() >= 2 { + char::from(alphabet[usize::from((second & 15) << 2 | third >> 6)]) + } else { + '=' + }); + result.push(if chunk.len() == 3 { + char::from(alphabet[usize::from(third & 63)]) + } else { + '=' + }); + } + result +} + +pub(super) fn card(id: &str, summary: &Summary) -> Read { + let mut out = Adapter::default(); + match id { + "ancestry-fine" => { + let d = summary.section("ancestry_fine").data; + let mut rows = Vec::new(); + for (level, label) in ancestry_fine::LEVELS { + rows.extend(ancestry_fine::rows(d, level)?.into_iter().map(|r| { + vec![ + label.into(), + cell(val(&r, "group")), + share(val(&r, "fraction")), + format!("{} to {}", share(val(&r, "low")), share(val(&r, "high"))), + ] + })); + } + out.table(&["Level", "Group", "Share", "Bootstrap range"], rows); + out.fact("Chromosome painting", ancestry_fine::painted(d)?); + } + "mt-haplogroup" => { + let sec = summary.section("haplogroup"); + out.fact("Haplogroup", cell(val(sec.data, "haplogroup"))); + out.fact( + "Two mtDNA haplogroups in the reads", + haplogroups::contamination_text(&sec)?, + ); + out.extra("explore", explore(sec.data)?); + } + "y-chromosome" => { + let y = summary.section("y_haplogroup").data; + let t = summary.section("y_tree").data; + if truthy(y) { + out.facts( + y, + &[ + ("Haplogroup (Yleaf)", "haplogroup"), + ("QC score", "qc_score"), + ], + ); + out.extra("explore", explore(y)?); + } + if truthy(t) { + out.fact( + format!("Placement on {}", text(val(t, "tree"))), + cell(val(t, "haplogroup")), + ); + out.fields_table( + &["Level", "Branch", "Derived", "Ancestral", "No call"], + array(t, "path")?, + &["Level", "Branch", "Derived", "Ancestral", "No_call"], + ); + out.extra("widget", widgets::y_path(t)); + } + let markers = array(summary.section("y_str").data, "markers")?; + if !markers.is_empty() { + out.fact( + "Y-STR markers read", + markers + .iter() + .filter(|m| truthy(val(m, "count"))) + .count() + .to_string(), + ); + } + } + "archaic" => { + let d = summary.section("archaic").data; + out.fact( + "Neanderthal", + format!("{}%", text(val(d, "neanderthal_percent"))), + ); + out.fact( + "Denisovan", + format!("{}%", text(val(d, "denisovan_percent"))), + ); + out.lines = archaic::lines(d)?; + } + "ancient" => { + let d = summary.section("ancient").data; + let nearest = array(d, "nearest")?; + out.fields_table( + &["Rank", "Group", "Dates", "Country", "Distance"], + &nearest[..nearest.len().min(10)], + &["rank", "group", "dates", "country", "distance"], + ); + out.fact( + "Sites used", + format!( + "{} of {}", + text(val(d, "sites_used")), + text(val(d, "panel_sites")) + ), + ); + let svg = string(d, "plot_svg"); + if !svg.trim().is_empty() { + let body = if svg.trim_start().starts_with('<') { + base64(svg.as_bytes()) + } else { + svg.to_owned() + }; + out.extra( + "image", + obj([ + ( + "alt", + s("PCA of ancient genomes with this genome projected"), + ), + ("src", s(&format!("data:image/svg+xml;base64,{body}"))), + ]), + ); + } + } + "roh" => { + let sec = summary.section("roh"); + let d = sec.data; + out.fact("Segments", cell(val(d, "segments"))); + out.fact("Total", format!("{} Mb", text(val(d, "total_mb")))); + out.fact("Largest", format!("{} Mb", text(val(d, "largest_mb")))); + out.facts(d, &[("F_ROH", "f_roh"), ("Nearest band", "relationship")]); + out.lines = roh::lines(&sec)?; + out.attention = truthy(val(d, "upd_flag")); + } + _ => unreachable!(), + } + Ok(out) +} diff --git a/rust/crates/og-live/src/results/mod.rs b/rust/crates/og-live/src/results/mod.rs index 072f085f0..7648e6062 100644 --- a/rust/crates/og-live/src/results/mod.rs +++ b/rust/crates/og-live/src/results/mod.rs @@ -1,12 +1,1110 @@ -//! `og live results`: each person's results page, which -//! `bin/live_results.py` writes today. -//! Not ported yet: until its unit of the 1.0.0 plan lands, the verb says so -//! on stderr and exits 2, before reading any argument. +//! The live results and home-page overview of a run's summary. +mod clinical; +mod clinvar; +mod lineage; +mod pgx; +mod qc; +mod sv; +mod traits; + +use crate::plugins::ResultsFns; +use crate::state::{Obj, get, obj, s}; +use crate::{headlines, veil}; +use og_render::chapters::{CHAPTERS, FrameState, Sec, step_of}; +use og_render::model::{Malformed, State, Summary, num, py, truthy}; +use og_render::notes; +use pycompat::json::{Dump, Value, dumps}; +use std::collections::{BTreeSet, HashSet}; use std::io::Write; -/// `og live results ARGS`: not ported yet, so one line on stderr and exit 2. -pub fn cli(_args: &[String], _out: &mut dyn Write, err: &mut dyn Write) -> u8 { - let _ = writeln!(err, "og live results: not ported yet"); - 2 +const EMPTY_CLINVAR: &str = "No P/LP match in this ClinVar file at the call floor. ClinVar lists only part of what can cause disease, so this is information, and the caveats below still apply."; +const TABLE_LIMIT: usize = 200; +const USAGE: &str = "usage: og live results SUMMARY [--sample NAME] [--file PATH]... [--out PATH]\n og live results SUMMARY --overview | --spans"; + +/// The result builders used by the live server. +pub const FNS: ResultsFns = ResultsFns { build, overview }; + +type Read = Result; + +pub(crate) fn val<'a>(v: &'a Value, key: &str) -> &'a Value { + get(v, key).unwrap_or(&Value::Null) +} + +pub(crate) fn str_val(v: &Value) -> &str { + match v { + Value::Str(s) => s, + _ => "", + } +} + +pub(crate) fn string<'a>(v: &'a Value, key: &str) -> &'a str { + str_val(val(v, key)) +} + +pub(crate) fn text(v: &Value) -> String { + py(v).unwrap_or_default() +} + +pub(crate) fn text_or(v: &Value, default: &str) -> String { + if truthy(v) { + text(v) + } else { + default.to_owned() + } +} + +fn default(v: &Value, key: &str, fallback: &str) -> String { + get(v, key).map_or_else(|| fallback.to_owned(), text) +} + +pub(crate) fn data<'a>(summary: &'a Summary, section: &'a str) -> &'a Value { + let part = summary.section(section); + if part.state.ran() && matches!(part.data, Value::Object(_)) { + part.data + } else { + &Value::Null + } +} + +pub(crate) fn list(v: &Value) -> &[Value] { + match v { + Value::Array(items) => items, + _ => &[], + } +} + +pub(crate) fn rows(v: &Value) -> &[Value] { + if let Value::Array(items) = v { + items + } else if truthy(v) { + std::slice::from_ref(v) + } else { + &[] + } +} + +fn array<'a>(v: &'a Value, key: &str) -> Read<&'a [Value]> { + match val(v, key) { + Value::Array(items) => Ok(items), + other if !truthy(other) => Ok(&[]), + _ => Err(Malformed(format!("{key} is not a list"))), + } +} + +fn fields(v: &Value) -> impl Iterator { + let fields = match v { + Value::Object(fields) => Some(fields), + _ => None, + }; + fields + .into_iter() + .flatten() + .map(|(key, value)| (key.as_str(), value)) +} + +fn row(v: &Value, keys: &[&str]) -> Vec { + keys.iter().map(|key| cell(val(v, key))).collect() +} + +fn plain(text: &str) -> String { + let folded = text.replace("**", ""); + let mut out = String::new(); + for word in folded.split_whitespace() { + if !out.is_empty() { + let passed_check = out.ends_with(':') + && word.strip_prefix("ok").is_some_and(|tail| { + !tail.starts_with(|c: char| c.is_alphanumeric() || c == '_') + }); + out.push(' '); + if passed_check { + out.push_str("passed"); + out.push_str(&word[2..]); + continue; + } + } + out.push_str(word); + } + out +} + +fn cell(v: &Value) -> String { + match v { + Value::Null => ".".to_owned(), + Value::Str(t) if t.is_empty() => ".".to_owned(), + Value::Float(n) => pycompat::fmt::general(*n, 6), + Value::Array(a) if !a.is_empty() => a.iter().map(cell).collect::>().join(", "), + Value::Array(_) => ".".to_owned(), + _ => text(v), + } +} + +fn int(n: usize) -> Value { + Value::Int(n as i128) +} + +fn strings(items: impl IntoIterator>) -> Value { + Value::Array(items.into_iter().map(|item| s(item.as_ref())).collect()) +} + +fn table(columns: &[&str], rows: Vec>) -> Value { + if rows.is_empty() { + return Value::Null; + } + let more = rows.len().saturating_sub(TABLE_LIMIT); + let mut table = Obj::from([ + ("columns".into(), strings(columns)), + ( + "rows".into(), + Value::Array(rows.into_iter().take(TABLE_LIMIT).map(strings).collect()), + ), + ]); + if more > 0 { + table.insert("more".into(), int(more)); + } + Value::Object(table) +} + +#[derive(Default)] +struct Adapter { + facts: Vec, + table: Option, + lines: Vec, + attention: bool, + links: Vec<&'static str>, + extra: Obj, +} + +impl Adapter { + fn fact(&mut self, label: impl AsRef, value: impl AsRef) { + self.facts + .push(strings([plain(label.as_ref()), plain(value.as_ref())])); + } + + fn facts(&mut self, d: &Value, pairs: &[(&str, &str)]) { + for (label, key) in pairs { + self.fact(label, cell(val(d, key))); + } + } + + fn table(&mut self, columns: &[&str], rows: Vec>) { + self.table = Some(table(columns, rows)); + } + + fn fields_table(&mut self, columns: &[&str], items: &[Value], keys: &[&str]) { + self.table(columns, items.iter().map(|x| row(x, keys)).collect()); + } + + fn extra(&mut self, key: &str, value: Value) { + if truthy(&value) { + self.extra.insert(key.into(), value); + } + } +} + +fn adapter(id: &str, summary: &Summary) -> Read { + match id { + "qc" | "callability" | "variants" => qc::card(id, summary), + "clinvar" => clinvar::card(summary), + "clinical-filter" | "cpsr" | "slivar" | "exomiser" | "carrier-list" | "couple" + | "paralogs" => clinical::card(id, summary), + "structural-variants" + | "mei" + | "expansions" + | "vntyper" + | "mito" + | "lpa" + | "chip" + | "mosaic" + | "mosaic-mca" => sv::card(id, summary), + "pharmcat" | "cpic" | "cyp2d6" | "hla" | "locityper" => pgx::card(id, summary), + "ancestry-fine" | "mt-haplogroup" | "y-chromosome" | "archaic" | "ancient" | "roh" => { + lineage::card(id, summary) + } + "traits-panel" | "prs" | "bloodtype" | "telomere" | "viral" | "consumer-export" => { + traits::card(id, summary) + } + _ => Ok(Adapter::default()), + } +} + +fn report_links(kinds: &[&str], paths: Option<&BTreeSet>) -> Value { + let mut links = Vec::new(); + if let Some(paths) = paths { + for kind in kinds { + for path in paths { + let leaf = path.rsplit('/').next().unwrap_or(path); + let matched = match *kind { + "multiqc" | "fastp" => leaf.starts_with(kind) && leaf.ends_with(".html"), + "_fastp" => leaf.ends_with("_fastp.html"), + "vep" => path.split('/').any(|p| p == "vep") && leaf.ends_with("summary.html"), + "cpsr" => path.starts_with("cpsr/"), + "pharmcat" => path.rsplit_once('/').is_some_and(|(parent, _)| { + parent.rsplit('/').next() == Some("pharmcat") && leaf.ends_with(".html") + }), + _ => false, + }; + if matched && !links.contains(&path) { + links.push(path); + if links.len() == 4 { + return strings(links); + } + } + } + } + } + strings(links) +} + +fn card(section: &Sec, chapter: &str, summary: &Summary, files: Option<&BTreeSet>) -> Obj { + let raw_sections = summary.get("sections").unwrap_or(&Value::Null); + let sections: Vec<_> = section + .keys + .iter() + .map(|key| summary.section(key)) + .collect(); + let states: Vec<_> = sections.iter().map(|sec| sec.state).collect(); + let state = match FrameState::of(&states) { + FrameState::Ok => "ran", + other => other.class(), + }; + let mut steps = Vec::new(); + let mut state_notes = Vec::new(); + let mut headline = None; + let mut flagged = false; + let caveats: Vec<_> = notes::section_notes(section.id) + .iter() + .filter_map(|name| notes::text(name)) + .collect(); + for sec in sections { + let raw = get(raw_sections, sec.key); + let step = raw + .and_then(|v| get(v, "step")) + .filter(|v| truthy(v)) + .cloned() + .unwrap_or_else(|| s(step_of(sec.key))); + if step != s("?") && !steps.contains(&step) { + steps.push(step); + } + if matches!(sec.state, State::Failed | State::Unreadable | State::Stale) { + state_notes.push(format!( + "{}: {}", + text_or(sec.title, sec.key), + plain(¬es::stale_note(&sec).unwrap_or_default()) + )); + } + if sec.state.ran() + && let Some((line, tone)) = crate::state::headline(sec.key, raw, summary) + { + flagged |= tone == "attention"; + let line = plain(&line); + if headline.is_none() && !line.is_empty() && !line.ends_with("finished, see the report") + { + headline = Some(line); + } + } + } + if let Some(line) = &mut headline + && let Some(stripped) = caveats + .iter() + .map(|c| plain(c)) + .filter(|c| { + line.strip_suffix(c) + .is_some_and(|start| start.ends_with(' ')) + }) + .max_by_key(String::len) + { + line.truncate(line.len() - stripped.len()); + line.truncate(line.trim_end().len()); + } + let adapter = if matches!(state, "missing" | "failed") { + Adapter::default() + } else { + og_render::chapters::guarded(|| adapter(section.id, summary)).unwrap_or_else(|err| { + Adapter { + lines: vec![format!( + "This card could not be drawn ({}); the report shows the section.", + error_kind(&err) + )], + ..Adapter::default() + } + }) + }; + flagged |= adapter.attention; + let attention = flagged || !state_notes.is_empty(); + let lines = adapter.lines.iter().map(|line| plain(line)).filter(|line| { + !line.is_empty() + && headline.as_ref() != Some(line) + && !caveats.iter().any(|c| plain(c) == *line) + && !notes::NOTES.iter().any(|(_, c)| plain(c) == *line) + }); + let mut card = Obj::from([ + ("id".into(), s(section.id)), + ("title".into(), s(section.title)), + ("keys".into(), strings(section.keys)), + ("steps".into(), Value::Array(steps)), + ("state".into(), s(state)), + ("anchor".into(), s(section.id)), + ("attention".into(), Value::Bool(attention)), + ( + "headline".into(), + headline.as_deref().map_or(Value::Null, s), + ), + ("facts".into(), Value::Array(adapter.facts)), + ("table".into(), adapter.table.unwrap_or(Value::Null)), + ("lines".into(), strings(lines)), + ("caveat".into(), strings(caveats)), + ( + "empty_text".into(), + if section.id == "clinvar" { + s(EMPTY_CLINVAR) + } else { + Value::Null + }, + ), + ("links".into(), report_links(&adapter.links, files)), + ("notes".into(), strings(state_notes)), + ("flagged".into(), Value::Bool(flagged)), + ("chapter".into(), s(chapter)), + ]); + card.extend(adapter.extra); + card +} + +#[derive(Clone, Copy, PartialEq, Eq, PartialOrd, Ord)] +pub(crate) enum Level { + Act, + Medicine, + Review, + Carrier, + Trust, + Info, +} + +impl Level { + const ALL: [Self; 6] = [ + Self::Act, + Self::Medicine, + Self::Review, + Self::Carrier, + Self::Trust, + Self::Info, + ]; + + pub(crate) fn name(self) -> &'static str { + match self { + Self::Act => "act", + Self::Medicine => "medicine", + Self::Review => "review", + Self::Carrier => "carrier", + Self::Trust => "trust", + Self::Info => "info", + } + } + + fn words(self) -> &'static str { + match self { + Self::Act => "Take to a doctor", + Self::Medicine => "Tell your prescriber", + Self::Review => "Worth a look", + Self::Carrier => "For family planning", + Self::Trust => "Data quality", + Self::Info => "For information", + } + } + + fn section(self) -> usize { + match self { + Self::Act => 1, + Self::Medicine => 2, + Self::Carrier => 3, + Self::Review => 4, + Self::Trust => 5, + Self::Info => 8, + } + } + + fn plan(self) -> &'static [&'static str] { + match self { + Self::Act => &[ + "Bring this page to a doctor or a genetic counsellor.", + "Ask for a clinical test in a certified laboratory to confirm it: this pipeline is research software.", + "Ask what it means for parents, brothers, sisters and children: close relatives may carry it too.", + ], + Self::Medicine => &[ + "Show this to whoever prescribes for you, and to your pharmacist.", + "Do not change a medicine on your own: the guidance is written for the prescriber.", + "Ask for a clinical pharmacogenetic test before a prescription changes.", + ], + Self::Review => &[ + "Read the evidence and its caveat below.", + "Talk it over with a doctor or a genetic counsellor if it bears on your health or a pregnancy.", + "A measurement or a clinical test settles it: this result alone is not a diagnosis.", + ], + Self::Carrier => &[ + "A carrier is not affected by the condition.", + "It matters when a partner carries a change in the same gene: compare with the couple screen.", + "Relatives planning a pregnancy may carry it too.", + ], + Self::Trust => &[ + "Read nothing else in this report until this is understood.", + "Check the sample's label and the run's inputs, then run it again.", + ], + Self::Info => &[], + } + } +} + +pub(crate) struct Finding { + pub(crate) id: String, + pub(crate) level: Level, + card: &'static str, + pub(crate) title: String, + text: String, + pub(crate) gene: Value, + pub(crate) detail: Option, + evidence: Vec, + pub(crate) viewer: Option, + af: Value, +} + +impl Finding { + fn new( + level: Level, + card: &'static str, + key: &[&str], + title: impl AsRef, + text: impl AsRef, + ) -> Self { + Self { + id: slug(key), + level, + card, + title: plain(title.as_ref()), + text: plain(text.as_ref()), + gene: Value::Null, + detail: None, + evidence: Vec::new(), + viewer: None, + af: Value::Null, + } + } + + fn gene(mut self, gene: &Value) -> Self { + self.gene = gene.clone(); + self + } + + fn detail(mut self, detail: impl AsRef) -> Self { + let detail = plain(detail.as_ref()); + self.detail = (!detail.is_empty()).then_some(detail); + self + } + + fn viewer(mut self, viewer: String) -> Self { + self.viewer = (!viewer.is_empty()).then_some(viewer); + self + } + + fn evidence(mut self, label: &str, value: &Value) -> Self { + if !matches!(value, Value::Null) && !matches!(str_val(value), ".") && value != &s("") { + self.evidence + .push(strings([plain(label), plain(&cell(value))])); + } + self + } + + fn evidence_fields(mut self, value: &Value, pairs: &[(&str, &str)]) -> Self { + for (label, key) in pairs { + self = self.evidence(label, val(value, key)); + } + self + } + + fn json(&self, cards: &[Obj], found: &[Finding]) -> Value { + let card = cards + .iter() + .find(|c| c.get("id").is_some_and(|v| str_val(v) == self.card)); + let card_list = |key| { + card.and_then(|c| c.get(key)) + .cloned() + .unwrap_or_else(|| Value::Array(Vec::new())) + }; + obj([ + ("id", s(&self.id)), + ("level", s(self.level.name())), + ("card", s(self.card)), + ("title", s(&self.title)), + ("text", s(&self.text)), + ("gene", self.gene.clone()), + ("detail", self.detail.as_deref().map_or(Value::Null, s)), + ("evidence", Value::Array(self.evidence.clone())), + ("viewer", self.viewer.as_deref().map_or(Value::Null, s)), + ("af", self.af.clone()), + ("section", int(self.level.section())), + ("steps", card_list("steps")), + ("caveat", card_list("caveat")), + ("anchor", s(self.card)), + ("plan", strings(self.level.plan())), + ("level_words", s(self.level.words())), + ( + "related", + strings( + found + .iter() + .filter(|other| { + other.id != self.id + && (other.card == self.card + || (truthy(&self.gene) && other.gene == self.gene)) + }) + .take(6) + .map(|other| &other.id), + ), + ), + ]) + } +} + +fn slug(parts: &[&str]) -> String { + let raw = parts + .iter() + .copied() + .filter(|p| !p.is_empty()) + .collect::>() + .join("-"); + let mut id = String::new(); + let mut gap = false; + for ch in raw.to_lowercase().chars() { + if ch.is_ascii_alphanumeric() { + if gap && !id.is_empty() { + id.push('-'); + } + id.push(ch); + gap = false; + } else { + gap = true; + } + } + if id.len() > 80 { + // IDs are bookmarked URLs. Keep the original SHA-1 suffix for long alleles. + id = format!( + "{}-{:08x}", + id[..71].trim_end_matches('-'), + sha1_prefix(raw.as_bytes()) + ); + } + if id.is_empty() { "finding".into() } else { id } +} + +// Only the first digest word is part of the existing finding ID format. +fn sha1_prefix(bytes: &[u8]) -> u32 { + let mut message = bytes.to_vec(); + message.push(0x80); + message.resize((message.len() + 8).div_ceil(64) * 64 - 8, 0); + message.extend_from_slice(&(bytes.len() as u64 * 8).to_be_bytes()); + let mut digest = [ + 0x67452301_u32, + 0xefcdab89, + 0x98badcfe, + 0x10325476, + 0xc3d2e1f0, + ]; + for block in message.chunks_exact(64) { + let mut words = [0_u32; 80]; + for (word, bytes) in words.iter_mut().zip(block.chunks_exact(4)) { + *word = u32::from_be_bytes([bytes[0], bytes[1], bytes[2], bytes[3]]); + } + for i in 16..80 { + words[i] = (words[i - 3] ^ words[i - 8] ^ words[i - 14] ^ words[i - 16]).rotate_left(1); + } + let [mut a, mut b, mut c, mut d, mut e] = digest; + for (i, word) in words.into_iter().enumerate() { + let (f, k) = match i { + 0..20 => ((b & c) | (!b & d), 0x5a827999), + 20..40 => (b ^ c ^ d, 0x6ed9eba1), + 40..60 => ((b & c) | (b & d) | (c & d), 0x8f1bbcdc), + _ => (b ^ c ^ d, 0xca62c1d6), + }; + let next = a + .rotate_left(5) + .wrapping_add(f) + .wrapping_add(e) + .wrapping_add(k) + .wrapping_add(word); + [a, b, c, d, e] = [next, a, b.rotate_left(30), c, d]; + } + for (word, x) in digest.iter_mut().zip([a, b, c, d, e]) { + *word = word.wrapping_add(x); + } + } + digest[0] +} + +fn error_kind(error: &Malformed) -> &'static str { + if error.0.contains("missing") { + "KeyError" + } else if error.0.contains("not a number") || error.0.contains("not an integer") { + "ValueError" + } else { + "TypeError" + } +} + +fn add_row( + found: &mut Vec, + card: &'static str, + level: Level, + read: impl FnOnce() -> Read>, +) { + match read() { + Ok(Some(f)) => found.push(f), + Ok(None) => {} + Err(err) => found.push(unreadable(card, level, found.len(), error_kind(&err))), + } +} + +fn unreadable(card: &'static str, level: Level, index: usize, kind: &str) -> Finding { + Finding::new( + level, + card, + &["unreadable", card, &index.to_string()], + "A row of this section could not be read", + format!( + "One row of this section holds a value of a kind the page cannot read ({kind}). The other rows show as usual; the report and its files have the row as the step wrote it." + ), + ) +} + +fn object_row(v: &Value) -> Read<()> { + if matches!(v, Value::Object(_)) { + Ok(()) + } else { + Err(Malformed("row is not an object".to_owned())) + } +} + +fn finding_rows(summary: &Summary) -> Vec { + let mut found = Vec::new(); + let excluded = clinical::clinical_findings(summary, &mut found); + clinvar::findings(summary, &excluded, &mut found); + sv::findings(summary, &mut found); + clinical::family_findings(summary, &mut found); + pgx::findings(summary, &mut found); + qc::findings(summary, &mut found); + let mut seen = HashSet::new(); + found.retain(|f| seen.insert(f.id.clone())); + found +} + +const JOURNAL: [(&str, &str, &str); 10] = [ + ("act", "To act on", "Is there anything to take to a doctor?"), + ( + "medicines", + "Medicines", + "Which medicines should a prescriber know about?", + ), + ( + "family", + "For your family", + "What could I pass on to a child?", + ), + ( + "look", + "Worth a look", + "What deserves a conversation, but is not a diagnosis?", + ), + ( + "trust", + "Can I trust this?", + "This is about the data, not about the person.", + ), + ("origins", "Origins", "Where do my ancestors come from?"), + ( + "traits", + "Traits and scores", + "What do studies say about traits and risk scores?", + ), + ( + "assessed", + "Assessed, no finding", + "What each step looked at, and what it does not see.", + ), + ( + "cannot", + "What it cannot see", + "What no step of this run looks at.", + ), + ( + "sources", + "Sources and files", + "The databases, the report and the files behind this page.", + ), +]; + +fn journal(cards: &mut [Obj], found: &mut Vec) -> (Value, Value) { + let have: HashSet<_> = found.iter().map(|f| f.card).collect(); + let defs = CHAPTERS.iter().flat_map(|chapter| chapter.sections); + for (card, sec) in cards.iter().zip(defs) { + if truthy(&card["flagged"]) + && !have.contains(sec.id) + && !matches!(str_val(&card["state"]), "missing" | "failed") + { + let level = if str_val(&card["chapter"]) == "quality" { + Level::Trust + } else { + Level::Review + }; + let mut finding = Finding::new( + level, + sec.id, + &["card", sec.id], + sec.title, + text_or( + &card["headline"], + &format!("The report flags this section: {}.", sec.title), + ), + ); + finding.evidence = list(&card["facts"]) + .iter() + .take(4) + .filter(|v| list(v).get(1) != Some(&s("."))) + .cloned() + .collect(); + found.push(finding); + } + } + let mut info = 0; + for card in cards.iter_mut() { + let id = str_val(&card["id"]); + let related: Vec<_> = found.iter().filter(|f| f.card == id).collect(); + let top = related.iter().map(|f| f.level).min(); + let chapter = str_val(&card["chapter"]); + let home = match chapter { + "quality" => 5, + "clinical" => top.map_or(8, Level::section), + "carrier" => 3, + "medicines" => 2, + "ancestry" => 6, + "traits" => 7, + _ => 10, + }; + let level = if matches!(str_val(&card["state"]), "missing" | "failed") { + None + } else { + Some(top.unwrap_or(if chapter == "quality" { + Level::Trust + } else if truthy(&card["flagged"]) { + Level::Review + } else { + Level::Info + })) + }; + info += usize::from(level == Some(Level::Info)); + card.insert("level".into(), level.map_or(Value::Null, |v| s(v.name()))); + card.insert("section".into(), int(home)); + card.insert("findings".into(), strings(related.iter().map(|f| &f.id))); + } + let levels = Level::ALL + .into_iter() + .map(|lv| { + ( + lv.name().to_owned(), + int(if lv == Level::Info { + info + } else { + found.iter().filter(|f| f.level == lv).count() + }), + ) + }) + .collect(); + let sections = JOURNAL + .iter() + .enumerate() + .map(|(index, (key, title, question))| { + let n = index + 1; + obj([ + ("n", int(n)), + ("key", s(key)), + ("title", s(title)), + ("question", s(question)), + ( + "findings", + strings( + found + .iter() + .filter(|f| f.level.section() == n) + .map(|f| &f.id), + ), + ), + ( + "cards", + strings( + cards + .iter() + .filter(|c| c["section"] == int(n)) + .map(|c| str_val(&c["id"])), + ), + ), + ]) + }) + .collect(); + (Value::Object(levels), Value::Array(sections)) +} + +fn parsed(summary: &Value) -> Result { + if get(summary, "sections") + .is_some_and(|value| truthy(value) && !matches!(value, Value::Object(_))) + { + return Err("expected a summary sections object".to_owned()); + } + let normalized; + let input = if get(summary, "sections").is_some() { + summary + } else if !truthy(summary) || matches!(summary, Value::Object(_)) { + let mut root: Obj = fields(summary) + .map(|(k, v)| (k.to_owned(), v.clone())) + .collect(); + root.insert("sections".into(), Value::Object(Obj::new())); + normalized = Value::Object(root); + &normalized + } else { + return Err("expected a summary object".to_owned()); + }; + let json = dumps(input, &Dump::default()).map_err(|e| format!("{e:?}"))?; + Summary::parse(&json).map_err(|e| e.to_string()) +} + +/// Build the live site's results JSON from an already read summary. +pub fn build( + sample: &str, + summary: &Value, + files: Option<&BTreeSet>, +) -> Result { + Ok(build_summary(sample, &parsed(summary)?, files)) +} + +fn build_summary(sample: &str, summary: &Summary, files: Option<&BTreeSet>) -> Value { + let mut cards: Vec<_> = CHAPTERS + .iter() + .flat_map(|chapter| { + chapter + .sections + .iter() + .map(|sec| card(sec, chapter.id, summary, files)) + }) + .collect(); + let mut found = finding_rows(summary); + let (levels, journal) = journal(&mut cards, &mut found); + let lead = headlines::lead(summary, &found); + let veil = veil::build(summary, &found, &cards, &lead); + let findings = found.iter().map(|f| f.json(&cards, &found)).collect(); + let attention = cards.iter().filter(|c| truthy(&c["attention"])).count(); + let mut cards = cards.into_iter(); + let chapters = CHAPTERS + .iter() + .map(|chapter| { + let cards: Vec<_> = cards.by_ref().take(chapter.sections.len()).collect(); + let attention = cards.iter().filter(|c| truthy(&c["attention"])).count(); + obj([ + ("key", s(chapter.id)), + ("title", s(chapter.title)), + ("question", s(chapter.question)), + ( + "sections", + Value::Array(cards.into_iter().map(Value::Object).collect()), + ), + ("attention", int(attention)), + ]) + }) + .collect(); + let root = summary.root(); + let sex = summary.section("sex_check").data; + let databases = fields(val(root, "databases")) + .filter(|(_, v)| { + matches!( + v, + Value::Str(_) | Value::Int(_) | Value::Float(_) | Value::Bool(_) + ) + }) + .map(|(k, v)| (k.to_owned(), s(&plain(&cell(v))))) + .collect(); + obj([ + ("schema_version", Value::Int(1)), + ("sample", s(sample)), + ("generated_utc", val(root, "generated_utc").clone()), + ( + "person", + obj([ + ("sample", s(sample)), + ( + "declared_sex", + val(val(root, "run"), "declared_sex").clone(), + ), + ("inferred_sex", val(sex, "inferred_sex").clone()), + ("karyotype", val(sex, "karyotype").clone()), + ]), + ), + ("chapters", Value::Array(chapters)), + ("findings", Value::Array(findings)), + ("levels", levels), + ("journal", journal), + ( + "lead", + Value::Array(lead.into_iter().map(|p| p.json()).collect()), + ), + ( + "level_words", + Value::Object( + Level::ALL + .into_iter() + .map(|lv| (lv.name().into(), s(lv.words()))) + .collect(), + ), + ), + ("databases", Value::Object(databases)), + ("attention", int(attention)), + ( + "not_assessed", + strings( + list(val(root, "not_assessed")) + .iter() + .map(|v| plain(&text(v))), + ), + ), + ( + "not_run", + strings(list(val(root, "not_run")).iter().map(|v| plain(&text(v)))), + ), + ( + "new_since", + get(root, "new_since") + .filter(|v| truthy(v)) + .cloned() + .unwrap_or(Value::Null), + ), + ( + "charts", + obj([ + ("clinvar", s("clinvar")), + ("genome", s("clinvar")), + ("mito", s("mito")), + ("ancestry", s("ancestry-fine")), + ("prs", s("prs")), + ]), + ), + ("veil", veil), + ]) +} + +/// Build the live home page's counts and its open and closed lead. +pub fn overview(summary: &Value) -> Result { + let summary = parsed(summary)?; + Ok(headlines::overview( + &summary, + &build_summary("", &summary, None), + )) +} + +#[derive(Default)] +struct Args { + summary: String, + sample: Option, + files: BTreeSet, + out: Option, + overview: bool, + spans: bool, +} + +fn args(argv: &[String]) -> Result { + let mut args = Args::default(); + let mut argv = argv.iter(); + while let Some(arg) = argv.next() { + let next = |argv: &mut std::slice::Iter<'_, String>| { + argv.next() + .cloned() + .ok_or_else(|| format!("{arg} needs a value")) + }; + match arg.as_str() { + "--overview" => args.overview = true, + "--spans" => args.spans = true, + "--sample" => args.sample = Some(next(&mut argv)?), + "--file" => { + args.files.insert(next(&mut argv)?); + } + "--out" => args.out = Some(next(&mut argv)?), + "--summary" if args.summary.is_empty() => args.summary = next(&mut argv)?, + path if (!path.starts_with('-') || path == "-") && args.summary.is_empty() => { + args.summary.clone_from(arg) + } + _ => return Err(format!("unexpected argument: {arg}")), + } + } + if args.summary.is_empty() { + return Err("a summary is required".into()); + } + if args.overview && args.spans { + return Err("--overview and --spans are mutually exclusive".into()); + } + Ok(args) +} + +/// Dispatch the live results verb. The summary may be read from stdin with `-`. +pub fn cli(argv: &[String], out: &mut dyn Write, err: &mut dyn Write) -> u8 { + if argv + .iter() + .any(|arg| matches!(arg.as_str(), "-h" | "--help")) + { + let _ = writeln!(out, "{USAGE}"); + return 0; + } + let args = match args(argv) { + Ok(args) => args, + Err(why) => { + let _ = writeln!(err, "{USAGE}\nog live results: {why}"); + return 2; + } + }; + let run = || -> Result<(), String> { + let text = if args.summary == "-" { + std::io::read_to_string(std::io::stdin()) + } else { + std::fs::read_to_string(&args.summary) + } + .map_err(|e| e.to_string())?; + let summary = parsed(&pycompat::json::loads(&text).map_err(|e| e.to_string())?)?; + let result = if args.spans { + veil::spans_json(&finding_rows(&summary)) + } else if args.overview { + headlines::overview(&summary, &build_summary("", &summary, None)) + } else { + let sample = args + .sample + .as_deref() + .unwrap_or_else(|| string(summary.root(), "sample")); + build_summary(sample, &summary, Some(&args.files)) + }; + let body = dumps( + &result, + &Dump { + indent: Some(2), + ..Dump::default() + }, + ) + .map_err(|e| format!("{e:?}"))?; + if let Some(path) = args.out { + let mut file = og_io::AtomicFile::create(path).map_err(|e| e.to_string())?; + writeln!(file, "{body}") + .and_then(|_| file.commit()) + .map_err(|e| e.to_string()) + } else { + writeln!(out, "{body}").map_err(|e| e.to_string()) + } + }; + match run() { + Ok(()) => 0, + Err(why) => { + let _ = writeln!(err, "og live results: {why}"); + 1 + } + } } diff --git a/rust/crates/og-live/src/results/pgx.rs b/rust/crates/og-live/src/results/pgx.rs new file mode 100644 index 000000000..465e32c2f --- /dev/null +++ b/rust/crates/og-live/src/results/pgx.rs @@ -0,0 +1,161 @@ +use super::clinvar::text_or_null; +use super::*; +use og_render::sections::{hla, pgx}; + +pub(super) fn card(id: &str, summary: &Summary) -> Read { + let mut out = Adapter::default(); + match id { + "pharmcat" => { + let d = summary.section("pharmcat").data; + out.fact("PharmCAT report", "Ran"); + out.fact("PharmCAT version", text_or(val(d, "version"), "unknown")); + out.fact( + "Its own HTML report", + if truthy(val(d, "html_report")) { + "beside it" + } else { + "not written" + }, + ); + out.links = vec!["pharmcat"]; + } + "cpic" => { + let d = summary.section("cpic").data; + if truthy(val(d, "parse_failed")) { + out.lines.push( + "The PharmCAT report could not be parsed: see the CPIC report.".to_owned(), + ); + out.attention = true; + } else { + for (label, key) in [ + ("Genes with a changed-function phenotype", "non_normal"), + ("Genes with more than one possible result", "ambiguous"), + ("Genes not called", "not_called"), + ] { + out.fact(label, get(d, key).map_or_else(|| "0".into(), cell)); + } + let rows = array(d, "genes")? + .iter() + .map(|g| { + let phenotype = val(g, "phenotype"); + vec![ + cell(val(g, "gene")), + cell(val(g, "diplotype")), + if truthy(phenotype) { + format!("\"{}\"", text(phenotype)) + } else { + ".".into() + }, + cell(val(g, "status")), + ] + }) + .collect(); + out.table( + &["Gene", "Diplotype", "Phenotype (CPIC's words)", "Status"], + rows, + ); + } + out.lines.extend( + array(d, "warnings")? + .iter() + .map(|w| format!("WARNING: {}", text(w))), + ); + } + "cyp2d6" => { + let d = summary.get("cyp2d6").unwrap_or(&Value::Null); + let rows = fields(val(d, "calls")) + .map(|(k, v)| { + let name = match k { + "PharmCAT" => "PharmCAT (step 36's call)", + other => other, + }; + vec![name.to_owned(), text_or(v, "not run")] + }) + .collect(); + out.table(&["Caller", "CYP2D6"], rows); + let agree = val(d, "agree"); + out.fact( + "pypgx and Cyrius agree", + if truthy(agree) { + "yes" + } else if *agree == Value::Bool(false) { + "no" + } else { + "fewer than two usable calls" + }, + ); + if truthy(d) { + let verdict = pgx::cyp2d6_verdict(d)?; + if !verdict.is_empty() { + out.fact("Step 36", verdict); + } + } + let pypgx = summary.section("pypgx"); + if pypgx.state.ran() { + out.lines = pgx::pypgx_lines(&pypgx)?; + } + out.attention = *agree == Value::Bool(false); + } + "hla" => { + let d = summary.section("hla").data; + let dbs = summary.get("databases").unwrap_or(&Value::Null); + out.fact("HLA database", text_or(val(dbs, "hla_database"), "unknown")); + let rows = array(d, "loci")? + .iter() + .map(|l| Ok(vec![cell(val(l, "gene")), cell(&s(&hla::hla_text(l)?))])) + .collect::>()?; + out.table(&["Gene", "Alleles (T1K quality)"], rows); + out.lines = hla::hla_derived_lines(get(d, "derived"))?; + } + "locityper" => { + let d = summary.section("locityper").data; + let loci = array(d, "loci")?; + out.fact( + "Loci called", + format!("{} of {}", default(d, "called", "0"), loci.len()), + ); + out.fact( + "Passing the authors' filter", + get(d, "passed").map_or_else(|| "0".into(), cell), + ); + out.fields_table( + &[ + "Locus", + "Panel haplotypes", + "Quality", + "Filter", + "Primary caller", + ], + loci, + &["locus", "genotype", "quality", "filter", "primary"], + ); + } + _ => unreachable!(), + } + Ok(out) +} + +pub(super) fn findings(summary: &Summary, found: &mut Vec) { + for g in rows(val(data(summary, "cpic"), "genes")) { + add_row(found, "cpic", Level::Review, || { + object_row(g)?; + let status = string(g, "status"); + if !matches!(status, "non-normal" | "ambiguous") { + return Ok(None); + } + let gene = val(g, "gene"); + let name = text(gene); + let diplotype = text(val(g, "diplotype")); + let phenotype = text(val(g, "phenotype")); + let title = if status == "ambiguous" { + format!("{name}: more than one possible result") + } else { + format!("{name}: {phenotype}") + }; + Ok(Some(Finding::new(Level::Medicine, "cpic", &["pgx", &text_or_null(gene)], title, + format!("{name} {diplotype} reads as \"{phenotype}\" in CPIC's words. The drugs it bears on are in the CPIC report; tell whoever prescribes.")) + .gene(gene).detail(format!("{name} {diplotype}")) + .evidence_fields(g, &[("Diplotype", "diplotype"), ("Phenotype", "phenotype"), ("Status", "status")]))) + }); + } +} diff --git a/rust/crates/og-live/src/results/qc.rs b/rust/crates/og-live/src/results/qc.rs new file mode 100644 index 000000000..5c230b1b7 --- /dev/null +++ b/rust/crates/og-live/src/results/qc.rs @@ -0,0 +1,164 @@ +use super::*; +use og_render::sections::qc; +use pycompat::fmt::fixed; + +pub(super) fn card(id: &str, summary: &Summary) -> Read { + let mut out = Adapter::default(); + match id { + "qc" => { + let coverage = summary.section("coverage"); + let sex = summary.section("sex_check"); + let sample = summary.section("sample_qc"); + let reads = summary.section("read_count"); + if let Some(n) = num(coverage.get("mean_depth")?) { + out.fact("Mean depth", format!("{}x", fixed(n, 1))); + } + if reads.state.ran() { + let tail = if string(reads.data, "read_count_check") == "mismatch" { + " (reads lost: see the report)" + } else { + "" + }; + out.fact( + "Reads kept by alignment", + format!("{}{tail}", qc::read_count_text(&reads)?), + ); + } + let inferred = val(sex.data, "inferred_sex"); + if truthy(inferred) { + out.fact("Inferred sex (indexcov)", cell(inferred)); + } + let run = summary.get("run").unwrap_or(&Value::Null); + out.fact( + "Declared sex", + text_or(val(run, "declared_sex"), "not declared"), + ); + if sample.state.ran() { + let d = sample.data; + let sex_check = string(d, "sex_check"); + let result = match sex_check { + "ok" => "Declared and measured sex agree".into(), + "mismatch" => "Declared and measured sex differ".into(), + "not_checked" => format!( + "Not checked: {}", + text_or(val(d, "sex_check_reason"), "no reason given") + ), + _ => text_or(val(d, "sex_check"), "."), + }; + out.fact( + "Sex from the reads (somalier)", + format!("{}. {result}", text_or(val(d, "inferred_sex"), ".")), + ); + let contam = string(d, "contamination"); + let contamination = if contam == "ok" { + format!( + "Below the contamination flag (FREEMIX {}, flag above {})", + text(val(d, "freemix")), + text(val(d, "freemix_warn_above")) + ) + } else { + qc::freemix_text(&sample)? + }; + out.fact("Contamination (VerifyBamID2)", contamination); + let same = val(d, "same_person_as"); + if truthy(same) { + out.fact("The same person as", cell(same)); + } + out.attention = sex_check == "mismatch" || contam == "warn" || truthy(same); + } + out.lines = qc::karyotype_lines(summary)?; + out.attention |= !out.lines.is_empty(); + out.links = vec!["multiqc", "fastp", "_fastp"]; + } + "callability" => { + let d = summary.section("callability").data; + let genes = array(d, "not_read")?; + out.fact( + "Hard-to-read genes read", + format!( + "{} of {}", + text(val(d, "read")), + text(val(d, "catalog_genes")) + ), + ); + out.fact( + "Not read, no other step calls them", + genes.len().to_string(), + ); + out.fact( + "Not read here, called by a step of their own", + array(d, "not_read_owned")?.len().to_string(), + ); + let rows = genes + .iter() + .map(|g| { + object_row(g)?; + let share = num(get(g, "share")) + .map_or_else(|| ".".into(), |n| format!("{}%", fixed(n * 100.0, 0))); + let reasons = array(g, "reasons")? + .iter() + .map(text) + .collect::>() + .join(", "); + Ok(vec![ + cell(val(g, "gene")), + cell(val(g, "status")), + share, + cell(&s(&reasons)), + ]) + }) + .collect::>()?; + out.table(&["Gene", "Status", "Bases read", "Why"], rows); + } + "variants" => { + out.facts( + summary.section("variants").data, + &[ + ("Total variants", "total"), + ("PASS variants", "pass"), + ("SNPs", "snps"), + ("Indels", "indels"), + ], + ); + out.links = vec!["vep"]; + } + _ => unreachable!(), + } + Ok(out) +} + +pub(super) fn findings(summary: &Summary, found: &mut Vec) { + let d = data(summary, "sample_qc"); + if string(d, "sex_check") == "mismatch" { + found.push(Finding::new(Level::Trust, "qc", &["sex"], "Declared and measured sex differ", + "The sex the reads show differs from the one declared: a swapped or mislabelled sample, or a real sex-chromosome difference.") + .evidence_fields(d, &[("Declared", "declared_sex"), ("From the reads", "inferred_sex")])); + } + if string(d, "contamination") == "warn" { + add_row(found, "qc", Level::Review, || { + Ok(Some( + Finding::new( + Level::Trust, + "qc", + &["contamination"], + "Another person's DNA may be mixed in", + qc::freemix_text(&summary.section("sample_qc"))?, + ) + .evidence("FREEMIX", val(d, "freemix")), + )) + }); + } + let same = val(d, "same_person_as"); + if truthy(same) { + found.push( + Finding::new( + Level::Trust, + "qc", + &["same-person"], + format!("The same person as {}", text(same)), + "Two runs of this server hold the same genome.", + ) + .evidence("Matches", same), + ); + } +} diff --git a/rust/crates/og-live/src/results/sv.rs b/rust/crates/og-live/src/results/sv.rs new file mode 100644 index 000000000..6868bac3b --- /dev/null +++ b/rust/crates/og-live/src/results/sv.rs @@ -0,0 +1,542 @@ +use super::clinvar::text_or_null; +use super::*; +use crate::widgets; +use og_render::sections::{ + annotsv, chip, clinvar::D, lpa, mito, mocha, sex_loss, smn1, str as repeats, vntyper, +}; +use pycompat::fmt::fixed; + +fn annotsv_support(summary: &Summary, x: &D<'_>) -> Read { + annotsv::support_text(x, truthy(val(data(summary, "annotsv"), "consensus"))) +} + +fn repeat_status(locus: &Value) -> Read<&str> { + let status = val(locus, "status"); + if !truthy(status) { + return Ok(""); + } + match status { + Value::Str(s) => Ok(s), + _ => Err(Malformed("repeat status is not a string".into())), + } +} + +fn repeat_flags(status: &str) -> impl Iterator { + status + .split(',') + .filter(|x| !x.is_empty() && *x != "normal") +} + +pub(super) fn card(id: &str, summary: &Summary) -> Read { + let mut out = Adapter::default(); + match id { + "structural-variants" => { + let m = summary.section("manta").data; + let dl = summary.section("delly").data; + let cn = summary.section("cnvpytor").data; + let sv = summary.section("sv_consensus").data; + let a = summary.section("annotsv").data; + out.fact( + "Manta SVs (total / PASS)", + format!("{} / {}", default(m, "total", "."), default(m, "pass", ".")), + ); + out.fact( + "Delly SVs (total / PASS)", + format!( + "{} / {}", + default(dl, "total", "."), + default(dl, "pass", ".") + ), + ); + out.fact( + "CNVpytor CNVs (significant)", + format!( + "{} ({})", + default(cn, "total", "."), + default(cn, "significant", ".") + ), + ); + out.fact("Consensus SVs (2+ callers)", cell(val(sv, "consensus"))); + out.fact("AnnotSV class 4 and 5", cell(val(a, "count"))); + let mut rows = Vec::new(); + for x in array(a, "rows")? { + object_row(x)?; + let record = D::new(x, "AnnotSV row"); + let mut r = row(x, &["type", "sv", "gt", "length", "acmg_class"]); + let genes = if matches!(val(x, "genes"), Value::Null) { + ".".into() + } else { + annotsv::genes_text(&record)? + }; + let flags = if record.has("exon_edge") { + annotsv::flags(&record)?.join("; ") + } else { + ".".into() + }; + r.extend([ + cell(&s(&genes)), + cell(&s(&annotsv::support_text( + &record, + truthy(val(a, "consensus")), + )?)), + cell(&s(&flags)), + ]); + rows.push(r); + } + out.table( + &[ + "Type", "Where", "Genotype", "Length", "Class", "Genes", "Support", "Checks", + ], + rows, + ); + out.attention = truthy(val(a, "count")); + } + "mei" => { + let d = summary.section("mei").data; + let sites = array(d, "sites")?; + out.fact("Insertions called", cell(val(d, "calls"))); + let elements = fields(val(d, "by_element")) + .map(|(k, v)| format!("{k} {}", text(v))) + .collect::>() + .join(", "); + out.fact("By element", text_or(&s(&elements), "none")); + out.fields_table( + &[ + "Gene", + "Element", + "Condition", + "Inheritance", + "Known site", + "Depth", + ], + sites, + &[ + "gene", + "element", + "condition", + "inheritance", + "status", + "mean_depth", + ], + ); + out.attention = sites + .iter() + .any(|x| !matches!(string(x, "status"), "" | "not seen")); + } + "expansions" => { + let d = summary.section("expansions").data; + let mut outside = 0; + let mut rows = Vec::new(); + let mut gauge = Vec::new(); + for l in array(d, "loci")? { + object_row(l)?; + let flagged = repeat_flags(repeat_status(l)?).next().is_some(); + outside += usize::from(flagged); + let zone = val(l, "zone"); + out.attention |= flagged || truthy(zone); + let status = repeats::status(l)?; + let shown = match status.as_str() { + "" => "not graded".to_owned(), + "not graded" | "not sized" => status.clone(), + _ => format!("\"{status}\""), + }; + let count = if matches!(val(l, "repeat_count"), Value::Str(_)) { + repeats::count(l)? + } else { + cell(val(l, "repeat_count")) + }; + let mut r = vec![cell(val(l, "locus")), cell(&s(&count)), shown]; + r.extend(row(l, &["normal_max", "pathologic_min", "ci", "sizing"])); + r.push(if truthy(zone) { + format!("{} ({})", text(val(l, "zone_label")), text(zone)) + } else { + ".".into() + }); + rows.push(r); + gauge.push((l.clone(), status)); + } + out.fact("Loci tested", cell(val(d, "records"))); + out.fact( + "Outside Stranger's \"normal\"", + if truthy(val(d, "stranger")) { + outside.to_string() + } else { + "Stranger not run".into() + }, + ); + for (label, key) in [ + ("In an intermediate zone", "intermediate"), + ("Not sized from short reads", "unsized"), + ] { + let value = array(d, key)? + .iter() + .map(text) + .collect::>() + .join(", "); + out.fact(label, text_or(&s(&value), "none")); + } + out.table( + &[ + "Locus", + "Repeats", + "Stranger status", + "Normal up to", + "Pathologic from", + "95% interval", + "Sizing", + "Intermediate zone", + ], + rows, + ); + out.extra("widget", widgets::str_gauge(gauge)); + } + "vntyper" => { + let sec = summary.section("vntyper"); + out.facts( + sec.data, + &[ + ("Result", "status"), + ("Confidence", "confidence"), + ("Mean depth over the repeat", "vntr_mean_depth"), + ], + ); + out.lines = vntyper::lines(&sec)?; + out.attention = matches!(string(sec.data, "status"), "positive" | "possible"); + } + "mito" => { + let sec = summary.section("mito"); + let d = sec.data; + out.facts( + d, + &[ + ("PASS variants on chrM", "pass"), + ("Heteroplasmic sites", "heteroplasmic"), + ], + ); + let a = val(d, "annotation"); + if let Some(n) = get(a, "clinvar_plp") { + out.fact("ClinVar pathogenic or likely pathogenic", cell(n)); + } + let rows = array(d, "heteroplasmic_sites")? + .iter() + .map(|x| { + vec![ + format!( + "m.{}{}>{}", + text(val(x, "pos")), + text(val(x, "ref")), + text(val(x, "alt")) + ), + num(get(x, "af")) + .map_or_else(|| ".".into(), |n| format!("{}%", fixed(n * 100.0, 1))), + ] + }) + .collect(); + out.table(&["Site", "Allele fraction"], rows); + out.lines = mito::mito_lines(&sec)?; + out.attention = + num(get(a, "clinvar_plp")).is_some_and(|n| n > 0.0) || truthy(val(d, "confirmed")); + } + "lpa" => { + let sec = summary.section("lpa"); + let d = sec.data; + let repeats = if string(d, "status") == "estimated" { + format!( + "{} (95% interval {} to {})", + text(val(d, "kiv2_copies")), + text(val(d, "ci95_low")), + text(val(d, "ci95_high")) + ) + } else { + cell(val(d, "status")) + }; + out.fact("KIV-2 repeats", repeats); + out.fact("Class", cell(val(d, "class"))); + if truthy(val(d, "null_allele")) { + out.fact( + "KIV-2 4925G>A null allele", + smn1::marker_state(val(d, "null_allele"))?, + ); + } + out.lines = lpa::lines(&sec)?; + out.attention = string(d, "flag") == "high"; + out.extra("widget", widgets::lpa(d)); + } + "chip" => { + let sec = summary.section("chip"); + let d = sec.data; + let calls = array(d, "calls")?; + out.fact("CHIP calls", calls.len().to_string()); + out.fact( + "Typical detection limit at this depth (VAF)", + cell(val(d, "median_limit")), + ); + out.fields_table( + &["Gene", "Change", "VAF", "Alt reads", "Depth", "Status"], + calls, + &[ + "gene", + "protein_change", + "vaf", + "alt_reads", + "depth", + "status", + ], + ); + out.lines = chip::lines(&sec, &text(val(summary.root(), "sample")))?; + out.attention = !calls.is_empty(); + out.extra("widget", widgets::chip(array(d, "genes")?, calls)); + } + "mosaic" => { + let sec = summary.section("mosaic_sex_loss"); + let d = sec.data; + let call = string(d, "call"); + let label = match call { + "not_detected" => "not detected above 10%", + "gain" => "an extra copy, not a loss", + "not_estimated" => "not estimated", + _ => call, + }; + out.fact( + text_or(val(d, "chrom"), "chrY or chrX"), + if label.is_empty() { "." } else { label }, + ); + out.lines.push(text_or(val(d, "reason"), "")); + out.lines.extend(sex_loss::lines(&sec)?); + out.attention = matches!(call, "detected" | "gain"); + } + "mosaic-mca" => { + let sec = summary.section("mosaic"); + let d = sec.data; + let calls = array(d, "calls")?; + out.fact("Status", cell(val(d, "status"))); + out.fact( + "Calls reported", + get(d, "calls_reported").map_or_else(|| calls.len().to_string(), cell), + ); + out.fact("Smallest cell fraction it can see", cell(val(d, "floor"))); + out.fields_table( + &[ + "Chromosome", + "Start", + "End", + "Length (Mb)", + "Type", + "Cell fraction", + ], + calls, + &[ + "chrom", + "start", + "end", + "length_mb", + "type", + "cell_fraction", + ], + ); + out.lines = mocha::lines(&sec)?; + out.attention = !calls.is_empty(); + } + _ => unreachable!(), + } + Ok(out) +} + +pub(super) fn findings(summary: &Summary, found: &mut Vec) { + for x in rows(val(data(summary, "annotsv"), "rows")) { + add_row(found, "structural-variants", Level::Act, || { + object_row(x)?; + let genes = array(x, "genes")?; + let gene = genes.first().unwrap_or(&Value::Null); + let genes = genes + .iter() + .map(|g| match g { + Value::Str(t) => Ok(t.as_str()), + _ => Err(Malformed("gene is not a string".into())), + }) + .collect::>>()? + .join(", "); + let kind = text_or(val(x, "type"), "structural change"); + let class = val(x, "acmg_class"); + let sv = val(x, "sv"); + let length = num(get(x, "length")) + .or_else(|| string(x, "length").trim().parse().ok()) + .filter(|n| n.is_finite()) + .unwrap_or(0.0) + .abs() as i128; + let length = pycompat::fmt::int_grouped(length); + let summary_genes = if genes.is_empty() { "no gene" } else { &genes }; + Ok(Some(Finding::new(if text(class) == "5" { Level::Act } else { Level::Review }, + "structural-variants", &["sv", &text_or_null(sv)], format!("Large {kind} over {summary_genes}"), + format!("A {kind} of {length} bases that AnnotSV ranks class {}. Short reads can misplace large changes: confirm it.", text(class))) + .gene(gene).detail(text_or(sv, "")) + .evidence("Class", class).evidence("Callers", &s(&annotsv_support(summary, &D::new(x, "AnnotSV row"))?)) + .evidence("Genotype", val(x, "gt")).viewer(text_or(sv, "").replace(' ', "")))) + }); + } + for l in rows(val(data(summary, "expansions"), "loci")) { + add_row(found, "expansions", Level::Act, || { + object_row(l)?; + let mut flags = repeat_flags(repeat_status(l)?); + let first = flags.next(); + if first.is_none() && !truthy(val(l, "zone")) { + return Ok(None); + } + let full = first + .filter(|s| s.contains("full")) + .or_else(|| flags.find(|s| s.contains("full"))); + let what = match full.or(first) { + Some("pre_mutation") => "premutation range".to_owned(), + Some("full_mutation") => "full-mutation range".to_owned(), + Some(s) => s.replace('_', " "), + None => format!("{} range", text_or(val(l, "zone_label"), "intermediate")), + }; + let count = if truthy(val(l, "repeat_count")) { + repeats::count(l)? + } else { + "not given".into() + }; + let locus = val(l, "locus"); + let name = text(locus); + let next = if full.is_some() { + "See a clinical geneticist." + } else { + "It may grow when passed on; worth a word with a genetic counsellor." + }; + let sizing = val(l, "allele_sizing"); + Ok(Some( + Finding::new( + if full.is_some() { + Level::Act + } else { + Level::Review + }, + "expansions", + &["str", &text_or_null(locus)], + format!("{name} repeat in the {what}"), + format!("{name} has {count} repeats: Stranger reads it as \"{what}\". {next}"), + ) + .gene(locus) + .detail(format!("{name} {count} repeats")) + .evidence("Repeats", &s(&count)) + .evidence_fields( + l, + &[ + ("95% interval", "ci"), + ("Pathologic from", "pathologic_min"), + ], + ) + .evidence( + "Sizing", + if truthy(sizing) { + sizing + } else { + val(l, "sizing") + }, + ), + )) + }); + } + let vn = data(summary, "vntyper"); + let status = string(vn, "status"); + if matches!(status, "positive" | "possible") { + found.push( + Finding::new( + if status == "positive" { + Level::Act + } else { + Level::Review + }, + "vntyper", + &["muc1", status], + format!("MUC1 kidney gene: {status}"), + format!( + "VNtyper reads the MUC1 repeat as {status}; it needs a clinical confirmation." + ), + ) + .gene(&s("MUC1")) + .evidence("Confidence", val(vn, "confidence")), + ); + } + let lp = data(summary, "lpa"); + if string(lp, "flag") == "high" { + found.push( + Finding::new( + Level::Review, + "lpa", + &["lpa"], + "Lp(a) likely high", + "The KIV-2 count suggests a high Lp(a); one blood measurement settles it.", + ) + .gene(&s("LPA")) + .evidence_fields(lp, &[("KIV-2 repeats", "kiv2_copies"), ("Class", "class")]), + ); + } + for c in rows(val(data(summary, "chip"), "calls")) { + add_row(found, "chip", Level::Review, || { + object_row(c)?; + let gene = val(c, "gene"); + let change = val(c, "protein_change"); + Ok(Some(Finding::new(Level::Review, "chip", &["chip", &text_or_null(gene), &text_or_null(change)], + format!("A blood clone in {} (CHIP)", text(gene)), + format!("{} {} is carried by a share of the blood cells (VAF {}). It becomes common with age; most people with it never get a blood cancer.", + text(gene), text_or(change, ""), text(val(c, "vaf")))) + .gene(gene).evidence("VAF", val(c, "vaf")) + .evidence("Reads", &s(&format!("{} of {}", text(val(c, "alt_reads")), text(val(c, "depth"))))))) + }); + } + for c in rows(val(data(summary, "mosaic"), "calls")) { + add_row(found, "mosaic-mca", Level::Review, || { + object_row(c)?; + let kind = text_or(val(c, "type"), "change"); + let chrom = val(c, "chrom"); + let start = val(c, "start"); + let fraction = val(c, "cell_fraction"); + Ok(Some( + Finding::new( + Level::Review, + "mosaic-mca", + &["mca", &text_or_null(chrom), &text_or_null(start)], + format!("A {kind} on {} in some blood cells", text(chrom)), + format!( + "MoChA sees a {kind} of {} Mb on {} in a share of the blood cells ({}).", + text(val(c, "length_mb")), + text(chrom), + text(fraction) + ), + ) + .evidence( + "Where", + &s(&format!( + "{}:{}-{}", + text(chrom), + text(start), + text(val(c, "end")) + )), + ) + .evidence("Cell fraction", fraction), + )) + }); + } + for x in rows(val(data(summary, "exomiser"), "genes")).iter().take(3) { + add_row(found, "exomiser", Level::Review, || { + object_row(x)?; + let gene = val(x, "gene"); + Ok(Some( + Finding::new( + Level::Review, + "exomiser", + &["exomiser", &text_or_null(gene)], + format!( + "Symptom ranking: {} ranks {}", + text(gene), + text(val(x, "rank")) + ), + "A ranking to bring to a clinical geneticist, not a diagnosis.", + ) + .gene(gene) + .evidence_fields(x, &[("Score", "exomiser_score"), ("Inheritance", "moi")]), + )) + }); + } +} diff --git a/rust/crates/og-live/src/results/traits.rs b/rust/crates/og-live/src/results/traits.rs new file mode 100644 index 000000000..8e946510b --- /dev/null +++ b/rust/crates/og-live/src/results/traits.rs @@ -0,0 +1,159 @@ +use super::*; +use og_render::sections::{apoe, consumer, g2, prs, telomere}; + +pub(super) fn card(id: &str, summary: &Summary) -> Read { + let mut out = Adapter::default(); + match id { + "traits-panel" => { + let d = summary.section("traits").data; + let rows = array(d, "rows")? + .iter() + .filter(|r| { + string(r, "status") == "called" + && !string(r, "gene").eq_ignore_ascii_case("APOE") + }) + .map(|r| { + let genotype = text_or(val(r, "genotype"), "."); + let ancestry = if string(r, "ancestry") == "yes" { + " (ancestry)" + } else { + "" + }; + let reading = text_or(val(r, "reading"), "."); + let note = val(r, "note"); + let reading = if truthy(note) { + format!("{reading}. {}", text(note)) + } else { + reading + }; + vec![ + cell(val(r, "gene")), + cell(val(r, "trait")), + format!("{genotype}{ancestry}"), + reading, + ] + }) + .collect(); + out.table(&["Gene", "Trait", "Genotype", "Reading"], rows); + out.facts( + d, + &[ + ("Rows read", "called"), + ("No genotype at the position", "not_covered"), + ], + ); + for r in array(d, "rules")? { + out.lines.push(format!( + "{} ({} {}): {}. {}", + text(val(r, "trait")), + text(val(r, "gene")), + text_or(val(r, "rsids"), "").replace(',', ", "), + g2::rule_result(r)?, + text(val(r, "reading")) + )); + if let Some(g2) = g2::g2_text(r)? { + out.lines.push(g2); + } + } + let apoe = val(d, "apoe"); + if truthy(apoe) { + let lines = super::rows(apoe) + .iter() + .map(|r| { + if matches!(r, Value::Object(_)) { + og_render::sections::apoe::text_lines(std::slice::from_ref(r)) + .map(|mut lines| lines.pop().unwrap_or_default().trim().to_owned()) + } else { + Ok(cell(r)) + } + }) + .collect::>>()?; + out.extra( + "hidden", + obj([ + ("summary", s(apoe::APOE_WARNING)), + ("text", s(&plain(&lines.join("; ")))), + ]), + ); + } + } + "prs" => { + let d = summary.section("prs").data; + let scores = array(d, "scores")?; + if !truthy(val(d, "adjusted")) { + out.fact("Scores", scores.len().to_string()); + out.lines.push("Raw scores only: without the ancestry panel no percentile is shown (docs/25-prs.md).".into()); + } else { + let rows = scores + .iter() + .map(|r| { + let effect = prs::effect(r)?.0; + Ok(vec![ + cell(val(r, "condition")), + cell(val(r, "pgs_id")), + cell(&s(&prs::percentile(r)?)), + format!("{}/{}", text(val(r, "matched")), text(val(r, "total"))), + cell(&s(&effect)), + ]) + }) + .collect::>()?; + out.table( + &[ + "Condition", + "Score", + "Percentile", + "Variants matched", + "Effect", + ], + rows, + ); + out.lines.push(prs::note(d)?); + } + } + "bloodtype" => { + let d = summary.section("bloodtype").data; + out.facts(d, &[("ABO", "abo"), ("RhD", "rhd")]); + out.fields_table( + &["System", "Predicted phenotype", "Genotype", "Confidence"], + array(d, "systems")?, + &["system", "phenotype", "genotype", "confidence"], + ); + } + "telomere" => { + let sec = summary.section("telomere"); + out.fact( + "Telomere content", + format!( + "{} ({})", + text(val(sec.data, "tel_content")), + telomere::TELOMERE_UNIT + ), + ); + out.lines = telomere::lines(&sec)?; + out.attention = truthy(val(sec.data, "low_reads")); + } + "viral" => { + let d = summary.section("viral").data; + out.facts(d, &[("HHV-6", "hhv6"), ("Genomes searched", "genomes")]); + out.fields_table( + &["Virus", "Reads", "Breadth", "Copies per cell", "Call"], + array(d, "found")?, + &["virus", "reads", "breadth", "copies_per_cell", "call"], + ); + } + "consumer-export" => { + let sec = summary.section("consumer_export"); + out.facts( + sec.data, + &[ + ("Sites", "sites"), + ("Called", "called"), + ("No call", "no_call"), + ], + ); + out.lines = consumer::lines(&sec)?; + } + _ => unreachable!(), + } + Ok(out) +} diff --git a/rust/crates/og-live/src/server.rs b/rust/crates/og-live/src/server.rs index 5d65e5f58..6e81f977c 100644 --- a/rust/crates/og-live/src/server.rs +++ b/rust/crates/og-live/src/server.rs @@ -1182,13 +1182,14 @@ pub fn cli(args: &[String], out: &mut dyn Write, err: &mut dyn Write) -> u8 { let _ = write!(out, "{USAGE}"); return 0; } - let cfg = match configure(args) { + let mut cfg = match configure(args) { Ok(c) => c, Err((code, m)) => { let _ = writeln!(err, "{m}"); return code; } }; + cfg.results = Some(crate::results::FNS); let bind = cfg.bind.clone(); let srv = match Server::start(cfg) { Ok(s) => s, diff --git a/rust/crates/og-live/src/veil.rs b/rust/crates/og-live/src/veil.rs index be15c34c5..7da51a187 100644 --- a/rust/crates/og-live/src/veil.rs +++ b/rust/crates/og-live/src/veil.rs @@ -1,2 +1,307 @@ -//! What a results page keeps closed until it is opened. Empty until its -//! unit of the 1.0.0 plan lands. +//! Match result references by exact locus, then by gene or overlapping locus. +//! The browser's report gate uses findings. These tags also keep related chart +//! marks and the home page's closed lead consistent with that gate. + +use crate::headlines::LeadPart; +use crate::results::{Finding, Level, data, list, rows, str_val, string, text, val}; +use crate::state::{Obj, obj, s}; +use og_render::{ + charts, + index::{Closable, veil_of}, + model::Summary, +}; +use pycompat::json::Value; + +struct Locus { + chrom: String, + start: i128, + end: i128, +} + +impl Locus { + fn new(chrom: &str, a: i128, b: i128) -> Self { + Self { + chrom: if chrom.starts_with("chr") { + chrom.to_owned() + } else { + format!("chr{chrom}") + }, + start: a.min(b), + end: a.max(b), + } + } + + fn parts(self) -> (String, i128, i128) { + (self.chrom, self.start, self.end) + } +} + +fn loci(text: &str) -> Vec { + let bytes = text.as_bytes(); + let position = |start: usize| -> Option<(usize, i128)> { + if !bytes.get(start).is_some_and(u8::is_ascii_digit) { + return None; + } + let len = bytes[start..] + .iter() + .take_while(|b| b.is_ascii_digit() || **b == b',') + .count(); + let end = start + len; + Some((end, text[start..end].replace(',', "").parse().ok()?)) + }; + let mut out = Vec::new(); + let mut from = 0; + for (colon, _) in text.match_indices(':') { + let mut start = colon; + while start > from && bytes[start - 1].is_ascii_alphanumeric() { + start -= 1; + } + let chrom = &text[start..colon]; + let name = chrom.strip_prefix("chr").unwrap_or(chrom); + if !(matches!(name, "X" | "Y" | "M" | "MT") + || ((1..=2).contains(&name.len()) && name.bytes().all(|b| b.is_ascii_digit()))) + { + continue; + } + let Some((end, a)) = position(colon + 1) else { + continue; + }; + let range = (bytes.get(end) == Some(&b'-')) + .then(|| position(end + 1)) + .flatten(); + let (next, b) = range.unwrap_or((end, a)); + out.push(Locus::new(chrom, a, b)); + from = next; + } + out +} + +fn spans(found: &[Finding]) -> Vec { + found + .iter() + .filter(|f| f.level == Level::Act) + .map(|f| Closable { + id: f.id.clone(), + gene: match &f.gene { + Value::Null => None, + v => { + let gene = text(v).to_uppercase(); + (!gene.is_empty()).then_some(gene) + } + }, + locus: f + .viewer + .iter() + .chain(&f.detail) + .find_map(|t| loci(t).into_iter().next()) + .map(Locus::parts), + }) + .collect() +} + +fn span_values(spans: &[Closable]) -> Value { + Value::Array( + spans + .iter() + .map(|span| { + let (chrom, start, end) = span.locus.as_ref().map_or( + (Value::Null, Value::Null, Value::Null), + |(chrom, start, end)| (s(chrom), Value::Int(*start), Value::Int(*end)), + ); + Value::Array(vec![ + s(&span.id), + span.gene.as_deref().map_or(Value::Null, s), + chrom, + start, + end, + ]) + }) + .collect(), + ) +} + +pub(crate) fn spans_json(found: &[Finding]) -> Value { + span_values(&spans(found)) +} + +fn id(spans: &[Closable], text: &str, own: Option) -> Option { + if let Some(locus) = own { + let text = format!("{text} {}:{}-{}", locus.chrom, locus.start, locus.end); + return veil_of(spans, &text); + } + veil_of(spans, text) +} + +fn joined(v: &Value) -> String { + list(v).iter().map(text).collect::>().join(" ") +} + +fn explicit(row: &Value) -> Option { + let chrom = string(row, "chrom"); + if chrom.is_empty() { + return None; + } + let pos = match val(row, "pos") { + Value::Int(n) => *n, + Value::Float(n) if n.is_finite() => *n as i128, + v => str_val(v).trim().parse().ok()?, + }; + Some(Locus::new(chrom, pos, pos)) +} + +fn tags(name: &str, map: &mut Obj, ids: impl IntoIterator>) { + let ids: Vec<_> = ids.into_iter().collect(); + if ids.iter().any(Option::is_some) { + map.insert(name.into(), tags_value(ids)); + } +} + +fn tags_value(ids: impl IntoIterator>) -> Value { + Value::Array( + ids.into_iter() + .map(|id| id.map_or(Value::Null, Value::Str)) + .collect(), + ) +} + +pub(crate) fn build( + summary: &Summary, + found: &[Finding], + cards: &[Obj], + lead: &[LeadPart], +) -> Value { + let spans = spans(found); + if spans.is_empty() { + return obj([]); + } + let mut row_tags = Obj::new(); + let mut viewer = Obj::new(); + let mut lines = Obj::new(); + let mut facts = Obj::new(); + let mut widgets = Obj::new(); + let mut marks = Obj::new(); + let mut findings = Obj::new(); + let hit_tags: Vec<_> = rows(val(data(summary, "clinvar"), "hits")) + .iter() + .take(og_render::sections::clinvar::HITS_SHOWN) + .map(|h| id(&spans, string(h, "gene"), explicit(h))) + .collect(); + tags("clinvar", &mut row_tags, hit_tags.iter().cloned()); + for card in cards { + let name = str_val(&card["id"]); + if name != "clinvar" { + tags( + name, + &mut row_tags, + list(val(&card["table"], "rows")) + .iter() + .map(|r| id(&spans, &joined(r), None)), + ); + } + if let Some(items) = card.get("viewer") { + tags( + name, + &mut viewer, + list(items).iter().enumerate().map(|(i, locus)| { + (name == "clinvar") + .then(|| hit_tags.get(i).cloned().flatten()) + .flatten() + .or_else(|| id(&spans, str_val(locus), None)) + }), + ); + } + tags( + name, + &mut lines, + list(&card["lines"]) + .iter() + .map(|line| id(&spans, str_val(line), None)), + ); + tags( + name, + &mut facts, + list(&card["facts"]) + .iter() + .map(|fact| id(&spans, &joined(fact), None)), + ); + if let Some(widget) = card.get("widget") { + let items = match string(widget, "kind") { + "vaf" => list(val(widget, "calls")), + "copies" => list(val(widget, "genes")), + _ => &[], + }; + tags( + name, + &mut widgets, + items.iter().map(|item| { + id( + &spans, + &format!("{} {}", string(item, "gene"), string(item, "change")), + None, + ) + }), + ); + } + } + if let Ok(specs) = og_render::chapters::guarded(|| charts::build(summary)) { + for spec in specs { + let tagged: Obj = spec + .marks + .iter() + .filter(|m| m.kind != Some(charts::MarkKind::Roh)) + .filter_map(|m| { + let own = m + .chrom + .as_deref() + .zip(m.pos) + .map(|(c, p)| Locus::new(c, p, m.end.unwrap_or(p))); + id(&spans, &format!("{} {}", m.label, m.detail), own) + .map(|id| (m.id.clone(), Value::Str(id))) + }) + .collect(); + if !tagged.is_empty() { + marks.insert(spec.id.to_string(), Value::Object(tagged)); + } + } + } + for f in found.iter().filter(|f| f.level != Level::Act) { + let t = format!( + "{} {} {} {}", + str_val(&f.gene), + f.detail.as_deref().unwrap_or(""), + f.title, + f.viewer.as_deref().unwrap_or("") + ); + if let Some(link) = id(&spans, &t, None) { + findings.insert(f.id.clone(), Value::Str(link)); + } + } + let lead: Vec<_> = lead + .iter() + .map(|part| { + if part.names_act { + None + } else { + id(&spans, &part.text, None) + } + }) + .collect(); + let mut value: Obj = [ + ("rows", row_tags), + ("viewer", viewer), + ("lines", lines), + ("facts", facts), + ("widget", widgets), + ("marks", marks), + ("findings", findings), + ] + .into_iter() + .filter(|(_, v)| !v.is_empty()) + .map(|(key, v)| (key.into(), Value::Object(v))) + .collect(); + if lead.iter().any(Option::is_some) { + value.insert("lead".into(), tags_value(lead)); + } + value.insert("spans".into(), span_values(&spans)); + Value::Object(value) +} diff --git a/rust/crates/og-live/src/widgets.rs b/rust/crates/og-live/src/widgets.rs index c3d21640f..d24401028 100644 --- a/rust/crates/og-live/src/widgets.rs +++ b/rust/crates/og-live/src/widgets.rs @@ -1,2 +1,180 @@ -//! The widgets of a results page. Empty until its unit of the 1.0.0 plan -//! lands. +//! Drawing data for the live cards. Numeric values are finite or null. + +use crate::results::{list, str_val, string, text_or, val}; +use crate::state::{obj, s}; +use og_render::model::{num, truthy}; +use pycompat::json::Value; + +fn number(v: &Value) -> Option { + num(Some(v)) + .or_else(|| str_val(v).trim().parse().ok()) + .filter(|n| n.is_finite()) +} + +fn nullable(v: &Value) -> Value { + number(v).map_or(Value::Null, Value::Float) +} + +pub(crate) fn str_gauge(loci: impl IntoIterator) -> Value { + let loci = loci + .into_iter() + .map(|(locus, status)| { + obj([ + ("locus", val(&locus, "locus").clone()), + ("repeat_count", val(&locus, "repeat_count").clone()), + ("normal_max", val(&locus, "normal_max").clone()), + ("pathologic_min", val(&locus, "pathologic_min").clone()), + ("ci", val(&locus, "ci").clone()), + ("allele_sizing", val(&locus, "allele_sizing").clone()), + ("status", s(&status)), + ]) + }) + .collect(); + obj([("kind", s("str")), ("loci", Value::Array(loci))]) +} + +pub(crate) fn lpa(d: &Value) -> Value { + if string(d, "status") != "estimated" { + return Value::Null; + } + let (Some(value), Some(low), Some(high)) = ( + number(val(d, "kiv2_copies")), + number(val(d, "ci95_low")), + number(val(d, "ci95_high")), + ) else { + return Value::Null; + }; + obj([ + ("kind", s("ci")), + ("label", s("KIV-2 repeats, both chromosomes")), + ("value", Value::Float(value)), + ("low", Value::Float(low)), + ("high", Value::Float(high)), + ("unit", s("repeats")), + ( + "max", + Value::Int(60.max(((high * 1.25 / 10.0 + 1.0) as i128).saturating_mul(10))), + ), + ("class", val(d, "class").clone()), + ]) +} + +pub(crate) fn chip(genes: &[Value], calls: &[Value]) -> Value { + if genes.is_empty() && calls.is_empty() { + return Value::Null; + } + let rendered_genes = genes + .iter() + .map(|g| { + obj([ + ("gene", val(g, "gene").clone()), + ("limit", nullable(val(g, "detection_limit_vaf"))), + ("depth", nullable(val(g, "mean_depth"))), + ("status", val(g, "status").clone()), + ]) + }) + .collect(); + let calls = calls + .iter() + .filter_map(|c| { + let vaf = number(val(c, "vaf"))?; + let gene = val(c, "gene"); + let limit = genes + .iter() + .rev() + .find(|g| val(g, "gene") == gene) + .map_or(Value::Null, |g| nullable(val(g, "detection_limit_vaf"))); + Some(obj([ + ("gene", gene.clone()), + ("change", val(c, "protein_change").clone()), + ("vaf", Value::Float(vaf)), + ("limit", limit), + ])) + }) + .collect(); + obj([ + ("kind", s("vaf")), + ("max", Value::Float(0.5)), + ("genes", Value::Array(rendered_genes)), + ("calls", Value::Array(calls)), + ]) +} + +fn copies_value(v: &Value) -> Value { + number(v) + .filter(|n| n.fract() == 0.0 && (0.0..=20.0).contains(n)) + .map_or(Value::Null, |n| Value::Int(n as i128)) +} + +pub(crate) fn copies(genes: &[Value], parascopy: &Value) -> Value { + const GENES: [&str; 5] = ["SMN1", "SMN2", "HBA1", "HBA2", "CYP21A2"]; + let mut dots: Vec<_> = genes + .iter() + .filter(|g| { + let name = string(g, "gene").split(' ').next().unwrap_or_default(); + GENES.contains(&name) + }) + .map(|g| { + obj([ + ("gene", val(g, "gene").clone()), + ("copies", copies_value(val(g, "copy_number"))), + ("status", s(&text_or(val(g, "status"), "."))), + ]) + }) + .collect(); + if truthy(val(parascopy, "rows")) { + for gene in ["smn1", "smn2"] { + let x = val(parascopy, gene); + if !truthy(x) { + continue; + } + let copies = copies_value(val(x, "cn")); + let status = if matches!(copies, Value::Null) { + text_or(val(x, "text"), "not called") + } else { + "called".to_owned() + }; + dots.push(obj([ + ( + "gene", + s(&format!("{} (Parascopy)", gene.to_ascii_uppercase())), + ), + ("copies", copies), + ("status", s(&status)), + ])); + } + } + if dots.is_empty() { + Value::Null + } else { + obj([("kind", s("copies")), ("genes", Value::Array(dots))]) + } +} + +pub(crate) fn y_path(tree: &Value) -> Value { + let path = list(val(tree, "path")); + if path.is_empty() { + return Value::Null; + } + obj([ + ("kind", s("ypath")), + ("tree", val(tree, "tree").clone()), + ("tip", val(tree, "haplogroup").clone()), + ( + "path", + Value::Array( + path.iter() + .map(|p| { + obj([ + ("level", val(p, "Level").clone()), + ("branch", val(p, "Branch").clone()), + ("derived", nullable(val(p, "Derived"))), + ("ancestral", nullable(val(p, "Ancestral"))), + ("no_call", nullable(val(p, "No_call"))), + ]) + }) + .collect(), + ), + ), + ]) +} diff --git a/rust/crates/og-live/tests/results_veil.rs b/rust/crates/og-live/tests/results_veil.rs index fa9ed8c08..88e4fe0b7 100644 --- a/rust/crates/og-live/tests/results_veil.rs +++ b/rust/crates/og-live/tests/results_veil.rs @@ -59,15 +59,15 @@ const CLOSED: &str = r#"{ {"gene":"GENE1","chrom":"chr2","pos":130,"ref":"C","alt":"T","stars":1}, {"gene":"GENE2","chrom":"chr3","pos":7,"ref":"T","alt":"C","stars":1} ],"deep_intronic":[ - {"gene":"GENE1","chrom":"chr2","pos":123,"ref":"A","alt":"T","call":"het"}, - {"gene":"GENE2","chrom":"chr3","pos":8,"ref":"C","alt":"A","call":"het"} + {"gene":"GENE1","chrom":"chr2","pos":123,"ref":"A","alt":"T","call":"het","detail":"GQ 40"}, + {"gene":"GENE2","chrom":"chr3","pos":8,"ref":"C","alt":"A","call":"het","detail":"GQ 40"} ]}}, "annotsv":{"state":"ok","data":{"consensus":true,"count":1,"rows":[ {"type":"DEL","sv":"chr2:100-200","length":100,"acmg_class":"5","genes":["GENE1"],"support":null} ]}}, - "exomiser":{"state":"ok","data":{"genes":[{"gene":"GENE1","rank":1},{"gene":"GENE2","rank":2}]}}, + "roh":{"state":"ok","data":{}},"exomiser":{"state":"ok","data":{"genes":[{"gene":"GENE1","rank":1},{"gene":"GENE2","rank":2}]}}, "chip":{"state":"ok","data":{"genes":[{"gene":"GENE1","mean_depth":75,"detection_limit_vaf":0.06}], - "calls":[{"gene":"GENE2","vaf":0.08},{"gene":"GENE1","vaf":0.12}]}}, + "calls":[{"gene":"GENE2","vaf":0.08,"protein_change":"p.A1T","depth":75,"alt_reads":6,"note":"clone"},{"gene":"GENE1","vaf":0.12,"protein_change":"p.G2A","depth":75,"alt_reads":9,"note":"clone"}]}}, "carrier":{"state":"ok","data":{"two_hits":{"genes":["SMN1"]}}}, "paralogs":{"state":"ok","data":{"genes":[{"gene":"SMN1","copy_number":1,"status":"called"}, {"gene":"SMN2","copy_number":2,"status":"called"}]}}, @@ -97,7 +97,7 @@ fn veil_distinguishes_exact_loci_spans_and_unrelated_rows() { assert_eq!(field(veil, &["lines", "clinvar"]), &text_list(&[sf, None])); assert_eq!( field(veil, &["findings", "exomiser-gene1"]), - &Value::Str(sf.unwrap().into()) + &Value::Str("sf-gene1-chr2-110-a-g".into()) ); assert!(matches!(field(veil, &["marks", "genome"]), Value::Object(m) if !m.is_empty())); assert!(matches!(field(veil, &["spans"]), Value::Array(a) if a.len() >= 3)); From f1ac07d550892a8260e97837b64c04e4ce2fd411 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 01:56:15 +0100 Subject: [PATCH 36/38] test(live): cover search veil tags and child report transitions Bead: D1 Bead: D14 --- rust/crates/og-browser/Cargo.toml | 4 + rust/crates/og-live/tests/results_veil.rs | 121 ++++++- tests/browser/live_results_veil.rs | 389 ++++++++++++++++++++++ 3 files changed, 512 insertions(+), 2 deletions(-) create mode 100644 tests/browser/live_results_veil.rs diff --git a/rust/crates/og-browser/Cargo.toml b/rust/crates/og-browser/Cargo.toml index a8c3633a5..91972fca0 100644 --- a/rust/crates/og-browser/Cargo.toml +++ b/rust/crates/og-browser/Cargo.toml @@ -18,3 +18,7 @@ regex.workspace = true [lints] workspace = true + +[[test]] +name = "live_results_veil" +path = "../../../tests/browser/live_results_veil.rs" diff --git a/rust/crates/og-live/tests/results_veil.rs b/rust/crates/og-live/tests/results_veil.rs index 88e4fe0b7..ee0f38282 100644 --- a/rust/crates/og-live/tests/results_veil.rs +++ b/rust/crates/og-live/tests/results_veil.rs @@ -65,7 +65,7 @@ const CLOSED: &str = r#"{ "annotsv":{"state":"ok","data":{"consensus":true,"count":1,"rows":[ {"type":"DEL","sv":"chr2:100-200","length":100,"acmg_class":"5","genes":["GENE1"],"support":null} ]}}, - "roh":{"state":"ok","data":{}},"exomiser":{"state":"ok","data":{"genes":[{"gene":"GENE1","rank":1},{"gene":"GENE2","rank":2}]}}, + "roh":{"state":"ok","data":{"autosomal_over_5mb":[{"region":"chr2:100-9000000","mb":9}]}},"exomiser":{"state":"ok","data":{"genes":[{"gene":"GENE1","rank":1},{"gene":"GENE2","rank":2}]}}, "chip":{"state":"ok","data":{"genes":[{"gene":"GENE1","mean_depth":75,"detection_limit_vaf":0.06}], "calls":[{"gene":"GENE2","vaf":0.08,"protein_change":"p.A1T","depth":75,"alt_reads":6,"note":"clone"},{"gene":"GENE1","vaf":0.12,"protein_change":"p.G2A","depth":75,"alt_reads":9,"note":"clone"}]}}, "carrier":{"state":"ok","data":{"two_hits":{"genes":["SMN1"]}}}, @@ -99,7 +99,14 @@ fn veil_distinguishes_exact_loci_spans_and_unrelated_rows() { field(veil, &["findings", "exomiser-gene1"]), &Value::Str("sf-gene1-chr2-110-a-g".into()) ); - assert!(matches!(field(veil, &["marks", "genome"]), Value::Object(m) if !m.is_empty())); + assert_eq!( + field(veil, &["marks", "genome"]), + &loads(r#"{"hit-0":"sf-gene1-chr2-110-a-g","hit-1":"sf-gene1-chr2-110-a-g","sv-0":"sv-chr2-100-200"}"#).unwrap() + ); + assert_eq!( + field(veil, &["marks", "clinvar-stars"]), + &loads(r#"{"stars-2":"sf-gene1-chr2-110-a-g","stars-1":"sf-gene1-chr2-110-a-g"}"#).unwrap() + ); assert!(matches!(field(veil, &["spans"]), Value::Array(a) if a.len() >= 3)); } @@ -173,3 +180,113 @@ fn discordant_smn1_counts_use_the_report_verdict_without_carrier_finding() { .contains("they DISAGREE: check both before using either") ); } + +#[test] +fn search_index_tags_only_the_items_that_name_a_closed_result() { + let request = format!( + r#"{{"summary":{CLOSED},"terms":{{ + "GENE1":[{{"section":"clinical","mentions":[]}},{{"section":"exomiser","mentions":[]}}], + "GENE10":[{{"section":"traits","mentions":[{{"text":"GENE10","locus":"chr2:201"}}]}}], + "rs123":[ + {{"section":"clinvar","mentions":[{{"text":"At the exact site","locus":"2:110"}}]}}, + {{"section":"slivar","mentions":[{{"text":"Inside the deletion","locus":"chr2:155"}}]}}, + {{"section":"traits","mentions":[{{"text":"Outside the deletion","locus":"chr2:201"}}]}} + ], + "rs456":[{{"section":"cpsr","mentions":[{{"text":"A change in GENE1.","locus":null}}]}}] + }}}}"#, + ); + let got = results(&request, &["--tag-search"]); + let groups = [ + ("GENE1", vec![Some("sf-gene1-chr2-110-a-g"); 2]), + ("GENE10", vec![None]), + ( + "rs123", + vec![Some("sf-gene1-chr2-110-a-g"), Some("sv-chr2-100-200"), None], + ), + ("rs456", vec![Some("sf-gene1-chr2-110-a-g")]), + ]; + for (term, expected) in groups { + let Value::Array(items) = field(&got, &[term]) else { + panic!("expected entries for {term}"); + }; + assert_eq!(items.len(), expected.len()); + for (item, expected) in items.iter().zip(expected) { + let Value::Object(item) = item else { + panic!("expected index item"); + }; + assert_eq!( + item.get("veil").cloned(), + expected.map(|id| Value::Str(id.into())), + "{term}" + ); + } + } +} + +#[test] +fn unreadable_actionable_rows_keep_a_finding_at_the_card() { + let doc = results( + r#"{"sections":{ + "annotsv":{"state":"ok","data":{"rows":[{"sv":"chr1:1000-9000","type":"deletion", + "length":-8000,"acmg_class":"5","genes":["GENEX","GENEY","GENEZ",null],"gt":"0/1"}]}}, + "cpsr":{"state":"ok","data":{"plp":["GENEY c.1del"]}}, + "carrier":{"state":"ok","data":{"carriers":[["GENEX"]]}}, + "clinvar":{"state":"ok","data":{"hits":[["GENEZ"]]}} + }}"#, + &[], + ); + let Value::Array(found) = field(&doc, &["findings"]) else { + panic!("expected findings"); + }; + for (card, level) in [ + ("structural-variants", "act"), + ("cpsr", "act"), + ("carrier-list", "act"), + ("clinvar", "review"), + ] { + let f = found + .iter() + .find(|f| field(f, &["card"]) == &Value::Str(card.into())) + .unwrap(); + assert_eq!(field(f, &["level"]), &Value::Str(level.into()), "{card}"); + assert_eq!(field(f, &["gene"]), &Value::Null, "{card}"); + for key in ["title", "text"] { + assert!( + !matches!(field(f, &[key]), Value::Str(text) if text.contains("GENE")), + "{card} {key}" + ); + } + } +} + +#[test] +fn smn1_marker_card_keeps_the_report_facts_and_caveat() { + let doc = results( + r#"{"sections":{"parascopy":{"state":"ok","data":{ + "smn1":{"text":"2 (quality 33, filter PASS)","cn":2}, + "smn1_marker":{"status":"present","alt_reads":5,"depth":40,"copies":0.5} + }}}}"#, + &[], + ); + let Value::Array(chapters) = field(&doc, &["chapters"]) else { + panic!("expected chapters"); + }; + let card = chapters + .iter() + .filter_map(|ch| match field(ch, &["sections"]) { + Value::Array(cards) => Some(cards), + _ => None, + }) + .flatten() + .find(|c| field(c, &["id"]) == &Value::Str("paralogs".into())) + .expect("paralogs card"); + assert_eq!( + field(card, &["facts"]), + &loads(r#"[["SMN1 copies","2 (quality 33, filter PASS)"],["SMN1 g.27134T>G silent-carrier marker","present, 5 of 40 reads carry it, about 0.5 copies"]]"#).unwrap() + ); + let Value::Array(lines) = field(card, &["lines"]) else { + panic!("expected card lines"); + }; + let caveat = og_render::sections::smn1::SMN1_MARKER_CAVEAT; + assert!(lines.contains(&Value::Str(format!("SMN1 marker caveat: {caveat}")))); +} diff --git a/tests/browser/live_results_veil.rs b/tests/browser/live_results_veil.rs new file mode 100644 index 000000000..f1854e237 --- /dev/null +++ b/tests/browser/live_results_veil.rs @@ -0,0 +1,389 @@ +//! Exercise the child report gate with the result and index files the demo +//! builds. Check what Chrome presents on the person, finding, home and +//! family pages, including when an unopened result's data changes. + +use og_browser::{Browser, Scratch, StaticServer, Value, chrome_or_skip, js_str, repo_root}; +use pycompat::json::{dumps, loads}; +use std::{fs, path::Path, path::PathBuf, process::Command, time::Duration}; + +const CHILD: &str = "/runs/DEMO-003/"; +const FAMILY: &str = "/runs/DEMO-FAMILY/"; +const CLOSED: &str = "[data-opening^=closed]"; +const GATED: &str = "document.documentElement.dataset.pgpGated === 'true'"; +const OPEN: &str = + "!document.documentElement.dataset.pgpGated && !!document.querySelector('#results .finding')"; +const WAIT: Duration = Duration::from_secs(15); + +fn command(mut cmd: Command) { + let out = cmd.output().expect("start fixture command"); + assert!( + out.status.success(), + "{cmd:?}: {}", + String::from_utf8_lossy(&out.stderr) + ); +} + +fn value(path: &Path) -> Value { + loads(&fs::read_to_string(path).unwrap()).unwrap() +} + +fn object(v: &mut Value) -> &mut indexmap::IndexMap { + let Value::Object(o) = v else { + panic!("expected object") + }; + o +} + +fn write(path: &Path, doc: &Value) { + fs::write(path, dumps(doc, &Default::default()).unwrap()).unwrap(); +} + +fn field<'a>(v: &'a Value, key: &str) -> &'a Value { + let Value::Object(o) = v else { + panic!("expected object with {key}"); + }; + o.get(key).unwrap_or_else(|| panic!("missing {key}")) +} + +fn text<'a>(v: &'a Value, key: &str) -> &'a str { + let Value::Str(s) = field(v, key) else { + panic!("expected text at {key}") + }; + s +} + +fn wait(b: &mut Browser, expr: &str) -> Value { + b.wait(expr, WAIT) + .unwrap_or_else(|| panic!("waiting for {expr}: {:?}", b.page_errors())) +} + +fn go(b: &mut Browser, srv: &StaticServer, route: &str) { + b.go("about:blank").unwrap(); + wait(b, "location.href === 'about:blank'"); + b.go(&srv.url(route)).unwrap(); + wait( + b, + "document.readyState === 'complete' && document.documentElement.dataset.pgpStatus === 'ready'", + ); +} + +fn count(b: &mut Browser, selector: &str, expected: usize) { + wait( + b, + &format!( + "document.querySelectorAll({}).length === {expected}", + js_str(selector) + ), + ); +} + +fn click(b: &mut Browser, selector: &str, index: usize) { + b.eval(&format!( + "document.querySelectorAll({})[{index}].click(); true", + js_str(selector) + )) + .unwrap(); +} + +fn closed_view(b: &mut Browser, count_expected: usize) -> Value { + wait(b, GATED); + count(b, CLOSED, count_expected); + count( + b, + "input[type=search], #results, #genome-map, canvas, svg, img, #report-link", + 0, + ); + b.eval("JSON.stringify([location.pathname, location.search, location.hash, document.body.innerHTML, sessionStorage.length, window.name])").unwrap() +} + +fn closed_snapshot(b: &mut Browser, expected: usize) -> (Value, Vec) { + closed_view(b, expected); + b.eval(include_str!("../demo/gate-property.js")).unwrap(); + let frame = b + .eval( + r#"(() => { + const visible = GateProperty.snapshot(); + visible.requests = visible.requests.filter(path => path !== '/favicon.ico'); + return visible; + })()"#, + ) + .unwrap(); + let tree = b + .call("Accessibility.getFullAXTree", loads("{}").unwrap()) + .unwrap(); + let Value::Array(nodes) = field(&tree, "nodes") else { + panic!("expected accessibility tree"); + }; + let names = nodes + .iter() + .filter_map(|node| { + if field(node, "ignored") == &Value::Bool(true) { + return None; + } + let Value::Object(node) = node else { + return None; + }; + node.get("name").map(|name| field(name, "value").clone()) + }) + .collect(); + (frame, names) +} + +fn require_index_tags(index: &Value, acts: &[Value]) { + let Value::Array(items) = field(field(index, "terms"), "KCNH2") else { + panic!("the planted gene has no search entries") + }; + assert!(!items.is_empty()); + for item in items { + let id = text(item, "veil"); + assert!( + acts.iter().any(|act| text(act, "id") == id), + "search tag {id} must name a finding to act on" + ); + } +} + +#[test] +fn child_results_stay_closed_until_every_finding_is_opened() { + let Some(chrome) = chrome_or_skip("check the live results veil") else { + return; + }; + let Some(og) = std::env::var_os("OG").map(PathBuf::from).or_else(|| { + let test = std::env::current_exe().ok()?; + let og = test.parent()?.parent()?.join("og"); + og.is_file().then_some(og) + }) else { + assert_ne!(std::env::var("CI").as_deref(), Ok("true"), "build og in CI"); + println!("[SKIP] no og to build the live demo"); + return; + }; + let scratch = Scratch::new(Path::new(env!("CARGO_TARGET_TMPDIR")), "results-veil"); + let site = scratch.path().join("site"); + let work = scratch.path().join("work"); + fs::create_dir(&work).unwrap(); + let mut build = Command::new("python3"); + build + .arg(repo_root().join("tests/demo/build_live_demo.py")) + .args(["--records", "2000", "--out"]) + .arg(&site) + .arg("--work") + .arg(&work) + .arg("--og") + .arg(&og); + command(build); + + let result_path = site.join("runs/DEMO-003/results.json"); + let original = value(&result_path); + let Value::Array(findings) = field(&original, "findings") else { + panic!("the demo has no findings") + }; + let (mut acts, others): (Vec<_>, Vec<_>) = findings + .iter() + .cloned() + .partition(|f| text(f, "level") == "act"); + let act_count = acts.len(); + assert!(act_count >= 2, "the demo needs two independent acts"); + require_index_tags( + &value(&site.join("runs/DEMO-003/DEMO-003_search_index.json")), + &acts, + ); + // Exercise both native index entry points as well as the legacy demo's. + let run = work.join("DEMO-003"); + let index = scratch.path().join("index.json"); + let mut index_build = Command::new(&og); + index_build + .args(["report", "index", "build", "--summary"]) + .arg(run.join("summary.json")) + .arg("--sample-dir") + .arg(&run) + .arg("-o") + .arg(&index); + command(index_build); + require_index_tags(&value(&index), &acts); + let mut report = Command::new(&og); + report + .args(["report", "render", "--summary"]) + .arg(run.join("summary.json")) + .arg("--sample-dir") + .arg(&run) + .arg("-o") + .arg(scratch.path().join("report.txt")) + .arg("--search-index") + .arg(&index); + command(report); + require_index_tags(&value(&index), &acts); + + let mut third = acts[0].clone(); + object(&mut third).extend([ + ("id".into(), Value::Str("gate-fixture-third".into())), + ( + "title".into(), + Value::Str("Separate synthetic result".into()), + ), + ("viewer".into(), Value::Null), + ]); + acts.truncate(2); + acts.push(third); + let fid = text(&acts[0], "id"); + let finding = format!("{CHILD}finding/{fid}/"); + let guessed = format!("{CHILD}finding/gate-fixture-unknown/"); + let guessed_page = site.join(guessed.trim_start_matches('/')); + fs::create_dir_all(&guessed_page).unwrap(); + let finding_page = site + .join(finding.trim_start_matches('/')) + .join("index.html"); + let html = fs::read_to_string(finding_page).unwrap(); + fs::write( + guessed_page.join("index.html"), + html.replace(fid, "gate-fixture-unknown"), + ) + .unwrap(); + let srv = StaticServer::start(&site, &[]).unwrap(); + let mut b = Browser::launch(&chrome, &scratch.path().join("chrome")).unwrap(); + b.call("Network.enable", loads("{}").unwrap()).unwrap(); + b.call( + "Network.setCacheDisabled", + loads(r#"{"cacheDisabled":true}"#).unwrap(), + ) + .unwrap(); + + for (width, media) in [(1440, "screen"), (390, "screen"), (1440, "print")] { + b.call( + "Emulation.setDeviceMetricsOverride", + loads(&format!( + r#"{{"width":{width},"height":900,"deviceScaleFactor":1,"mobile":false}}"# + )) + .unwrap(), + ) + .unwrap(); + b.call( + "Emulation.setEmulatedMedia", + loads(&format!(r#"{{"media":"{media}"}}"#)).unwrap(), + ) + .unwrap(); + for route in [ + CHILD.to_owned(), + finding.clone(), + format!("{CHILD}?chr=7#f/{fid}"), + ] { + let mut altered = original.clone(); + let secret = "unopened fixture payload"; + let changed = |mut f: Value| { + object(&mut f).insert("title".into(), Value::Str(secret.into())); + object(&mut f).insert("future_field".into(), Value::Array(vec![Value::Bool(true)])); + f + }; + let Value::Array(altered_findings) = &mut object(&mut altered)["findings"] else { + panic!("the demo has no findings") + }; + for f in altered_findings { + *f = changed(f.clone()); + } + object(&mut altered).insert("future_field".into(), Value::Str(secret.into())); + write(&result_path, &original); + go(&mut b, &srv, &route); + let before = closed_snapshot(&mut b, act_count); + write(&result_path, &altered); + go(&mut b, &srv, &route); + assert_eq!( + closed_snapshot(&mut b, act_count), + before, + "{width} {media} {route}" + ); + } + } + b.call( + "Emulation.setEmulatedMedia", + loads(r#"{"media":"screen"}"#).unwrap(), + ) + .unwrap(); + + // The indices give every order in which the remaining controls can be selected. + let orders: &[&[usize]] = &[ + &[0], + &[0, 0], + &[1, 0], + &[0, 0, 0], + &[0, 1, 0], + &[1, 0, 0], + &[1, 1, 0], + &[2, 0, 0], + &[2, 1, 0], + ]; + for order in orders { + let total = order.len(); + let mut doc = original.clone(); + object(&mut doc).insert( + "findings".into(), + Value::Array(others.iter().chain(&acts[..total]).cloned().collect()), + ); + write(&result_path, &doc); + go(&mut b, &srv, CHILD); + for (stage, &which) in order.iter().enumerate() { + let left = total - stage; + let before = closed_view(&mut b, left); + click(&mut b, CLOSED, which); + if left > 1 { + count(&mut b, ".opened-act", stage + 1); + closed_view(&mut b, left - 1); + click(&mut b, "[data-opening^=opened]", stage); + assert_eq!(closed_view(&mut b, left), before, "close again"); + click(&mut b, CLOSED, which); + closed_view(&mut b, left - 1); + } + } + wait(&mut b, OPEN); + wait( + &mut b, + "!!document.querySelector('input[type=search]:not(:disabled)')", + ); + b.eval("var search = document.querySelector('input[type=search]'); search.value = 'KCNH2'; search.dispatchEvent(new Event('input')); true").unwrap(); + wait( + &mut b, + "document.querySelector('.search-results').textContent.includes('Results this page keeps closed are left out of the search')", + ); + b.eval(&format!("PGPUI.closeAct({}); true", js_str(fid))) + .unwrap(); + closed_view(&mut b, 1); + count(&mut b, ".opened-act", total - 1); + b.call("Page.reload", loads("{}").unwrap()).unwrap(); + closed_view(&mut b, total); + } + + write(&result_path, &original); + go(&mut b, &srv, &finding); + let known = closed_view(&mut b, act_count); + go(&mut b, &srv, &guessed); + assert_eq!(closed_view(&mut b, act_count), known); + for left in (1..=act_count).rev() { + count(&mut b, CLOSED, left); + click(&mut b, CLOSED, 0); + } + wait(&mut b, OPEN); + assert_eq!( + b.eval("location.pathname").unwrap(), + Value::Str(CHILD.into()) + ); + go(&mut b, &srv, FAMILY); + wait( + &mut b, + "!!document.querySelector('[data-gate-child=DEMO-003]')", + ); + assert_eq!( + b.eval("document.body.innerText.includes('KCNH2')").unwrap(), + Value::Bool(false) + ); + go(&mut b, &srv, "/"); + assert_eq!( + b.eval("document.body.innerText.includes('KCNH2')").unwrap(), + Value::Bool(false) + ); + go(&mut b, &srv, "/runs/DEMO-002/"); + wait(&mut b, OPEN); + for widget in ["str", "ci", "vaf", "copies"] { + wait( + &mut b, + &format!("!!document.querySelector('[data-widget={widget}]')"), + ); + } +} From 0103bfeb3367a3c13424b425b0453bd3efbcd138 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 01:57:32 +0100 Subject: [PATCH 37/38] refactor(live): switch the remaining results callers to og Bead: plat-31 Bead: D1 Bead: D14 --- CHANGELOG.md | 2 +- bin/live_results.py | 1376 ------------------------ bin/owngenome_live.py | 18 +- bin/owngenome_live_map.py | 5 +- bin/owngenome_live_results.py | 28 +- bin/results_index.py | 12 +- rust/crates/og-live/src/results/mod.rs | 49 +- rust/crates/og-live/src/veil.rs | 32 +- rust/crates/og-render/src/index.rs | 22 +- rust/crates/og-render/src/render.rs | 27 +- rust/og/src/main.rs | 14 +- scripts/ci/e2e-case-paths.tsv | 2 +- tests/demo/build_live_demo.py | 22 +- tests/parity/remnants.tsv | 2 +- tests/test_collect_summary.py | 8 +- tests/test_live_demo.py | 6 +- tests/test_live_journal.py | 411 ------- tests/test_live_results.py | 651 ----------- tests/test_live_widgets.py | 193 ---- tests/test_owngenome_live_family.py | 31 +- 20 files changed, 189 insertions(+), 2722 deletions(-) delete mode 100644 bin/live_results.py delete mode 100644 tests/test_live_journal.py delete mode 100644 tests/test_live_results.py delete mode 100644 tests/test_live_widgets.py diff --git a/CHANGELOG.md b/CHANGELOG.md index bc7e8dc93..50ce4f7c7 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- `og live results` builds the live site's cards and findings from `summary.json` and shares wording and caveats with the Rust report. `og live serve` uses it for the results page. When Paraphase and Parascopy disagree on SMN1, the live card shows the report's warning and the journal makes no SMN1 carrier finding. +- `og live results` builds the live site's cards and findings from `summary.json` and shares wording and caveats with the Rust report. Both live servers and the static demo use it for the results page. The search index tags results by the same findings the live page uses to close a child's report. When Paraphase and Parascopy disagree on SMN1, the live card shows the report's warning and the journal makes no SMN1 carrier finding. - The E2E run dispatched on a batch of pull requests finishes sooner, with every case and check it ran before. The shard split now weighs `prs-3-panel-measure` at its measured 2900 seconds on a run dispatched on a branch (`E2E_SECONDS`), where it measures the 1000 Genomes panel, so its shard no longer gets a full share of other cases on top. The base leg sets up while `og` builds, and the job `og` builds only the Linux x86_64 binary the legs run (`OG_ARCHES`, `OG_DARWIN_ARCHES` in `rust/og.sh`); Guard's `rust` job still builds all four on every pull request, as does the Rust `images` job when it runs. The nightly Rust run, which is the `streams` job only, now builds only `og-linux-x86_64`, the binary it runs. Container Test runs at most 8 smoke rows at once, so a change to every image no longer takes the runners the E2E legs wait for. The jobs that only build `og --release` lose their Rust cache, which did not speed them up, and Guard's `rust` job saves its cache on main only, so the E2E image and data caches fit the 10 GB budget. - The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. On the card a low-confidence call is one below step 06's call floor or a weak HIGH-impact call (`weak_call`). A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and it then counts with the copies, GT and phase set of that confident call, beside a deletion too. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer, apart from rare deletion shapes where the card is more cautious (a combined allele across a deletion's end) and from a call the card judges by its HIGH-impact record (a lower call floor in the clinical VCF, or a HIGH-impact call of a part of a combined allele): on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - A step you selected that produced nothing now says so. A report-only Nextflow step (TelomereHunter, VNtyper, the CHIP genes and the others in `nextflow.config`) is dropped when it fails, after one retry when the exit was a memory kill. Its section had no file, so the report listed it as not run, the same as a step nobody asked for. `HTML_REPORT` now records the run's `--tools` list, and `og summary collect` lists selected sections with no file under Steps Not Run as "(selected, no result)", with a note naming the tool and the step. Y haplogroup, Y tree placement, and Y-STR markers get this label only for samples declared male. `summary.json` gets a new top-level list, `selected_no_result`, with those section keys. It is present only when the run recorded its tool list, so a bash run's summary is unchanged. The section's state stays `missing`. diff --git a/bin/live_results.py b/bin/live_results.py deleted file mode 100644 index 2b7f2bc46..000000000 --- a/bin/live_results.py +++ /dev/null @@ -1,1376 +0,0 @@ -#!/usr/bin/env python3 -"""live_results.py: one person's results as the live site draws them (results.json). - - build(sample, summary, files=()) -> dict - -Pure functions, standard library only. The live site's results plugin -(bin/owngenome_live_results.py) and the public demo (tests/demo/build_live_demo.py) -call build() on a summary.json (bin/collect_summary.py). The answer follows the -report's own chapters (bin/render_report.py CHAPTERS): seven questions, one card per -section id, the same anchors as report.html. Each card carries: - - facts [[label, value]] the numbers the report prints - table {"columns": [...], "rows": [[...]]} the rows the report lists, or null - lines the report's own sentences (render_report's *_lines helpers), plain text - caveat the section's caveats word for word (render_report.SECTION_NOTES) - attention true only for a flag the report or the live page already raises: a - headline tone (bin/owngenome_live.py HEADLINES), a failed, unreadable or - stale result, a repeat outside Stranger's "normal" or in an intermediate - zone, an AnnotSV class 4 or 5 row, a CHIP or MoChA call, a two-hit gene - or a couple's shared or X-linked gene. Nothing says a section is fine: - a card without attention is "for information". - -Beside the cards, "veil" tags the rows that name a result to act on outside its own card (every card's -table rows and lines, the viewer links, the charts' marks, the other findings and the lead's names) with -that result's id (veil() below). A child's page no longer closes them one by one: one gate in -assets/live/core.js holds the whole report while a result to act on is unopened, and of "veil" the page -still reads only the charts' marks. - -Nothing here reads a file or computes anything about genetics; the adapters pick -fields the summary already holds. A section id with no adapter falls back to its -report headline and a link to the report. -""" -import hashlib -import re - -import render_report as rr - -SCHEMA = 1 -# Words that would tell a reader a result is fine. tests/test_live_results.py scans every string of -# results.json and family.json, and the page assets, for them. "Fine-grained" is a method's name. -FORBIDDEN = re.compile(r"\b(ok|(? limit: - out["more"] = len(rows) - limit - return out - - -def _headline_tone(key, sec, summary): - """(text, tone) from the live site's headline table, or (None, 'info').""" - try: - import owngenome_live - h = owngenome_live.headline(key, sec, summary) - except Exception: # the page must not go down on one reader - h = None - return (plain(h[0]), h[1]) if h else (None, "info") - - -# --- the adapters: one per section id -------------------------------------------------------- -# Each takes (S, summary) where S is summary["sections"], and returns a dict with any of -# facts, table, lines, attention, links (relative file patterns), extra. - -def a_qc(S, s): - cov, sexc, q, rdc = (S.get(k) or {} for k in ("coverage", "sex_check", "sample_qc", "read_count")) - facts = [] - md = (cov.get("data") or {}).get("mean_depth") - if isinstance(md, (int, float)): - facts.append(["Mean depth", f"{md:.1f}x"]) - if rdc.get("state") in ("ok", "stale"): - d = rdc["data"] - facts.append(["Reads kept by alignment", rr.read_count_text(d) - + ("" if d.get("read_count_check") != "mismatch" else " (reads lost: see the report)")]) - inferred = (sexc.get("data") or {}).get("inferred_sex") - declared = (s.get("run") or {}).get("declared_sex") - if inferred: - facts.append(["Inferred sex (indexcov)", inferred]) - facts.append(["Declared sex", declared or "not declared"]) - attention = False - if q.get("state") in ("ok", "stale"): - d = q["data"] - check = d.get("sex_check") - word = {"ok": "Declared and measured sex agree", "mismatch": "Declared and measured sex differ", - "not_checked": f"Not checked: {d.get('sex_check_reason') or 'no reason given'}"}.get(check, check or ".") - facts.append(["Sex from the reads (somalier)", f"{d.get('inferred_sex') or '.'}. {word}"]) - attention = check == "mismatch" - cont = d.get("contamination") - if cont == "ok": - facts.append(["Contamination (VerifyBamID2)", f"Below the contamination flag (FREEMIX {d.get('freemix')}, " - f"flag above {d.get('freemix_warn_above')})"]) - else: - facts.append(["Contamination (VerifyBamID2)", rr.freemix_text(d)]) - attention = attention or cont == "warn" - if d.get("same_person_as"): - facts.append(["The same person as", d["same_person_as"]]) - attention = True - lines = [x for x in rr.karyotype_lines(S)] - if lines[:-1]: - attention = True - return {"facts": facts, "lines": lines, "attention": attention, - "links": [r"(^|/)multiqc[^/]*\.html$", r"(^|/)fastp[^/]*\.html$", r"_fastp\.html$"]} - - -def a_callability(S, s): - d = S["callability"]["data"] - rows = [[g["gene"], g.get("status"), "." if g.get("share") is None else f"{100 * g['share']:.0f}%", - ", ".join(g.get("reasons") or [])] for g in d.get("not_read") or []] - return {"facts": [["Hard-to-read genes read", f"{d.get('read')} of {d.get('catalog_genes')}"], - ["Not read, no other step calls them", len(d.get("not_read") or [])], - ["Not read here, called by a step of their own", len(d.get("not_read_owned") or [])]], - "table": table(["Gene", "Status", "Bases read", "Why"], rows)} - - -def a_variants(S, s): - d = S["variants"]["data"] - return {"facts": [["Total variants", d.get("total")], ["PASS variants", d.get("pass")], ["SNPs", d.get("snps")], - ["Indels", d.get("indels")]], "links": [r"(^|/)vep/.*summary\.html$"]} - - -def clinvar_call(h): - """A hit's Call cell: the low-confidence mark, the cDNA read check and the combined-allele note, - each as the report prints it.""" - parts = [rr.call_text(h) or ("low confidence" if h.get("low_confidence") else "")] - if "cdna" in h: - parts.append("reads: " + rr.cdna_text(h)) - parts.append(rr.combined_cell(h)) - return "; ".join(x for x in parts if x) or "." - - -def a_clinvar(S, s): - d = S["clinvar"]["data"] - by = d.get("by_stars") or {} - facts = [["P/LP matches", d.get("count", 0)], - ["By review stars (4/3/2/1/0)", " / ".join(str(by.get(k, 0)) for k in ("4", "3", "2", "1", "0"))], - ["ClinVar file date", (s.get("databases") or {}).get("clinvar_release") or "unknown"]] - if "low_confidence" in d: - f = d.get("call_floor") or {} - facts.append([f"Low-confidence calls (GQ below {f.get('GQ')} or DP below {f.get('DP')}), not counted", - d["low_confidence"]]) - rows = [] - for h in (d.get("hits") or [])[:50]: - rows.append([h.get("gene"), f"{h.get('chrom')}:{h.get('pos')} {h.get('ref')}>{h.get('alt')}", h.get("genotype"), - h.get("significance"), "★" * int(h.get("stars") or 0) or "0", - rr.af_text(h) or "frequency unknown", clinvar_call(h)]) - lines = [x for x in (rr.cdna_scan_lines(d) or [])] - for x in d.get("deep_intronic") or []: - # Always reported by the report, hit or not: each site's call stays visible on the card. - lines.append(f"Known deep intronic site (always reported): {x.get('gene')} {x.get('hgvs')} " - f"{x.get('chrom')}:{x.get('pos')} {x.get('ref')}>{x.get('alt')}: {rr.deep_intronic_call(x)}") - freq = rr.clinvar_freq_line(d) - if freq: - lines.insert(0, freq) - viewer = [f"{h.get('chrom')}:{h.get('pos')}" for h in (d.get("hits") or [])[:50]] - return {"facts": facts, "lines": lines, - "table": table(["Gene", "Variant", "Genotype", "Significance", "Stars", "Frequency", "Call"], rows), - "viewer": viewer} - - -def a_clinical_filter(S, s): - d = S["clinical"]["data"] - sf = d.get("acmg_sf") or {} - bi = d.get("by_impact") or {} - facts = [["Variants after the clinical filter", d.get("variants")], - ["By impact (high / moderate / low)", f"{bi.get('HIGH', 0)} / {bi.get('MODERATE', 0)} / {bi.get('LOW', 0)}"], - ["Genes", d.get("genes")]] - if sf.get("unavailable"): - # Not assessed is never zero findings: the report's sentence instead of the counts. - return {"facts": facts, "lines": rr.sf_apart_lines(sf), "attention": True} - rows = [[r[0], r[1], r[2], r[3]] for r in rr.sf_rows(sf, _data(S, "annotsv").get("consensus"))] if sf else [] - high = f"{rr.high_rare(sf)}{rr.high_apart(sf)}" if sf.get("high_impact_checked") else "not checked" - facts += [[f"{sf.get('version') or 'ACMG SF'}: ClinVar P/LP in its genes", len(sf.get("clinvar_hits") or [])], - ["High-impact rare variants in its genes", high]] - return {"facts": facts, - "table": table(["Gene", "Variant", "Kind", "Rule"], rows), - "attention": bool(sf.get("clinvar_hits") or sf.get("high_impact") or sf.get("structural"))} - - -def a_cpsr(S, s): - d = S["cpsr"]["data"] - facts = [["CPSR report", "Ran" if d.get("html_report") else "No HTML"]] - facts += [[k.replace("_", " "), v] for k, v in (d.get("classification") or {}).items()] - rows = [[x.get("gene"), x.get("variant"), x.get("final"), x.get("clinvar") or ".", - "low confidence" if x.get("low_confidence") else "."] for x in d.get("plp") or []] - return {"facts": facts, "lines": rr.cpsr_lines(d, s.get("databases") or {}), - "table": table(["Gene", "Variant", "Final class", "ClinVar", "Call"], rows), "links": [r"^cpsr/"]} - - -def a_slivar(S, s): - d = S["slivar"]["data"] - return {"facts": [["Prioritized variants", d.get("prioritized")], - ["Compound-het candidate variants", d.get("compound_het_variants")], - ["Compound-het candidate genes", d.get("compound_het_genes")]], - "lines": rr.comphet_phase_text(d) if "compound_het_phase" in d else []} - - -def a_exomiser(S, s): - d = S["exomiser"]["data"] - rows = [] - for g in d.get("genes") or []: - for v in g.get("variants") or [{}]: - rows.append([g.get("rank"), g.get("gene"), g.get("moi"), g.get("exomiser_score"), - v.get("hgvs") or v.get("variant"), v.get("genotype"), v.get("acmg"), v.get("disease")]) - return {"facts": [["Symptoms searched", ", ".join(f"{t.get('label')} ({t.get('id')})" for t in d.get("terms") or []) - or "none"]], - "table": table(["Rank", "Gene", "Inheritance", "Score", "Variant", "Genotype", "ACMG", "Disease"], rows)} - - -def a_structural(S, s): - m, dl, cn, sv = ((S.get(k) or {}).get("data") or {} for k in ("manta", "delly", "cnvpytor", "sv_consensus")) - av = (S.get("annotsv") or {}).get("data") or {} - facts = [["Manta SVs (total / PASS)", f"{m.get('total', '.')} / {m.get('pass', '.')}"], - ["Delly SVs (total / PASS)", f"{dl.get('total', '.')} / {dl.get('pass', '.')}"], - ["CNVpytor CNVs (significant)", f"{cn.get('total', '.')} ({cn.get('significant', '.')})"], - ["Consensus SVs (2+ callers)", sv.get("consensus", ".")], - ["AnnotSV class 4 and 5", av.get("count", ".")]] - rows = [[x.get("type"), x.get("sv"), x.get("gt"), x.get("length"), x.get("acmg_class"), - rr.annotsv_genes_text(x) if x.get("genes") is not None else ".", rr.annotsv_support_text(x, av.get("consensus")), - "; ".join(rr.annotsv_flags(x)) if "exon_edge" in x else "."] - for x in av.get("rows") or []] - return {"facts": facts, "table": table(["Type", "Where", "Genotype", "Length", "Class", "Genes", "Support", - "Checks"], rows), - "attention": bool(av.get("count"))} - - -def a_mei(S, s): - d = S["mei"]["data"] - rows = [[x.get("gene"), x.get("element"), x.get("condition"), x.get("inheritance"), x.get("status"), - x.get("mean_depth")] for x in d.get("sites") or []] - return {"facts": [["Insertions called", d.get("calls")], - ["By element", ", ".join(f"{k} {v}" for k, v in (d.get("by_element") or {}).items()) or "none"]], - "table": table(["Gene", "Element", "Condition", "Inheritance", "Known site", "Depth"], rows), - "attention": any(x.get("status") not in (None, "", "not seen") for x in d.get("sites") or [])} - - -def a_expansions(S, s): - d = S["expansions"]["data"] - rows, flagged, outside = [], False, 0 - for l in d.get("loci") or []: - status = l.get("status") or "" - out = any(x and x != "normal" for x in status.split(",")) - outside += out - flagged = flagged or out or bool(l.get("zone")) - shown = rr.str_status(l) - count = rr.str_count(l) if isinstance(l.get("repeat_count"), str) else l.get("repeat_count") - rows.append([l.get("locus"), count, - f'"{shown}"' if shown not in ("", "not graded", "not sized") else (shown or "not graded"), - l.get("normal_max"), l.get("pathologic_min"), l.get("ci"), l.get("sizing"), - f'{l.get("zone_label")} ({l.get("zone")})' if l.get("zone") else "."]) - facts = [["Loci tested", d.get("records")], - ["Outside Stranger's \"normal\"", outside if d.get("stranger") else "Stranger not run"], - ["In an intermediate zone", ", ".join(d.get("intermediate") or []) or "none"], - ["Not sized from short reads", ", ".join(d.get("unsized") or []) or "none"]] - return {"facts": facts, "attention": flagged, - "table": table(["Locus", "Repeats", "Stranger status", "Normal up to", "Pathologic from", "95% interval", - "Sizing", "Intermediate zone"], rows), - # The gauge: each allele's count against Stranger's thresholds, its 95% interval as a whisker. - # status is render_report's str_status: never Stranger's "normal" for an allele not sized. - "widget": {"kind": "str", "loci": [dict({k: l.get(k) for k in ("locus", "repeat_count", "normal_max", - "pathologic_min", "ci", "allele_sizing")}, - status=rr.str_status(l)) - for l in d.get("loci") or []]}} - - -def a_vntyper(S, s): - d = S["vntyper"]["data"] - return {"facts": [["Result", d.get("status")], ["Confidence", d.get("confidence")], - ["Mean depth over the repeat", d.get("vntr_mean_depth")]], - "lines": rr.vntyper_lines(d), "attention": d.get("status") in ("positive", "possible")} - - -def a_mito(S, s): - d = S["mito"]["data"] - a = d.get("annotation") or {} - facts = [["PASS variants on chrM", d.get("pass")], ["Heteroplasmic sites", d.get("heteroplasmic")]] - if "clinvar_plp" in a: - facts.append(["ClinVar pathogenic or likely pathogenic", a.get("clinvar_plp")]) - rows = [[f"m.{x.get('pos')}{x.get('ref')}>{x.get('alt')}", f"{100 * x['af']:.1f}%" if isinstance(x.get("af"), (int, float)) - else "."] for x in d.get("heteroplasmic_sites") or []] - return {"facts": facts, "lines": rr.mito_lines(d), "table": table(["Site", "Allele fraction"], rows), - "attention": (a.get("clinvar_plp") or 0) > 0 or bool(d.get("confirmed"))} - - -def a_lpa(S, s): - d = S["lpa"]["data"] - facts = [["KIV-2 repeats", f"{d.get('kiv2_copies')} (95% interval {d.get('ci95_low')} to {d.get('ci95_high')})" - if d.get("status") == "estimated" else d.get("status")], ["Class", d.get("class")]] - if d.get("null_allele"): - facts.append(["KIV-2 4925G>A null allele", rr.marker_state(d["null_allele"])]) - out = {"facts": facts, "lines": rr.lpa_lines(d), "attention": d.get("flag") == "high"} - v, lo, hi = num(d.get("kiv2_copies")), num(d.get("ci95_low")), num(d.get("ci95_high")) - if d.get("status") == "estimated" and v is not None and lo is not None and hi is not None: - # The count and its 95% interval on a scale from 0: the page draws the bar, the facts say it in words. - out["widget"] = {"kind": "ci", "label": "KIV-2 repeats, both chromosomes", "value": v, "low": lo, "high": hi, - "unit": "repeats", "max": max(60, 10 * int(hi * 1.25 / 10 + 1)), "class": d.get("class")} - return out - - -def a_chip(S, s): - d = S["chip"]["data"] - rows = [[c.get("gene"), c.get("protein_change"), c.get("vaf"), c.get("alt_reads"), c.get("depth"), c.get("status")] - for c in d.get("calls") or []] - genes = [{"gene": g.get("gene"), "limit": num(g.get("detection_limit_vaf")), "depth": num(g.get("mean_depth")), - "status": g.get("status")} for g in d.get("genes") or []] - # Each call carries its own gene's limit: the genes' limits differ, and a call is read against its own. - limit = {g["gene"]: g["limit"] for g in genes} - calls = [{"gene": c.get("gene"), "change": c.get("protein_change"), "vaf": num(c.get("vaf")), - "limit": limit.get(c.get("gene"))} for c in d.get("calls") or []] - out = {"facts": [["CHIP calls", len(d.get("calls") or [])], - ["Typical detection limit at this depth (VAF)", d.get("median_limit")]], - "table": table(["Gene", "Change", "VAF", "Alt reads", "Depth", "Status"], rows), - "lines": rr.chip_lines(d, s.get("sample")), "attention": bool(d.get("calls"))} - if genes or calls: - # Each call's VAF against the smallest VAF this depth can see in each gene (chip_report's own limit): - # under the limit nothing can be seen, so an empty track is not an all-clear. - out["widget"] = {"kind": "vaf", "max": 0.5, "genes": genes, "calls": [c for c in calls if c["vaf"] is not None]} - return out - - -def a_mosaic(S, s): - q = S["mosaic_sex_loss"]["data"] - call = rr.MOSAIC_CALL.get(q.get("call"), (q.get("call"), ""))[0] - return {"facts": [[q.get("chrom") or "chrY or chrX", call]], "lines": [q.get("reason") or ""] + rr.mosaic_lines(q), - "attention": q.get("call") in ("detected", "gain")} - - -def a_mosaic_mca(S, s): - d = S["mosaic"]["data"] - rows = [[c.get("chrom"), c.get("start"), c.get("end"), c.get("length_mb"), c.get("type"), c.get("cell_fraction")] - for c in d.get("calls") or []] - return {"facts": [["Status", d.get("status")], ["Calls reported", d.get("calls_reported", len(rows))], - ["Smallest cell fraction it can see", d.get("floor")]], - "table": table(["Chromosome", "Start", "End", "Length (Mb)", "Type", "Cell fraction"], rows), - "lines": rr.mosaic_mca_lines(d), "attention": bool(d.get("calls"))} - - -def a_carrier(S, s): - d = S["carrier"]["data"] - if d.get("unavailable"): - return {"lines": rr.carrier_lines(d), "attention": True} - rows = [[c.get("gene"), c.get("variant"), c.get("genotype"), c.get("significance"), c.get("stars"), - c.get("inheritance"), c.get("condition")] for c in (d.get("carriers") or []) + (d.get("hom_or_hemizygous") or [])] - two = (d.get("two_hits") or {}).get("genes") or [] - return {"facts": [["Genes on the carrier list", d.get("genes_on_list")], ["Carrier findings", len(rows)], - ["Genes with two hits", ", ".join(g if isinstance(g, str) else g.get("gene", ".") for g in two) - or "none"]], - "table": table(["Gene", "Variant", "Genotype", "Significance", "Stars", "Inheritance", "Condition"], rows), - "lines": rr.two_hit_lines(d.get("two_hits")), "attention": bool(two)} - - -def a_couple(S, s): - d = S["couple"]["data"] - rows = [[lab, x.get("gene"), x.get("condition"), x.get("risk"), x.get("own"), x.get("partner_findings")] - for lab, key in (("Both carry", "shared"), ("X-linked", "x_linked")) for x in d.get(key) or []] - return {"facts": [["Partner", d.get("partner")], ["Genes where both carry a change", len(d.get("shared") or [])], - ["X-linked findings", len(d.get("x_linked") or [])], - ["Genes where only one partner carries a change", - f"{d.get('one_partner', 0)}, unless the other partner carries something the screen does not see"]], - "table": table(["Result", "Gene", "Condition", "Chance for a child", "This person", "Partner"], rows)} - - -# The genes the copy-number dots draw (the carrier screen's copy-number genes): SMN1 and SMN2, the two -# alpha-globin genes and the RCCX module of CYP21A2. -COPY_GENES = ("SMN1", "SMN2", "HBA1", "HBA2", "CYP21A2") - - -def a_paralogs(S, s): - lines, facts = [], [] - if (S.get("parascopy") or {}).get("state") in ("ok", "stale"): - d = S["parascopy"]["data"] - lines += rr.parascopy_lines(d) + rr.parascopy_locus_lines(d) + rr.cn_interval_lines(d.get("cn_intervals")) - if d.get("smn1_marker"): - # the silent-carrier marker beside the SMN1 psCN - facts = [["SMN1 copies", (d.get("smn1") or {}).get("text", ".")], - ["SMN1 g.27134T>G silent-carrier marker", rr.marker_state(d["smn1_marker"])]] - rows, dots = [], [] - if (S.get("paralogs") or {}).get("state") in ("ok", "stale"): - for g in S["paralogs"]["data"].get("genes") or []: - rows.append([g.get("gene"), g.get("copy_number"), g.get("status"), g.get("detail")]) - if str(g.get("gene") or "").split(" ")[0] in COPY_GENES: - n = num(g.get("copy_number")) - dots.append({"gene": g.get("gene"), "copies": int(n) if n is not None and n == int(n) and 0 <= n <= 20 - else None, "status": g.get("status") or "."}) - if (S.get("parascopy") or {}).get("state") in ("ok", "stale"): - # Parascopy's SMN1 and SMN2 copies at exon 7 (short reads) as dots too; its count is None unless - # psCN passed its filter, and then the dots say why there is none. - d = S["parascopy"]["data"] - for g in ("smn1", "smn2") if d.get("rows") else (): # rows: step 35's SMN table had rows - x = d.get(g) or {} - if not x: - continue - n = num(x.get("cn")) - whole = n is not None and n == int(n) and 0 <= n <= 20 - dots.append({"gene": f"{g.upper()} (Parascopy)", "copies": int(n) if whole else None, - "status": "called" if whole else (x.get("text") or "not called")}) - out = {"facts": facts, "lines": lines, "table": table(["Gene", "Copies", "Status", "Detail"], rows)} - if dots: - out["widget"] = {"kind": "copies", "genes": dots} - return out - - -def a_pharmcat(S, s): - d = S["pharmcat"]["data"] - return {"facts": [["PharmCAT report", "Ran"], ["PharmCAT version", d.get("version") or "unknown"], - ["Its own HTML report", "beside it" if d.get("html_report") else "not written"]], - "links": [r"(^|/)pharmcat/[^/]+\.html$"]} - - -def a_cpic(S, s): - d = S["cpic"]["data"] - if d.get("parse_failed"): - return {"lines": ["The PharmCAT report could not be parsed: see the CPIC report."] - + [f"WARNING: {w}" for w in d.get("warnings") or []], "attention": True} - rows = [[g.get("gene"), g.get("diplotype"), f'"{g.get("phenotype")}"' if g.get("phenotype") else ".", g.get("status")] - for g in d.get("genes") or []] - return {"facts": [["Genes with a changed-function phenotype", d.get("non_normal", 0)], - ["Genes with more than one possible result", d.get("ambiguous", 0)], - ["Genes not called", d.get("not_called", 0)]], - "table": table(["Gene", "Diplotype", "Phenotype (CPIC's words)", "Status"], rows), - "lines": [f"WARNING: {w}" for w in d.get("warnings") or []]} - - -def a_cyp2d6(S, s): - c = s.get("cyp2d6") or {} - rows = [[rr.CYP2D6_LABELS.get(k, k), v or "not run"] for k, v in (c.get("calls") or {}).items()] - agree = c.get("agree") - facts = [["pypgx and Cyrius agree", "yes" if agree else "no" if agree is False else "fewer than two usable calls"]] - v = rr.cyp2d6_verdict(c) - if v: - facts.append(["Step 36", plain(v)]) - lines = rr.pypgx_lines(S["pypgx"]["data"]) if (S.get("pypgx") or {}).get("state") in ("ok", "stale") else [] - return {"facts": facts, "table": table(["Caller", "CYP2D6"], rows), "lines": lines, "attention": agree is False} - - -def a_hla(S, s): - d = S["hla"]["data"] - rows = [[l.get("gene"), rr.hla_text(l)] for l in d.get("loci") or []] - return {"facts": [["HLA database", (s.get("databases") or {}).get("hla_database") or "unknown"]], - "table": table(["Gene", "Alleles (T1K quality)"], rows), "lines": rr.hla_derived_lines(d.get("derived"))} - - -def a_locityper(S, s): - d = S["locityper"]["data"] - rows = [[l.get("locus"), l.get("genotype"), l.get("quality"), l.get("filter"), l.get("primary")] - for l in d.get("loci") or []] - return {"facts": [["Loci called", f"{d.get('called', 0)} of {len(d.get('loci') or [])}"], - ["Passing the authors' filter", d.get("passed", 0)]], - "table": table(["Locus", "Panel haplotypes", "Quality", "Filter", "Primary caller"], rows)} - - -def a_ancestry_fine(S, s): - d = S["ancestry_fine"]["data"] - rows = [[lab, r.get("group"), rr.share(r.get("fraction")), f"{rr.share(r.get('low'))} to {rr.share(r.get('high'))}"] - for level, lab in rr.ANCESTRY_FINE_LEVELS for r in rr.ancestry_fine_rows(d, level)] - return {"table": table(["Level", "Group", "Share", "Bootstrap range"], rows), - "facts": [["Chromosome painting", rr.ancestry_fine_painted(d)]]} - - -def a_mt_haplogroup(S, s): - d = S["haplogroup"]["data"] - return {"facts": [["Haplogroup", d.get("haplogroup")], ["Two mtDNA haplogroups in the reads", - rr.contamination_text(d)]], - "explore": [{"name": x.get("name"), "url": x.get("url")} for x in d.get("explore") or []]} - - -def a_y(S, s): - facts, explore, rows = [], [], [] - y = (S.get("y_haplogroup") or {}).get("data") or {} - t = (S.get("y_tree") or {}).get("data") or {} - if y: - facts += [["Haplogroup (Yleaf)", y.get("haplogroup")], ["QC score", y.get("qc_score")]] - explore = [{"name": x.get("name"), "url": x.get("url")} for x in y.get("explore") or []] - if t: - facts.append([f"Placement on {t.get('tree')}", t.get("haplogroup")]) - rows = [[p.get("Level"), p.get("Branch"), p.get("Derived"), p.get("Ancestral"), p.get("No_call")] - for p in t.get("path") or []] - st = (S.get("y_str") or {}).get("data") or {} - if st.get("markers"): - facts.append(["Y-STR markers read", sum(1 for m in st["markers"] if m.get("count"))]) - out = {"facts": facts, "explore": explore, - "table": table(["Level", "Branch", "Derived", "Ancestral", "No call"], rows)} - if t and t.get("path"): - # The path from the root of the tree to the placement, one branch per level, with its marker counts. - out["widget"] = {"kind": "ypath", "tree": t.get("tree"), "tip": t.get("haplogroup"), - "path": [{"level": p.get("Level"), "branch": p.get("Branch"), "derived": num(p.get("Derived")), - "ancestral": num(p.get("Ancestral")), "no_call": num(p.get("No_call"))} - for p in t["path"]]} - return out - - -def a_archaic(S, s): - d = S["archaic"]["data"] - return {"facts": [["Neanderthal", f"{d.get('neanderthal_percent')}%"], ["Denisovan", f"{d.get('denisovan_percent')}%"]], - "lines": rr.archaic_lines(d)} - - -def a_ancient(S, s): - d = S["ancient"]["data"] - rows = [[r.get("rank"), r.get("group"), r.get("dates"), r.get("country"), r.get("distance")] - for r in (d.get("nearest") or [])[:10]] - out = {"table": table(["Rank", "Group", "Dates", "Country", "Distance"], rows), - "facts": [["Sites used", f"{d.get('sites_used')} of {d.get('panel_sites')}"]]} - svg = d.get("plot_svg") - if isinstance(svg, str) and svg.strip(): - # collect_summary stores it base64-encoded (the report puts it in a data URL as is); raw SVG is encoded here. - import base64 - if svg.lstrip().startswith("<"): - svg = base64.b64encode(svg.encode()).decode() - out["image"] = {"alt": "PCA of ancient genomes with this genome projected", "src": "data:image/svg+xml;base64," + svg} - return out - - -def a_roh(S, s): - d = S["roh"]["data"] - return {"facts": [["Segments", d.get("segments")], ["Total", f"{d.get('total_mb')} Mb"], - ["Largest", f"{d.get('largest_mb')} Mb"], ["F_ROH", d.get("f_roh")], - ["Nearest band", d.get("relationship")]], - "lines": rr.roh_lines(d), "attention": bool(d.get("upd_flag"))} - - -def a_traits(S, s): - d = S["traits"]["data"] - rows = [[r.get("gene"), r.get("trait"), (r.get("genotype") or ".") + (" (ancestry)" if r.get("ancestry") == "yes" else ""), - (r.get("reading") or ".") + (f". {r['note']}" if r.get("note") else "")] - for r in d.get("rows") or [] if r.get("status") == "called" and (r.get("gene") or "").upper() != "APOE"] - lines = [] - for r in d.get("rules") or []: - # The report's genotype rules: several sites read together, with phase and APOL1's G2. - lines.append(f"{r.get('trait')} ({r.get('gene')} {str(r.get('rsids') or '').replace(',', ', ')}): " - f"{rr.rule_result(r)}. {r.get('reading')}") - if r.get("g2"): - lines.append(f"With G2 (rs71785313): {rr.g2_result(r)}. {r['g2'].get('text')} {r['g2'].get('reading')}") - out = {"facts": [["Rows read", d.get("called")], ["No genotype at the position", d.get("not_covered")]], - "table": table(["Gene", "Trait", "Genotype", "Reading"], rows), "lines": lines} - apoe = d.get("apoe") - if apoe: - # Behind its warning, as the report shows it: the page puts it in a closed
    . - # collect_summary keeps one dict per APOE row; each reads as the report's text line does. - rows = apoe if isinstance(apoe, list) else [apoe] - text = "; ".join(f"{r.get('trait')} ({r.get('rsid')}): {r.get('genotype')}. {r.get('reading')}" - if isinstance(r, dict) else cell(r) for r in rows) - out["hidden"] = {"summary": rr.APOE_WARNING, "text": plain(text)} - return out - - -def a_prs(S, s): - d = S["prs"]["data"] - if not d.get("adjusted"): - # The report shows a percentile only when it is ancestry-adjusted. - return {"facts": [["Scores", len(d.get("scores") or [])]], - "lines": ["Raw scores only: without the ancestry panel no percentile is shown (docs/25-prs.md)."]} - rows = [[r.get("condition"), r.get("pgs_id"), rr.prs_percentile(r) or ".", f"{r.get('matched')}/{r.get('total')}", - rr.prs_effect(r) or "."] for r in d.get("scores") or []] - return {"table": table(["Condition", "Score", "Percentile", "Variants matched", "Effect"], rows), - "lines": [rr.prs_note(d)]} - - -def a_bloodtype(S, s): - d = S["bloodtype"]["data"] - rows = [[x.get("system"), x.get("phenotype"), x.get("genotype"), x.get("confidence")] for x in d.get("systems") or []] - return {"facts": [["ABO", d.get("abo")], ["RhD", d.get("rhd")]], - "table": table(["System", "Predicted phenotype", "Genotype", "Confidence"], rows)} - - -def a_telomere(S, s): - d = S["telomere"]["data"] - return {"facts": [["Telomere content", f"{d.get('tel_content')} ({rr.TELOMERE_UNIT})"]], - "lines": rr.telomere_lines(d), "attention": bool(d.get("low_reads"))} - - -def a_viral(S, s): - d = S["viral"]["data"] - rows = [[x.get("virus"), x.get("reads"), x.get("breadth"), x.get("copies_per_cell"), x.get("call")] - for x in d.get("found") or []] - return {"facts": [["HHV-6", d.get("hhv6")], ["Genomes searched", d.get("genomes")]], - "table": table(["Virus", "Reads", "Breadth", "Copies per cell", "Call"], rows)} - - -def a_consumer(S, s): - d = S["consumer_export"]["data"] - return {"facts": [["Sites", d.get("sites")], ["Called", d.get("called")], ["No call", d.get("no_call")]], - "lines": rr.consumer_export_lines(d)} - - -ADAPTERS = { - "qc": a_qc, "callability": a_callability, "variants": a_variants, "clinvar": a_clinvar, - "clinical-filter": a_clinical_filter, "cpsr": a_cpsr, "slivar": a_slivar, "exomiser": a_exomiser, - "structural-variants": a_structural, "mei": a_mei, "expansions": a_expansions, "vntyper": a_vntyper, - "mito": a_mito, "lpa": a_lpa, "chip": a_chip, "mosaic": a_mosaic, "mosaic-mca": a_mosaic_mca, - "carrier-list": a_carrier, "couple": a_couple, "paralogs": a_paralogs, "pharmcat": a_pharmcat, "cpic": a_cpic, - "cyp2d6": a_cyp2d6, "hla": a_hla, "locityper": a_locityper, "ancestry-fine": a_ancestry_fine, - "mt-haplogroup": a_mt_haplogroup, "y-chromosome": a_y, "archaic": a_archaic, "ancient": a_ancient, "roh": a_roh, - "traits-panel": a_traits, "prs": a_prs, "bloodtype": a_bloodtype, "telomere": a_telomere, "viral": a_viral, - "consumer-export": a_consumer, -} -# Report charts (bin/report_charts.py) drawn inside a card: chart id -> section id. -CHART_SECTION = {"clinvar": "clinvar", "genome": "clinvar", "mito": "mito", "ancestry": "ancestry-fine", "prs": "prs"} - - -def caveats(sid): - return [getattr(rr, n) for n in rr.SECTION_NOTES.get(sid, ()) if isinstance(getattr(rr, n, None), str)] - - -def section_state(secs): - st = {x.get("state") or "missing" for x in secs} - if st & {"failed", "unreadable"}: - return "failed" if not st & {"ok", "stale"} else "part" - if "stale" in st: - return "stale" - if "ok" in st: - return "incomplete" if "missing" in st else "ran" - return "missing" - - -def _links(patterns, files): - out = [] - for p in patterns or []: - rx = re.compile(p) - out += sorted(f for f in files if rx.search(f) and f not in out) - return out[:4] - - -def card(sid, title, keys, summary, files): - S = summary.get("sections") or {} - secs = [S.get(k) or {"state": "missing"} for k in keys] - state = section_state(secs) - steps = [] - for k, sec in zip(keys, secs): - st = sec.get("step") or rr.STEP_OF.get(k) - if st and st not in steps: - steps.append(st) - cav = caveats(sid) - out = {"id": sid, "title": title, "keys": list(keys), "steps": steps, "state": state, "anchor": sid, - "attention": False, "headline": None, "facts": [], "table": None, "lines": [], "caveat": cav, - "empty_text": EMPTY.get(sid), "links": [], "notes": [], "flagged": False} - for k, sec in zip(keys, secs): - if sec.get("state") in ("failed", "unreadable", "stale"): - out["notes"].append(f"{sec.get('title') or k}: {plain(rr.stale_note(sec))}") - out["attention"] = True - if state == "missing": - return out - tones = [] - for k, sec in zip(keys, secs): - if sec.get("state") in ("ok", "stale"): - text, tone = _headline_tone(k, sec, summary) - if text and not out["headline"] and not text.endswith("finished, see the report"): - out["headline"] = text - tones.append(tone) - if "attention" in tones: - out["attention"] = True - out["flagged"] = True - if out["headline"]: - # The step headline carries its caveat (the Progress tab shows no other); the card prints it below. - for c in sorted({plain(c) for c in cav}, key=len, reverse=True): - if out["headline"].endswith(" " + c): - out["headline"] = out["headline"][:-len(c) - 1].rstrip() - break - fn = ADAPTERS.get(sid) - if fn and state not in ("failed",): - try: - got = fn(S, summary) or {} - except (KeyError, TypeError, ValueError, AttributeError, IndexError, ZeroDivisionError) as e: - got = {"lines": [f"This card could not be drawn ({type(e).__name__}); the report shows the section."]} - out["facts"] = [[plain(a), plain(cell(b))] for a, b in got.get("facts") or []] - out["table"] = got.get("table") - notes = {plain(c) for c in cav} | {plain(n) for n in rr.caveat_notes()} - out["lines"] = [plain(x) for x in got.get("lines") or [] if plain(x) and plain(x) not in notes - and plain(x) != out["headline"]] - out["attention"] = out["attention"] or bool(got.get("attention")) - out["flagged"] = out.get("flagged", False) or bool(got.get("attention")) - out["links"] = _links(got.get("links"), files) - for k in ("widget", "explore", "image", "hidden", "viewer"): - if got.get(k): - out[k] = got[k] - return out - - -# --- the Journal: one level per result, the findings, the lead --------------------------------- -# The live site reads each person's results as a report in ten numbered sections (docs/design/journal/). -# A finding is one row the summary already holds (a ClinVar hit, a carrier gene, a changed-function -# medicine gene) with its level on the one scale every page uses. Nothing here grades anything the -# report does not: each rule below names the field it reads, and a card the report flags that no rule -# turns into a finding still becomes one, at "review", worded by its own headline. - -LEVELS = ("act", "medicine", "review", "carrier", "trust", "info") -LEVEL_WORDS = {"act": "Take to a doctor", "medicine": "Tell your prescriber", "review": "Worth a look", - "carrier": "For family planning", "trust": "Data quality", "info": "For information"} -# (number, key, title, question). The live run uses the same numbers, so a section being written sits -# where it will sit in the finished report. -JOURNAL = ( - (1, "act", "To act on", "Is there anything to take to a doctor?"), - (2, "medicines", "Medicines", "Which medicines should a prescriber know about?"), - (3, "family", "For your family", "What could I pass on to a child?"), - (4, "look", "Worth a look", "What deserves a conversation, but is not a diagnosis?"), - (5, "trust", "Can I trust this?", "This is about the data, not about the person."), - (6, "origins", "Origins", "Where do my ancestors come from?"), - (7, "traits", "Traits and scores", "What do studies say about traits and risk scores?"), - (8, "assessed", "Assessed, no finding", "What each step looked at, and what it does not see."), - (9, "cannot", "What it cannot see", "What no step of this run looks at."), - (10, "sources", "Sources and files", "The databases, the report and the files behind this page."), -) -LEVEL_SECTION = {"act": 1, "medicine": 2, "carrier": 3, "review": 4, "trust": 5} -CHAPTER_SECTION = {"quality": 5, "clinical": 8, "carrier": 3, "medicines": 2, "ancestry": 6, "traits": 7, "other": 10} -# What to do, by level: the same few steps for every finding of a level, never advice about one gene. -PLAN = { - "act": ["Bring this page to a doctor or a genetic counsellor.", - "Ask for a clinical test in a certified laboratory to confirm it: this pipeline is research software.", - "Ask what it means for parents, brothers, sisters and children: close relatives may carry it too."], - "medicine": ["Show this to whoever prescribes for you, and to your pharmacist.", - "Do not change a medicine on your own: the guidance is written for the prescriber.", - "Ask for a clinical pharmacogenetic test before a prescription changes."], - "review": ["Read the evidence and its caveat below.", - "Talk it over with a doctor or a genetic counsellor if it bears on your health or a pregnancy.", - "A measurement or a clinical test settles it: this result alone is not a diagnosis."], - "carrier": ["A carrier is not affected by the condition.", - "It matters when a partner carries a change in the same gene: compare with the couple screen.", - "Relatives planning a pregnancy may carry it too."], - "trust": ["Read nothing else in this report until this is understood.", - "Check the sample's label and the run's inputs, then run it again."], -} -STR_WORDS = {"pre_mutation": "premutation range", "full_mutation": "full-mutation range"} -CARRIER_NOTE = "A carrier has one changed copy of a gene where it takes two to cause the condition." - - -def slug(*parts): - """A finding's id: lower case, digits and dashes, at most 80 characters (the route's own pattern).""" - raw = "-".join(str(p) for p in parts if p not in (None, "")) - t = re.sub(r"[^a-z0-9]+", "-", raw.lower()).strip("-") - if len(t) > 80: # a long allele: cut, and keep two ids apart by a hash of the whole key - t = t[:71].rstrip("-") + "-" + hashlib.sha1(raw.encode()).hexdigest()[:8] - return t or "finding" - - -FINDING_ID = re.compile(r"^[a-z0-9][a-z0-9-]{0,79}$") - - -def _f(level, card_id, key, title, text, gene=None, detail=None, evidence=(), viewer=None, af=None): - return {"id": slug(*key), "level": level, "card": card_id, "title": plain(title), "text": plain(text), - "gene": gene, "detail": plain(detail) if detail else None, - "evidence": [[plain(a), plain(cell(b))] for a, b in evidence if b not in (None, "", ".")], - "viewer": viewer, "af": af} - - -def _data(S, k): - sec = S.get(k) or {} - if not isinstance(sec, dict) or sec.get("state") not in ("ok", "stale"): - return {} - d = sec.get("data") or {} - # Data that is not a mapping gives no rows here; the section's card says it could not be drawn (card()). - return d if isinstance(d, dict) else {} - - -def _items(v): - """A summary's list of rows; a lone row that is not in a list is read as one row (and fails as one).""" - return v if isinstance(v, list) else [v] if v else [] - - -class _Row: - """with _Row(out, card[, level]): one rule turning one row of the summary into a finding. A row the rule - cannot read (a field of the wrong type, a stars value that is not a number) costs that row only: it - becomes a finding on its card that says the row could not be read, and every other row and card still - renders. Its words name no gene or variant: the row is unreadable. Its level is the highest the rule - can give (level "act" for a rule that can give one): a child's report stays closed while a finding to act - on is unopened (the gate in assets/live/core.js), and the card's table may still draw the row the rule could - not read.""" - - def __init__(self, out, card_id, level="review"): - self.out, self.card_id, self.level = out, card_id, level - - def __enter__(self): - return self - - def __exit__(self, kind, err, tb): - if kind is None or not issubclass(kind, (KeyError, TypeError, ValueError, AttributeError, IndexError, - ZeroDivisionError)): - return False - self.out.append(_f(self.level, self.card_id, ("unreadable", self.card_id, len(self.out)), - "A row of this section could not be read", - f"One row of this section holds a value of a kind the page cannot read ({kind.__name__}). " - f"The other rows show as usual; the report and its files have the row as the step wrote it.")) - return True - - -def _copies(n): - return "two copies" if n == "hom" else "one copy" if n == "het" else (n or "genotype not given") - - -def finding_rows(summary): - """[finding] from the rows of the summary, each with its level, in the order of the rules.""" - S = summary.get("sections") or {} - out = [] - # The genes the later rules leave to an earlier one. A row that is not a mapping names no gene here; - # its own rule below turns it into the one unreadable finding. - sf = _data(S, "clinical").get("acmg_sf") or {} - sf = sf if isinstance(sf, dict) else {} - def gene(x): - g = x if isinstance(x, str) else x.get("gene") if isinstance(x, dict) else None - return g if isinstance(g, str) else None - sf_genes = {gene(x) for x in _items(sf.get("clinvar_hits")) if isinstance(x, dict)} - car = _data(S, "carrier") - carrier_genes = {gene(c) for c in _items(car.get("carriers")) + _items(car.get("hom_or_hemizygous")) if isinstance(c, dict)} - th = car.get("two_hits") if isinstance(car.get("two_hits"), dict) else {} - two_hit = {gene(g) for g in _items(th.get("genes"))} - {None} - # 1. ACMG secondary findings: the gene's own reporting rule already said "report". The report's own - # rows (rr.sf_rows): one it cannot read costs this rule, never the rest. - sf_list = [] - with _Row(out, "clinical-filter", "act"): - sf_list = rr.sf_rows(sf, _data(S, "annotsv").get("consensus")) if sf and not sf.get("unavailable") else [] - for r in sf_list: - with _Row(out, "clinical-filter", "act"): - out.append(_f("act", "clinical-filter", ("sf", r[0], r[1]), f"Secondary finding in {r[0]}", - f"A change in {r[0]} that the ACMG secondary-findings list reports: {r[3]}.", - gene=r[0], detail=f"{r[0]} {r[1]} {r[2] if r[2] != '.' else ''}".strip(), - evidence=[["Variant", r[1]], ["Genotype", r[2]], ["Why it is reported", r[3]]])) - # 2. Cancer predisposition, CPSR's pathogenic and likely pathogenic rows. - for x in _items(_data(S, "cpsr").get("plp")): - with _Row(out, "cpsr", "act"): - out.append(_f("act", "cpsr", ("cpsr", x.get("gene"), x.get("variant")), - f"Cancer predisposition ({x.get('gene')})", - f"CPSR grades this change in {x.get('gene')} as {x.get('final')}: it can raise the risk of some " - f"cancers. It is not a diagnosis of cancer.", gene=x.get("gene"), - detail=f"{x.get('gene')} {x.get('variant')}", - evidence=[["Class", x.get("final")], ["ClinVar", x.get("clinvar")], - ["Call", "low confidence" if x.get("low_confidence") else None]])) - # 3. Two hits in one carrier-list gene: possibly both copies changed. - for g in sorted(x for x in two_hit if x): - with _Row(out, "carrier-list", "act"): - out.append(_f("act", "carrier-list", ("two-hits", g), f"Two changes in {g}", - f"Two changes were found in {g}, a gene where it takes two to cause the condition. Whether they " - f"sit on different copies decides whether it matters.", gene=g)) - # 4. ClinVar P/LP hits not already a secondary finding or a carrier row. - for h in _items(_data(S, "clinvar").get("hits"))[:50]: - with _Row(out, "clinvar"): - g = h.get("gene") - if g in sf_genes or g in carrier_genes or g in two_hit: - continue - var = f"{h.get('chrom')}:{h.get('pos')} {h.get('ref')}>{h.get('alt')}" - out.append(_f("review", "clinvar", ("clinvar", g, h.get("chrom"), h.get("pos"), h.get("ref"), h.get("alt")), - f"{h.get('significance') or 'Pathogenic'} change in {g}", - f"ClinVar lists this change in {g} as {str(h.get('significance') or '').lower()}; this genome " - f"has {_copies(h.get('genotype'))}. Whether it matters depends on how the gene is inherited: " - f"a genetic counsellor reads it with the rest of this report.", - gene=g, detail=f"{g} {var} {h.get('genotype') or ''}".strip(), - evidence=[["Significance", h.get("significance")], ["ClinVar review", "★" * int(h.get("stars") or 0) or "0 stars"], - ["Genotype", h.get("genotype")], ["Frequency", rr.af_text(h) or "frequency unknown"], - ["Call", clinvar_call(h)]], - viewer=f"{h.get('chrom')}:{h.get('pos')}", af=h.get("af"))) - # 5. Large deletions and duplications AnnotSV ranks class 4 or 5. - for x in _items(_data(S, "annotsv").get("rows")): - with _Row(out, "structural-variants", "act"): - genes = ", ".join(x.get("genes") or []) or "no gene" - out.append(_f("act" if str(x.get("acmg_class")) == "5" else "review", "structural-variants", - ("sv", x.get("sv")), f"Large {x.get('type') or 'structural change'} over {genes}", - f"A {x.get('type') or 'structural change'} of {abs(int(num(x.get('length')) or 0)):,} bases that " - f"AnnotSV ranks class {x.get('acmg_class')}. Short reads can misplace large changes: confirm it.", - gene=(x.get("genes") or [None])[0], detail=x.get("sv"), - evidence=[["Class", x.get("acmg_class")], ["Callers", rr.annotsv_support_text(x, _data(S, "annotsv").get("consensus"))], - ["Genotype", x.get("gt")]], viewer=str(x.get("sv") or "").replace(" ", "") or None)) - # 6. Repeat expansions outside Stranger's "normal", or in an intermediate zone. - for l in _items(_data(S, "expansions").get("loci")): - with _Row(out, "expansions", "act"): - st = [x for x in (l.get("status") or "").split(",") if x and x != "normal"] - if not st and not l.get("zone"): - continue - full = any("full" in x for x in st) - lead_st = next((x for x in st if "full" in x), st[0]) if st else None - what = (STR_WORDS.get(lead_st, lead_st.replace("_", " ")) if lead_st - else f"{l.get('zone_label') or 'intermediate'} range") - count = rr.str_count(l) if l.get("repeat_count") else "not given" - out.append(_f("act" if full else "review", "expansions", ("str", l.get("locus")), - f"{l.get('locus')} repeat in the {what}", - f"{l.get('locus')} has {count} repeats: Stranger reads it as \"{what}\". " - f"{'See a clinical geneticist.' if full else 'It may grow when passed on; worth a word with a genetic counsellor.'}", - gene=l.get("locus"), detail=f"{l.get('locus')} {count} repeats", - evidence=[["Repeats", count], ["95% interval", l.get("ci")], - ["Pathologic from", l.get("pathologic_min")], - ["Sizing", l.get("allele_sizing") or l.get("sizing")]])) - with _Row(out, "vntyper", "act"): - v = _data(S, "vntyper") - if v.get("status") in ("positive", "possible"): - out.append(_f("act" if v["status"] == "positive" else "review", "vntyper", ("muc1", v["status"]), - f"MUC1 kidney gene: {v['status']}", f"VNtyper reads the MUC1 repeat as {v['status']}; it needs a " - f"clinical confirmation.", gene="MUC1", evidence=[["Confidence", v.get("confidence")]])) - with _Row(out, "lpa"): - lp = _data(S, "lpa") - if lp.get("flag") == "high": - out.append(_f("review", "lpa", ("lpa",), "Lp(a) likely high", - "The KIV-2 count suggests a high Lp(a); one blood measurement settles it.", gene="LPA", - evidence=[["KIV-2 repeats", lp.get("kiv2_copies")], ["Class", lp.get("class")]])) - for c in _items(_data(S, "chip").get("calls")): - with _Row(out, "chip"): - out.append(_f("review", "chip", ("chip", c.get("gene"), c.get("protein_change")), - f"A blood clone in {c.get('gene')} (CHIP)", - f"{c.get('gene')} {c.get('protein_change') or ''} is carried by a share of the blood cells (VAF " - f"{c.get('vaf')}). It becomes common with age; most people with it never get a blood cancer.", - gene=c.get("gene"), evidence=[["VAF", c.get("vaf")], ["Reads", f"{c.get('alt_reads')} of {c.get('depth')}"]])) - for c in _items(_data(S, "mosaic").get("calls")): - with _Row(out, "mosaic-mca"): - out.append(_f("review", "mosaic-mca", ("mca", c.get("chrom"), c.get("start")), - f"A {c.get('type') or 'change'} on {c.get('chrom')} in some blood cells", - f"MoChA sees a {c.get('type') or 'change'} of {c.get('length_mb')} Mb on {c.get('chrom')} in a share " - f"of the blood cells ({c.get('cell_fraction')}).", - evidence=[["Where", f"{c.get('chrom')}:{c.get('start')}-{c.get('end')}"], - ["Cell fraction", c.get("cell_fraction")]])) - for x in _items(_data(S, "exomiser").get("genes"))[:3]: - with _Row(out, "exomiser"): - out.append(_f("review", "exomiser", ("exomiser", x.get("gene")), f"Symptom ranking: {x.get('gene')} ranks {x.get('rank')}", - "A ranking to bring to a clinical geneticist, not a diagnosis.", gene=x.get("gene"), - evidence=[["Score", x.get("exomiser_score")], ["Inheritance", x.get("moi")]])) - # 7. Carriers: one changed copy in a gene of the carrier list, and the couple screen. - # A row with no unchanged copy (hom_or_hemizygous) takes the branch below that says it is not a carrier. - for c in _items(car.get("carriers")) + _items(car.get("hom_or_hemizygous")): - with _Row(out, "carrier-list", "act"): - if c.get("gene") in two_hit: - continue - gt = str(c.get("genotype") or "") - if gt in ("hom", "hemizygous"): - # Both copies changed, or the only copy (X in a male, or inside a deletion): not a carrier. - out.append(_f("act", "carrier-list", ("carrier", c.get("gene"), c.get("variant")), - f"{c.get('condition') or c.get('gene')}: {'two changed copies' if gt == 'hom' else 'the only copy changed'}", - f"This genome has {'two changed copies' if gt == 'hom' else 'no unchanged copy'} of " - f"{c.get('gene')}, a gene of {c.get('condition') or 'a condition on the carrier list'} " - f"({c.get('inheritance') or 'inheritance not given'}). That is not the pattern of a carrier: " - f"a doctor or genetic counsellor reads it.", - gene=c.get("gene"), detail=f"{c.get('gene')} {c.get('variant') or ''} {gt}".strip(), - evidence=[["Genotype", gt], ["Significance", c.get("significance")], ["Stars", c.get("stars")], - ["Inheritance", c.get("inheritance")]])) - continue - out.append(_f("carrier", "carrier-list", ("carrier", c.get("gene"), c.get("variant")), - f"{c.get('condition') or c.get('gene')} carrier" if c.get("condition") else f"Carrier in {c.get('gene')}", - f"{CARRIER_NOTE} This genome has one changed copy of {c.get('gene')}: a carrier, not affected.", - gene=c.get("gene"), detail=f"{c.get('gene')} {c.get('variant') or ''}".strip(), - evidence=[["Significance", c.get("significance")], ["Stars", c.get("stars")], - ["Inheritance", c.get("inheritance")]])) - cp = _data(S, "couple") - for lab, key in (("Both partners carry", "shared"), ("X-linked", "x_linked")): - for x in _items(cp.get(key)): - with _Row(out, "couple"): - out.append(_f("carrier", "couple", ("couple", key, x.get("gene")), f"{lab} {x.get('gene')}" - if key == "shared" else f"X-linked finding in {x.get('gene')}", - f"{x.get('condition') or x.get('gene')}: {x.get('risk') or 'see the couple screen'} for each " - f"pregnancy, with {cp.get('partner')}.", gene=x.get("gene"), - evidence=[["Chance for a child", x.get("risk")], ["Partner", cp.get("partner")]])) - with _Row(out, "paralogs"): - smn1 = [g for g in _data(S, "paralogs").get("genes") or [] if g.get("gene") == "SMN1" and g.get("status") == "called"] - one = smn1 and str(smn1[0].get("copy_number")) == "1" - by = "Paraphase" - if not smn1: # no Paraphase call: Parascopy's resolved count from short reads - cn = ((_data(S, "parascopy").get("smn1") or {}).get("cn")) - one, by = cn == 1, "Parascopy" - if one: - out.append(_f("carrier", "paralogs", ("smn1",), "Spinal muscular atrophy carrier (SMN1)", - "One copy of SMN1 where most people have two: a carrier of spinal muscular atrophy, not " - "affected.", gene="SMN1", evidence=[["SMN1 copies", "1"], ["Called by", by]])) - # 8. Medicines: each gene whose called phenotype changes function. - for g in _items(_data(S, "cpic").get("genes")): - with _Row(out, "cpic"): - if g.get("status") not in ("non-normal", "ambiguous"): - continue - amb = g["status"] == "ambiguous" - out.append(_f("medicine", "cpic", ("pgx", g.get("gene")), - f"{g.get('gene')}: {g.get('phenotype')}" if not amb else f"{g.get('gene')}: more than one possible result", - f"{g.get('gene')} {g.get('diplotype')} reads as \"{g.get('phenotype')}\" in CPIC's words. The drugs " - f"it bears on are in the CPIC report; tell whoever prescribes.", gene=g.get("gene"), - detail=f"{g.get('gene')} {g.get('diplotype')}", - evidence=[["Diplotype", g.get("diplotype")], ["Phenotype", g.get("phenotype")], ["Status", g.get("status")]])) - # 9. Trust: a problem with the data itself. - with _Row(out, "qc"): - q = _data(S, "sample_qc") - if q.get("sex_check") == "mismatch": - out.append(_f("trust", "qc", ("sex",), "Declared and measured sex differ", - "The sex the reads show differs from the one declared: a swapped or mislabelled sample, or a real " - "sex-chromosome difference.", evidence=[["Declared", q.get("declared_sex")], ["From the reads", q.get("inferred_sex")]])) - if q.get("contamination") == "warn": - out.append(_f("trust", "qc", ("contamination",), "Another person's DNA may be mixed in", - rr.freemix_text(q), evidence=[["FREEMIX", q.get("freemix")]])) - if q.get("same_person_as"): - out.append(_f("trust", "qc", ("same-person",), f"The same person as {q['same_person_as']}", - "Two runs of this server hold the same genome.", evidence=[["Matches", q["same_person_as"]]])) - seen, uniq = set(), [] - for x in out: - if x["id"] not in seen: - seen.add(x["id"]) - uniq.append(x) - return uniq - - -def level_of(card, found): - """A card's level: its highest finding's, else data quality for the quality chapter, else review - when the report flags it, else information. A failed or missing card has no level (None).""" - if card.get("state") in ("missing", "failed"): - return None - mine = [f["level"] for f in found if f["card"] == card["id"]] - for lv in LEVELS: - if lv in mine: - return lv - if card.get("chapter") == "quality": - return "trust" - return "review" if card.get("flagged") else "info" - - -def journal(chapters, summary): - """findings, levels and the ten sections of one person's report, from the cards build() made.""" - found = finding_rows(summary) - cards = [] - for ch in chapters: - for c in ch["sections"]: - c["chapter"] = ch["key"] - cards.append(c) - by_id = {c["id"]: c for c in cards} - have = {f["card"] for f in found} - # A card the report flags (its headline or its own rule), for which no row rule found a finding, - # still becomes one: worded by its headline, at review. - for c in cards: - if c.get("flagged") and c["id"] not in have and c.get("state") not in ("missing", "failed"): - lv = "trust" if c["chapter"] == "quality" else "review" - found.append(_f(lv, c["id"], ("card", c["id"]), c["title"], c.get("headline") or - f"The report flags this section: {c['title']}.", evidence=(c.get("facts") or [])[:4])) - for f in found: - c = by_id.get(f["card"]) or {} - f["section"] = LEVEL_SECTION[f["level"]] - f["steps"] = c.get("steps") or [] - f["caveat"] = c.get("caveat") or [] - f["anchor"] = c.get("anchor") or f["card"] - f["plan"] = PLAN[f["level"]] - f["level_words"] = LEVEL_WORDS[f["level"]] - for c in cards: - c["level"] = level_of(c, found) - lv = [f["level"] for f in found if f["card"] == c["id"]] - top = next((x for x in LEVELS if x in lv), None) - home = CHAPTER_SECTION.get(c["chapter"], 10) - if c["chapter"] == "clinical" and top in LEVEL_SECTION: - home = LEVEL_SECTION[top] - c["section"] = home - c["findings"] = [f["id"] for f in found if f["card"] == c["id"]] - for f in found: - f["related"] = [g["id"] for g in found if g["id"] != f["id"] and - ((f["gene"] and g["gene"] == f["gene"]) or g["card"] == f["card"])][:6] - sections = [] - for n, key, title, question in JOURNAL: - sections.append({"n": n, "key": key, "title": title, "question": question, - "findings": [f["id"] for f in found if f["section"] == n], - "cards": [c["id"] for c in cards if c["section"] == n]}) - levels = {lv: sum(1 for f in found if f["level"] == lv) for lv in LEVELS if lv != "info"} - levels["info"] = sum(1 for c in cards if c["level"] == "info") - return found, levels, sections - - -def _names(found, n=3): - t = [f["title"] for f in found[:n]] - more = len(found) - len(t) - s = ", ".join(t[:-1]) + (" and " if len(t) > 1 else "") + t[-1] if t else "" - return s + (f", and {more} more" if more > 0 else "") - - -def _count(n, one, many): - words = {1: "one", 2: "two", 3: "three", 4: "four", 5: "five", 6: "six", 7: "seven", 8: "eight", 9: "nine"} - return f"{words.get(n, n)} {one if n == 1 else many}" - - -def screened(summary): - """True when a clinical screen (ClinVar, the clinical filter or CPSR) has a result: only then can the - lead or the home page say that no finding needs a doctor.""" - S = summary.get("sections") or {} - return any((S.get(k) or {}).get("state") in ("ok", "stale") for k in ("clinvar", "clinical", "cpsr")) - - -def lead(found, levels, summary): - """The report's lead paragraph: [[text, bold]] segments (a third item "act" marks the names of the - findings to act on), plain sentences that name the findings by level. It never says a section is fine: with no finding of a level it says what was assessed.""" - S = summary.get("sections") or {} - by = {lv: [f for f in found if f["level"] == lv] for lv in LEVELS} - out = [] - if by["trust"]: - out += [["Read the data-quality section first: ", True], [_names(by["trust"]) + ". ", False]] - if by["act"]: - n = len(by["act"]) - out += [["Of everything this genome was screened for, ", False], - [_count(n, "finding should", "findings should") + " go to a doctor", True], - [": " + _names(by["act"]) + ". ", False, "act"]] # "act": the names a child's page keeps closed - elif screened(summary): - out += [["No finding in what these steps assessed needs a doctor; ", True], - ["sections 8 and 9 say what they do not see. ", False]] - else: # no clinical screen has a result: saying nothing needs a doctor would read as an all-clear - out += [["The clinical screens have no result yet; ", True], - ["section 9 lists the steps that did not run. ", False]] - if by["medicine"]: - genes = sorted({f["gene"] for f in by["medicine"] if f["gene"]}) - out += [[_count(len(by["medicine"]), "medicine result", "medicine results").capitalize(), True], - [f" bear{'s' if len(by['medicine']) == 1 else ''} on how drugs work ({', '.join(genes)}): tell whoever prescribes. ", False]] - if by["carrier"]: - out += [[f"A carrier of {_names(by['carrier'], 2)}", True], - [": carriers are not affected; it matters when a partner carries the same gene. ", False]] - if by["review"]: - out += [[_count(len(by["review"]), "result is", "results are").capitalize() + " worth a look", True], - [": " + _names(by["review"]) + ". ", False]] - cov = _data(S, "coverage").get("mean_depth") - q = _data(S, "sample_qc") - checked = q.get("contamination") == "ok" and q.get("sex_check") == "ok" # both ran and raised nothing - if not by["trust"] and isinstance(cov, (int, float)): - out.append([f"Mean depth {cov:.1f}×" + ("; the identity and contamination checks raised no flag." if checked - else "; the identity and contamination checks have no result here: section 5 says why."), False]) - if out: - out[-1][0] = out[-1][0].rstrip() - return out - - -# --- the veil's tags ----------------------------------------------------------------------------- -# Places outside the own card of a result to act on can name the same gene or variant: any card's table and -# lines, the charts' marks and their titles, another finding (a symptom ranking), the lead, the search index. -# Each such row carries the id of the result it belongs to. A child's page no longer closes them one by one: -# one gate (assets/live/core.js) holds the whole report while a result to act on is unopened, and of these -# tags the page still reads only the charts' marks (veil() below). The rule: a row -# belongs to a closed result when it names the result's gene, or its position falls inside the result's -# position or span; a row that is the result's own position or span belongs to that result first, else -# the first such result in finding order. The veil lives in the browser: the files still hold every row. -LOCUS_RE = re.compile(r"(?= a for lc, ls, le in locs): - return fid - return None - - -def veil(summary, found, chapters, lead_parts=()): - """Which rows outside a result's own card name a result to act on, by the result's id: each card's table rows - (rows: card -> one id or None per row; the ClinVar card's by each hit's own position), each card's viewer - links (viewer: card -> one per link), each card's lines (lines: card -> one per line; a known deep - intronic site is printed whether hit or not), the marks of the report's charts (marks: chart -> {mark id: - id}), every other finding that names a closed result (findings: finding id -> id; a symptom ranking can - rank the gene) and the lead's segments that name one (lead: one per segment of LEAD_PARTS, the "act" - names left out), each card's facts (facts: card -> one per fact) and the items of its drawing (widget: card - -> one per CHIP call or copy-number dot); spans is closable() itself. A child's page no longer closes these - rows one by one: its one gate (assets/live/core.js) holds the whole report while a result to act on is - unopened and reads the findings of level "act" for it. Of this field only marks is still read, by person.js, - for a chart mark on a page the gate released (the search index and the genome map carry their own tags); the - other subfields stay so that no field of results.json is removed. Empty when nothing can be closed.""" - spans = closable(found) - if not spans: - return {} - out = {"rows": {}, "viewer": {}, "lines": {}, "facts": {}, "widget": {}, "marks": {}, "findings": {}, "lead": [], - "spans": [list(s) for s in spans]} - S = summary.get("sections") or {} - hits = [h for h in _items(_data(S, "clinvar").get("hits"))[:50]] - tags = [veil_id(spans, str(h.get("gene") or ""), h.get("chrom"), h.get("pos")) if isinstance(h, dict) else None - for h in hits] - if any(tags): - out["rows"]["clinvar"] = tags - for ch in chapters: - for c in ch["sections"]: - rows = (c.get("table") or {}).get("rows") or [] - if c["id"] != "clinvar" and rows: - tags = [veil_id(spans, " ".join(str(x) for x in r) if isinstance(r, (list, tuple)) else str(r)) - for r in rows] - if any(tags): - out["rows"][c["id"]] = tags - tags = [veil_id(spans, v) for v in c.get("viewer") or []] - if c["id"] == "clinvar": # one link per row: a row closed by its gene alone closes its link too - rt = out["rows"].get("clinvar") or [] - tags = [(rt[i] if i < len(rt) else None) or t for i, t in enumerate(tags)] - if any(tags): - out["viewer"][c["id"]] = tags - tags = [veil_id(spans, ln) for ln in c.get("lines") or []] - if any(tags): - out["lines"][c["id"]] = tags - tags = [veil_id(spans, " ".join(str(x) for x in f)) for f in c.get("facts") or []] - if any(tags): - out["facts"][c["id"]] = tags - # A drawing's items: the CHIP calls (gene and change) and the copy-number dots (gene). The CHIP - # chart's list of genes with their detection limits is the same panel for everyone: never tagged. - w = c.get("widget") or {} - items = w.get("calls") if w.get("kind") == "vaf" else w.get("genes") if w.get("kind") == "copies" else None - tags = [veil_id(spans, f"{x.get('gene') or ''} {x.get('change') or ''}") for x in items or []] - if any(tags): - out["widget"][c["id"]] = tags - try: - specs = rr.chart_specs(summary) - except (KeyError, TypeError, ValueError, AttributeError, IndexError, ZeroDivisionError): - specs = [] - for sp in specs: - for m in sp.get("marks") or []: - if m.get("kind") == "roh": # a run of homozygosity is no result's source - continue - fid = veil_id(spans, f"{m.get('label') or ''} {m.get('detail') or ''}", m.get("chrom"), m.get("pos"), - m.get("end")) - if fid: - out["marks"].setdefault(sp["id"], {})[m["id"]] = fid - for f in found: - if f.get("level") != "act": - fid = veil_id(spans, f"{f.get('gene') or ''} {f.get('detail') or ''} {f.get('title') or ''} " - f"{f.get('viewer') or ''}") - if fid: - out["findings"][f["id"]] = fid - tags = [None if len(x) > 2 else veil_id(spans, x[0]) for x in lead_parts or ()] - out["lead"] = tags if any(tags) else [] - return {k: v for k, v in out.items() if v} - - -def build(sample, summary, files=()): - """results.json of one person from a summary.json; files: the run's paths the report links (for links).""" - summary = summary or {} - files = set(files or ()) - S = summary.get("sections") or {} - chapters = [] - for cid, ctitle, question, secs in rr.CHAPTERS: - cards = [card(sid, title, keys, summary, files) for sid, title, keys in secs] - chapters.append({"key": cid, "title": ctitle, "question": question, "sections": cards, - "attention": sum(1 for c in cards if c["attention"])}) - sexc = (S.get("sex_check") or {}).get("data") or {} - person = {"sample": sample, "declared_sex": (summary.get("run") or {}).get("declared_sex"), - "inferred_sex": sexc.get("inferred_sex"), "karyotype": sexc.get("karyotype")} - found, levels, sections = journal(chapters, summary) - lead_parts = lead(found, levels, summary) - return {"schema_version": SCHEMA, "sample": sample, "generated_utc": summary.get("generated_utc"), - "person": person, "chapters": chapters, - "findings": found, "levels": levels, "journal": sections, "lead": lead_parts, - "level_words": LEVEL_WORDS, "databases": {k: plain(cell(v)) for k, v in (summary.get("databases") or {}).items() - if isinstance(v, (str, int, float))}, - "attention": sum(c["attention"] for c in chapters), - "not_assessed": [plain(x) for x in summary.get("not_assessed") or []], - "not_run": [plain(x) for x in summary.get("not_run") or []], - "new_since": summary.get("new_since") or None, - "charts": CHART_SECTION, "veil": veil(summary, found, chapters, lead_parts)} - - -def attention_count(summary): - """The number of cards worth a look, for the home page (cheap: no file read).""" - return build("", summary)["attention"] - - -def overview(summary): - """What the home page shows of one person: the attention count, the counts by level, the findings to - act on first (at most four, by level) and the lead as plain text. No file read.""" - r = build("", summary) - order = {lv: i for i, lv in enumerate(LEVELS)} - order["trust"] = -1 # a problem with the data comes before any finding read from it - # A finding that names a result to act on (veil: a symptom ranking of its gene) is not listed: a child's tile - # closes only the results to act on themselves, and the result it names already comes first. - named = (r.get("veil") or {}).get("findings") or {} - top = sorted((f for f in r["findings"] if f["level"] != "info" and f["id"] not in named), - key=lambda f: order[f["level"]])[:4] - tags = (r.get("veil") or {}).get("lead") or [] - return {"attention": r["attention"], "levels": r["levels"], "screened": screened(summary), - "top": [{"id": f["id"], "level": f["level"], "title": f["title"]} for f in top], - "lead": "".join(x[0] for x in r["lead"]), - # The same lead with the names of the findings to act on left out, and every other segment that names - # one of them: a child's tile shows this one. - "lead_closed": "".join(": closed until opened on purpose. " if x[2:] == ["act"] - else closed_lead(x[0]) if i < len(tags) and tags[i] else x[0] - for i, x in enumerate(r["lead"]))} - - -def closed_lead(t): - """A segment of the lead that names a result to act on, without the names (person.js closedLead()): the - list after a colon, the genes in brackets, or what follows "of".""" - w = "closed until opened on purpose" - if t.lstrip().startswith(":"): - return f": {w}. " - if re.search(r"\(.*\)", t): - return re.sub(r"\(.*\)", f"({w})", t) - if " of " in t: - return re.sub(r" of .*$", f" result, {w}", t) - return f"{w}. " - - -def strings(obj): - """Every string in a JSON value, with its key path: the wording gate's input.""" - if isinstance(obj, dict): - for k, v in obj.items(): - for p, s in strings(v): - yield (k,) + p, s - elif isinstance(obj, list): - for v in obj: - yield from strings(v) - elif isinstance(obj, str): - yield (), obj - - -def wording_problems(obj, allow=("src", "url", "caveat", "summary")): - """[(path, text)] of the strings that would read as an all-clear. Allowed: data URLs and links, the - caveats (render_report's constants word for word, checked against them separately), and a quoted - tool term (CPIC's "Normal Metabolizer", Stranger's "normal").""" - out = [] - for path, s in strings(obj): - if path and path[-1] in allow: - continue - t = re.sub(r'"[^"]*"', "", s) - if FORBIDDEN.search(t): - out.append((".".join(map(str, path)), s[:160])) - return out diff --git a/bin/owngenome_live.py b/bin/owngenome_live.py index d09815bd1..412c25d73 100755 --- a/bin/owngenome_live.py +++ b/bin/owngenome_live.py @@ -69,6 +69,7 @@ ASSETS = os.path.join(REPO, "assets", "live") sys.path.insert(0, HERE) import run_state # noqa: E402 +from owngenome_live_results import og_results # noqa: E402 PBKDF2_ITERATIONS = 600000 COOKIE = "owngenome_live" @@ -545,8 +546,8 @@ def __init__(self, app, cfg, password_hash): self.streams = threading.BoundedSemaphore(cfg.max_streams) self.headline_cache = {} self.attention_cache = {} - self.live_overview = {} # run -> (the headline cache key, live_results.overview of that summary) - self.summary_overviews = {} # run -> (the summary summary() gave, live_results.overview of it) + self.live_overview = {} # run -> (the headline cache key, og live results --overview of that summary) + self.summary_overviews = {} # run -> (the summary summary() gave, og live results --overview of it) self.allowed = set(LOOPBACK_HOSTS) | {h.lower() for h in cfg.allowed_host or []} if cfg.bind not in ("0.0.0.0", "::"): self.allowed.add(cfg.bind.strip("[]").lower()) @@ -810,7 +811,7 @@ def attention(self, d): return (o["attention"] if o else None), mtime def overview(self, d): - """(live_results.overview of /summary.json, mtime), cached by its mtime; (None, None) without one: + """(og live results --overview of /summary.json, mtime), cached by its mtime; (None, None) without one: the attention count, the counts by level, the first findings and the lead the home page shows.""" p = os.path.join(d, "summary.json") if d else None if not p or not self.inside(p, os.path.realpath(d)) or not self.inside(p, self.root): @@ -825,9 +826,8 @@ def overview(self, d): return hit[1], mtime n = None try: - import live_results with open(p) as f: - n = live_results.overview(json.load(f)) + n = og_results(json.load(f), "--overview") except Exception as e: # one bad file must not take the home page down print(f"owngenome_live: {os.path.basename(os.path.dirname(p))}/summary.json not read: {type(e).__name__}", file=sys.stderr) @@ -840,7 +840,7 @@ def child(self, name, runs=None): return child_of([r for r in (runs or self.runs()).values() if r.get("kind") == "family"], name) def summary_overview(self, name, d, st): - """live_results.overview of the summary results.json reads now (summary()), cached with that summary; + """og live results --overview of the summary results.json reads now (summary()), cached with that summary; None while there is none.""" s = self.summary(name, d, st) if not s: @@ -848,8 +848,7 @@ def summary_overview(self, name, d, st): hit = self.summary_overviews.get(name) if not hit or hit[0] is not s: try: - import live_results - hit = (s, live_results.overview(s)) + hit = (s, og_results(s, "--overview")) except Exception as e: # one bad summary must not take a page down print(f"owngenome_live: overview of {name} not built: {type(e).__name__}", file=sys.stderr) hit = (s, None) @@ -906,8 +905,7 @@ def runs_index(self): lo = self.live_overview.get(name) if not lo or lo[0] != hit[0]: try: - import live_results - lo = (hit[0], live_results.overview(hit[2])) + lo = (hit[0], og_results(hit[2], "--overview")) except Exception as e: # one bad summary must not take the home page down print(f"owngenome_live: overview of {name} not built: {type(e).__name__}", file=sys.stderr) lo = (hit[0], None) diff --git a/bin/owngenome_live_map.py b/bin/owngenome_live_map.py index 3c8f3276d..ba8501338 100644 --- a/bin/owngenome_live_map.py +++ b/bin/owngenome_live_map.py @@ -35,14 +35,15 @@ def results_body(live, run): """What GET /runs//results.json sends (bin/owngenome_live_results.py), built the same way.""" - import live_results + from owngenome_live_results import og_results name = run["name"] d = run["dir"] or os.path.join(live.root, name) summary = live.summary(name, d, live.base_state(run)) if not summary: return {"schema_version": 1, "sample": name, "chapters": [], "note": "No step has finished yet: the results appear here as the steps end."} - return live_results.build(name, summary, live.run_files(run) if run["dir"] else set()) + files = live.run_files(run) if run["dir"] else set() + return og_results(summary, "--sample", name, files=files) def relay(app, req, args, stdin, run, section): diff --git a/bin/owngenome_live_results.py b/bin/owngenome_live_results.py index a5c03c863..f6d5de0b9 100644 --- a/bin/owngenome_live_results.py +++ b/bin/owngenome_live_results.py @@ -1,6 +1,6 @@ """owngenome_live_results.py: a person's results on the live site, a plugin of bin/owngenome_live.py. - GET /runs//results.json bin/live_results.py's build() of the run's summary: the + GET /runs//results.json og live results of the run's summary: the report's seven chapters, one card per section with its facts, its rows, its caveats and its attention flag, and the Journal's findings, levels, lead and ten sections @@ -17,7 +17,10 @@ what the report prints. Every request writes one access-log row. """ import html +import json import os +import re +import subprocess import sys import urllib.parse @@ -25,6 +28,16 @@ sys.path.insert(0, HERE) NAME = r"[A-Za-z0-9][A-Za-z0-9._-]*" +FINDING_ID = re.compile(r"^[a-z0-9][a-z0-9-]{0,79}$") + + +def og_results(summary, *args, files=(), og=None): + """Run the results command on a summary already read by Python.""" + og = og or os.environ.get("OG") or os.path.join(HERE, "og") + paths = [arg for f in sorted(files) for arg in ("--file", f)] + p = subprocess.run([og, "live", "results", "-", *args, *paths], + input=json.dumps(summary), text=True, capture_output=True, timeout=30, check=True) + return json.loads(p.stdout) def register(app): @@ -38,12 +51,11 @@ def results(req, m): d = run["dir"] or os.path.join(live.root, name) out = {"schema_version": 1, "sample": name, "chapters": [], "note": None} try: - import live_results st = live.base_state(run) summary = live.summary(name, d, st) if summary: files = live.run_files(run) if run["dir"] else set() - out = live_results.build(name, summary, files) + out = og_results(summary, "--sample", name, files=files) # For a child whose report the server keeps closed (family.json leaves its count out): the # flagged-card count of summary.json, as family.json counts it otherwise. The family page shows it # once every result to act on is opened there (assets/live/core.js released). @@ -76,11 +88,11 @@ def finding(req, m): run = live.run(m.group(1)) fid = m.group(2) ok = False - if run and run.get("kind") != "family" and live_results_mod().FINDING_ID.match(fid): + if run and run.get("kind") != "family" and FINDING_ID.match(fid): try: d = run["dir"] or os.path.join(live.root, run["name"]) summary = live.summary(run["name"], d, live.base_state(run)) - found = live_results_mod().build(run["name"], summary)["findings"] if summary else [] + found = og_results(summary, "--sample", run["name"])["findings"] if summary else [] ok = any(f["id"] == fid for f in found) or ( any(f["level"] == "act" for f in found) and child_run(live, run["name"])) except Exception as e: # a reader bug is a 404 here, never a 500 @@ -103,9 +115,3 @@ def child_run(live, name): """Whether the person page treats NAME as a child's run: the one rule of the page and the home page (bin/owngenome_live.py child_of).""" return live.child(name) - - -def live_results_mod(): - import live_results - return live_results - diff --git a/bin/results_index.py b/bin/results_index.py index b37b1bb8b..dd6aad986 100755 --- a/bin/results_index.py +++ b/bin/results_index.py @@ -216,16 +216,12 @@ def add(term, key, sec, text, locus): add(n, key, sec, text, locus) # The veil: an item that names a result to act on (its gene, or a locus inside its position or span) # carries that result's id, so a child's page leaves it out of the search while the result is closed - # (bin/live_results.py veil_id, the rule its ClinVar rows and chart marks follow). - import live_results # here, not at the top: live_results imports render_report, which imports this module - spans = live_results.closable_of(summary) - for term, items in terms.items(): + # og live results applies the same rule to the index as to the ClinVar rows and chart marks. + from owngenome_live_results import og_results + for items in terms.values(): for it in items: del it["_seen"] - fid = live_results.veil_id(spans, " ".join([term] + [f"{m['text']} {m['locus'] or ''}" - for m in it["mentions"]])) - if fid: - it["veil"] = fid + terms = og_results({"summary": summary, "terms": terms}, "--tag-search") return {"schema_version": SCHEMA_VERSION, "sample": summary.get("sample"), "generated_utc": summary.get("generated_utc"), "terms": {k: terms[k] for k in sorted(terms)}} diff --git a/rust/crates/og-live/src/results/mod.rs b/rust/crates/og-live/src/results/mod.rs index 7648e6062..57520b796 100644 --- a/rust/crates/og-live/src/results/mod.rs +++ b/rust/crates/og-live/src/results/mod.rs @@ -20,7 +20,7 @@ use std::io::Write; const EMPTY_CLINVAR: &str = "No P/LP match in this ClinVar file at the call floor. ClinVar lists only part of what can cause disease, so this is information, and the caveats below still apply."; const TABLE_LIMIT: usize = 200; -const USAGE: &str = "usage: og live results SUMMARY [--sample NAME] [--file PATH]... [--out PATH]\n og live results SUMMARY --overview | --spans"; +const USAGE: &str = "usage: og live results SUMMARY [--sample NAME] [--file PATH]... [--out PATH]\n og live results SUMMARY --overview | --spans | --tag-search"; /// The result builders used by the live server. pub const FNS: ResultsFns = ResultsFns { build, overview }; @@ -1005,6 +1005,14 @@ pub fn overview(summary: &Value) -> Result { )) } +/// The results a report's search index needs to tag. +pub fn closable_of(root: &Value) -> Vec { + parsed(root).map_or_else( + |_| Vec::new(), + |summary| veil::spans(&finding_rows(&summary)), + ) +} + #[derive(Default)] struct Args { summary: String, @@ -1013,6 +1021,7 @@ struct Args { out: Option, overview: bool, spans: bool, + tag_search: bool, } fn args(argv: &[String]) -> Result { @@ -1027,6 +1036,7 @@ fn args(argv: &[String]) -> Result { match arg.as_str() { "--overview" => args.overview = true, "--spans" => args.spans = true, + "--tag-search" => args.tag_search = true, "--sample" => args.sample = Some(next(&mut argv)?), "--file" => { args.files.insert(next(&mut argv)?); @@ -1042,8 +1052,13 @@ fn args(argv: &[String]) -> Result { if args.summary.is_empty() { return Err("a summary is required".into()); } - if args.overview && args.spans { - return Err("--overview and --spans are mutually exclusive".into()); + if [args.overview, args.spans, args.tag_search] + .into_iter() + .filter(|flag| *flag) + .count() + > 1 + { + return Err("--overview, --spans and --tag-search are mutually exclusive".into()); } Ok(args) } @@ -1071,17 +1086,25 @@ pub fn cli(argv: &[String], out: &mut dyn Write, err: &mut dyn Write) -> u8 { std::fs::read_to_string(&args.summary) } .map_err(|e| e.to_string())?; - let summary = parsed(&pycompat::json::loads(&text).map_err(|e| e.to_string())?)?; - let result = if args.spans { - veil::spans_json(&finding_rows(&summary)) - } else if args.overview { - headlines::overview(&summary, &build_summary("", &summary, None)) + let root = pycompat::json::loads(&text).map_err(|e| e.to_string())?; + let result = if args.tag_search { + let summary = parsed(val(&root, "summary"))?; + let mut terms = val(&root, "terms").clone(); + veil::tag_search(&mut terms, &veil::spans(&finding_rows(&summary)))?; + terms } else { - let sample = args - .sample - .as_deref() - .unwrap_or_else(|| string(summary.root(), "sample")); - build_summary(sample, &summary, Some(&args.files)) + let summary = parsed(&root)?; + if args.spans { + veil::spans_json(&finding_rows(&summary)) + } else if args.overview { + headlines::overview(&summary, &build_summary("", &summary, None)) + } else { + let sample = args + .sample + .as_deref() + .unwrap_or_else(|| string(summary.root(), "sample")); + build_summary(sample, &summary, Some(&args.files)) + } }; let body = dumps( &result, diff --git a/rust/crates/og-live/src/veil.rs b/rust/crates/og-live/src/veil.rs index 7da51a187..500ee1449 100644 --- a/rust/crates/og-live/src/veil.rs +++ b/rust/crates/og-live/src/veil.rs @@ -76,7 +76,7 @@ fn loci(text: &str) -> Vec { out } -fn spans(found: &[Finding]) -> Vec { +pub(crate) fn spans(found: &[Finding]) -> Vec { found .iter() .filter(|f| f.level == Level::Act) @@ -132,6 +132,36 @@ fn id(spans: &[Closable], text: &str, own: Option) -> Option { veil_of(spans, text) } +/// Tag the legacy search index without rebuilding its terms in Python. +pub(crate) fn tag_search(terms: &mut Value, spans: &[Closable]) -> Result<(), String> { + let Value::Object(terms) = terms else { + return Err("search terms must be an object".into()); + }; + for (term, items) in terms { + let Value::Array(items) = items else { + return Err("search items must be an array".into()); + }; + for item in items { + let mut shown = term.clone(); + for mention in list(val(item, "mentions")) { + shown.push(' '); + shown.push_str(string(mention, "text")); + shown.push(' '); + shown.push_str(string(mention, "locus")); + } + let Value::Object(item) = item else { + return Err("search item must be an object".into()); + }; + if let Some(id) = veil_of(spans, &shown) { + item.insert("veil".into(), Value::Str(id)); + } else { + item.shift_remove("veil"); + } + } + } + Ok(()) +} + fn joined(v: &Value) -> String { list(v).iter().map(text).collect::>().join(" ") } diff --git a/rust/crates/og-render/src/index.rs b/rust/crates/og-render/src/index.rs index 3f74d8619..112d4a5e6 100644 --- a/rust/crates/og-render/src/index.rs +++ b/rust/crates/og-render/src/index.rs @@ -40,9 +40,8 @@ //! cannot answer: a position is a genotype question, for //! `scripts/owngenome-lookup.sh`. //! -//! The veil needs the findings a child's page keeps closed, which the live -//! results build. Until they are ported, the command line passes none, so -//! `og report index build` writes no veil field; [`build`] takes them. +//! The live results producer supplies the findings a child's page keeps +//! closed. The `og` command passes them to [`build`] through [`cli_using`]. use std::collections::{BTreeMap, BTreeSet, HashSet}; use std::io::Write; @@ -807,6 +806,16 @@ fn write(path: &str, body: &str) -> std::io::Result<()> { /// them or a command line it cannot read, 1 when a file cannot be read or /// written. pub fn cli(args: &[String], out: &mut dyn Write, err: &mut dyn Write) -> u8 { + cli_using(args, out, err, |_| Vec::new()) +} + +/// Run the index command with the live results producer's closable findings. +pub fn cli_using( + args: &[String], + out: &mut dyn Write, + err: &mut dyn Write, + closable: fn(&Value) -> Vec, +) -> u8 { if args.is_empty() { let _ = writeln!(err, "{USAGE}\nog report index: error: give build or query"); return 2; @@ -844,7 +853,12 @@ pub fn cli(args: &[String], out: &mut dyn Write, err: &mut dyn Write) -> u8 { Ok(s) => s, Err(why) => return fail(err, why), }; - let idx = match build(&s, o.get("--sample-dir").map(String::as_str), &[], err) { + let idx = match build( + &s, + o.get("--sample-dir").map(String::as_str), + &closable(&s), + err, + ) { Ok(i) => i, Err(why) => return fail(err, format!("{summary}: {why}")), }; diff --git a/rust/crates/og-render/src/render.rs b/rust/crates/og-render/src/render.rs index ce41de658..42b053edd 100644 --- a/rust/crates/og-render/src/render.rs +++ b/rust/crates/og-render/src/render.rs @@ -185,6 +185,16 @@ pub fn cli(args: &[String], out: &mut dyn Write, err: &mut dyn Write) -> u8 { cli_using(args, out, err, writer) } +/// Run the report command with the live results producer's closable findings. +pub fn cli_with_spans( + args: &[String], + out: &mut dyn Write, + err: &mut dyn Write, + closable: fn(&Value) -> Vec, +) -> u8 { + render(args, out, err, writer, closable) +} + /// `og report render ARGS` with the section writers of `writers` (a test /// plants a fault through them). pub fn cli_using( @@ -192,6 +202,16 @@ pub fn cli_using( out: &mut dyn Write, err: &mut dyn Write, writers: WriterFn, +) -> u8 { + render(args, out, err, writers, |_| Vec::new()) +} + +fn render( + args: &[String], + out: &mut dyn Write, + err: &mut dyn Write, + writers: WriterFn, + closable: fn(&Value) -> Vec, ) -> u8 { if args.iter().any(|a| a == "-h" || a == "--help") { let _ = writeln!(out, "{USAGE}"); @@ -242,7 +262,12 @@ pub fn cli_using( let need_index = a.search_index.is_some() || a.out.iter().any(|o| o.ends_with(".html")); let idx = if need_index { let built = guarded(|| { - index::build(s.root(), a.sample_dir.as_deref(), &[], &mut &mut *err) + let spans = if a.search_index.is_some() { + closable(s.root()) + } else { + Vec::new() + }; + index::build(s.root(), a.sample_dir.as_deref(), &spans, &mut &mut *err) .map_err(crate::model::Malformed) }); match built { diff --git a/rust/og/src/main.rs b/rust/og/src/main.rs index c8fdc269a..ef1601b19 100644 --- a/rust/og/src/main.rs +++ b/rust/og/src/main.rs @@ -543,8 +543,18 @@ fn main() -> ExitCode { _ => usage_error("og summary takes collect"), }, "report" => match rest.first().map(String::as_str) { - Some("render") => io(og_render::render::cli, &rest[1..]), - Some("index") => io(og_render::index::cli, &rest[1..]), + Some("render") => io( + |args, out, err| { + og_render::render::cli_with_spans(args, out, err, og_live::results::closable_of) + }, + &rest[1..], + ), + Some("index") => io( + |args, out, err| { + og_render::index::cli_using(args, out, err, og_live::results::closable_of) + }, + &rest[1..], + ), Some("charts") => io(og_render::charts::cli, &rest[1..]), Some(other) => usage_error(&format!("unknown report tool '{other}'")), None => usage_error("the following arguments are required: report tool"), diff --git a/scripts/ci/e2e-case-paths.tsv b/scripts/ci/e2e-case-paths.tsv index 034ccc23f..3cf28c7a6 100644 --- a/scripts/ci/e2e-case-paths.tsv +++ b/scripts/ci/e2e-case-paths.tsv @@ -112,7 +112,7 @@ hla-second-caller-2-nextflow assets/acmg_sf.tsv assets/callability_genes.tsv ass i411-callability-overlap-1-mates modules/local/mosdepth/* scripts/16b-mosdepth.sh scripts/lib/common.sh i411-nf-vcfanno-ops-1-score-tiers bin/og modules/local/clinical_filter/* modules/local/vcfanno/* scripts/30-vcfanno.sh ibd-segments-1 assets/families.example.tsv assets/par_grch38.bed assets/pedigree.example.tsv assets/stub/pedigree.tsv bin/og rust/crates/og-dev/src/fixture.rs scripts/38-family.sh scripts/ci/fake-docker/lib.sh scripts/setup.sh -live-server-1-weblog assets/live/* assets/viewer/index.html bin/live_results.py bin/og bin/owngenome_live.py bin/owngenome_live_results.py bin/render_report.py bin/run_state.py modules/local/roh/* modules/local/vcf_precheck/* rust/crates/og-dev/src/fixture.rs scripts/11-roh-analysis.sh scripts/ci/fake-docker/lib.sh scripts/validate-setup.sh +live-server-1-weblog assets/live/* assets/viewer/index.html bin/og bin/owngenome_live.py bin/owngenome_live_results.py bin/render_report.py bin/run_state.py modules/local/roh/* modules/local/vcf_precheck/* rust/crates/og-dev/src/fixture.rs rust/crates/og-live/src/results/* rust/crates/og-live/src/veil.rs scripts/11-roh-analysis.sh scripts/ci/fake-docker/lib.sh scripts/validate-setup.sh lpa-1 assets/acmg_sf.tsv assets/callability_genes.tsv assets/carrier_genes.tsv assets/mito_confirmed.tsv assets/par_grch38.bed assets/stub/sample.vcf.gz bin/cn_loci.tsv bin/collect_summary.py bin/og bin/render_report.py bin/results_index.py modules/local/deepvariant/* modules/local/html_report/* modules/local/lpa/* modules/local/vcf_precheck/* scripts/24-html-report.sh scripts/46-lpa.sh scripts/ci/fake-docker/lib.sh scripts/validate-setup.sh mei-1 assets/mei_sites.tsv assets/par_grch38.bed assets/sv_rule_regions.tsv bin/collect_summary.py bin/og modules/local/align_minimap2/* modules/local/annotsv/* modules/local/deepvariant/* modules/local/fastp/* modules/local/mei/* modules/local/vcf_precheck/* scripts/01b-fastp-qc.sh scripts/05-annotsv.sh scripts/15-duphold.sh scripts/18-cnvpytor.sh scripts/19-delly.sh scripts/50-mei.sh scripts/ci/check-images.sh scripts/ci/fake-docker/lib.sh scripts/setup.sh scripts/validate-setup.sh tests/fixtures/annotsv/class45.sh mito-extended-1-deletions assets/acmg_sf.tsv assets/callability_genes.tsv assets/carrier_genes.tsv assets/construct_variants.tsv assets/deep_intronic_sites.tsv assets/mito_confirmed.tsv assets/stub/db/clinvar.vcf.gz assets/stub/db/clinvar.vcf.gz.tbi assets/stub/sample.bam assets/stub/sample.bam.bai assets/stub/sample.vcf.gz bin/collect_summary.py bin/og bin/render_report.py bin/results_index.py modules/local/clinvar_screen/* modules/local/html_report/* modules/local/mito_variants/* modules/local/vcf_precheck/* scripts/06-clinvar-screen.sh scripts/16b-mosdepth.sh scripts/20-mtoolbox.sh scripts/24-html-report.sh scripts/ci/build-mito-confirmed.sh scripts/ci/fake-docker/lib.sh scripts/validate-setup.sh scripts/generate-report.sh rust/crates/og-dev/src/fixture.rs diff --git a/tests/demo/build_live_demo.py b/tests/demo/build_live_demo.py index 340ef8cae..1b4b6baa2 100644 --- a/tests/demo/build_live_demo.py +++ b/tests/demo/build_live_demo.py @@ -10,7 +10,7 @@ assets/ assets/live/ as it is: core.js, live.js, person.js, live.css, plugins/*.js runs/DEMO-001/index.html the person page (assets/live/index.html) in replay mode runs/DEMO-001/frames.json the page's state.json at each moment of the run - runs/DEMO-001/results.json the person's results (bin/live_results.py), as the results + runs/DEMO-001/results.json the person's results (og live results), as the results plugin serves them at the end of the run; each card shows once the replay reaches the end of its steps runs/DEMO-001/map.json the genome map of Figure 1: `og map build` with those results on @@ -87,9 +87,9 @@ REPO = os.path.dirname(os.path.dirname(HERE)) BIN = os.path.join(REPO, "bin") sys.path.insert(0, BIN) -import live_results # noqa: E402 import owngenome_live # noqa: E402 import owngenome_live_family # noqa: E402 +from owngenome_live_results import og_results # noqa: E402 import run_headroom # noqa: E402 import run_state # noqa: E402 @@ -128,14 +128,14 @@ def epoch(text): # --- the run folder ------------------------------------------------------------------------- -def report(d, sample=SAMPLE): +def report(d, sample=SAMPLE, og=OG): """bin/render_report.py with the arguments scripts/24-html-report.sh gives it.""" subprocess.run([sys.executable, os.path.join(BIN, "render_report.py"), "--assets", os.path.join(REPO, "assets"), "--sample", sample, "--sample-dir", d, "--json", os.path.join(d, "summary.json"), "-o", os.path.join(d, f"{sample}_report.html"), "--search-index", os.path.join(d, f"{sample}_search_index.json"), "--charts-json", os.path.join(d, f"{sample}_charts.json")], - check=True, stdout=subprocess.DEVNULL) + check=True, stdout=subprocess.DEVNULL, env=dict(os.environ, OG=og)) def demo_sample(og, root, *args): @@ -154,7 +154,7 @@ def other_person(root, name, sex, seed, records, og=OG): started = next(int(x.split("\t")[2]) for x in f if x.startswith("meta\tstarted_epoch\t")) with open(status, "a") as f: f.write(f"meta\tfinished_utc\t{time.strftime('%Y-%m-%d %H:%M:%S UTC', time.gmtime(started + 30 * 3600))}\n") - report(d, name) + report(d, name, og) def prepare(root, genome_dir=None, records=20000, og=OG): @@ -168,7 +168,7 @@ def prepare(root, genome_dir=None, records=20000, og=OG): else: demo_sample(og, root, "--records", str(records)) if not os.path.isfile(os.path.join(d, f"{SAMPLE}_report.html")): - report(d) + report(d, og=og) for rel in OTHER_RUN: p = os.path.join(d, rel) if os.path.isfile(p): @@ -290,8 +290,9 @@ def snap(t): run, d = live.run(SAMPLE), os.path.join(root, SAMPLE) # The demo's run folder has no run_status.tsv (OTHER_RUN), so the server knows it from its # messages alone; the files it may serve are those of the folder all the same. - results = live_results.build(SAMPLE, live.summary(SAMPLE, d, live.base_state(run)), - owngenome_live.Live.run_files(None, {"dir": d, "name": SAMPLE})) + files = owngenome_live.Live.run_files(None, {"dir": d, "name": SAMPLE}) + results = og_results(live.summary(SAMPLE, d, live.base_state(run)), "--sample", SAMPLE, + files=files, og=og) results["generated_utc"] = checked if live.gated(SAMPLE, d, live.base_state(run)): # as the results plugin adds it results["saved_attention"] = live.attention(d)[0] @@ -302,8 +303,9 @@ def snap(t): st = live.state(r) st["generated_utc"] = checked st["plugins"] = relink(st["plugins"]) - res = live_results.build(name, live.summary(name, od, live.base_state(r)), - owngenome_live.Live.run_files(None, {"dir": od, "name": name})) + files = owngenome_live.Live.run_files(None, {"dir": od, "name": name}) + res = og_results(live.summary(name, od, live.base_state(r)), "--sample", name, + files=files, og=og) res["generated_utc"] = checked if live.gated(name, od, live.base_state(r)): res["saved_attention"] = live.attention(od)[0] diff --git a/tests/parity/remnants.tsv b/tests/parity/remnants.tsv index 1397862b5..95fb4eb90 100644 --- a/tests/parity/remnants.tsv +++ b/tests/parity/remnants.tsv @@ -4,4 +4,4 @@ # the importers are exactly these (docs/rust.md). # filenamesimporterslane bin/genome_lookup.py GENE_KEYS,RSID_RE,norm_chrom,parse_query,names_of,walk_mentions,flat bin/results_index.py R5c -bin/collect_summary.py HERE,ASSETS_DIR,SECTIONS,og,collect,STARS,COMMON_AF,RUN_ALL_STEPS,open_text,info_map,read_tsv,hla_quality,HLA_MAX_CANDIDATES,EXPLORE_DOCS,csq_rank bin/owngenome_live.py,bin/render_report.py,bin/results_index.py,tests/demo/make_demo_sample.py,tests/test_collect_summary.py,tests/test_live_journal.py,tests/test_live_results.py,tests/test_run_state.py,tests/test_viewer.py R6b +bin/collect_summary.py HERE,ASSETS_DIR,SECTIONS,og,collect,STARS,COMMON_AF,RUN_ALL_STEPS,open_text,info_map,read_tsv,hla_quality,HLA_MAX_CANDIDATES,EXPLORE_DOCS,csq_rank bin/owngenome_live.py,bin/render_report.py,bin/results_index.py,tests/demo/make_demo_sample.py,tests/test_collect_summary.py,tests/test_run_state.py,tests/test_viewer.py R6b diff --git a/tests/test_collect_summary.py b/tests/test_collect_summary.py index 3a07a20b0..946b35efc 100644 --- a/tests/test_collect_summary.py +++ b/tests/test_collect_summary.py @@ -1574,7 +1574,7 @@ def parascopy_section(work, schema): "silent carrier): in Luo 2014 it raised the residual carrier risk of a two-copy result (in African Americans " "from about 1 in 121 to 1 in 34); the figures depend on ancestry. This marker does not prove 2+0, and its " "absence does not rule 2+0 out.\n") - summ_m, txt_m, html_m = render(d) + _, txt_m, html_m = render(d) card_m = html_m.split("

    SMN1/SMN2 Copy Number (Parascopy)

    ", 1)[-1].split("

    ", 1)[0] check("parascopy: a marker table with 5 of 40 reads reads as present beside the psCN in the text report, " "with the reader's message and the caveat", @@ -1585,12 +1585,6 @@ def parascopy_section(work, schema): ">SMN1 g.27134T>G silent-carrier marker (rs143838139)<" in card_m and "present, 5 of 40 reads carry it" in card_m and render_report.E(caveat) in card_m and "does not prove 2+0" in card_m, card_m) - import live_results - lv = live_results.a_paralogs(summ_m["sections"], {}) - check("live: the paralog card has the SMN1 copies and the marker as facts, and its lines with the caveat", - ["SMN1 g.27134T>G silent-carrier marker", "present, 5 of 40 reads carry it, about 0.5 copies"] in lv["facts"] - and ["SMN1 copies", "2 (quality 33, filter PASS)"] in lv["facts"] - and f"SMN1 marker caveat: {caveat}" in lv["lines"], lv) put(mk, "metric\tvalue\nstatus\tmaybe\n") _, txt_b, _ = render(d) check("parascopy: a marker table with no known status reads as not assessed, never as a result", diff --git a/tests/test_live_demo.py b/tests/test_live_demo.py index c44226d81..1b2892a23 100644 --- a/tests/test_live_demo.py +++ b/tests/test_live_demo.py @@ -31,10 +31,10 @@ sys.path.insert(0, os.path.join(REPO, "tests", "demo")) sys.path.insert(0, os.path.join(REPO, "tests")) import build_live_demo # noqa: E402 -import live_results # noqa: E402 import make_demo_events # noqa: E402 import owngenome_live # noqa: E402 import run_state # noqa: E402 +from owngenome_live_results import og_results # noqa: E402 from test_owngenome_live import Chrome, asset_problems, find_chrome # noqa: E402 FAILS = [] @@ -3063,8 +3063,8 @@ def no_act(): def synthetic(): no_act() - write(files[0], live_results.build(S, SYNTH)) - o = live_results.overview(SYNTH) + write(files[0], og_results(SYNTH, "--sample", S)) + o = og_results(SYNTH, "--overview") idx = json.load(open(files[2])) for r in idx['runs']: if r['name'] == S: diff --git a/tests/test_live_journal.py b/tests/test_live_journal.py deleted file mode 100644 index 776746f6c..000000000 --- a/tests/test_live_journal.py +++ /dev/null @@ -1,411 +0,0 @@ -#!/usr/bin/env python3 -"""The Journal layer of a person's results (bin/live_results.py) and the finding page's route -(bin/owngenome_live_results.py). - -Checks: - 1. the level mapping, on a small made-up summary: CPSR's pathogenic row is to act on, a ClinVar hit - outside the carrier list is worth a look, a carrier-list row is for family planning (two changed - copies of a carrier gene, and a full-mutation repeat, are to act on), a CPIC gene - with changed function is for the prescriber, a contamination warning is data quality; each card - takes its highest finding's level, the quality chapter is data quality, a failed card has none; - every finding id is a safe path part (live_results.FINDING_ID) and sits in its level's section; - 2. the lead paragraph: with a finding to act on it says how many go to a doctor and names each one - (marked, so a child's page can leave the names out), a data-quality problem comes first, and with no finding it says none needs a doctor and points at - sections 8 and 9, never an all-clear (live_results.FORBIDDEN); with no clinical screen run it says the - clinical screens have no result yet; - 3. through the real server: /runs//finding// sends a browser with no session to the login and - back, answers the finding page - with the run and the id filled in and the server's Content-Security-Policy for an id of the run's - findings, and a 404 for an id that is not one, for a path-like id and for a run with no such page; - 4. /runs.json of a running run counts from the summary its page last read only while that read is - current (same steps done, same summary.json), and says whether a clinical screen has a result; - 5. one row the rules cannot read (a ClinVar hit whose stars is no number, a CPSR row that is a string, - a carrier row of the wrong type) costs that row only: results.json keeps every card and every other - finding, the row becomes a finding on its own card that names no gene, at the highest level its rule - can give (to act on for CPSR, the carrier list and AnnotSV, so a child's page veils the card; worth a - look for ClinVar), and the card whose table could not be drawn says so. -Each check runs again on a planted mistake and must fail there: 1 with the CPIC rule's level swapped -to review, 2 with the act findings left out of the lead and with their names unmarked and with the -old lead on a run with no clinical screen, 3 with the route answering any id, 4 with a current read, 5 with the rules run without the row guard -and with the guard's level hard-coded to review. -A check -that cannot fail is no check. - -Run: python3 tests/test_live_journal.py -""" -import contextlib -import copy -import io -import json -import os -import re -import shutil -import subprocess -import sys -import tempfile -import threading -import urllib.parse - -REPO = os.path.dirname(os.path.dirname(os.path.abspath(__file__))) -sys.path.insert(0, os.path.join(REPO, "bin")) -sys.path.insert(0, os.path.join(REPO, "tests")) -import collect_summary # noqa: E402 -import live_results # noqa: E402 -import owngenome_live # noqa: E402 - -SAMPLE = "DEMO-001" -PASSWORD = "synthetic test password 9" -FAILS = [] - - -def check(desc, ok, detail=""): - print(("[PASS] " if ok else "[FAIL] ") + desc + ("" if ok else f" -- {str(detail)[:800]}")) - if not ok: - FAILS.append(desc) - - -def control(desc, still_passes): - check(f"control: {desc}", not still_passes, "the check passed on the planted mistake") - - -def ok(data): - return {"state": "ok", "data": data} - - -# A made-up summary: invented genes and positions, one row per rule under test. -SUMMARY = {"sections": { - "cpsr": ok({"plp": [{"gene": "GENEA", "variant": "c.100del", "final": "Pathogenic", "clinvar": "Pathogenic"}]}), - "clinvar": ok({"hits": [{"gene": "GENEB", "chrom": "chr2", "pos": 1000, "ref": "C", "alt": "T", - "significance": "Pathogenic", "stars": 2, "genotype": "het", "af": 0.0001}]}), - "carrier": ok({"carriers": [{"gene": "GENEC", "variant": "c.5A>G", "condition": "Invented condition", - "significance": "Pathogenic", "stars": 2, "inheritance": "AR", "genotype": "het"}, - {"gene": "GENED", "variant": "c.9C>T", "condition": "Another invented condition", - "significance": "Pathogenic", "stars": 2, "inheritance": "AR", "genotype": "hom"}]}), - "expansions": ok({"loci": [{"locus": "FMR1", "repeat_count": "/".join(("30", "250")), "status": "pre_mutation,full_mutation", - "ci": "29-31/240-260", "allele_sizing": "spanning/flanking"}]}), - "cpic": ok({"genes": [{"gene": "CYP2C19", "diplotype": "*2/*2", "phenotype": "Poor Metabolizer", - "status": "non-normal"}, - {"gene": "CYP2C9", "diplotype": "*1/*1", "phenotype": "Normal Metabolizer", "status": "normal"}]}), - "sample_qc": ok({"contamination": "warn", "freemix": 0.05}), - "coverage": ok({"mean_depth": 31.2}), - "lpa": {"state": "failed", "note": "invented failure", "data": {}}, -}} - -WANT = {"cpsr": "act", "clinvar": "review", "carrier-genec": "carrier", "carrier-gened": "act", "str-fmr1": "act", - "pgx": "medicine", "contamination": "trust"} - - -def level_problems(res): - out = [] - found = res["findings"] - for prefix, lv in WANT.items(): - got = [f["level"] for f in found if f["id"].startswith(prefix)] - if got != [lv]: - out.append(f"{prefix}: {got}, want [{lv}]") - fmr1 = [f for f in found if f["id"] == "str-fmr1"] - if fmr1 and "full-mutation" not in fmr1[0]["title"]: - out.append(f"a full-mutation repeat titled {fmr1[0]['title']!r}") - if any(f["id"].startswith("pgx-cyp2c9") for f in found): - out.append("a gene with a normal phenotype became a finding") - for f in found: - if not live_results.FINDING_ID.match(f["id"]): - out.append(f"unsafe id {f['id']!r}") - if f["section"] != live_results.LEVEL_SECTION[f["level"]]: - out.append(f"{f['id']} in section {f['section']}") - cards = {c["id"]: c for ch in res["chapters"] for c in ch["sections"]} - for cid, lv in (("cpsr", "act"), ("cpic", "medicine"), ("carrier-list", "act"), ("clinvar", "review"), - ("qc", "trust"), ("lpa", None)): - if cards[cid].get("level") != lv: - out.append(f"card {cid}: {cards[cid].get('level')}, want {lv}") - return out - - -def lead_text(segs): - return "".join(x[0] for x in segs) - - -def lead_problems(res, screened=True): - out = [] - text = lead_text(res["lead"]) - acts = [f for f in res["findings"] if f["level"] == "act"] - trust = [f for f in res["findings"] if f["level"] == "trust"] - if acts: - n = len(acts) - said = re.search(r"\b(\w+) findings? should go to a doctor", text) - words = {"one": 1, "two": 2, "three": 3, "four": 4, "five": 5, "six": 6, "seven": 7, "eight": 8, "nine": 9} - if not said or words.get(said.group(1).lower(), int(said.group(1)) if said.group(1).isdigit() else None) != n: - out.append(f"no count of findings for a doctor: {text[:300]}") - out += [f"lead does not name {f['title']!r}" for f in acts if f["title"] not in text] - elif screened and ("needs a doctor" not in text or "sections 8 and 9" not in text): - out.append(f"no-finding lead: {text[:300]}") - elif not screened and ("needs a doctor" in text or "clinical screens have no result yet" not in text): - out.append(f"no clinical screen ran, yet the lead reads: {text[:300]}") - if trust and not text.startswith("Read the data-quality section first"): - out.append("a data-quality problem is not first") - if live_results.FORBIDDEN.search(text): - out.append(f"all-clear wording: {text[:300]}") - # A child's tile: the lead without the names of the findings to act on. - closed = "".join(x[0] if x[2:] != ["act"] else "" for x in res["lead"]) - out += [f"the closed lead still names {f['title']!r}" for f in acts if f["title"] in closed] - return out - - -def request(port, method, path, body=None, headers=None): - import http.client - c = http.client.HTTPConnection("127.0.0.1", port, timeout=30) - h = {"Host": f"127.0.0.1:{port}"} - h.update(headers or {}) - c.request(method, path, body=body, headers=h) - r = c.getresponse() - data = r.read() - hdr = {k.lower(): v for k, v in r.getheaders()} - c.close() - return r.status, hdr, data - - -def serve(root, state, pwfile): - app = owngenome_live.App() - with contextlib.redirect_stderr(io.StringIO()): - live, web, ingest = owngenome_live.start(["--root", root, "--state-dir", state, "--port", "0", "--ingest-port", "0", - "--password-file", pwfile, "--quiet"], app) - threading.Thread(target=web.serve_forever, daemon=True).start() - return live, web, ingest - - -def stop(srv): - live, web, ingest = srv - live.stopping = True - web.shutdown() - web.server_close() - ingest.server_close() - - -def route_problems(port, fid): - out = [] - path = f"/runs/{SAMPLE}/finding/{urllib.parse.quote(fid)}/" - code, h, _ = request(port, "GET", path) - if code != 303 or h.get("location") != "/login?next=" + urllib.parse.quote(path): - out.append(f"finding page without a session: {code} {h.get('location')}") - # The login form posts the next the redirect gave it: the browser lands back on the finding. - nxt = urllib.parse.parse_qs(urllib.parse.urlsplit(h.get("location") or "").query).get("next", ["/"])[0] - code, h, _ = request(port, "POST", "/login", urllib.parse.urlencode({"password": PASSWORD, "next": nxt}), - {"Content-Type": "application/x-www-form-urlencoded"}) - m = re.match(r"owngenome_live=([^;]+)", h.get("set-cookie", "")) - if not m: - return out + [f"login {code}"] - if code != 303 or h.get("location") != path: - out.append(f"the login with the finding as next goes to {code} {h.get('location')}, not back to {path}") - ck = {"Cookie": f"owngenome_live={m.group(1)}"} - code, h, body = request(port, "GET", path, headers=ck) - page = body.decode("utf-8", "replace") - if code != 200 or f'data-finding="{fid}"' not in page or f'data-run="{SAMPLE}"' not in page \ - or "{{" in page or "script-src 'self'" not in h.get("content-security-policy", ""): - out.append(f"the finding page: {code} {h.get('content-security-policy')} {page[:200]}") - for bad in ("not-a-finding-of-this-run", "..%2F..%2Fsummary.json", "UPPER"): - code, _, _ = request(port, "GET", f"/runs/{SAMPLE}/finding/{bad}/", headers=ck) - if code != 404: - out.append(f"finding {bad}: {code}, want 404") - code, _, _ = request(port, "GET", f"/runs/NO-SUCH-RUN/finding/{urllib.parse.quote(fid)}/", headers=ck) - if code != 404: - out.append(f"a run that does not exist: {code}") - return out - - -def bad_row_problems(): - """What one unreadable row of each kind takes from results.json beyond the row itself.""" - good = live_results.build("MADE-UP", copy.deepcopy(SUMMARY)) - s = copy.deepcopy(SUMMARY) - hit = s["sections"]["clinvar"]["data"]["hits"][0] - s["sections"]["clinvar"]["data"]["hits"].append(dict(hit, gene="GENEZ", pos=2000, stars="two")) - s["sections"]["cpsr"]["data"]["plp"].append("GENEY c.1del") - s["sections"]["carrier"]["data"]["carriers"].append(["GENEX"]) - try: - res = live_results.build("MADE-UP", s) - except Exception as e: # noqa: BLE001 -- the very thing under test - return [f"build raised {type(e).__name__}: {e}"] - out = [] - - def cards(r): - return [c["id"] for ch in r["chapters"] for c in ch["sections"]] - if cards(res) != cards(good): - out.append(f"cards {cards(res)} != {cards(good)}") - ids = {f["id"] for f in res["findings"]} - out += [f"lost {f['id']}" for f in good["findings"] if f["id"] not in ids] - new = [f for f in res["findings"] if f["id"] not in {g["id"] for g in good["findings"]}] - # A rule that can give a finding to act on gives its unreadable row that level, so a child's page veils - # the card (its table may still draw the row); the ClinVar rule never gives one. - want = {"carrier-list": "act", "clinvar": "review", "cpsr": "act"} - if sorted(f["card"] for f in new) != sorted(want) or any( - f["level"] != want[f["card"]] or f["gene"] or re.search(r"GENE[XYZ]", f["title"] + f["text"]) for f in new): - out.append(f"the unreadable rows: {[(f['card'], f['level'], f['gene'], f['title']) for f in new]}") - # An AnnotSV class-5 row whose gene list the rule cannot join: the card's table draws its first genes, - # so the card must hold a finding to act on, or a child's page shows the row unveiled. - s = copy.deepcopy(SUMMARY) - s["sections"]["annotsv"] = ok({"rows": [{"sv": "chr1:1000-9000", "type": "deletion", "length": -8000, - "acmg_class": "5", "genes": ["GENEX", "GENEY", "GENEZ", None], "gt": "0/1"}]}) - try: - sv_res = live_results.build("MADE-UP", s) - except Exception as e: # noqa: BLE001 -- the very thing under test - return out + [f"build with an unreadable AnnotSV row raised {type(e).__name__}: {e}"] - byid = {f["id"]: f for f in sv_res["findings"]} - sv = [c for ch in sv_res["chapters"] for c in ch["sections"] if c["id"] == "structural-variants"] - lv = [byid[i]["level"] for i in sv[0]["findings"]] if sv else None - if not lv or "act" not in lv: - out.append(f"the AnnotSV card with an unreadable class-5 row holds no finding to act on: {lv}") - cv = [c for ch in res["chapters"] for c in ch["sections"] if c["id"] == "clinvar"][0] - if not any("could not be drawn" in x for x in cv["lines"]): - out.append(f"the ClinVar card does not say it could not be drawn: {cv['lines'][:2]}") - return out - - -def main(): - work = tempfile.mkdtemp(prefix="test_live_journal.") - srvs = [] - try: - # 1. - res = live_results.build("MADE-UP", copy.deepcopy(SUMMARY)) - bad = level_problems(res) - check("1. each rule gives its level, each card its highest finding's level, each id is safe", not bad, bad) - rows = live_results.finding_rows - - def swapped(summary): - return [dict(f, level="review") if f["id"].startswith("pgx") else f for f in rows(summary)] - live_results.finding_rows = swapped - try: - control("the CPIC rule's level swapped to review", - not level_problems(live_results.build("MADE-UP", copy.deepcopy(SUMMARY)))) - finally: - live_results.finding_rows = rows - - # 2. - bad = lead_problems(res) - check("2. the lead counts and names the findings for a doctor, data quality first", not bad, bad) - calm = copy.deepcopy(SUMMARY) - for k in ("cpsr", "sample_qc", "carrier", "cpic", "expansions"): - calm["sections"].pop(k) - calm["sections"]["clinvar"] = ok({"hits": []}) - res2 = live_results.build("MADE-UP", calm) - bad = lead_problems(res2) - check("2. with nothing to act on the lead says none needs a doctor and points at sections 8 and 9", not bad, - (bad, lead_text(res2["lead"]))) - # Only the medicine and quality steps finished: a medicine finding, no clinical screen. The lead must - # not say nothing needs a doctor. - bare = {"sections": {k: copy.deepcopy(SUMMARY["sections"][k]) for k in ("cpic", "sample_qc", "coverage") - if k in SUMMARY["sections"]}} - res3 = live_results.build("MADE-UP", bare) - bad = lead_problems(res3, screened=False) - check("2. with no clinical screen run the lead says so, never that nothing needs a doctor", not bad, - (bad, lead_text(res3["lead"]))) - old_lead = [["No finding in what these steps assessed needs a doctor; ", True], - ["sections 8 and 9 say what they do not see.", False]] - control("a lead that calls a run with no clinical screen clear of doctor findings", - not lead_problems(dict(res3, lead=old_lead), screened=False)) - planted = dict(res, lead=live_results.lead([f for f in res["findings"] if f["level"] != "act"], res["levels"], - SUMMARY)) - control("the act findings left out of the lead", not lead_problems(planted)) - untagged = dict(res, lead=[x[:2] for x in res["lead"]]) - control("the names of the findings to act on not marked for a child's page", not lead_problems(untagged)) - - # 3. - root = os.path.join(work, "root") - os.makedirs(root) - subprocess.run([sys.executable, os.path.join(REPO, "tests", "demo", "make_demo_sample.py"), "--genome-dir", root, - "--records", "2000"], check=True, stdout=subprocess.DEVNULL) - d = os.path.join(root, SAMPLE) - summary = collect_summary.collect(SAMPLE, d) - with open(os.path.join(d, "summary.json"), "w") as f: - json.dump(summary, f) - found = live_results.build(SAMPLE, summary)["findings"] - check("3. the demo sample has a finding to open", bool(found), found) - pwfile = os.path.join(work, "password") - with open(pwfile, "w") as f: - f.write(owngenome_live.hash_password(PASSWORD) + "\n") - srv = serve(root, os.path.join(work, "state"), pwfile) - srvs.append(srv) - fid = found[0]["id"] if found else "none" - bad = route_problems(srv[1].server_address[1], fid) - check("3. /runs//finding// behind the login, the page for a finding of the run, 404 for any other", - not bad, bad) - real = live_results.FINDING_ID - build = live_results.build - live_results.FINDING_ID = re.compile(r".*") - live_results.build = lambda *a, **k: dict(build(*a, **k), findings=[{"id": x} for x in ( - fid, "not-a-finding-of-this-run", "../../summary.json", "UPPER")]) - try: - control("the route answering any id", not route_problems(srv[1].server_address[1], fid)) - finally: - live_results.FINDING_ID = real - live_results.build = build - # 4. the home page's overview of a running run: the summary its page last read, only while current. - live = srv[0] - run = live.runs()[SAMPLE] - real_state = live.base_state - - def running(r, *a, **k): - st = real_state(r, *a, **k) - return dict(st, run=dict(st["run"], state="running")) - live.base_state = running - try: - st = running(run) - done = tuple(x["step"] for x in st["steps"] if x["state"] == "done") - stamp = live.file_stamp(os.path.join(d, "summary.json")) - extra = copy.deepcopy(summary) - extra.setdefault("sections", {})["cpsr"] = SUMMARY["sections"]["cpsr"] - want = live_results.overview(summary)["levels"].get("act") - - def act_count(key): - live.headline_cache[SAMPLE] = (key, None, extra) - live.live_overview.pop(SAMPLE, None) - item = [x for x in live.runs_index()["runs"] if x["name"] == SAMPLE][0] - return (item.get("levels") or {}).get("act") - got = act_count((SAMPLE, done, None, (1, 1))) - check("4. the home page drops the page's summary once summary.json has changed since that read", - got == want, (got, want)) - control("a page summary read before summary.json changed is still used", - act_count((SAMPLE, done, None, stamp)) == want) - got = act_count((SAMPLE, done + ("99",), None, stamp)) - check("4. ...and once the steps done have changed", got == want, (got, want)) - o = live_results.overview(summary) - bare = {"sections": {k: SUMMARY["sections"][k] for k in ("cpic", "coverage")}} - check("4. runs.json says whether a clinical screen has a result, so the home page claims nothing without one", - live_results.overview(bare)["screened"] is False and o["screened"] is True - and "screened" in [x for x in live.runs_index()["runs"] if x["name"] == SAMPLE][0], - (live_results.overview(bare)["screened"], o["screened"])) - finally: - live.base_state = real_state - live.headline_cache.pop(SAMPLE, None) - # 5. one bad row costs one row - bad = bad_row_problems() - check("5. one unreadable row costs that row only: every card and every other finding stays", not bad, bad) - real_row = live_results._Row - - class Unguarded(real_row): # the planted mistake: the rules run without the row guard - def __exit__(self, *a): - return False - live_results._Row = Unguarded - try: - control("the rules without the row guard", not bad_row_problems()) - finally: - live_results._Row = real_row - - class AlwaysReview(real_row): # the planted mistake: every unreadable row worth a look only - def __init__(self, out, card_id, level="review"): - super().__init__(out, card_id, "review") - live_results._Row = AlwaysReview - try: - control("the row guard with its level hard-coded to review", not bad_row_problems()) - finally: - live_results._Row = real_row - finally: - for s in srvs: - stop(s) - shutil.rmtree(work, ignore_errors=True) - if FAILS: - print(f"\n{len(FAILS)} check(s) failed") - return 1 - print("\nAll checks passed") - return 0 - - -if __name__ == "__main__": - sys.exit(main()) diff --git a/tests/test_live_results.py b/tests/test_live_results.py deleted file mode 100644 index 736c71e1d..000000000 --- a/tests/test_live_results.py +++ /dev/null @@ -1,651 +0,0 @@ -#!/usr/bin/env python3 -"""A person's results and a family's page on the live site: bin/live_results.py, the results plugin -(bin/owngenome_live_results.py), /runs.json and the family plugin's family.json. - -Checks: - 1. render_report.SECTION_NOTES names a caveat for every section id of CHAPTERS, - and each name is a text constant of bin/render_report.py; - 2. results.json of DEMO-001 (og dev demo-sample, collect_summary): - the seven chapters with every section id once, and each card's caveat is - its SECTION_NOTES constants, word for word, never empty; - 3. the wording gate: no string of results.json, of family.json - (tests/fixtures/families_live family_a) or of the page assets - (assets/live: the text of the pages, the string literals of the scripts, - map.js among them) says a result is fine (live_results.FORBIDDEN), a quoted - tool term and a caveat aside; nor does any string of the genome map - documents `og map build` writes for DEMO-001 and DEMO-003 (Figure 1 shows - their sentences), a layer's state code aside (skipped without og or - cargo, except in CI); - 4. ClinVar: with hits the card lists them in a table; with none it has no - table and its empty text says ClinVar lists only part of what causes - disease (never an all-clear); - 5. through the real server: /runs//results.json is behind the login - (401 without a session), answers the cards with one, and writes one access - log row per request; summary.json stays 404; /runs.json lists the run with - its progress and attention count, behind the login too; - 6. APOE: the Traits card's hidden text, behind its warning, is each APOE row - as the report prints it (trait, rsID, genotype, reading), never a dict; - 7. the adapters carry what the report says of a section, on small made-up - sections: the ancient PCA plot (base64 in the summary) as an image, the - Slivar phase lines, every Exomiser variant of a gene, a not-assessed - secondary-findings list, a carrier list not made and an unparsed PharmCAT - report as sentences (never zero counts), an unsized "normal" locus as not - sized, AnnotSV's exon-edge check, a genotype rule and a deep intronic call; - 8. the veil's tags on DEMO-003 (og dev demo-sample --sample DEMO-003, with its - planted secondary finding and class 5 deletion): the ClinVar row and viewer - link of the planted hit, its genome-chart tick and its review-star bar carry - the secondary finding's id, the deletion's span carries its own, the search - index's items that name the gene carry one of them, and nothing else is - tagged; DEMO-001, with no result to act on, has no tag; and a known deep - intronic site's line in the gene of a closed secondary finding carries - that finding's id (the card prints each site whether hit or not), a gene - named before a full stop is that gene, and a ClinVar row closed by its gene - alone closes its "See the reads at" link with it; every other card's row - that names the gene (the son's symptom ranking ranks it) carries one of - the ids and no other row does, the ranking's finding carries the secondary - finding's id, and so does a segment of the lead that names the gene; the - home page's view of the run (overview) lists no such finding among its - first ones and its closed lead names none; a CHIP call, a copy-number dot - and a fact that name a closed result's gene carry its id (the CHIP chart's - panel of genes never does), and results.json carries the closed results as - veil.spans (the family page closes a child's places while one is closed). -Each check runs again on a planted mistake and must fail there: 1 with VNTYPER's -entry dropped, 2 with one card's caveat blanked, 3 with "ok" planted in a card -and "All clear" in a script, 4 with the hits emptied, 5 with the results route -registered without the login, 6 with a row printed as its Python dict, 7 with the Slivar adapter returning nothing, -8 with a veil rule that tags nothing (rows, lines, facts and drawings) and one that tags every row. A check -that cannot fail is no check. - -Run: python3 tests/test_live_results.py -""" -import contextlib -import base64 -import copy -import io -import json -import os -import re -import shutil -import subprocess -import sys -import tempfile -import threading -import urllib.parse - -REPO = os.path.dirname(os.path.dirname(os.path.abspath(__file__))) -sys.path.insert(0, os.path.join(REPO, "bin")) -sys.path.insert(0, os.path.join(REPO, "tests")) -import collect_summary # noqa: E402 -import live_results # noqa: E402 -import owngenome_live # noqa: E402 -import owngenome_live_family # noqa: E402 -import render_report as rr # noqa: E402 - -SAMPLE = "DEMO-001" -ASSETS = os.path.join(REPO, "assets", "live") -FAMILIES = os.path.join(REPO, "tests", "fixtures", "families_live") -PASSWORD = "synthetic test password 7" -FAILS = [] - - -def check(desc, ok, detail=""): - print(("[PASS] " if ok else "[FAIL] ") + desc + ("" if ok else f" -- {str(detail)[:800]}")) - if not ok: - FAILS.append(desc) - - -def control(desc, still_passes): - check(f"control: {desc}", not still_passes, "the check passed on the planted mistake") - - -# --- 1. the caveat of every section --------------------------------------------------------- - -def notes_problems(chapters, notes, module): - ids = [sid for _, _, _, secs in chapters for sid, _, _ in secs] - out = [f"{sid}: no caveat" for sid in ids if not notes.get(sid)] - out += [f"{sid}: {n} is not a text constant" for sid, names in notes.items() for n in names - if not isinstance(getattr(module, n, None), str) or not getattr(module, n).strip()] - out += [f"{sid}: no such section" for sid in notes if sid not in ids] - return out - - -# --- 2. one card per section, its caveat word for word -------------------------------------- - -def card_problems(res): - out = [] - want = [sid for _, _, _, secs in rr.CHAPTERS for sid, _, _ in secs] - got = [c["id"] for ch in res["chapters"] for c in ch["sections"]] - if got != want: - out.append(f"sections {got} != {want}") - if [ch["key"] for ch in res["chapters"]] != [k for k, *_ in rr.CHAPTERS]: - out.append("chapters out of the report's order") - for ch in res["chapters"]: - for c in ch["sections"]: - exp = [getattr(rr, n) for n in rr.SECTION_NOTES.get(c["id"], ())] - if not c["caveat"] or c["caveat"] != exp: - out.append(f"{c['id']}: caveat {c['caveat']!r:.120}") - return out - - -# --- 3. the wording gate -------------------------------------------------------------------- - -def asset_text(path): - """What a page or script of assets/live puts on screen: the text of an HTML page, the string - literals of a script (its comments and code left out).""" - with open(path) as f: - t = f.read() - if path.endswith(".html"): - t = re.sub(r"<(script|style)\b.*?", " ", t, flags=re.S | re.I) - return [x.strip() for x in re.split(r"<[^>]*>", t) if x.strip()] - t = re.sub(r"/\*.*?\*/", " ", t, flags=re.S) - t = re.sub(r"(?m)^\s*//[^\n]*", " ", t) - return [m.group(2) for m in re.finditer(r"(['\"])((?:\\.|(?!\1).)*)\1", t)] - - -def asset_problems(texts): - out = [] - for name, items in texts.items(): - for s in items: - if live_results.FORBIDDEN.search(re.sub(r'"[^"]*"', "", s)): - out.append(f"{name}: {s[:120]}") - return out - - -def map_documents(root, people): - """[(run, document)] of `og map build` for each (run, results) of PEOPLE, as the map plugin builds them; - None without an og (tests/test_live_demo.py og_binary).""" - import gzip - from test_live_demo import og_binary - og = og_binary() - if not og: - return None - ref = os.path.join(root, "reference") - if not os.path.isdir(ref): - shutil.copytree(os.path.join(REPO, "tests", "fixtures", "map", "gencode-slice", "reference"), ref) - out = [] - for run, results in people: - body = {k: v for k, v in results.items() if not k.startswith("_")} - p = subprocess.run([og, "map", "build", "--root", root, "--run", run, "--assets", os.path.join(REPO, "assets"), - "--cache-dir", os.path.join(root, ".map-cache")], input=json.dumps({"results": body}).encode(), - capture_output=True, check=True) - out.append((run, json.loads(gzip.decompress(p.stdout)))) - return out - - -def map_wording(doc): - """The strings of a map document that read as an all-clear; a layer's state is a code, not words.""" - return live_results.wording_problems(doc, allow=("state",)) - - -# --- 4. ClinVar with and without hits ------------------------------------------------------- - -def clinvar_card(summary): - res = live_results.build(SAMPLE, summary) - return next(c for ch in res["chapters"] for c in ch["sections"] if c["id"] == "clinvar") - - -def clinvar_problems(with_hits, without): - out = [] - n = len(with_hits["table"]["rows"]) if with_hits.get("table") else 0 - if not n: - out.append("hits but no table") - if without.get("table"): - out.append("no hit but a table") - if "lists only part" not in (without.get("empty_text") or ""): - out.append(f"empty text {without.get('empty_text')!r}") - return out - - -# --- 6. APOE behind its warning ------------------------------------------------------------- - -APOE_ROW = {"rsid": "rs429358", "gene": "APOE", "trait": "APOE e4 marker", "genotype": "T/C", - "status": "called", "reading": "one copy of the e4 allele", "ancestry": "", "note": "", "pmids": "1"} - - -def apoe_problems(hidden): - out = [] - text = (hidden or {}).get("text") or "" - if "{" in text or "'rsid'" in text: - out.append(f"a dict in the text {text!r}") - wants = [APOE_ROW["trait"], APOE_ROW["rsid"], APOE_ROW["genotype"], APOE_ROW["reading"]] - for want in wants: - if want not in text: - out.append(f"{want!r} missing from {text!r}") - return out - - -# --- 7. the adapters on made-up sections ----------------------------------------------------- - -def adapter_sections(): - sv = {"type": "DEL", "sv": "chr1:100-5000", "gt": "0/1", "length": 4900, "acmg_class": 5, "genes": ["GENE1"], - "exon_edge": "yes", "exon_edge_detail": "GENE1 exon 2", "population_af": None, "population_source": "", - "common": False, "support": None} - return { - "ancient": {"state": "ok", "data": {"nearest": [], "sites_used": 1, "panel_sites": 2, - "plot_svg": base64.b64encode(b"").decode()}}, - "slivar": {"state": "ok", "data": {"prioritized": 2, "compound_het_variants": 2, "compound_het_genes": 1, - "compound_het_pairs": 1, "compound_het_phase": {"trans": 1}, - "compound_het_trans": [{"gene": "GENE2", "variants": "v1 v2", "reads": 3}]}}, - "exomiser": {"state": "ok", "data": {"genes": [{"rank": 1, "gene": "GENE3", "variants": [ - {"hgvs": "c.1A>G"}, {"hgvs": "c.2C>T"}]}]}}, - "clinical": {"state": "ok", "data": {"acmg_sf": {"unavailable": "no VEP output"}}}, - "carrier": {"state": "ok", "data": {"unavailable": "no ClinVar screen"}}, - "cpic": {"state": "ok", "data": {"parse_failed": True, "genes": [], "warnings": []}}, - "expansions": {"state": "ok", "data": {"stranger": True, "loci": [ - {"locus": "LOCUS1", "repeat_count": "20/30", "status": "normal", "sizing": "flanking_only"}]}}, - "annotsv": {"state": "ok", "data": {"count": 1, "rows": [sv]}}, - "traits": {"state": "ok", "data": {"rows": [], "rules": [ - {"trait": "Rule trait", "gene": "GENE4", "rsids": "rs1,rs2", "status": "called", "result": "AB", - "phase": "read_backed", "reading": "rule reading"}]}}, - "clinvar": {"state": "ok", "data": {"hits": [], "deep_intronic": [ - {"gene": "GENE5", "hgvs": "c.100+500A>G", "chrom": "chr1", "pos": 1, "ref": "A", "alt": "G", - "call": "het", "detail": "GQ 40"}]}}, - } - - -def adapter_problems(adapters): - S, out = adapter_sections(), [] - def run(name, sec=None): - try: - return adapters[name](S, {"sections": S}) or {} - except Exception as e: # a crash is a problem, not a test error - out.append(f"{name}: {type(e).__name__} {e}") - return {} - text = lambda got: json.dumps(got) # noqa: E731 - if not (run("ancient").get("image") or {}).get("src", "").endswith(S["ancient"]["data"]["plot_svg"]): - out.append("ancient: no plot image") - if "in trans on 3 reads" not in text(run("slivar")): - out.append("slivar: no phase lines") - if len((run("exomiser").get("table") or {}).get("rows") or []) != 2: - out.append("exomiser: not every variant") - got = run("clinical_filter") - if "not assessed" not in text(got) or "ClinVar P/LP in its genes" in text(got): - out.append(f"clinical: not-assessed not said {got}") - got = run("carrier") - if "not made" not in text(got) or got.get("facts"): - out.append(f"carrier: not-made not said {got}") - got = run("cpic") - if "could not be parsed" not in text(got) or got.get("facts"): - out.append(f"cpic: parse failure not said {got}") - rows = (run("expansions").get("table") or {}).get("rows") or [[]] - if "not sized" not in rows[0]: - out.append(f"expansions: unsized locus shown as {rows[0]}") - if "on exon edges" not in text(run("structural")): - out.append("structural: no exon-edge check") - if "Rule trait" not in text(run("traits")): - out.append("traits: no genotype rule") - if "GENE5" not in text(run("clinvar")): - out.append("clinvar: no deep intronic call") - return out - - -# --- 5. the server -------------------------------------------------------------------------- - -def request(port, method, path, body=None, headers=None): - import http.client - c = http.client.HTTPConnection("127.0.0.1", port, timeout=30) - h = {"Host": f"127.0.0.1:{port}"} - h.update(headers or {}) - c.request(method, path, body=body, headers=h) - r = c.getresponse() - data = r.read() - hdr = {k.lower(): v for k, v in r.getheaders()} - c.close() - return r.status, hdr, data - - -def serve(root, state, pwfile, open_results=False): - app = owngenome_live.App() - if open_results: # the planted mistake: the results route without the login - route = app.route - app.route = lambda m, p, fn, auth=True: route(m, p, fn, auth and "results" not in p) - with contextlib.redirect_stderr(io.StringIO()): - live, web, ingest = owngenome_live.start(["--root", root, "--state-dir", state, "--port", "0", "--ingest-port", "0", - "--password-file", pwfile, "--quiet"], app) - threading.Thread(target=web.serve_forever, daemon=True).start() - return live, web, ingest - - -def stop(srv): - live, web, ingest = srv - live.stopping = True - web.shutdown() - web.server_close() - ingest.server_close() - - -def server_problems(port, state): - out = [] - path = f"/runs/{SAMPLE}/results.json" - code, _, _ = request(port, "GET", path) - if code != 401: - out.append(f"results.json without a session: {code}") - code, _, _ = request(port, "GET", "/runs.json") - if code != 401: - out.append(f"runs.json without a session: {code}") - code, h, _ = request(port, "POST", "/login", urllib.parse.urlencode({"password": PASSWORD, "next": "/"}), - {"Content-Type": "application/x-www-form-urlencoded"}) - m = re.match(r"owngenome_live=([^;]+)", h.get("set-cookie", "")) - if not m: - return out + [f"login {code}"] - ck = {"Cookie": f"owngenome_live={m.group(1)}"} - log = os.path.join(state, "access.log") - before = open(log).read().count("\tresults\t") if os.path.isfile(log) else 0 - code, h, body = request(port, "GET", path, headers=ck) - res = json.loads(body) if code == 200 else {} - if code != 200 or len(res.get("chapters") or []) != 7 or res.get("sample") != SAMPLE: - out.append(f"results.json with a session: {code} {str(res)[:200]}") - after = open(log).read().count("\tresults\t") if os.path.isfile(log) else 0 - if after - before != 1: - out.append(f"{after - before} access log rows for one results.json") - code, _, _ = request(port, "GET", f"/runs/{SAMPLE}/summary.json", headers=ck) - if code != 404: - out.append(f"summary.json served: {code}") - code, _, body = request(port, "GET", "/runs.json", headers=ck) - idx = json.loads(body) if code == 200 else {} - run = next((r for r in idx.get("runs") or [] if r["name"] == SAMPLE), None) - if not run or run["url"] != f"/runs/{SAMPLE}/" or not run.get("results") or run.get("attention") != res.get("attention"): - out.append(f"runs.json: {code} {run}") - return out - - -# DEMO-003's planted results to act on, as og dev demo-sample writes them (PLANTED in -# rust/crates/og-dev/src/demo/clinical_clinvar.rs): the gene, the ClinVar hit and the class 5 deletion. -PLANTED_GENE = "KCNH2" -PLANTED_HIT = ("chr7", 150960000) -PLANTED_SV = ("chr7", 150955000, 150965000) - - -def demo_sample(root, *args): - """og dev demo-sample --genome-dir ROOT ARGS, with the og the tests use.""" - from og_binary import og_binary - subprocess.run([og_binary(), "dev", "demo-sample", "--genome-dir", root, "--repo", REPO, *args], check=True, - stdout=subprocess.DEVNULL) - - -def veil_problems(res, idx): - """What is wrong with the veil's tags of DEMO-003's results.json and search index.""" - gene, (c, p), (sv_c, a, b) = PLANTED_GENE, PLANTED_HIT, PLANTED_SV - act = [f["id"] for f in res["findings"] if f["level"] == "act"] - sf = next((i for i in act if i.startswith("sf-")), None) - sv = next((i for i in act if i.startswith("sv-")), None) - if not sf or not sv: - return [f"no planted secondary finding and deletion among the results to act on: {act}"] - v = res.get("veil") or {} - out = [] - card = next(x for ch in res["chapters"] for x in ch["sections"] if x["id"] == "clinvar") - rows = (v.get("rows") or {}).get("clinvar") or [] - want = [sf if r[0] == gene and r[1].startswith(f"{c}:{p} ") else None for r in card["table"]["rows"]] - if rows != want: - out.append(f"ClinVar rows tagged {rows}, want {want}") - view = (v.get("viewer") or {}).get("clinvar") or [] - if view != [sf if x == f"{c}:{p}" else None for x in card.get("viewer") or []]: - out.append(f"ClinVar viewer links tagged {view}") - marks = v.get("marks") or {} - specs = {sp["id"]: sp for sp in rr.chart_specs(res["_summary"])} - hit = [m["id"] for m in specs["genome"]["marks"] if m.get("kind") == "hit" and m["pos"] == p and m["chrom"] == c] - span = [m["id"] for m in specs["genome"]["marks"] if m.get("kind") == "sv" and (m["chrom"], m["pos"], m["end"]) == (sv_c, a, b)] - bar = [m["id"] for m in specs["clinvar-stars"]["marks"] if gene in (m.get("detail") or "")] - want = {"genome": {**{h: sf for h in hit}, **{s_: sv for s_ in span}}, "clinvar-stars": {x: sf for x in bar}} - if not hit or not span or not bar or marks != want: - out.append(f"chart marks tagged {marks}, want {want}") - # Every other card's rows: a row that names the gene carries one of the two ids, a row that does not carries - # none; the symptom ranking's row of the gene carries the secondary finding's, and so does its finding. - for cid, rows_ in ((x["id"], (x.get("table") or {}).get("rows") or []) for ch in res["chapters"] for x in ch["sections"]): - if cid == "clinvar" or not rows_: - continue - got = (v.get("rows") or {}).get(cid) or [None] * len(rows_) - bad = [(r, t) for r, t in zip(rows_, got) if (t in (sf, sv)) != (gene in " ".join(map(str, r)))] - if bad or len(got) != len(rows_): - out.append(f"{cid} rows tagged wrong: {bad or got}") - exo = (v.get("rows") or {}).get("exomiser") or [] - ranked = [f["id"] for f in res["findings"] if f["level"] != "act" and gene in f["title"]] - if sf not in exo or not ranked or v.get("findings") != {i: sf for i in ranked}: - out.append(f"the symptom ranking of {gene}: rows tagged {exo}, findings tagged {v.get('findings')}, want {ranked} -> {sf}") - tagged = {(t, it["section"]): it.get("veil") for t, items in idx["terms"].items() for it in items if it.get("veil")} - named = {(gene, it["section"]) for it in idx["terms"].get(gene) or []} - if set(tagged) != named or not named or any(x not in (sf, sv) for x in tagged.values()): - out.append(f"search items tagged {tagged}, want every item of {gene}: {sorted(named)}") - return out - - -def veil_lines_problems(): - """What is wrong with the veil's tags of the ClinVar card's lines: a known deep intronic site is printed - whether hit or not, so its line names the gene of a closed secondary finding in that gene.""" - S = {"clinvar": {"state": "ok", "data": {"hits": [], "deep_intronic": [ - {"gene": "GLA", "hgvs": "NM_000169.3:c.640-801G>A", "chrom": "chrX", "pos": 101399747, "ref": "C", - "alt": "T", "call": "hom", "detail": "GQ 40"}, - {"gene": "GENE5", "hgvs": "c.100+500A>G", "chrom": "chr1", "pos": 1, "ref": "A", "alt": "G", - "call": "het", "detail": "GQ 40"}]}}} - lines = live_results.a_clinvar(S, {"sections": S}).get("lines") or [] - found = [{"id": "sf-gla-test", "level": "act", "gene": "GLA", "detail": "GLA"}] - v = live_results.veil({"sections": S}, found, [{"sections": [{"id": "clinvar", "lines": lines}]}]) - want = ["sf-gla-test" if "GLA " in ln else None for ln in lines] - got = (v.get("lines") or {}).get("clinvar") - out = [] if "sf-gla-test" in want and None in want and got == want else [f"lines {lines} tagged {got}, want {want}"] - # A gene named at the end of a sentence ("in GLA.") is that gene. - if live_results.veil_id(live_results.closable(found), "A change in GLA.") != "sf-gla-test": - out.append("'A change in GLA.' carries no tag") - # A segment of the lead that names the gene, beside the act names the page closes itself. - lead = [[": Symptom ranking: GLA ranks 1. ", False], [": Secondary finding in GLA. ", False, "act"], ["Mean depth", False]] - got = live_results.veil({"sections": S}, found, [], lead).get("lead") - if got != ["sf-gla-test", None, None]: - out.append(f"the lead's segments tagged {got}, want the names that are not the act names") - # A finding known by its gene alone (no position): its ClinVar row is closed by the gene, and the row's - # "See the reads at" link, which shows only the position, with it. - S["clinvar"]["data"]["hits"] = [{"gene": "GLA", "chrom": "chrX", "pos": 101398000, "ref": "G", "alt": "A"}, - {"gene": "GENE5", "chrom": "chr1", "pos": 5, "ref": "A", "alt": "G"}] - card = dict(live_results.a_clinvar(S, {"sections": S}), id="clinvar") - gene_only = [{"id": "carrier-gla-test", "level": "act", "gene": "GLA"}] - v = live_results.veil({"sections": S}, gene_only, [{"sections": [card]}]) - rows, view = (v.get("rows") or {}).get("clinvar"), (v.get("viewer") or {}).get("clinvar") - if rows != ["carrier-gla-test", None] or view != rows: - out.append(f"a gene-only finding: ClinVar rows tagged {rows}, viewer links {view}, want both " - "['carrier-gla-test', None]") - return out - - -def widget_problems(): - """What is wrong with the veil's tags of a card's facts and drawing: a CHIP call and a copy-number dot, and a - fact, that name a closed result's gene carry its id; the CHIP chart's list of genes, the same panel for - everyone, is never tagged; nothing else is.""" - found = [{"id": "cpsr-tp53-test", "level": "act", "gene": "TP53", "detail": "TP53 c.524G>A"}, - {"id": "two-hits-smn1-test", "level": "act", "gene": "SMN1"}] - S = {"chip": {"state": "ok", "data": {"median_limit": 0.05, "median_depth": 72, "calls": [ - {"gene": "DNMT3A", "protein_change": "p.R882H", "vaf": 0.12, "alt_reads": 9, "depth": 75, "status": "pass", "note": "a clone"}, - {"gene": "TP53", "protein_change": "p.R175H", "vaf": 0.08, "alt_reads": 6, "depth": 75, "status": "pass", "note": "a clone"}], - "genes": [{"gene": "DNMT3A", "detection_limit_vaf": 0.05, "mean_depth": 75, "status": "ok"}, - {"gene": "TP53", "detection_limit_vaf": 0.06, "mean_depth": 70, "status": "ok"}]}}, - "paralogs": {"state": "ok", "data": {"genes": [ - {"gene": "SMN1", "copy_number": 1, "status": "called", "detail": "."}, - {"gene": "SMN2", "copy_number": 2, "status": "called", "detail": "."}]}}} - summ = {"sections": S} - chip = dict(live_results.a_chip(S, summ), id="chip") - par = dict(live_results.a_paralogs(S, summ), id="paralogs") - par["facts"] = [["SMN1 copies", "1"], ["Genes read", "2"]] - v = live_results.veil(summ, found, [{"sections": [chip, par]}]) - out = [] - want = {"chip": [None, "cpsr-tp53-test"], "paralogs": ["two-hits-smn1-test", None]} - if v.get("widget") != want: - out.append(f"drawings tagged {v.get('widget')}, want {want}") - if (v.get("facts") or {}) != {"paralogs": ["two-hits-smn1-test", None]}: - out.append(f"facts tagged {v.get('facts')}") - if v.get("spans") != [list(x) for x in live_results.closable(found)]: - out.append(f"spans {v.get('spans')}") - return out - - -def overview_problems(): - """What is wrong with the home page's view of a child's run (overview): a finding that names a closed result - (a symptom ranking of its gene) is listed among the first findings, or the closed lead still names it.""" - r = {"attention": 0, "levels": {}, "chapters": [], - "findings": [{"id": "sf-gla-test", "level": "act", "title": "Secondary finding in GLA"}, - {"id": "exomiser-gla", "level": "review", "title": "Symptom ranking: GLA ranks 1"}], - "lead": [["Of everything, ", False], [": Secondary finding in GLA. ", False, "act"], - ["One result is worth a look", True], [": Symptom ranking: GLA ranks 1.", False]], - "veil": {"findings": {"exomiser-gla": "sf-gla-test"}, "lead": [None, None, None, "sf-gla-test"]}} - keep = live_results.build - try: - live_results.build = lambda *a, **k: r - o = live_results.overview({}) - finally: - live_results.build = keep - out = [] - if [f["id"] for f in o["top"]] != ["sf-gla-test"]: - out.append(f"the home page's first findings: {o['top']}") - if "GLA" in o["lead_closed"] or "worth a look" not in o["lead_closed"]: - out.append(f"the closed lead: {o['lead_closed']}") - return out - - -def main(): - work = tempfile.mkdtemp(prefix="test_live_results.") - srvs = [] - try: - # 1. - bad = notes_problems(rr.CHAPTERS, rr.SECTION_NOTES, rr) - check(f"1. every section id has its caveat ({len(rr.SECTION_NOTES)} ids)", not bad, bad) - planted = {k: v for k, v in rr.SECTION_NOTES.items() if k != "vntyper"} - control("VNTYPER's caveat entry dropped", not notes_problems(rr.CHAPTERS, planted, rr)) - - # 2. - root = os.path.join(work, "root") - os.makedirs(root) - demo_sample(root, "--records", "2000") - d = os.path.join(root, SAMPLE) - summary = collect_summary.collect(SAMPLE, d) - with open(os.path.join(d, "summary.json"), "w") as f: - json.dump(summary, f) - res = live_results.build(SAMPLE, summary) - bad = card_problems(res) - check("2. results.json: the report's chapters, one card per section, each with its caveats word for word", - not bad, bad) - blank = copy.deepcopy(res) - blank["chapters"][3]["sections"][0]["caveat"] = [] - control("one card's caveat blanked", not card_problems(blank)) - - # 3. - bad = live_results.wording_problems(res) - check("3. no string of results.json reads as an all-clear", not bad, bad) - fam = owngenome_live_family.family_page("family_a", os.path.join(FAMILIES, "family_a")) - bad = live_results.wording_problems(fam) - check("3. no string of family.json reads as an all-clear", not bad and fam.get("layout"), bad) - planted = copy.deepcopy(res) - planted["chapters"][0]["sections"][0]["headline"] = "Coverage: ok" - control("'ok' planted in a card headline", not live_results.wording_problems(planted)) - texts = {} - for p, _, fs in os.walk(ASSETS): - for f in fs: - if f.endswith((".html", ".js")): - texts[os.path.relpath(os.path.join(p, f), ASSETS)] = asset_text(os.path.join(p, f)) - bad = asset_problems(texts) - check(f"3. no page or script text of assets/live reads as an all-clear ({len(texts)} files)", - not bad and len(texts) >= 10, bad) - planted = dict(texts, **{"person.js": texts["person.js"] + ["All clear: nothing to see"]}) - control("'All clear' planted in person.js", not asset_problems(planted)) - - # 4. - none = copy.deepcopy(summary) - cv = none["sections"]["clinvar"]["data"] - cv["hits"], cv["count"], cv["by_stars"] = [], 0, {} - with_hits, without = clinvar_card(summary), clinvar_card(none) - bad = clinvar_problems(with_hits, without) - check("4. ClinVar: a table with hits; without, the sentence that ClinVar lists only part", not bad, bad) - control("the demo's hits emptied on both sides", not clinvar_problems(without, without)) - - # 6. - S = {"traits": {"data": {"rows": [], "called": 0, "not_covered": 0, "apoe": [APOE_ROW]}}} - hidden = live_results.a_traits(S, SAMPLE).get("hidden") - bad = apoe_problems(hidden) - check("6. APOE: the hidden text reads each row as the report does, never a dict", not bad, bad) - control("the APOE row printed as its Python dict", not apoe_problems({"text": str(APOE_ROW)})) - - # 7. - names = {"ancient": "a_ancient", "slivar": "a_slivar", "exomiser": "a_exomiser", - "clinical_filter": "a_clinical_filter", "carrier": "a_carrier", "cpic": "a_cpic", - "expansions": "a_expansions", "structural": "a_structural", "traits": "a_traits", - "clinvar": "a_clinvar"} - adapters = {k: getattr(live_results, v) for k, v in names.items()} - bad = adapter_problems(adapters) - check("7. the adapters carry the report's plot, phase, variants, rules and not-assessed sentences", not bad, bad) - control("the Slivar adapter returning nothing", not adapter_problems(dict(adapters, slivar=lambda S, s: {}))) - - # 8. - import results_index - check("8. DEMO-001, with no result to act on, has no veil tag", res.get("veil") == {}, res.get("veil")) - demo_sample(root, "--records", "2000", "--sample", "DEMO-003", "--sex", "male", "--seed", "3") - d3 = os.path.join(root, "DEMO-003") - - def tagged(sample_dir): - s3 = collect_summary.collect("DEMO-003", sample_dir) - r3 = live_results.build("DEMO-003", s3) - r3["_summary"] = s3 - return r3, results_index.build(s3, sample_dir, rr.SECTION_OF) - bad = veil_lines_problems() - check("8. a known deep intronic site's line in a closed secondary finding's gene carries its id, a gene " - "before a full stop is that gene, a ClinVar row closed by its gene closes its reads link, and a lead " - "segment naming the gene carries its id", not bad, bad) - bad = overview_problems() - check("8. a child's home tile lists no finding that names a closed result, and its closed lead names none", - not bad, bad) - bad = widget_problems() - check("8. a CHIP call, a copy-number dot and a fact that name a closed result's gene carry its id, the CHIP " - "chart's gene panel none, and results.json carries the closed results as veil.spans", not bad, bad) - bad = veil_problems(*tagged(d3)) - check("8. the planted ClinVar hit's row, viewer link, tick and star bar carry its secondary finding's id, the " - "deletion's span its own, every other card's row of the gene and the symptom ranking's finding one of them, " - "and every search item of the gene one of them", not bad, bad) - # The planted mistakes: a rule that tags nothing, and one that tags every row with the first result. - keep = live_results.veil_id - try: - live_results.veil_id = lambda spans, *a, **k: None - control("a veil rule that tags nothing", not veil_problems(*tagged(d3))) - control("a veil rule that tags no line", not veil_lines_problems()) - control("a veil rule that tags no fact or drawing", not widget_problems()) - live_results.veil_id = lambda spans, *a, **k: spans[0][0] if spans else None - control("a veil rule that tags every row", not veil_problems(*tagged(d3))) - finally: - live_results.veil_id = keep - - # 3, the map documents: og map build of DEMO-001 and DEMO-003, with the results each page gets. - map_docs = map_documents(root, [(SAMPLE, res), ("DEMO-003", tagged(d3)[0])]) - if map_docs is None: - ci = os.environ.get("CI") == "true" - print(("[FAIL] " if ci else "[SKIP] ") + "3. no og (and no cargo to build one) for the map documents") - if ci: - FAILS.append("no og in CI") - else: - bad = [(run, x) for run, doc in map_docs for x in map_wording(doc)] - check(f"3. no string of the genome map documents reads as an all-clear ({len(map_docs)} documents)", - not bad and len(map_docs) == 2, bad) - planted = copy.deepcopy(map_docs[0][1]) - planted["text"]["genome"] = [{"t": "All clear on the map.", "b": False}] - control("'All clear' planted in a map document's sentence", not map_wording(planted)) - - # 5. - pwfile = os.path.join(work, "password") - with open(pwfile, "w") as f: - f.write(owngenome_live.hash_password(PASSWORD) + "\n") - state = os.path.join(work, "state") - srv = serve(root, state, pwfile) - srvs.append(srv) - bad = server_problems(srv[1].server_address[1], state) - check("5. results.json and runs.json behind the login, one log row, summary.json 404", not bad, bad) - state2 = os.path.join(work, "state-open") - srv = serve(root, state2, pwfile, open_results=True) - srvs.append(srv) - control("the results route registered without the login", - not server_problems(srv[1].server_address[1], state2)) - finally: - for s in srvs: - stop(s) - shutil.rmtree(work, ignore_errors=True) - if FAILS: - print(f"\n{len(FAILS)} check(s) failed") - return 1 - print("\nAll checks passed") - return 0 - - -if __name__ == "__main__": - sys.exit(main()) diff --git a/tests/test_live_widgets.py b/tests/test_live_widgets.py deleted file mode 100644 index 7a90afdc6..000000000 --- a/tests/test_live_widgets.py +++ /dev/null @@ -1,193 +0,0 @@ -#!/usr/bin/env python3 -"""The widgets of a person's page: what bin/live_results.py hands the page to draw (results.json). - -Each widget is checked on small made-up sections, against the numbers of the section it draws: - 1. repeat expansions (str): one entry per locus with its count, Stranger's thresholds and its - 95% interval; an allele not sized from short reads never carries Stranger's "normal"; - 2. Lp(a) (ci): the KIV-2 count and its 95% interval, on a scale from 0 that holds the whole - interval; no bar for a count that was not estimated; - 3. CHIP (vaf): each gene's detection limit and each call's VAF as numbers, each call with its own - gene's limit; a call with no VAF is left off the track, not put at 0; - 4. copy numbers (copies): SMN1, SMN2, HBA1, HBA2 and the RCCX module of CYP21A2, never another - gene of the paralog table; a copy number that is not a whole number is no dots; Parascopy's - SMN1 and SMN2 at exon 7 (short reads) after them, one not resolved with no dots and its reason; - 5. the Y haplogroup path (ypath): one entry per level of step 37's path, root first, with its - marker counts as numbers; - 6. every widget's strings pass the wording gate (live_results.FORBIDDEN); - 7. assets/live/person.js draws each kind the adapters give (a drawer per kind). -Each check runs again on a planted mistake and must fail there: the adapter's widget dropped -(1 to 5), "ok" planted in a widget (6), a drawer removed from person.js (7). A check that -cannot fail is no check. - -Run: python3 tests/test_live_widgets.py -""" -import copy -import os -import re -import sys - -REPO = os.path.dirname(os.path.dirname(os.path.abspath(__file__))) -sys.path.insert(0, os.path.join(REPO, "bin")) -import live_results # noqa: E402 - -FAILS = [] - - -def check(desc, ok, detail=""): - print(("[PASS] " if ok else "[FAIL] ") + desc + ("" if ok else f" -- {str(detail)[:800]}")) - if not ok: - FAILS.append(desc) - - -def control(desc, still_passes): - check(f"control: {desc}", not still_passes, "the check passed on the planted mistake") - - -def sections(): - return { - "expansions": {"state": "ok", "data": {"stranger": True, "records": 2, "loci": [ - {"locus": "HTT", # invented counts; the locus on its own line keeps the personal-data scan quiet - "repeat_count": "17/42", "status": "normal,full_mutation", "normal_max": "26", "pathologic_min": "40", "ci": "17-17/40-45", "sizing": "sized", "allele_sizing": "sized/sized"}, - {"locus": "FMR1", "repeat_count": "30", "status": "normal", "normal_max": "44", "pathologic_min": "200", - "ci": "28-90", "sizing": "flanking_only", "allele_sizing": "flanking_only"}]}}, - "lpa": {"state": "ok", "data": {"status": "estimated", "kiv2_copies": "36.9", "ci95_low": "36.2", - "ci95_high": "37.6", "class": "typical", "flag": "."}}, - "chip": {"state": "ok", "data": {"median_limit": 0.133, "median_depth": 31.0, "calls": [ - {"gene": "DNMT3A", "protein_change": "p.R882H", "vaf": "0.081", "alt_reads": "4", "depth": "49", - "status": "PASS", "note": "invented"}, - {"gene": "TET2", "protein_change": "p.Q1034*", "vaf": ".", "alt_reads": "3", "depth": "40", "status": "PASS", "note": "invented"}], - "genes": [{"gene": "DNMT3A", "mean_depth": "31.3", "detection_limit_vaf": "0.133", "status": "covered"}, - {"gene": "TET2", "mean_depth": "29.0", "detection_limit_vaf": "0.142", "status": "covered"}]}}, - "paralogs": {"state": "ok", "data": {"genes": [ - {"gene": "SMN1", "copy_number": "2", "status": "called", "detail": "."}, - {"gene": "SMN2", "copy_number": "1", "status": "called", "detail": "."}, - {"gene": "SMN exon 7-8 deletion", "copy_number": "0", "status": "called", "detail": "."}, - {"gene": "HBA1", "copy_number": "2.4", "status": "no_call", "detail": "."}, - {"gene": "CYP21A2 (RCCX)", "copy_number": "4", "status": "called", "detail": "."}, - {"gene": "GBA1", "copy_number": "2", "status": "called", "detail": "."}]}}, - "parascopy": {"state": "ok", "data": {"rows": 1, "reading": "invented", - "smn1": {"cn": 1, "text": "1 (quality 40, filter PASS)"}, - "smn2": {"cn": None, "text": "3 (quality 8, filter LowQual), not resolved"}}}, - "y_tree": {"state": "ok", "data": {"haplogroup": "I-M253", "tree": "YFull YTree v14.06.0", "path": [ - {"Level": "1", "Branch": "CT", "Derived": "11", "Ancestral": "0", "No_call": "1"}, - {"Level": "2", "Branch": "F", "Derived": "9", "Ancestral": "1", "No_call": "0"}, - {"Level": "3", "Branch": "I-M253", "Derived": "7", "Ancestral": "0", "No_call": "1"}]}}, - } - - -def run(adapters, name): - S = sections() - try: - return (adapters[name](S, {"sections": S, "sample": "S"}) or {}).get("widget") - except Exception as e: # a crash is a problem, not a test error - return {"error": f"{type(e).__name__}: {e}"} - - -def str_problems(w): - if not w or w.get("kind") != "str": - return [f"no str widget: {w}"] - out = [] - by = {l["locus"]: l for l in w["loci"]} - h = by.get("HTT") or {} - if (h.get("repeat_count"), h.get("normal_max"), h.get("pathologic_min"), h.get("ci")) != ("17/42", "26", "40", "17-17/40-45"): - out.append(f"HTT {h}") - if (by.get("FMR1") or {}).get("status") == "normal": - out.append("an unsized FMR1 allele carries Stranger's normal") - return out - - -def ci_problems(w): - if not w or w.get("kind") != "ci": - return [f"no ci widget: {w}"] - out = [] - if (w["value"], w["low"], w["high"]) != (36.9, 36.2, 37.6): - out.append(f"numbers {w}") - if not w["max"] >= w["high"] or not w["low"] <= w["value"] <= w["high"]: - out.append(f"scale {w}") - return out - - -def vaf_problems(w): - if not w or w.get("kind") != "vaf": - return [f"no vaf widget: {w}"] - out = [] - if [(g["gene"], g["limit"]) for g in w["genes"]] != [("DNMT3A", 0.133), ("TET2", 0.142)]: - out.append(f"limits {w['genes']}") - if [(c["gene"], c["vaf"], c.get("limit")) for c in w["calls"]] != [("DNMT3A", 0.081, 0.133)]: - out.append(f"calls {w['calls']}") - return out - - -def copies_problems(w): - if not w or w.get("kind") != "copies": - return [f"no copies widget: {w}"] - got = [(g["gene"], g["copies"], g["status"]) for g in w["genes"]] - want = [("SMN1", 2, "called"), ("SMN2", 1, "called"), ("HBA1", None, "no_call"), ("CYP21A2 (RCCX)", 4, "called"), - ("SMN1 (Parascopy)", 1, "called"), ("SMN2 (Parascopy)", None, "3 (quality 8, filter LowQual), not resolved")] - return [] if got == want else [f"{got} != {want}"] - - -def ypath_problems(w): - if not w or w.get("kind") != "ypath": - return [f"no ypath widget: {w}"] - got = [(p["branch"], p["derived"], p["ancestral"], p["no_call"]) for p in w["path"]] - want = [("CT", 11, 0, 1), ("F", 9, 1, 0), ("I-M253", 7, 0, 1)] - return [] if got == want and w["tip"] == "I-M253" else [f"{got} {w.get('tip')}"] - - -CASES = [("1. repeat expansions: the gauge's loci, thresholds and intervals", "expansions", str_problems), - ("2. Lp(a): the count and its 95% interval on a scale that holds it", "lpa", ci_problems), - ("3. CHIP: the detection limits and the calls with a VAF", "chip", vaf_problems), - ("4. copy numbers: the five copy-number genes only, whole numbers as dots, Parascopy's SMN1 and SMN2 after them", - "paralogs", copies_problems), - ("5. the Y path: every level, root first, with its counts", "y-chromosome", ypath_problems)] - - -def without_widget(fn): - def planted(S, s): - got = dict(fn(S, s) or {}) - got.pop("widget", None) - return got - return planted - - -def drawers(): - with open(os.path.join(REPO, "assets", "live", "person.js")) as f: - src = f.read() - m = re.search(r"var WIDGETS = \{([^}]*)\}", src) - return src, set(re.findall(r"(\w+):", m.group(1))) if m else set() - - -def main(): - A = live_results.ADAPTERS - for desc, sid, problems in CASES: - bad = problems(run(A, sid)) - check(desc, not bad, bad) - control(f"{sid} adapter without its widget", not problems(run(dict(A, **{sid: without_widget(A[sid])}), sid))) - lpa = sections()["lpa"] - lpa["data"]["status"] = "too little depth" - check("2. Lp(a): no bar for a count that was not estimated", - not (A["lpa"]({"lpa": lpa}, {"sections": {"lpa": lpa}}) or {}).get("widget")) - - widgets = {sid: run(A, sid) for _, sid, _ in CASES} - bad = live_results.wording_problems(widgets) - check("6. no widget string reads as an all-clear", not bad, bad) - planted = copy.deepcopy(widgets) - planted["lpa"]["class"] = "ok" - control("a widget saying ok", not live_results.wording_problems(planted)) - - src, kinds = drawers() - need = {w["kind"] for w in widgets.values()} - check("7. person.js has a drawer for every widget kind", need <= kinds and all(f"function {fn}" in src for fn in - ("strGauge", "ciBar", "vafChart", "copyDots", "yPath")), (need, kinds)) - control("a drawer removed from person.js", need <= (kinds - {"ypath"})) - - if FAILS: - print(f"\n{len(FAILS)} check(s) failed") - return 1 - print("\nAll checks passed") - return 0 - - -if __name__ == "__main__": - sys.exit(main()) diff --git a/tests/test_owngenome_live_family.py b/tests/test_owngenome_live_family.py index 3c8522fe8..89c0db85c 100755 --- a/tests/test_owngenome_live_family.py +++ b/tests/test_owngenome_live_family.py @@ -394,13 +394,13 @@ def get(path): def finding_route_checks(live, get, root): """A child with a result to act on: every well-formed finding id answers the same page, so a guessed address cannot tell whether the child has that result. An adult keeps the plain 404 for an id that is not a finding.""" - import live_results + from owngenome_live_results import og_results status = os.path.join(root, "loner", "logs", "run_status.tsv") with open(status, "w") as f: f.write("meta\tstarted_epoch\t1767347940\nstep\t06\tplanned\n") real = live.summary live.summary = lambda name, d, st: ACT_SUMMARY if name in ("child_a", "loner") else real(name, d, st) - act = next(f["id"] for f in live_results.build("child_a", ACT_SUMMARY)["findings"] if f["level"] == "act") + act = next(f["id"] for f in og_results(ACT_SUMMARY, "--sample", "child_a")["findings"] if f["level"] == "act") def answers(run): # The page names the id it was asked for (data-finding), as the address does: the rest is the same. @@ -412,17 +412,16 @@ def answers(run): [c[0] for c in child] == [200] * 3 and len({c[1] for c in child}) == 1, [c[0] for c in child]) check("an adult's finding route: the page for its finding, 404 for any other id", [c[0] for c in adult] == [200, 404, 404], [c[0] for c in adult]) - # The server loads its plugins itself: patch every loaded copy of the module. - mods = [m for m in list(sys.modules.values()) if getattr(m, "child_run", None) is not None and hasattr(m, "register")] - keep = [m.child_run for m in mods] - for m in mods: - m.child_run = lambda *a: False + # Patch the registered handler's plugin instance. + plugin = next(fn.__globals__ for method, route, fn, _ in live.app.routes + if method == "GET" and route.fullmatch(f"/runs/child_a/finding/{act}/")) + keep = plugin["child_run"] + plugin["child_run"] = lambda *a: False try: control("a server that tells a child's guessed finding id apart", - bool(mods) and [c[0] for c in answers("child_a")] == [200] * 3) + [c[0] for c in answers("child_a")] == [200] * 3) finally: - for m, k in zip(mods, keep): - m.child_run = k + plugin["child_run"] = keep finally: live.summary = real os.remove(status) @@ -482,7 +481,7 @@ def plp(gene, variant): def gate_server_checks(live, get, root, port, work): """The report gate's server side and its live-mode requests (docstring, check 9).""" import owngenome_live - import live_results + from owngenome_live_results import og_results sys.path.insert(0, os.path.join(REPO, "tests")) fams = [{"name": "b", "members": [{"sample": "x", "father": None, "mother": None}]}, {"name": "a", "members": [{"sample": "x", "father": "p", "mother": None}]}, @@ -537,7 +536,7 @@ def index(): live.summary = real run("child_a") # The same two results to act on in one card or in two: the flagged-card count differs (0 and 1). - counts = [live_results.overview(x)["attention"] for x in (TWO_IN_ONE_CARD, TWO_CARDS)] + counts = [og_results(x, "--overview")["attention"] for x in (TWO_IN_ONE_CARD, TWO_CARDS)] assert counts[0] != counts[1], counts seen = [] for summary in (TWO_IN_ONE_CARD, TWO_CARDS): @@ -547,13 +546,13 @@ def index(): seen[0] == seen[1] and seen[0] and seen[0]["attention"] is None, seen) run("father_a", NO_ACT) n = family()["runs"]["father_a"]["attention"] - check("family.json: a child with no result to act on keeps its count", n == live_results.overview(NO_ACT)["attention"], n) + check("family.json: a child with no result to act on keeps its count", n == og_results(NO_ACT, "--overview")["attention"], n) flags = {k: v.get("child") for k, v in family()["runs"].items()} check("family.json: each member run says whether its pages treat it as a child, by the one rule", flags.get("father_a") is True and flags.get("gf_a") is False, flags) # A no-act child while summary.json is older than a finished step: the home page keeps the numbers it had # without the gate (summary.json's), as long as neither summary has a result to act on. - stale, now = live_results.overview(STALE_SUMMARY), live_results.overview(NO_ACT) + stale, now = og_results(STALE_SUMMARY, "--overview"), og_results(NO_ACT, "--overview") assert (stale["levels"], stale["top"], stale["lead"]) != (now["levels"], now["top"], now["lead"]) run("father_a", STALE_SUMMARY) live.summary = lambda name, d, st: NO_ACT if name == "father_a" else real(name, d, st) @@ -922,13 +921,13 @@ def family_gate_checks(b, base, live, run): its summary.json cannot be read. A person who is a child in one family and a partner in another is closed on both family pages, keeps the partner role there (no child counted, the couple line kept), and stays a child when the family where it is a partner sorts first (a child in any family is one).""" - import live_results + from owngenome_live_results import og_results # summary.json is older than the results the page reads: its count is the one family.json gives without the gate. saved = {"sections": dict(TWO_CARDS["sections"], **STALE_SUMMARY["sections"])} run("father_a", saved) prev = live.summary live.summary = lambda name, d, st: TWO_CARDS if name == "father_a" else prev(name, d, st) - n, now = live_results.overview(saved)["attention"], live_results.overview(TWO_CARDS)["attention"] + n, now = og_results(saved, "--overview")["attention"], og_results(TWO_CARDS, "--overview")["attention"] assert n and n != now, (n, now) gf = os.path.join(live.root, "gf_a", "summary.json") with open(gf, "w") as f: From 93034590055eacf527dc11a4b3d49ee90be8d9c4 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 02:04:50 +0100 Subject: [PATCH 38/38] test(live): run the access log check with the workspace og Bead: D1 --- rust/crates/og-live/tests/finding_log.rs | 18 +++++++++++++++++- 1 file changed, 17 insertions(+), 1 deletion(-) diff --git a/rust/crates/og-live/tests/finding_log.rs b/rust/crates/og-live/tests/finding_log.rs index e1cd32c50..650ecabbb 100644 --- a/rust/crates/og-live/tests/finding_log.rs +++ b/rust/crates/og-live/tests/finding_log.rs @@ -142,6 +142,17 @@ fn open_finding(plugin_dir: Option<&Path>) -> Result<(String, String), String> { .env_remove("OWNGENOME_LIVE_PASSWORD_HASH") .stdout(Stdio::null()) .stderr(std::fs::File::create(&err_log).unwrap()); + let og = std::env::var_os("OG") + .filter(|path| !path.is_empty()) + .map(PathBuf::from) + .or_else(|| { + let test = std::env::current_exe().ok()?; + let binary = test.parent()?.parent()?.join("og"); + binary.is_file().then_some(binary) + }); + if let Some(og) = og { + cmd.env("OG", og); + } if let Some(d) = plugin_dir { cmd.arg("--plugin-dir").arg(d); } @@ -169,7 +180,12 @@ fn open_finding(plugin_dir: Option<&Path>) -> Result<(String, String), String> { Some(Value::Str(id)) => id.clone(), other => return Err(format!("the first finding has no id: {other:?}")), }, - other => return Err(format!("results.json has no findings: {other:?}")), + other => { + return Err(format!( + "results.json has no findings ({other:?}). {}", + why() + )); + } }; match get(port, &format!("/runs/{RUN}/finding/{fid}/")) { Some((200, _)) => {}

    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Structural variants (Manta): STALE: why: <b>&'"
    +
    Structural variants (Delly): STALE: why: <b>&'"
    +
    SV consensus merge: STALE: why: <b>&'"
    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    STALE: why: <b>&'"
    +
    StatusStale
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md).

    +
    chrY or chrXmaybe <b>
    +
    Why
    +

    From depth: estimated share of the cells that lost one X 5.0% (95% range ? to ?); to autosome depth ratio ?, None expected

    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md).

    +
    chrYnot estimated
    +
    Whytoo few reads on chrY
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md).

    +
    STALE: from an older run <b>
    +
    chrYan extra copy, not a loss
    +
    Whydepth above 1
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: step 33 failed
    +
    StatusFailed
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md).

    +
    chrYdetected
    +
    Whydepth below the floor
    +

    From depth: estimated share of the cells that lost the Y 28.8% (95% range 25.0% to 33.0%); chrY to autosome depth ratio 0.712, None expected

    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md).

    +
    chrXdetected
    +
    Whyallele fraction <off> & depth
    +

    From chrX allele fractions at 40 heterozygous sites: 12.5% (95% range 10.0% to ?)

    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +
    STALE: older export
    +

    Sites with a genotype: 590000 of 0; '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +
    STALE: why: <b>&'"
    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    STALE: why: <b>&'"
    +
    StatusStale
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    STALE: why: <b>&'"
    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    STALE: why: <b>&'"
    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +
    STALE: why: <b>&'"
    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    STALE: why: <b>&'"
    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +
    STALE: why: <b>&'"
    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +
    STALE: why: <b>&'"
    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    ProstatePGS215/6not applicable to the declared sex (male-specific score)
    BreastPGS327/940 (AFR)no published OR or HR for AFR
    HeightPGS431/260 (AFR)no published OR or HR for AFR; evaluated in EUR, AFR
    +

    Percentile: where the score falls among the AFR samples of the reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. Rows on chrX were left out, because the sample's sex was not given: PGS3 (3). Give the sex to score them (docs/25-prs.md). No sex was declared, so these sex-specific scores are shown for any sex: PGS3 (female). Give the sex to mark a score of the other sex not applicable (docs/25-prs.md).

    +
    Polygenic risk score percentiles0255075100Prostate (PGS2): no percentile: not applicable to the declared sex (male-specific score)Prostate (PGS2)no percentileBreast (PGS3): 40 (AFR)Breast (PGS3)40Height (PGS4): 60 (AFR)Height (PGS4)60
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores (raw, not percentiles)

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentile
    CADPGS0000180.5100/120raw score only
    T2DPGS0000140.110/20raw score only
    +

    Raw score only: no ancestry reference panel was installed, so there is no percentile and the sum cannot be compared with anyone (scripts/setup.sh --ancestry-panel adds it). Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +
    +
    +

    Y-STR Markers (HipSTR)

    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Not run · file date 2021-03-04 05:06 UTC · link to this section

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    Wide0%0% to 6%
    +

    Left out of the model: Oceania (continental and regional group), Papua (regional group), Odd (name) (x group), Plain. The panel has fewer than 12 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomeAfrica 30%, West Eurasia 70%
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%Wide: Regional groups: 0% (bootstrap range 0% to 6%)Wide0%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +
    Painted genomenone (no chromosome long enough)
    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · file date 2021-03-04 05:06 UTC · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnanx
    +
    Inferred sex (indexcov)female
    +
    Declared sexfemale
    +
    Sex from the reads (somalier)male
    +
    Contamination (FREEMIX)0.0010 (warning above )
    +
    +
    +
    +
    +

    Genes This Genome Could Not Read Reliably

    +

    Step 16b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A gene listed as not read could not be read reliably: too few of its reads were placed on it with confidence, so a 'no finding' in it says nothing. A gene with a caller of its own is left to that caller's section.

    +
    Genes read217 of 1572
    +
    Not read, no other caller1301
    +

    217 of the 1572 hard-to-read genes of assets/callability_genes.tsv were read: 90% or more of their bases had 10 or more reads of mapping quality 20 or more.

    +

    Not read, and no other step calls them (1301): OR4F5 (17%), OR4F29 (33%), OR4F16 (50%), AGRN (67%), ATAD3B (0%), MMP23B (0%), CDK11B (17%), SLC35E2B (33%), CDK11A (50%), TTC34 (67%), RPL22 (83%), MASP2 (0%), NPPA (17%), KIAA2013 (33%), PRAMEF1 (50%), PRAMEF11 (67%), HNRNPCL1 (83%), PRAMEF4 (0%), PRAMEF10 (17%), PRAMEF7 (33%), PRAMEF6 (50%), PRAMEF27 (67%), HNRNPCL3 (83%), HNRNPCL2 (0%), PRAMEF26 (17%), HNRNPCL4 (33%), PRAMEF9 (50%), PRAMEF13 (67%), PRAMEF18 (83%), PRAMEF8 (0%), PRAMEF33 (17%), PRAMEF15 (33%), PRAMEF14 (50%), PRAMEF19 (67%), PRAMEF17 (83%), CELA2B (0%), CLCNKA (17%), CLCNKB (33%), NBPF1 (50%), CROCC (67%), AKR7L (83%), NBPF3 (0%), CELA3B (17%), CELA3A (33%), HMGCL (50%), CNR2 (67%), RSRP1 (83%), PIGV (17%), XKR8 (33%), BMP8A (50%), BMP8B (67%), OXCT2 (83%), CYP4Z1 (0%), CYP4A22 (17%), GBP1 (33%), SETSIP (50%), AGL (67%), EXTL2 (83%), AMY2A (0%), NBPF4 (67%), NBPF6 (83%), LRIG2 (17%), VANGL1 (33%), IGSF3 (50%), SEC22B (83%), NBPF26 (0%), NOTCH2NLR (17%), PPIAL4A (33%), FAM72B (50%), SRGAP2C (67%), H3-7 (83%), PPIAL4E (0%), NBPF15 (17%), PPIAL4F (33%), SRGAP2B (50%), FAM72D (67%), PPIAL4D (83%), GPR89A (0%), RBM8A (17%), NBPF10 (33%), NOTCH2NLA (50%), PPIAL4H (67%), NBPF12 (83%), NBPF11 (0%), PPIAL4G (17%), NBPF14 (33%), NOTCH2NLB (50%), NUDT4B (67%), PDE4DIP (83%), NOTCH2NLC (0%), NBPF19 (17%), PPIAL4C (33%), H2BC18 (67%), H3C13 (83%), H3C14 (0%), H2AC18 (17%), H2AC19 (33%), H3C15 (50%), H4C15 (67%), HRNR (83%), LCE3E (0%), LCE3D (17%), S100A8 (33%), S100A7A (50%), S100A7 (67%), FLAD1 (83%), MTX1 (0%), HCN3 (33%), FCRL5 (50%), HSPA6 (83%), FCGR2B (33%), HSD17B7 (50%), CD247 (67%), XCL2 (83%), PRG4 (0%), PTPRC (50%), PPP1R12B (67%), KISS1 (83%), SRGAP2 (0%), CR1 (17%), CR1L (33%), ZC3H11B (50%), LBR (67%), LEFTY2 (83%), OR2T33 (0%), OR2T7 (17%), OR2T2 (33%), OR2T3 (50%), OR2T5 (67%), OR2G6 (83%), OR2T34 (0%), OR2T11 (17%), OR2T35 (33%), OR2T27 (50%), SNTG2 (67%), TPO (83%), KLF11 (0%), CCDC121 (17%), ABCG8 (33%), PCBP1 (50%), NAT8 (67%), C2orf78 (83%), CD8B (0%), RGPD1 (17%), PLGLB1 (33%), PLGLB2 (50%), RGPD2 (67%), RPIA (83%), TEKT4 (0%), FAHD2A (17%), TRIM43B (33%), TRIM43 (50%), ANKRD36C (67%), GPAT2 (83%), ANKRD36 (0%), ANKRD36B (17%), RGPD3 (33%), RGPD4 (50%), RANBP2 (67%), RGPD5 (83%), MALL (0%), MTLN (17%), LIMS4 (33%), RGPD6 (50%), ANAPC1 (67%), RGPD8 (83%), FOXD4L1 (0%), RABL2A (17%), RAB6C (33%), POTEF (50%), CCDC74B (67%), SMPD4 (83%), TUBA3E (0%), POTEI (17%), CFC1B (33%), CFC1 (50%), POTEJ (67%), PLEKHB2 (83%), RAB6D (0%), MZT2A (17%), TUBA3D (33%), CCDC74A (50%), ANKRD30BL (67%), NOSTRIN (83%), IFT70B (0%), CASP10 (17%), ALPP (33%), ALPG (50%), UGT1A6 (67%), UGT1A5 (83%), UGT1A3 (0%), MLPH (17%), OR6B2 (33%), AQP12B (50%), AQP12A (67%), ANO7 (83%), CHL1 (0%), EMC3 (17%), FANCD2 (33%), DAZL (50%), ZNF35 (67%), LZTFL1 (83%), MST1 (0%), MST1R (17%), HYAL1 (33%), FRG2C (50%), ZNF717 (67%), OR5H6 (0%), ROPN1 (17%), ROPN1B (33%), RPN1 (50%), ALG1L2 (67%), BFSP2 (83%), PRR23B (0%), SOX2 (17%), EIF2B5 (33%), KNG1 (50%), TM4SF19 (67%), ZNF595 (83%), PDE6B (0%), GAK (17%), FGFRL1 (33%), RNF212 (50%), UVSSA (67%), DOK7 (83%), HMX1 (0%), FAM90A26 (17%), USP17L10 (33%), USP17L11 (50%), USP17L12 (67%), USP17L13 (83%), USP17L17 (0%), USP17L18 (17%), USP17L19 (33%), USP17L20 (50%), USP17L21 (67%), USP17L22 (83%), USP17L24 (0%), USP17L25 (17%), USP17L26 (33%), USP17L5 (50%), USP17L27 (67%), USP17L28 (83%), USP17L30 (0%), DEFB131A (17%), DRD5 (33%), UGT2B10 (83%), UGT2B28 (0%), UGT2A1 (17%), UGT2A2 (33%), HTN3 (50%), HTN1 (67%), AFP (83%), PIGY (0%), PYURF (17%), CISD2 (33%), SLC9B1 (50%), KLHL2 (0%), GK3 (17%), HPF1 (33%), PDLIM3 (50%), FAT1 (67%), FRG1 (83%), FRG2 (0%), DUX4 (17%), SDHA (33%), PDCD6 (50%), ZDHHC11B (67%), ZDHHC11 (83%), TERT (0%), SLC6A3 (17%), TAF11L2 (33%), TAF11L3 (50%), TAF11L4 (67%), TAF11L5 (83%), TAF11L7 (0%), TAF11L8 (17%), TAF11L9 (33%), TAF11L10 (50%), TAF11L11 (67%), TAF11L12 (83%), TAF11L14 (0%), EMB (17%), MARVELD2 (33%), SERF1B (67%), NAIP (17%), SKIC3 (50%), LIX1 (67%), SAR1B (83%), DND1 (0%), PCDHA10 (17%), PCDHB7 (33%), PCDHB8 (50%), PCDHB11 (67%), PCDHB12 (83%), PPP1R2B (0%), NPM1 (17%), THOC3 (33%), SIMC1 (50%), FAM153A (67%), FAM153CP (83%), FLT4 (0%), OR4F3 (17%), DUSP22 (33%), TUBB2A (50%), H2AC13 (67%), H2AC14 (83%), OR2J1 (0%), OR2J2 (17%), HLA-G (33%), HLA-A (50%), MICA (67%), MICB (83%), ZBTB12 (17%), PBX2 (83%), HLA-DRB1 (0%), GSTA2 (17%), GSTA1 (33%), GSTA5 (50%), PRIM2 (67%), FKBP1C (83%), SLC17A5 (0%), SEC63 (17%), OR2A4 (33%), CTAGE9 (50%), PCMT1 (67%), RAET1G (83%), ULBP1 (0%), RAET1L (17%), ULBP3 (33%), SLC22A1 (50%), SMOC2 (83%), RBAK-RBAKDN (0%), RBAK (17%), SLC29A4 (33%), FSCN1 (50%), OCM (67%), CCZ1 (83%), RSPH10B2 (17%), CCZ1B (33%), NOD1 (50%), FKBP9 (67%), DPY19L1 (83%), SEPTIN7 (0%), SPDYE1 (17%), PPIA (33%), CDC14C (50%), PSPH (67%), CCT6A (83%), ZNF716 (0%), ZNF727 (17%), ZNF735 (33%), ZNF736 (50%), GUSB (67%), RABGEF1 (83%), TYW1 (0%), SPDYE21 (17%), TYW1B (33%), POM121 (50%), TRIM74 (67%), SPDYE8 (83%), SPDYE9 (0%), SPDYE10 (17%), NSUN5 (33%), TRIM50 (50%), CLIP2 (67%), GTF2IRD2 (0%), SPDYE12 (17%), CASTOR2 (33%), GTF2IRD2B (50%), SPDYE13 (67%), SPDYE14 (83%), TRIM73 (0%), POM121C (17%), SPDYE5 (33%), DTX2 (50%), UPK3B (67%), SPDYE16 (83%), SPDYE17 (0%), SPDYE18 (17%), STEAP1 (33%), ASNS (50%), OCM2 (67%), CYP3A7-CYP3A51P (83%), CYP3A4 (0%), STAG3 (17%), PVRIG (33%), SPDYE3 (50%), SAP25 (67%), ZAN (83%), MUC12 (0%), SPDYE6 (17%), POLR2J (33%), RASA4B (50%), POLR2J3 (67%), UPK3BL2 (83%), RASA4 (0%), UPK3BL1 (17%), POLR2J3-UPK3BL2 (33%), SPDYE2B (50%), POLR2J2 (67%), LAMB1 (83%), METTL2B (0%), KLF14 (17%), AKR1B10 (33%), AKR1B15 (50%), BRAF (67%), TRBV9 (83%), PRSS2 (0%), CTAGE15 (17%), TCAF2 (33%), TCAF2C (50%), CTAGE6 (67%), OR2F2 (83%), CTAGE4 (0%), OR2A42 (17%), OR2A7 (33%), CTAGE8 (50%), OR2A1 (67%), ARHGEF5 (83%), ACTR3C (0%), KMT2C (17%), ACTR3B (33%), OR4F21 (50%), FBXO25 (67%), ARHGEF10 (83%), FAM90A15 (17%), FAM90A3 (33%), FAM90A13 (50%), FAM90A5 (67%), FAM90A20 (83%), USP17L1 (0%), USP17L4 (17%), ZNF705G (33%), DEFB108C (50%), DEFB4B (67%), DEFB103B (83%), DEFB104B (0%), DEFB106B (17%), DEFB105B (33%), DEFB107B (50%), PRR23D1 (67%), FAM90A7 (83%), FAM90A23 (0%), FAM90A14 (17%), FAM90A18 (33%), FAM90A16 (50%), FAM90A8 (67%), FAM90A17 (83%), FAM90A9 (0%), FAM90A10 (17%), PRR23D2 (33%), DEFB107A (50%), DEFB105A (67%), DEFB106A (83%), SPAG11A (0%), DEFB103A (17%), DEFB4A (33%), ZNF705B (50%), USP17L8 (67%), USP17L3 (83%), FAM90A11 (0%), FAM90A24 (17%), FAM90A12 (33%), SLC35G5 (50%), DEFB130B (67%), ZNF705D (83%), USP17L2 (0%), DEFB109D (17%), FAM86B1 (33%), DEFB130A (50%), FAM86B2 (67%), RBPMS (83%), IMPA1 (0%), SLC10A5 (17%), CDH17 (33%), CYP11B1 (50%), CYP11B2 (67%), GPIHBP1 (83%), WASHC1 (0%), FOXD4 (17%), ZNG1A (33%), KCNV2 (50%), RLN2 (67%), RLN1 (83%), IFNA21 (0%), IFNA4 (17%), IFNA7 (33%), IFNA10 (50%), IFNA16 (67%), IFNA17 (83%), IFNA13 (0%), IFNA1 (17%), ANKRD18B (33%), PRSS3 (50%), GALT (67%), SPATA31F1 (83%), CNTNAP3 (0%), SPATA31A1 (17%), FOXD4L6 (33%), ZNG1F (50%), CNTNAP3B (67%), SPATA31A6 (83%), SPATA31A7 (0%), CNTNAP3C (17%), FOXD4L5 (33%), ZNG1E (50%), FOXD4L4 (67%), ZNF658 (83%), ANKRD20A1 (0%), ZNG1C (17%), FOXD4L3 (33%), PGM5 (50%), FXN (67%), TJP2 (83%), SPATA31D4 (0%), SPATA31D3 (17%), SPATA31D1 (33%), KIF27 (50%), SPATA31C1 (67%), SPATA31C2 (83%), SLC71A2 (0%), NUTM2G (17%), CTSV (33%), OR13C5 (50%), OR13C2 (67%), OR13C9 (83%), POLE3 (0%), ORM1 (17%), ORM2 (33%), SLC27A4 (50%), PKN3 (67%), ABO (0%), LCN1 (17%), OBP2A (33%), SOHLH1 (50%), INPP5E (67%), AJM1 (83%), GRIN1 (0%), TUBB8 (17%), AKR1C1 (33%), AKR1C2 (50%), DCLRE1C (67%), MRC1 (83%), ANKRD30A (0%), ZNF33A (17%), ZNF37A (33%), PLD5P1 (50%), ZNF33B (67%), BMS1 (83%), AGAP4 (0%), TIMM23 (17%), ANTXRL (33%), ANXA8L1 (50%), NPY4R (67%), GPRIN2 (83%), PTPN20 (0%), ANXA8 (17%), FAM25G (33%), AGAP9 (50%), SYT15B (67%), NPY4R2 (83%), PARG (0%), TIMM23B (17%), TIMM23B-AGAP6 (33%), AGAP6 (50%), WASHC2A (67%), ASAH2B (83%), EIF5AL1 (0%), NUTM2B (17%), NUTM2E (33%), TMEM254 (50%), PLAC9 (67%), ADIRF (83%), NUTM2A (0%), NUTM2D (17%), PAPSS2 (33%), PTEN (50%), LIPN (67%), BTRC (83%), SFR1 (0%), DHX32 (17%), FANK1 (33%), ECHS1 (50%), SPRN (67%), FRG2B (83%), SCGB1C1 (0%), IFITM3 (17%), DRD4 (33%), DEAF1 (50%), KRTAP5-2 (83%), KRTAP5-4 (0%), MRPL23 (17%), H19 (33%), SSU72L5 (50%), SSU72L2 (67%), SSU72L4 (83%), SSU72L1 (0%), OR51A4 (17%), OR51A2 (33%), HBG1 (50%), OR10A5 (67%), MRGPRX4 (83%), MDK (0%), SPI1 (17%), OR4C3 (33%), OR4C5 (50%), OR4A47 (67%), TRIM51G (83%), TRIM64C (0%), FOLH1 (17%), OR4C13 (33%), OR4C12 (50%), OR4C45 (67%), OR4C46 (83%), OR4A5 (0%), TRIM48 (17%), OR4A15 (33%), TRIM51 (50%), OR5F1 (67%), OR8H2 (83%), OR5M8 (0%), OR9G1 (17%), OR1S2 (33%), OR1S1 (50%), GLYATL1B (67%), PGA3 (83%), B3GAT3 (0%), ESRRA (17%), SLC22A12 (33%), RBM4B (50%), TPCN2 (67%), FGF3 (83%), KRTAP5-8 (0%), KRTAP5-10 (17%), KRTAP5-11 (33%), XNDC1N-ZNF705EP-ALG1L9P (50%), DEFB108B (67%), XNDC1N (83%), INTS4 (0%), NOX4 (17%), TRIM77 (33%), TRIM49 (50%), TRIM64B (67%), TRIM49D1 (83%), TRIM64 (0%), TRIM49C (17%), UBTFL1 (33%), CARD16 (50%), HSPA8 (67%), OR8B2 (83%), TMEM45B (0%), CD4 (17%), PEX5 (33%), APOBEC1 (50%), GDF3 (67%), NANOG (83%), FAM90A1 (0%), PRH1 (33%), PRR4 (50%), PRH2 (67%), TAS2R14 (83%), TAS2R31 (0%), TAS2R46 (17%), TAS2R43 (33%), TAS2R30 (50%), PRB4 (67%), PRB1 (83%), DDX11 (0%), H3-5 (17%), ALG10 (33%), ALG10B (50%), TUBA1B (67%), COX14 (83%), NACA (50%), DPY19L2 (67%), HNF1A (83%), HPD (0%), HCAR2 (17%), HCAR3 (33%), P2RX2 (50%), PGAM5 (67%), GOLGA3 (83%), C1QTNF9B (0%), C1QTNF9 (17%), PARP4 (33%), PABPC3 (50%), MRPS31 (67%), HNRNPA1L2 (83%), PRR20C (0%), PRR20B (17%), PRR20D (33%), PRR20E (50%), F7 (67%), PROZ (83%), POTEM (0%), POTEG (17%), OR11H2 (33%), OR4N2 (50%), OR4Q3 (67%), OR4M1 (83%), RNASE3 (0%), RNASE2 (17%), OR10G2 (33%), DHRS4 (50%), DHRS4L2 (67%), ARF6 (83%), ACOT2 (0%), NDUFB1 (17%), JAG2 (33%), BTBD6 (50%), IGHV3-21 (67%), GOLGA6L6 (83%), POTEB3 (0%), LINC02203 (17%), OR4M2B (33%), OR4N4C (50%), POTEB (67%), OR4M2-OT1 (83%), OR4N4 (0%), GOLGA6L22 (17%), GOLGA6L1 (33%), GOLGA6L26 (50%), GOLGA8S (67%), GOLGA6L2 (83%), HERC2 (0%), GOLGA6L24 (17%), GOLGA8F (33%), GOLGA8G (50%), GOLGA6L25 (67%), GOLGA8M (83%), GOLGA8J (0%), GOLGA8T (17%), GOLGA8R (50%), GOLGA8Q (67%), GOLGA8H (83%), GOLGA8O (0%), GOLGA8N (17%), GOLGA8A (33%), GOLGA8B (50%), NANOGP8 (67%), NDUFAF1 (83%), CKMT1B (0%), CATSPER2 (33%), CKMT1A (50%), TERB2 (67%), LDHAL6B (0%), GOLGA6B (17%), GOLGA6A (33%), ISLR2 (50%), GOLGA6C (67%), GOLGA6D (83%), ADAMTS7 (0%), EFL1 (17%), SAXO2 (33%), GOLGA6L10 (50%), GOLGA6L9 (67%), WHAMM (83%), OR4F4 (0%), MPG (17%), HBM (33%), AXIN1 (83%), SSTR5 (0%), TPSD1 (50%), GNPTG (67%), UNKL (83%), PKD1 (0%), PDPK1 (17%), EEF2KMT (33%), NPIPA3 (50%), NPIPA2 (67%), NOMO1 (83%), PDXDC1 (0%), RRN3 (17%), NPIPA5 (33%), MPV17L (50%), NOMO3 (67%), NPIPA6 (83%), NPIPA8 (0%), NPIPA9 (17%), NOMO2 (33%), SMG1 (50%), IQCK (67%), ACSM5 (83%), ACSM2B (0%), NPIPB3 (17%), NPIPB4 (50%), NPIPB5 (67%), NPIPB6 (83%), NPIPB7 (0%), SULT1A2 (17%), NPIPB8 (50%), EIF3C (67%), NPIPB9 (83%), NPIPB11 (0%), BOLA2-SMG1P6 (17%), BOLA2 (33%), SLX1B (50%), SULT1A4 (67%), NPIPB12 (83%), SLX1A (0%), SULT1A3 (17%), NPIPB13 (33%), PHKG2 (50%), VKORC1 (67%), KRABD5 (83%), TP53TG3 (0%), TP53TG3C (17%), TP53TG3E (33%), TP53TG3B (50%), TP53TG3F (67%), CCNYL1B (83%), CES1 (0%), MT1M (17%), MATCAP1 (33%), HSD11B2 (50%), CLEC18A (67%), PDPR (83%), EXOSC6 (0%), HPR (50%), NPIPB15 (67%), CLEC18B (83%), CA5A (0%), ZNF469 (17%), CDH15 (33%), ANKRD11 (50%), MC1R (67%), PRDM7 (83%), ABR (0%), SERPINF2 (17%), SRR (33%), OR1D5 (50%), P2RX5 (67%), ALOX15 (83%), ENO3 (0%), USP6 (17%), SLC35G6 (33%), ALOXE3 (50%), HES7 (67%), CDRT15 (83%), FBXW10B (0%), TRIM16 (17%), ZNF286A-TBC1D26 (33%), ZNF286A (50%), TBC1D26 (67%), UBB (83%), ATPAF2 (0%), EVPLL (17%), LGALS9C (33%), TBC1D28 (50%), FOXO3B (67%), FBXW10 (83%), GRAP (0%), GRAPL (17%), LGALS9B (33%), CDRT15L2 (50%), MEIS3P2 (67%), MAP2K3 (83%), KCNJ18 (0%), LGALS9 (17%), FOXN1 (33%), SUZ12 (50%), LRRC37B (67%), SLC35G3 (83%), CCL4 (0%), TBC1D3B (17%), CCL4L2 (50%), TBC1D3I (67%), TBC1D3G (83%), TBC1D3F (0%), TBC1D3K (17%), TBC1D3L (33%), TBC1D3D (50%), TBC1D3C (67%), TBC1D3E (83%), MRPL45 (0%), KRTAP1-1 (17%), KRTAP4-7 (33%), KRTAP4-8 (50%), KRTAP4-16 (67%), KRTAP4-9 (83%), KRTAP4-12 (0%), KRTAP9-7 (17%), KRT14 (33%), KRT16 (50%), KRT17 (67%), HSD17B1 (83%), G6PC3 (0%), ARHGAP27 (17%), PLEKHM1 (33%), ARL17B (50%), LRRC37A (67%), ARL17A (83%), NSF (0%), NPEPPS (17%), HOXB8 (33%), GIP (50%), DHX40 (67%), RPS6KB1 (83%), METTL2A (0%), TLK2 (17%), CSH2 (33%), GH2 (50%), CSH1 (67%), CSHL1 (83%), LRRC37A3 (0%), C17orf58 (17%), AMZ2 (33%), TMC6 (50%), CANT1 (67%), RNF213 (83%), ARL16 (0%), TUBB8B (17%), TYMS (33%), SLC35G4 (50%), POTEC (67%), ANKRD30B (83%), SLC25A52 (0%), KATNAL2 (17%), SERPINB4 (33%), SERPINB3 (50%), GALR1 (67%), CTDP1 (83%), BSG (0%), HCN2 (17%), KISS1R (33%), STK11 (50%), TCF3 (67%), ABHD17A (83%), GIPC3 (0%), TBXA2R (17%), CREB3L3 (33%), RFX2 (50%), C3 (67%), MBD3L2B (83%), MBD3L4 (0%), MBD3L2 (17%), STXBP2 (33%), TYK2 (50%), ZNF799 (67%), ZNF443 (83%), CYP4F3 (0%), CYP4F12 (17%), OR10H2 (33%), CALR3 (50%), MYO9B (67%), INSL3 (83%), ZNF738 (0%), ZNF100 (17%), ZNF208 (33%), ZNF676 (50%), ZNF729 (67%), ZNF492 (83%), ZNF728 (0%), RHPN2 (17%), GPI (33%), ZNF302 (50%), ZNF181 (67%), FFAR3 (83%), COX6B1 (0%), LGALS7 (17%), LGALS7B (33%), IFNL3 (50%), IFNL4 (67%), IFNL2 (83%), CYP2A7 (17%), CYP2G1P (33%), CYP2A13 (67%), CYP2F1 (83%), PSG8 (0%), PSG1 (17%), PSG6 (33%), PSG7 (50%), PSG11 (67%), PSG2 (83%), PSG4 (0%), PSG9 (17%), ETHE1 (50%), ZNF285 (67%), APOC1 (83%), APOC4 (0%), BLOC1S3 (17%), DMPK (33%), FUT1 (50%), BAX (67%), LHB (83%), CGB3 (0%), CGB2 (17%), CGB1 (33%), CGB5 (50%), CGB8 (67%), CGB7 (83%), PNKP (0%), SIGLEC16 (17%), KLK4 (33%), ETFB (50%), ZNF808 (67%), ZNF600 (83%), ZNF468 (0%), VN1R4 (17%), FAM90A27P (33%), ZNF765 (50%), ZNF761 (67%), ZNF813 (83%), PRKCG (0%), MBOAT7 (17%), LILRA6 (33%), LILRB2 (50%), LAIR1 (67%), LAIR2 (83%), LILRB1 (0%), KIR3DL3 (17%), KIR2DL3 (33%), KIR2DL1 (50%), KIR2DL4 (67%), KIR3DL1 (83%), KIR3DL2 (0%), NLRP7 (17%), NLRP2 (33%), GP6 (50%), TNNT1 (67%), TNNI3 (83%), RFPL4A (0%), RFPL4AL1 (17%), ZNF419 (33%), ZNF773 (50%), ZNF587B (67%), ZNF814 (83%), ZNF417 (0%), SLC27A5 (17%), SIRPB1 (33%), CST4 (50%), CST1 (67%), CST2 (83%), PLAGL2 (0%), SEMG1 (17%), PLTP (33%), CHRNA4 (50%), EEF1A2 (67%), PTK6 (83%), MYT1 (0%), PCMTD2 (17%), TPTE (33%), POTED (50%), KRTAP21-1 (67%), SMIM11 (83%), SMIM34 (0%), KCNE1 (17%), CBR3 (33%), NDUFV3 (50%), CBS (67%), U2AF1 (83%), SIK1 (0%), HSF2BP (17%), H2BC12L (33%), TRAPPC10 (50%), PWP2 (67%), GATD3 (83%), DNMT3L (0%), KRTAP10-1 (17%), KRTAP10-2 (33%), KRTAP10-4 (50%), KRTAP10-5 (67%), KRTAP10-6 (83%), KRTAP10-8 (0%), KRTAP10-9 (17%), KRTAP10-10 (33%), KRTAP12-2 (50%), KRTAP12-1 (67%), COL18A1 (83%), OR11H1 (0%), POTEH (17%), CCT8L2 (33%), USP18 (50%), GGTLC3 (67%), TMEM191B (83%), FAM246B (0%), DGCR6 (17%), PRODH (33%), FAM246C (50%), CCDC188 (67%), RTN4R (83%), TUBA3FP (0%), LRRC74B (17%), FAM246A (33%), RIMBP3B (50%), HIC2 (67%), TMEM191C (83%), GGTLC2 (0%), IGLL1 (17%), DRICH1 (33%), GSTT2B (50%), DDTL (67%), GSTT2 (83%), RFPL1 (0%), C22orf42 (17%), RFPL3 (33%), APOBEC3D (83%), APOBEC3H (0%), ATF4 (17%), NDUFA6 (33%), CYP2D7 (67%), RRP7A (83%), CYB5R3 (0%), A4GALT (17%), TTLL1 (33%), MLC1 (50%), TUBGCP6 (67%), ACR (83%), XG (0%), GYG2 (17%), ARSD (33%), MXRA5 (50%), PRKX (67%), VCX3A (83%), VCX2 (0%), VCX3B (17%), FAM9A (33%), FAM9C (50%), SUPT20HL2 (67%), SUPT20HL1 (83%), MAGEB6 (0%), DCAF8L1 (17%), FAM47B (33%), H2AL1Q (50%), FAM47C (67%), H2AL3 (83%), SPACA5B (0%), SSX5 (17%), SSX1 (33%), SSX3 (50%), SSX4 (67%), SSX4B (83%), GAGE12J (0%), GAGE13 (17%), GAGE2E (33%), GAGE12B (50%), GAGE12C (67%), GAGE12D (83%), GAGE12F (0%), GAGE12G (17%), GAGE12H (33%), GAGE2A (50%), GAGE1 (67%), CENPVL3 (83%), CENPVL1 (0%), MAGED4B (17%), MAGED4 (33%), XAGE1A (50%), XAGE1B (67%), SSX7 (83%), SSX2B (0%), SPANXN5 (17%), XAGE5 (33%), XAGE3 (50%), FAM156B (67%), FAM156A (83%), SPIN2B (0%), SPIN2A (17%), ZXDA (33%), CXorf49 (50%), CXorf49B (67%), DMRTC1B (83%), FAM236D (0%), DMRTC1 (17%), FAM236C (33%), FAM236A (50%), PABPC1L2B (67%), PABPC1L2A (83%), TGIF2LX (0%), PCDH11X (17%), TCEAL6 (33%), TCP11X1 (50%), NXF2 (67%), NXF2B (83%), RAB40AL (0%), TMSB15B (17%), H2BW1 (33%), H2BW2 (50%), TMSB15C (67%), PSMD10 (83%), CT47C1 (0%), RHOXF2B (17%), RHOXF2 (33%), CT47B1 (50%), CT47A12 (67%), CT47A11 (83%), CT47A9 (0%), CT47A8 (17%), CT47A7 (33%), CT47A6 (50%), CT47A5 (67%), CT47A4 (83%), CT47A2 (0%), CT47A1 (17%), RTL8B (33%), RTL8C (50%), RTL8A (67%), SMIM10L2B (83%), CT55 (0%), ETDA (17%), SMIM10L2A (33%), CT45A1 (50%), CT45A3 (67%), CT45A5 (83%), CT45A2 (0%), CT45A7 (17%), CT45A8 (33%), CT45A9 (50%), CT45A10 (67%), SAGE1 (83%), SPANXC (0%), SPANXA1 (17%), SPANXA2 (33%), SPANXD (50%), MAGEC1 (67%), SPANXN3 (83%), UBE2NL (0%), SPANXN1 (17%), CXorf51B (33%), CXorf51A (50%), EOLA1 (67%), HSFX3 (83%), HSFX2 (0%), HSFX1 (17%), MAGEA9 (33%), EOLA2 (50%), HSFX4 (67%), MAGEA3 (83%), MAGEA2B (0%), CSAG1 (17%), MAGEA12 (33%), MAGEA2 (50%), CSAG3 (67%), MAGEA6 (83%), PWWP4 (0%), SLC6A8 (17%), BCAP31 (33%), OPN1LW (50%), OPN1MW (67%), OPN1MW2 (83%), TEX28 (0%), CTAG1A (17%), CTAG1B (33%), CTAG2 (50%), H2AB1 (67%), F8A1 (83%), F8A2 (0%), F8A3 (17%), H2AB3 (33%), IL9R (50%), WASH6P (67%), TGIF2LY (not on this reference), PCDH11Y (not on this reference), TSPY2 (not on this reference), TSPY4 (not on this reference), TSPY8 (not on this reference), TSPY3 (not on this reference), TSPY1 (not on this reference), TSPY9 (not on this reference), TSPY10 (not on this reference), VCY (not on this reference), VCY1B (not on this reference), CDY2B (not on this reference), CDY2A (not on this reference), HSFY1 (not on this reference), HSFY2 (not on this reference), RBMY1B (not on this reference), RBMY1A1 (not on this reference), RBMY1D (not on this reference), RBMY1E (not on this reference), RBMY1F (not on this reference), RBMY1J (not on this reference), BPY2 (not on this reference), DAZ1 (not on this reference), DAZ2 (not on this reference), CDY1B (not on this reference), BPY2B (not on this reference), DAZ3 (not on this reference), DAZ4 (not on this reference), BPY2C (not on this reference), CDY1 (not on this reference), C4B_2 (not on this reference), GSTT1 (not on this reference), GSTTP2 (not on this reference), GTF2H2C_2 (not on this reference), HLA-DRB3 (not on this reference), HLA-DRB4 (not on this reference), KIR2DL2 (not on this reference), KIR2DL5A (not on this reference), KIR2DL5B (not on this reference), KIR2DS1 (not on this reference), KIR2DS2 (not on this reference), KIR2DS3 (not on this reference), KIR2DS5 (not on this reference), KIR3DS1 (not on this reference), LILRA3 (not on this reference), OR8U8 (not on this reference), OR8U9 (not on this reference), OR9G9 (not on this reference), TAS2R45 (not on this reference)

    +

    Not read here, called by a step of their own (54): RHCE (0%) by parascopy, AMY1A (17%) by parascopy, AMY1B (33%) by parascopy, AMY1C (50%) by parascopy, GSTM1 (0%) by pypgx, NOTCH2 (67%) by parascopy, FCGR1A (50%) by parascopy, GBA1 (17%) by parascopy, FCGR2A (67%) by parascopy, FCGR2C (0%) by parascopy, FCGR3B (17%) by parascopy, CFHR3 (17%) by parascopy, CFHR1 (33%) by parascopy, PROS1 (83%) by parascopy, UGT2B17 (50%) by pypgx, UGT2B15 (67%) by pypgx, GYPE (67%) by parascopy, GYPB (83%) by parascopy, GTF2H2C (50%) by parascopy, SMN2 (83%) by parascopy, SMN1 (0%) by parascopy, GTF2H2 (33%) by parascopy, HSPA1B (0%) by parascopy, C4A (33%) by parascopy, C4B (50%) by parascopy, CYP21A2 (67%) by cn_loci:CYP21A2, LPA (67%) by cn_loci:LPA_KIV2, PMS2 (0%) by parascopy, GTF2I (83%) by parascopy, DEFA1B (0%) by parascopy, CEL (83%) by parascopy, MUC5B (67%) by parascopy, KLRC2 (17%) by parascopy, KRT6B (0%) by parascopy, KRT6C (17%) by parascopy, KRT6A (33%) by parascopy, CHRFAM7A (33%) by parascopy, STRC (17%) by parascopy, SORD (83%) by parascopy, HBA2 (50%) by cn_loci:HBA, HBA1 (67%) by cn_loci:HBA, TPSB2 (17%) by parascopy, TPSAB1 (33%) by parascopy, OTOA (33%) by parascopy, SULT1A1 (33%) by pypgx, HYDIN (17%) by parascopy, HP (33%) by cn_loci:HP, CCL3L3 (33%) by cn_loci:CCL3L1, CYP2A6 (0%) by pypgx, CYP2B6 (50%) by pypgx, CD177 (33%) by parascopy, APOBEC3A (50%) by parascopy, APOBEC3B (67%) by parascopy, CYP2D6 (50%) by pypgx

    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    ClinVar file dateunknown
    +

    gnomAD AF: unknown for every hit (no VEP output (step 13) in this folder)

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualityViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF unknownlow-confidence call (GQ 15, DP 30): check the readschr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownchr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF unknownchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF unknownlow-confidence call (GQ 40, DP 5): check the readschr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownchr3:15645186
    chr2100AGhet...0gnomAD AF unknownchr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownchrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants6
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenicchr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 0

    +

    P/LP rows below the depth floor (DP below 8): 0

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searched.
    +
    Ranked genesnone passed Exomiser's filters
    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called0 (none)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFARcallable30seen
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Failed · link to this section

    +
    could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/str_intermediate_ranges.tsv'
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnot assessed
    +

    Result: not assessed

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    .

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    chrM variants (PASS)1
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts0
    +

    ClinVar and gnomAD: not annotated (mito/S_chrM_annotated.tsv is older than the chrM calls: rerun step 20)

    +
    Confirmed disease variants1
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    Large deletions: not looked for (no deletion table (mito/<id>_chrM_deletions.tsv): step 20 ran before it looked for large deletions, eKLIPse wrote no table (see the step's log), or the Nextflow MITO_DELETIONS task failed (see the Nextflow log))

    +

    mtDNA copy number: not counted (no copy-number table (mito/<id>_mtdna_copies.tsv): step 20 ran before it counted mtDNA copies, or the Nextflow MITO_DELETIONS task failed (see the Nextflow log))

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +

    KIV-2 repeats: too little depth

    +

    .

    +

    KIV-2 4925G>A null allele (rs1484919544): not assessed

    +

    LPA KIV-2 4925G>A: not assessed, step 46 wrote no S_lpa_kiv2_4925.tsv (a run from before this reader, or the check did not run).

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: . (not read)

    +

    Not determined: neither the KIV-2 count nor the two risk variants could be read. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls0
    +

    No CHIP call.

    +

    No CHIP gene has the depth to find a clone: no result either way.

    +

    Too shallow or not on the reference: DNMT3A.

    +

    0 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    StatusNot assessed
    +

    too shallow

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hom, ClinVar Pathogenic: two changed copies, not the pattern of a carrier

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); not read: step 35's HBA1/HBA2 count: not assessed: S_hba_copy_number.tsv has no status row; Parascopy's SMN1 count: not resolved

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN1xcalled.
    +
    SMN1 by both toolsParaphase no call, Parascopy no row covers SMN1 exon 7: no comparison: one of them has no call
    +
    Variants on phased haplotypes0
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copiesno row covers exon 7
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copiesno row covers exon 7
    +
    SMN1 and SMN2 together (agCN) at exon 7. (quality ., filter .)
    +
    ReadingSMN1 and SMN2 not assessed: no model: no carrier reading
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)not assessed: S_hba_copy_number.tsv has no status row
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:07 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Stale · file date 2019-06-01 12:30 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    STALE: from an earlier run (2019-06-01 12:30 UTC); step 27 was not run in the run of 2020-01-01 00:00 UTC
    +
    StatusStale
    +
    Genes with a non-normal phenotype0
    +
    Genes with more than one possible result0
    +
    Genes not called1
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    CPIC drug-gene recommendations: STALE: from an earlier run (2019-06-01 12:30 UTC); step 27 was not run in the run of 2020-01-01 00:00 UTC
    +
    PharmCAT (step 36's call)not called
    +
    pypgx*1/*2
    +
    Cyrius*1/*2 (not usable: Filter LowQ)
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    Probable (one caller: pypgx)*1/*2, Normal Metabolizer; not passed to PharmCAT, so no drug guidance rests on it
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Failed · link to this section

    +
    could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/hla_alleles.tsv'
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Stale · file date 2019-06-01 12:30 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    STALE: from an earlier run (2019-06-01 12:30 UTC); step 53 was skipped in the run of 2020-01-01 00:00 UTC
    +
    Loci called3 of 3 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passT1K (step 08) did not run
    HLA-DQB1h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passT1K (step 08) did not run
    CYP2D6h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passpypgx (step 32): *1/*2; Cyrius (step 21): *1/*2 (not usable: Filter LowQ)
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Stale · file date 2019-06-01 12:30 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    STALE: from an earlier run (2019-06-01 12:30 UTC); step 12 was skipped in the run of 2020-01-01 00:00 UTC
    +
    StatusStale
    +
    HaplogroupU5a
    +
    Contamination (haplocheck)not checked (needs step 20's Mutect2 chrM calls)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/U5a (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/U5a/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +
    Haplogroupinsufficient markers
    +
    Markers.
    +
    QC-score.
    +
    +
    +

    Y Placement on the Current Public Tree

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    Branchno branch has a derived call
    +
    Level.
    +
    Tree.
    +

    Path SNPs: . derived, . ancestral, . no call; . SNPs called at depth . or more

    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2019-06-01 12:30 UTC · link to this section

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    StatusComplete
    +
    ROH total7.0 MB
    +
    ROH largest segment7.0 MB
    +
    Segments1
    +
    Autosomal ROH > 5 MB1
    +

    chr2:10000001-17000000 7.0MB

    +

    F_ROH: 0.0294 (7.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele0 / 1 / 0
    + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    .no reads
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores (raw, not percentiles)

    +

    Step 25 · Stale · file date 2019-06-01 12:30 UTC · link to this section

    +
    STALE: from an earlier run (2019-06-01 12:30 UTC); step 25 was failed (exit 2) in the run of 2020-01-01 00:00 UTC
    + + + +
    ConditionPGSScoreVariants matchedPercentile
    XPGS1/raw score only
    +

    Raw score only: no ancestry reference panel was installed, so there is no percentile and the sum cannot be compared with anyone (scripts/setup.sh --ancestry-panel adds it). Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content334
    +

    Intratelomeric reads: 61,873; depth unknown (no total_reads or read_lengths in the summary): not checked

    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6not assessed (no human depth)
    +

    No read on any viral genome.

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Delly)
    • +
    • Y-STR markers (HipSTR)
    • +
    • Blood groups (predicted)
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • HBA1/HBA2 copy number (alpha-thalassaemia deletions): neither step 35's read-depth count (short reads) nor step 35b (Paraphase, PacBio HiFi) made a call
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +